Citrus Sinensis ID: 022003
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 304 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFP7 | 493 | Probable receptor-like pr | yes | no | 0.957 | 0.590 | 0.822 | 1e-143 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.970 | 0.602 | 0.795 | 1e-137 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.851 | 0.631 | 0.704 | 1e-102 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.759 | 0.566 | 0.699 | 3e-95 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.769 | 0.570 | 0.684 | 2e-93 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.776 | 0.572 | 0.679 | 1e-92 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.855 | 0.668 | 0.613 | 3e-90 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.930 | 0.664 | 0.552 | 6e-88 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.769 | 0.549 | 0.639 | 2e-85 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.766 | 0.598 | 0.621 | 7e-84 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 508 bits (1309), Expect = e-143, Method: Compositional matrix adjust.
Identities = 250/304 (82%), Positives = 268/304 (88%), Gaps = 13/304 (4%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AE+NFLG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA
Sbjct: 194 LAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 253
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGL+FLHEEA +PVIYRDFKTSNILLDADYNAKLSDFGLAKD P+ KTHVSTRVM
Sbjct: 254 LGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVM 313
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL +
Sbjct: 314 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLD 373
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
+RRFYRL+DPRLEGHFSIKGAQK QLAA CLSRDPK RP MS+VVEALKPLP+LKDMAS
Sbjct: 374 KRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMAS 433
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ-----RSLSIPNGSYASPYHHQFPH 295
SSYYFQTMQAER+ +NG G SRNGQ R+LS P+GS SPY HQ P
Sbjct: 434 SSYYFQTMQAERL------KNGSGRSQGFGSRNGQHQPVFRTLSSPHGS--SPYRHQIPS 485
Query: 296 PSPK 299
P PK
Sbjct: 486 PKPK 489
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1258), Expect = e-137, Method: Compositional matrix adjust.
Identities = 241/303 (79%), Positives = 265/303 (87%), Gaps = 8/303 (2%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AE+N+LG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA
Sbjct: 188 LAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 247
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGL+FLHEEA +PVIYRDFKTSNILLD +YNAKLSDFGLAKD P+ KTHVSTRVM
Sbjct: 248 LGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVM 307
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL +
Sbjct: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLD 367
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
+RRFYRL+DPRLEGHFS+KGAQK QLAA CLSRD K RP MSEVVE LKPLP+LKDMAS
Sbjct: 368 KRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDMAS 427
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ---RSLSIPNGSY-ASPYHHQFPHP 296
+SYYFQTMQAER+ + + +G SRNGQ R+LS P+G +SPY HQ P P
Sbjct: 428 ASYYFQTMQAERLKAGSGSGSGRGFG----SRNGQPVFRTLSSPHGQAGSSPYRHQIPSP 483
Query: 297 SPK 299
PK
Sbjct: 484 KPK 486
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (951), Expect = e-102, Method: Compositional matrix adjust.
Identities = 184/261 (70%), Positives = 210/261 (80%), Gaps = 2/261 (0%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKI 59
+ EVNFLG L H NLVKLIGYC EDD RLLVYEFM RGSLENHLFR++ PL WS RM I
Sbjct: 118 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMMI 177
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
ALGAAKGLAFLH AERPVIYRDFKTSNILLD+DY AKLSDFGLAK GP+GD+THVSTRV
Sbjct: 178 ALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 236
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
MGTYGYAAPEYVMTGHLT+RSDVYSFGVVLLEMLTGR+S+DK RP+ E NLV+WARP L
Sbjct: 237 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLN 296
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 239
++R+ ++IDPRLE +S++ AQKA LA +CLS++PKARPLMS+VVE L+PL D
Sbjct: 297 DKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGDAL 356
Query: 240 SSSYYFQTMQAERIGSSPNTR 260
A +G P+ R
Sbjct: 357 IPCATTTAGAAFAMGGVPDYR 377
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (892), Expect = 3e-95, Method: Compositional matrix adjust.
Identities = 163/233 (69%), Positives = 198/233 (84%), Gaps = 2/233 (0%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKI 59
+AEV FLG L H NLVKLIGYC ED+ R+L+YE+M RGS+EN+LF R L PL W+IRMKI
Sbjct: 128 LAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLSWAIRMKI 187
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A GAAKGLAFLHE A++PVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDK+HVSTR+
Sbjct: 188 AFGAAKGLAFLHE-AKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTRI 246
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
MGTYGYAAPEY+MTGHLT SDVYSFGVVLLE+LTGR+S+DK+RP E NL++WA P L
Sbjct: 247 MGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLLK 306
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
E+++ ++DP++ + +K QKAA LA HCL+R+PKARPLM ++V++L+PL
Sbjct: 307 EKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPL 359
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (876), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 163/238 (68%), Positives = 199/238 (83%), Gaps = 4/238 (1%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---PLPWSIRM 57
+AEVN+LG H +LVKLIGYC+ED+ RLLVYEFMPRGSLENHLFRR L PL W +R+
Sbjct: 120 LAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRL 179
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
K+ALGAAKGLAFLH R VIYRDFKTSNILLD++YNAKLSDFGLAKDGP GDK+HVST
Sbjct: 180 KVALGAAKGLAFLHSSETR-VIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVST 238
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
RVMGT+GYAAPEY+ TGHLT++SDVYSFGVVLLE+L+GRR++DKNRP+GE NLVEWA+P+
Sbjct: 239 RVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPY 298
Query: 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 235
L +R+ +R+ID RL+ +S++ A K A L+ CL+ + K RP MSEVV L+ + +L
Sbjct: 299 LVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQSL 356
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 340 bits (871), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 163/240 (67%), Positives = 197/240 (82%), Gaps = 4/240 (1%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRM 57
+AEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLENHLFRR PL W++R+
Sbjct: 121 LAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRL 180
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
K+ALGAAKGLAFLH AE VIYRDFKTSNILLD++YNAKLSDFGLAKDGP GDK+HVST
Sbjct: 181 KVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVST 239
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
R+MGTYGYAAPEY+ TGHLT++SDVYS+GVVLLE+L+GRR++DKNRP GE LVEWARP
Sbjct: 240 RIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPL 299
Query: 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 237
L +R+ +R+ID RL+ +S++ A K A LA CL+ + K RP M+EVV L+ + L +
Sbjct: 300 LANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLNE 359
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 332 bits (850), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 162/264 (61%), Positives = 203/264 (76%), Gaps = 4/264 (1%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---PLPWSIRM 57
+AE+N+LG L H NLVKLIGYC+E++ RLLVYEFM RGSLENHLFRR PL W+ R+
Sbjct: 120 LAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRV 179
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
++ALGAA+GLAFLH A+ VIYRDFK SNILLD++YNAKLSDFGLA+DGP GD +HVST
Sbjct: 180 RMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVST 238
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
RVMGT GYAAPEY+ TGHL+ +SDVYSFGVVLLE+L+GRR++DKN+P GEHNLV+WARP+
Sbjct: 239 RVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPY 298
Query: 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 237
L +RR R++DPRL+G +S+ A K A LA C+S D K+RP M+E+V+ ++ L K+
Sbjct: 299 LTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKE 358
Query: 238 MASSSYYFQTMQAERIGSSPNTRN 261
+ Q I SP N
Sbjct: 359 ASKEQQNPQISIDNIINKSPQAVN 382
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (830), Expect = 6e-88, Method: Compositional matrix adjust.
Identities = 167/302 (55%), Positives = 211/302 (69%), Gaps = 19/302 (6%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKI 59
+ EVN+LG L H NLVKL+GYC+E + RLLVYEFMP+GSLENHLFRR + PL W+IRMK+
Sbjct: 135 LTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKV 194
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A+GAAKGL FLH+ A+ VIYRDFK +NILLDA++N+KLSDFGLAK GP GDKTHVST+V
Sbjct: 195 AIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQV 253
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
MGT+GYAAPEYV TG LT++SDVYSFGVVLLE+L+GRR++DK++ E +LV+WA P+LG
Sbjct: 254 MGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPYLG 313
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 239
++R+ +R++D RL G + KGA AA LA CL+ D K RP MSEV+ L L + K
Sbjct: 314 DKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTK--- 370
Query: 240 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASPYHHQFPHPSPK 299
+G+ + R GS+ + R SY P H P SP
Sbjct: 371 ---------PGTGVGNRQAQIDSPRGSNGSIVQKSPRRY-----SYDRPLLHITPGASPL 416
Query: 300 PN 301
P
Sbjct: 417 PT 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (808), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 151/236 (63%), Positives = 190/236 (80%), Gaps = 2/236 (0%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKI 59
+ EVN+LG L H NLV L+GYC E + RLLVYEFMP+GSLENHLFRR + PL W+IRMK+
Sbjct: 138 LTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKV 197
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A+GAAKGL FLHE A+ VIYRDFK +NILLDAD+NAKLSDFGLAK GP GD THVST+V
Sbjct: 198 AVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKV 256
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+GT+GYAAPEYV TG LT++SDVYSFGVVLLE+++GRR+MD + E++LV+WA P+LG
Sbjct: 257 IGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDWATPYLG 316
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 235
++R+ +R++D +L G + KGA AA LA CL+ D K RP MSEV+ L+ L ++
Sbjct: 317 DKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLESV 372
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 7e-84, Method: Compositional matrix adjust.
Identities = 148/238 (62%), Positives = 186/238 (78%), Gaps = 5/238 (2%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF----RRSLPLPWSIR 56
+ E+N+LG L H NLVKLIGYC+ED+QRLLVYEFM +GSLENHLF + PL W +R
Sbjct: 113 LTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKDFKPLSWILR 172
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
+K+AL AAKGLAFLH + + VIYRD K SNILLD+D+NAKLSDFGLA+DGP G++++VS
Sbjct: 173 IKVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDSDFNAKLSDFGLARDGPMGEQSYVS 231
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 176
TRVMGT+GYAAPEYV TGHL +RSDVYSFGVVLLE+L GR+++D NRP E NLV+WARP
Sbjct: 232 TRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKEQNLVDWARP 291
Query: 177 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 234
+L RR+ ++D RL + +GA + A +A CLS +PK+RP M +VV AL L +
Sbjct: 292 YLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALVQLQD 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 304 | ||||||
| 359473277 | 481 | PREDICTED: probable receptor-like protei | 1.0 | 0.632 | 0.931 | 1e-167 | |
| 147857978 | 495 | hypothetical protein VITISV_008843 [Viti | 1.0 | 0.614 | 0.931 | 1e-167 | |
| 224100451 | 445 | predicted protein [Populus trichocarpa] | 0.990 | 0.676 | 0.937 | 1e-167 | |
| 356498172 | 491 | PREDICTED: probable receptor-like protei | 0.993 | 0.615 | 0.927 | 1e-166 | |
| 351722951 | 485 | serine/threonine protein kinase-like pro | 0.993 | 0.622 | 0.927 | 1e-166 | |
| 356567562 | 487 | PREDICTED: probable receptor-like protei | 0.993 | 0.620 | 0.931 | 1e-165 | |
| 53689728 | 603 | serine/threonine protein kinase-like [So | 0.990 | 0.499 | 0.924 | 1e-165 | |
| 224100247 | 478 | predicted protein [Populus trichocarpa] | 1.0 | 0.635 | 0.908 | 1e-164 | |
| 356526888 | 487 | PREDICTED: probable receptor-like protei | 0.993 | 0.620 | 0.924 | 1e-164 | |
| 255558222 | 495 | Protein kinase APK1B, chloroplast precur | 0.993 | 0.610 | 0.921 | 1e-163 |
| >gi|359473277|ref|XP_003631281.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] gi|296086431|emb|CBI32020.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1533), Expect = e-167, Method: Compositional matrix adjust.
Identities = 287/308 (93%), Positives = 297/308 (96%), Gaps = 4/308 (1%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AEVNFLGDL+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW+IRMKIA
Sbjct: 174 LAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPWAIRMKIA 233
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVSTRVM
Sbjct: 234 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRVM 293
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE
Sbjct: 294 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 353
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK RPLMSEVVEALKPLPNLKDMAS
Sbjct: 354 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPLPNLKDMAS 413
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG---QRSLSIPNGSYASPYH-HQFPHP 296
SSYYFQTMQAERIGSSPN RNG+R Q G LSRNG QRSLSIPNGS+ASPYH +Q+P+
Sbjct: 414 SSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPYHQNQYPYQ 473
Query: 297 SPKPNGKP 304
SPKPNGKP
Sbjct: 474 SPKPNGKP 481
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147857978|emb|CAN82516.1| hypothetical protein VITISV_008843 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1528), Expect = e-167, Method: Compositional matrix adjust.
Identities = 287/308 (93%), Positives = 297/308 (96%), Gaps = 4/308 (1%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AEVNFLGDL+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW+IRMKIA
Sbjct: 188 LAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPWAIRMKIA 247
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVSTRVM
Sbjct: 248 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRVM 307
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE
Sbjct: 308 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 367
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK RPLMSEVVEALKPLPNLKDMAS
Sbjct: 368 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPLPNLKDMAS 427
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG---QRSLSIPNGSYASPYH-HQFPHP 296
SSYYFQTMQAERIGSSPN RNG+R Q G LSRNG QRSLSIPNGS+ASPYH +Q+P+
Sbjct: 428 SSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPYHQNQYPYQ 487
Query: 297 SPKPNGKP 304
SPKPNGKP
Sbjct: 488 SPKPNGKP 495
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100451|ref|XP_002311881.1| predicted protein [Populus trichocarpa] gi|222851701|gb|EEE89248.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1525), Expect = e-167, Method: Compositional matrix adjust.
Identities = 284/303 (93%), Positives = 294/303 (97%), Gaps = 2/303 (0%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AEVNFLGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA
Sbjct: 143 LAEVNFLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 202
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGLAFLHEE ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM
Sbjct: 203 LGAAKGLAFLHEETERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 262
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM+TGRRSMDKNRPNGEHNLVEWARPHLGE
Sbjct: 263 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPNGEHNLVEWARPHLGE 322
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV ALKPLPNLKDMAS
Sbjct: 323 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVNALKPLPNLKDMAS 382
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSP 298
+SYYFQTMQAER+GSSPN RNG+R+Q G LSRNG QRSLSIP+GS+ASPYH+Q+PH SP
Sbjct: 383 TSYYFQTMQAERVGSSPNARNGVRSQAGLLSRNGHQQRSLSIPHGSHASPYHYQYPHKSP 442
Query: 299 KPN 301
KPN
Sbjct: 443 KPN 445
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498172|ref|XP_003517927.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 591 bits (1523), Expect = e-166, Method: Compositional matrix adjust.
Identities = 283/305 (92%), Positives = 295/305 (96%), Gaps = 3/305 (0%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AEVNFLGDLVH NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRS+PLPWSIRMKIA
Sbjct: 187 LAEVNFLGDLVHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSMPLPWSIRMKIA 246
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM
Sbjct: 247 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 306
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDK+RPNGEHNLVEWARPHLGE
Sbjct: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKHRPNGEHNLVEWARPHLGE 366
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
RRRFYRLIDPRLEGHFS+KGAQKAAQLAAHCLSRDPK+RPLMSEVVEALKPLP+LKDMAS
Sbjct: 367 RRRFYRLIDPRLEGHFSVKGAQKAAQLAAHCLSRDPKSRPLMSEVVEALKPLPSLKDMAS 426
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSP 298
SSYYFQ MQA+R G+SPNTRNG R QG L+RNG QRSLSIPNG+YASPYHHQFP PSP
Sbjct: 427 SSYYFQAMQADRFGASPNTRNG-RMQGALLTRNGQQQRSLSIPNGTYASPYHHQFPQPSP 485
Query: 299 KPNGK 303
KPNGK
Sbjct: 486 KPNGK 490
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351722951|ref|NP_001235470.1| serine/threonine protein kinase-like protein [Glycine max] gi|223452506|gb|ACM89580.1| serine/threonine protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1521), Expect = e-166, Method: Compositional matrix adjust.
Identities = 283/305 (92%), Positives = 295/305 (96%), Gaps = 3/305 (0%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AEVNFLGDLVH NLVKL+GYCIE+DQRLLVYEFMPRGSLENHLFRRS+PLPWSIRMKIA
Sbjct: 181 LAEVNFLGDLVHPNLVKLVGYCIEEDQRLLVYEFMPRGSLENHLFRRSIPLPWSIRMKIA 240
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVSTRVM
Sbjct: 241 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRVM 300
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDK+RPNGEHNLVEWARPHLGE
Sbjct: 301 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKHRPNGEHNLVEWARPHLGE 360
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
RRRFYRLIDPRLEGHFS+KGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS
Sbjct: 361 RRRFYRLIDPRLEGHFSVKGAQKAALLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 420
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSP 298
SSYYFQ MQA+RIG+SPNTRNG R QG L+RNG QRSLSIPNG+YASPYHHQFP PSP
Sbjct: 421 SSYYFQAMQADRIGASPNTRNG-RMQGALLTRNGQQQRSLSIPNGTYASPYHHQFPQPSP 479
Query: 299 KPNGK 303
KPNGK
Sbjct: 480 KPNGK 484
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567562|ref|XP_003551987.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1514), Expect = e-165, Method: Compositional matrix adjust.
Identities = 284/305 (93%), Positives = 294/305 (96%), Gaps = 3/305 (0%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AEVN+LGDLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA
Sbjct: 183 LAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVSTRVM
Sbjct: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE
Sbjct: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
RRRFYRLIDPRLEGHFSIKGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS
Sbjct: 363 RRRFYRLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 422
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSP 298
SSYYFQTMQA+R +SPNTRNG R QG L+RNG QRSLSIP+G++ASPYHHQFP PSP
Sbjct: 423 SSYYFQTMQADRFSASPNTRNG-RTQGALLTRNGQQQRSLSIPHGTHASPYHHQFPQPSP 481
Query: 299 KPNGK 303
KPNGK
Sbjct: 482 KPNGK 486
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|53689728|gb|AAU89742.1| serine/threonine protein kinase-like [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1513), Expect = e-165, Method: Compositional matrix adjust.
Identities = 282/305 (92%), Positives = 294/305 (96%), Gaps = 4/305 (1%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
AEVNFLGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS+PLPWSIRMKIAL
Sbjct: 299 AEVNFLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSMPLPWSIRMKIAL 358
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 121
GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG
Sbjct: 359 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 418
Query: 122 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 181
TYGYAAPEYVMTGHLTS+SDVYSFGVVLLEM+TGRRSMDKNRPNGEHNLVEWARPHLGER
Sbjct: 419 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMITGRRSMDKNRPNGEHNLVEWARPHLGER 478
Query: 182 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASS 241
RRFYRL+DPRLEGHFSIKGAQKAAQLAA CLSRDPKARP+MS+VVEALKPLPNLKDMASS
Sbjct: 479 RRFYRLVDPRLEGHFSIKGAQKAAQLAARCLSRDPKARPMMSDVVEALKPLPNLKDMASS 538
Query: 242 SYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ---RSLSIPNGSYASPYHHQFPHPSP 298
SYYFQTMQA+R+GSSP+T+NG+R Q GS SRNGQ RSLSIPNGS+ASPYH QFP SP
Sbjct: 539 SYYFQTMQADRVGSSPSTKNGVRTQ-GSFSRNGQQHPRSLSIPNGSHASPYHQQFPQNSP 597
Query: 299 KPNGK 303
KPNGK
Sbjct: 598 KPNGK 602
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100247|ref|XP_002311801.1| predicted protein [Populus trichocarpa] gi|222851621|gb|EEE89168.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1507), Expect = e-164, Method: Compositional matrix adjust.
Identities = 278/306 (90%), Positives = 294/306 (96%), Gaps = 2/306 (0%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AEVN+LGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA
Sbjct: 173 LAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 232
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD PEGDKTHVSTRVM
Sbjct: 233 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEGDKTHVSTRVM 292
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM+TGRRSMDKNRPNGEHNLVEWARP+LGE
Sbjct: 293 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPNGEHNLVEWARPYLGE 352
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
RRRFYRLIDPRL+GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV+ LKPLPNLKDMAS
Sbjct: 353 RRRFYRLIDPRLQGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVDTLKPLPNLKDMAS 412
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSP 298
SSYYFQTMQ +R+GSSPN +NG+R+Q G LSRNG QRS SIP+G +ASP+HHQ+PH SP
Sbjct: 413 SSYYFQTMQGDRVGSSPNAKNGVRSQAGLLSRNGHQQRSFSIPHGPHASPFHHQYPHQSP 472
Query: 299 KPNGKP 304
KP+GKP
Sbjct: 473 KPSGKP 478
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526888|ref|XP_003532048.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1506), Expect = e-164, Method: Compositional matrix adjust.
Identities = 282/305 (92%), Positives = 293/305 (96%), Gaps = 3/305 (0%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AEVN+LGDLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA
Sbjct: 183 LAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YN+KLSDFGLAKDGPEGDKTHVSTRVM
Sbjct: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNSKLSDFGLAKDGPEGDKTHVSTRVM 302
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE
Sbjct: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
RRRFY+LIDPRLEGHFSIKGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS
Sbjct: 363 RRRFYKLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 422
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSP 298
SSYYFQTMQA+R SPNTRNG R QG L+RNG QRSLSIP+G++ASPYHHQFP PSP
Sbjct: 423 SSYYFQTMQADRFSVSPNTRNG-RTQGALLTRNGQQQRSLSIPHGTHASPYHHQFPQPSP 481
Query: 299 KPNGK 303
KPNGK
Sbjct: 482 KPNGK 486
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558222|ref|XP_002520138.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223540630|gb|EEF42193.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 581 bits (1498), Expect = e-163, Method: Compositional matrix adjust.
Identities = 281/305 (92%), Positives = 291/305 (95%), Gaps = 3/305 (0%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AEVN+LGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA
Sbjct: 191 LAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 250
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM
Sbjct: 251 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 310
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM+TGRRSMDKNRP GEHNLVEWARPHLGE
Sbjct: 311 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPIGEHNLVEWARPHLGE 370
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE LKPLPNLKDMAS
Sbjct: 371 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEVLKPLPNLKDMAS 430
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSP 298
SSYYFQ+MQA++I SSPN ++ R QGG L RNG QRSLSIPNGS+ASPYHHQ+P SP
Sbjct: 431 SSYYFQSMQADKIASSPNAKSSNRTQGG-LLRNGQQQRSLSIPNGSHASPYHHQYPFQSP 489
Query: 299 KPNGK 303
KPNGK
Sbjct: 490 KPNGK 494
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 304 | ||||||
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.953 | 0.588 | 0.826 | 5.7e-130 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.970 | 0.602 | 0.801 | 1.2e-127 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.967 | 0.649 | 0.767 | 4e-122 | |
| TAIR|locus:2150019 | 410 | AT5G01020 [Arabidopsis thalian | 0.759 | 0.563 | 0.768 | 3.4e-93 | |
| TAIR|locus:2161093 | 408 | AT5G56460 [Arabidopsis thalian | 0.782 | 0.583 | 0.683 | 2.9e-87 | |
| TAIR|locus:2064712 | 462 | RIPK "RPM1-induced protein kin | 0.973 | 0.640 | 0.613 | 4.7e-87 | |
| TAIR|locus:2200863 | 424 | AT1G61590 [Arabidopsis thalian | 0.884 | 0.634 | 0.612 | 3e-85 | |
| TAIR|locus:2060167 | 442 | AT2G07180 [Arabidopsis thalian | 0.891 | 0.613 | 0.635 | 4.9e-85 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.776 | 0.557 | 0.679 | 1.3e-84 | |
| TAIR|locus:2057770 | 424 | ARSK1 "root-specific kinase 1" | 0.759 | 0.544 | 0.695 | 6.4e-83 |
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1275 (453.9 bits), Expect = 5.7e-130, P = 5.7e-130
Identities = 252/305 (82%), Positives = 271/305 (88%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AE+NFLG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA
Sbjct: 194 LAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 253
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGL+FLHEEA +PVIYRDFKTSNILLDADYNAKLSDFGLAKD P+ KTHVSTRVM
Sbjct: 254 LGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVM 313
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL +
Sbjct: 314 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLD 373
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
+RRFYRL+DPRLEGHFSIKGAQK QLAA CLSRDPK RP MS+VVEALKPLP+LKDMAS
Sbjct: 374 KRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMAS 433
Query: 241 SSYYFQTMQAERIGSSPNTRNGI-RAQGGSLSRNGQ-----RSLSIPNGSYASPYHHQFP 294
SSYYFQTMQAER+ +NG R+QG SRNGQ R+LS P+GS SPY HQ P
Sbjct: 434 SSYYFQTMQAERL------KNGSGRSQGFG-SRNGQHQPVFRTLSSPHGS--SPYRHQIP 484
Query: 295 HPSPK 299
P PK
Sbjct: 485 SPKPK 489
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1253 (446.1 bits), Expect = 1.2e-127, P = 1.2e-127
Identities = 243/303 (80%), Positives = 267/303 (88%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AE+N+LG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA
Sbjct: 188 LAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 247
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGL+FLHEEA +PVIYRDFKTSNILLD +YNAKLSDFGLAKD P+ KTHVSTRVM
Sbjct: 248 LGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVM 307
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL +
Sbjct: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLD 367
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
+RRFYRL+DPRLEGHFS+KGAQK QLAA CLSRD K RP MSEVVE LKPLP+LKDMAS
Sbjct: 368 KRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDMAS 427
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ---RSLSIPNGSY-ASPYHHQFPHP 296
+SYYFQTMQAER+ + + +G R G SRNGQ R+LS P+G +SPY HQ P P
Sbjct: 428 ASYYFQTMQAERLKAGSGSGSG-RGFG---SRNGQPVFRTLSSPHGQAGSSPYRHQIPSP 483
Query: 297 SPK 299
PK
Sbjct: 484 KPK 486
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1201 (427.8 bits), Expect = 4.0e-122, P = 4.0e-122
Identities = 235/306 (76%), Positives = 265/306 (86%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AE+NFLG+LVH +LVKL+GYC+E+DQRLLVYEFMPRGSLENHLFRR+LPLPWS+RMKIA
Sbjct: 155 LAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRRTLPLPWSVRMKIA 214
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
LGAAKGLAFLHEEAE+PVIYRDFKTSNILLD +YNAKLSDFGLAKD P+ K+HVSTRVM
Sbjct: 215 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEKKSHVSTRVM 274
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GTYGYAAPEYVMTGHLT++SDVYSFGVVLLE+LTGRRS+DK+RPNGE NLVEW RPHL +
Sbjct: 275 GTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQNLVEWVRPHLLD 334
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240
++RFYRL+DPRLEGH+SIKGAQKA Q+AA CL+RD KARP MSEVVEALKPLPNLKD AS
Sbjct: 335 KKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEALKPLPNLKDFAS 394
Query: 241 SSYYFQTMQAERIGSSPNTRNGIRAQGGS-LSRNG--QRSLSIPNGSYASPYHHQFPHPS 297
SS FQTMQ P +NG+R QGG +SRNG RSLS N ASPY ++ S
Sbjct: 395 SSSSFQTMQ-------PVAKNGVRTQGGGFVSRNGPPMRSLSSLNLPQASPY--RYARQS 445
Query: 298 PKPNGK 303
PKP GK
Sbjct: 446 PKPKGK 451
|
|
| TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 928 (331.7 bits), Expect = 3.4e-93, P = 3.4e-93
Identities = 179/233 (76%), Positives = 203/233 (87%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKI 59
+ EVNFLG L H NLVKLIGYC EDD RLLVYEFM RGSLENHLFR++ PL WS RM I
Sbjct: 118 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMMI 177
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
ALGAAKGLAFLH AERPVIYRDFKTSNILLD+DY AKLSDFGLAK GP+GD+THVSTRV
Sbjct: 178 ALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 236
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
MGTYGYAAPEYVMTGHLT+RSDVYSFGVVLLEMLTGR+S+DK RP+ E NLV+WARP L
Sbjct: 237 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLN 296
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
++R+ ++IDPRLE +S++ AQKA LA +CLS++PKARPLMS+VVE L+PL
Sbjct: 297 DKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
|
| TAIR|locus:2161093 AT5G56460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 164/240 (68%), Positives = 201/240 (83%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKI 59
+AEV FLG L H NLVKLIGYC ED+ R+L+YE+M RGS+EN+LF R L PL W+IRMKI
Sbjct: 128 LAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLSWAIRMKI 187
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A GAAKGLAFLHE A++PVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDK+HVSTR+
Sbjct: 188 AFGAAKGLAFLHE-AKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTRI 246
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
MGTYGYAAPEY+MTGHLT SDVYSFGVVLLE+LTGR+S+DK+RP E NL++WA P L
Sbjct: 247 MGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLLK 306
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 239
E+++ ++DP++ + +K QKAA LA HCL+R+PKARPLM ++V++L+PL ++ A
Sbjct: 307 EKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQATEEEA 366
|
|
| TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 870 (311.3 bits), Expect = 4.7e-87, P = 4.7e-87
Identities = 184/300 (61%), Positives = 212/300 (70%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKI 59
+ EV FLG L H NLVKLIGYC E++ R LVYEFMPRGSLEN LFRR S LPWS RMKI
Sbjct: 136 LTEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQLFRRYSASLPWSTRMKI 195
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A GAA GL FLHE AE PVIYRDFK SNILLD+DY AKLSDFGLAKDGPEGD THVSTRV
Sbjct: 196 AHGAATGLQFLHE-AENPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 254
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
MGT GYAAPEY+MTGHLT+RSDVYSFGVVLLE+LTGRRS+DK R + E NLV+WARP L
Sbjct: 255 MGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKRSSREQNLVDWARPMLN 314
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 239
+ R+ R++DPRLEG +S GA+KAA LA CLS PK RP MS VV L L + D+
Sbjct: 315 DPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMSAVVSILNDLKDYNDIP 374
Query: 240 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASPYHHQFPHPSPK 299
++ + T+ + R G + + S + Q+ S S SP P P+ K
Sbjct: 375 MGTFTY-TVPNTPDNKEDDGRVGNKPRKSSHHHHHQQQQSNHPRSSPSPTTKS-PSPTAK 432
|
|
| TAIR|locus:2200863 AT1G61590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 853 (305.3 bits), Expect = 3.0e-85, P = 3.0e-85
Identities = 169/276 (61%), Positives = 214/276 (77%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKI 59
++EV FLG L H NLVKLIGYC E+++R+L+YEFMPRGSLENHLFRR SL LPW+ R+KI
Sbjct: 148 LSEVIFLGQLKHPNLVKLIGYCCEEEERVLIYEFMPRGSLENHLFRRISLSLPWATRLKI 207
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A+ AAKGLAFLH+ E P+IYRDFKTSNILLD+D+ AKLSDFGLAK GPEG K+HV+TRV
Sbjct: 208 AVAAAKGLAFLHD-LESPIIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSKSHVTTRV 266
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
MGTYGYAAPEYV TGHLT++SDVYS+GVVLLE+LTGRR+ +K+RP + N+++W++P+L
Sbjct: 267 MGTYGYAAPEYVSTGHLTTKSDVYSYGVVLLELLTGRRATEKSRPKNQQNIIDWSKPYLT 326
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 239
RR ++DPRL G +S+K A+ A LA C+S +PK RP M VVEAL+ L + KDMA
Sbjct: 327 SSRRLRCVMDPRLAGQYSVKAAKDTALLALQCVSPNPKDRPKMLAVVEALESLIHYKDMA 386
Query: 240 SSSYYFQTMQAERIGS-SPNTR----NGIRAQGGSL 270
SS ++ + G SP R +G ++ GSL
Sbjct: 387 VSSGHWPLSPKSQGGKVSPKVRGDHRSGRKSAPGSL 422
|
|
| TAIR|locus:2060167 AT2G07180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 851 (304.6 bits), Expect = 4.9e-85, P = 4.9e-85
Identities = 176/277 (63%), Positives = 199/277 (71%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKI 59
+AEVN+LG L H NLVKLIGYC EDD RLLVYE+M GSLE HLFRR L W+ RMKI
Sbjct: 139 LAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMAMGSLEKHLFRRVGCTLTWTKRMKI 198
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
AL AAKGLAFLH AER +IYRD KT+NILLD YNAKLSDFGLAKDGP GD+THVSTRV
Sbjct: 199 ALDAAKGLAFLHG-AERSIIYRDLKTANILLDEGYNAKLSDFGLAKDGPRGDQTHVSTRV 257
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
MGTYGYAAPEYVMTGHLTSRSDVY FGV+LLEML G+R+MDK+R EHNLVEWARP L
Sbjct: 258 MGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGKRAMDKSRACREHNLVEWARPLLN 317
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 239
++ R+IDPR++G + K K A LA CLS++PK RPLM+ VVE L+ LKD
Sbjct: 318 HNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNPKGRPLMNHVVEVLE---TLKDDG 374
Query: 240 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQR 276
+ T R G S G+ NGQR
Sbjct: 375 DAQEEVMTNLHSR-GKSVTLYEASSDSQGTRDGNGQR 410
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 847 (303.2 bits), Expect = 1.3e-84, P = 1.3e-84
Identities = 163/240 (67%), Positives = 197/240 (82%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---PLPWSIRM 57
+AEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLENHLFRR PL W++R+
Sbjct: 132 LAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRL 191
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
K+ALGAAKGLAFLH AE VIYRDFKTSNILLD++YNAKLSDFGLAKDGP GDK+HVST
Sbjct: 192 KVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVST 250
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
R+MGTYGYAAPEY+ TGHLT++SDVYS+GVVLLE+L+GRR++DKNRP GE LVEWARP
Sbjct: 251 RIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPL 310
Query: 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 237
L +R+ +R+ID RL+ +S++ A K A LA CL+ + K RP M+EVV L+ + L +
Sbjct: 311 LANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLNE 370
|
|
| TAIR|locus:2057770 ARSK1 "root-specific kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 6.4e-83, P = 6.4e-83
Identities = 162/233 (69%), Positives = 192/233 (82%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKI 59
+AE+ FLG L + +LVKLIG+C E++QR+LVYE+MPRGSLEN LFRR SL + W IRMKI
Sbjct: 137 LAEILFLGQLSNKHLVKLIGFCCEEEQRVLVYEYMPRGSLENQLFRRNSLAMAWGIRMKI 196
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
ALGAAKGLAFLHE AE+PVIYRDFKTSNILLD+DYNAKLSDFGLAKDGPEG+ THV+TRV
Sbjct: 197 ALGAAKGLAFLHE-AEKPVIYRDFKTSNILLDSDYNAKLSDFGLAKDGPEGEHTHVTTRV 255
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
MGT GYAAPEY+MTGHLT+ +DVYSFGVVLLE++TG+RSMD R E +LVEWARP L
Sbjct: 256 MGTQGYAAPEYIMTGHLTTMNDVYSFGVVLLELITGKRSMDNTRTRREQSLVEWARPMLR 315
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
++R+ R+IDPRL + AQ AA LA CLS+ PK RP M EVV+ L+ +
Sbjct: 316 DQRKLERIIDPRLANQHKTEAAQVAASLAYKCLSQHPKYRPTMCEVVKVLESI 368
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LFP7 | Y5158_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8223 | 0.9572 | 0.5902 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 304 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-39 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-12 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-45
Identities = 63/229 (27%), Positives = 96/229 (41%), Gaps = 56/229 (24%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L L H N+VKL G +++ LV E+ GSL++ L L ++I L
Sbjct: 41 EIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQ 100
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMG 121
+GL +LH +I+RD K NILLD+D KL+DFGL+K ++G
Sbjct: 101 ILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVG 155
Query: 122 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
T Y APE ++ G+ + +SD++S GV+L E+
Sbjct: 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------- 187
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229
+ L L +DP+ RP E++E L
Sbjct: 188 ---------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 2e-41
Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 24/231 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + L H N+VKL+G C E++ +V E+M G L ++L + L S + A
Sbjct: 49 LREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFA 108
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
L A+G+ +L + I+RD N L+ + K+SDFGL++D + D
Sbjct: 109 LQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-K 164
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL-- 178
+ APE + G TS+SDV+SFGV+L E+ T P + E +L
Sbjct: 165 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYLKN 218
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229
G R P L L C + DP+ RP SE+VE L
Sbjct: 219 GYRLPQPPNCPPEL------------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 4e-41
Identities = 75/229 (32%), Positives = 109/229 (47%), Gaps = 22/229 (9%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
E+ L L H N+V+LI + D LV E+ G L R PL KIAL
Sbjct: 47 REIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIAL 105
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 121
+GL +LH +I+RD K NILLD + K++DFGLAK + ++T V G
Sbjct: 106 QILRGLEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-G 160
Query: 122 TYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
T Y APE ++ G + DV+S GV+L E+LTG+ L +
Sbjct: 161 TPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQ 207
Query: 181 RRRFYRLIDPRLEGHF--SIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+ R++ P LE G+++A L CL++DP RP E+++
Sbjct: 208 LQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-41
Identities = 73/232 (31%), Positives = 108/232 (46%), Gaps = 25/232 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKI 59
+ E + L H N+VKL+G C E++ ++V E+MP G L ++L R L S +
Sbjct: 49 LREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSF 108
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
AL A+G+ +L + I+RD N L+ + K+SDFGL++D + D V
Sbjct: 109 ALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG- 164
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL- 178
+ APE + G TS+SDV+SFGV+L E+ T P + E +L
Sbjct: 165 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEYLK 218
Query: 179 -GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229
G R P L +L C + DP+ RP SE+VE L
Sbjct: 219 KGYRLPKPPNCPPEL------------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 8e-40
Identities = 72/235 (30%), Positives = 110/235 (46%), Gaps = 31/235 (13%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + + L H N+V+L+G C + + +V E+MP G L + L + L +++A
Sbjct: 49 LEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMA 108
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST--- 117
L AKG+ +L + ++RD N L+ + K+SDFGL++D E D
Sbjct: 109 LQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGK 165
Query: 118 ---RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 174
+ M APE + G TS+SDV+SFGV+L E+ T P + E
Sbjct: 166 LPIKWM------APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-V 213
Query: 175 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229
L + YRL PR E + +L C + DP+ RP SE+VE L
Sbjct: 214 LELLEDG---YRL--PRPEN-----CPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-39
Identities = 74/248 (29%), Positives = 110/248 (44%), Gaps = 47/248 (18%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------LP 52
+ E + L H N+V+L+G C E++ LV E+M G L ++L + L
Sbjct: 44 LKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLS 103
Query: 53 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
+ A+ AKG+ +L + ++RD N L+ D K+SDFGL++D + D
Sbjct: 104 LKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160
Query: 113 THVST------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 166
T R M APE + G TS+SDV+SFGV+L E+ T G
Sbjct: 161 YRKKTGGKLPIRWM------APESLKDGIFTSKSDVWSFGVLLWEIFT----------LG 204
Query: 167 E---HNL-VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222
L E +L R+ YRL P + + +L C DP+ RP
Sbjct: 205 ATPYPGLSNEEVLEYL---RKGYRLPKPE---YCP----DELYELMLSCWQLDPEDRPTF 254
Query: 223 SEVVEALK 230
SE+VE L+
Sbjct: 255 SELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 70/229 (30%), Positives = 104/229 (45%), Gaps = 25/229 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKI 59
+ E+ L L H N+V+L ++D+ LV E+ G L + L R L R
Sbjct: 45 LREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FY 102
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
L +LH + +++RD K NILLD D + KL+DFGLA+ G+K T V
Sbjct: 103 LRQILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV 157
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHL 178
GT Y APE ++ D++S GV+L E+LTG+ P G+ L+E +
Sbjct: 158 -GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIG 210
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+ F P E S +A L L +DP+ R E ++
Sbjct: 211 KPKPPF-----PPPEWDIS----PEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 23/223 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR-LLVY-EFMPRGSLENHLFRRSLPLPWS-IRM 57
E+ L L H N+V+ G ++++ L ++ E++ GSL + L ++ LP IR
Sbjct: 47 EREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIR- 104
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
K +GLA+LH +++RD K +NIL+D+D KL+DFG AK + + +
Sbjct: 105 KYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG 161
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
V GT + APE + +D++S G ++EM TG+ P E A
Sbjct: 162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAALYK 215
Query: 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
+G P + H S ++A CL RDPK RP
Sbjct: 216 IG-----SSGEPPEIPEHLS----EEAKDFLRKCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 6/154 (3%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L H N+VK G ++ D+ +V EF GSL++ L + L S +
Sbjct: 47 EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKE 106
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
KGL +LH +I+RD K +NILL +D KL DFGL+ + + ++GT
Sbjct: 107 LLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGT 160
Query: 123 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
+ APE + ++D++S G+ +E+ G+
Sbjct: 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 5e-26
Identities = 59/160 (36%), Positives = 83/160 (51%), Gaps = 14/160 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR-SLPLPWSIRM- 57
+ E N L + H +VKL Y + +++L LV E+ P G L +HL + +
Sbjct: 41 LTERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYA 99
Query: 58 -KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
+I L L +LH +IYRD K NILLDAD + KL+DFGLAK+ + +
Sbjct: 100 AEIVLA----LEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTN 151
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
T GT Y APE ++ D +S GV+L EMLTG+
Sbjct: 152 TFC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 77/236 (32%), Positives = 114/236 (48%), Gaps = 27/236 (11%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ +G L H N+VKLIG C + L++E++ +L L L W R KIA+G
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIG 788
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
AK L FLH V+ + I++D L L+ G T+ +
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGL----LCTDTKCFIS 841
Query: 123 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWAR-----P 176
Y APE T +T +SD+Y FG++L+E+LTG+ D G H ++VEWAR
Sbjct: 842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE--FGVHGSIVEWARYCYSDC 899
Query: 177 HLGERRRFYRLIDPRLEGHFSIKGAQ--KAAQLAAHCLSRDPKARPLMSEVVEALK 230
HL IDP + G S+ + + LA HC + DP ARP ++V++ L+
Sbjct: 900 HLD------MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-25
Identities = 59/158 (37%), Positives = 88/158 (55%), Gaps = 10/158 (6%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
M E++ L +L H N+VK IG IE L ++ E+ GSL + ++ P P S+
Sbjct: 47 MQEIDLLKNLKHPNIVKYIG-SIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVY 104
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
+GLA+LHE+ VI+RD K +NIL D KL+DFG+A + K V
Sbjct: 105 VYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASV 159
Query: 120 MGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTGR 156
+GT + APE + M+G T+ SD++S G ++E+LTG
Sbjct: 160 VGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-25
Identities = 77/278 (27%), Positives = 116/278 (41%), Gaps = 20/278 (7%)
Query: 1 MAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRM 57
+ E+ L L H N+VKL + ++ LV E++ GSLE+ L R PL S +
Sbjct: 45 LREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL 104
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAK----DGPEGDK 112
I L +LH + +I+RD K NILLD D KL DFGLAK G
Sbjct: 105 FILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI 161
Query: 113 THVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 169
+ + +GT GY APE ++ + +S SD++S G+ L E+LTG + + + +
Sbjct: 162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS 221
Query: 170 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-A 228
+ P S + A+ L L++DPK R S +
Sbjct: 222 QT-LKIILELPTPSLASPLSPSNPELIS----KAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 229 LKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQ 266
L LK+ S A S P + + +
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISS 314
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 53/156 (33%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+ L L H N+VK G C + R L+ E++P GSL ++L R + + +
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS 115
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST--R 118
KG+ +L + I+RD NIL++++ K+SDFGLAK PE +
Sbjct: 116 SQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ Y APE + T +S SDV+SFGV L E+ T
Sbjct: 173 ESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-23
Identities = 52/161 (32%), Positives = 90/161 (55%), Gaps = 16/161 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 59
+AE + + L H NLV+L+G ++ + +V E+M +GSL ++L R + + ++
Sbjct: 48 LAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF 107
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD---GPEGDKTHVS 116
AL +G+ +L E+ ++RD N+L+ D AK+SDFGLAK+ G + K V
Sbjct: 108 ALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK 164
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 156
+ APE + +++SDV+SFG++L E+ + GR
Sbjct: 165 --------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-23
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 71
H N+VKLIG C++ +V E +P GSL L ++ L ++++L AA G+ +L
Sbjct: 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 72 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 131
+ I+RD N L+ + K+SDFG++++ G T + APE +
Sbjct: 111 ---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL 167
Query: 132 MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 191
G TS SDV+S+G++L E + + N + R + YR+ P+
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERI---ESGYRMPAPQ 218
Query: 192 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230
L + +L C + DP+ RP SE+ L+
Sbjct: 219 LCPE-------EIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-22
Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
EV+ L L H+N+V+ +G C++D+ + EF+P GS+ + L R PLP + K
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQ 110
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD----GPEGDKTHVSTR 118
G+A+LH V++RD K +N++L + KL DFG A+ G G +++
Sbjct: 111 ILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWAR 175
+ GT + APE + +SD++S G + EM TG+ SMD+ A
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----------AM 217
Query: 176 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
++G R PRL FS A CL+RD RP
Sbjct: 218 FYIGAHRGLM----PRLPDSFS----AAAIDFVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-22
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLP----WSIRM 57
E L L +++ ++ + +V E+ G L L +R PLP W +
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI 108
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
+I LG LA LH + +++RD K+ N+ LDA N K+ D G+AK D T+ +
Sbjct: 109 QILLG----LAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFAN 159
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
++GT Y +PE +SDV++ GVVL E TG+ D N + L+
Sbjct: 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALI------ 210
Query: 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
+ R + P + +S Q+ AQL CL++D + RP
Sbjct: 211 ----LKIIRGVFPPVSQMYS----QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-22
Identities = 53/167 (31%), Positives = 77/167 (46%), Gaps = 16/167 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSL----- 49
E L + H N+VK G C E D ++V+E+M G L L
Sbjct: 56 EREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSP 115
Query: 50 --PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 107
L S ++IA+ A G+ +L A + ++RD T N L+ D K+ DFG+++D
Sbjct: 116 MGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV 172
Query: 108 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
D V M + PE +M T+ SDV+SFGVVL E+ T
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-22
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 26/230 (11%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E + L H NLV+L G C + +V E+M G L N+L R L + +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRV 119
+ + +L I+RD N L+ D K+SDFGLA+ D D+ S
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGT 161
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+A PE +S+SDV+SFGV++ E+ + + + N E +VE G
Sbjct: 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE--SVSAG 217
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229
YRL P+L + + C P+ RP +++ L
Sbjct: 218 -----YRLYRPKL-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 8e-22
Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 22/151 (14%)
Query: 14 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 73
+V G + + E+M GSL+ L +P I KIA+ KGL +LHE+
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM--------GTYGY 125
+I+RD K SNIL+++ KL DFG VS +++ GT Y
Sbjct: 120 --HKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSY 165
Query: 126 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
APE + + +SD++S G+ L+E+ TGR
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 8e-22
Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 20/227 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E + L H LV+L G C E LV+EFM G L ++L + + + L
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
+G+A+L VI+RD N L+ + K+SDFG+ + + D+ ST
Sbjct: 109 VCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFP 164
Query: 123 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 182
+++PE +S+SDV+SFGV++ E+ + ++ +NR N E +VE
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE-------TIN 215
Query: 183 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229
+RL PRL +Q +L HC P+ RP S ++ L
Sbjct: 216 AGFRLYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-21
Identities = 70/235 (29%), Positives = 106/235 (45%), Gaps = 42/235 (17%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS-IRM---K 58
E+ L L H N+V+ +G E+D + E +P GSL L ++ P IR+ +
Sbjct: 52 EIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQ 110
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
I LG L +LH+ R ++RD K +NIL+D + KL+DFG+AK V
Sbjct: 111 ILLG----LEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEF 155
Query: 119 VM-----GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 172
G+ + APE + G +D++S G +LEM TG+ P + V
Sbjct: 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK------PPWSQLEGVA 209
Query: 173 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
A +G + P + H S +A CL RDP RP +E++E
Sbjct: 210 -AVFKIGRSKEL-----PPIPDHLS----DEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-21
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 14 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 73
+VK G ++ + +V E+M GSL + L ++ +P + IA KGL +LH
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLH-- 116
Query: 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEY 130
+R +I+RD K SN+L+++ K++DFG++K + + T V GT Y +PE
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPER 171
Query: 131 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID- 189
+ + +D++S G+ LLE G+ F+ L+
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----------------FFELMQA 214
Query: 190 ------PRL-EGHFSIKGAQKAAQLAAHCLSRDPKARP 220
P L FS + + CL +DPK RP
Sbjct: 215 ICDGPPPSLPAEEFS----PEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-20
Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 61
E + L H NL++L G + ++V E P GSL + L + +L S A+
Sbjct: 46 EAAIMHSLDHENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV 104
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST---R 118
A G+ +L + I+RD NILL +D K+ DFGL + P+ + +V +
Sbjct: 105 QIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
V + + APE + T + SDV+ FGV L EM T
Sbjct: 162 V--PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-20
Identities = 71/241 (29%), Positives = 110/241 (45%), Gaps = 22/241 (9%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+N L L H N+VK G C E + L+ E++P GSL ++L + L L + + A
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFA 113
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRV 119
+G+A+LH + I+RD N+LLD D K+ DFGLAK PEG + + V
Sbjct: 114 QQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+ A E + + SDV+SFGV L E+LT ++ P ++ + +
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMT 229
Query: 180 ERR------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233
R R RL P+ Q+ L +C + K RP ++ LK +
Sbjct: 230 VVRLIELLERGMRLPCPK-------NCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282
Query: 234 N 234
+
Sbjct: 283 H 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-20
Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 18/228 (7%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
+E+ L DL HLN+V+ +G+ ++ + E++P GS+ + R +
Sbjct: 57 SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTE 115
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 121
+GLA+LH + +++RD K N+L+DAD K+SDFG++K + + + G
Sbjct: 116 QVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172
Query: 122 TYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+ + APE + + +++ D++S G V+LEM GR RP + + A LG
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIA-AMFKLG 225
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+R P + S+ + A C + +P RP E+++
Sbjct: 226 NKRS-----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-20
Identities = 67/234 (28%), Positives = 94/234 (40%), Gaps = 37/234 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L L H NLVK G + ++ + E+ G+LE L L + L
Sbjct: 49 EMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQ 107
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV--- 119
+GLA+LH +++RD K +NI LD + KL DFG A T + V
Sbjct: 108 LLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSL 163
Query: 120 MGTYGYAAPEYVMTGHLTSR---SDVYSFGVVLLEMLTGRR---SMDKNRPNGEHNLVEW 173
GT Y APE + G +D++S G V+LEM TG+R +D E+
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----------EF 213
Query: 174 A---RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224
G + + EG + CL DPK RP SE
Sbjct: 214 QIMFHVGAGHKPPIPDSLQLSPEGKDFLD----------RCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-20
Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------------- 48
E + DL H N+V L+G C ++ +++E++ G L L R S
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 49 -LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 107
L S + IA+ A G+ +L + ++RD N L+ K+SDFGL++D
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 108 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152
D V ++ + + PE ++ G T+ SD++SFGVVL E+
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 40/233 (17%)
Query: 14 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--------FRRSLPLPWSIRM-KIALGAA 64
++V+L+G L+V E M +G L+++L L P + ++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 124
G+A+L A + ++RD N ++ D K+ DFG+ +D E D + +
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 125 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----E 180
+ APE + G T++SDV+SFGVVL EM T L E +P+ G E
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAE--QPYQGLSNEE 229
Query: 181 RRRFYRLIDPRLEGHFS--IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231
+F +ID GH K +L C +PK RP E+V +LK
Sbjct: 230 VLKF--VID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (213), Expect = 1e-19
Identities = 57/242 (23%), Positives = 97/242 (40%), Gaps = 53/242 (21%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSL---PLP---- 52
+ EV L L H N++K E+ +L V E+ G L + ++ P P
Sbjct: 47 LNEVKILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI 105
Query: 53 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
+++ L L +LH R +++RD K NI L ++ KL DFG++K
Sbjct: 106 LDWFVQLCLA----LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTV 157
Query: 113 THVSTRVMGTYGYAAPE------YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 166
T V GT Y +PE Y +SD++S G VL E+ T + +
Sbjct: 158 DLAKTVV-GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGENLLE 210
Query: 167 EHNLVEWARPHLGERRRFYRLID---PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223
L +++ P + +S + L + L +DP+ RP ++
Sbjct: 211 ---L-------------ALKILKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIA 250
Query: 224 EV 225
++
Sbjct: 251 QI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-19
Identities = 53/155 (34%), Positives = 79/155 (50%), Gaps = 10/155 (6%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKI 59
EV L L H +L+ L C + ++ E M +GSL L + LP+ I M
Sbjct: 52 EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDM-- 109
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A A+G+A+L E + I+RD NIL+ D K++DFGLA+ E ++
Sbjct: 110 ACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI 166
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
Y + APE G +++SDV+SFG++L EM T
Sbjct: 167 --PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-19
Identities = 48/149 (32%), Positives = 66/149 (44%), Gaps = 8/149 (5%)
Query: 10 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGL 67
V + + Y E L LV M G L+ H++ P P + + A GL
Sbjct: 49 KVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL 108
Query: 68 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 127
LH+ R ++YRD K N+LLD N ++SD GLA + G K GT GY A
Sbjct: 109 EHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMA 162
Query: 128 PEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
PE + D ++ G L EM+ GR
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 63/224 (28%), Positives = 92/224 (41%), Gaps = 20/224 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLEN---HLFRRSLPLPWSIRM 57
E+ +VK G +++ + E+ GSL++ + +R + +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVS 116
KIA KGL++LH R +I+RD K SNILL KL DFG++ + T
Sbjct: 109 KIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 176
GT Y APE + + SDV+S G+ LLE+ R P GE L
Sbjct: 165 ----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLGPIELL 217
Query: 177 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
L D E IK +++ CL +DP RP
Sbjct: 218 SYIVNMPNPELKD---EPGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 68/235 (28%), Positives = 101/235 (42%), Gaps = 30/235 (12%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKI 59
EV + H N+VK + D+ LV ++ GSL + + S P L +I +
Sbjct: 49 EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATV 107
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHV 115
KGL +LH + I+RD K NILL D + K++DFG LA G V
Sbjct: 108 LKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGG--DRTRKV 162
Query: 116 STRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 173
+GT + APE VM ++D++SFG+ +E+ TG K P L
Sbjct: 163 RKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ 221
Query: 174 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKA-AQLAAHCLSRDPKARPLMSEVVE 227
P P LE K K+ ++ + CL +DP RP E+++
Sbjct: 222 NDP-------------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 13/162 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR----------SLPLP 52
EV L L N+ +L+G C D ++ E+M G L L + S L
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 53 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
+S + +A A G+ +L ++RD T N L+ +Y K++DFG++++ D
Sbjct: 129 FSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 113 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
V R + A E V+ G T++SDV++FGV L E+LT
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-18
Identities = 71/231 (30%), Positives = 105/231 (45%), Gaps = 41/231 (17%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRM 57
+ E + L H LV+L C E++ +V E+M +GSL + L + L LP + M
Sbjct: 49 LQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM 108
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEG 110
A A+G+A+L R I+RD NIL+ + K++DFGLA+ EG
Sbjct: 109 --AAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHN 169
K + + APE G T +SDV+SFG++L E++T R P G N
Sbjct: 164 AKFPIK--------WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV-----PYPGMTN 210
Query: 170 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
R L + R YR+ PR ++ L C +DP+ RP
Sbjct: 211 -----REVLEQVERGYRM--PRPPNC-----PEELYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-18
Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 14/165 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI- 59
+ E+ + L + N+++L+G C+ DD ++ E+M G L L +R + ++ I
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 60 ----------ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 109
A+ A G+ +L A ++RD T N L+ Y K++DFG++++
Sbjct: 125 SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 110 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
GD + R + + A E ++ G T+ SDV++FGV L EM T
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-18
Identities = 55/164 (33%), Positives = 89/164 (54%), Gaps = 13/164 (7%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM-KI 59
+ E + L H NLV+L+G I + +V E M +G+L N L R L I++ +
Sbjct: 47 LEETAVMTKLHHKNLVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF 105
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTR 118
+L A+G+ +L + +++RD NIL+ D AK+SDFGLA+ G G D + + +
Sbjct: 106 SLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK 162
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDK 161
+ APE + +S+SDV+S+GV+L E+ + GR K
Sbjct: 163 ------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-18
Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 9/164 (5%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
+ E L +L H LV L Y +D++ + LV + + G L HL ++ ++ I
Sbjct: 48 LNERRILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWI 106
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
L +LH + +I+RD K NILLD + ++DF +A T T
Sbjct: 107 C-EIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TST 159
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 163
GT GY APE + + D +S GV E L G+R +
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 4e-18
Identities = 46/165 (27%), Positives = 71/165 (43%), Gaps = 26/165 (15%)
Query: 12 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 69
H ++KL Y +D++ L V E+ P G L ++ SL R A L +
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAE-ILLALEY 117
Query: 70 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM--------- 120
LH + +I+RD K NILLD D + K++DFG AK +
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 121 ---------GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
GT Y +PE + SD+++ G ++ +MLTG+
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-18
Identities = 66/246 (26%), Positives = 112/246 (45%), Gaps = 35/246 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------- 49
+ EV L L N+++L+G C+++D ++ E+M G L L L
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 50 ----PLP---WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 102
LP +S + +AL A G+ +L + ++RD T N L+ + K++DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 103 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 162
++++ GD + R + + A E ++ G T+ SDV++FGV L E+L + K
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKE 239
Query: 163 RPNGE---HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219
+P GE ++E A ++ R L P Q +L C SRD + R
Sbjct: 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPP-------CPQGLYELMLQCWSRDCRER 292
Query: 220 PLMSEV 225
P S++
Sbjct: 293 PSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 6e-18
Identities = 50/155 (32%), Positives = 85/155 (54%), Gaps = 7/155 (4%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E++ L +L H N+VKL+ + + LV+E+ L+ +L +R PL ++ I
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
+GLA+ H +++RD K NIL++ D KL+DFGLA+ +T+ + V+ T
Sbjct: 107 LLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-T 161
Query: 123 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
Y APE ++ S + D++S G + EM+TG+
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-18
Identities = 50/141 (35%), Positives = 74/141 (52%), Gaps = 17/141 (12%)
Query: 22 CIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSI--RMKIALGAAKGLAFLHEEAERP 77
C + RL V E++ G L H+ R P + +I LG L FLHE R
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFLHE---RG 116
Query: 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTGHL 136
+IYRD K N+LLD++ + K++DFG+ K+G G T + GT Y APE +++
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPE-ILSYQP 172
Query: 137 TSRS-DVYSFGVVLLEMLTGR 156
+ D ++ GV+L EML G+
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 8e-18
Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 7/156 (4%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + +G H N+++L G + +++ E+M GSL+ L + +
Sbjct: 53 LTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGML 112
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTR 118
G A G+ +L +E ++RD NIL++++ K+SDFGL++ + E T +
Sbjct: 113 RGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGK 169
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ + APE + TS SDV+SFG+V+ E+++
Sbjct: 170 I--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 9e-18
Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 7/154 (4%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ + D H N+V + D+ +V E+M GSL + + + + + +
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCRE 124
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
+GL +LH + VI+RD K+ NILL D + KL+DFG A + S V+GT
Sbjct: 125 VLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGT 179
Query: 123 YGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 155
+ APE V+ + D++S G++ +EM G
Sbjct: 180 PYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 45/179 (25%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWS 54
+ E + + H ++V+L+G C+ Q L+ + MP G L +++ L W
Sbjct: 57 LDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC 115
Query: 55 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 114
+++ AKG+++L E + +++RD N+L+ + K++DFGLAK +K +
Sbjct: 116 VQI------AKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY 166
Query: 115 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 172
+ + A E ++ T +SDV+S+GV + E++T G + + +L+E
Sbjct: 167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 50/173 (28%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------------- 48
E + + H N+VKL+G C L++E+M G L L RS
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 49 -------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 101
LPL + ++ IA A G+A+L +ER ++RD T N L+ + K++DF
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADF 174
Query: 102 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
GL+++ D S + PE + T+ SDV+++GVVL E+ +
Sbjct: 175 GLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-17
Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 34/236 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMK 58
+AE + + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K
Sbjct: 47 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 106
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
+L + + +L ++RD N+L+ D AK+SDFGL K E T + +
Sbjct: 107 FSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGK 160
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 178
+ + APE + +++SDV+SFG++L E+ + R V + R L
Sbjct: 161 L--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPL 205
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAA----QLAAHCLSRDPKARPLMSEVVEALK 230
+ + PR+E + + + C D RP ++ E L+
Sbjct: 206 KD-------VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 53/156 (33%), Positives = 84/156 (53%), Gaps = 8/156 (5%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+ L +L H N+VK G C ED L+ EF+P GSL+ +L R + ++K A
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-- 118
+ KG+ +L R ++RD N+L+++++ K+ DFGL K E DK + + +
Sbjct: 116 VQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDD 171
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ + APE ++ SDV+SFGV L E+LT
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 48/162 (29%), Positives = 85/162 (52%), Gaps = 13/162 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+ + L H ++++++G ED L E+M GS+ +HL + ++ +
Sbjct: 51 RKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYT 109
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFG----LAKDGPEGDKTHV 115
+GL++LH E +I+RD K +N+L+D+ +++DFG LA G +
Sbjct: 110 EQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--F 164
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
+++GT + APE V+ G RS DV+S G V++EM T +
Sbjct: 165 QGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 52/156 (33%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
E+ L +L H +V+ G C+ DD+ L ++ E+MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTR 111
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTRV 119
+G+ +LH +++RD K +NIL D+ N KL DFG +K T + + V
Sbjct: 112 QILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-V 167
Query: 120 MGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLT 154
GT + +PE V++G R +DV+S G ++EMLT
Sbjct: 168 TGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP------------ 50
E L +L H ++VK G C+E D ++V+E+M G L N R P
Sbjct: 57 EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPA 115
Query: 51 -LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 109
L S + IA A G+ +L A + ++RD T N L+ + K+ DFG+++D
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 172
Query: 110 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
D V M + PE +M T+ SDV+S GVVL E+ T
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 53/168 (31%), Positives = 79/168 (47%), Gaps = 20/168 (11%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP------------ 50
E L +L H ++VK G C + D ++V+E+M G L N R P
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQ 115
Query: 51 ----LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106
L S + IA A G+ +L A + ++RD T N L+ A+ K+ DFG+++D
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 172
Query: 107 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
D V M + PE +M T+ SDV+SFGV+L E+ T
Sbjct: 173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-17
Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 4/148 (2%)
Query: 7 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 66
+G L H +V+L+G C LV + P GSL +H+ + L + + AKG
Sbjct: 63 MGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 126
+ +L E +++R+ NILL +D +++DFG+A DK + + +
Sbjct: 122 MYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 127 APEYVMTGHLTSRSDVYSFGVVLLEMLT 154
A E ++ G T +SDV+S+GV + EM++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-17
Identities = 57/177 (32%), Positives = 81/177 (45%), Gaps = 14/177 (7%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIRM 57
+ E + H N+V+LIG E R ++ E M G L++ L R + P P S+ M
Sbjct: 57 LMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTM 115
Query: 58 K----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDGPEG 110
K A AKG +L E I+RD N LL AK++DFG+A+D
Sbjct: 116 KDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 167
R M + PE + G TS++DV+SFGV+L E+ + R N E
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-17
Identities = 56/157 (35%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 22 CIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 75
C + + RL V EF+ G L H+ R R LP +S + +AL FLHE
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------FLHE--- 114
Query: 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTG 134
R +IYRD K N+LLDA+ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 135 HLTSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHN 169
D ++ GV++ EM+ GR D N + N
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 22 CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80
C + RL LV E++ G L H+ +R LP A L FLHE R +IY
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFLHE---RGIIY 119
Query: 81 RDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 139
RD K N+LLDAD + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRGEEYGFS 176
Query: 140 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 199
D ++ GV++ EM+ GR D N + N ++ + E+ R+ S+
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-------PIRIPRFLSV- 228
Query: 200 GAQKAAQLAAHCLSRDPKAR 219
KA+ + L++DPK R
Sbjct: 229 ---KASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 51/167 (30%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP------------ 50
E L L H ++V+ G C E L+V+E+M G L N R P
Sbjct: 57 EAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVA 115
Query: 51 ---LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 107
L + IA A G+ +L A ++RD T N L+ K+ DFG+++D
Sbjct: 116 PGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172
Query: 108 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
D V R M + PE ++ T+ SD++SFGVVL E+ T
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 55/164 (33%), Positives = 80/164 (48%), Gaps = 27/164 (16%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM- 57
+ E L + H LV L G +DD L LV E++P G L +HL + P P + R
Sbjct: 49 LNEKRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFY 106
Query: 58 --KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 115
++ L L +LH ++YRD K N+LLD+D K++DFG AK V
Sbjct: 107 AAQVVLA----LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RV 151
Query: 116 STRVM---GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 155
R GT Y APE ++ G+ D ++ G+++ EML G
Sbjct: 152 KGRTYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 25/170 (14%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRS----LPLP--- 52
+EVN L +L H N+V+ I+ + L V E+ G L L ++ +
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEF 106
Query: 53 -WSIRMKIALGAAKGLAFLH--EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 109
W I ++ L L H + V++RD K +NI LDA+ N KL DFGLAK
Sbjct: 107 IWRILTQLLLA----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162
Query: 110 GD---KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
KT+V GT Y +PE + +SD++S G ++ E+
Sbjct: 163 DSSFAKTYV-----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 9 DLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAK 65
D H N++ L+G C+ + L+V +M G L N F RS +++ I G AK
Sbjct: 52 DFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAK 109
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTY 123
G+ +L A + ++RD N +LD + K++DFGLA+D E H T
Sbjct: 110 GMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
Query: 124 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ A E + T T++SDV+SFGV+L E++T
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 44/143 (30%), Positives = 81/143 (56%), Gaps = 9/143 (6%)
Query: 15 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 74
+V G + ++ + EFM GSL+ ++++ P+P I KIA+ +GL +L+
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT 133
+++RD K SNIL+++ KL DFG++ G+ + ++ +GT Y +PE +
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQG 176
Query: 134 GHLTSRSDVYSFGVVLLEMLTGR 156
G T +SDV+S G+ ++E+ G+
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L +L H N++KL+ LV+EFM L + R LP S+
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTH-VSTRV 119
+GLAF H +++RD K N+L++ + KL+DFGLA+ P TH V TR
Sbjct: 107 LLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR- 162
Query: 120 MGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 156
Y APE ++ ++ D++S G + E+L+ R
Sbjct: 163 ----WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 53/166 (31%), Positives = 85/166 (51%), Gaps = 16/166 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-------FRRSLPLPW 53
+ E + + + H N+VKL+G C+ ++ + ++ E M G L ++L F L L
Sbjct: 47 LKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTL 105
Query: 54 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDGP 108
+ I L AKG +L + I+RD N L+ DAD K+ DFGLA+D
Sbjct: 106 KELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY 162
Query: 109 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ D + + APE ++ G T++SDV+SFGV++ E+LT
Sbjct: 163 KSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-16
Identities = 56/240 (23%), Positives = 104/240 (43%), Gaps = 39/240 (16%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRM 57
+ E+ L L H N++ + ++D+ L+ E+ G+L + + R+ +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
+ +A ++++H+ +++RD KT NI L KL DFG++K G + ++
Sbjct: 107 LFQIVSA--VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAE 159
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV------ 171
V+GT Y +PE +SD+++ G VL E+LT +R+ D P NLV
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQG 216
Query: 172 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231
+ P + + + + L L +DP+ RP EV++
Sbjct: 217 NYT---------------PVVSVY-----SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-16
Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
M E++ L + H N+V L +++ ++ EF G+L++ + L +
Sbjct: 50 MVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVC 109
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRV 119
+ L FLH VI+RD K NILL D + KL+DFG+ AK+ K
Sbjct: 110 RQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---F 163
Query: 120 MGTYGYAAPEYVMTGHLTS-----RSDVYSFGVVLLEMLTGR 156
+GT + APE V ++D++S G+ L+E+
Sbjct: 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-16
Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 36/238 (15%)
Query: 9 DLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRM 57
D H N++KLIG C E +++ FM G L + L L LP +
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTH 114
K + A G+ +L + R I+RD N +L D ++DFGL+K GD +
Sbjct: 117 KFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 115 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 174
++ + + A E + TS+SDV++FGV + E+ T R H + ++
Sbjct: 174 IAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYL 228
Query: 175 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
R RL P + L C DPK RP +++ E L+ +
Sbjct: 229 -------RHGNRLKQPE-------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-16
Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + + L H +V+LIG C + +LV E P G L +L +R +P S ++A
Sbjct: 44 LREASVMAQLDHPCIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELA 101
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
A G+A+L E++ V +RD N+LL + AK+SDFG+++ G + +T
Sbjct: 102 HQVAMGMAYL--ESKHFV-HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT--- 155
Query: 121 GTYG-----YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
T G + APE + G +S+SDV+S+GV L E +
Sbjct: 156 -TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-15
Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 22/230 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
++E L H N+VKLIG C + +V E +P G + L ++ L +K A
Sbjct: 40 LSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFA 99
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
L AA G+A+L + I+RD N L+ + K+SDFG+++ E D + S+ +
Sbjct: 100 LDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLK 154
Query: 121 GT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+ APE + G +S SDV+S+G++L E S+ G N + AR +
Sbjct: 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETF----SLGVCPYPGMTN--QQAREQV- 207
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229
+ YR+ P+ K ++ C P+ RP SE+ + L
Sbjct: 208 --EKGYRMSCPQ-------KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 44/124 (35%), Positives = 73/124 (58%), Gaps = 7/124 (5%)
Query: 33 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 92
E M GSL+ L +++ +P +I KI++ +GL +L E+ +++RD K SNIL+++
Sbjct: 79 EHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNS 135
Query: 93 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152
KL DFG++ G D ++ +GT Y +PE + H T +SD++S G+ L+EM
Sbjct: 136 RGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
Query: 153 LTGR 156
GR
Sbjct: 192 AIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 57/155 (36%), Positives = 84/155 (54%), Gaps = 10/155 (6%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
E + L ++ H +VKL Y + + +L L+ +F+ G L L + + ++ +A
Sbjct: 48 ERDILAEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA- 105
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 121
A L LH +IYRD K NILLD + + KL+DFGL+K+ + +K S G
Sbjct: 106 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCG 160
Query: 122 TYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTG 155
T Y APE V GH S +D +SFGV++ EMLTG
Sbjct: 161 TVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-15
Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 20/229 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + L H LV+L G C + +V EFM G L N+L +R L + + +
Sbjct: 47 IEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC 106
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+G+ +L + I+RD N L+ + K+SDFG+ + + D+ S+
Sbjct: 107 QDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAK 162
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
++ PE +S+SDV+SFGV++ E+ T + + + N E +VE
Sbjct: 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVE-------M 213
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229
R +RL P+L + + C P+ RP +E++ A+
Sbjct: 214 ISRGFRLYRPKLASMTVYE-------VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMP---RGSLENHLFRRSLPLPWSI 55
+ E+ L L H N+V+L + +V+E+M G L++ + + I
Sbjct: 46 IREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES---QI 102
Query: 56 R--MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 113
+ MK L +GL +LH +++RD K SNIL++ D KL+DFGLA+ +
Sbjct: 103 KCYMKQLL---EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNS 155
Query: 114 HVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
T + T Y PE ++ D++S G +L E+ G+
Sbjct: 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 73/228 (32%), Positives = 105/228 (46%), Gaps = 44/228 (19%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP-----WSI 55
AE N L + H +V LI Y + +L L+ E++ G L HL R + + +
Sbjct: 49 AERNILEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTH 114
+ +AL LH++ +IYRD K NILLDA + KL+DFGL K+ EG TH
Sbjct: 108 EISLALE------HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158
Query: 115 VSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 173
GT Y APE +M +GH D +S G ++ +MLTG
Sbjct: 159 T---FCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTG------------------ 196
Query: 174 ARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKAR 219
A P E R+ + ID L+G ++ +A L L R+P +R
Sbjct: 197 APPFTAENRK--KTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 27/228 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---PLPWSIRM 57
+ E+ L + H N++ ++ ++ +V E+ P G L + +R +P
Sbjct: 47 VNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW 106
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
+I + +GL LHE + +++RD K++NILL A+ K+ D G++K K +++
Sbjct: 107 RIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAK 159
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
+GT Y APE + +SD++S G +L EM T + AR
Sbjct: 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARSM 206
Query: 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225
R + R P + +S Q L PK RP ++
Sbjct: 207 QDLRYKVQRGKYPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 55/157 (35%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+ L L H N+VK G C +R LV E++P GSL ++L + L + A
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA 114
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
KG+ +L + ++RD T NIL++++ K+ DFGL K P+ DK + R
Sbjct: 115 SQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREP 170
Query: 121 G---TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
G + Y APE + + SDV+SFGVVL E+ T
Sbjct: 171 GESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 54/147 (36%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 14 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 73
+VK GY I D + E M L+ L R P+P I K+ + K L +L E+
Sbjct: 75 YIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 133
VI+RD K SNILLDA N KL DFG++ + K TR G Y APE +
Sbjct: 134 --HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD-SKAK--TRSAGCAAYMAPERIDP 188
Query: 134 GHLTS----RSDVYSFGVVLLEMLTGR 156
R+DV+S G+ L+E+ TG+
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 41/98 (41%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GT 122
A GL FLH + +IYRD K N++LDA+ + K++DFG+ K+ G KT TR GT
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGT 164
Query: 123 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160
Y APE + D ++FGV+L EML G+ D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-15
Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 44/232 (18%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRM 57
+AE N + L H LV+L + + ++ E+M GSL + L L + I M
Sbjct: 49 LAEANLMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM 107
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEG 110
A A+G+AF+ + I+RD + +NIL+ K++DFGLA+ EG
Sbjct: 108 --AAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--H 168
K + + APE + G T +SDV+SFG++L E++T R N E
Sbjct: 163 AKFPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ 214
Query: 169 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
NL R YR+ P ++ +L C P+ RP
Sbjct: 215 NL-----------ERGYRMPRPD-------NCPEELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 61/249 (24%), Positives = 91/249 (36%), Gaps = 40/249 (16%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKI 59
+ EV L L H N+V L + LV+E++ R LE LP P ++R
Sbjct: 48 LREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLP-PDAVR-SY 105
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
+ +A+ H +I+RD K NIL+ KL DFG A+ + ++ V
Sbjct: 106 IWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV 162
Query: 120 MGTYGYAAPE----YVMTGHLTSRSDVYSFGVVLLEMLTGR----------------RSM 159
T Y APE G DV++ G ++ E+L G + +
Sbjct: 163 -ATRWYRAPELLVGDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCL 218
Query: 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPR----LEGHFSIKGAQKAAQLAAHCLSRD 215
P H + + P +P LE + K + A CL D
Sbjct: 219 GPLPP--SHQELFSSNPRF----AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMD 272
Query: 216 PKARPLMSE 224
PK R E
Sbjct: 273 PKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-15
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE-------NHLFRRSLPLPWSI 55
E L L H N+++ +ED ++V E+ P G+L N L L + +
Sbjct: 49 ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTH 114
++ +A LH + +++RD KT NILLD K+ DFG++K K+
Sbjct: 109 QILLA---------LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSK 157
Query: 115 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160
T V+GT Y +PE +SD+++ G VL E+ + +R+ +
Sbjct: 158 AYT-VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-15
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 26 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 85
D LV E++ G + L + LP + G+ LH+ R +I+RD K
Sbjct: 70 DYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKP 125
Query: 86 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145
N+L+D + KL+DFGL+++G + + +GT Y APE ++ SD +S
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 146 GVVLLEMLTGRRSMDKNRP-----NGEHNLVEW 173
G V+ E L G P N + W
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-15
Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 24/167 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRM 57
+AE + L H L++L C ++ +V E M GSL +L R+L LP I M
Sbjct: 49 LAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM 108
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEG 110
A A G+A+L + I+RD N+L+ + K++DFGLA+ + EG
Sbjct: 109 --AAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 156
K + + APE + + +SDV+SFG++L E++T GR
Sbjct: 164 AKFPIK--------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 26/177 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---------------F 45
++E N L + H +++KL G C +D LL+ E+ GSL + L
Sbjct: 51 LSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110
Query: 46 RRSLPL------PWSIRMKI--ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 97
R S L ++ I A ++G+ +L AE +++RD N+L+ K
Sbjct: 111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMK 167
Query: 98 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+SDFGL++D E D ++ + A E + T++SDV+SFGV+L E++T
Sbjct: 168 ISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 58/175 (33%), Positives = 77/175 (44%), Gaps = 45/175 (25%)
Query: 15 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGLA 68
+VKL Y +D++ L LV E+MP G L N L R+ + + R + +AL + L
Sbjct: 63 IVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 69 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--------------- 113
F+H RD K NIL+DAD + KL+DFGL K +
Sbjct: 122 FIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 114 -------HVSTRVM-----GTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTG 155
H RV GT Y APE V+ G D +S GV+L EML G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 6e-15
Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 13/164 (7%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP-------- 52
+ E+ + L N+++L+ CI D ++ E+M G L L R
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 53 --WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 110
+S + +A A G+ +L + ++RD T N L+ +Y K++DFG++++ G
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
D + R + + + E ++ G T+ SDV++FGV L E+LT
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 8e-15
Identities = 53/148 (35%), Positives = 74/148 (50%), Gaps = 15/148 (10%)
Query: 12 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-ALGAAKGLAF 69
H LV L C + + + V E+ G L H+ P R A GL +
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAVFYAACVVLGLQY 116
Query: 70 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP-EGDKTHVSTRVMGTYGYAAP 128
LHE ++YRD K N+LLD + K++DFGL K+G GD+T ST GT + AP
Sbjct: 117 LHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPEFLAP 170
Query: 129 EYVMTGHLTSRS-DVYSFGVVLLEMLTG 155
E V+T +R+ D + GV++ EML G
Sbjct: 171 E-VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-15
Identities = 37/91 (40%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 125
GL FLH+ + +IYRD K N+LLD D + K++DFG+ K+ G+ ++ GT Y
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 126 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
APE + D +SFGV+L EML G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 8/158 (5%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E+ L H +VKL+ +LV E+MP L L PLP +
Sbjct: 47 LREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYM 105
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
KG+A++H +++RD K +N+L+ AD K++DFGLA+ E + S +V
Sbjct: 106 RMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV- 161
Query: 121 GTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 156
T Y APE ++ G D+++ G + E+L G
Sbjct: 162 ATRWYRAPE-LLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 32/207 (15%)
Query: 22 CIEDDQRLL-VYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 75
C + + RL V E++ G L H+ R R LP +S + +AL +LHE
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE--- 114
Query: 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTG 134
R +IYRD K N+LLD++ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 135 HLTSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 192
D ++ GV++ EM+ GR D + N + N ++ + E++ R+
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------IRI 224
Query: 193 EGHFSIKGAQKAAQLAAHCLSRDPKAR 219
S+ KAA + L++DPK R
Sbjct: 225 PRSLSV----KAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L +L H N+V+ +G ++ D + E++P GS+ L ++
Sbjct: 56 EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVRNFVRQ 114
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---- 118
KGL +LH R +I+RD K +NIL+D K+SDFG++K E + T
Sbjct: 115 ILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARP 170
Query: 119 -VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
+ G+ + APE V T ++D++S G +++EMLTG+
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 46/161 (28%), Positives = 86/161 (53%), Gaps = 9/161 (5%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
++E + +G H N+++L G + +++ E+M G+L+ +L + +
Sbjct: 54 LSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML 113
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVST 117
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PEG T
Sbjct: 114 RGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG 170
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
++ + APE + TS SDV+SFG+V+ E+++ G R
Sbjct: 171 KI--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 14 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 62
++V+L+G + L++ E M RG L+++L RSL P +++A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 128 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 123 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ +PE + G T+ SDV+SFGVVL E+ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 33/233 (14%)
Query: 1 MAEVNFLGD-LVHLNLVKLIGYCIEDDQRLLVYEFM---PRGSLENHLFRRSLPLP---- 52
++EV + + L H N+V+ +E+D+ +V + + P G N L +
Sbjct: 56 VSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI 115
Query: 53 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
W+I +++ L L +LH+E + +++RD +NI+L D ++DFGLAK K
Sbjct: 116 WNIFVQMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK 169
Query: 113 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 172
T V+GT Y+ PE V ++DV++FG +L +M T P N++
Sbjct: 170 L---TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLS 220
Query: 173 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225
A + + +P EG +S + + CL+ D +ARP + +V
Sbjct: 221 LA------TKIVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 52/159 (32%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 1 MAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMK 58
M+E+ + L H N+V L+G C L++ E+ G L N L R R L +
Sbjct: 86 MSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV--- 115
+ AKG+AFL A + I+RD N+LL K+ DFGLA+D D +V
Sbjct: 146 FSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKG 201
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ R+ + APE + T SDV+S+G++L E+ +
Sbjct: 202 NARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-- 60
EV + D H N+V++ + D+ +V EF+ G+L + + + +IA
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIATV 120
Query: 61 -LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHV 115
L K L+FLH + VI+RD K+ +ILL +D KLSDFG ++K+ P
Sbjct: 121 CLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR------ 171
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 175
++GT + APE + + D++S G++++EM+ G P
Sbjct: 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----------- 220
Query: 176 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
L +R + P+L+ K + + L RDP R +E++
Sbjct: 221 --LQAMKRIRDNLPPKLKNL--HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-------SLPLPWSIRMKI----- 59
H N++ L+G C ++ +V E+ G+L + L R S P +
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 60 ---ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
A A+G+ FL A + I+RD N+L+ D+ K++DFGLA+D D +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
T + APE + T +SDV+SFGV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 48/141 (34%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 21 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79
Y + D +L L+ +++ G L HL++R +R+ IA L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ---LGII 127
Query: 80 YRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYVMT---G 134
YRD K NILLD++ + L+DFGL+K+ E ++ + GT Y APE + G
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGG 184
Query: 135 HLTSRSDVYSFGVVLLEMLTG 155
H D +S GV+ E+LTG
Sbjct: 185 H-DKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 42/198 (21%)
Query: 43 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 102
++ + L +P I KIA+ K L +LH + VI+RD K SN+L++ + KL DFG
Sbjct: 92 KVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 103 --------LAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLL 150
+AK G K Y APE + +SDV+S G+ ++
Sbjct: 150 ISGYLVDSVAKTIDAGCKP-----------YMAPERINPELNQKGYDVKSDVWSLGITMI 198
Query: 151 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL-EGHFSIKGAQKAAQLAA 209
E+ TGR D W P + ++ P+L FS +
Sbjct: 199 ELATGRFPYDS-----------WKTP-FQQLKQVVEEPSPQLPAEKFSP----EFQDFVN 242
Query: 210 HCLSRDPKARPLMSEVVE 227
CL ++ K RP E+++
Sbjct: 243 KCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
+ E + L +VKL Y + + L LV E++P G L L L +
Sbjct: 41 LTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIY 98
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS--- 116
L +LH +I+RD K NIL+D++ + KL+DFGL+K G + +++
Sbjct: 99 IAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155
Query: 117 ---TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 155
R++GT Y APE V+ G S++ D +S G +L E L G
Sbjct: 156 KEDKRIVGTPDYIAPE-VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-14
Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 24/236 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
++E + +G H N++ L G + +++ EFM G+L++ L + + +
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGML 112
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
G A G+ +L +E ++RD NIL++++ K+SDFGL++ + T +
Sbjct: 113 RGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL 169
Query: 121 G---TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP 176
G + APE + TS SDV+S+G+V+ E+++ G R N +E
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---- 225
Query: 177 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
+ YRL P + QL C +D ARP ++V L +
Sbjct: 226 ------QDYRLPPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 52/154 (33%), Positives = 73/154 (47%), Gaps = 20/154 (12%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 125
GL LH+E ++YRD K NILLD + ++SD GLA PEG + RV GT GY
Sbjct: 114 GLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGY 167
Query: 126 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 185
APE V T D ++ G +L EM+ G+ + + + VE
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------- 214
Query: 186 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219
RL+ ++ +S K + A L L +DPK R
Sbjct: 215 RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 61/159 (38%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 1 MAEVN-FLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM 57
MAE N L ++ H LV L Y + +L V +++ G L HL R RS P P R
Sbjct: 43 MAERNVLLKNVKHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RA 98
Query: 58 KI-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
+ A A L +LH +IYRD K NILLD+ + L+DFGL K+G E KT +
Sbjct: 99 RFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--T 153
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
+ GT Y APE + D + G VL EML G
Sbjct: 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRM 57
+ E + L H LV+L + ++ +V E+M +GSL + L R+L LP + M
Sbjct: 49 LEEAQIMKKLRHDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM 107
Query: 58 KIALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
A A G+A++ ER I+RD +++NIL+ K++DFGLA+ + + T
Sbjct: 108 --AAQVAAGMAYI----ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT--- 158
Query: 117 TRVMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 174
R + + APE + G T +SDV+SFG++L E++T R N
Sbjct: 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------- 209
Query: 175 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
R L + R YR+ P+ +L C +DP+ RP
Sbjct: 210 REVLEQVERGYRMPCPQ-------DCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 11 VHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---G 66
V+ V + Y E D LV M G L+ H++ ++ P + AA+ G
Sbjct: 57 VNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFEEERALFYAAEILCG 114
Query: 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 126
L LH E +YRD K NILLD + ++SD GLA PEG+ + RV GT GY
Sbjct: 115 LEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYM 168
Query: 127 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 186
APE + T D + G ++ EM+ G+ P G + + R
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQ------------------SPFRGRKEKVKR 210
Query: 187 -LIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKAR 219
+D R+ E +S K +++A + L++DPK R
Sbjct: 211 EEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 126
L FLH VIYRD K NILLDA+ + KL+DFG+ K+G T +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163
Query: 127 APEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
APE + D ++ GV++ EM+ G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-14
Identities = 41/163 (25%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMK 58
+ E + ++ H NLV+L+G C + ++ EFM G+L ++L R + + +
Sbjct: 50 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLY 108
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGD 111
+A + + +L ++ I+RD N L+ ++ K++DFGL++ G
Sbjct: 109 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 165
Query: 112 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
K + + APE + + +SDV++FGV+L E+ T
Sbjct: 166 KFPIK--------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-14
Identities = 38/91 (41%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 125
GL FLH + ++YRD K NILLD D + K++DFG+ K+ GD + GT Y
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162
Query: 126 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
APE ++ + D +SFGV+L EML G+
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 9e-14
Identities = 37/90 (41%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 126
+LH R +IYRD K N+LLD++ KL DFG AK G KT GT Y
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYV 159
Query: 127 APEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
APE ++ D +S G++L E+LTGR
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 44/157 (28%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
++E + +G H N++ L G + ++V E+M GSL+ L + + +
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGML 112
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVST 117
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T
Sbjct: 113 RGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 169
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
++ + APE + TS SDV+S+G+V+ E+++
Sbjct: 170 KI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 28/228 (12%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E + L H LV+L G C + +V E+M G L N+L S +++
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
+G+A+L + I+RD N L+D K+SDFGL++ D + S+ +G+
Sbjct: 109 VCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGS 161
Query: 123 ---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 178
++ PE ++ +S+SDV++FGV++ E+ + G+ ++ N E VE +
Sbjct: 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSE--TVE----KV 214
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226
+ R YR P L ++K + C + RP +++
Sbjct: 215 SQGLRLYR---PHL-------ASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 23/164 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRM 57
+ E N + L H LV+L +++ ++ E+M +GSL + L + LP I
Sbjct: 49 LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF 108
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEG 110
+ A+G+A++ + I+RD + +N+L+ K++DFGLA+ EG
Sbjct: 109 SAQI--AEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
K + + APE + G T +SDV+SFG++L E++T
Sbjct: 164 AKFPIK--------WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 7/159 (4%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AE LG H N+V+L G + ++V E+M G+L++ L + L M +
Sbjct: 54 LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML 113
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG-LAKDGPEGDKTHVSTRV 119
G A G+ +L +E +++ +L+++D K+S F L +D E T +S +
Sbjct: 114 PGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKS 170
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ AAPE + H +S SDV+SFG+V+ E+++ G R
Sbjct: 171 PVLW--AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 38/91 (41%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 125
GL FLH + +IYRD K N++LD D + K++DFG+ K+ GD ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 126 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
APE + T D +SFGV+L EML G+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 18/158 (11%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIR 56
H N++ L+G C +D ++ E+ +G+L +L R P L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
+ A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
T + APE + T +SDV+SFGV+L E+ T
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 31/235 (13%)
Query: 2 AEVNFLGDLVHLNLVKLI--GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
E L H N+V L+ G V+E++P +L L LP ++
Sbjct: 27 RETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAADG-ALPAGETGRL 84
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGP---EGDKT 113
L LA H + +++RD K NI++ +AK+ DFG+ P + D
Sbjct: 85 MLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVA 141
Query: 114 HVS--TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 171
++ T V+GT Y APE + +T SD+Y++G++ LE LTG+R + G ++
Sbjct: 142 TLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ-----GA-SVA 195
Query: 172 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226
E L + P + GH Q+ L++DP+ R + +
Sbjct: 196 EILYQQLSPVD---VSLPPWIAGH-------PLGQVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 7/156 (4%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
M E + L + +V++IG C E + +LV E G L L + + S +++
Sbjct: 43 MREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM 101
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ G+ +L + ++RD N+LL + AK+SDFGL+K D ++ R
Sbjct: 102 HQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSA 157
Query: 121 GTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
G + + APE + +SRSDV+S+G+ + E +
Sbjct: 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-13
Identities = 41/153 (26%), Positives = 73/153 (47%), Gaps = 5/153 (3%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + H ++VKLIG ++ +V E P G L ++L L + + +
Sbjct: 55 LQEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ LA+L + ++RD N+L+ + KL DFGL++ E + + +++
Sbjct: 114 YQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGK 169
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 153
+ APE + TS SDV+ FGV + E+L
Sbjct: 170 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-13
Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 46/243 (18%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE---NHLFRRSLPLP----WSI 55
E++ L L H N++K + IE+++ +V E G L H ++ +P W
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 115
+++ L +H + +++RD K +N+ + A KL D GL + KT
Sbjct: 112 FVQLC----SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTA 162
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 175
+ ++GT Y +PE + +SD++S G +L EM
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQS 204
Query: 176 PHLGERRRFYRLID--------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
P G++ Y L P H+S ++ L + C++ DP+ RP +S V++
Sbjct: 205 PFYGDKMNLYSLCKKIEKCDYPPLPADHYS----EELRDLVSRCINPDPEKRPDISYVLQ 260
Query: 228 ALK 230
K
Sbjct: 261 VAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 52/161 (32%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIR--MKI 59
E+ L +L H N++ L+ LV+EFM LE + +S+ L P I+ M +
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLM 110
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VS 116
L +GL +LH +++RD K +N+L+ +D KL+DFGLA+ P TH V
Sbjct: 111 TL---RGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 117 TRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
TR Y APE + H D++S G + E+L
Sbjct: 165 TRW-----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 45/142 (31%), Positives = 65/142 (45%), Gaps = 12/142 (8%)
Query: 19 IGYCIEDDQRL-LVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEA 74
+ Y E L LV M G L+ H++ R L + I + G+ LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGILHLHSMD 115
Query: 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 134
++YRD K N+LLD N +LSD GLA + +G T+ GT GY APE +
Sbjct: 116 ---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEE 169
Query: 135 HLTSRSDVYSFGVVLLEMLTGR 156
+ D ++ G + EM+ GR
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-13
Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 10 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAA 64
L H N+++ +G CIE LLV EF P G L+N+L + + ++A A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVA 110
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 124
GL +LH+ I+ D N L AD + K+ D+GLA + D
Sbjct: 111 SGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167
Query: 125 YAAPEYV-------MTGHLTSRSDVYSFGVVLLEMLT 154
+ APE V + T +S+++S GV + E+ T
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-13
Identities = 50/145 (34%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 12 HLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 70
H L +L C + RL V EF+ G L H+ ++S + A L FL
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFL 112
Query: 71 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 130
H+ + +IYRD K N+LLD + + KL+DFG+ K+G KT ++ GT Y APE
Sbjct: 113 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEI 167
Query: 131 VMTGHLTSRSDVYSFGVVLLEMLTG 155
+ D ++ GV+L EML G
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 45/229 (19%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ FL + K G ++ + ++ E+ GS + L + L + I
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILRE 106
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---V 119
GL +LHEE I+RD K +NILL + + KL+DFG++ G T ++
Sbjct: 107 VLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTF 158
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHL 178
+GT + APE + ++D++S G+ +E+ G P + H +
Sbjct: 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG------EPPLSDLHPM-------- 204
Query: 179 GERRRFYRLID----PRLEGH-FS--IKGAQKAAQLAAHCLSRDPKARP 220
R LI P LEG+ FS K + CL++DPK RP
Sbjct: 205 ----RVLFLIPKNNPPSLEGNKFSKPFKD------FVSLCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 53/161 (32%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
+ E+ L L H NLV LI ++L LV+E+ ++ N L + +P + KI
Sbjct: 48 LREIRMLKQLKHPNLVNLI-EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKI 105
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT-HVS 116
+ + F H+ I+RD K NIL+ KL DFG A+ GP D T +V+
Sbjct: 106 IWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA 162
Query: 117 TRVMGTYGYAAPEYVMTGHLT--SRSDVYSFGVVLLEMLTG 155
TR Y APE ++ G DV++ G V E+LTG
Sbjct: 163 TR-----WYRAPE-LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-13
Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 19/168 (11%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------------- 48
E + + +L H N+V L+G ++ +++E++ +G L L RS
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 49 --LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106
L + IA+ A G+ +L + +++D NIL+ + K+SD GL+++
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSRE 173
Query: 107 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
D V + + + PE +M G +S SD++SFGVVL E+ +
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-13
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 11 VHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---G 66
V+ V + Y E D LV M G L+ H++ ++ P + AA+ G
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFDEQRAIFYAAELCCG 114
Query: 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 126
L L E ++YRD K NILLD + ++SD GLA PEG+ V RV GT GY
Sbjct: 115 LEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYM 168
Query: 127 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 186
APE + T D + G ++ EM+ G+ K + V+
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREE----------- 212
Query: 187 LIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKAR 219
+D R+ + +S K ++ A + L+++PK R
Sbjct: 213 -VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-13
Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 24/222 (10%)
Query: 15 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 74
+ K G ++D + ++ E++ GS + L PL + I KGL +LH E
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEK 121
Query: 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 134
+ I+RD K +N+LL KL+DFG+A G D +GT + APE +
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 135 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 194
S++D++S G+ +E+ G + P L+ P P LEG
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLEG 223
Query: 195 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 236
++S + + CL+++P RP E+++ + K
Sbjct: 224 NYS----KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-13
Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 32/226 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRM 57
+ E + L H LV L + ++ +V EFM +GSL + L + L LP + M
Sbjct: 49 LQEAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 58 KIALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
A A G+A++ ER I+RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 108 --AAQIADGMAYI----ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT--- 158
Query: 117 TRVMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 174
R + + APE + G T +SDV+SFG++L E++T R N
Sbjct: 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------- 209
Query: 175 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
R L + R YR+ P+ + +L C +DP RP
Sbjct: 210 REVLEQVERGYRMPCPQ-------GCPESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 7e-13
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 5/154 (3%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E++ L +VK G ++ +V E+ GS+ + + + L I
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQ 107
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
KGL +LH I+RD K NILL+ + AKL+DFG++ G D V+GT
Sbjct: 108 TLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGT 162
Query: 123 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
+ APE + +++D++S G+ +EM G+
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 18/158 (11%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIR 56
H N++ L+G C +D ++ E+ +G+L +L R P L +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
+ A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
T + APE + T +SDV+SFGV+L E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 34/229 (14%)
Query: 14 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------PLPWSIRMKIALGA 63
++V+L+G + L+V E M G L+++L RSL P P +++ I + A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPP-TLQEMIQMAA 126
Query: 64 --AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 121
A G+A+L+ + ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 127 EIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 122 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 181
+ APE + G T+ SD++SFGVVL E+ + L E L
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNE 228
Query: 182 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230
+ ++D ++ L C +PK RP E+V LK
Sbjct: 229 QVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-13
Identities = 56/167 (33%), Positives = 86/167 (51%), Gaps = 24/167 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRM 57
+AE N + L H LVKL + + ++ EFM +GSL + L PLP I
Sbjct: 49 LAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEG 110
+ A+G+AF+ + R I+RD + +NIL+ A K++DFGLA+ EG
Sbjct: 108 SAQI--AEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157
K + + APE + G T +SDV+SFG++L+E++T R
Sbjct: 163 AKFPIK--------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 45/142 (31%), Positives = 79/142 (55%), Gaps = 7/142 (4%)
Query: 15 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 74
+V G D + + E M GSL+ + +++ +P I K+++ KGL +L E+
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 123
Query: 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 134
+ +++RD K SNIL+++ KL DFG++ G D ++ +GT Y +PE +
Sbjct: 124 K--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGT 177
Query: 135 HLTSRSDVYSFGVVLLEMLTGR 156
H + +SD++S G+ L+EM GR
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E + L +L H +V ++ ++++ + EF+ G L HL R++ P +
Sbjct: 66 AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYH 124
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+LH + +IYRD K N+LLD + K++DFG AK P+ T +
Sbjct: 125 AELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LC 176
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
GT Y APE + + D ++ GV+L E + G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 42/142 (29%), Positives = 78/142 (54%), Gaps = 7/142 (4%)
Query: 15 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 74
+V G D + + E M GSL+ + + + +P I K+++ +GLA+L E+
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 134
+ +++RD K SNIL+++ KL DFG++ + ++ +GT Y +PE +
Sbjct: 124 Q--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGT 177
Query: 135 HLTSRSDVYSFGVVLLEMLTGR 156
H + +SD++S G+ L+E+ GR
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 71/246 (28%), Positives = 103/246 (41%), Gaps = 30/246 (12%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
M E+ L L H NLV LI + LV+EF+ L + L + L S K
Sbjct: 48 MREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYL 106
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT-HVST 117
+G+ F H +I+RD K NIL+ KL DFG A+ P T +V+T
Sbjct: 107 FQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVAT 163
Query: 118 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR------RSMDK--------- 161
R Y APE ++ R+ D+++ G ++ EMLTG +D+
Sbjct: 164 R-----WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218
Query: 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 221
N + + G R + I+P LE F K + LA CL DP RP
Sbjct: 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEP-LEKRFP-KLSGLVLDLAKQCLRIDPDDRPS 276
Query: 222 MSEVVE 227
S+++
Sbjct: 277 SSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 63/227 (27%), Positives = 93/227 (40%), Gaps = 39/227 (17%)
Query: 3 EVNFLGDLVHL---NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 58
EV L L N+ K G RL ++ E+ GS+ R+L I K
Sbjct: 49 EVALLSQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEK 101
Query: 59 ----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 114
I L ++H+ VI+RD K +NIL+ N KL DFG+A +
Sbjct: 102 YISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158
Query: 115 VSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 173
ST V GT + APE + G +++D++S G+ + EM TG L+
Sbjct: 159 -STFV-GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK 216
Query: 174 ARPHLGERRRFYRLIDPRLEG-HFSIKGAQKAAQLAAHCLSRDPKAR 219
++P PRLE +S + + A CL +PK R
Sbjct: 217 SKP-------------PRLEDNGYS----KLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 27/235 (11%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIR 56
E++ L H N+V+L+G C E + ++ E+ G L+ L + P P S +
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117
Query: 57 MKIALGA--AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 114
K+AL A G+ L + ++RD N L+ + K+S L+KD + +
Sbjct: 118 QKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYY 173
Query: 115 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 174
+ + APE V +++SDV+SFGV++ E+ T E
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------------QGELP 218
Query: 175 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229
L + RL +LE + +L C + +PK RP SE+V AL
Sbjct: 219 FYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 57/164 (34%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 3 EVNFLGDLV-HLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIR 56
E+ FL +L H N+VKL+ E+D+ + LV+E+M E L R ++ R
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKR 110
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKT 113
I K L ++H VI+RD K SNILL++D KL+DFGLA+ + E +
Sbjct: 111 Y-IMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
V T + T Y APE ++ ++ D++S G +L EML G+
Sbjct: 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP---------------WSIR 56
H N++ L+G C ++ ++ E+ +G+L L R P P +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
+ A A+G+ +L R I+RD N+L+ D K++DFGLA+ + D +
Sbjct: 137 VSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ + APE + T +SDV+SFG+++ E+ T
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 74/287 (25%), Positives = 114/287 (39%), Gaps = 54/287 (18%)
Query: 26 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGLAFLHEEAERPVIYRDF 83
D+ V E+ G L HL R + +S GA L +LH +E+ V+YRD
Sbjct: 68 DRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLH--SEKNVVYRDL 122
Query: 84 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 143
K N++LD D + K++DFGL K+G + T + GT Y APE + D +
Sbjct: 123 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWW 180
Query: 144 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK 203
GVV+ EM+ GR L+ L E RF R + P +
Sbjct: 181 GLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEIRFPRTLSP------------E 222
Query: 204 AAQLAAHCLSRDPK---------ARPLMS---------EVVEALKPLPNLKDMASSS--- 242
A L + L +DPK A+ +M + V K +P K +S
Sbjct: 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDT 282
Query: 243 -YYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASP 288
Y+ + A+ I +P ++ + +R P SY++
Sbjct: 283 RYFDEEFTAQMITITPPDQDDSMETVDN-----ERRPHFPQFSYSAS 324
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 38/241 (15%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRM 57
+ E++ L L H N++K IED++ +V E G L H ++ +P
Sbjct: 50 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
K + L +H R V++RD K +N+ + A KL D GL + KT +
Sbjct: 110 KYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAH 164
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
++GT Y +PE + +SD++S G +L EM P
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPF 206
Query: 178 LGERRRFYRLID--------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229
G++ Y L P H+S ++ QL C++ DP+ RP ++ V +
Sbjct: 207 YGDKMNLYSLCKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDITYVYDVA 262
Query: 230 K 230
K
Sbjct: 263 K 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 27/162 (16%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHL-----FRRSLPLPWSI 55
E L ++ H +++L + E DQR L + E++P G L ++L F S L ++
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 115
+ AL +LH + ++YRD K NILLD + + KL+DFG AK K
Sbjct: 109 EIVCAL------EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRD 153
Query: 116 STRVM-GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 155
T + GT Y APE + GH + D ++ G+++ EML G
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 7/156 (4%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E L H N+V+LIG C + +V E + G L L +++
Sbjct: 41 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMV 100
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
AA G+ +L + I+RD N L+ K+SDFG++++ E D + ST M
Sbjct: 101 ENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGM 155
Query: 121 GT--YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ APE + G +S SDV+SFG++L E +
Sbjct: 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 45/109 (41%), Positives = 59/109 (54%), Gaps = 8/109 (7%)
Query: 51 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 110
+P I KIA+ K L +L EE + +I+RD K SNILLD + N KL DFG++ G
Sbjct: 104 IPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS--GQLV 159
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSDVYSFGVVLLEMLTGR 156
D TR G Y APE + RSDV+S G+ L E+ TG+
Sbjct: 160 DSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 47/146 (32%), Positives = 73/146 (50%), Gaps = 9/146 (6%)
Query: 26 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 85
D+ + + M G L HL + + +R A GL +H R V+YRD K
Sbjct: 70 DKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHN---RFVVYRDLKP 125
Query: 86 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYS 144
+NILLD + ++SD GLA D + K H S +GT+GY APE + G S +D +S
Sbjct: 126 ANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYMAPEVLQKGTAYDSSADWFS 181
Query: 145 FGVVLLEMLTGRRSMDKNRPNGEHNL 170
G +L ++L G +++ +H +
Sbjct: 182 LGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIRMKI 59
E++ + +L H N+V+L +++ +LV+E+M + ++ H R +L
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTY 107
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
L KG+AF HE V++RD K N+L++ KL+DFGLA+ T + V
Sbjct: 108 QL--LKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV 162
Query: 120 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
T Y AP+ ++ S S D++S G ++ EM+TGR
Sbjct: 163 --TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 60/158 (37%), Positives = 79/158 (50%), Gaps = 11/158 (6%)
Query: 1 MAEVN-FLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM 57
MAE N L ++ H LV L Y + ++L V +F+ G L HL R RS P P + R
Sbjct: 43 MAERNVLLKNVKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RF 100
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
A A L +LH ++YRD K NILLD+ + L+DFGL K+G T +T
Sbjct: 101 YAA-EIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TT 154
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
GT Y APE + + D + G VL EML G
Sbjct: 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 53/171 (30%), Positives = 71/171 (41%), Gaps = 24/171 (14%)
Query: 2 AEVNFLGDLV-HLNLVKLIG------YCIEDDQRLLVYEFMPRGS---LENHLFRRSLPL 51
E N L H N+ G DDQ LV E GS L L ++ L
Sbjct: 51 EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110
Query: 52 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPE 109
I +GLA+LHE VI+RD K NILL + KL DFG++ D
Sbjct: 111 KEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL 167
Query: 110 GDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTG 155
G + + GT + APE + +RSDV+S G+ +E+ G
Sbjct: 168 G-RRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
M E++ L H N+VKL+ ++ ++ EF G+++ + PL +
Sbjct: 50 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVC 109
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ L +LHE +I+RD K NIL D + KL+DFG++ + S +
Sbjct: 110 KQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FI 164
Query: 121 GTYGYAAPEYVMTGHLTSR-----SDVYSFGVVLLEM 152
GT + APE VM R +DV+S G+ L+EM
Sbjct: 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 6e-12
Identities = 35/94 (37%), Positives = 56/94 (59%), Gaps = 5/94 (5%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTY 123
+GL ++H V++RD K SN+LL+ + + K+ DFGLA+ PE D T T + T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 124 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
Y APE ++ +++ D++S G +L EML+ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-12
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 32/226 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRM 57
+ E + L H LV+L + ++ +V E+M +GSL + L + L LP + M
Sbjct: 49 LQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 107
Query: 58 KIALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
A A G+A++ ER ++RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 108 --AAQIASGMAYV----ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--- 158
Query: 117 TRVMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 174
R + + APE + G T +SDV+SFG++L E+ T R N
Sbjct: 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------- 209
Query: 175 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
R L + R YR+ P + + L C ++P+ RP
Sbjct: 210 REVLDQVERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-12
Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 9/158 (5%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKI 59
E+ L +L H +V+ G C+ D ++ L ++ E+MP GS+++ L + L S+ K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKY 111
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR- 118
+G+++LH +++RD K +NIL D+ N KL DFG +K + R
Sbjct: 112 TRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
V GT + +PE + ++DV+S G ++EMLT +
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-12
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 47/229 (20%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAF 69
H ++V L G C+ D + ++V EF+ G L+ + R+S L PW + K+A A L++
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 70 LHEEAERPVIYRDFKTSNILL-----DADYNA--KLSDFGLAKDGPEGDKTHVSTR--VM 120
L ++ +++ + T NILL D + KLSD G+ V +R +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQECV 169
Query: 121 GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+ APE V + +L+ +D +SFG L E+ NGE L + L
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----------NGEIPLKD---KTLA 216
Query: 180 ERRRFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVV 226
E+ RFY EG + ++ A L HC++ DP RP ++
Sbjct: 217 EKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 47/144 (32%), Positives = 66/144 (45%), Gaps = 19/144 (13%)
Query: 21 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI----RMKIALGAAKGLAFLHEEAE 75
Y +DD+ L +V E+MP G L N + +P W+ + +AL A + F+H
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 133
RD K N+LLD + KL+DFG T V GT Y +PE + +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 134 --GHLTSRSDVYSFGVVLLEMLTG 155
G+ D +S GV L EML G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-12
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 29/199 (14%)
Query: 33 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 92
EFM GSL+ ++R+ +P + +IA+ KGL +L +++RD K SN+L++
Sbjct: 79 EFMDGGSLD--VYRK---IPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNT 130
Query: 93 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152
KL DFG++ ++ +GT Y APE + SDV+S G+ +E+
Sbjct: 131 RGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMEL 186
Query: 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID---PRL-EGHFSIKGAQKAAQLA 208
GR + + N + L + ++D P L G FS +K
Sbjct: 187 ALGRFPYPQIQKN---------QGSLMPLQLLQCIVDEDPPVLPVGQFS----EKFVHFI 233
Query: 209 AHCLSRDPKARPLMSEVVE 227
C+ + PK RP +++
Sbjct: 234 TQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-12
Identities = 42/154 (27%), Positives = 80/154 (51%), Gaps = 4/154 (2%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
M E + + H +LV+L+G C+ +L V + MP G L +++ + + +
Sbjct: 57 MDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWC 115
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ AKG+ +L E R +++RD N+L+ + + K++DFGLA+ +K + +
Sbjct: 116 VQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGK 172
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ A E + T +SDV+S+GV + E++T
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP---- 50
++E + + H N+++LIG C++ + +++ FM G L + L L
Sbjct: 48 LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107
Query: 51 -LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 109
LP + +K A G+ +L + + I+RD N +L+ + N ++DFGL+K
Sbjct: 108 YLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN 164
Query: 110 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
GD + A E + T++SDV+SFGV + E+ T
Sbjct: 165 GDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKI 59
E++ L +L H N+VKL+ +++ LV+EF+ + F + P +P +
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASPLSGIPLPLIKSY 105
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
+GLAF H + R V++RD K N+L++ + KL+DFGLA+ G T
Sbjct: 106 LFQLLQGLAFCH--SHR-VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHE 160
Query: 120 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
+ T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 18/158 (11%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRM------------- 57
H N++ L+G C +D ++ E+ +G+L +L RR + +S +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 58 -KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
T + APE + T +SDV+SFGV++ E+ T
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 47/146 (32%), Positives = 73/146 (50%), Gaps = 19/146 (13%)
Query: 22 CIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75
C + RL V E++ G L H+ F+ + ++ + + GL FLH
Sbjct: 69 CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GLFFLHR--- 119
Query: 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTG 134
R +IYRD K N++LD++ + K++DFG+ K E V+TR GT Y APE +
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 135 HLTSRSDVYSFGVVLLEMLTGRRSMD 160
D +++GV+L EML G+ D
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 57/157 (36%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 1 MAEVN-FLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 58
MAE N L +L H LV L Y + ++L V +++ G L HL R L R
Sbjct: 43 MAERNVLLKNLKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF- 100
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
A A + +LH +IYRD K NILLD+ + L+DFGL K+G E ++T ++
Sbjct: 101 YAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TST 155
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
GT Y APE + D + G VL EML G
Sbjct: 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ + + H N+V + + D+ +V E++ GSL + + M
Sbjct: 66 EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--------MDEGQI 117
Query: 63 AA------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHV 115
AA + L FLH VI+RD K+ NILL D + KL+DFG A+ PE K
Sbjct: 118 AAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--- 171
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
+ ++GT + APE V + D++S G++ +EM+ G
Sbjct: 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 54/156 (34%), Positives = 73/156 (46%), Gaps = 29/156 (18%)
Query: 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGY 125
L +LH V+YRD K N++LD D + K++DFGL K+G +G GT Y
Sbjct: 108 LGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEY 161
Query: 126 AAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRR 183
APE V+ + R+ D + GVV+ EM+ GR N +H L E L E R
Sbjct: 162 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHEKLFELI---LMEEIR 213
Query: 184 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219
F R + P +A L A L +DPK R
Sbjct: 214 FPRTLSP------------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 56/172 (32%), Positives = 77/172 (44%), Gaps = 24/172 (13%)
Query: 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVM 120
A+G+ FL A R I+RD NILL + K+ DFGLA+D + D +V S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGSARL- 238
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
+ APE + T++SDV+SFGV+L E+ + S P + N R G
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS---PYPGVQINEEFCQRLKDGT 294
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
R R P + + C DPK RP S +VE L L
Sbjct: 295 RMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ EV FL L H N ++ G +++ LV E+ GS + L PL I
Sbjct: 69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAIT 127
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
GA +GLA+LH +I+RD K NILL KL+DFG A K+ + +
Sbjct: 128 HGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFV 178
Query: 121 GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 152
GT + APE ++ G + DV+S G+ +E+
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 48/134 (35%), Positives = 68/134 (50%), Gaps = 11/134 (8%)
Query: 26 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---GLAFLHEEAERPVIYRD 82
D LV M G L+ H++ ++ P + AA+ GL LH E ++YRD
Sbjct: 73 DALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRD 127
Query: 83 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 142
K NILLD + ++SD GLA + PEG+ + RV GT GY APE V T D
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERYTFSPDW 184
Query: 143 YSFGVVLLEMLTGR 156
+ G ++ EM+ G+
Sbjct: 185 WGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 2e-11
Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 15/99 (15%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDKT-----HVSTR 118
+GL +LH VI+RD K SNIL++++ + K+ DFGLA+ P+ D+ +V TR
Sbjct: 114 RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 119 VMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
Y APE +++ +++ D++S G + E+LT +
Sbjct: 171 W-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 26/165 (15%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 124
KGL +LH E + I+RD K +N+LL + KL+DFG+A G D +GT
Sbjct: 112 KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF 166
Query: 125 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 184
+ APE + S++D++S G+ +E+ G PN + + + R F
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGE------PPNSDMHPM---------RVLF 211
Query: 185 Y--RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+ P L G FS + + CL++DP RP E+++
Sbjct: 212 LIPKNNPPTLTGEFS----KPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMK 58
M E+ L H +VKL+G D + ++ EF P G+++ + R L P I++
Sbjct: 57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQV- 114
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
I + L +LH +I+RD K N+LL D + KL+DFG++ + + S
Sbjct: 115 ICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-- 169
Query: 119 VMGTYGYAAPEYVMTGHLTS-----RSDVYSFGVVLLEM 152
+GT + APE VM + ++D++S G+ L+EM
Sbjct: 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 66/205 (32%), Positives = 86/205 (41%), Gaps = 35/205 (17%)
Query: 21 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGLAFLHEEAERP 77
Y + RL V E+ G L HL R + R GA L +LH R
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YGAEIVSALEYLHS---RD 115
Query: 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 137
V+YRD K N++LD D + K++DFGL K+G T + GT Y APE +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYG 173
Query: 138 SRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 194
D + GVV+ EM+ GR + D R L E L E RF R + P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELI---LMEEIRFPRTLSP---- 220
Query: 195 HFSIKGAQKAAQLAAHCLSRDPKAR 219
+A L A L +DPK R
Sbjct: 221 --------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 50/153 (32%), Positives = 68/153 (44%), Gaps = 15/153 (9%)
Query: 11 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---G 66
VH + + Y + L LV M G L H++ P + A+ G
Sbjct: 50 VHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRVMGTY 123
L LH+ R +IYRD K N+LLD D N ++SD GLA KDG K + GT
Sbjct: 110 LEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTP 161
Query: 124 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
G+ APE + D ++ GV L EM+ R
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 14/173 (8%)
Query: 3 EVNFLGDLVHLNLVKLI-GYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMK 58
E++ L + H ++ LI Y + V MP+ + LF RS PLP +
Sbjct: 136 EIDILKTISHRAIINLIHAY----RWKSTVCMVMPKYKCD--LFTYVDRSGPLPLEQAIT 189
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
I + LA+LH R +I+RD KT NI LD NA L DFG A T
Sbjct: 190 IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNL 170
GT +PE + +++D++S G+VL EM ++ K + L
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299
|
Length = 392 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 65/191 (34%), Positives = 81/191 (42%), Gaps = 26/191 (13%)
Query: 30 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 89
LV F+ G L +HL R R A + L L + VIYRD K NIL
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTA----ELLCALENLHKFNVIYRDLKPENIL 125
Query: 90 LDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 148
LD + L DFGL K + + DKT+ GT Y APE ++ T D ++ GV+
Sbjct: 126 LDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYLAPELLLGHGYTKAVDWWTLGVL 182
Query: 149 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 208
L EMLTG P + N+ E R L E RF D + A L
Sbjct: 183 LYEMLTGL------PPFYDENVNEMYRKILQEPLRFPDGFD------------RDAKDLL 224
Query: 209 AHCLSRDPKAR 219
LSRDP R
Sbjct: 225 IGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 39/106 (36%), Positives = 59/106 (55%), Gaps = 8/106 (7%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 125
GL +H R V+YRD K +NILLD + ++SD GLA D + K H S +GT+GY
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGY 161
Query: 126 AAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 170
APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 24/161 (14%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIA 60
E++ L + H N+V G + D+ +V E+ GSL++ + R L +IA
Sbjct: 50 EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-----QIA 104
Query: 61 L---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
KGLA+LHE I+RD K +NILL D + KL+DFG++ T
Sbjct: 105 YVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIA 156
Query: 118 R---VMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEM 152
+ +GT + APE G + D+++ G+ +E+
Sbjct: 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 15 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 74
+ + G ++ + ++ E++ GS + L + PL + I KGL +LH E
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSER 121
Query: 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 134
+ I+RD K +N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 135 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 194
++D++S G+ +E+ G P L+ P P LEG
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEG 223
Query: 195 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+S + + CL++DP+ RP E+++
Sbjct: 224 QYS----KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 38/241 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKI 59
E++ L L H N++K + IED++ +V E G L + ++ +P K
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
+ + +H R V++RD K +N+ + A KL D GL + KT + +
Sbjct: 112 FVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSL 166
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+GT Y +PE + +SD++S G +L EM P G
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYG 208
Query: 180 ERRRFYRLID-------PRLEG-HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231
++ + L P L H+S +K +L + C+ DP RP + V + K
Sbjct: 209 DKMNLFSLCQKIEQCDYPPLPTEHYS----EKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264
Query: 232 L 232
+
Sbjct: 265 M 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 5e-11
Identities = 53/169 (31%), Positives = 80/169 (47%), Gaps = 34/169 (20%)
Query: 3 EVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-----RRSLPLPWSIR 56
EV L L H N+VKL E+D+ V+E+M E +L+ R+ P S+
Sbjct: 47 EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVI 101
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD----GPEGDK 112
I +GLA +H+ +RD K N+L+ K++DFGLA++ P D
Sbjct: 102 RSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD- 157
Query: 113 THVSTRVMGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGR 156
+VSTR Y APE + L S S D+++ G ++ E+ T R
Sbjct: 158 -YVSTR-----WYRAPEIL----LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI---RMKI 59
E++ L +L H N+V L +++ + L++EF+ L+ +L SLP + +K
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKS 105
Query: 60 AL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
L +G+ F H R V++RD K N+L+D KL+DFGLA+ G V T
Sbjct: 106 YLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTH 160
Query: 119 VMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
+ T Y APE ++ S D++S G + EM T +
Sbjct: 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 20/145 (13%)
Query: 21 YC-IEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEA 74
+C +DD+ L +V E+MP G L N + +P W + + +AL A + +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--- 165
Query: 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT- 133
RD K N+LLD + KL+DFG E T V GT Y +PE + +
Sbjct: 166 ------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 134 ---GHLTSRSDVYSFGVVLLEMLTG 155
G+ D +S GV L EML G
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 19/146 (13%)
Query: 22 CIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75
C + RL V E++ G L + F+ + ++ + I GL FLH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHSKG- 121
Query: 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTG 134
+IYRD K N++LD++ + K++DFG+ K E V+T+ GT Y APE +
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 135 HLTSRSDVYSFGVVLLEMLTGRRSMD 160
D ++FGV+L EML G+ +
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-11
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 20/166 (12%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+ L H N+V+ +G E+ + E +P GSL L + PL + + I
Sbjct: 53 HEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF 112
Query: 61 LGAA--KGLAFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFG----LAKDGPEGDK 112
+GL +LH+ +++RD K N+L++ Y+ K+SDFG LA P
Sbjct: 113 YTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP---- 164
Query: 113 THVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGR 156
+ GT Y APE + G + +D++S G ++EM TG+
Sbjct: 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 45/160 (28%), Positives = 81/160 (50%), Gaps = 21/160 (13%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL- 61
EV + D H N+V++ + ++ ++ EF+ G+L + + + L +IA
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLN-----EEQIATV 122
Query: 62 --GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHV 115
+ L +LH + VI+RD K+ +ILL D KLSDFG ++KD P+
Sbjct: 123 CESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------ 173
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
++GT + APE + + D++S G++++EM+ G
Sbjct: 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 56/189 (29%), Positives = 78/189 (41%), Gaps = 38/189 (20%)
Query: 15 LVKLIGYCIEDDQRL-LVYEFMP----------RGSLENHLFRRSLPLPWSIRMKIALGA 63
LVKL+ Y +DD+ L L E++P G L R + M A+ A
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM-----AEMFEAVDA 116
Query: 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 123
L ++H RD K N L+DA + KL+DFGL+K + V+G+
Sbjct: 117 LHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSP 162
Query: 124 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA----RPH 177
Y APE V+ G + D +S G +L E L G + PN NL W RP
Sbjct: 163 DYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPV 221
Query: 178 LGERRRFYR 186
+ R
Sbjct: 222 YDDPRFNLS 230
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 10/139 (7%)
Query: 21 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79
Y + D +L L+ +++ G L HL +R +++ L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALEHLHKLG---II 127
Query: 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHL 136
YRD K NILLD++ + L+DFGL+K+ E D+ + GT Y AP+ V GH
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIVRGGDGGH- 185
Query: 137 TSRSDVYSFGVVLLEMLTG 155
D +S GV++ E+LTG
Sbjct: 186 DKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 47/144 (32%), Positives = 67/144 (46%), Gaps = 19/144 (13%)
Query: 21 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEAE 75
Y +DD+ L +V E+MP G L N + +P W + + +AL A + F+H
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 133
RD K N+LLD + KL+DFG + T V GT Y +PE + +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 134 --GHLTSRSDVYSFGVVLLEMLTG 155
G+ D +S GV L EML G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 17/162 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+ L +L+H +V+ G + +R L E MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYT 112
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------GPEGDKTH 114
+G+++LH +++RD K +NIL D+ N KL DFG +K G K+
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS- 168
Query: 115 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
V GT + +PE + ++D++S G ++EMLT +
Sbjct: 169 ----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 53/184 (28%), Positives = 77/184 (41%), Gaps = 45/184 (24%)
Query: 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 126
L LH+ ++YRD K NILLDA + L DFGL+K +KT + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 127 APEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 184
APE ++ G+ T D +S GV++ EM G W+ + + ++
Sbjct: 164 APEVLLDEKGY-TKHVDFWSLGVLVFEMCCG-----------------WSPFYAEDTQQM 205
Query: 185 YRLID------PR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 234
YR I P+ EG +KG L+R+P+ R LK P
Sbjct: 206 YRNIAFGKVRFPKNVLSDEGRQFVKG----------LLNRNPQHRLGAHRDAVELKEHPF 255
Query: 235 LKDM 238
D+
Sbjct: 256 FADI 259
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 50/171 (29%), Positives = 76/171 (44%), Gaps = 37/171 (21%)
Query: 3 EVNFLGDLVHLNLVKL---------------IGYCIEDDQRLLVYEFMPRGSLENHLFRR 47
E+ L +L H N+V+L + YC +D LL + MP
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT---------- 103
Query: 48 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 107
P S + L +GL +LHE +I+RD K SN+LL K++DFGLA+
Sbjct: 104 --PFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLAR-- 156
Query: 108 PEGDKTHVSTRVMGTYGYAAPEYV--MTGHLTSRSDVYSFGVVLLEMLTGR 156
G T + T Y APE + T + T+ D+++ G +L E+L +
Sbjct: 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 47/161 (29%), Positives = 85/161 (52%), Gaps = 27/161 (16%)
Query: 10 LVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIRMK----I 59
L H N++ ++ CIED + ++Y +M G+L+ LF + L P ++ + +
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHM 122
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPE-----GDKT 113
A+ A G+++LH+ R VI++D N ++D + K++D L++D P GD
Sbjct: 123 AIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ + M A E ++ +S SDV+SFGV+L E++T
Sbjct: 180 NRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 14/165 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIED--DQRL----LVYEFMPRGSLENHLFRRSL----- 49
+ E + + H N++KLIG + RL ++ FM G L L +
Sbjct: 49 LREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF 108
Query: 50 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 109
LP ++ + A G+ +L + + I+RD N +L+ + ++DFGL+K
Sbjct: 109 TLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165
Query: 110 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
GD + A E + T+ SDV++FGV + E++T
Sbjct: 166 GDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 46/161 (28%), Positives = 83/161 (51%), Gaps = 17/161 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRM 57
E++ L ++ H N+V+L + + LV+E++ L+ H+ F ++ L +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVS 116
+I +G+A+ H V++RD K N+L+D NA KL+DFGLA+ G
Sbjct: 110 QI----LRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTF 160
Query: 117 TRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
T + T Y APE ++ + H ++ D++S G + EM+ +
Sbjct: 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 75/285 (26%), Positives = 118/285 (41%), Gaps = 45/285 (15%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIA 60
+E++ L H +VK DD+ LL+ E+ G L + +R LP+ ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
L + + L E R +++RD K++NI L KL DFG +K + V++
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GT Y APE + ++D++S GV+L E+LT RP G
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLT------------------LHRPFKGP 274
Query: 181 RRR------FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV--EALKPL 232
+R Y DP F + L LS++P RP +++ E LK +
Sbjct: 275 SQREIMQQVLYGKYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329
Query: 233 PNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRS 277
NL FQ + SP+ R I Q L +G+R+
Sbjct: 330 ANL---------FQDIVRHSETISPHDREEILRQ---LQESGERA 362
|
Length = 478 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L D+ H N+VK + + ++ EFM GSLE L +A
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQ 176
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMG 121
G+A+LH R +++RD K SN+L+++ N K++DFG+++ + D + S +G
Sbjct: 177 ILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VG 230
Query: 122 TYGYAAPEYVMTGHLTSR-----SDVYSFGVVLLEMLTGR 156
T Y +PE + T D++S GV +LE GR
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH-------LFRRSLPLPWSI 55
EV L + H N+V E+ + +V E+ G L LF L W +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTH 114
+I+LG L +H+ R +++RD K+ NI L + AKL DFG+A+ D
Sbjct: 109 --QISLG----LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSME 157
Query: 115 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 162
++ +GT Y +PE +++D++S G VL E+ T + + N
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 11/94 (11%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 124
+GL ++H +I+RD K SNI ++ D K+ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 125 YAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGR 156
Y APE +M H D++S G ++ E+LTG+
Sbjct: 181 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 19/161 (11%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKI 59
E+ L +L H +V+ G C+ D +++L ++ E+MP GS+++ L + L ++ +
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRY 111
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------GPEGDKT 113
+G+++LH +++RD K +NIL D+ N KL DFG +K G K+
Sbjct: 112 TRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
V GT + +PE + ++DV+S ++EMLT
Sbjct: 169 -----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 6/142 (4%)
Query: 37 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 96
L +L +RS PLP + I +GL +LH A+R +I+RD KT NI ++
Sbjct: 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH--AQR-IIHRDVKTENIFINDVDQV 196
Query: 97 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
+ D G A+ P + + GT APE + S++D++S G+VL EML
Sbjct: 197 CIGDLGAAQ-FPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYP 253
Query: 157 RSMDKNRPNGEHNLVEWARPHL 178
++ ++ P+ V+ HL
Sbjct: 254 STIFEDPPSTPEEYVKSCHSHL 275
|
Length = 357 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 32/179 (17%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIE-----DDQRLLVYEFMP------RGSLENHLFRRSL 49
+ E+ L L H N+V LI +E +R VY P G LEN + +
Sbjct: 55 LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTE 114
Query: 50 PLPWSIR--MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-- 105
I+ M L +G+ +LHE +++RD K +NIL+D K++DFGLA+
Sbjct: 115 S---QIKCYMLQLL---EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPY 165
Query: 106 -------DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
G G T T ++ T Y PE ++ T+ D++ G V EM T R
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 57/235 (24%), Positives = 102/235 (43%), Gaps = 42/235 (17%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK---- 58
EV + D H N+V + + D+ +V EF+ G+L + + RM
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQI 120
Query: 59 --IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDK 112
+ L + L++LH + VI+RD K+ +ILL +D KLSDFG ++K+ P+
Sbjct: 121 ATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--- 174
Query: 113 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 172
++GT + APE + + D++S G++++EM+ G
Sbjct: 175 ---RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY------------- 218
Query: 173 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+ P L RR + PR++ + + L R+P R E+++
Sbjct: 219 FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG--FLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 26/165 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E++ L +L H N+V+L+ +++ LV+EF+ L+ + S P L
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSP-------LTGLD 97
Query: 63 AA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
+G+A+ H V++RD K N+L+D + KL+DFGLA+ G
Sbjct: 98 PPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVP 152
Query: 113 THVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
T + T Y APE ++ S D++S G + EM+ R
Sbjct: 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-10
Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 24/160 (15%)
Query: 14 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGL 67
N+V L Y + +D LV + G L +H+ + L +P W+ M +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDA---- 100
Query: 68 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYA 126
LH E ++ RD +NILLD + +L+ F + D V Y
Sbjct: 101 --LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 127 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 166
APE T D +S G +L E+LTG +++ + P+G
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 49/153 (32%), Positives = 69/153 (45%), Gaps = 13/153 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
EV FL L H N ++ G + + LV E+ GS + L PL I G
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHG 123
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
A +GLA+LH I+RD K NILL KL+DFG A + +GT
Sbjct: 124 ALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSAS------LVSPANSFVGT 174
Query: 123 YGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 152
+ APE ++ G + DV+S G+ +E+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 44/141 (31%), Positives = 73/141 (51%), Gaps = 15/141 (10%)
Query: 21 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM---KIALGAAKGLAFLHEEAER 76
Y + + +L L+ +++ G + HL++R +R +I L L LH+
Sbjct: 72 YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA----LEHLHKLG-- 125
Query: 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV--MTG 134
++YRD K NILLD++ + L+DFGL+K+ +K + GT Y APE + G
Sbjct: 126 -IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGG 183
Query: 135 HLTSRSDVYSFGVVLLEMLTG 155
H D +S G+++ E+LTG
Sbjct: 184 H-GKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 49/151 (32%), Positives = 70/151 (46%), Gaps = 17/151 (11%)
Query: 70 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 129
+H + +I+RD K++NILL ++ KL DFG +K V GT Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 130 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 189
+ ++D++S GV+L E+LT +R D GE N+ E L R D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE-NMEEVMHKTLAGR------YD 263
Query: 190 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
P L S + ++ LS DPK RP
Sbjct: 264 P-LPPSIS----PEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 42/235 (17%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK---- 58
EV + D H N+V++ + D+ +V EF+ G+L + + RM
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQI 118
Query: 59 --IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDK 112
+ L K L+ LH + VI+RD K+ +ILL D KLSDFG ++K+ P
Sbjct: 119 AAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--- 172
Query: 113 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 172
++GT + APE + D++S G++++EM+ G P ++
Sbjct: 173 ---RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI- 228
Query: 173 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
R +L + + + P L+G L RDP R +E+++
Sbjct: 229 --RDNLPPKLKNLHKVSPSLKGFLD------------RLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMK 58
E+ L + N++K+ G+ I+ L L+ E+ RG L L + L + ++
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLD 126
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
+A+ KGL L++ +P Y++ + + L+ +Y K+ GL K +V+
Sbjct: 127 MAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM 184
Query: 119 VMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGR 156
V Y + + + T + D+YS GVVL E+ TG+
Sbjct: 185 V-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTY 123
+ L FLH VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT
Sbjct: 127 QALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTP 180
Query: 124 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
+ APE V + D++S G++ +EM+ G
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL- 61
E+ + +L + N+V + + D+ +V E++ GSL + + + +IA
Sbjct: 66 EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD-----EAQIAAV 120
Query: 62 --GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTR 118
+ L FLH VI+RD K+ N+LL D + KL+DFG A+ PE K +
Sbjct: 121 CRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RST 174
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
++GT + APE V + D++S G++ +EM+ G
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 56/173 (32%), Positives = 76/173 (43%), Gaps = 26/173 (15%)
Query: 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVM 120
AKG+ FL A R I+RD NILL + K+ DFGLA+D + D +V R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARL- 243
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLG 179
+ APE + T +SDV+SFGV+L E+ S+ + G E+ R G
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF----SLGASPYPGVKIDEEFCRRLKEG 298
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
R R P + Q C +P RP SE+VE L L
Sbjct: 299 TRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 45/161 (27%), Positives = 82/161 (50%), Gaps = 27/161 (16%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR------------ 56
H N++ L+G C + E+ P G+L + L R+S L P +
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 57 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 115
++ A A G+ +L +E+ I+RD N+L+ + +K++DFGL++ G++ +V
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYV 173
Query: 116 STRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ MG + A E + T++SDV+SFGV+L E+++
Sbjct: 174 K-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 53/156 (33%), Positives = 72/156 (46%), Gaps = 7/156 (4%)
Query: 1 MAEVN-FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
M+E N L ++ H LV L D+ V +++ G L HL R L R
Sbjct: 43 MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-Y 101
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A A L +LH ++YRD K NILLD+ + L+DFGL K+ E + T ++
Sbjct: 102 AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTF 156
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
GT Y APE + D + G VL EML G
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 38/208 (18%)
Query: 33 EFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 89
E+M GSL+ L+ + +P + +I KGL FL EE +I+RD K +N+L
Sbjct: 79 EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVL 135
Query: 90 LDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYVMTGHLTSR------SDV 142
++ + KL DFG++ + KT++ G Y APE + +G SDV
Sbjct: 136 VNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQNPTYTVQSDV 190
Query: 143 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID---PRLEGHFSIK 199
+S G+ +LEM GR P N+ + ++D P L +S
Sbjct: 191 WSLGLSILEMALGRYPYP---PETYANIFA----------QLSAIVDGDPPTLPSGYS-- 235
Query: 200 GAQKAAQLAAHCLSRDPKARPLMSEVVE 227
A A CL++ P RP ++++E
Sbjct: 236 --DDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA------LGAAK 65
H N++ L+G C L E+ P G+L + L R+S L IA L + +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 66 GLAFLHEEA-------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
L F + A ++ I+RD NIL+ +Y AK++DFGL++ G + +V +
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-K 180
Query: 119 VMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 26/145 (17%)
Query: 48 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 107
S PL ++ + A+G+ FL A + I+RD N+LL AK+ DFGLA+D
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD- 261
Query: 108 PEGDKTHVSTRVMGT----YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 163
D +V V G + APE + T +SDV+S+G++L E+ S+ K+
Sbjct: 262 IMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGKS- 313
Query: 164 PNGEHNLVEWARPHLGERRRFYRLI 188
P + +FY+++
Sbjct: 314 ----------PYPGILVNSKFYKMV 328
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 48/155 (30%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ EV FL + H N ++ G + + LV E+ GS + L PL I
Sbjct: 73 IKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAIT 131
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
GA +GLA+LH +I+RD K NILL KL+DFG A + +
Sbjct: 132 HGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FV 182
Query: 121 GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 152
GT + APE ++ G + DV+S G+ +E+
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 13/156 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
E+ L L H N++ L I + + V E + + H S PL
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFLY 115
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 121
+GL ++H V++RD K SNIL++ + + K+ DFGLA+ +VSTR
Sbjct: 116 QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-- 170
Query: 122 TYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGR 156
Y APE ++T D++S G + EML G+
Sbjct: 171 ---YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 48/155 (30%), Positives = 70/155 (45%), Gaps = 13/155 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ EV FL L H N ++ G + + LV E+ GS + L PL +
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVT 121
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
GA +GLA+LH +I+RD K NILL KL DFG A + +
Sbjct: 122 HGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANXFV 172
Query: 121 GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 152
GT + APE ++ G + DV+S G+ +E+
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 3e-09
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTY 123
+ L FLH VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT
Sbjct: 126 QALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTP 179
Query: 124 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
+ APE V + D++S G++ +EM+ G
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-09
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 35/232 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSI 55
EV L ++ H N+V+ E+ +V ++ G L LF L W +
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 115
++ +AL +H+ R +++RD K+ NI L D KL DFG+A+ +
Sbjct: 109 QICLAL------KHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVEL 157
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 175
+ +GT Y +PE ++SD+++ G VL EM T + + + NLV
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA---GNMKNLV---- 210
Query: 176 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
L R Y P + H+S +QL R+P+ RP ++ ++E
Sbjct: 211 --LKIIRGSY----PPVSSHYSYDLRNLVSQL----FKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
+ E L + H L L Y + RL V E++ G L HL R + R
Sbjct: 43 LTESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYG 101
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A L +LH ++YRD K N++LD D + K++DFGL K+G T +
Sbjct: 102 A-EIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--F 155
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
GT Y APE + D + GVV+ EM+ GR
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 124
+GL +LH +++RD K N+L++++ K+ DFGLA+ + H++ V+ Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 125 YAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
Y APE +M + H TS D++S G + E+L R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 27/161 (16%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR------------ 56
H N++ L+G C L E+ P G+L + L R+S L P
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 57 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 115
+ A A+G+ +L +++ I+RD NIL+ +Y AK++DFGL++ G + +V
Sbjct: 114 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV 166
Query: 116 STRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 167 K-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E N + L + +V++IG C E + +LV E G L L + +I ++
Sbjct: 44 LREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELV 101
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ G+ +L E ++RD N+LL + AK+SDFGL+K D+ + +
Sbjct: 102 HQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTH 157
Query: 121 GTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLE 151
G + + APE + +S+SDV+SFGV++ E
Sbjct: 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL----------LVYEFMPR---GSLENHLFRRSL 49
E+ L L H N+V L + L LV+E+M G LE+ L S
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 50 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 109
S MK L +GL + H+ + ++RD K SNILL+ KL+DFGLA+
Sbjct: 116 DHIKSF-MKQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 110 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
+ + +V+ T Y PE ++ + DV+S G +L E+ T +
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 124
+GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 125 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 156
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-09
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 124
KGL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 125 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 156
Y APE ++ H T D++S G ++ EMLTG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 10 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWS 54
L H N+V L+G ++ +++ + L L RS L +
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 55 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 114
+ I A G+ FL + V+++D T N+L+ N K+SD GL ++ D
Sbjct: 125 DFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 115 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ + + +PE +M G + SD++S+GVVL E+ +
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 7/155 (4%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
EV+ L DL H N+V L D LV+E++ + L+ ++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
+GLA+ H R V++RD K N+L++ KL+DFGLA+ KT+ + V T
Sbjct: 113 ILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--T 167
Query: 123 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
Y P+ ++ + +++ D++ G + EM +GR
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 124
GL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 125 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 156
Y APE ++ H D++S G ++ EMLTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 24/167 (14%)
Query: 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 123
AKG++FL A + I+RD NILL K+ DFGLA+D V
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 124 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 183
+ APE + T SDV+S+G++L E+ + L P + +
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPGMPVDSK 325
Query: 184 FYRLIDPRLEGH--FSIKGA-QKAAQLAAHCLSRDPKARPLMSEVVE 227
FY++I EG+ S + A + + C DP RP ++V+
Sbjct: 326 FYKMIK---EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 41/161 (25%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPW 53
+ E + + + ++ +L+G C+ +L + + MP G L ++++ + L L W
Sbjct: 57 LDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-LNW 114
Query: 54 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 113
+++ AKG+ +L E R +++RD N+L+ + K++DFGLAK +K
Sbjct: 115 CVQI------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ + + A E ++ T +SDV+S+GV + E++T
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 29/167 (17%)
Query: 3 EVNFLGDLVHLNLVKL----IGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSI 55
E+N L L H N+V + +G + D+ +V E++ + +E P+
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM------KQPFLQ 105
Query: 56 R-----MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 110
M L G+A LH+ +++RD KTSN+LL+ K+ DFGLA+ G
Sbjct: 106 SEVKCLMLQLL---SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYG 157
Query: 111 DKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
T+++ T Y APE ++ ++ D++S G + E+LT +
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 52/200 (26%), Positives = 77/200 (38%), Gaps = 60/200 (30%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI- 59
AE + L + + +VKL Y +D+ L L+ E++P G + L ++ R I
Sbjct: 50 AERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA 108
Query: 60 ----ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTH 114
A+ + L ++H RD K N+LLDA + KLSDFGL G K+H
Sbjct: 109 ETILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSH 155
Query: 115 VST----------------------------------RVM-----GTYGYAAPEYVMTGH 135
+ R + GT Y APE +
Sbjct: 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215
Query: 136 LTSRSDVYSFGVVLLEMLTG 155
D +S GV++ EML G
Sbjct: 216 YNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVM 120
A+G+ FL A R I+RD NILL + K+ DFGLA+D + D +V R+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARL- 237
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ APE + T++SDV+SFGV+L E+ +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 40/144 (27%), Positives = 73/144 (50%), Gaps = 16/144 (11%)
Query: 17 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76
+L+G C+ +L V + MP G L +++ + + + AKG+++L E
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR-- 129
Query: 77 PVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPE--GDKTHVSTRVMGTYGYAAPEY 130
+++RD N+L+ + + K++DFGLA+ D E D V + M A E
Sbjct: 130 -LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM------ALES 182
Query: 131 VMTGHLTSRSDVYSFGVVLLEMLT 154
++ T +SDV+S+GV + E++T
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 48/166 (28%), Positives = 71/166 (42%), Gaps = 15/166 (9%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
+E L + H V L G ++ LV EF+ G L RR+ P +
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVG---CF 135
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR--- 118
AA+ + ++YRD K N+LLD D K++DFG AK V TR
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYT 187
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 164
+ GT Y APE ++ +D ++ G+ + E+L G N P
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMG 121
+GL ++H VI+RD K SN+L++ D ++ DFG+A+ P K + T +
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM-TEYVA 173
Query: 122 TYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSM 159
T Y APE +++ + + D++S G + EML GRR +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-08
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 29/157 (18%)
Query: 7 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-ENH--LFRRSLPLPWSIRMKIALGA 63
+G L LN V ++ +E D + + +G L E H LF L
Sbjct: 82 VGSLTELNSVYIVQEYMETDLANV----LEQGPLSEEHARLFMYQL-------------- 123
Query: 64 AKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAK--DGPEGDKTHVSTRVM 120
+GL ++H V++RD K +N+ ++ D K+ DFGLA+ D K ++S ++
Sbjct: 124 LRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 121 GTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 156
+ Y +P +++ + T D+++ G + EMLTG+
Sbjct: 181 TKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-08
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 10 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALG 62
L H NL++ +G C E LLV EF P G L+ +L RS P P +++ ++A
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQ-RMACE 108
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
A GL LH+ I+ D N LL AD K+ D+GL+ + + D ++
Sbjct: 109 IALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP 165
Query: 123 YGYAAPEYVMTGH-------LTSRSDVYSFGVVLLEML 153
+ APE V H T S+V+S GV + E+
Sbjct: 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 7/155 (4%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
EV+ L DL H N+V L + LV+E++ + L+ +L +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
+GL + H R V++RD K N+L++ KL+DFGLA+ KT+ + V T
Sbjct: 113 LLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--T 167
Query: 123 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
Y P+ ++ + +++ D++ G + EM TGR
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 34/102 (33%), Positives = 59/102 (57%), Gaps = 9/102 (8%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGT 122
GL ++H V++RD K N+L++AD K+ DFGLA+ + P + + T + T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 123 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNR 163
Y APE +++ +++ DV+S G +L E+L GR+ + K +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 43/143 (30%), Positives = 62/143 (43%), Gaps = 11/143 (7%)
Query: 21 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79
Y +D L LV E+ P G L + L R + A+ + +H + +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIHSVHQMGYV 124
Query: 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY--VMTGHLT 137
+RD K N+L+D + KL+DFG A +K S +GT Y APE M G
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 138 SRSDV----YSFGVVLLEMLTGR 156
V +S GV+ EM+ GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 47/201 (23%), Positives = 85/201 (42%), Gaps = 26/201 (12%)
Query: 10 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGA 63
L H N+++ +G C+E LLV+E+ G L+++L R S L + ++A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEI 108
Query: 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 123
A G+ +H+ ++ D N L +D K+ D+G+ + D
Sbjct: 109 AAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPL 165
Query: 124 GYAAPEYV-------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 176
+ APE V +T T S+V++ GV L E+ +N +L +
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF-------ENAAQPYSHLSDREVL 218
Query: 177 HLGERRRFYRLIDPRLEGHFS 197
+ + + +L P+LE +S
Sbjct: 219 NHVIKDQQVKLFKPQLELPYS 239
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 55/173 (31%), Positives = 74/173 (42%), Gaps = 29/173 (16%)
Query: 2 AEVNFLGDLV-HLNLVKLIGYCIEDD-----QRLLVYEFMPRGS---LENHLFRRSLPLP 52
AE N L L H N+VK G + D Q LV E GS L L L
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126
Query: 53 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
++ I GA GL LH +I+RD K +NILL + KL DFG++
Sbjct: 127 EAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQ------ 177
Query: 113 THVSTRV-----MGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTG 155
STR+ +GT + APE + +R DV+S G+ +E+ G
Sbjct: 178 -LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 44/199 (22%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFR-----RSLPLPWSI 55
E DL+H +V + Y I D VY MP G L + SL +
Sbjct: 52 EAKIAADLIHPGIVPV--YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAE 108
Query: 56 R------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDG 107
+ + I + ++H + V++RD K NILL + D+G A K
Sbjct: 109 KTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKL 165
Query: 108 PEGDKTHVST--------------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 153
E D + +++GT Y APE ++ + +D+Y+ GV+L +ML
Sbjct: 166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
Query: 154 T---------GRRSMDKNR 163
T GR+ ++
Sbjct: 226 TLSFPYRRKKGRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 7/155 (4%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
EV+ L +L H N+V L + LV+E++ L+ +L +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
+GL++ H+ R +++RD K N+L++ KL+DFGLA+ KT+ + V T
Sbjct: 112 LLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--T 166
Query: 123 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
Y P+ ++ + ++ D++ G +L EM TGR
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 124
+GL ++H V++RD K SN+LL+A+ + K+ DFGLA+ +K T + T
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 125 YAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 156
Y APE ++ T+ DV+S G + E+L +
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 42/169 (24%), Positives = 77/169 (45%), Gaps = 26/169 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL--LVYEFMPRGSLE---NHLFRRSLPLPWSIRM 57
E+ L +L H N+V L+ +E + L++++ + H + + +P S+
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DGP--- 108
+ G+ +LH V++RD K +NIL+ + K+ D GLA+ + P
Sbjct: 112 SLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 109 --EGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 154
+ D V+ T Y APE ++ H T D+++ G + E+LT
Sbjct: 169 LADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 53/187 (28%), Positives = 79/187 (42%), Gaps = 29/187 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPR---GSLENHLFRRSLPL 51
E+ L L H N+V LI C LV+EF G L N + +L
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 52 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPE 109
+ MK+ L GL ++H +++RD K +NIL+ D KL+DFGLA+ +
Sbjct: 121 IKKV-MKMLL---NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSK 173
Query: 110 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGRRSMDKNRP 164
K + T + T Y PE + L R D++ G ++ EM T M N
Sbjct: 174 NSKPNRYTNRVVTLWYRPPELL----LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229
Query: 165 NGEHNLV 171
+ L+
Sbjct: 230 QHQLTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 3 EVNFLGDLVHLNLVKLI-GYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIA 60
E L L H N+V + ED +V F G L + L ++ LP + ++
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ A L +LHE+ +++RD KT N+ L K+ D G+A+ ++ +++ ++
Sbjct: 109 VQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLI 163
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GT Y +PE +SDV++ G + EM T + + + N +LV
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLV--------- 211
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226
YR+I+ +L + + +L A LS+ P+ RP + ++
Sbjct: 212 ----YRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 12 HLNLVKLIGYC--IEDDQRL---LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAK 65
H N+V+L+ C D+ LV+E + + L +L + P LP + +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS-TRVMGTYG 124
GL FLH +++RD K NIL+ + KL+DFGLA+ ++ T V+ T
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLW 172
Query: 125 YAAPEYVMTGHLTSRSDVYSFGVVLLEML 153
Y APE ++ + D++S G + EM
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 124
+GL ++H +I+RD K SN+ ++ D ++ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 125 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 156
Y APE ++ H D++S G ++ E+L G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 33/98 (33%), Positives = 47/98 (47%), Gaps = 12/98 (12%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTHVSTRVM 120
+ L ++H V +RD K NIL +AD K+ DFGLA+ D P T +
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP---TAIFWTDYV 167
Query: 121 GTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGR 156
T Y APE + T D++S G + E+LTG+
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 47/174 (27%), Positives = 67/174 (38%), Gaps = 48/174 (27%)
Query: 21 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-----ALGAAKGLAFLHEEA 74
Y +D + L L+ EF+P G + L ++ + + I A+ A L F+H
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH--- 124
Query: 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLA---------------KDGPEGD-------- 111
RD K N+LLDA + KLSDFGL P D
Sbjct: 125 ------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 112 ----------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
+ ++ +GT Y APE M D +S GV++ EML G
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 27/166 (16%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP----------RGSLENHLFRRSLPLP 52
E+ L +L H N+V+L D + LV+E+ G ++ + + +
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM--- 105
Query: 53 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
KGLAF H V++RD K N+L++ + KL+DFGLA+ G
Sbjct: 106 --------FQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIP 152
Query: 113 THVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRR 157
+ + T Y P+ + L S S D++S G + E+ R
Sbjct: 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 50/193 (25%), Positives = 75/193 (38%), Gaps = 49/193 (25%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
AE + L + L +VK+ Y +D L L+ EF+P G + L ++ + IA
Sbjct: 50 AERDILVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA 108
Query: 61 -----LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-- 113
+ + L F+H RD K N+LLD+ + KLSDFGL + +T
Sbjct: 109 ETVLAIDSIHQLGFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159
Query: 114 -------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDV 142
++ +GT Y APE M D
Sbjct: 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDW 219
Query: 143 YSFGVVLLEMLTG 155
+S GV++ EML G
Sbjct: 220 WSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 13/151 (8%)
Query: 12 HLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAK 65
H N+V+L C + + LV+E + + L +L + P +P + +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 125
GL FLH V++RD K NIL+ + KL+DFGLA+ T V+ T Y
Sbjct: 122 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWY 175
Query: 126 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
APE ++ + D++S G + EM +
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 23/172 (13%)
Query: 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGT 122
A+G+ FL A + ++RD N+LL K+ DFGLA+D D +VS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH-DSNYVSKGSTFLP 302
Query: 123 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 182
+ APE + T+ SDV+S+G++L E+ + L P +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS---------------LGGTPYPGMIVDS 347
Query: 183 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEALKP 231
FY I Q+ + C + +P+ RP +S++VE+L P
Sbjct: 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 23/163 (14%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG---SLENHLFRRSLPLPWSIRM-- 57
E + L DL H N+V L LV+E++ +++ + M
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC--------GGGLSMHN 104
Query: 58 -KIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 115
++ L +GLA+ H+ R V++RD K N+L+ KL+DFGLA+ KT+
Sbjct: 105 VRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS 161
Query: 116 STRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGR 156
+ V T Y P+ ++ T + TS D++ G + EM TGR
Sbjct: 162 NEVV--TLWYRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 14/133 (10%)
Query: 30 LVYEFMP---RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 86
LV+E++ + ++++ PLP KG+A H+ V++RD K
Sbjct: 83 LVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQ 139
Query: 87 NILLDADYNA-KLSDFGLAKDG--PEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDV 142
N+L+D K++D GL + P TH + T Y APE ++ H ++ D+
Sbjct: 140 NLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWYRAPEVLLGSTHYSTPVDI 195
Query: 143 YSFGVVLLEMLTG 155
+S G + EM
Sbjct: 196 WSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 125
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 183
Query: 126 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
APE ++ D++S G ++ EM+ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 18/165 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGY----CIEDDQRLL----VYEFMPRG--SLENHLFRRSLPLP 52
E+ + +L H+N++ L Y C + +++ + V EF+P+ H R + LP
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP 168
Query: 53 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGD 111
+ + + LA++H + + +RD K N+L+D + + KL DFG AK+ G
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
Query: 112 KTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 155
+ S + + Y APE ++ + T+ D++S G ++ EM+ G
Sbjct: 226 R---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 36/119 (30%), Positives = 47/119 (39%), Gaps = 32/119 (26%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--------------DGPEGD 111
L +LH ++YRD K NILL + LSDF L+K G
Sbjct: 115 ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 112 KTH----------VSTRVM---GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
+ S R GT Y APE + GH S D ++ G++L EML G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 8e-07
Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 9/156 (5%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIAL 61
E + L L H N+V L + V+E+M L ++ + L P+++R+
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMF 110
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 121
+GLA++H + +++RD K N+L+ KL+DFGLA+ +T+ S V
Sbjct: 111 QLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-- 165
Query: 122 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
T Y P+ ++ +S D++ G + +EML G+
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 54/171 (31%), Positives = 76/171 (44%), Gaps = 26/171 (15%)
Query: 2 AEVNFLGDLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPL 51
E+N L H N+ G I+ DDQ LV EF GS+ + + +L
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 52 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 111
W I +GLA LH VI+RD K N+LL + KL DFG++ + D
Sbjct: 121 DWI--AYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLD 172
Query: 112 KTHVSTR--VMGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTG 155
+T V R +GT + APE + RSD++S G+ +EM G
Sbjct: 173 RT-VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 21/151 (13%)
Query: 12 HLNLVKLIGYC--IEDDQRL---LVYEFMPR---GSLENHLFRRSLPLPWSIR--MKIAL 61
H N+V+L+ C D+ L LV+E + + L + LP P +I+ M+ L
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-KPGLP-PETIKDLMRQLL 117
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 121
+G+ FLH +++RD K NIL+ +D K++DFGLA+ T V+
Sbjct: 118 ---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVV 168
Query: 122 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152
T Y APE ++ + D++S G + E+
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ + D H N+V G + D+ + EF GSL++ ++ + PL S ++
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRE 114
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
+GL +LH + + ++RD K +NILL + + KL+DFG++ S +GT
Sbjct: 115 TLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGT 169
Query: 123 YGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 152
+ APE G D+++ G+ +E+
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 125
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 126 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 51/185 (27%), Positives = 78/185 (42%), Gaps = 36/185 (19%)
Query: 16 VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLA 68
+ + Y +D+ L LV ++ G L L + LP + M IA+ + L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 69 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 124
++H RD K NIL+D + + +L+DFG L +DG T S+ +GT
Sbjct: 123 YVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPD 168
Query: 125 YAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
Y +PE + G D +S GV + EML G P +LVE +
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMN 222
Query: 180 ERRRF 184
+ RF
Sbjct: 223 HKERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 43/226 (19%)
Query: 7 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 66
+ L H +LVKL G C+ D + ++V E++ G L+ L R + ++ +A A
Sbjct: 55 MSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASA 113
Query: 67 LAFLHEEAERPVIYRDFKTSNILL-DADYN------AKLSDFGLAKDGPEGDKTHVSTRV 119
L +L ++ +++ + NIL+ N KLSD G+ + R+
Sbjct: 114 LHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI 168
Query: 120 MGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
+ APE + G LT +D +SFG LLE+ + NGE L +
Sbjct: 169 ----PWIAPECIRNGQASLTIAADKWSFGTTLLEICS----------NGEEPLSTLSS-- 212
Query: 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA---HCLSRDPKARP 220
E+ RFY+ + H A+LA C + DP RP
Sbjct: 213 -SEKERFYQ------DQH--RLPMPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-06
Identities = 65/242 (26%), Positives = 101/242 (41%), Gaps = 42/242 (17%)
Query: 3 EVNFLGDLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLP 52
E+N L H N+ G I+ DDQ LV EF GS+ + + +L
Sbjct: 52 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111
Query: 53 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
W I +GL+ LH+ VI+RD K N+LL + KL DFG++ + D+
Sbjct: 112 WI--AYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDR 163
Query: 113 THVSTR--VMGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 165
T V R +GT + APE + +SD++S G+ +EM G + P
Sbjct: 164 T-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222
Query: 166 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225
L+ R PRL+ S K ++K CL ++ RP ++
Sbjct: 223 RALFLIP-------------RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
Query: 226 VE 227
++
Sbjct: 267 MK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 18/167 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ + ++ H N++ L+ +E D LV + M L+ + R + L S I L
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQ 127
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--------DGPEGDKTH 114
GL LH+ ++RD +NI +++ K++DFGLA+ D D+T
Sbjct: 128 ILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 115 VSTRVMG----TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
M T Y APE +M D++S G + E+LTG+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 11/159 (6%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRM 57
+ E+ L L N+V+L + LV+E++ + LE +P P +R
Sbjct: 48 LRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRS 104
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
I K + + H+ +++RD K N+L+ + KL DFG A++ EG + T
Sbjct: 105 YI-YQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-T 159
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
+ T Y +PE ++ D++S G +L E+ G+
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGT 122
A G+ FL A + ++RD N+L+ K+ DFGLA+D D ++S
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR-DSNYISKGSTFLP 304
Query: 123 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ APE + T+ SDV+SFG++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 47/169 (27%), Positives = 70/169 (41%), Gaps = 22/169 (13%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSI 55
E L + H N+V D +V E+ G L LF L W +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT 113
+M + G+ +HE + V++RD K+ NI L + KL DFG A+ P
Sbjct: 108 QMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GA 155
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 162
+ T V GT Y PE ++SD++S G +L E+ T + N
Sbjct: 156 YACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 52/208 (25%), Positives = 79/208 (37%), Gaps = 60/208 (28%)
Query: 15 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 68
+VKL Y +D L V +++P G + + L F L + + A+ + +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121
Query: 69 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--------------DGPEGDKTH 114
F+H RD K NIL+D D + KL+DFGL D D
Sbjct: 122 FIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 115 VSTRV---------------------------MGTYGYAAPEYVM-TGHLTSRSDVYSFG 146
S +GT Y APE ++ TG+ T D +S G
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVG 231
Query: 147 VVLLEMLTGRRSMDKNRPNG-EHNLVEW 173
V+L EML G+ + P + ++ W
Sbjct: 232 VILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 125
G+ LH +I+RD K SNI++ +D K+ DFGLA+ + T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYY 188
Query: 126 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
APE ++ D++S G ++ E++ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 53/168 (31%), Positives = 71/168 (42%), Gaps = 19/168 (11%)
Query: 2 AEVNFLGDLV-HLNLVKLIG-YCIED----DQRLLVYEFMPRGS---LENHLFRRSLPLP 52
AE N L L H N+VK G Y +D DQ LV E GS L +R +
Sbjct: 63 AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122
Query: 53 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
I I A GL LH I+RD K +NILL + KL DFG++
Sbjct: 123 EPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTST 177
Query: 113 THVSTRVMGTYGYAAPEYV-----MTGHLTSRSDVYSFGVVLLEMLTG 155
+GT + APE + + +R DV+S G+ +E+ G
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-06
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 125
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184
Query: 126 AAPEYVMTGHLTSRSDVYSFGVVLLEML------TGRRSMDK-NR---------PNGEHN 169
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 170 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 219
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 302
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 21/151 (13%)
Query: 21 YCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSI-RMKIALGAAKGLAFLHEEAERP 77
+C + +R L V E++ G L + LP + RM A L +LH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFA-ETVLALEYLHNYG--- 121
Query: 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDG--------PEGD-----KTHVSTRVMGTYG 124
+++RD K N+L+ + + KL+DFGL+K G EG + + +V GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 125 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
Y APE ++ D ++ G++L E L G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 16/95 (16%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTHVSTRVM 120
K L +H + +RD K NIL+ D KL+DFG + P + ++STR
Sbjct: 111 KSLDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTE--YISTR-- 162
Query: 121 GTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154
Y APE ++T G+ + D+++ G V E+L+
Sbjct: 163 ---WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 40/167 (23%), Positives = 66/167 (39%), Gaps = 21/167 (12%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--LPWSIRMKI 59
E+ L H N++ + I D + +V M GS E+ L + P LP I
Sbjct: 48 QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFI 106
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---- 115
L ++H + I+R K S+ILL D LS + + K
Sbjct: 107 LKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 116 ----STRVMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTG 155
S + + + +PE + + G+ +SD+YS G+ E+ G
Sbjct: 164 FPKSSVKNL---PWLSPEVLQQNLQGY-NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 61/206 (29%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPWSI 55
AE + L + + +VKL Y +D L V +++P G + + L R L +
Sbjct: 50 AERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA 108
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA----------- 104
+ +A+ + + F+H RD K NIL+D D + KL+DFGL
Sbjct: 109 ELTLAIESVHKMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159
Query: 105 --------KDGPE-------------GD----------KTH---VSTRVMGTYGYAAPEY 130
+D E GD K H ++ ++GT Y APE
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219
Query: 131 VMTGHLTSRSDVYSFGVVLLEMLTGR 156
++ T D +S GV+L EML G+
Sbjct: 220 LLRKGYTQLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 39/153 (25%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ + + H N+V G + ++ + E+ GSL++ ++ + PL +
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRE 114
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
+GLA+LH + + ++RD K +NILL + + KL+DFG+A S +GT
Sbjct: 115 TLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGT 169
Query: 123 YGYAAPEYVM---TGHLTSRSDVYSFGVVLLEM 152
+ APE G D+++ G+ +E+
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 9e-06
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 13/155 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRM 57
E L L H +VK +E D ++ E+ L+ L ++L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
I L G+ ++H+ R +++RD K NI L + K+ DFG+++ ++T
Sbjct: 112 FIQL--LLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLAT 163
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152
GT Y +PE + S+SD++S G +L EM
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 44/151 (29%), Positives = 65/151 (43%), Gaps = 30/151 (19%)
Query: 21 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI------RMKIALGAAKGLAFLHEE 73
Y +D+ L LV ++ G L L + LP + M +A+ + L ++H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH-- 125
Query: 74 AERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 129
RD K N+LLD + + +L+DFG L DG T S +GT Y +PE
Sbjct: 126 -------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG-----TVQSNVAVGTPDYISPE 173
Query: 130 YVM-----TGHLTSRSDVYSFGVVLLEMLTG 155
+ G D +S GV + EML G
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 43/221 (19%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 71
H++L + G C+ + ++V EF+ G L+ L + +P + ++ +A A L++L
Sbjct: 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE 134
Query: 72 EEAERPVIYRDFKTSNILLD----ADYNA---KLSDFGLAKDGPEGDKTHVSTRVMGTYG 124
+ + +++ + NILL A+ + KLSD G++ ++ RV
Sbjct: 135 D---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE-----RV-ERIP 185
Query: 125 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 183
+ APE V G L++ +D +SFG LLE+ +GE L E E+ R
Sbjct: 186 WIAPECVPGGNSLSTAADKWSFGTTLLEICF----------DGEVPLKERTPS---EKER 232
Query: 184 FY----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
FY RL +P ++ A L + CL+ +P RP
Sbjct: 233 FYEKKHRLPEP---------SCKELATLISQCLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 30/151 (19%)
Query: 21 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLAFLHEE 73
Y +D+ L LV ++ G L L + LP + M +A+ + L ++H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 74 AERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 129
RD K N+LLD + + +L+DFG + +DG T S+ +GT Y +PE
Sbjct: 126 -------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPE 173
Query: 130 YVMT-----GHLTSRSDVYSFGVVLLEMLTG 155
+ G D +S GV + EML G
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 50/206 (24%), Positives = 78/206 (37%), Gaps = 61/206 (29%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHL-----FRRSLPLPWSI 55
AE + L + + +V+L Y +D D V +++P G + + L F L +
Sbjct: 50 AERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA 108
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL------------ 103
+ A+ + + F+H RD K NIL+D D + KL+DFGL
Sbjct: 109 ELTCAVESVHKMGFIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 104 --AKDGPEGDKTHVSTR-------------------------------VMGTYGYAAPEY 130
+ D D S ++GT Y APE
Sbjct: 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV 219
Query: 131 VMTGHLTSRSDVYSFGVVLLEMLTGR 156
++ T D +S GV+L EML G+
Sbjct: 220 LLRTGYTQLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 12/160 (7%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKI 59
E + L + H ++++L G + L+ +PR + + + +R++ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAI--CDILAI 187
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
+ + +LHE +I+RD K NI ++ + L DFG A P +
Sbjct: 188 ERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGW 243
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159
GT APE + D++S G+VL EM T S+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 46/187 (24%), Positives = 65/187 (34%), Gaps = 62/187 (33%)
Query: 21 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-----LGAAKGLAFLHEEA 74
Y +D Q L L+ EF+P G L L + R +A + A L F+H
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIH--- 124
Query: 75 ERPVIYRDFKTSNILLDADYNAKLSDFGL---------------------AKDGPEGDKT 113
RD K NIL+D + KLSDFGL K+ + +
Sbjct: 125 ------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178
Query: 114 HV-------------------STRVM-----GTYGYAAPEYVMTGHLTSRS-DVYSFGVV 148
+ R+M GT Y APE + + D +S G +
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLGAI 237
Query: 149 LLEMLTG 155
+ E L G
Sbjct: 238 MFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 21/162 (12%)
Query: 3 EVNFLGDLVHLNLVKL--------IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 54
E+ LG L H N++K+ Y I +Y FM + + + PL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDRPLLKQ 268
Query: 55 IR--MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
R MK L A + ++H+ + +I+RD K NI L+ D L DFG A E ++
Sbjct: 269 TRAIMKQLLCA---VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKER 321
Query: 113 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+GT +PE + +D++S G++LL+ML+
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 25/92 (27%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 124
+GL+++H+ R +++RD K N+L+ KL+DFGLA+ + +H + + T
Sbjct: 114 RGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLW 168
Query: 125 YAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 155
Y P+ ++ + ++ D++ G + +EM+ G
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 37/150 (24%), Positives = 72/150 (48%), Gaps = 8/150 (5%)
Query: 10 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 69
L H +LV G C+ D+ ++V E++ GSL+ +L + + S ++++ AK LA+
Sbjct: 56 LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV----AKQLAW 111
Query: 70 -LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYA 126
LH ++ + + + N+LL + + K + K G V + + +
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWV 171
Query: 127 APEYVMTG-HLTSRSDVYSFGVVLLEMLTG 155
PE + +L+ +D +SFG L E+ +G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 33/115 (28%), Positives = 51/115 (44%), Gaps = 3/115 (2%)
Query: 37 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 96
R L +L R PL + +A + ++H E +I+RD KT N+L++ +
Sbjct: 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDI 299
Query: 97 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 151
L DFG A T + GT APE + T D++S G+V+ E
Sbjct: 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 21/136 (15%)
Query: 34 FMPRGSLENHLFRRSLP--LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 91
FM GS N L + P + ++ I GA +GL +LH+ I+R+ K S+IL+
Sbjct: 80 FMAYGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 92 ADYNAKLSD----FGLAKDGPEG----DKTHVSTRVMGTYGYAAPEYV---MTGHLTSRS 140
D LS + L ++G + D ST V+ + +PE + + G+ +S
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGY-NVKS 191
Query: 141 DVYSFGVVLLEMLTGR 156
D+YS G+ E+ TGR
Sbjct: 192 DIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 33/188 (17%)
Query: 3 EVNFLGDLVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRM 57
EVN + +L H N+V+ I + + +Q+L ++ EF G L ++ ++ + +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 58 KIALGAAKGLAFLHEEAERP----VIYRDFKTSNILLD----------ADYN-------A 96
I LA+ H + P V++RD K NI L A N A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 97 KLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEML 153
K+ DFGL+K+ G E ++ +GT Y +PE ++ T +SD+++ G ++ E+
Sbjct: 182 KIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 154 TGRRSMDK 161
+G+ K
Sbjct: 238 SGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 31/116 (26%), Positives = 57/116 (49%), Gaps = 11/116 (9%)
Query: 46 RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NAKLSDF 101
++ + LP S+ + G+ +LH V++RD K +NIL+ + K++D
Sbjct: 100 KKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156
Query: 102 GLAK--DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 154
G A+ + P + V+ T+ Y APE ++ H T D+++ G + E+LT
Sbjct: 157 GFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 304 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.5 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.42 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.34 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.1 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.03 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.98 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.8 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.49 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.47 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.45 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.44 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.16 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.0 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.82 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.77 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.75 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.66 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.65 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.41 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.39 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.32 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.32 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.92 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.77 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.63 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.03 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.01 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.77 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.51 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.36 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.28 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.26 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.19 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.18 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.18 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.01 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.97 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.69 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 94.64 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.61 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.5 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.33 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.23 | |
| PLN02236 | 344 | choline kinase | 94.11 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.01 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.49 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.82 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.78 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.75 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.54 | |
| PF10140 | 359 | YukC: WXG100 protein secretion system (Wss), prote | 91.56 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=333.16 Aligned_cols=210 Identities=26% Similarity=0.425 Sum_probs=175.4
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCe-eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPV 78 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i 78 (304)
++|++|+++.+|||||.+|+.|..++. .+|+||||++|||++++.+- +.+++..+.+++.+|++||.|||. .+ |
T Consensus 125 ~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~---I 200 (364)
T KOG0581|consen 125 LRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK---I 200 (364)
T ss_pred HHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC---e
Confidence 479999999999999999999999994 99999999999999998554 579999999999999999999996 66 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|||||||+||||+..|.+||||||.+...... ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.|
T Consensus 201 IHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP 276 (364)
T KOG0581|consen 201 IHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFP 276 (364)
T ss_pred eeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCC
Confidence 99999999999999999999999999886543 45678999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI-KGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
|....... ....+... .+++.. ....+. .+++++++|+..||++||.+|||++|+++|..
T Consensus 277 ~~~~~~~~-~~~~~Ll~----------~Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 277 YPPPNPPY-LDIFELLC----------AIVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred CCCcCCCC-CCHHHHHH----------HHhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 97652111 11111111 111110 111222 36789999999999999999999999998753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=336.76 Aligned_cols=208 Identities=28% Similarity=0.413 Sum_probs=171.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++||++|+|||||+++++|...+..||||||+.||+|.+++..++ .+.+..-+.++.|++.||.|||+.| |+||
T Consensus 225 ~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G---I~HR 300 (475)
T KOG0615|consen 225 NEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG---IIHR 300 (475)
T ss_pred HHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC---cccc
Confidence 79999999999999999999999999999999999999999997764 6888888999999999999999999 9999
Q ss_pred cCCCCCeEECCC---CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC---CCchhhhHHHHHHHHHHHhC
Q 022003 82 DFKTSNILLDAD---YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 82 dlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg 155 (304)
||||+|||++.+ ..+||+|||+|+..+.. ....++|||+.|.|||++.+.. +..++|||||||++|-+++|
T Consensus 301 DiKPeNILl~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG 377 (475)
T KOG0615|consen 301 DIKPENILLSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSG 377 (475)
T ss_pred cCCcceEEeccCCcceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEecc
Confidence 999999999765 77999999999987643 2356789999999999998654 34488999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.+||....... ...+.... +++. +.| ......++++.+||.+||..||++|||++|+++|.
T Consensus 378 ~pPFS~~~~~~--sl~eQI~~-----G~y~--f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 378 YPPFSEEYTDP--SLKEQILK-----GRYA--FGP----LQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred CCCcccccCCc--cHHHHHhc-----Cccc--ccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 99997653322 11111110 1100 001 11234578999999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=346.15 Aligned_cols=204 Identities=26% Similarity=0.414 Sum_probs=175.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+||+|.++|+|||||+++++|++.++.|||+|+|..++|..+++ +.+.++|.+++.++.||+.||.|||+.+ |+||
T Consensus 67 ~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHR 142 (592)
T KOG0575|consen 67 NEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHR 142 (592)
T ss_pred HHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceec
Confidence 69999999999999999999999999999999999999999997 4558999999999999999999999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
|||..|+|++++..|||+|||+|........ .+.+.|||+.|+|||++.....+..+||||+|||+|-|++|++||+.
T Consensus 143 DLKLGNlfL~~~~~VKIgDFGLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 143 DLKLGNLFLNENMNVKIGDFGLATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred ccchhheeecCcCcEEecccceeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 9999999999999999999999998764322 34568999999999999999999999999999999999999999976
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
....+....+. .-++. ++...+.++.+||.++|+.||.+|||+++|+.+-
T Consensus 221 k~vkety~~Ik-----------~~~Y~-------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 221 KTVKETYNKIK-----------LNEYS-------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred chHHHHHHHHH-----------hcCcc-------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 53221111110 00111 2224467899999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=321.15 Aligned_cols=222 Identities=25% Similarity=0.329 Sum_probs=179.1
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
||||++|++|+|+|+|.++++|...+.+++|+|||+. ++.+-+.+....++.+.+.+++.|++.|+.|+|+++ +||
T Consensus 49 lREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IH 124 (396)
T KOG0593|consen 49 LREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIH 124 (396)
T ss_pred HHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eec
Confidence 6899999999999999999999999999999999955 666667787778999999999999999999999999 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
|||||+||||+.+|.+||||||+|+...... ...+..+.|.||+|||.+.| .+|+..+||||+||++.||++|.+.|
T Consensus 125 RDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~ 202 (396)
T KOG0593|consen 125 RDIKPENILITQNGVVKLCDFGFARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW 202 (396)
T ss_pred ccCChhheEEecCCcEEeccchhhHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC
Confidence 9999999999999999999999999876422 23455788999999999987 78999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhcc--------cccccccc--CCccCCCCC---HHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 022003 160 DKNRPNGEHNLVEWARPHLGE--------RRRFYRLI--DPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEVV 226 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~--~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~ell 226 (304)
.+..+.++...+......+.. ...|..+. .+...+..+ ...+..+.+|+.+||++||.+|++++|++
T Consensus 203 PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 203 PGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred CCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 987766554433322221111 11121111 111111111 12356889999999999999999999999
Q ss_pred HH
Q 022003 227 EA 228 (304)
Q Consensus 227 ~~ 228 (304)
.+
T Consensus 283 ~H 284 (396)
T KOG0593|consen 283 HH 284 (396)
T ss_pred cC
Confidence 75
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=321.67 Aligned_cols=206 Identities=29% Similarity=0.460 Sum_probs=170.2
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|++||++|+|||||.+++++..++.+|+|||||.||+|.++|.+++ .+++..++.++.||+.||++||+++ |||
T Consensus 57 ~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiH 132 (429)
T KOG0595|consen 57 LSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIH 132 (429)
T ss_pred HHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 469999999999999999999999999999999999999999997765 7999999999999999999999998 999
Q ss_pred ccCCCCCeEECCC------CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh
Q 022003 81 RDFKTSNILLDAD------YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 81 ~dlkp~Nili~~~------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 154 (304)
|||||+||||+.. -.+||+|||+|+....+. ...+.+|++.|||||++....|+.|+|+||+|+|+|+|++
T Consensus 133 RDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~ 209 (429)
T KOG0595|consen 133 RDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLT 209 (429)
T ss_pred ccCCcceEEeccCCCCCCCceEEecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHh
Confidence 9999999999764 468999999999986443 3556899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|++||......+.....+. +.......+...+..+.+++...|+.++.+|-+..+...+
T Consensus 210 g~~Pf~a~t~~eL~~~~~k---------------~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 210 GKPPFDAETPKELLLYIKK---------------GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred CCCCccccCHHHHHHHHhc---------------cccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 9999986544322111100 1111122233334566688888888888888877776654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=310.98 Aligned_cols=211 Identities=25% Similarity=0.352 Sum_probs=169.8
Q ss_pred ChHhhHhhcCCCCcccceee-EEEeCCe-eEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 1 MAEVNFLGDLVHLNLVKLIG-YCIEDDQ-RLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~-~~~~~~~-~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
++|+.+|++|+|||||++++ .+.++.. ++||||||.+|+|...|+. ..+.+++..+|+++.|++.||..+|+.-+
T Consensus 66 v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~ 145 (375)
T KOG0591|consen 66 VKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP 145 (375)
T ss_pred HHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc
Confidence 36999999999999999999 4444444 8999999999999998854 35579999999999999999999999432
Q ss_pred C-CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh
Q 022003 76 R-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 76 ~-~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 154 (304)
+ -|+||||||.||+|+.+|.+||+|||+++.+... .......+||+.||+||.+.+.+|+.|+||||+||++|||+.
T Consensus 146 r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMca 223 (375)
T KOG0591|consen 146 RGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCA 223 (375)
T ss_pred ccceeeccCcchheEEcCCCceeeccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHh
Confidence 2 2999999999999999999999999999987543 233456899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.++||.+.+- ..... .+ ..-.........++.++..||..|+..||+.||+...++..+
T Consensus 224 L~~PF~g~n~------~~L~~-KI---------~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 224 LQSPFYGDNL------LSLCK-KI---------EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred cCCCcccccH------HHHHH-HH---------HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 9999987621 11111 00 001111112246788999999999999999999855555443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=325.53 Aligned_cols=229 Identities=59% Similarity=1.019 Sum_probs=199.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC-eeEEEEecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++|.+++|||+|+++|||.+.+ ..+||+||++.|+|.+++..... .++|..+.+|+.++|.||+|||.....+||
T Consensus 120 ~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~ii 199 (361)
T KOG1187|consen 120 NEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPII 199 (361)
T ss_pred HHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEe
Confidence 6999999999999999999999998 59999999999999999987765 899999999999999999999998877899
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecc-cccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV-MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|||||++|||+|+++.+||+|||+|+........ .... .||.+|+|||++..+..+.|+||||||+++.||+||+.+
T Consensus 200 HrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~ 277 (361)
T KOG1187|consen 200 HRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKA 277 (361)
T ss_pred cCCCCHHHeeECCCCCEEccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcc
Confidence 9999999999999999999999999665431111 1112 799999999999999999999999999999999999998
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccC-CCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE-GHFSI-KGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
.............+|....+.+. .+.+++|+.+. ..+.. .....+..+..+|++.+|.+||++.|+++.|+.+.
T Consensus 278 ~d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 278 VDQSRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cCCCCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 88766555666888887666655 78899999987 55554 57788999999999999999999999999985543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=324.31 Aligned_cols=221 Identities=27% Similarity=0.350 Sum_probs=179.4
Q ss_pred ChHhhHhhcCC-CCcccceeeEEEeCC-eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 1 MAEVNFLGDLV-HLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 1 l~E~~il~~l~-h~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
|||++-|++|+ |||||++.+++.+++ .+|+||||| ..+|.++++.+...|++..++.|+.||++||+|+|++| +
T Consensus 56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---f 131 (538)
T KOG0661|consen 56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---F 131 (538)
T ss_pred HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---c
Confidence 58999999998 999999999999988 999999999 67999999999889999999999999999999999999 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-cCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
.|||+||+||||..+..+||+|||+||..... ...+..+.|.||+|||++. .+.|+.++||||+|||++|+.+.++
T Consensus 132 FHRDlKPENiLi~~~~~iKiaDFGLARev~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrP 208 (538)
T KOG0661|consen 132 FHRDLKPENILISGNDVIKIADFGLAREVRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRP 208 (538)
T ss_pred ccccCChhheEecccceeEecccccccccccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcc
Confidence 99999999999998889999999999986432 2345678899999999876 6789999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhh--hh---hccc--------cccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 158 SMDKNRPNGEHNLVEWAR--PH---LGER--------RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~--~~---~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
.|.+....++...+--+. +. +.+. -++.....-.+...++. .+.++.+||.+||.+||++||||.|
T Consensus 209 LFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~ 287 (538)
T KOG0661|consen 209 LFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQ 287 (538)
T ss_pred cCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHH
Confidence 999876554322111110 00 0010 11111222222222232 5789999999999999999999999
Q ss_pred HHHHh
Q 022003 225 VVEAL 229 (304)
Q Consensus 225 ll~~l 229 (304)
++++.
T Consensus 288 al~~p 292 (538)
T KOG0661|consen 288 ALQHP 292 (538)
T ss_pred HhcCc
Confidence 99864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=327.06 Aligned_cols=213 Identities=35% Similarity=0.569 Sum_probs=177.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC-eeEEEEecCCCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+.+|++++|||||+++|++.... .+++||||+++|+|.+++.. ....+++..+..|+.||+.||.|||++++ ||
T Consensus 88 ~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iI 165 (362)
T KOG0192|consen 88 REASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--II 165 (362)
T ss_pred HHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--ee
Confidence 6999999999999999999999887 79999999999999999987 36789999999999999999999999874 89
Q ss_pred eccCCCCCeEECCCC-cEEEccccCcccCCCCCcceeeecccccccccCcchhh--cCCCCchhhhHHHHHHHHHHHhCC
Q 022003 80 YRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 80 H~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tg~ 156 (304)
|||||++|||++.++ ++||+|||+++...... .......||+.|||||++. ...|+.|+||||||+++|||+||.
T Consensus 166 HrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~ 243 (362)
T KOG0192|consen 166 HRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGE 243 (362)
T ss_pred ecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCC
Confidence 999999999999997 99999999998754321 1223367999999999999 569999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCC
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 234 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~ 234 (304)
.||...... ....... . .......+..++..+..||.+||..||..||++.+++..|+.+..
T Consensus 244 ~Pf~~~~~~---~~~~~v~-~------------~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 244 IPFEDLAPV---QVASAVV-V------------GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCCCHH---HHHHHHH-h------------cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 999876541 1111110 0 111111222356789999999999999999999999998875543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=316.12 Aligned_cols=218 Identities=29% Similarity=0.372 Sum_probs=177.3
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|..||.+++||.||+++-.|++.+++|+|+||+.||.|..+|++.+ .|++..++-++..|+.||.|||+.+ |||
T Consensus 73 ~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g---Iiy 148 (357)
T KOG0598|consen 73 KAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG---IIY 148 (357)
T ss_pred HHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC---eee
Confidence 369999999999999999999999999999999999999999996554 7999999999999999999999999 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.+|+++|+|||+++....... ...+++||+.|||||++.+.+|+..+|.||||+++|||++|.+||.
T Consensus 149 RDlKPENILLd~~GHi~LtDFgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 149 RDLKPENILLDEQGHIKLTDFGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred ccCCHHHeeecCCCcEEEeccccchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 99999999999999999999999996443322 3445899999999999999999999999999999999999999998
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCCCccCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~~~~~~~ 240 (304)
..+.. .+.......+. ...+.-.+.++++++.++|+.||++|.....=.+.++..+.+.++.+
T Consensus 227 ~~~~~------~~~~~I~~~k~-----------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 227 AEDVK------KMYDKILKGKL-----------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred CccHH------HHHHHHhcCcC-----------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 65432 11111111110 01111235689999999999999999753333334556666666654
Q ss_pred C
Q 022003 241 S 241 (304)
Q Consensus 241 ~ 241 (304)
.
T Consensus 290 ~ 290 (357)
T KOG0598|consen 290 E 290 (357)
T ss_pred H
Confidence 3
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=326.74 Aligned_cols=207 Identities=27% Similarity=0.410 Sum_probs=176.0
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+.+|+.++|+|||.+++.|...+.+++||||++||+|.+.+... .+++.++..+++++++||+|||.++ |+|
T Consensus 318 lnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g---IiH 392 (550)
T KOG0578|consen 318 LNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG---IIH 392 (550)
T ss_pred HHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc---eee
Confidence 57999999999999999999999999999999999999999998665 3999999999999999999999999 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||.+|||++.+|.+||+|||++..+..... .....+||+.|||||++....|++|+||||||++++||+-|.+||.
T Consensus 393 rDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 393 RDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred eccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 99999999999999999999999998765433 3456789999999999999999999999999999999999999998
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
...+......+ ... + .|. -..+...+..+.+|+.+||+.|+++|+++.|||+|-
T Consensus 471 nE~PlrAlyLI----a~n---g------~P~--lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 471 NENPLRALYLI----ATN---G------TPK--LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred CCChHHHHHHH----hhc---C------CCC--cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 64332111111 000 0 011 112334578999999999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=315.81 Aligned_cols=213 Identities=30% Similarity=0.419 Sum_probs=171.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC--eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++|++|+|||||+++|...... .++++|||+++|+|.+++.+.+..+++..+..+.+||++||+|||++| |+
T Consensus 63 ~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~v 139 (313)
T KOG0198|consen 63 REIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IV 139 (313)
T ss_pred HHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 6999999999999999999755444 689999999999999999877658999999999999999999999999 99
Q ss_pred eccCCCCCeEECC-CCcEEEccccCcccCCC-CCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCC
Q 022003 80 YRDFKTSNILLDA-DYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 80 H~dlkp~Nili~~-~~~~kl~Dfg~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~ 156 (304)
||||||+||||+. ++.+||+|||++..... ...........||+.|||||++..+ ....++|||||||++.||+||+
T Consensus 140 H~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~ 219 (313)
T KOG0198|consen 140 HCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGK 219 (313)
T ss_pred ccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCC
Confidence 9999999999999 79999999999987653 1111223347899999999999953 3446999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
.||... .. ...+...... ......++...+.++.+|+.+|+..||++||||+++|++....
T Consensus 220 ~PW~~~--~~---~~~~~~~ig~----------~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 220 PPWSEF--FE---EAEALLLIGR----------EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred Ccchhh--cc---hHHHHHHHhc----------cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 999764 11 1111110000 0011133444578999999999999999999999999987543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=322.10 Aligned_cols=211 Identities=33% Similarity=0.471 Sum_probs=175.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++||++|+|+|||+++++|..++.+||||||++.|+|.++|+. .+..+.......++.||++|++||++++ +||
T Consensus 250 ~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IH 326 (468)
T KOG0197|consen 250 REAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIH 326 (468)
T ss_pred HHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 699999999999999999999999899999999999999999986 4667999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||...||||+++..+||+|||+|+...+.. ........-...|.|||.+..+.++.|+||||||++||||+| |+.||
T Consensus 327 RDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py 405 (468)
T KOG0197|consen 327 RDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPY 405 (468)
T ss_pred hhhhhhheeeccCceEEEcccccccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCC
Confidence 9999999999999999999999999554432 222222233568999999999999999999999999999998 77777
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
......+. .+. ..+.+++.. +..++..+.++|..||+.+|++|||++.+...|+.+.
T Consensus 406 ~~msn~ev---~~~-------le~GyRlp~-------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 406 PGMSNEEV---LEL-------LERGYRLPR-------PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCHHHH---HHH-------HhccCcCCC-------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 66533221 111 112223333 3346789999999999999999999999998876543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=293.09 Aligned_cols=221 Identities=24% Similarity=0.345 Sum_probs=179.1
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|||+.|+.++|+||+.++++|...+.+.||+||+ ..+|...|+.+...++...++.|+.++++||+|||++. |+|
T Consensus 49 lREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlH 124 (318)
T KOG0659|consen 49 LREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILH 124 (318)
T ss_pred HHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhc
Confidence 58999999999999999999999999999999999 56999999988889999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
|||||+|+||+.+|.+||+|||+|+.+......... .+-|.||+|||.+.| ..|+..+||||+|||+.||+-|.+.|
T Consensus 125 RDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f 202 (318)
T KOG0659|consen 125 RDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF 202 (318)
T ss_pred ccCCccceEEcCCCcEEeecccchhccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence 999999999999999999999999998765543332 266999999999986 57999999999999999999999888
Q ss_pred CCCCCCCCcchhHh--hhh---hhcc------ccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 160 DKNRPNGEHNLVEW--ARP---HLGE------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 160 ~~~~~~~~~~~~~~--~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.+..+.++...+-. ..+ .|.+ ..++.....+.. ...-...+.++.+|+.+||.+||.+|+|+.|++++
T Consensus 203 pG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 203 PGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 87655443222110 001 1111 111111111222 22334556788999999999999999999999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=315.56 Aligned_cols=206 Identities=26% Similarity=0.357 Sum_probs=173.5
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|-.+|.+| .||.|+++|..|.+...+|+|+||+++|+|.++|.+.+ .|++...+.++.+|+.||+|||+.| |||
T Consensus 122 ~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~G---IIH 197 (604)
T KOG0592|consen 122 REKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNG---IIH 197 (604)
T ss_pred HHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcC---cee
Confidence 477788999 89999999999999999999999999999999996664 7999999999999999999999999 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcc---------ee--eecccccccccCcchhhcCCCCchhhhHHHHHHH
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT---------HV--STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 149 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 149 (304)
|||||+|||++.++++||+|||.|+.+...... .. ...++||..|.+||++.....++.+|||+||||+
T Consensus 198 RDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCil 277 (604)
T KOG0592|consen 198 RDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCIL 277 (604)
T ss_pred ccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHH
Confidence 999999999999999999999999987543222 11 1348999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 150 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 150 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|+|+.|.+||...++....+.+. .++-.+.. ..++.+.+||.++|..||.+|+|+.||.+|.
T Consensus 278 yQmlaG~PPFra~NeyliFqkI~--------------~l~y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 278 YQMLAGQPPFRAANEYLIFQKIQ--------------ALDYEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHhcCCCCCccccHHHHHHHHH--------------HhcccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 99999999998765432221111 11112222 2347889999999999999999998887754
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=313.72 Aligned_cols=219 Identities=24% Similarity=0.330 Sum_probs=175.7
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
.+||.||++|+||||+++.+..... +.+|||+||| ..+|..++......|++.+++.++.||+.||+|||.+| |
T Consensus 164 ~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---v 239 (560)
T KOG0600|consen 164 IREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---V 239 (560)
T ss_pred HHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---e
Confidence 3799999999999999999998876 6899999999 56999999887889999999999999999999999999 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~ 157 (304)
+|||||.+|||||.+|.+||+|||+|+.+....... .+..+-|.||+|||++.|. .|+.++|+||+||||.||++|++
T Consensus 240 lHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 240 LHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred eeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 999999999999999999999999999876654433 3345569999999999875 79999999999999999999999
Q ss_pred CCCCCCCCCCcchh----------HhhhhhhccccccccccCCccC-----CCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 158 SMDKNRPNGEHNLV----------EWARPHLGERRRFYRLIDPRLE-----GHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 158 p~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
.|.+....++...+ .|....+. ....+.+... .+.....+..+.+|+..+|..||.+|.|+
T Consensus 319 I~~G~tEveQl~kIfklcGSP~e~~W~~~kLP----~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA 394 (560)
T KOG0600|consen 319 ILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP----HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTA 394 (560)
T ss_pred CcCCccHHHHHHHHHHHhCCCChhccccccCC----cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccH
Confidence 99887655433221 11111111 0011111111 00112235688999999999999999999
Q ss_pred HHHHHH
Q 022003 223 SEVVEA 228 (304)
Q Consensus 223 ~ell~~ 228 (304)
.++++.
T Consensus 395 ~~aL~s 400 (560)
T KOG0600|consen 395 SSALQS 400 (560)
T ss_pred HHHhcC
Confidence 999974
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=292.09 Aligned_cols=217 Identities=27% Similarity=0.346 Sum_probs=179.4
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|.++|+.+.||.++++++.+.+.+++||||||++||.|..++++. .+|++..++.++.||+.||+|||+.+ |++
T Consensus 92 ~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~---iiY 167 (355)
T KOG0616|consen 92 HNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLD---IIY 167 (355)
T ss_pred hhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcC---eee
Confidence 47999999999999999999999999999999999999999999554 48999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||||++|.+||+|||.|+..... .-+.|||+.|+|||++...+|+.++|.||||+++|||+.|.+||.
T Consensus 168 RDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 168 RDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred ccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999986432 445799999999999999999999999999999999999999998
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhCCCCCCccCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPNLKDMA 239 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~ell~~l~~~~~~~~~~ 239 (304)
...+... ....+..... ++...+.++.+|+.++|++|-.+|. +...=.+.++..++++...
T Consensus 243 ~~~~~~i------Y~KI~~~~v~------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 243 DDNPIQI------YEKILEGKVK------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred CCChHHH------HHHHHhCccc------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 7655211 1111111122 2333457899999999999999994 3333444555566666555
Q ss_pred CCccc
Q 022003 240 SSSYY 244 (304)
Q Consensus 240 ~~~~~ 244 (304)
+..-+
T Consensus 305 W~~i~ 309 (355)
T KOG0616|consen 305 WEAIL 309 (355)
T ss_pred HHHHh
Confidence 44333
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.35 Aligned_cols=206 Identities=27% Similarity=0.373 Sum_probs=172.1
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.+++++. ||||+++++++.....+++|||||.||+|.+++.+ ..++.+..+..+++|++.|++|||+.| |+|
T Consensus 68 rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~H 143 (370)
T KOG0583|consen 68 REISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVH 143 (370)
T ss_pred HHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---Eee
Confidence 5999999998 99999999999999999999999999999999988 568999999999999999999999999 999
Q ss_pred ccCCCCCeEECCC-CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC-CC-chhhhHHHHHHHHHHHhCCC
Q 022003 81 RDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LT-SRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 81 ~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~el~tg~~ 157 (304)
|||||+|+|++.+ +.+||+|||++.... .......+.+||+.|+|||++.+.. |+ .++||||+|+++|.|++|..
T Consensus 144 RDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~ 221 (370)
T KOG0583|consen 144 RDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRL 221 (370)
T ss_pred CCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence 9999999999999 999999999999873 1122355689999999999999877 85 78999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
||........ ..........+... .. +.++.+|+.+||..||.+|+|+.+++++-+
T Consensus 222 PF~d~~~~~l------~~ki~~~~~~~p~~--------~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 222 PFDDSNVPNL------YRKIRKGEFKIPSY--------LL---SPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred CCCCccHHHH------HHHHhcCCccCCCC--------cC---CHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 9987322111 01011111111111 11 578999999999999999999999997544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=319.97 Aligned_cols=204 Identities=29% Similarity=0.423 Sum_probs=174.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+||-||+.|.|||++++|++++++.++|+|.||++||-|.+++.+++ ++++.++.++++||+.|+.|+|+.+ |+||
T Consensus 61 rEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~---icHR 136 (786)
T KOG0588|consen 61 REIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN---ICHR 136 (786)
T ss_pred hhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc---ceec
Confidence 68999999999999999999999999999999999999999997776 7999999999999999999999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|+|++..+.+||+|||+|..-..+. ...+-||++.|.|||++.|.+| +.++||||.|+|||.|+||+.||+
T Consensus 137 DLKpENlLLd~~~nIKIADFGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd 213 (786)
T KOG0588|consen 137 DLKPENLLLDVKNNIKIADFGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD 213 (786)
T ss_pred cCCchhhhhhcccCEeeeccceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence 999999999999999999999998754432 3456799999999999999998 579999999999999999999998
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
+.+. ..+..-+. ++.| + ++...+.++.+||++||.+||.+|.|++||++|..
T Consensus 214 DdNi---r~LLlKV~-----~G~f-~---------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 214 DDNI---RVLLLKVQ-----RGVF-E---------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred CccH---HHHHHHHH-----cCcc-c---------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 4322 11111111 1111 1 22334679999999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=300.84 Aligned_cols=216 Identities=27% Similarity=0.368 Sum_probs=174.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+..|+.++||||++++..|..+..+|+||.||.+||+.++++.. ...+++..+..|++++++||.|||.+| .||
T Consensus 73 kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IH 149 (516)
T KOG0582|consen 73 KEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIH 149 (516)
T ss_pred HHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---cee
Confidence 6999999999999999999999999999999999999999999754 446999999999999999999999999 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCC-cceee-ecccccccccCcchhh--cCCCCchhhhHHHHHHHHHHHhCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVS-TRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+.||||+.+|.|||+|||.+..+-... ..... ..+.||++|||||++. ...|+.|+||||||++..||.+|.
T Consensus 150 RdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~ 229 (516)
T KOG0582|consen 150 RDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGH 229 (516)
T ss_pred cccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCC
Confidence 9999999999999999999999877644332 22222 5678999999999965 357999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||....+....-. .+.... +...-...........+..++.++..||+.||.+|||+++++++
T Consensus 230 aPf~k~pPmkvLl~------tLqn~p--p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 230 APFSKYPPMKVLLL------TLQNDP--PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCcccCChHHHHHH------HhcCCC--CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 99988765432111 111111 00000111112223445689999999999999999999999975
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=306.04 Aligned_cols=203 Identities=27% Similarity=0.372 Sum_probs=176.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++|+++|+|||||.++++|++..++|+|+|||.| +|..++.+.+ .++++.+..++.|++.||.|||+.+ |+||
T Consensus 50 ~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~r---ilhr 124 (808)
T KOG0597|consen 50 QEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNR---ILHR 124 (808)
T ss_pred HHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcC---cccc
Confidence 699999999999999999999999999999999966 9999997665 7999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
|+||.|||++.+|.+|+||||+|+.... .........||+.|||||++.+.+|+..+|+||||||+|||++|++||..
T Consensus 125 d~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 125 DMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred cCCcceeeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 9999999999999999999999998765 34456678899999999999999999999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.. +...+.....+ +. .++.+.+..+.+|+...|.+||.+|.|+.+++.|-
T Consensus 203 ~s------i~~Lv~~I~~d---------~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 203 RS------ITQLVKSILKD---------PV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred HH------HHHHHHHHhcC---------CC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 32 22222222221 11 12335678999999999999999999999999764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=297.43 Aligned_cols=223 Identities=27% Similarity=0.350 Sum_probs=172.6
Q ss_pred ChHhhHhhcCCCCcccceeeEEEe-----CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
++|+++|+.++|+||+.+++++.. -+..|+|+|+| +.+|.+.++. ++.++...+..++.||+.||.|+|+.+
T Consensus 69 lRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAn- 145 (359)
T KOG0660|consen 69 LRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSAN- 145 (359)
T ss_pred HHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhccc-
Confidence 489999999999999999999876 34689999999 7799998854 446999999999999999999999999
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-cCCCCchhhhHHHHHHHHHHHh
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~t 154 (304)
|+||||||.|+|++.+..+||+|||+|+...........+..+.|.||+|||++. ...|+.+.||||+|||+.||++
T Consensus 146 --ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~ 223 (359)
T KOG0660|consen 146 --VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT 223 (359)
T ss_pred --ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc
Confidence 9999999999999999999999999999875432222234567899999999876 5789999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhcc----------cccccc----ccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGE----------RRRFYR----LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 220 (304)
|++.|.+.+...+...+......-.+ ...+.+ .....+...++ .....+.+|+.+||..||.+|+
T Consensus 224 gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRi 302 (359)
T KOG0660|consen 224 GKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRI 302 (359)
T ss_pred CCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccC
Confidence 99999887654433222211100000 000000 00111111112 3357899999999999999999
Q ss_pred CHHHHHHHh
Q 022003 221 LMSEVVEAL 229 (304)
Q Consensus 221 s~~ell~~l 229 (304)
|++|+++|.
T Consensus 303 ta~eAL~hP 311 (359)
T KOG0660|consen 303 TAEEALAHP 311 (359)
T ss_pred CHHHHhcCh
Confidence 999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=290.55 Aligned_cols=222 Identities=23% Similarity=0.294 Sum_probs=174.6
Q ss_pred ChHhhHhhcCCCCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
||||.+|.+++|||||.+-++..- -+.+|||||||+ .+|..++....++|...+++.++.|++.||+|||.+. |
T Consensus 123 LREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---i 198 (419)
T KOG0663|consen 123 LREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---I 198 (419)
T ss_pred HHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---e
Confidence 589999999999999999998764 357999999994 5999999988889999999999999999999999987 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~ 157 (304)
+|||||++|+|++..|.+||+|||+|+.++..... .+..+-|.||+|||++.+. .|+..+|+||+|||+.||+++.+
T Consensus 199 lHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kP 276 (419)
T KOG0663|consen 199 LHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKP 276 (419)
T ss_pred EecccchhheeeccCCcEEecccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCC
Confidence 99999999999999999999999999998765332 3345669999999999864 69999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhh--hhhhccc-----------cccccccCCccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHH
Q 022003 158 SMDKNRPNGEHNLVEWA--RPHLGER-----------RRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~--~~~~~~~-----------~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
.|.+....++.+.+-.. .+.-..+ ..+.......+...+... .++..++|+..+|..||++|.|++
T Consensus 277 lf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~ 356 (419)
T KOG0663|consen 277 LFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAE 356 (419)
T ss_pred CCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHH
Confidence 99887554433221100 0000000 011111111111122222 457889999999999999999999
Q ss_pred HHHHH
Q 022003 224 EVVEA 228 (304)
Q Consensus 224 ell~~ 228 (304)
|.|++
T Consensus 357 ~~L~h 361 (419)
T KOG0663|consen 357 DGLKH 361 (419)
T ss_pred Hhhcc
Confidence 99985
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=306.53 Aligned_cols=207 Identities=27% Similarity=0.377 Sum_probs=177.6
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCe-eEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
++|+.++++++|||||.+.+.|+.++. .||||+||+||+|.+.|.+. +..|+++.+..|+.|++.|+.|||++. |
T Consensus 51 ~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---i 127 (426)
T KOG0589|consen 51 IQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---V 127 (426)
T ss_pred HHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---h
Confidence 369999999999999999999999988 99999999999999999765 477999999999999999999999888 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+|||||+.|||++.++.|||+|||+|+...... .......||+.|+.||++.+.+|+.|+|||||||++|||++-+++
T Consensus 128 LHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~a 205 (426)
T KOG0589|consen 128 LHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPA 205 (426)
T ss_pred hcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccc
Confidence 999999999999999999999999999976543 134557899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|...+-.... .... .......+..++.++..+|..||..+|..||++.+++...
T Consensus 206 F~a~~m~~Li--~ki~---------------~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 206 FKASNMSELI--LKIN---------------RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred cCccchHHHH--HHHh---------------hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 9765332111 0000 1111223445678999999999999999999999999863
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=315.95 Aligned_cols=212 Identities=25% Similarity=0.333 Sum_probs=170.3
Q ss_pred hHhhHhhcCC-CCcccceee-EEEeC------CeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDLV-HLNLVKLIG-YCIED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~-~~~~~------~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+||++|++|+ |+|||.++| ..... -..+|+||||.||+|-+++.++ ...|++.++++|+.|+++|+.+||.
T Consensus 83 ~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~ 162 (738)
T KOG1989|consen 83 REIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY 162 (738)
T ss_pred HHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc
Confidence 6999999996 999999999 33321 2568999999999999999765 4459999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCc-ce----e--eecccccccccCcchhh---cCCCCchhhh
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-TH----V--STRVMGTYGYAAPEYVM---TGHLTSRSDV 142 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~----~--~~~~~gt~~y~aPE~~~---~~~~~~~~Di 142 (304)
.. .+|||||||-|||||+.+|..||||||.|......-. .. . .-....|+.|+|||++. +.++++|+||
T Consensus 163 ~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDI 241 (738)
T KOG1989|consen 163 LK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDI 241 (738)
T ss_pred CC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHH
Confidence 88 6799999999999999999999999999875332211 00 0 00134689999999875 7789999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 143 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 143 wslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
|+|||+||.||+...||+..... .+++..+.---...++..+.+||+.||+.||.+||++
T Consensus 242 WALGclLYkLCy~t~PFe~sg~l--------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI 301 (738)
T KOG1989|consen 242 WALGCLLYKLCYFTTPFEESGKL--------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNI 301 (738)
T ss_pred HHHHHHHHHHHHhCCCcCcCcce--------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCH
Confidence 99999999999999999865321 2222222211123678899999999999999999999
Q ss_pred HHHHHHhCCCCC
Q 022003 223 SEVVEALKPLPN 234 (304)
Q Consensus 223 ~ell~~l~~~~~ 234 (304)
-+++.++..+..
T Consensus 302 ~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 302 YQVLEEIFELAN 313 (738)
T ss_pred HHHHHHHHHHhc
Confidence 999998865544
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=285.96 Aligned_cols=207 Identities=27% Similarity=0.414 Sum_probs=172.8
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.||+++ .||||+++.++++++...|+|+|.|+.|.|.+++... ..+++.....|++|+++|++|||..+ |+|
T Consensus 71 ~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~---IVH 146 (411)
T KOG0599|consen 71 QEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN---IVH 146 (411)
T ss_pred HHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh---hhh
Confidence 699999999 6999999999999999999999999999999999554 47999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc------CCCCchhhhHHHHHHHHHHHh
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~t 154 (304)
|||||+|||++++-.+||+|||+++.+..+.+ ....|||++|.|||.+.. ..|+..+|+|++|+|+|-|+.
T Consensus 147 RDLKpENILlddn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa 223 (411)
T KOG0599|consen 147 RDLKPENILLDDNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA 223 (411)
T ss_pred cccChhheeeccccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc
Confidence 99999999999999999999999999877654 445799999999999863 468899999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|.+||-..........+. ++ -+++-.|.. .+.+.+..+||.+||+.||.+|.|++|+|+|.
T Consensus 224 GcpPFwHRkQmlMLR~Im-------eG--kyqF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 224 GCPPFWHRKQMLMLRMIM-------EG--KYQFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred CCCchhHHHHHHHHHHHH-------hc--ccccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 999996432211111110 00 012222221 24467889999999999999999999999864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=302.99 Aligned_cols=206 Identities=28% Similarity=0.460 Sum_probs=176.3
Q ss_pred HhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 82 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d 82 (304)
+|+.|++|+|+||+.+.|+|....-+|||||||..|-|...|+.. ..+.......|..+||.|+.|||.+. |||||
T Consensus 162 dIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRD 237 (904)
T KOG4721|consen 162 DIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRD 237 (904)
T ss_pred hHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhh---Hhhhc
Confidence 688999999999999999999999999999999999999999654 47899999999999999999999988 99999
Q ss_pred CCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 022003 83 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 162 (304)
Q Consensus 83 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 162 (304)
||.-||||+-+..|||+|||-++...+. .+...++||..|||||+++..+.+.|+||||||+|||||+||..||.+.
T Consensus 238 LKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 238 LKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred cCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 9999999999999999999999876543 2345689999999999999999999999999999999999999999765
Q ss_pred CCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 163 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
+... +.|... ... +.-..+..+++-+.-||+.||+..|.+|||+.+++.||..
T Consensus 315 dssA----IIwGVG-----sNs-------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 315 DSSA----IIWGVG-----SNS-------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred chhe----eEEecc-----CCc-------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 3321 122211 111 1112345667888999999999999999999999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=300.78 Aligned_cols=213 Identities=31% Similarity=0.477 Sum_probs=167.5
Q ss_pred ChHhhHhhcC-CCCcccceeeEEEeCC-eeEEEEecCCCCCHHHHhhcCC------------------------------
Q 022003 1 MAEVNFLGDL-VHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRS------------------------------ 48 (304)
Q Consensus 1 l~E~~il~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~------------------------------ 48 (304)
++|+++|+++ +||||+++++++...+ ..++||||+++|+|.+++....
T Consensus 58 ~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (338)
T cd05102 58 MSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRI 137 (338)
T ss_pred HHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccccc
Confidence 3699999999 8999999999887644 5789999999999999986431
Q ss_pred -------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEE
Q 022003 49 -------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 97 (304)
Q Consensus 49 -------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~k 97 (304)
..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~k 214 (338)
T cd05102 138 EAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVK 214 (338)
T ss_pred ccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEE
Confidence 24788889999999999999999988 99999999999999999999
Q ss_pred EccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhh
Q 022003 98 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP 176 (304)
Q Consensus 98 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 176 (304)
|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... ....
T Consensus 215 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~---- 288 (338)
T cd05102 215 ICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ---- 288 (338)
T ss_pred EeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH----
Confidence 999999986543322222233445678999999999999999999999999999997 999997543211 0100
Q ss_pred hhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 177 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
....... .. .+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 289 ~~~~~~~------~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 289 RLKDGTR------MR----APENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHhcCCC------CC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000000 00 1112356889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=293.77 Aligned_cols=203 Identities=24% Similarity=0.364 Sum_probs=174.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+||+||+.|+||||+++|++|+..+.+.|||||..+|.|.+++.+++ .+++.++..+++||..|+.|+|.++ ++||
T Consensus 102 REIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknr---VvHR 177 (668)
T KOG0611|consen 102 REIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNR---VVHR 177 (668)
T ss_pred HHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhcc---ceec
Confidence 69999999999999999999999999999999999999999997765 7999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||.+|||+|.++.+||+|||++..+.... ..+++||++.|.+||++.|.+| ++.+|-||||++||-|+.|..||+
T Consensus 178 DLKLENILLD~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD 254 (668)
T KOG0611|consen 178 DLKLENILLDQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD 254 (668)
T ss_pred ccchhheeecCCCCeeeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC
Confidence 999999999999999999999998875432 3567899999999999999998 689999999999999999999998
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
+.+... ++.... .+ .+..| ..+.++..||++||.+||++|.|++++..|.+
T Consensus 255 G~Dhk~---lvrQIs-----~G---aYrEP--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 255 GRDHKR---LVRQIS-----RG---AYREP--------ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred CchHHH---HHHHhh-----cc---cccCC--------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 764321 111110 00 11122 22457889999999999999999999999864
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=287.22 Aligned_cols=221 Identities=27% Similarity=0.320 Sum_probs=179.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|-+||+.++||.+..+|+.++.++..|+|||||+||+|..+.++. +..|++..++.++..|+.||+|||..| ||+
T Consensus 126 tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivY 202 (459)
T KOG0610|consen 126 TEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVY 202 (459)
T ss_pred HHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eee
Confidence 3788999999999999999999999999999999999999988654 567999999999999999999999999 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCC---------------------------------CCcc--------------
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPE---------------------------------GDKT-------------- 113 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~---------------------------------~~~~-------------- 113 (304)
|||||+||||.++|++.|+||.++..... ....
T Consensus 203 RDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~ 282 (459)
T KOG0610|consen 203 RDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPE 282 (459)
T ss_pred ccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchh
Confidence 99999999999999999999998754211 0000
Q ss_pred -------eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhcccccccc
Q 022003 114 -------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 186 (304)
Q Consensus 114 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (304)
.....++||-.|.|||++.|..-+.++|.|+|||++|||++|..||.+.+...... ..+.+..+|.+
T Consensus 283 ~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~------NIv~~~l~Fp~ 356 (459)
T KOG0610|consen 283 LVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR------NIVGQPLKFPE 356 (459)
T ss_pred hhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH------HHhcCCCcCCC
Confidence 01123689999999999999999999999999999999999999998865433221 11222222221
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCCCccCCCC
Q 022003 187 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASS 241 (304)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~~~~~~~~ 241 (304)
. ...+..+.+||+++|.+||.+|.....=..+++.++.++.+.+.
T Consensus 357 ~----------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 357 E----------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred C----------CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 1 13357899999999999999999855555666667777777664
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=297.65 Aligned_cols=204 Identities=26% Similarity=0.371 Sum_probs=175.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+|.+++++||.++|+.+..+..++++||||.||++.+.+... ..+.+..+..++++++.||.|||.++ .+||
T Consensus 60 qei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~---kiHr 135 (467)
T KOG0201|consen 60 QEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEK---KIHR 135 (467)
T ss_pred HHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcc---eecc
Confidence 4899999999999999999999999999999999999999998544 35689999999999999999999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
|||+.|||+..+|.+||+|||++........ ...+++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+..
T Consensus 136 DIKaanil~s~~g~vkl~DfgVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~ 213 (467)
T KOG0201|consen 136 DIKAANILLSESGDVKLADFGVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK 213 (467)
T ss_pred cccccceeEeccCcEEEEecceeeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence 9999999999999999999999987654333 23678999999999999999999999999999999999999999987
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..+......+ .+-..|.+. ..++..+.+|+..||..||+.||||.+++++
T Consensus 214 ~hPmrvlflI-------------pk~~PP~L~----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 214 LHPMRVLFLI-------------PKSAPPRLD----GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cCcceEEEec-------------cCCCCCccc----cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 7663221111 111223333 2456789999999999999999999999975
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=298.12 Aligned_cols=219 Identities=26% Similarity=0.355 Sum_probs=172.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
.|-+||.....++||++|-.|.+.+++||||||++||++..+|.+.+ .|++..++.++.+++.|++.+|+.| +|||
T Consensus 190 aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~g---yIHR 265 (550)
T KOG0605|consen 190 AERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLG---YIHR 265 (550)
T ss_pred HHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcC---cccc
Confidence 47788889999999999999999999999999999999999997665 7999999999999999999999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCC----------------------CCcce----e-------------------e
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPE----------------------GDKTH----V-------------------S 116 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~----------------------~~~~~----~-------------------~ 116 (304)
||||+|+|||..|++||+|||++.-+.. .+... . .
T Consensus 266 DIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a 345 (550)
T KOG0605|consen 266 DIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLA 345 (550)
T ss_pred cCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhh
Confidence 9999999999999999999999853211 00000 0 0
Q ss_pred ecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCC
Q 022003 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF 196 (304)
Q Consensus 117 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (304)
...+||+.|+|||++.+..|+..+|.||||||+|||+.|.+||....+...-..+...+..+ .++.
T Consensus 346 ~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l----~fP~---------- 411 (550)
T KOG0605|consen 346 YSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL----KFPE---------- 411 (550)
T ss_pred hcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc----cCCC----------
Confidence 12579999999999999999999999999999999999999998876654432222111111 1111
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCCCccCCC
Q 022003 197 SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 240 (304)
Q Consensus 197 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~~~~~~~ 240 (304)
....+.++.+||.+||. ||++|.. ..=+++++.++.+++..+
T Consensus 412 ~~~~s~eA~DLI~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 412 EVDLSDEAKDLITRLLC-DPENRLG-SKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred cCcccHHHHHHHHHHhc-CHHHhcC-cccHHHHhcCCccccCCc
Confidence 11224789999999999 9999986 333344444555555544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.17 Aligned_cols=203 Identities=30% Similarity=0.368 Sum_probs=167.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..++..|+||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||
T Consensus 44 ~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHr 119 (323)
T cd05571 44 TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD---VVYR 119 (323)
T ss_pred HHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeC
Confidence 5889999999999999999999999999999999999999998654 47899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 120 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 120 DLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred CCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 999999999999999999999987532211 122345789999999999999999999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~ 228 (304)
.... ........... . ++...+.++.++|.+||+.||++|| ++.+++++
T Consensus 198 ~~~~------~~~~~~~~~~~--------~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 198 QDHE------KLFELILMEEI--------R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHH------HHHHHHHcCCC--------C----CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 3221 11110111100 1 1122356889999999999999999 78998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=292.73 Aligned_cols=207 Identities=21% Similarity=0.358 Sum_probs=168.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEe----CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ 76 (304)
+|+++|++++|||||++++++.+ ....++||||+++|+|.+++.+. ..+++.....++.|++.||.|||+. +
T Consensus 67 ~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~-- 143 (283)
T PHA02988 67 NEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN-- 143 (283)
T ss_pred HHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC--
Confidence 69999999999999999999877 34689999999999999999654 4789999999999999999999984 6
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc--CCCCchhhhHHHHHHHHHHHh
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~t 154 (304)
++||||||+||+++.++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++
T Consensus 144 -~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~ 217 (283)
T PHA02988 144 -KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT 217 (283)
T ss_pred -CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence 8899999999999999999999999988653321 23457889999999976 689999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
|..||...... .... .......+ +. .+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 218 g~~Pf~~~~~~---~~~~---~i~~~~~~------~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 218 GKIPFENLTTK---EIYD---LIINKNNS------LK----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCCCCHH---HHHH---HHHhcCCC------CC----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 99999754321 1111 11000000 11 11234678999999999999999999999999987653
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=310.12 Aligned_cols=207 Identities=27% Similarity=0.376 Sum_probs=169.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|+++|+.++|||||++++++..++..|+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+ |
T Consensus 114 ~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---i 190 (478)
T PTZ00267 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---M 190 (478)
T ss_pred HHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 5999999999999999999999999999999999999999987542 346899999999999999999999988 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+||||||+|||++.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 191 vHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~P 270 (478)
T PTZ00267 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270 (478)
T ss_pred EECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999876543332334456799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|...... ......... ...+ .+...+.++.++|.+||+.||++||++++++.+
T Consensus 271 f~~~~~~------~~~~~~~~~------~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 271 FKGPSQR------EIMQQVLYG------KYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCCHH------HHHHHHHhC------CCCC-----CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 9653221 111100000 0000 111234688999999999999999999999864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=283.77 Aligned_cols=222 Identities=25% Similarity=0.355 Sum_probs=170.6
Q ss_pred ChHhhHhhcCCCCc-ccceeeEEEeCC------eeEEEEecCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHh
Q 022003 1 MAEVNFLGDLVHLN-LVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFL 70 (304)
Q Consensus 1 l~E~~il~~l~h~n-iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~L 70 (304)
++|+.+|+.|+|+| ||++++++.+.. .+++|+||+ ..+|..++.... ..++...++.+++||+.||+||
T Consensus 58 iREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~ 136 (323)
T KOG0594|consen 58 IREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL 136 (323)
T ss_pred hHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 58999999999999 999999998877 789999999 679999997765 4688899999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHH
Q 022003 71 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVL 149 (304)
Q Consensus 71 H~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il 149 (304)
|+++ |+||||||+||||+++|.+||+|||+|+.+.-.... ....++|.+|+|||++.+. .|+..+||||+|||+
T Consensus 137 H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIf 211 (323)
T KOG0594|consen 137 HSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIF 211 (323)
T ss_pred HhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHH
Confidence 9999 999999999999999999999999999976533322 3446789999999999876 799999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcch----------hHhhhhh-hcccc-ccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 150 LEMLTGRRSMDKNRPNGEHNL----------VEWARPH-LGERR-RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 150 ~el~tg~~p~~~~~~~~~~~~----------~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
+||+++++.|.+....+.... ..|-... ..+.. .+.....+............+..+++.+||+.+|.
T Consensus 212 aEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~ 291 (323)
T KOG0594|consen 212 AEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPA 291 (323)
T ss_pred HHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcc
Confidence 999999999987655221110 0110000 00000 11111101000000001124788999999999999
Q ss_pred CCCCHHHHHHH
Q 022003 218 ARPLMSEVVEA 228 (304)
Q Consensus 218 ~Rps~~ell~~ 228 (304)
+|.|++.+++|
T Consensus 292 ~R~Sa~~al~h 302 (323)
T KOG0594|consen 292 KRISAKGALTH 302 (323)
T ss_pred cCcCHHHHhcC
Confidence 99999999986
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=287.43 Aligned_cols=216 Identities=27% Similarity=0.466 Sum_probs=168.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC------------------CCCCHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------LPLPWSIRMKIALGA 63 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~~l~~~~~~~i~~qi 63 (304)
+|+++|++++||||+++++++...+..++||||+.+++|.+++.... ..+++..++.++.||
T Consensus 68 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 147 (304)
T cd05096 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQI 147 (304)
T ss_pred HHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHH
Confidence 69999999999999999999999999999999999999999885421 246788899999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhH
Q 022003 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 143 (304)
Q Consensus 64 ~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 143 (304)
+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||
T Consensus 148 ~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 224 (304)
T cd05096 148 ASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224 (304)
T ss_pred HHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhH
Confidence 99999999988 999999999999999999999999999875443333333344567889999999988999999999
Q ss_pred HHHHHHHHHHh--CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 144 SFGVVLLEMLT--GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 144 slG~il~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
||||++|+|++ +..||...... .................... .+..++..+.+|+.+||+.||++|||
T Consensus 225 slG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 225 AFGVTLWEILMLCKEQPYGELTDE---QVIENAGEFFRDQGRQVYLF-------RPPPCPQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred HHHHHHHHHHHccCCCCCCcCCHH---HHHHHHHHHhhhcccccccc-------CCCCCCHHHHHHHHHHccCCchhCcC
Confidence 99999999987 45566543221 11111111111000000000 11123568899999999999999999
Q ss_pred HHHHHHHhC
Q 022003 222 MSEVVEALK 230 (304)
Q Consensus 222 ~~ell~~l~ 230 (304)
+.+|.+.|+
T Consensus 295 ~~~i~~~l~ 303 (304)
T cd05096 295 FSDIHAFLT 303 (304)
T ss_pred HHHHHHHHh
Confidence 999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=285.95 Aligned_cols=210 Identities=28% Similarity=0.487 Sum_probs=171.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKG 66 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~ 66 (304)
+|++++++++||||+++++++...+..+++|||+++++|.+++.... ..+++..++.++.|++.|
T Consensus 57 ~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~a 136 (283)
T cd05048 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAG 136 (283)
T ss_pred HHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHH
Confidence 58999999999999999999999999999999999999999986531 458889999999999999
Q ss_pred HHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHH
Q 022003 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 146 (304)
Q Consensus 67 l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 146 (304)
|.|||+.+ ++|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||
T Consensus 137 l~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG 213 (283)
T cd05048 137 MEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFG 213 (283)
T ss_pred HHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHH
Confidence 99999988 999999999999999999999999999865433322233344567889999999888999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 147 VVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 147 ~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
|++|||++ |..||...... ....... .. .....+..++.++.+|+.+||+.||++||++.|+
T Consensus 214 ~il~el~~~g~~p~~~~~~~---~~~~~i~----~~----------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i 276 (283)
T cd05048 214 VVLWEIFSYGLQPYYGFSNQ---EVIEMIR----SR----------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHH---HHHHHHH----cC----------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999998 99998754321 1111110 00 0011123446789999999999999999999999
Q ss_pred HHHhCC
Q 022003 226 VEALKP 231 (304)
Q Consensus 226 l~~l~~ 231 (304)
+++|+.
T Consensus 277 ~~~l~~ 282 (283)
T cd05048 277 HTRLRS 282 (283)
T ss_pred HHHHhc
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=286.57 Aligned_cols=218 Identities=25% Similarity=0.337 Sum_probs=170.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC-----eeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|++||+.++|||||++.-+|.... ...+||||++. +|.+.++. .+..++.-.++-++.||++||.|||+.
T Consensus 66 rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~ 144 (364)
T KOG0658|consen 66 RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH 144 (364)
T ss_pred HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc
Confidence 5999999999999999999887543 34699999964 99998864 356799999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEECCC-CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLE 151 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~e 151 (304)
+ |+||||||.|+|+|.+ |.+||||||.|+....+... .....|..|+|||.+.|. .|+.+.||||.|||+.|
T Consensus 145 ~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aE 218 (364)
T KOG0658|consen 145 G---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAE 218 (364)
T ss_pred C---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHH
Confidence 8 9999999999999876 99999999999987655432 334568899999999864 79999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhHhhhhhhcc-------------ccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCC
Q 022003 152 MLTGRRSMDKNRPNGEHNLVEWARPHLGE-------------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 218 (304)
Q Consensus 152 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 218 (304)
|+-|++.|.+....++ +.+.....-.. ..++.++........+....++++.+|+.++|+++|.+
T Consensus 219 Ll~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~ 296 (364)
T KOG0658|consen 219 LLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSK 296 (364)
T ss_pred HhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhh
Confidence 9999999988644332 22221111000 01112222222222234455789999999999999999
Q ss_pred CCCHHHHHHH
Q 022003 219 RPLMSEVVEA 228 (304)
Q Consensus 219 Rps~~ell~~ 228 (304)
|.++.|++.+
T Consensus 297 R~~~~~~l~h 306 (364)
T KOG0658|consen 297 RLSALEALAH 306 (364)
T ss_pred cCCHHHHhcc
Confidence 9999999975
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=286.80 Aligned_cols=221 Identities=22% Similarity=0.330 Sum_probs=167.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+.+..++||||+. ++|.+++......+++..+..++.||+.||+|||+.+ |+||
T Consensus 52 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~ 127 (288)
T cd07871 52 REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHR 127 (288)
T ss_pred HHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 69999999999999999999999999999999996 5999988766667899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||++.++.+||+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 128 dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 205 (288)
T cd07871 128 DLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP 205 (288)
T ss_pred CCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999976432221 1223467899999999875 568999999999999999999999997
Q ss_pred CCCCCCCcchhHhhh--------hhhccccccccccCCccCCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWAR--------PHLGERRRFYRLIDPRLEGH----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
............... ........+.....+..... .....+.++.+||.+||+.||.+|||++|+++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 206 GSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 643321111000000 00000011111111111000 001124678999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=287.48 Aligned_cols=207 Identities=28% Similarity=0.384 Sum_probs=168.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++++.+++..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+|
T Consensus 49 ~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH 125 (285)
T cd05631 49 NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVY 125 (285)
T ss_pred HHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEe
Confidence 6899999999999999999999999999999999999999887543 346899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||++........ .....||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 126 ~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 202 (285)
T cd05631 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202 (285)
T ss_pred CCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987543221 234568999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~~ 228 (304)
........... .. .... ....+....+.++.+|+.+||+.||++||+ +++++++
T Consensus 203 ~~~~~~~~~~~--~~-~~~~-----------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 203 KRKERVKREEV--DR-RVKE-----------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCCcchhHHHH--HH-Hhhc-----------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 65432111110 00 0000 001112233568899999999999999997 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=299.46 Aligned_cols=208 Identities=26% Similarity=0.394 Sum_probs=175.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
.||.+.++|+|.|||+++|.+-+++.+-|.||-++||||..+++.+-+++ .+.++-.+.+||++||.|||.+. ||
T Consensus 621 EEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IV 697 (1226)
T KOG4279|consen 621 EEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IV 697 (1226)
T ss_pred HHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---ee
Confidence 58999999999999999999999999999999999999999998887777 88899999999999999999988 99
Q ss_pred eccCCCCCeEEC-CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC--CCCchhhhHHHHHHHHHHHhCC
Q 022003 80 YRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 80 H~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~ 156 (304)
|||||-+||||+ -.|.+||+|||-+++.... ..+..++.||..|||||++..+ .|+.++|||||||++.||.||+
T Consensus 698 HRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGr 775 (1226)
T KOG4279|consen 698 HRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGR 775 (1226)
T ss_pred eccccCCcEEEeeccceEEecccccchhhccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCC
Confidence 999999999995 5799999999999886432 3345678899999999999854 6999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
+||...... +-.++.. .++ ..-...+.+.+.++..+|.+|+..||.+||++.++++..
T Consensus 776 PPF~Elgsp---qAAMFkV-------Gmy-----KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 776 PPFVELGSP---QAAMFKV-------GMY-----KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred CCeeecCCh---hHhhhhh-------cce-----ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 999653221 1111111 111 112335667789999999999999999999999999754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=287.80 Aligned_cols=222 Identities=21% Similarity=0.266 Sum_probs=167.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++..++..++||||+++++|..+. +....+++..++.++.||+.||.|||+.+ ++||
T Consensus 49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~ 124 (287)
T cd07848 49 RELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHR 124 (287)
T ss_pred HHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 6899999999999999999999999999999999887666544 44457999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++......... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 125 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 125 DIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred CCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876432221 12335689999999999988999999999999999999999999976
Q ss_pred CCCCCCcchhHhhhh--------hhccccccccccCCccC------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 162 NRPNGEHNLVEWARP--------HLGERRRFYRLIDPRLE------GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
............... .......+.....+... .......+.++.+||.+||+.||++|||++|+++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 204 ESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 432211100000000 00000000000000000 0011123568999999999999999999999997
Q ss_pred H
Q 022003 228 A 228 (304)
Q Consensus 228 ~ 228 (304)
|
T Consensus 284 h 284 (287)
T cd07848 284 H 284 (287)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=299.42 Aligned_cols=211 Identities=27% Similarity=0.456 Sum_probs=168.4
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC--------------------------------
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------------------------------- 48 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------------------- 48 (304)
+|+++++.+ +|+|||++++++...+..++|||||++|+|.+++.+..
T Consensus 90 ~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (374)
T cd05106 90 SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRS 169 (374)
T ss_pred HHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccc
Confidence 699999999 89999999999999999999999999999999885421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC
Q 022003 49 -------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 91 (304)
Q Consensus 49 -------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~ 91 (304)
..+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~ 246 (374)
T cd05106 170 DSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLT 246 (374)
T ss_pred cccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEe
Confidence 24788899999999999999999988 99999999999999
Q ss_pred CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 022003 92 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 170 (304)
Q Consensus 92 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~ 170 (304)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 247 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~ 324 (374)
T cd05106 247 DGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF 324 (374)
T ss_pred CCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH
Confidence 999999999999986543322222223345678999999998899999999999999999997 999997543211 11
Q ss_pred hHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 171 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
..... .. .....+ ...+.++.+++.+||+.||++|||+.++++.|+.
T Consensus 325 ~~~~~----~~---~~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 325 YKMVK----RG---YQMSRP-------DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred HHHHH----cc---cCccCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11000 00 000111 1124689999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=295.32 Aligned_cols=222 Identities=20% Similarity=0.238 Sum_probs=166.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++|+|||||++++++..+...++|||++ +++|..++... ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 132 ~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHr 206 (391)
T PHA03212 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHR 206 (391)
T ss_pred HHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 6999999999999999999999999999999999 57898888554 36899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 207 DiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 207 DIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred CCChHhEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 9999999999999999999999975432211 122345799999999999999999999999999999999999987754
Q ss_pred CCCCCCc----chhHhhhhhhcc-ccc-----------cc----c--ccCCccCCC--CCHHHHHHHHHHHHHhccCCCC
Q 022003 162 NRPNGEH----NLVEWARPHLGE-RRR-----------FY----R--LIDPRLEGH--FSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 162 ~~~~~~~----~~~~~~~~~~~~-~~~-----------~~----~--~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~ 217 (304)
....... ............ ... .. . ...+..... .....+.++.+||.+||+.||+
T Consensus 286 ~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~ 365 (391)
T PHA03212 286 KDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAH 365 (391)
T ss_pred cccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChh
Confidence 3221110 000000000000 000 00 0 000000000 0112356889999999999999
Q ss_pred CCCCHHHHHHHh
Q 022003 218 ARPLMSEVVEAL 229 (304)
Q Consensus 218 ~Rps~~ell~~l 229 (304)
+|||++|++++-
T Consensus 366 ~Rpta~elL~hp 377 (391)
T PHA03212 366 HRPSAEALLDFA 377 (391)
T ss_pred hCCCHHHHhcCh
Confidence 999999999853
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=290.30 Aligned_cols=201 Identities=26% Similarity=0.348 Sum_probs=166.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+++..++||||+++++|.+++.++. .+++..+..++.|++.||+|||+.+ ++||
T Consensus 50 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 125 (291)
T cd05612 50 NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKE---IVYR 125 (291)
T ss_pred HHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 58999999999999999999999999999999999999999986544 6899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||++...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 126 dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 126 DLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred CCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999865332 2235689999999999998999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~~l 229 (304)
..... .......... .++...+..+.+||.+||+.||.+|++ +++++++.
T Consensus 201 ~~~~~------~~~~i~~~~~------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 201 DNPFG------IYEKILAGKL------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred CCHHH------HHHHHHhCCc------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 43211 1111110000 011122467899999999999999995 88887653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=291.36 Aligned_cols=217 Identities=24% Similarity=0.359 Sum_probs=168.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH 80 (304)
+|+++|++++||||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. + |+|
T Consensus 52 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH 127 (331)
T cd06649 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQ---IMH 127 (331)
T ss_pred HHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEc
Confidence 6899999999999999999999999999999999999999998654 3689999999999999999999985 5 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 128 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred CCCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998765332 1234568999999999999999999999999999999999999996
Q ss_pred CCCCCCCcchhHhhhhhh-----------ccc------------------cc----cccccCCccCCCCCHHHHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHL-----------GER------------------RR----FYRLIDPRLEGHFSIKGAQKAAQL 207 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~-----------~~~------------------~~----~~~~~~~~~~~~~~~~~~~~~~~l 207 (304)
...... ......... ... .. +..+.............+.++.+|
T Consensus 204 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (331)
T cd06649 204 PPDAKE---LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEF 280 (331)
T ss_pred CCCHHH---HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHH
Confidence 533211 000000000 000 00 000000000000011245789999
Q ss_pred HHHhccCCCCCCCCHHHHHHHh
Q 022003 208 AAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 208 i~~~l~~dp~~Rps~~ell~~l 229 (304)
|.+||+.||++|||++|++++.
T Consensus 281 i~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 281 VNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred HHHHccCCcccCCCHHHHhcCh
Confidence 9999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=288.07 Aligned_cols=212 Identities=27% Similarity=0.369 Sum_probs=166.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+||.||+++.|||||+++++.-+ .+.+|||+|||..|.+...= .... +++.++++++++++.||+|||.+| |
T Consensus 157 ~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---i 231 (576)
T KOG0585|consen 157 REIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQG---I 231 (576)
T ss_pred HHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcC---e
Confidence 69999999999999999998765 45899999999998887632 2234 999999999999999999999999 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCc---ceeeecccccccccCcchhhcC---C-CCchhhhHHHHHHHHH
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMTG---H-LTSRSDVYSFGVVLLE 151 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~-~~~~~DiwslG~il~e 151 (304)
|||||||+|+||+++|++||+|||.+.....+.. ........||+.|+|||...++ . .+.+.||||+|++||.
T Consensus 232 iHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYC 311 (576)
T KOG0585|consen 232 IHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYC 311 (576)
T ss_pred eccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHH
Confidence 9999999999999999999999999987633211 1122236899999999998763 2 3678999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 152 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 152 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
|+.|+.||......+.. . .++...+.-....+...++.+||.+||++||++|.+..+|..|...
T Consensus 312 llfG~~PF~~~~~~~l~------~----------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 312 LLFGQLPFFDDFELELF------D----------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred hhhccCCcccchHHHHH------H----------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 99999999764321111 1 1111111111112346789999999999999999999999998865
Q ss_pred CCC
Q 022003 232 LPN 234 (304)
Q Consensus 232 ~~~ 234 (304)
...
T Consensus 376 t~~ 378 (576)
T KOG0585|consen 376 TRD 378 (576)
T ss_pred ccC
Confidence 443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=294.38 Aligned_cols=200 Identities=26% Similarity=0.382 Sum_probs=165.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..++..++||||+.+++|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||
T Consensus 67 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~ 142 (329)
T PTZ00263 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---IIYR 142 (329)
T ss_pred HHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 6899999999999999999999999999999999999999998654 46899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||||+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 143 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 143 DLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred CCCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999875432 1235689999999999999999999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~~ 228 (304)
.... ............ ++...+..+.+||.+||+.||.+|++ ++++++|
T Consensus 218 ~~~~------~~~~~i~~~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 218 DTPF------RIYEKILAGRLK------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCHH------HHHHHHhcCCcC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 4221 100100000000 11112467889999999999999996 5666664
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=268.06 Aligned_cols=208 Identities=24% Similarity=0.309 Sum_probs=170.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++|-+.|+|||||++.+.+...+..|||+|++.|++|..-|.++ ..+++..+-..++||+++|.|+|.++ ||||
T Consensus 59 rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHR 134 (355)
T KOG0033|consen 59 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHR 134 (355)
T ss_pred HHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceec
Confidence 6999999999999999999999999999999999999998877665 36889999999999999999999998 9999
Q ss_pred cCCCCCeEEC---CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|+||+|+++. ...-+||+|||+|.....+. .-..+.||++|||||+++..+|+..+|||+-|+|+|-|+.|.+|
T Consensus 135 DvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~P 211 (355)
T KOG0033|consen 135 DLKPENLLLASKAKGAAVKLADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 211 (355)
T ss_pred cCChhheeeeeccCCCceeecccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCC
Confidence 9999999994 34569999999999876332 24457899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
|.+..... +.+..... . -.+++... ...++++.+|+++||..||.+|.|+.|.|+|.+
T Consensus 212 F~~~~~~r---lye~I~~g--~-----yd~~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 212 FWDEDQHR---LYEQIKAG--A-----YDYPSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred CCCccHHH---HHHHHhcc--c-----cCCCCccc----CcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 97643211 11111100 0 01111111 123578999999999999999999999998754
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=287.78 Aligned_cols=219 Identities=21% Similarity=0.297 Sum_probs=165.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++||||+++++++..+...++||||+ +++|.+++.+....+++..+..++.||+.||+|||+.+ |+||
T Consensus 52 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~ 127 (303)
T cd07869 52 REASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHR 127 (303)
T ss_pred HHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 6999999999999999999999999999999999 56888888776667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||++.++.+||+|||++........ ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 128 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 205 (303)
T cd07869 128 DLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205 (303)
T ss_pred CCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999875432211 1233567899999999875 468999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhcc--------cccccccc--------CCccCCCC-CHHHHHHHHHHHHHhccCCCCCCCCHH
Q 022003 161 KNRPNGEHNLVEWARPHLGE--------RRRFYRLI--------DPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~--------~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
...... ............ ........ .......+ ....+..+.+|+.+||+.||++|||++
T Consensus 206 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~ 283 (303)
T cd07869 206 GMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ 283 (303)
T ss_pred CCccHH--HHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHH
Confidence 643211 011000000000 00000000 00000000 001135788999999999999999999
Q ss_pred HHHHH
Q 022003 224 EVVEA 228 (304)
Q Consensus 224 ell~~ 228 (304)
|+++|
T Consensus 284 ~~l~h 288 (303)
T cd07869 284 AALSH 288 (303)
T ss_pred HHhcC
Confidence 99975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=292.11 Aligned_cols=203 Identities=33% Similarity=0.345 Sum_probs=166.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||
T Consensus 42 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~Hr 117 (312)
T cd05585 42 AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VIYR 117 (312)
T ss_pred HHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeC
Confidence 5889999999999999999999999999999999999999998654 46999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 118 Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 118 DLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred CCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 999999999999999999999987643221 123345789999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~~ 228 (304)
.... ........... .++...+.++.++|.+||+.||++||+ +.|++.+
T Consensus 196 ~~~~------~~~~~~~~~~~------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 196 ENVN------EMYRKILQEPL------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHH------HHHHHHHcCCC------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 3211 11111111110 111223568899999999999999975 6677765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=288.12 Aligned_cols=205 Identities=23% Similarity=0.365 Sum_probs=179.5
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|++.|+.++|||||++|++..+...+|||+|+=.+|+|.++|.++...+.++...+++.||+.|+.|+|+.. +||
T Consensus 65 fqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVH 141 (864)
T KOG4717|consen 65 FQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVH 141 (864)
T ss_pred HHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhc
Confidence 47999999999999999999999999999999999999999999999889999999999999999999999988 999
Q ss_pred ccCCCCCeEE-CCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCC-chhhhHHHHHHHHHHHhCCCC
Q 022003 81 RDFKTSNILL-DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 81 ~dlkp~Nili-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p 158 (304)
|||||+||.+ .+-|-+||+|||++..+..+.. .++.+|+..|-|||++.|..|+ +++||||||+|||.|++|++|
T Consensus 142 RDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~P 218 (864)
T KOG4717|consen 142 RDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPP 218 (864)
T ss_pred ccCCcceeEEeeecCceEeeeccccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCc
Confidence 9999999877 5679999999999998876654 4567999999999999999885 789999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|...++.+....+. |=. -..+...+.++++||..||..||++|.|.+||...-
T Consensus 219 FqeANDSETLTmIm----------------DCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 219 FQEANDSETLTMIM----------------DCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred cccccchhhhhhhh----------------ccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 98876654433322 111 113445678999999999999999999999998754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=296.96 Aligned_cols=211 Identities=28% Similarity=0.459 Sum_probs=168.2
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC--------------------------------
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------------------------------- 48 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------------------- 48 (304)
+|+++|+.+ +||||+++++++...+..++|||||++|+|.+++.+..
T Consensus 87 ~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 166 (375)
T cd05104 87 SELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLN 166 (375)
T ss_pred HHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhh
Confidence 699999999 89999999999999999999999999999999986432
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 022003 49 ------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 86 (304)
Q Consensus 49 ------------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~ 86 (304)
..+++..+..++.||+.||+|||+.+ ++||||||+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 243 (375)
T cd05104 167 EYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAAR 243 (375)
T ss_pred hhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchh
Confidence 24788899999999999999999988 999999999
Q ss_pred CeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCCC
Q 022003 87 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 165 (304)
Q Consensus 87 Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~ 165 (304)
|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 244 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~ 323 (375)
T cd05104 244 NILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323 (375)
T ss_pred hEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch
Confidence 99999999999999999987644332222223345677999999999999999999999999999998 88888654221
Q ss_pred CCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 166 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
. ....... ... ....+ ...+.++.+||.+||+.||++|||+.|+++.|+.
T Consensus 324 ~--~~~~~~~----~~~---~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 324 S--KFYKMIK----EGY---RMLSP-------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred H--HHHHHHH----hCc---cCCCC-------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1 1111111 000 00011 1124688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.65 Aligned_cols=204 Identities=27% Similarity=0.348 Sum_probs=167.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++||||+++++++..++..|+||||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||
T Consensus 44 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHr 119 (328)
T cd05593 44 TESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK---IVYR 119 (328)
T ss_pred HHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEec
Confidence 5889999999999999999999999999999999999999888554 46999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 120 Dikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 120 DLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred ccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence 999999999999999999999987532211 112345789999999999999999999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~l 229 (304)
.... .......... .. ++...+.++.++|.+||+.||++|+ ++.|++++.
T Consensus 198 ~~~~------~~~~~~~~~~--------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 198 QDHE------KLFELILMED--------IK----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CCHH------HHHHHhccCC--------cc----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 4221 1111111000 01 1112356889999999999999997 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.40 Aligned_cols=200 Identities=27% Similarity=0.316 Sum_probs=166.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++||||+++++++.+.+..|+||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||
T Consensus 80 ~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHr 155 (340)
T PTZ00426 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYR 155 (340)
T ss_pred HHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcc
Confidence 5899999999999999999999999999999999999999998654 36999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 156 DLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 156 DLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred CCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 99999999999999999999999865322 2235789999999999998999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~ 228 (304)
..... .+ ......... ++...+..+.++|.+||+.||++|+ ++++++++
T Consensus 231 ~~~~~-----~~-~~i~~~~~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 231 NEPLL-----IY-QKILEGIIY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCHHH-----HH-HHHhcCCCC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 43211 00 000000000 1112246788999999999999995 78888875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=280.53 Aligned_cols=210 Identities=24% Similarity=0.360 Sum_probs=169.3
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+.++++++||||+++++++..++..++||||+++++|.+++......+++..++.++.||+.||+|||+.+ ++|
T Consensus 54 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH 130 (266)
T cd05064 54 LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVH 130 (266)
T ss_pred HHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eee
Confidence 36899999999999999999999999999999999999999999776667999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+||+++.++.+|++|||.+........ .......++..|+|||++.+..++.++|||||||++||+++ |..||
T Consensus 131 ~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~ 209 (266)
T cd05064 131 KGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY 209 (266)
T ss_pred ccccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCc
Confidence 99999999999999999999998765422111 11112345678999999999999999999999999999775 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ..... .... ... .+..++..+.+++.+||+.+|.+||+++++++.|..
T Consensus 210 ~~~~~~~---~~~~~----~~~~------~~~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 210 WDMSGQD---VIKAV----EDGF------RLP----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CcCCHHH---HHHHH----HCCC------CCC----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 6543211 11110 0000 001 112345688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=291.49 Aligned_cols=204 Identities=30% Similarity=0.362 Sum_probs=167.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..++..|+||||+++++|..++.+. ..+++..++.++.||+.||+|||+.+ |+||
T Consensus 44 ~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~ 119 (323)
T cd05595 44 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYR 119 (323)
T ss_pred HHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEec
Confidence 5889999999999999999999999999999999999999888554 36899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||++....... .......||..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 120 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 120 DIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred CCCHHHEEEcCCCCEEecccHHhccccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987532211 112335689999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~l 229 (304)
...... . ........ . ++...+.++.++|.+||+.||++|+ ++.+++++-
T Consensus 198 ~~~~~~---~---~~~~~~~~--------~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 198 QDHERL---F---ELILMEEI--------R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CCHHHH---H---HHHhcCCC--------C----CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 432110 0 00000100 0 1112356889999999999999998 899988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=306.01 Aligned_cols=213 Identities=31% Similarity=0.495 Sum_probs=179.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---------CC----CCCHHHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------SL----PLPWSIRMKIALGAAKGLA 68 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------~~----~l~~~~~~~i~~qi~~~l~ 68 (304)
+|+++|..|+|||||+++|+|..++..|||+|||..|||.++|+.+ +. +++..+...|+.|||.|++
T Consensus 538 REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~ 617 (774)
T KOG1026|consen 538 REAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGME 617 (774)
T ss_pred HHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHH
Confidence 6999999999999999999999999999999999999999999643 12 2889999999999999999
Q ss_pred HhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHH
Q 022003 69 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 148 (304)
Q Consensus 69 ~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 148 (304)
||-++. +|||||...|+||+++..|||+|||+++.....+.+.....-.-...|||||.+..+.|+.++||||+|++
T Consensus 618 YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVv 694 (774)
T KOG1026|consen 618 YLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVV 694 (774)
T ss_pred HHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhh
Confidence 999988 99999999999999999999999999998766555554434445778999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 149 LLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 149 l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
|||+++ |..||.+....+ +++..+. .-.-..+..++.++++||..||+.+|++||+++||-.
T Consensus 695 LWEIFsyG~QPy~glSn~E---VIe~i~~--------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 695 LWEIFSYGKQPYYGLSNQE---VIECIRA--------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred hhhhhccccCcccccchHH---HHHHHHc--------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 999988 788887654332 2222211 0011234466889999999999999999999999999
Q ss_pred HhCCCCC
Q 022003 228 ALKPLPN 234 (304)
Q Consensus 228 ~l~~~~~ 234 (304)
.|+.+..
T Consensus 758 ~L~~~~~ 764 (774)
T KOG1026|consen 758 RLQAWAQ 764 (774)
T ss_pred HHHHHHh
Confidence 8876544
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=277.65 Aligned_cols=209 Identities=25% Similarity=0.394 Sum_probs=167.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||
T Consensus 42 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~ 118 (252)
T cd05084 42 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHR 118 (252)
T ss_pred HHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 6899999999999999999999999999999999999999999776667899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 119 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~ 198 (252)
T cd05084 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198 (252)
T ss_pred ccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999876543211111111123456999999998889999999999999999998 888885
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
...... ... ..... ... ..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 199 ~~~~~~---~~~----~~~~~------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 199 NLSNQQ---TRE----AIEQG------VRL----PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCHHH---HHH----HHHcC------CCC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 432211 000 00000 000 111223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=292.26 Aligned_cols=209 Identities=24% Similarity=0.279 Sum_probs=169.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++..++||||+++++++...+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||
T Consensus 50 ~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 125 (333)
T cd05600 50 TERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG---YIHR 125 (333)
T ss_pred HHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 5889999999999999999999999999999999999999998654 36899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||++..... ......||..|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 126 dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 200 (333)
T cd05600 126 DLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200 (333)
T ss_pred CCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence 9999999999999999999999986533 23345789999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
........... ..... ...+... ......+.++.++|.+||..+|.+||++++++++.
T Consensus 201 ~~~~~~~~~i~-------~~~~~--~~~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 201 STPNETWENLK-------YWKET--LQRPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred CCHHHHHHHHH-------hcccc--ccCCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 43221110000 00000 0001000 00112357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.23 Aligned_cols=224 Identities=23% Similarity=0.259 Sum_probs=168.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++|+|+|||++++++..++..++|||++ .++|.+++......+++..++.++.||+.||.|||+.+ |+||
T Consensus 209 ~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHr 284 (461)
T PHA03211 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHR 284 (461)
T ss_pred HHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEC
Confidence 6999999999999999999999999999999999 57898888776667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||||+.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||++|..++..
T Consensus 285 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 285 DIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred cCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 99999999999999999999999875433222222345799999999999999999999999999999999998866543
Q ss_pred CCCC-CCc----chhHhhhhhhccccccccc----------------cCCccC-CCCC--HHHHHHHHHHHHHhccCCCC
Q 022003 162 NRPN-GEH----NLVEWARPHLGERRRFYRL----------------IDPRLE-GHFS--IKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 162 ~~~~-~~~----~~~~~~~~~~~~~~~~~~~----------------~~~~~~-~~~~--~~~~~~~~~li~~~l~~dp~ 217 (304)
.... ... .+.............+... ..+... ..+. ...+.++.+||.+||+.||.
T Consensus 365 ~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~ 444 (461)
T PHA03211 365 ASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGA 444 (461)
T ss_pred CCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChh
Confidence 2211 110 1111111000000000000 000000 0000 01235788999999999999
Q ss_pred CCCCHHHHHHHh
Q 022003 218 ARPLMSEVVEAL 229 (304)
Q Consensus 218 ~Rps~~ell~~l 229 (304)
+|||+.|++++-
T Consensus 445 ~RPsa~elL~hp 456 (461)
T PHA03211 445 RRPSAAELLRLP 456 (461)
T ss_pred hCcCHHHHhhCc
Confidence 999999999863
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=287.13 Aligned_cols=204 Identities=29% Similarity=0.364 Sum_probs=166.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|+.++||||+++++++..++..|+||||+.+++|.+++.+. ..+.+..+..++.||+.||+|||+.+ |+||
T Consensus 49 ~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 124 (323)
T cd05584 49 AERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG---IIYR 124 (323)
T ss_pred HHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 5899999999999999999999999999999999999999998654 36889999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 125 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred CCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999875432221 12335789999999999988899999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~l 229 (304)
..... .......... . .+...+..+.++|.+||+.||++|| ++++++++.
T Consensus 203 ~~~~~------~~~~~~~~~~--------~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 203 ENRKK------TIDKILKGKL--------N----LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CCHHH------HHHHHHcCCC--------C----CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 43211 1111110000 0 1112246789999999999999999 788888753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.09 Aligned_cols=210 Identities=24% Similarity=0.331 Sum_probs=173.7
Q ss_pred ChHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
.+|+.+|.+| .|.+||++|||-..++.+||||||= ..+|...|.++..-.+.-.++.+..|+++++.++|.+| ||
T Consensus 407 ~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IV 482 (677)
T KOG0596|consen 407 RNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IV 482 (677)
T ss_pred HHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---ee
Confidence 3799999999 5899999999999999999999996 56999999887666665588999999999999999999 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-----------CCCchhhhHHHHHH
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----------HLTSRSDVYSFGVV 148 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~i 148 (304)
|.||||.|+|+ -.|.+||+|||+|..+............+||+.||+||.+... ..+.++||||||||
T Consensus 483 HSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCI 561 (677)
T KOG0596|consen 483 HSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCI 561 (677)
T ss_pred ecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhH
Confidence 99999999999 4578999999999998877777777788999999999998532 25679999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHH-HHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 149 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA-QKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
+|+|+.|++||..... ...++..+.+|.....|+.... .++.++++.||+.||++|||+.|+|+
T Consensus 562 LYqMvYgktPf~~~~n---------------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 562 LYQMVYGKTPFGQIIN---------------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHHhcCCchHHHHH---------------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 9999999999975321 1123344555544333332222 23999999999999999999999998
Q ss_pred HhC
Q 022003 228 ALK 230 (304)
Q Consensus 228 ~l~ 230 (304)
+..
T Consensus 627 hpF 629 (677)
T KOG0596|consen 627 HPF 629 (677)
T ss_pred Ccc
Confidence 643
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=266.12 Aligned_cols=217 Identities=25% Similarity=0.353 Sum_probs=170.9
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCC-----eeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
|+|++..++++|||+++++++...+. ..||+++|...|+|.+.+... +..+++.++.+|+.+|++||++||+
T Consensus 66 ~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~ 145 (302)
T KOG2345|consen 66 LREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE 145 (302)
T ss_pred HHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc
Confidence 58999999999999999999876544 489999999999999998653 4579999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCccee-------eecccccccccCcchhh---cCCCCchhhh
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-------STRVMGTYGYAAPEYVM---TGHLTSRSDV 142 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~Di 142 (304)
.. .++.||||||.|||++.++.++|.|||.++...-...... ......|..|+|||.+. +...++++||
T Consensus 146 ~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDI 224 (302)
T KOG2345|consen 146 KE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDI 224 (302)
T ss_pred cC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccch
Confidence 88 5699999999999999999999999999876432111100 01235688999999986 4467899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 143 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 143 wslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
|||||++|.|++|..||...-..+..-. .....+.+.-.....+++.+.++|.+||+.||.+||++
T Consensus 225 WSLGCtLYa~mf~~sPfe~~~~~GgSla--------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i 290 (302)
T KOG2345|consen 225 WSLGCTLYAMMFGESPFERIYQQGGSLA--------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTI 290 (302)
T ss_pred hhhhHHHHHHHHcCCcchHHhhcCCeEE--------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCH
Confidence 9999999999999999975433221100 01111122111122357899999999999999999999
Q ss_pred HHHHHHhCCC
Q 022003 223 SEVVEALKPL 232 (304)
Q Consensus 223 ~ell~~l~~~ 232 (304)
.+++..+..+
T Consensus 291 ~~ll~~~d~L 300 (302)
T KOG2345|consen 291 PELLSKLDDL 300 (302)
T ss_pred HHHHHHHHhh
Confidence 9999988654
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.61 Aligned_cols=209 Identities=28% Similarity=0.356 Sum_probs=166.3
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++++ +|+||+++++++..++..++||||+++|+|.+++.++ ..+++..+..++.||+.||+|||+.+ |+|
T Consensus 53 ~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH 128 (332)
T cd05614 53 TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVY 128 (332)
T ss_pred HHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEe
Confidence 588899999 5899999999999999999999999999999998654 36999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
|||||+|||++.++.+||+|||+++........ ......||..|+|||++.+. .++.++|||||||++|+|++|..||
T Consensus 129 rDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf 207 (332)
T cd05614 129 RDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207 (332)
T ss_pred cCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCC
Confidence 999999999999999999999999865432221 12345789999999999865 4789999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 229 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~l 229 (304)
.......... ........ .++.. +...+..+.+++.+||+.||++|| ++++++++.
T Consensus 208 ~~~~~~~~~~--~~~~~~~~--------~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 208 TLEGERNTQS--EVSRRILK--------CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred CCCCCCCCHH--HHHHHHhc--------CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 6543222111 11110000 11111 112356789999999999999999 677888753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=292.40 Aligned_cols=211 Identities=29% Similarity=0.360 Sum_probs=168.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++..++..|+||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 47 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 122 (318)
T cd05582 47 MERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYR 122 (318)
T ss_pred HHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 5899999999999999999999999999999999999999998554 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 123 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 123 DLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred CCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 9999999999999999999999886543211 22345789999999999988899999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH-HHHHhCCCCCCc
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE-VVEALKPLPNLK 236 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e-ll~~l~~~~~~~ 236 (304)
..... . ......... ..+...+..+.++|.+||+.||++||++.+ .++.+...+.+.
T Consensus 201 ~~~~~---~---~~~i~~~~~------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~ 258 (318)
T cd05582 201 KDRKE---T---MTMILKAKL------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFS 258 (318)
T ss_pred CCHHH---H---HHHHHcCCC------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcC
Confidence 43211 1 110000000 011123567899999999999999999555 233333344443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=282.74 Aligned_cols=212 Identities=28% Similarity=0.456 Sum_probs=171.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKG 66 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~ 66 (304)
+|++++++++|+||+++++++...+..++||||+++++|.+++.... ..+++..++.++.||+.|
T Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 135 (291)
T cd05094 56 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 135 (291)
T ss_pred HHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHH
Confidence 58899999999999999999999999999999999999999986432 348999999999999999
Q ss_pred HHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHH
Q 022003 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 146 (304)
Q Consensus 67 l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 146 (304)
|+|||+++ ++||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||
T Consensus 136 l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 212 (291)
T cd05094 136 MVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 212 (291)
T ss_pred HHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHH
Confidence 99999998 999999999999999999999999999865443322223334567889999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 147 VVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 147 ~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
|++|+|++ |..||....... ...... . ... + ......+..+.+++.+||+.||++|||+.++
T Consensus 213 ~il~el~t~g~~p~~~~~~~~---~~~~~~----~-~~~-----~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v 275 (291)
T cd05094 213 VILWEIFTYGKQPWFQLSNTE---VIECIT----Q-GRV-----L----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275 (291)
T ss_pred HHHHHHHhCCCCCCCCCCHHH---HHHHHh----C-CCC-----C----CCCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 99999998 999986543211 111100 0 000 0 0111235688999999999999999999999
Q ss_pred HHHhCCCC
Q 022003 226 VEALKPLP 233 (304)
Q Consensus 226 l~~l~~~~ 233 (304)
++.|+.+.
T Consensus 276 ~~~l~~~~ 283 (291)
T cd05094 276 YKILHALG 283 (291)
T ss_pred HHHHHHHH
Confidence 99987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=290.16 Aligned_cols=223 Identities=24% Similarity=0.328 Sum_probs=162.9
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeC-----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
++|++++++++||||+++++++... ...|+||||| +++|.+++... ..+++..+..++.||+.||.|||+.+
T Consensus 47 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~- 123 (338)
T cd07859 47 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN- 123 (338)
T ss_pred HHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3699999999999999999988643 2479999999 57999988554 36999999999999999999999998
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCc-ceeeecccccccccCcchhhc--CCCCchhhhHHHHHHHHHH
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el 152 (304)
|+||||||+|||++.++.+||+|||+++....... ........||..|+|||++.+ ..++.++|||||||++|+|
T Consensus 124 --ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el 201 (338)
T cd07859 124 --VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 201 (338)
T ss_pred --eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHH
Confidence 99999999999999999999999999986432211 111234578999999999875 6789999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhH---------hhhhhh-ccccccccccCCccCCCC---CHHHHHHHHHHHHHhccCCCCCC
Q 022003 153 LTGRRSMDKNRPNGEHNLVE---------WARPHL-GERRRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKAR 219 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~---------~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R 219 (304)
++|+.||............. ...... .....+...+.......+ ....+..+.+++.+||+.||++|
T Consensus 202 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 281 (338)
T cd07859 202 LTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDR 281 (338)
T ss_pred HcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccC
Confidence 99999997543211100000 000000 000000000000000000 00124578899999999999999
Q ss_pred CCHHHHHHH
Q 022003 220 PLMSEVVEA 228 (304)
Q Consensus 220 ps~~ell~~ 228 (304)
||++|++++
T Consensus 282 pt~~e~l~h 290 (338)
T cd07859 282 PTAEEALAD 290 (338)
T ss_pred CCHHHHhcC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.68 Aligned_cols=223 Identities=23% Similarity=0.273 Sum_probs=170.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++......|+|||++ +++|.+++. ....+++..++.++.||+.||.|||+.+ |+||
T Consensus 135 ~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHr 209 (392)
T PHA03207 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHR 209 (392)
T ss_pred HHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 6999999999999999999999999999999999 568888884 4457999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 210 Dlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 210 DVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred CCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999876544333333346789999999999999999999999999999999999999976
Q ss_pred CCCCCCcchhHhhhhhhcc-c---------------cccccccCCccC-CC--CCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 162 NRPNGEHNLVEWARPHLGE-R---------------RRFYRLIDPRLE-GH--FSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~-~---------------~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
................... . ..+.....+... .. .....+.++.++|.+||+.||++|||+
T Consensus 290 ~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa 369 (392)
T PHA03207 290 KQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA 369 (392)
T ss_pred CCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH
Confidence 5433211111100000000 0 000000000000 00 001124578899999999999999999
Q ss_pred HHHHHHh
Q 022003 223 SEVVEAL 229 (304)
Q Consensus 223 ~ell~~l 229 (304)
.|++.+-
T Consensus 370 ~e~l~~p 376 (392)
T PHA03207 370 QDILSLP 376 (392)
T ss_pred HHHhhCc
Confidence 9999863
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=279.24 Aligned_cols=209 Identities=30% Similarity=0.486 Sum_probs=169.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------------LPLPWSIRMKIALGAAKGLA 68 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------~~l~~~~~~~i~~qi~~~l~ 68 (304)
+|+++|++++|+||+++++++......++||||+++++|.+++...+ ..+++..+..++.|++.||.
T Consensus 57 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~ 136 (280)
T cd05049 57 REAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMV 136 (280)
T ss_pred HHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHH
Confidence 68999999999999999999999999999999999999999996532 34788999999999999999
Q ss_pred HhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHH
Q 022003 69 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 148 (304)
Q Consensus 69 ~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 148 (304)
|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||+
T Consensus 137 ~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 213 (280)
T cd05049 137 YLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV 213 (280)
T ss_pred HHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHH
Confidence 999988 99999999999999999999999999976533222222233445778999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 149 LLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 149 l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
+|+|++ |..||....... ...... .... . ..+...+..+.+++.+||+.||++||++.|+++
T Consensus 214 l~e~~~~g~~p~~~~~~~~---~~~~~~-----~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 214 LWEIFTYGKQPWYGLSNEE---VIECIT-----QGRL-----L----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHhcCCCCCCCCCHHH---HHHHHH-----cCCc-----C----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999998 999986543211 111111 0000 0 011123568899999999999999999999999
Q ss_pred HhC
Q 022003 228 ALK 230 (304)
Q Consensus 228 ~l~ 230 (304)
.|+
T Consensus 277 ~l~ 279 (280)
T cd05049 277 RLQ 279 (280)
T ss_pred Hhh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=287.79 Aligned_cols=207 Identities=25% Similarity=0.267 Sum_probs=175.2
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++||++|. |||||.+++++++....++|||+|.||.|.+.+.+. .+++..+..++.|++.++.|||+.| |+|
T Consensus 84 ~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvH 158 (382)
T KOG0032|consen 84 REVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVH 158 (382)
T ss_pred HHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---cee
Confidence 6999999998 999999999999999999999999999999999777 3999999999999999999999998 999
Q ss_pred ccCCCCCeEECC----CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCC
Q 022003 81 RDFKTSNILLDA----DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 81 ~dlkp~Nili~~----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 156 (304)
|||||+|+|+.. ++.+|++|||++..... .......+||+.|+|||++.+..|+..+||||+|+++|.|++|.
T Consensus 159 rDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~ 235 (382)
T KOG0032|consen 159 RDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGV 235 (382)
T ss_pred ccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCC
Confidence 999999999953 35799999999998765 22355689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
+||...........+... . ..+....-...+..+.++|++||..||.+|+|+.++++|.+
T Consensus 236 ~PF~~~~~~~~~~~i~~~--------~------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 236 PPFWGETEFEIFLAILRG--------D------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CCCcCCChhHHHHHHHcC--------C------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 999876543322211100 0 01112222244788999999999999999999999999743
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=296.71 Aligned_cols=213 Identities=29% Similarity=0.466 Sum_probs=175.3
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
|+|+++|++++|||||++||+......+++|||+|+||+|.++|++....++..+...++.+.+.||+|||+++ +||
T Consensus 209 m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IH 285 (474)
T KOG0194|consen 209 MKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIH 285 (474)
T ss_pred HHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---Ccc
Confidence 68999999999999999999999999999999999999999999888778999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeee-cccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
|||..+|+|++.++.+||+|||+++... ...... ...-...|+|||.+....|+.++|||||||++||+++ |..|
T Consensus 286 RDIAARNcL~~~~~~vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~P 362 (474)
T KOG0194|consen 286 RDIAARNCLYSKKGVVKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEP 362 (474)
T ss_pred hhHhHHHheecCCCeEEeCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCC
Confidence 9999999999999999999999988643 111111 1123568999999999999999999999999999998 7888
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 235 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~~ 235 (304)
|.+..... ...++. . ..++. ..+...+.++..++.+||..||++||++.++.+.++.+...
T Consensus 363 y~g~~~~~---v~~kI~---~---~~~r~-------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 363 YPGMKNYE---VKAKIV---K---NGYRM-------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred CCCCCHHH---HHHHHH---h---cCccC-------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 87654321 111110 0 00111 11223467889999999999999999999999988765543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=280.16 Aligned_cols=217 Identities=24% Similarity=0.335 Sum_probs=172.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|++++++++||||+++++++..+...++||||++|++|.+++... ...+++..+..++.|++.||+|||+.+ ++|
T Consensus 42 ~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH 118 (277)
T cd05607 42 LEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVY 118 (277)
T ss_pred HHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEE
Confidence 4899999999999999999999999999999999999999888554 345899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 119 ~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~ 195 (277)
T cd05607 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195 (277)
T ss_pred ccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999988754322 1233568999999999998889999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCCCcc
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 237 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~~~~ 237 (304)
....... ............ ... .....+.++.+|+.+||+.||++||++.|+++.+...+.++.
T Consensus 196 ~~~~~~~--~~~~~~~~~~~~------~~~-----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 196 DHKEKVA--KEELKRRTLEDE------VKF-----EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CCcchhh--HHHHHHHhhccc------ccc-----ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 5432111 111111111000 000 001235688999999999999999999888877666555433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=282.19 Aligned_cols=212 Identities=29% Similarity=0.475 Sum_probs=170.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC------------CCCCHHHHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------LPLPWSIRMKIALGAAKGLAF 69 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~l~~~~~~~i~~qi~~~l~~ 69 (304)
+|++++++++|+||+++++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||+|
T Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~ 135 (288)
T cd05093 56 REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVY 135 (288)
T ss_pred HHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 68999999999999999999999999999999999999999986432 248999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHH
Q 022003 70 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 149 (304)
Q Consensus 70 LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 149 (304)
||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++
T Consensus 136 lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il 212 (288)
T cd05093 136 LASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 212 (288)
T ss_pred HHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 99988 999999999999999999999999999865433222222234457789999999988999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 150 LEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 150 ~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|+|++ |..||....... ...... .. .. ... +...+.++.+++.+||+.||.+|||+.++++.
T Consensus 213 ~~l~t~g~~p~~~~~~~~---~~~~i~----~~-~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~ 275 (288)
T cd05093 213 WEIFTYGKQPWYQLSNNE---VIECIT----QG-RV-----LQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSL 275 (288)
T ss_pred HHHHhCCCCCCCCCCHHH---HHHHHH----cC-Cc-----CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 99998 888886543211 111100 00 00 000 11224679999999999999999999999998
Q ss_pred hCCCC
Q 022003 229 LKPLP 233 (304)
Q Consensus 229 l~~~~ 233 (304)
|+.+.
T Consensus 276 l~~~~ 280 (288)
T cd05093 276 LQNLA 280 (288)
T ss_pred HHHHH
Confidence 87654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=262.60 Aligned_cols=204 Identities=26% Similarity=0.384 Sum_probs=173.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++|-+.|+||||+++|++|.+....|+++||..+|+|...+.. ...++++...+.++.|++.||.|+|..+ +||
T Consensus 71 REiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIh 147 (281)
T KOG0580|consen 71 REIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIH 147 (281)
T ss_pred heeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---ccc
Confidence 689999999999999999999999999999999999999999973 3557999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|+|++..|.+|++|||.+..... ....+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||.
T Consensus 148 RdiKpenlLlg~~~~lkiAdfGwsV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFe 223 (281)
T KOG0580|consen 148 RDIKPENLLLGSAGELKIADFGWSVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFE 223 (281)
T ss_pred CCCCHHHhccCCCCCeeccCCCceeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchh
Confidence 99999999999999999999999887542 23456799999999999999999999999999999999999999998
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
.....+. ...... .++..| ...+..+.++|.+||..+|.+|.+..|++++..
T Consensus 224 s~~~~et--YkrI~k---------~~~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 224 SQSHSET--YKRIRK---------VDLKFP-------STISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred hhhhHHH--HHHHHH---------ccccCC-------cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 6642111 111100 011122 233578899999999999999999999998754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=290.32 Aligned_cols=204 Identities=28% Similarity=0.359 Sum_probs=166.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH 80 (304)
+|+++++.++||||+++++++..++..|+||||+++++|..++.+. ..+++..+..++.||+.||+|||+ .+ |+|
T Consensus 44 ~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivH 119 (325)
T cd05594 44 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVY 119 (325)
T ss_pred HHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEe
Confidence 5888999999999999999999999999999999999999988554 469999999999999999999997 67 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 120 rDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~ 197 (325)
T cd05594 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 197 (325)
T ss_pred cCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCC
Confidence 99999999999999999999999875322111 1233568999999999999999999999999999999999999996
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~l 229 (304)
...... .......... . ++...+.++.++|.+||+.||++|+ ++.+++++.
T Consensus 198 ~~~~~~------~~~~i~~~~~--------~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 198 NQDHEK------LFELILMEEI--------R----FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CCCHHH------HHHHHhcCCC--------C----CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 543211 1110000000 1 1112346789999999999999996 899999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=279.68 Aligned_cols=208 Identities=25% Similarity=0.358 Sum_probs=167.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
.|++++++++|+||+++++++..+...++||||+++|+|..++.. ....+++..+..++.||+.||.|||+.+ |
T Consensus 42 ~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i 118 (280)
T cd05608 42 VEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---I 118 (280)
T ss_pred HHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 588999999999999999999999999999999999999988743 3456999999999999999999999988 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+||||||+||+++.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 119 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p 196 (280)
T cd05608 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196 (280)
T ss_pred ccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999976543322 12335689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~ 228 (304)
|......... ....... .... ..++...+..+.+++.+||+.||++|| ++++++++
T Consensus 197 f~~~~~~~~~--~~~~~~~----------~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 197 FRARGEKVEN--KELKQRI----------LNDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCCCCcchhH--HHHHHhh----------cccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 9754322111 0000000 0000 011223457889999999999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=295.98 Aligned_cols=197 Identities=26% Similarity=0.407 Sum_probs=165.5
Q ss_pred ChHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
|.|.+|+... +||.+++++..|.+.+++|+||||+.||++..+ ++...|++..+..++..|+.||+|||+++ ||
T Consensus 416 ~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~---II 490 (694)
T KOG0694|consen 416 MCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENG---II 490 (694)
T ss_pred HHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcC---ce
Confidence 4578888877 599999999999999999999999999994333 34457999999999999999999999999 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
|||||.+|||+|.+|.+||+|||+++...... ....+++||+.|||||++.+..|+.++|.||||+++|||+.|..||
T Consensus 491 YRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF 568 (694)
T KOG0694|consen 491 YRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPF 568 (694)
T ss_pred eeecchhheEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999998743222 2466799999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
.+.+..+..+-+ +.+ ++ .++...+.++.++++++|+++|++|..+
T Consensus 569 ~gddEee~FdsI------~~d--------~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 569 PGDDEEEVFDSI------VND--------EV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCHHHHHHHH------hcC--------CC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 876543322211 111 11 2344557899999999999999999854
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=276.85 Aligned_cols=211 Identities=27% Similarity=0.459 Sum_probs=171.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++|+||+++++++..++..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++|+
T Consensus 54 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~ 130 (266)
T cd05033 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHR 130 (266)
T ss_pred HHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 5899999999999999999999999999999999999999999776667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 131 di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 131 DLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred CCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 9999999999999999999999988753222222222344678999999998899999999999999999998 988885
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
..... ....... ... .. + .+...+..+.+++.+||+.+|++||+++|++++|+.+
T Consensus 211 ~~~~~---~~~~~~~----~~~---~~--~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 211 DMSNQ---DVIKAVE----DGY---RL--P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCHH---HHHHHHH----cCC---CC--C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 43211 1111110 000 00 0 1112356889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=273.63 Aligned_cols=209 Identities=25% Similarity=0.356 Sum_probs=179.8
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+.||++.+.|++|++||.+..+..+++|||||..|++.+.++.+.+++++.++..+++..+.||+|||... -||
T Consensus 76 IKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIH 152 (502)
T KOG0574|consen 76 IKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIH 152 (502)
T ss_pred HHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHH
Confidence 36999999999999999999999999999999999999999999999999999999999999999999999987 899
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||..|||++.+|.+||+|||.+..+.+. -...++..||+.|||||++....|+.++||||||++..||.-|++||.
T Consensus 153 RDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYs 230 (502)
T KOG0574|consen 153 RDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYS 230 (502)
T ss_pred hhcccccEEEcccchhhhhhccccchhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcc
Confidence 999999999999999999999999876432 223456789999999999999999999999999999999999999998
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
...+.-....+ -..|...=..+...+.++.+++++||..+|++|-|+.++++|.
T Consensus 231 DIHPMRAIFMI---------------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 231 DIHPMRAIFMI---------------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred cccccceeEec---------------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 76543221110 0111111123456688999999999999999999999999874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=285.69 Aligned_cols=220 Identities=24% Similarity=0.366 Sum_probs=166.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH 80 (304)
+|++++++++|+||+++++++..++..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+. + ++|
T Consensus 52 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH 127 (333)
T cd06650 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMH 127 (333)
T ss_pred HHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEe
Confidence 6999999999999999999999999999999999999999998654 3689999999999999999999974 5 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 128 ~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred cCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999998765322 1233568999999999998899999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhh-hhcc------cc--------------------cccc-ccCCccCCCCCHHHHHHHHHHHHHhc
Q 022003 161 KNRPNGEHNLVEWARP-HLGE------RR--------------------RFYR-LIDPRLEGHFSIKGAQKAAQLAAHCL 212 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~-~~~~------~~--------------------~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l 212 (304)
................ .... .. .... ..............+.++.+|+.+||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 283 (333)
T cd06650 204 PPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCL 283 (333)
T ss_pred CcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhc
Confidence 5432111000000000 0000 00 0000 00000000000012467899999999
Q ss_pred cCCCCCCCCHHHHHHHh
Q 022003 213 SRDPKARPLMSEVVEAL 229 (304)
Q Consensus 213 ~~dp~~Rps~~ell~~l 229 (304)
+.||++|||++|++++.
T Consensus 284 ~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 284 IKNPAERADLKQLMVHA 300 (333)
T ss_pred cCCcccCcCHHHHhhCH
Confidence 99999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=286.57 Aligned_cols=206 Identities=29% Similarity=0.344 Sum_probs=162.9
Q ss_pred HhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 022003 6 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 85 (304)
Q Consensus 6 il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp 85 (304)
+++.++||||+++++++...+..++||||+++++|..++.+. ..+++..+..++.||+.||.|||+.+ |+||||||
T Consensus 49 ~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp 124 (323)
T cd05575 49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKP 124 (323)
T ss_pred HHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCH
Confidence 467899999999999999999999999999999999988654 47999999999999999999999998 99999999
Q ss_pred CCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCC
Q 022003 86 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 165 (304)
Q Consensus 86 ~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 165 (304)
+|||++.++.+||+|||++....... .......||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 125 ~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 202 (323)
T cd05575 125 ENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA 202 (323)
T ss_pred HHeEECCCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH
Confidence 99999999999999999987532221 1233457899999999999999999999999999999999999999754221
Q ss_pred CCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCCC
Q 022003 166 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 235 (304)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~~ 235 (304)
.......... ... ....+..+.++|.+||+.||.+||++.+.+..+...+.+
T Consensus 203 ------~~~~~i~~~~--------~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~ 254 (323)
T cd05575 203 ------EMYDNILNKP--------LRL----KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254 (323)
T ss_pred ------HHHHHHHcCC--------CCC----CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence 1111111100 001 112256889999999999999999986433333334444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=275.97 Aligned_cols=210 Identities=23% Similarity=0.359 Sum_probs=169.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++++..++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|
T Consensus 51 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H 127 (263)
T cd05052 51 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127 (263)
T ss_pred HHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eee
Confidence 6899999999999999999999999999999999999999998654 346899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+||++++++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 128 ~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 206 (263)
T cd05052 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206 (263)
T ss_pred cccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999999876432211 1112234567999999999999999999999999999998 88888
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
....... ...... ....+ ..+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 207 ~~~~~~~---~~~~~~----------~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 207 PGIDLSQ---VYELLE----------KGYRM----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHH---HHHHHH----------CCCCC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 6542211 100000 00001 11122357899999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=278.75 Aligned_cols=209 Identities=25% Similarity=0.418 Sum_probs=166.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|+.+++.++|+||+++++++..+...++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+
T Consensus 58 ~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (277)
T cd05062 58 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA 137 (277)
T ss_pred HHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999999999999999999999999999986432 235778899999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
.+ ++|+||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||
T Consensus 138 ~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 214 (277)
T cd05062 138 NK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214 (277)
T ss_pred CC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHH
Confidence 88 999999999999999999999999998765433222222223457789999999988999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 153 LT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 153 ~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
++ |..||...... ....... . ... +. .+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 215 ~~~~~~p~~~~~~~---~~~~~~~----~-~~~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 215 ATLAEQPYQGMSNE---QVLRFVM----E-GGL-----LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HcCCCCCCCCCCHH---HHHHHHH----c-CCc-----CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 99 67888643221 1111100 0 000 00 11123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=280.66 Aligned_cols=208 Identities=36% Similarity=0.593 Sum_probs=162.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++||||+++++++...+..++||||+++|+|.+++... ...+++..++.|+.||+.||.|||+.+ ++|
T Consensus 50 ~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH 126 (259)
T PF07714_consen 50 NEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIH 126 (259)
T ss_dssp HHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc
Confidence 6899999999999999999999888899999999999999999877 667999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
+||+++||+++.++.+||+|||++................+...|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 127 ~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~ 206 (259)
T PF07714_consen 127 GNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPF 206 (259)
T ss_dssp ST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999987643333333334456778999999998889999999999999999999 67887
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..... ....... .+... .. .+..++..+.++|..||..||++|||+.++++.|
T Consensus 207 ~~~~~---~~~~~~~----~~~~~---~~-------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 207 SDYDN---EEIIEKL----KQGQR---LP-------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSCH---HHHHHHH----HTTEE---TT-------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccc---ccccccc----ccccc---ce-------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 54421 1111111 11111 00 1112356789999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=286.99 Aligned_cols=220 Identities=23% Similarity=0.311 Sum_probs=164.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
.|+.++++++|+||+++++++......++|||++ .++|.+++......+++..++.++.||+.||.|||+.+ |+||
T Consensus 106 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 181 (357)
T PHA03209 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHR 181 (357)
T ss_pred HHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 5899999999999999999999999999999999 56898888777678999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||+++..++..
T Consensus 182 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 182 DVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred CCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 999999999999999999999997533211 12235689999999999999999999999999999999986655433
Q ss_pred CCCCCCcchh--------Hhhhhhhccccccc---------cccC------CccCC---CCCHHHHHHHHHHHHHhccCC
Q 022003 162 NRPNGEHNLV--------EWARPHLGERRRFY---------RLID------PRLEG---HFSIKGAQKAAQLAAHCLSRD 215 (304)
Q Consensus 162 ~~~~~~~~~~--------~~~~~~~~~~~~~~---------~~~~------~~~~~---~~~~~~~~~~~~li~~~l~~d 215 (304)
.......... ............+. .+++ ..... ......+.++.+||.+||+.|
T Consensus 259 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 338 (357)
T PHA03209 259 DPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFD 338 (357)
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCC
Confidence 3222111000 00000000000000 0000 00000 000122456778999999999
Q ss_pred CCCCCCHHHHHHH
Q 022003 216 PKARPLMSEVVEA 228 (304)
Q Consensus 216 p~~Rps~~ell~~ 228 (304)
|++|||++|+++|
T Consensus 339 P~~Rpta~e~l~h 351 (357)
T PHA03209 339 AAMRPSAEEILNY 351 (357)
T ss_pred cccCcCHHHHhcC
Confidence 9999999999986
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.81 Aligned_cols=198 Identities=26% Similarity=0.371 Sum_probs=159.0
Q ss_pred HhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 022003 6 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 85 (304)
Q Consensus 6 il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp 85 (304)
+++.++||||+++++++...+..|+||||+++++|..++.. ..+++..+..++.||+.||.|||+.+ ++||||||
T Consensus 55 ~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp 129 (324)
T cd05589 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKL 129 (324)
T ss_pred hccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCH
Confidence 34567899999999999999999999999999999988754 36999999999999999999999988 99999999
Q ss_pred CCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCC
Q 022003 86 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 165 (304)
Q Consensus 86 ~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 165 (304)
+||+++.++.+||+|||+++...... .......|+..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 130 ~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~ 207 (324)
T cd05589 130 DNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE 207 (324)
T ss_pred HHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999987533221 1223467899999999999999999999999999999999999999754321
Q ss_pred CCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 022003 166 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 228 (304)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~ 228 (304)
. ......... .. ++...+..+.++|.+||+.||.+|| ++.+++++
T Consensus 208 ~------~~~~i~~~~--------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 208 E------VFDSIVNDE--------VR----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred H------HHHHHHhCC--------CC----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1 111110000 00 1112356788999999999999999 46666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=273.18 Aligned_cols=207 Identities=27% Similarity=0.456 Sum_probs=167.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++...+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||
T Consensus 48 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 124 (256)
T cd05114 48 EEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124 (256)
T ss_pred HHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 5899999999999999999999999999999999999999999765557899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||.++....... .......++..|+|||++.+..++.++||||||+++|+|++ |+.||.
T Consensus 125 dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~ 203 (256)
T cd05114 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203 (256)
T ss_pred ccCcceEEEcCCCeEEECCCCCccccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999886533221 11122234567999999988889999999999999999999 888986
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..... ........ .. ....+. ..+..+.+++.+||+.+|.+|||++++++.|
T Consensus 204 ~~~~~---~~~~~i~~----~~---~~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 204 KKSNY---EVVEMISR----GF---RLYRPK-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHH---HHHHHHHC----CC---CCCCCC-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 54321 11111110 00 111111 1245789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=273.80 Aligned_cols=208 Identities=24% Similarity=0.395 Sum_probs=168.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++......++||||+.+++|.+++......+++..++.++.||+.||.|||+.+ ++|+
T Consensus 48 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 124 (256)
T cd05113 48 EEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHR 124 (256)
T ss_pred HHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 6899999999999999999999888899999999999999999766557999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||.++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 125 dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~ 203 (256)
T cd05113 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203 (256)
T ss_pred ccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 9999999999999999999999886543221 11122335678999999998889999999999999999998 888886
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
...... ...... .... ... +...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 204 ~~~~~~---~~~~~~----~~~~------~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 204 RFNNSE---TVEKVS----QGLR------LYR----PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred cCCHHH---HHHHHh----cCCC------CCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 543211 111110 0000 000 1112468899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.43 Aligned_cols=195 Identities=28% Similarity=0.330 Sum_probs=157.9
Q ss_pred hHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 022003 5 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 84 (304)
Q Consensus 5 ~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlk 84 (304)
.+++.++||||+++++++.+.+..++||||+++++|...+.+. ..+++..+..++.||+.||.|||+.+ |+|||||
T Consensus 48 ~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlk 123 (321)
T cd05603 48 VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLK 123 (321)
T ss_pred HHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCC
Confidence 3578899999999999999999999999999999999888554 46899999999999999999999988 9999999
Q ss_pred CCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Q 022003 85 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 164 (304)
Q Consensus 85 p~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 164 (304)
|+||+|+.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 124 p~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (321)
T cd05603 124 PENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV 201 (321)
T ss_pred HHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH
Confidence 999999999999999999987532221 123345789999999999998999999999999999999999999975421
Q ss_pred CCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 022003 165 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
............ . .+...+..+.+++.+||+.||.+|+++.
T Consensus 202 ------~~~~~~i~~~~~--------~----~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 202 ------SQMYDNILHKPL--------Q----LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ------HHHHHHHhcCCC--------C----CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111111111000 0 1112246789999999999999999765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=291.46 Aligned_cols=215 Identities=27% Similarity=0.447 Sum_probs=175.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+..|++-+|.||+-+.|+|..... .||+.+|+|.+|..+|.....+|.....+.|++||++|+.|||+++ ||||
T Consensus 437 nEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHr 512 (678)
T KOG0193|consen 437 NEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHR 512 (678)
T ss_pred HHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhh
Confidence 69999999999999999999998876 9999999999999999877778999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|||..|||+.++++|||+|||++................|...|||||+++ ..+|++.+||||||||+|||+||..|
T Consensus 513 DLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lP 592 (678)
T KOG0193|consen 513 DLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELP 592 (678)
T ss_pred hccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCC
Confidence 999999999999999999999998754332222333456788999999997 45899999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
|....... +.|. .++. ++.+... .....+++++.+|+..||..++++||.+.+|+..|+.+.
T Consensus 593 ysi~~~dq----Iifm------VGrG--~l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 593 YSIQNRDQ----IIFM------VGRG--YLMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred cCCCChhh----eEEE------eccc--ccCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 98433221 1111 1111 1112211 123356789999999999999999999999999766543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=286.90 Aligned_cols=203 Identities=26% Similarity=0.378 Sum_probs=163.9
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|.+++..+ +||||+++++++...+..|+||||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|
T Consensus 44 ~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH 119 (320)
T cd05590 44 TEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIY 119 (320)
T ss_pred HHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEe
Confidence 577778776 7999999999999999999999999999999988654 46999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 120 ~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (320)
T cd05590 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197 (320)
T ss_pred CCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 9999999999999999999999987542211 12234578999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~~ 228 (304)
...... .......... . .+...+.++.++|.+||+.||++||++ ++++++
T Consensus 198 ~~~~~~------~~~~i~~~~~--------~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 198 AENEDD------LFEAILNDEV--------V----YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCHHH------HHHHHhcCCC--------C----CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 543211 1111111000 0 111235688999999999999999998 556553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=286.38 Aligned_cols=206 Identities=26% Similarity=0.313 Sum_probs=164.4
Q ss_pred HhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 022003 6 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 85 (304)
Q Consensus 6 il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp 85 (304)
+++.++|+||+++++++...+..++||||+++++|.+++... ..+.+..+..++.||+.||.|||+.+ |+||||||
T Consensus 49 ~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp 124 (325)
T cd05602 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKP 124 (325)
T ss_pred HHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCH
Confidence 467789999999999999999999999999999999998654 46889999999999999999999998 99999999
Q ss_pred CCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCC
Q 022003 86 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 165 (304)
Q Consensus 86 ~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 165 (304)
+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 125 ~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 202 (325)
T cd05602 125 ENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 202 (325)
T ss_pred HHeEECCCCCEEEccCCCCcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999987543221 1233457899999999999999999999999999999999999999754321
Q ss_pred CCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCCC
Q 022003 166 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 235 (304)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~~ 235 (304)
. ... ....... . .....+..+.+++.+||+.||.+|+++.+.+..+.....+
T Consensus 203 ~---~~~---~i~~~~~--------~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~ 254 (325)
T cd05602 203 E---MYD---NILNKPL--------Q----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF 254 (325)
T ss_pred H---HHH---HHHhCCc--------C----CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCccc
Confidence 1 111 0000000 0 1112346789999999999999999988655555544444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=277.42 Aligned_cols=210 Identities=26% Similarity=0.476 Sum_probs=168.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC----------------CCCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR----------------SLPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~l~~~~~~~i~~qi~~ 65 (304)
+|++++++++||||+++++++......|+||||+++++|.+++..+ ...+++..+..++.|++.
T Consensus 56 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 135 (283)
T cd05090 56 QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAA 135 (283)
T ss_pred HHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHH
Confidence 5899999999999999999999999999999999999999998532 124788899999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||
T Consensus 136 al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05090 136 GMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212 (283)
T ss_pred HHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence 999999988 99999999999999999999999999987544332222333445678999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|||++ |..||...... ........ ... .. .+...+..+.+++.+||+.||++||++.+
T Consensus 213 G~il~el~~~g~~p~~~~~~~---~~~~~~~~-----~~~-----~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 275 (283)
T cd05090 213 GVVLWEIFSFGLQPYYGFSNQ---EVIEMVRK-----RQL-----LP----CSEDCPPRMYSLMTECWQEGPSRRPRFKD 275 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHH---HHHHHHHc-----CCc-----CC----CCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 999999998 88888653211 11111110 000 00 11123468899999999999999999999
Q ss_pred HHHHhCC
Q 022003 225 VVEALKP 231 (304)
Q Consensus 225 ll~~l~~ 231 (304)
++++|..
T Consensus 276 i~~~l~~ 282 (283)
T cd05090 276 IHTRLRS 282 (283)
T ss_pred HHHHhhc
Confidence 9998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=282.79 Aligned_cols=211 Identities=22% Similarity=0.353 Sum_probs=169.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++||||+++++++..+ ..++|+||+++|+|.+++.+....+++..++.++.||+.||+|||+.+ |+||
T Consensus 58 ~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~ 133 (316)
T cd05108 58 DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHR 133 (316)
T ss_pred HHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eecc
Confidence 588999999999999999998765 578999999999999999877667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 134 dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~ 213 (316)
T cd05108 134 DLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213 (316)
T ss_pred ccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999987654333222223344678999999999999999999999999999997 999986
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
...... ..... ..... ... +..++.++.+++.+||..||.+||++.+++..+..+.
T Consensus 214 ~~~~~~---~~~~~----~~~~~---~~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 214 GIPASE---ISSIL----EKGER---LPQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCCHHH---HHHHH----hCCCC---CCC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 532111 11100 00000 000 1112457889999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=273.14 Aligned_cols=210 Identities=23% Similarity=0.373 Sum_probs=167.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++. ....++||||+++++|.+++..+...+++..++.++.|++.||.|||+.+ ++||
T Consensus 44 ~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 119 (257)
T cd05115 44 REAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHR 119 (257)
T ss_pred HHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeec
Confidence 6899999999999999999875 45789999999999999999766667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCccee-eecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||+||+++.++.+||+|||++........... .....++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 120 dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 199 (257)
T cd05115 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199 (257)
T ss_pred ccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 9999999999999999999999986543322111 111223568999999988889999999999999999996 99998
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
....... ...... .... ...+...+.++.++|.+||..||++||++.++.+.|+..
T Consensus 200 ~~~~~~~---~~~~~~----~~~~----------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 200 KKMKGPE---VMSFIE----QGKR----------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CcCCHHH---HHHHHH----CCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 7543211 111110 0000 011123357899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=280.79 Aligned_cols=211 Identities=28% Similarity=0.415 Sum_probs=168.9
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~ 65 (304)
+|+++++++ +|+||+++++++..++..++||||+++++|..++..+ ...+++..++.++.|++.
T Consensus 64 ~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 143 (293)
T cd05053 64 SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVAR 143 (293)
T ss_pred HHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHH
Confidence 588999999 8999999999999999999999999999999998532 346899999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||+|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||
T Consensus 144 al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 220 (293)
T cd05053 144 GMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 220 (293)
T ss_pred HHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeeh
Confidence 999999988 99999999999999999999999999987644322222222335678999999988899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|+|++ |..||....... ..... .... ....+...+..+.+|+.+||..||++|||+.|
T Consensus 221 G~il~el~~~g~~p~~~~~~~~---~~~~~----~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 283 (293)
T cd05053 221 GVLLWEIFTLGGSPYPGIPVEE---LFKLL----KEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ 283 (293)
T ss_pred hhHHHHHhcCCCCCCCCCCHHH---HHHHH----HcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 999999997 888886542211 11100 0000 00111223568899999999999999999999
Q ss_pred HHHHhCCC
Q 022003 225 VVEALKPL 232 (304)
Q Consensus 225 ll~~l~~~ 232 (304)
+++.|+.+
T Consensus 284 il~~l~~~ 291 (293)
T cd05053 284 LVEDLDRM 291 (293)
T ss_pred HHHHHHHh
Confidence 99998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=284.83 Aligned_cols=203 Identities=28% Similarity=0.407 Sum_probs=162.7
Q ss_pred hHhhHhhc-CCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGD-LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|.+++.. .+||||+++++++..++..++||||++|++|..++... ..+++..+..++.||+.||.|||+.+ |+|
T Consensus 44 ~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH 119 (316)
T cd05592 44 VERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG---IIY 119 (316)
T ss_pred HHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 35566654 48999999999999999999999999999999988654 36999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||++....... .......||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 120 ~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~ 197 (316)
T cd05592 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999997643222 22334678999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~~ 228 (304)
...... ........ .+. ++...+.++.+++.+||+.||.+||++. +++++
T Consensus 198 ~~~~~~------~~~~i~~~--------~~~----~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 198 GEDEDE------LFDSILND--------RPH----FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCHHH------HHHHHHcC--------CCC----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 543211 11111000 011 1122356788999999999999999875 55553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=276.59 Aligned_cols=209 Identities=27% Similarity=0.416 Sum_probs=165.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+.++++++|+||+++++++.+.+..++||||+.+++|.+++.+.. ..+++..+..++.||+.||+|||+.+
T Consensus 58 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~- 136 (277)
T cd05036 58 MEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH- 136 (277)
T ss_pred HHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 58899999999999999999999999999999999999999986542 25899999999999999999999988
Q ss_pred CCeEeccCCCCCeEECCCC---cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 76 RPVIYRDFKTSNILLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
++||||||+||+++.++ .+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|
T Consensus 137 --ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el 214 (277)
T cd05036 137 --FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214 (277)
T ss_pred --EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHH
Confidence 99999999999998654 5999999999876332221112222335679999999989999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 153 LT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 153 ~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
++ |..||....... ...... .... ...+...+..+.+++.+||+.+|++|||+.+++++|+
T Consensus 215 ~~~g~~pf~~~~~~~---~~~~~~----~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 215 FSLGYMPYPGRTNQE---VMEFVT----GGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCCCCCCCCCHHH---HHHHHH----cCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 97 888887543211 111100 0000 0111223568899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=287.70 Aligned_cols=209 Identities=23% Similarity=0.392 Sum_probs=173.9
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
|-||+||...+||+||++++.|...+.++|+.|||.||-++..+..-+..+.+.++..+++|++.||.|||+.+ |||
T Consensus 77 lVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIH 153 (1187)
T KOG0579|consen 77 LVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIH 153 (1187)
T ss_pred hhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhh
Confidence 45899999999999999999999999999999999999999999888888999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHHHHHHHhC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg 155 (304)
||||..|||++.+|.++|+|||.+..... .......+.||+.|||||++. ..+|+.++||||||++|.||..+
T Consensus 154 RDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqi 231 (1187)
T KOG0579|consen 154 RDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQI 231 (1187)
T ss_pred hhccccceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhcc
Confidence 99999999999999999999999876321 223345689999999999875 46899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.+|-...++.-. ++.... --.|.+ ..+...+..+.+++.+||..||..||++.++++|.
T Consensus 232 EPPHhelnpMRV--llKiaK-----------SePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 232 EPPHHELNPMRV--LLKIAK-----------SEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred CCCccccchHHH--HHHHhh-----------cCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 988765433211 111100 011111 12445577899999999999999999999999864
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=276.96 Aligned_cols=210 Identities=23% Similarity=0.365 Sum_probs=168.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKG 66 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~ 66 (304)
+|+.+++.++||||+++++++......++++||+.+++|.+++... ...+++..+..++.|++.|
T Consensus 57 ~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~a 136 (283)
T cd05091 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAG 136 (283)
T ss_pred HHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHH
Confidence 5888999999999999999999999999999999999999998522 2348888999999999999
Q ss_pred HHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHH
Q 022003 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 146 (304)
Q Consensus 67 l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 146 (304)
|+|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||
T Consensus 137 L~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 213 (283)
T cd05091 137 MEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYG 213 (283)
T ss_pred HHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHH
Confidence 99999988 999999999999999999999999998875443322222334567889999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 147 VVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 147 ~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
|++|||++ |..||...... ....... .. . ....+..++..+.+++.+||+.+|++||+++++
T Consensus 214 ~~l~el~~~g~~p~~~~~~~---~~~~~i~---~~-~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i 276 (283)
T cd05091 214 VVLWEVFSYGLQPYCGYSNQ---DVIEMIR---NR-Q----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHH---HHHHHHH---cC-C----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 99999998 77888654221 1111100 00 0 001122345788999999999999999999999
Q ss_pred HHHhCC
Q 022003 226 VEALKP 231 (304)
Q Consensus 226 l~~l~~ 231 (304)
++.|+.
T Consensus 277 ~~~l~~ 282 (283)
T cd05091 277 HSRLRT 282 (283)
T ss_pred HHHhhC
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=280.72 Aligned_cols=220 Identities=24% Similarity=0.316 Sum_probs=162.1
Q ss_pred hHhhHhhcC---CCCcccceeeEEEe-----CCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDL---VHLNLVKLIGYCIE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l---~h~niv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|+++++.+ +||||+++++++.. ....++||||+. ++|.+++... ...+++..++.++.||+.||.|||+
T Consensus 50 ~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~ 128 (290)
T cd07862 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128 (290)
T ss_pred HHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 466666665 69999999999863 446899999995 6899988654 3458999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
.+ |+||||||+|||++.++.+||+|||+++..... .......||..|+|||++.+..++.++|||||||++|||
T Consensus 129 ~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el 202 (290)
T cd07862 129 HR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202 (290)
T ss_pred CC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHH
Confidence 88 999999999999999999999999999865432 122345689999999999988999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhh-----hhccccccc-cccCCccC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARP-----HLGERRRFY-RLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
++|.+||......+.......... .+.....+. ..+.+... .......+..+.+++.+||+.||++|||+.
T Consensus 203 ~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 282 (290)
T cd07862 203 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 282 (290)
T ss_pred HcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHH
Confidence 999999976543221110000000 000000000 00000000 000112356788999999999999999999
Q ss_pred HHHHH
Q 022003 224 EVVEA 228 (304)
Q Consensus 224 ell~~ 228 (304)
|++++
T Consensus 283 ~~l~h 287 (290)
T cd07862 283 SALSH 287 (290)
T ss_pred HHhcC
Confidence 99975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=287.56 Aligned_cols=204 Identities=25% Similarity=0.376 Sum_probs=160.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|+||+++++++..++.+++||||+.+++|.+.. ...+..+..++.||+.||+|||+.+ |+||
T Consensus 121 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 192 (353)
T PLN00034 121 REIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHR 192 (353)
T ss_pred HHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---Eeec
Confidence 6999999999999999999999999999999999999986532 3567888999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-----CCCCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+|||++.++.+||+|||+++....... ......||..|+|||++.. ...+.++|||||||++|||++|+
T Consensus 193 Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~ 270 (353)
T PLN00034 193 DIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270 (353)
T ss_pred CCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999987543211 1233568999999998742 33457999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.||............ ...... ..+ ......+.++.+||.+||+.||++|||+.|++++-
T Consensus 271 ~pf~~~~~~~~~~~~---~~~~~~-------~~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 271 FPFGVGRQGDWASLM---CAICMS-------QPP----EAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred CCCCCCCCccHHHHH---HHHhcc-------CCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 999733221111000 000000 000 11123356899999999999999999999999853
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=272.17 Aligned_cols=209 Identities=32% Similarity=0.474 Sum_probs=172.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|+++++.++|+||+++++++..+...++||||+++++|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 45 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 124 (262)
T cd00192 45 KEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK 124 (262)
T ss_pred HHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC
Confidence 5899999999999999999999999999999999999999999775 46799999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 153 (304)
+ ++|+||||+||+++.++.+||+|||.+................++..|+|||.+....++.++|||||||++|+|+
T Consensus 125 ~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 201 (262)
T cd00192 125 K---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF 201 (262)
T ss_pred C---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHH
Confidence 8 9999999999999999999999999998865543222333456788999999998889999999999999999999
Q ss_pred h-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 154 T-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 154 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
+ |..||...... ....... .. .....+...+.++.+++.+||+.+|.+|||+.+++++|+
T Consensus 202 ~~g~~p~~~~~~~---~~~~~~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 202 TLGATPYPGLSNE---EVLEYLR----KG----------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred hcCCCCCCCCCHH---HHHHHHH----cC----------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9 58888765221 1111100 00 000112223578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=276.10 Aligned_cols=209 Identities=27% Similarity=0.443 Sum_probs=167.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAKGL 67 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~l 67 (304)
+|++++++++|+||+++++++......++||||+++++|.+++.... ..+++..++.++.|++.||
T Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al 135 (280)
T cd05092 56 REAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGM 135 (280)
T ss_pred HHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHH
Confidence 58899999999999999999999999999999999999999986532 3588999999999999999
Q ss_pred HHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHH
Q 022003 68 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 147 (304)
Q Consensus 68 ~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 147 (304)
+|||+.+ ++||||||+|||+++++.+||+|||++................++..|+|||++.+..++.++|||||||
T Consensus 136 ~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05092 136 VYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGV 212 (280)
T ss_pred HHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHH
Confidence 9999988 9999999999999999999999999997654332222222334567899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 022003 148 VLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226 (304)
Q Consensus 148 il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 226 (304)
++|+|++ |..||....... ...... .... .. .+...+..+.+++.+||+.||.+||++.+++
T Consensus 213 il~el~~~g~~p~~~~~~~~---~~~~~~----~~~~------~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~ 275 (280)
T cd05092 213 VLWEIFTYGKQPWYQLSNTE---AIECIT----QGRE------LE----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIH 275 (280)
T ss_pred HHHHHHcCCCCCCccCCHHH---HHHHHH----cCcc------CC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 9999998 888886432211 111000 0000 00 0112346788999999999999999999999
Q ss_pred HHhC
Q 022003 227 EALK 230 (304)
Q Consensus 227 ~~l~ 230 (304)
+.|+
T Consensus 276 ~~l~ 279 (280)
T cd05092 276 SRLQ 279 (280)
T ss_pred HHHh
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=278.68 Aligned_cols=211 Identities=27% Similarity=0.409 Sum_probs=169.9
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++++++ +|+||+++++++...+..++||||+.+++|.+++.... ..+++.++..++.|++.||+|||+.+ ++
T Consensus 87 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---iv 163 (302)
T cd05055 87 SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CI 163 (302)
T ss_pred HHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 589999999 79999999999999999999999999999999996543 34899999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
|+||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 164 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p 243 (302)
T cd05055 164 HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243 (302)
T ss_pred hhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986544332222223445778999999999999999999999999999998 8999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
|........ ...... ... . . ..+...+..+.+++.+||..+|++|||+.|+++.|+.
T Consensus 244 ~~~~~~~~~--~~~~~~----~~~---~---~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 244 YPGMPVDSK--FYKLIK----EGY---R---M----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred cCCCCchHH--HHHHHH----cCC---c---C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 865432110 111000 000 0 0 0111224689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=282.69 Aligned_cols=210 Identities=28% Similarity=0.412 Sum_probs=165.0
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.++.++ +||||+++++++...+..|+||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ ++|
T Consensus 44 ~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH 119 (329)
T cd05588 44 TEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---IIY 119 (329)
T ss_pred HHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEe
Confidence 477888888 7999999999999999999999999999999888554 47999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 120 ~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 9999999999999999999999987532211 12234578999999999999999999999999999999999999996
Q ss_pred CCCCCCC--cchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 022003 161 KNRPNGE--HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL------MSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~ell~~ 228 (304)
....... .....+........ ... .+...+..+.++|.+||+.||.+|+| +++++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 198 IVGMSDNPDQNTEDYLFQVILEK-------QIR----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred cccccccccccchHHHHHHHHcC-------CCC----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 4322211 11111111111000 001 11123467899999999999999997 5667654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=290.67 Aligned_cols=213 Identities=23% Similarity=0.387 Sum_probs=169.3
Q ss_pred ChHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-------------------------------
Q 022003 1 MAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------------------- 48 (304)
Q Consensus 1 l~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------------- 48 (304)
++|+++|+++. ||||+++++++...+..|+|||||++|+|.+++.++.
T Consensus 88 ~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (400)
T cd05105 88 MSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYV 167 (400)
T ss_pred HHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchh
Confidence 46999999996 9999999999999999999999999999999885421
Q ss_pred ----------------------------------------------------------------CCCCHHHHHHHHHHHH
Q 022003 49 ----------------------------------------------------------------LPLPWSIRMKIALGAA 64 (304)
Q Consensus 49 ----------------------------------------------------------------~~l~~~~~~~i~~qi~ 64 (304)
..+++..+..++.||+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~ 247 (400)
T cd05105 168 ILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVA 247 (400)
T ss_pred hhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHH
Confidence 2477888899999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHH
Q 022003 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 144 (304)
Q Consensus 65 ~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 144 (304)
.||+|||+.+ ++||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||
T Consensus 248 ~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS 324 (400)
T cd05105 248 RGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324 (400)
T ss_pred HHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHH
Confidence 9999999988 9999999999999999999999999998654332222223345678899999999889999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 022003 145 FGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 145 lG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
|||++|+|++ |..||........ .... ..... ... .+...+.++.+++.+||+.||++|||+.
T Consensus 325 lGvil~ellt~g~~P~~~~~~~~~--~~~~----~~~~~------~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ 388 (400)
T cd05105 325 YGILLWEIFSLGGTPYPGMIVDST--FYNK----IKSGY------RMA----KPDHATQEVYDIMVKCWNSEPEKRPSFL 388 (400)
T ss_pred HHHHHHHHHHCCCCCCcccchhHH--HHHH----HhcCC------CCC----CCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence 9999999997 8888865422111 0000 00000 001 1123357889999999999999999999
Q ss_pred HHHHHhCCC
Q 022003 224 EVVEALKPL 232 (304)
Q Consensus 224 ell~~l~~~ 232 (304)
++.+.|+.+
T Consensus 389 ~l~~~l~~l 397 (400)
T cd05105 389 HLSDIVESL 397 (400)
T ss_pred HHHHHHHHH
Confidence 999988753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=275.36 Aligned_cols=211 Identities=26% Similarity=0.416 Sum_probs=168.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++. +...++++||+++|+|.+++......+++..+..++.||+.||.|||+.+ ++||
T Consensus 58 ~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~ 133 (279)
T cd05111 58 DHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHR 133 (279)
T ss_pred HHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---Eecc
Confidence 3666888999999999999875 45678999999999999999776667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 134 dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 213 (279)
T cd05111 134 NLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213 (279)
T ss_pred ccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999987644333222333456778999999998899999999999999999998 999986
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
...... ..+... ... ....+. .++.++.+++.+||..||++|||+.|+++.|..+.
T Consensus 214 ~~~~~~---~~~~~~----~~~---~~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 214 GMRPHE---VPDLLE----KGE---RLAQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCHHH---HHHHHH----CCC---cCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 543211 111110 000 001111 12457789999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=283.26 Aligned_cols=203 Identities=28% Similarity=0.382 Sum_probs=162.9
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|.+++..+ +||||+++++++..++..|+||||+.+++|..++... ..+++..+..++.||+.||+|||+.+ |+|
T Consensus 44 ~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH 119 (316)
T cd05620 44 VEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG---IIY 119 (316)
T ss_pred HHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEe
Confidence 466777654 8999999999999999999999999999999988654 46899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 120 rDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred cCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987532211 12334678999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~~ 228 (304)
..... ....... . ..+... ...+.++.++|.+||+.||++||++. +++++
T Consensus 198 ~~~~~---~~~~~~~---~--------~~~~~~----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 198 GDDED---ELFESIR---V--------DTPHYP----RWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCHH---HHHHHHH---h--------CCCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 54321 1111000 0 011111 12346789999999999999999974 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=306.28 Aligned_cols=213 Identities=30% Similarity=0.444 Sum_probs=177.5
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
|+|..+|++++|||||+++|++.+....+|++|||.||+|..+|++. ...++......++.|||+|+.||++++
T Consensus 743 l~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~ 822 (1025)
T KOG1095|consen 743 LKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH 822 (1025)
T ss_pred HHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC
Confidence 57999999999999999999999999999999999999999999876 567999999999999999999999988
Q ss_pred CCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh
Q 022003 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 154 (304)
+|||||...|+|++....+||+|||+|+.+...+.+.....-.-...|||||.+..+.++.|+||||||+++||++|
T Consensus 823 ---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifs 899 (1025)
T KOG1095|consen 823 ---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFS 899 (1025)
T ss_pred ---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHh
Confidence 99999999999999999999999999996555444443333234578999999999999999999999999999999
Q ss_pred -CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 155 -GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 155 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
|..||......+... .+. +.. ++. .+..++..+.++|..||+.+|++||++..|++.+..+.
T Consensus 900 lG~~PY~~~~n~~v~~--~~~-----~gg---RL~-------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 900 LGATPYPSRSNFEVLL--DVL-----EGG---RLD-------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred CCCCCCCCcchHHHHH--HHH-----hCC---ccC-------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 778887654322111 011 111 121 23355789999999999999999999999999766543
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=272.91 Aligned_cols=207 Identities=26% Similarity=0.395 Sum_probs=167.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++...+..++||||+++++|.+++..+...+++..++.++.|++.||+|||+.+ ++||
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~ 124 (256)
T cd05059 48 EEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124 (256)
T ss_pred HHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 5899999999999999999999999999999999999999999776667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 125 dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 203 (256)
T cd05059 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203 (256)
T ss_pred cccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCC
Confidence 99999999999999999999998865432111 1111223457999999998899999999999999999999 788886
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
...... ..... ... .... .+...+..+.+++.+||..+|++|||+.|+++.|
T Consensus 204 ~~~~~~---~~~~~----~~~------~~~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 204 RFSNSE---VVESV----SAG------YRLY----RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHH---HHHHH----HcC------CcCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 543211 11100 000 0001 1112356899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=278.38 Aligned_cols=211 Identities=27% Similarity=0.428 Sum_probs=168.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-----------------------CCCCCHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-----------------------SLPLPWSIRMK 58 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----------------------~~~l~~~~~~~ 58 (304)
+|+++++.++||||+++++.+..++..++||||+.+++|.+++... ...+++..++.
T Consensus 52 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 131 (290)
T cd05045 52 SEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLIS 131 (290)
T ss_pred HHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHH
Confidence 5899999999999999999999999999999999999999988532 13478999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCc
Q 022003 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 138 (304)
Q Consensus 59 i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 138 (304)
++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus 132 i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 208 (290)
T cd05045 132 FAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT 208 (290)
T ss_pred HHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch
Confidence 9999999999999988 9999999999999999999999999998654332222222334567899999998888999
Q ss_pred hhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 139 RSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 139 ~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
++||||||+++|+|++ |..||...... ....... .. .... .+...+.++.+++.+||+.+|+
T Consensus 209 ~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~------~~~~----~~~~~~~~~~~~i~~cl~~~P~ 271 (290)
T cd05045 209 QSDVWSFGVLLWEIVTLGGNPYPGIAPE---RLFNLLK----TG------YRME----RPENCSEEMYNLMLTCWKQEPD 271 (290)
T ss_pred HhHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHh----CC------CCCC----CCCCCCHHHHHHHHHHccCCcc
Confidence 9999999999999998 99988654321 1111110 00 0011 1122356899999999999999
Q ss_pred CCCCHHHHHHHhCCC
Q 022003 218 ARPLMSEVVEALKPL 232 (304)
Q Consensus 218 ~Rps~~ell~~l~~~ 232 (304)
+||++.|+++.|+.+
T Consensus 272 ~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 272 KRPTFADISKELEKM 286 (290)
T ss_pred cCCCHHHHHHHHHHH
Confidence 999999999988654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.33 Aligned_cols=203 Identities=26% Similarity=0.391 Sum_probs=164.5
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|++++..+ +||||+++++++..++..|+||||+++++|..++.+. ..+++..+..++.||+.||.|||+.+ |+|
T Consensus 44 ~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH 119 (321)
T cd05591 44 TEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VIY 119 (321)
T ss_pred HHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 477888766 8999999999999999999999999999999988654 46899999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 120 rDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~ 197 (321)
T cd05591 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197 (321)
T ss_pred cCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCC
Confidence 99999999999999999999999875432211 2234568999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-------CHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-------LMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-------s~~ell~~ 228 (304)
...... . ........ .. ++...+.++.+++.+||+.||++|+ ++.+++++
T Consensus 198 ~~~~~~---~---~~~i~~~~-----~~-------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 198 ADNEDD---L---FESILHDD-----VL-------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHH---H---HHHHHcCC-----CC-------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 543211 1 11111000 00 1112246889999999999999999 77777765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=283.79 Aligned_cols=203 Identities=28% Similarity=0.410 Sum_probs=165.0
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++.+ +||||+++++++...+..|+||||+++++|..++.+. ..+++..+..++.||+.||.|||+.+ ++|
T Consensus 44 ~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH 119 (318)
T cd05570 44 TEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIY 119 (318)
T ss_pred HHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEc
Confidence 577888877 7999999999999999999999999999999988654 36999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||+++.++.+||+|||+++....... .....+|+..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 120 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~ 197 (318)
T cd05570 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197 (318)
T ss_pred cCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCC
Confidence 99999999999999999999999875322111 1233568999999999999999999999999999999999999996
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~~ 228 (304)
..... .......... .. ++...+..+.+||.+||+.||++|||+ .+++++
T Consensus 198 ~~~~~------~~~~~i~~~~--------~~----~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 198 GDDED------ELFQSILEDE--------VR----YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCHH------HHHHHHHcCC--------CC----CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 54311 1111100000 00 111235688999999999999999999 777764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=284.70 Aligned_cols=209 Identities=23% Similarity=0.274 Sum_probs=167.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|+||+++++++...+..++||||+++++|.+++.+....+++..+..++.||+.||.|||+.+ |+||
T Consensus 50 ~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~ 126 (330)
T cd05601 50 EERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHR 126 (330)
T ss_pred HHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcc
Confidence 5788999999999999999999999999999999999999999776568999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh------cCCCCchhhhHHHHHHHHHHHhC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el~tg 155 (304)
||||+|||++.++.+||+|||++......... ......||..|+|||++. ...++.++|||||||++|+|++|
T Consensus 127 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g 205 (330)
T cd05601 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG 205 (330)
T ss_pred cCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccC
Confidence 99999999999999999999999876443222 223356899999999986 45678999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..||........ + .... ........ +. ....+.++.+|+.+||+ +|.+|||+++++++-
T Consensus 206 ~~Pf~~~~~~~~-----~-~~i~-~~~~~~~~--~~-----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 206 RSPFHEGTSAKT-----Y-NNIM-NFQRFLKF--PE-----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred CCCCCCCCHHHH-----H-HHHH-cCCCccCC--CC-----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 999975432110 0 0000 00000010 00 01235688999999998 999999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=289.62 Aligned_cols=210 Identities=24% Similarity=0.337 Sum_probs=163.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++.+.+..|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+.+ |+||
T Consensus 50 ~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~g---ivHr 125 (381)
T cd05626 50 AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMG---FIHR 125 (381)
T ss_pred HHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 58999999999999999999999999999999999999999986543 6899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCc---------------------------------------------ceee
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDK---------------------------------------------THVS 116 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---------------------------------------------~~~~ 116 (304)
||||+||||+.++.+||+|||++........ ....
T Consensus 126 DlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (381)
T cd05626 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLA 205 (381)
T ss_pred CCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccccc
Confidence 9999999999999999999999754311000 0001
Q ss_pred ecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCC
Q 022003 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF 196 (304)
Q Consensus 117 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (304)
...+||..|+|||++.+..++.++|||||||++|||++|..||......... ... ........ . +.
T Consensus 206 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~i--~~~~~~~~---~--~~----- 271 (381)
T cd05626 206 HSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQ--LKV--INWENTLH---I--PP----- 271 (381)
T ss_pred ccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHH--HHH--HccccccC---C--CC-----
Confidence 2357999999999999989999999999999999999999999764322110 000 00000000 0 00
Q ss_pred CHHHHHHHHHHHHHhc--cCCCCCCCCHHHHHHHh
Q 022003 197 SIKGAQKAAQLAAHCL--SRDPKARPLMSEVVEAL 229 (304)
Q Consensus 197 ~~~~~~~~~~li~~~l--~~dp~~Rps~~ell~~l 229 (304)
....+.++.+||.+|+ ..++..|+++++++++.
T Consensus 272 ~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 272 QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 0123568889999955 55566699999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=289.27 Aligned_cols=209 Identities=25% Similarity=0.311 Sum_probs=164.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|+||+++++.+.+++.+|+|||||++|+|.+++.+.. .+++..++.++.||+.||+|||+.+ |+||
T Consensus 50 ~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---ivHr 125 (376)
T cd05598 50 AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMG---FIHR 125 (376)
T ss_pred HHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeC
Confidence 58999999999999999999999999999999999999999996653 6899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCC-----------------------------------------cceeeeccc
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGD-----------------------------------------KTHVSTRVM 120 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-----------------------------------------~~~~~~~~~ 120 (304)
||||+|||++.++.+||+|||++..+.... ........+
T Consensus 126 Dlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (376)
T cd05598 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLV 205 (376)
T ss_pred CCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccC
Confidence 999999999999999999999975321000 000011347
Q ss_pred ccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHH
Q 022003 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 200 (304)
Q Consensus 121 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (304)
||+.|+|||++.+..++.++|||||||++|||++|..||.......... ... .... ....+. ....
T Consensus 206 gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~-~~~~--~~~~~~-----~~~~ 271 (376)
T cd05598 206 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQL------KVI-NWET--TLHIPS-----QAKL 271 (376)
T ss_pred CCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHH------HHh-ccCc--cccCCC-----CCCC
Confidence 9999999999999999999999999999999999999997653321100 000 0000 000000 0122
Q ss_pred HHHHHHHHHHhccCCCCCCC---CHHHHHHHh
Q 022003 201 AQKAAQLAAHCLSRDPKARP---LMSEVVEAL 229 (304)
Q Consensus 201 ~~~~~~li~~~l~~dp~~Rp---s~~ell~~l 229 (304)
+.++.++|.+|+ .+|.+|+ ++.|++++.
T Consensus 272 s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~ 302 (376)
T cd05598 272 SREASDLILRLC-CGAEDRLGKNGADEIKAHP 302 (376)
T ss_pred CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCC
Confidence 467889999976 5999999 899999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=277.48 Aligned_cols=207 Identities=29% Similarity=0.387 Sum_probs=168.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++.+..++..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|
T Consensus 49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH 125 (285)
T cd05605 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVY 125 (285)
T ss_pred HHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEe
Confidence 5899999999999999999999999999999999999999888654 346999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||++++++.++|+|||++........ .....|+..|+|||++.+..++.++||||+||++|+|++|..||.
T Consensus 126 ~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~ 202 (285)
T cd05605 126 RDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202 (285)
T ss_pred cCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999987543221 223568999999999998899999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~ 228 (304)
........ ..... .... ....++...+..+.+||.+||..||++|| ++++++++
T Consensus 203 ~~~~~~~~--~~~~~-~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 203 QRKEKVKR--EEVER-RVKE-----------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CCchhhHH--HHHHH-Hhhh-----------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 54321110 01000 0000 00111223456889999999999999999 78888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.88 Aligned_cols=216 Identities=27% Similarity=0.428 Sum_probs=169.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHhh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLH 71 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~l~~~~~~~i~~qi~~~l~~LH 71 (304)
+|++++++++|+||+++++++..++..++||||+.+++|.+++.+.. ..+++..++.++.|++.||+|||
T Consensus 68 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH 147 (296)
T cd05051 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE 147 (296)
T ss_pred HHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 58999999999999999999999999999999999999999986543 26899999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHH
Q 022003 72 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 151 (304)
Q Consensus 72 ~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 151 (304)
+.+ ++||||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+
T Consensus 148 ~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 224 (296)
T cd05051 148 SLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224 (296)
T ss_pred HcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHH
Confidence 988 99999999999999999999999999986544333233334456778999999988889999999999999999
Q ss_pred HHh--CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 152 MLT--GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 152 l~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|++ +..||..... ............... .......+...+.++.+++.+||+.||.+|||+.|+++.|
T Consensus 225 l~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 225 ILTLCREQPYEHLTD---QQVIENAGHFFRDDG-------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred HHhcCCCCCCCCcCh---HHHHHHHHhcccccc-------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 998 5666654321 111111111100000 0000001112346899999999999999999999999987
Q ss_pred C
Q 022003 230 K 230 (304)
Q Consensus 230 ~ 230 (304)
+
T Consensus 295 ~ 295 (296)
T cd05051 295 Q 295 (296)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=275.30 Aligned_cols=209 Identities=27% Similarity=0.437 Sum_probs=168.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|+.+++.++|+||+++++++..+...++||||+++++|.+++.... ..+++..+..++.|++.||.|||+
T Consensus 58 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 137 (277)
T cd05032 58 NEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA 137 (277)
T ss_pred HHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 68899999999999999999999999999999999999999986431 247888999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||
T Consensus 138 ~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 214 (277)
T cd05032 138 KK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214 (277)
T ss_pred CC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHh
Confidence 88 999999999999999999999999999865433222222334567889999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 153 LT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 153 ~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
++ |..||....... ...+.. ... . .. .+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 215 ~t~g~~p~~~~~~~~---~~~~~~----~~~-~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 215 ATLAEQPYQGLSNEE---VLKFVI----DGG-H-----LD----LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hccCCCCCccCCHHH---HHHHHh----cCC-C-----CC----CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 98 888886432211 111111 000 0 01 11122578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=293.55 Aligned_cols=219 Identities=23% Similarity=0.335 Sum_probs=161.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--------CeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--------DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 70 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~L 70 (304)
+|+.+|+.++|||||++++++... ..+++||||++ ++|.+++.. ....+++..++.++.||+.||+||
T Consensus 108 ~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL 186 (440)
T PTZ00036 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186 (440)
T ss_pred HHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 599999999999999999987532 24679999996 477776642 345799999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEECCCC-cEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHH
Q 022003 71 HEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVV 148 (304)
Q Consensus 71 H~~~~~~iiH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~i 148 (304)
|+.+ |+||||||+||||+.++ .+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 187 H~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvi 260 (440)
T PTZ00036 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCI 260 (440)
T ss_pred HHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHH
Confidence 9998 99999999999998664 799999999987643322 223567999999999876 469999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhHhhhhhhcc-------------ccccccccCCccCCCCCHHHHHHHHHHHHHhccCC
Q 022003 149 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-------------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 215 (304)
Q Consensus 149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 215 (304)
+|||++|.+||.+....... .......... ...+.......+...++...+.++.+||.+||+.|
T Consensus 261 l~elltG~~pf~~~~~~~~~--~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~d 338 (440)
T PTZ00036 261 IAEMILGYPIFSGQSSVDQL--VRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYE 338 (440)
T ss_pred HHHHHhCCCCCCCCChHHHH--HHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCC
Confidence 99999999999765432111 1110000000 00000000011111122223578999999999999
Q ss_pred CCCCCCHHHHHHHh
Q 022003 216 PKARPLMSEVVEAL 229 (304)
Q Consensus 216 p~~Rps~~ell~~l 229 (304)
|.+|||+.|++++.
T Consensus 339 P~~R~ta~e~l~hp 352 (440)
T PTZ00036 339 PLKRLNPIEALADP 352 (440)
T ss_pred hhHCcCHHHHhCCh
Confidence 99999999999864
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=281.78 Aligned_cols=209 Identities=27% Similarity=0.410 Sum_probs=163.9
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.++.++ +||||+++++++...+..++||||+++++|..++.+. ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 44 ~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH 119 (329)
T cd05618 44 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIY 119 (329)
T ss_pred HHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 477777776 8999999999999999999999999999999888554 46999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 120 ~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 9999999999999999999999987532211 12234578999999999999999999999999999999999999996
Q ss_pred CCCCCCC--cchhHhhhhhh-ccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 022003 161 KNRPNGE--HNLVEWARPHL-GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 228 (304)
Q Consensus 161 ~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~~ 228 (304)
....... .....+..... .... . ++...+..+.++|.+||+.||++||++ .+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~i~~~~~--------~----~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 198 IVGSSDNPDQNTEDYLFQVILEKQI--------R----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred cCCCcCCcccccHHHHHHHHhcCCC--------C----CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 4222111 11111111110 0000 0 112235678899999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=281.26 Aligned_cols=203 Identities=28% Similarity=0.412 Sum_probs=163.2
Q ss_pred hHhhHhhc-CCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGD-LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|..+++. ++||||+++++++.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|
T Consensus 44 ~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH 119 (316)
T cd05619 44 VEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG---IVY 119 (316)
T ss_pred HHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEe
Confidence 46677775 49999999999999999999999999999999998654 46899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 120 rdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (316)
T cd05619 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999875322211 1234578999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~~ 228 (304)
..... ....... ...+.. +...+.++.+++.+||+.||++||++. +++++
T Consensus 198 ~~~~~---~~~~~i~-----------~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 198 GHDEE---ELFQSIR-----------MDNPCY----PRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred CCCHH---HHHHHHH-----------hCCCCC----CccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 54321 1111100 001111 112346788999999999999999996 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=290.72 Aligned_cols=208 Identities=26% Similarity=0.340 Sum_probs=162.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++.+.+++..|+|||||++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||
T Consensus 50 ~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHr 125 (382)
T cd05625 50 AERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHR 125 (382)
T ss_pred HHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 5899999999999999999999999999999999999999998654 36899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCC---------------------------------------------cceee
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGD---------------------------------------------KTHVS 116 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---------------------------------------------~~~~~ 116 (304)
||||+|||++.++.+||+|||++..+.... .....
T Consensus 126 DlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (382)
T cd05625 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLA 205 (382)
T ss_pred CCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccc
Confidence 999999999999999999999975321000 00001
Q ss_pred ecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCC
Q 022003 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF 196 (304)
Q Consensus 117 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (304)
...+||+.|+|||++.+..++.++|||||||++|||++|..||......... .. ....... ...+.
T Consensus 206 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~--~~----i~~~~~~---~~~p~----- 271 (382)
T cd05625 206 HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQ--MK----VINWQTS---LHIPP----- 271 (382)
T ss_pred cccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHH--HH----HHccCCC---cCCCC-----
Confidence 2346899999999999999999999999999999999999999764321110 00 0000000 00010
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 022003 197 SIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEA 228 (304)
Q Consensus 197 ~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~~ 228 (304)
....+.++.++|.+|+ .+|++|++ ++|+++|
T Consensus 272 ~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 272 QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 1122467889999976 59999997 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=286.50 Aligned_cols=209 Identities=26% Similarity=0.346 Sum_probs=162.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++.+++|+||+++++.+.+....|+|||||+||+|.+++.+. ..+++..+..++.|++.||+|||+.+ |+||
T Consensus 50 ~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHr 125 (363)
T cd05628 50 AERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FIHR 125 (363)
T ss_pred HHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEec
Confidence 5889999999999999999999999999999999999999999654 47999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcc---------------------------------eeeecccccccccCc
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKT---------------------------------HVSTRVMGTYGYAAP 128 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aP 128 (304)
||||+||||+.++.+||+|||+++........ ......+||..|+||
T Consensus 126 DlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 205 (363)
T cd05628 126 DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAP 205 (363)
T ss_pred CCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCH
Confidence 99999999999999999999998754321100 001235799999999
Q ss_pred chhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHH
Q 022003 129 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 208 (304)
Q Consensus 129 E~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 208 (304)
|++.+..++.++|||||||++|||++|..||........ .. ....... ....+. . ...+.++.++|
T Consensus 206 E~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~---~~---~i~~~~~---~~~~p~---~--~~~s~~~~~li 271 (363)
T cd05628 206 EVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET---YK---KVMNWKE---TLIFPP---E--VPISEKAKDLI 271 (363)
T ss_pred HHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHH---HH---HHHcCcC---cccCCC---c--CCCCHHHHHHH
Confidence 999999999999999999999999999999975432111 00 0000000 000011 0 01246788899
Q ss_pred HHhcc--CCCCCCCCHHHHHHH
Q 022003 209 AHCLS--RDPKARPLMSEVVEA 228 (304)
Q Consensus 209 ~~~l~--~dp~~Rps~~ell~~ 228 (304)
.+|+. .++..||+++|++++
T Consensus 272 ~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 272 LRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHcCChhhcCCCCCHHHHhCC
Confidence 88665 233456899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=289.20 Aligned_cols=209 Identities=24% Similarity=0.339 Sum_probs=165.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|+.++||||+++++++.+++..|+|||||++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||
T Consensus 50 ~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~ 125 (364)
T cd05599 50 AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLG---YIHR 125 (364)
T ss_pred HHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEec
Confidence 58999999999999999999999999999999999999999986544 6999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcc------------------------------------eeeecccccccc
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKT------------------------------------HVSTRVMGTYGY 125 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~------------------------------------~~~~~~~gt~~y 125 (304)
||||+|||++.++.+||+|||++......... ......+||+.|
T Consensus 126 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 205 (364)
T cd05599 126 DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDY 205 (364)
T ss_pred cCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccc
Confidence 99999999999999999999998754321100 001124689999
Q ss_pred cCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHH
Q 022003 126 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA 205 (304)
Q Consensus 126 ~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (304)
+|||++.+..++.++|||||||++|||++|..||........ .......... ...+. ....+.++.
T Consensus 206 ~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~------~~~i~~~~~~---~~~~~-----~~~~s~~~~ 271 (364)
T cd05599 206 IAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET------YRKIINWKET---LQFPD-----EVPLSPEAK 271 (364)
T ss_pred cCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH------HHHHHcCCCc---cCCCC-----CCCCCHHHH
Confidence 999999999999999999999999999999999975432111 0000000000 00000 012256888
Q ss_pred HHHHHhccCCCCCCCC---HHHHHHHh
Q 022003 206 QLAAHCLSRDPKARPL---MSEVVEAL 229 (304)
Q Consensus 206 ~li~~~l~~dp~~Rps---~~ell~~l 229 (304)
++|.+||. +|.+|++ ++|++++.
T Consensus 272 ~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 272 DLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred HHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 99999997 9999997 99988753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=290.33 Aligned_cols=209 Identities=22% Similarity=0.294 Sum_probs=163.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+++..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||
T Consensus 50 ~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHr 125 (377)
T cd05629 50 AERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG---FIHR 125 (377)
T ss_pred HHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 5899999999999999999999999999999999999999998654 46899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcc---------------------------------------------eee
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKT---------------------------------------------HVS 116 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------------------~~~ 116 (304)
||||+|||++.++.+||+|||+++.+...... ...
T Consensus 126 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (377)
T cd05629 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMA 205 (377)
T ss_pred CCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc
Confidence 99999999999999999999998643210000 000
Q ss_pred ecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCC
Q 022003 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF 196 (304)
Q Consensus 117 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (304)
...+||+.|+|||++.+..++.++|||||||++|||++|..||........ .. ........ ... +.
T Consensus 206 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~---~i~~~~~~-~~~--p~----- 271 (377)
T cd05629 206 YSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHET---YR---KIINWRET-LYF--PD----- 271 (377)
T ss_pred cccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHH---HH---HHHccCCc-cCC--CC-----
Confidence 124689999999999999999999999999999999999999975432111 00 00000000 000 10
Q ss_pred CHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHHh
Q 022003 197 SIKGAQKAAQLAAHCLSRDPKAR---PLMSEVVEAL 229 (304)
Q Consensus 197 ~~~~~~~~~~li~~~l~~dp~~R---ps~~ell~~l 229 (304)
....+.++.+||.+||. +|.+| +|+.|++++.
T Consensus 272 ~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 272 DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 01124678999999998 77765 5999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=277.85 Aligned_cols=223 Identities=22% Similarity=0.323 Sum_probs=160.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLH 71 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~~LH 71 (304)
+|+++|++++||||+++++++.. +...++||||+ +++|.+++... ...+++..++.++.||+.||+|||
T Consensus 47 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 125 (317)
T cd07868 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125 (317)
T ss_pred HHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH
Confidence 69999999999999999998864 45689999999 56888877432 235899999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEE----CCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhc-CCCCchhhhHHH
Q 022003 72 EEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSF 145 (304)
Q Consensus 72 ~~~~~~iiH~dlkp~Nili----~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diwsl 145 (304)
+.+ |+||||||+|||+ +.++.+||+|||+++........ .......||..|+|||++.+ ..++.++||||+
T Consensus 126 ~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (317)
T cd07868 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred hCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHH
Confidence 998 9999999999999 45678999999999876432211 11234578999999999876 468999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcc------hhHhhhhh--------hccccc------cccccCCc------cC---CCC
Q 022003 146 GVVLLEMLTGRRSMDKNRPNGEHN------LVEWARPH--------LGERRR------FYRLIDPR------LE---GHF 196 (304)
Q Consensus 146 G~il~el~tg~~p~~~~~~~~~~~------~~~~~~~~--------~~~~~~------~~~~~~~~------~~---~~~ 196 (304)
||++|+|++|.+||.......... ........ +..... ........ .. ...
T Consensus 203 G~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (317)
T cd07868 203 GCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 282 (317)
T ss_pred HHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhc
Confidence 999999999999997543321100 00000000 000000 00000000 00 000
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 197 SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 197 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.......+.+||.+||+.||++|||++|++++
T Consensus 283 ~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 283 KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred CCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00113468899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.70 Aligned_cols=209 Identities=25% Similarity=0.377 Sum_probs=168.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++++...+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|
T Consensus 50 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H 126 (261)
T cd05068 50 AEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126 (261)
T ss_pred HHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 6899999999999999999999999999999999999999999664 356899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
+||||+||+++.++.+||+|||++......... .......+..|+|||+..+..++.++||||||+++|+|++ |+.||
T Consensus 127 ~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 205 (261)
T cd05068 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205 (261)
T ss_pred ccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999876532111 1111223457999999998899999999999999999999 88888
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... .... ...... .. .+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 206 ~~~~~~~---~~~~----~~~~~~------~~----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 206 PGMTNAE---VLQQ----VDQGYR------MP----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCHHH---HHHH----HHcCCC------CC----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 6542111 1110 000000 00 111235689999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=270.93 Aligned_cols=208 Identities=29% Similarity=0.440 Sum_probs=169.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++.++|+||+++++++...+..++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++|
T Consensus 51 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h 127 (261)
T cd05148 51 KEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIH 127 (261)
T ss_pred HHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 5889999999999999999999999999999999999999999763 456899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
+||||+||+++.++.+||+|||.+......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 128 ~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~ 205 (261)
T cd05148 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205 (261)
T ss_pred cccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999999875432211 123345678999999988899999999999999999998 88888
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ...... .. .....+...+..+.++|.+||+.||.+|||+.++++.|+.
T Consensus 206 ~~~~~~~---~~~~~~----~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 206 PGMNNHE---VYDQIT----AG----------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CcCCHHH---HHHHHH----hC----------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 6543211 111111 00 0001112335788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=281.45 Aligned_cols=211 Identities=28% Similarity=0.449 Sum_probs=166.8
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeC-CeeEEEEecCCCCCHHHHhhcCC-------------------------------
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRS------------------------------- 48 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------------------------------- 48 (304)
+|+++++++ +|+||+++++++... ..++++|||+++++|.+++....
T Consensus 59 ~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (337)
T cd05054 59 TELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSS 138 (337)
T ss_pred HHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCc
Confidence 589999999 899999999988754 46789999999999999885321
Q ss_pred -----------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEc
Q 022003 49 -----------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 99 (304)
Q Consensus 49 -----------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~ 99 (304)
..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~ 215 (337)
T cd05054 139 SQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKIC 215 (337)
T ss_pred cccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEe
Confidence 25889999999999999999999988 9999999999999999999999
Q ss_pred cccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhh
Q 022003 100 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 178 (304)
Q Consensus 100 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 178 (304)
|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||....... .... ..
T Consensus 216 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~----~~ 289 (337)
T cd05054 216 DFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR----RL 289 (337)
T ss_pred ccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH----HH
Confidence 9999987643332222333455778999999999999999999999999999998 999986532211 0100 00
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 179 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
..... .. .+...+.++.+++.+||+.+|++||++.|++++|+.
T Consensus 290 ~~~~~---~~-------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 290 KEGTR---MR-------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred hccCC---CC-------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 01000 00 111224688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=277.87 Aligned_cols=213 Identities=25% Similarity=0.418 Sum_probs=169.6
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~ 65 (304)
+|+.+++.+ +||||+++++++......++||||+++++|.+++.+.. ..+++..+..++.||+.
T Consensus 69 ~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 148 (304)
T cd05101 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVAR 148 (304)
T ss_pred HHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHH
Confidence 588999999 89999999999999999999999999999999986531 34788889999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||
T Consensus 149 al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 225 (304)
T cd05101 149 GMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225 (304)
T ss_pred HHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHH
Confidence 999999988 99999999999999999999999999987644332222223345678999999998889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
|+++|+|++ |..||...... +.... ...... . ..+...+..+.+|+.+||..+|.+|||+.|
T Consensus 226 G~~l~el~~~g~~p~~~~~~~------~~~~~-~~~~~~---~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e 288 (304)
T cd05101 226 GVLMWEIFTLGGSPYPGIPVE------ELFKL-LKEGHR---M-------DKPANCTNELYMMMRDCWHAIPSHRPTFKQ 288 (304)
T ss_pred HHHHHHHHcCCCCCcccCCHH------HHHHH-HHcCCc---C-------CCCCCCCHHHHHHHHHHcccChhhCCCHHH
Confidence 999999998 77777543211 11111 000000 0 011233578999999999999999999999
Q ss_pred HHHHhCCCCC
Q 022003 225 VVEALKPLPN 234 (304)
Q Consensus 225 ll~~l~~~~~ 234 (304)
+++.|+.+..
T Consensus 289 ~l~~l~~~~~ 298 (304)
T cd05101 289 LVEDLDRILT 298 (304)
T ss_pred HHHHHHHHHH
Confidence 9999875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=274.99 Aligned_cols=224 Identities=30% Similarity=0.423 Sum_probs=168.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++|++++||||+++++++... ...++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++
T Consensus 55 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~---i~ 129 (283)
T cd05080 55 KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH---YI 129 (283)
T ss_pred HHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 589999999999999999988764 3578999999999999998653 5999999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcce-eeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||||+||+++.++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 130 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p 209 (283)
T cd05080 130 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDS 209 (283)
T ss_pred ccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998764432211 11223456679999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
|........ ......... ..........+.......+...+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 210 ~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 210 KQSPPKKFE-EMIGPKQGQ-MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCcchhh-hhhcccccc-cchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 865322110 000000000 000000111111111111223457899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=280.68 Aligned_cols=210 Identities=30% Similarity=0.402 Sum_probs=165.6
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.++.++ +||||+++++++...+..|+||||+++++|..++... ..+++..++.++.||+.||+|||+.+ ++|
T Consensus 44 ~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivH 119 (327)
T cd05617 44 TEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---IIY 119 (327)
T ss_pred HHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 577888888 6999999999999999999999999999999988554 36999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 120 rDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred cCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987532211 12334678999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~~ 228 (304)
............+......... .. .+...+..+.+++.+||+.||++|+++ ++++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~-------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 198 IITDNPDMNTEDYLFQVILEKP-------IR----IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ccCCCcccccHHHHHHHHHhCC-------CC----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 5433222221111111111100 00 111224678899999999999999985 466654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=271.17 Aligned_cols=209 Identities=29% Similarity=0.469 Sum_probs=167.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+++++.++||||+++++++..++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+
T Consensus 48 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~- 126 (269)
T cd05044 48 KEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH- 126 (269)
T ss_pred HHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 6899999999999999999999999999999999999999998642 234788999999999999999999988
Q ss_pred CCeEeccCCCCCeEECCCC-----cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 76 RPVIYRDFKTSNILLDADY-----NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~-----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
++|+||||+||+++.++ .++|+|||++................++..|+|||++.+..++.++|||||||++|
T Consensus 127 --i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 204 (269)
T cd05044 127 --FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMW 204 (269)
T ss_pred --cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHH
Confidence 99999999999999887 89999999998654332222222334567899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 151 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 151 el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
+|++ |..||...... ....... .... ...+...+..+.++|.+||..+|.+||+++++++.|
T Consensus 205 ellt~g~~p~~~~~~~---~~~~~~~----~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 205 EILTLGQQPYPALNNQ---EVLQHVT----AGGR----------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred HHHHcCCCCCcccCHH---HHHHHHh----cCCc----------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 9998 99998643211 1111100 0000 011123467889999999999999999999999987
Q ss_pred C
Q 022003 230 K 230 (304)
Q Consensus 230 ~ 230 (304)
+
T Consensus 268 ~ 268 (269)
T cd05044 268 Q 268 (269)
T ss_pred h
Confidence 5
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=288.11 Aligned_cols=209 Identities=29% Similarity=0.350 Sum_probs=169.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++..++|+||+++++++.+++..|+||||+++++|.+++.+. ..+++..++.++.||+.||+|||+.+ |+||
T Consensus 50 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~ 125 (350)
T cd05573 50 AERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHR 125 (350)
T ss_pred HHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 5889999999999999999999999999999999999999999765 57999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCC---------------------------cceeeecccccccccCcchhhcC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGD---------------------------KTHVSTRVMGTYGYAAPEYVMTG 134 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~ 134 (304)
||||+|||++.++.+||+|||++....... .........||..|+|||++.+.
T Consensus 126 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 205 (350)
T cd05573 126 DIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT 205 (350)
T ss_pred CCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 999999999999999999999998754332 00112335689999999999999
Q ss_pred CCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccC
Q 022003 135 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 214 (304)
Q Consensus 135 ~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 214 (304)
.++.++|||||||++|+|++|..||........ +. ........ ...+... ..+.++.++|.+||.
T Consensus 206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-----~~-~i~~~~~~---~~~p~~~-----~~~~~~~~li~~ll~- 270 (350)
T cd05573 206 PYGLECDWWSLGVILYEMLYGFPPFYSDTLQET-----YN-KIINWKES---LRFPPDP-----PVSPEAIDLICRLLC- 270 (350)
T ss_pred CCCCceeeEecchhhhhhccCCCCCCCCCHHHH-----HH-HHhccCCc---ccCCCCC-----CCCHHHHHHHHHHcc-
Confidence 999999999999999999999999976532110 00 00000000 0001100 135788999999998
Q ss_pred CCCCCCC-HHHHHHHh
Q 022003 215 DPKARPL-MSEVVEAL 229 (304)
Q Consensus 215 dp~~Rps-~~ell~~l 229 (304)
||.+||+ +++++++.
T Consensus 271 dp~~R~~s~~~ll~hp 286 (350)
T cd05573 271 DPEDRLGSFEEIKSHP 286 (350)
T ss_pred ChhhcCCCHHHHhcCC
Confidence 9999999 99999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=268.93 Aligned_cols=208 Identities=24% Similarity=0.349 Sum_probs=165.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++|+||+++++++. .+..++||||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++||
T Consensus 45 ~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~ 119 (257)
T cd05116 45 REANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FVHR 119 (257)
T ss_pred HHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---Eeec
Confidence 5889999999999999999875 45679999999999999998654 46899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCccee-eecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||.||+++.++.+||+|||+++.......... .....++..|+|||.+....++.++|||||||++|||++ |..||
T Consensus 120 dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 199 (257)
T cd05116 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199 (257)
T ss_pred ccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987644332211 112234578999999988889999999999999999998 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ...... ... .+.. +...+.++.++|.+||+.||++||++.+|.+.|+.
T Consensus 200 ~~~~~~~---~~~~i~----~~~------~~~~----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 200 KGMKGNE---VTQMIE----SGE------RMEC----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHH---HHHHHH----CCC------CCCC----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 7543211 111111 000 0111 11235688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=270.90 Aligned_cols=209 Identities=22% Similarity=0.368 Sum_probs=168.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.++++++|+||+++++.+...+..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|
T Consensus 50 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H 126 (261)
T cd05072 50 EEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIH 126 (261)
T ss_pred HHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 5899999999999999999999999999999999999999998654 456899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+||+++.++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 127 ~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~ 205 (261)
T cd05072 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205 (261)
T ss_pred cccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCC
Confidence 999999999999999999999999876432211 1222345678999999988889999999999999999998 89998
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ...... .. ...... ...+.++.+++.+||..+|++|||++++++.|+.
T Consensus 206 ~~~~~~~---~~~~~~----~~------~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 206 PGMSNSD---VMSALQ----RG------YRMPRM----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHH---HHHHHH----cC------CCCCCC----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 6532211 111110 00 000011 1234678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=287.59 Aligned_cols=205 Identities=22% Similarity=0.380 Sum_probs=166.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCe--eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQ--RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~--~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
.|+.+|+.|+|+|||++|+++.+..+ +.+|+|++.+|+|..|+.+.. ..+...++.|++||++||.|||++. .+||
T Consensus 90 ~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~-PPII 167 (632)
T KOG0584|consen 90 SEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQD-PPII 167 (632)
T ss_pred HHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCC-CCcc
Confidence 49999999999999999999998665 779999999999999986654 7999999999999999999999998 6799
Q ss_pred eccCCCCCeEECCC-CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|||||.+||||+.+ |.|||+|+|+|....... ....+||+.|||||++. ..|+..+||||||+++.||+|+..|
T Consensus 168 HRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYP 242 (632)
T KOG0584|consen 168 HRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYP 242 (632)
T ss_pred ccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCC
Confidence 99999999999764 999999999999864322 23368999999999987 8899999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|....... ++.+.+..... ...|...- .+++++||.+||.. ..+|+|+.|||++-
T Consensus 243 YsEC~n~A--QIYKKV~SGiK-P~sl~kV~------------dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 243 YSECTNPA--QIYKKVTSGIK-PAALSKVK------------DPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred hhhhCCHH--HHHHHHHcCCC-HHHhhccC------------CHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 97653221 11111111110 01111111 35889999999999 99999999999753
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=270.59 Aligned_cols=208 Identities=24% Similarity=0.351 Sum_probs=167.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+
T Consensus 53 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~ 128 (263)
T cd06625 53 CEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHR 128 (263)
T ss_pred HHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 5889999999999999999999999999999999999999998654 36899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCccee-eecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||+|+||+++.++.++|+|||+++.......... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 129 dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 208 (263)
T cd06625 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA 208 (263)
T ss_pred CCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 9999999999999999999999876533211111 123457889999999999889999999999999999999999986
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..... ..... .... ......+...+..+.++|.+||..+|.+|||+.+++++.
T Consensus 209 ~~~~~-----~~~~~-~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 209 EFEAM-----AAIFK-IATQ----------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ccchH-----HHHHH-Hhcc----------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 43211 10000 0000 000111223356889999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=272.77 Aligned_cols=211 Identities=27% Similarity=0.438 Sum_probs=167.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCe------eEEEEecCCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQ------RLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFL 70 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~~L 70 (304)
+|+++++.++|+||+++++++..... .++||||+++++|..++... ...+++..+..++.|++.||+||
T Consensus 50 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~l 129 (273)
T cd05035 50 SEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL 129 (273)
T ss_pred HHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998876554 79999999999999988432 23689999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 71 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 71 H~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
|+.+ ++||||||+||++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|
T Consensus 130 H~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~ 206 (273)
T cd05035 130 SNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 206 (273)
T ss_pred HhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHH
Confidence 9988 9999999999999999999999999998764433222222234567899999998889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 151 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 151 el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
||++ |..||...... ...+.... .. ... .+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 207 el~~~g~~p~~~~~~~---~~~~~~~~----~~------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 207 EIATRGQTPYPGVENH---EIYDYLRH----GN------RLK----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred HHHhCCCCCCCCCCHH---HHHHHHHc----CC------CCC----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999 88888653221 11111110 00 001 1122356899999999999999999999999998
Q ss_pred CCC
Q 022003 230 KPL 232 (304)
Q Consensus 230 ~~~ 232 (304)
+.+
T Consensus 270 ~~~ 272 (273)
T cd05035 270 ENI 272 (273)
T ss_pred Hhh
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=267.45 Aligned_cols=208 Identities=28% Similarity=0.413 Sum_probs=167.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++......+++..+..++.|++.||.|||+.+ ++|+
T Consensus 41 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~ 117 (250)
T cd05085 41 SEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117 (250)
T ss_pred HHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 6899999999999999999999999999999999999999998766667899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 118 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~ 196 (250)
T cd05085 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYP 196 (250)
T ss_pred ccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999876433211 11112234567999999998889999999999999999998 888986
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
...... ..... ... .... .+...+..+.+++.+||..+|++||++.|+++.|.
T Consensus 197 ~~~~~~---~~~~~----~~~------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 197 GMTNQQ---AREQV----EKG------YRMS----CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHH---HHHHH----HcC------CCCC----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 542211 11000 000 0000 11123568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=269.43 Aligned_cols=201 Identities=25% Similarity=0.436 Sum_probs=161.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++||||+++++++..+...++||||+++++|..++.+....+++..++.++.||+.||+|||+.+ ++||
T Consensus 53 ~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 129 (262)
T cd05077 53 ETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHG 129 (262)
T ss_pred HHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECC
Confidence 4678999999999999999999999999999999999999998766667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCc-------EEEccccCcccCCCCCcceeeecccccccccCcchhh-cCCCCchhhhHHHHHHHHHHH
Q 022003 82 DFKTSNILLDADYN-------AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 82 dlkp~Nili~~~~~-------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~ 153 (304)
||||+|||++.++. ++++|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+
T Consensus 130 dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~ 203 (262)
T cd05077 130 NVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEIC 203 (262)
T ss_pred CCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHH
Confidence 99999999987654 899999998754321 2235678899999887 567899999999999999998
Q ss_pred -hCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 154 -TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 154 -tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
+|..||........ ... ... . ..... ....++.+||.+||+.||.+||++.+|+++++
T Consensus 204 ~~~~~p~~~~~~~~~---~~~----~~~--~-~~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 204 YNGEIPLKDKTLAEK---ERF----YEG--Q-CMLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hCCCCCCCCcchhHH---HHH----Hhc--C-ccCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 47777754321110 000 000 0 00011 12457899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=286.88 Aligned_cols=208 Identities=24% Similarity=0.305 Sum_probs=166.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++||||+++++++.+++..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||
T Consensus 92 ~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHr 166 (370)
T cd05596 92 EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG---FIHR 166 (370)
T ss_pred HHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 5889999999999999999999999999999999999999988553 5889999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC----CCCchhhhHHHHHHHHHHHhCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~tg~~ 157 (304)
||||+|||++.++.+||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus 167 DLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~ 245 (370)
T cd05596 167 DVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245 (370)
T ss_pred CCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCC
Confidence 9999999999999999999999986543221 122345789999999998653 47899999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHh
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 229 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~~l 229 (304)
||....... .+.. ....... ...+. ....+.++.+||.+||+.+|.+ |+|+++++++.
T Consensus 246 Pf~~~~~~~-----~~~~-i~~~~~~---~~~~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 246 PFYADSLVG-----TYSK-IMDHKNS---LTFPD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CcCCCCHHH-----HHHH-HHcCCCc---CCCCC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 997643211 0100 0000000 00000 1123578899999999999988 99999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.18 Aligned_cols=211 Identities=26% Similarity=0.431 Sum_probs=167.3
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~ 65 (304)
+|+++++++ +||||+++++++..++..++||||+++++|.+++.... ..+++..+..++.||+.
T Consensus 66 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 145 (314)
T cd05099 66 SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVAR 145 (314)
T ss_pred HHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHH
Confidence 588999999 69999999999999999999999999999999996531 35889999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||
T Consensus 146 aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 222 (314)
T cd05099 146 GMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (314)
T ss_pred HHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHH
Confidence 999999988 99999999999999999999999999987543222111112234467999999998899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|+|++ |..||....... ...... .... . ..+...+.++.+++.+||..||++|||+.+
T Consensus 223 G~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~~------~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 285 (314)
T cd05099 223 GILMWEIFTLGGSPYPGIPVEE---LFKLLR----EGHR------M----DKPSNCTHELYMLMRECWHAVPTQRPTFKQ 285 (314)
T ss_pred HHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCCC------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 999999999 888886542211 111110 0000 0 011123468889999999999999999999
Q ss_pred HHHHhCCC
Q 022003 225 VVEALKPL 232 (304)
Q Consensus 225 ll~~l~~~ 232 (304)
+++.|..+
T Consensus 286 ll~~l~~~ 293 (314)
T cd05099 286 LVEALDKV 293 (314)
T ss_pred HHHHHHHH
Confidence 99988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=269.02 Aligned_cols=205 Identities=29% Similarity=0.432 Sum_probs=169.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++||||+++++++..++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|
T Consensus 48 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h 124 (256)
T cd08529 48 DEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILH 124 (256)
T ss_pred HHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 5899999999999999999999999999999999999999999764 457999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
+||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++++|++|..||.
T Consensus 125 ~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 202 (256)
T cd08529 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202 (256)
T ss_pred CCCCcceEEEeCCCCEEEcccccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999887644322 1233567889999999999899999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... ... .... +...+. .....+..+.+++.+||+.+|++||++.+++++
T Consensus 203 ~~~~~---~~~---~~~~-------~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 203 ANNQG---ALI---LKII-------RGVFPP----VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCHH---HHH---HHHH-------cCCCCC----CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 54311 000 0000 000011 111345789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=271.90 Aligned_cols=216 Identities=26% Similarity=0.446 Sum_probs=166.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------LPLPWSIRMKIALGAAKGLAFL 70 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~l~~L 70 (304)
+|++++++++|+||+++++++...+..++||||+.+++|.+++.... ..+++..++.++.|++.||+||
T Consensus 66 ~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 145 (295)
T cd05097 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL 145 (295)
T ss_pred HHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH
Confidence 58999999999999999999999999999999999999999985432 2368889999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 71 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 71 H~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
|+.+ ++|+||||+||+++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|
T Consensus 146 H~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~ 222 (295)
T cd05097 146 ASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222 (295)
T ss_pred HhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHH
Confidence 9988 9999999999999999999999999998654333222223344567899999999888999999999999999
Q ss_pred HHHh--CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 151 EMLT--GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 151 el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+|++ +..||....... ................... .+...+..+.+|+.+||+.||++|||++++++.
T Consensus 223 el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 292 (295)
T cd05097 223 EMFTLCKEQPYSLLSDEQ---VIENTGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292 (295)
T ss_pred HHHHcCCCCCCcccChHH---HHHHHHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 9998 556665432211 1111100000000000000 011124689999999999999999999999998
Q ss_pred hC
Q 022003 229 LK 230 (304)
Q Consensus 229 l~ 230 (304)
|+
T Consensus 293 l~ 294 (295)
T cd05097 293 LR 294 (295)
T ss_pred Hh
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=271.78 Aligned_cols=210 Identities=25% Similarity=0.421 Sum_probs=164.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC------CeeEEEEecCCCCCHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFL 70 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~-----~~~~l~~~~~~~i~~qi~~~l~~L 70 (304)
+|+++++.++|+||+++++++... ...++||||+.+++|.+++.. ....+++..+..++.|++.||+||
T Consensus 49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 128 (272)
T cd05075 49 SEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL 128 (272)
T ss_pred HHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHH
Confidence 588999999999999999987542 246899999999999988742 234589999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 71 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 71 H~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
|+.+ |+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|
T Consensus 129 H~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~ 205 (272)
T cd05075 129 SSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMW 205 (272)
T ss_pred HHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHH
Confidence 9988 9999999999999999999999999998764433222222234567899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 151 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 151 el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
+|++ |..||...... ....... ..... . .....+..+.++|.+||+.||++|||+.++++.|
T Consensus 206 el~~~g~~p~~~~~~~---~~~~~~~----~~~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 206 EIATRGQTPYPGVENS---EIYDYLR----QGNRL------K----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred HHHcCCCCCCCCCCHH---HHHHHHH----cCCCC------C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999 78888653221 1111110 11000 0 0112346789999999999999999999999988
Q ss_pred CC
Q 022003 230 KP 231 (304)
Q Consensus 230 ~~ 231 (304)
+.
T Consensus 269 ~~ 270 (272)
T cd05075 269 EK 270 (272)
T ss_pred Hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=284.44 Aligned_cols=204 Identities=27% Similarity=0.310 Sum_probs=159.5
Q ss_pred hHhhHhhcC---CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDL---VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|.+++..+ .||||+++++++......|+||||+.+++|.+++.+. ..+++..+..++.||+.||+|||+.+ |
T Consensus 42 ~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~---i 117 (330)
T cd05586 42 GERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD---I 117 (330)
T ss_pred HHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 355666655 6999999999999999999999999999999988654 46999999999999999999999998 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~ 157 (304)
+||||||+|||++.++.+||+|||++........ ......||..|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 118 vHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~ 195 (330)
T cd05586 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWS 195 (330)
T ss_pred EeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCC
Confidence 9999999999999999999999999876432221 23346789999999998754 58999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC----HHHHHHH
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL----MSEVVEA 228 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~ell~~ 228 (304)
||....... ........... +.. ...+.++.++|.+||+.||.+||+ +.+++++
T Consensus 196 Pf~~~~~~~------~~~~i~~~~~~--------~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 196 PFYAEDTQQ------MYRNIAFGKVR--------FPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCCCCCHHH------HHHHHHcCCCC--------CCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 996542211 00000000000 000 012467889999999999999984 5555553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=278.45 Aligned_cols=211 Identities=27% Similarity=0.415 Sum_probs=167.3
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~ 65 (304)
+|+++++++ +|+||+++++++..++..++||||+++++|.+++.... ..+++.++..++.|++.
T Consensus 72 ~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 151 (307)
T cd05098 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVAR 151 (307)
T ss_pred HHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHH
Confidence 588999999 79999999999999999999999999999999996532 24889999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||+|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||
T Consensus 152 aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 228 (307)
T cd05098 152 GMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228 (307)
T ss_pred HHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHH
Confidence 999999988 99999999999999999999999999876543221111122234568999999998899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|+|++ |..||...... ...... .... ....+...+.++.+++.+||..+|.+|||+.+
T Consensus 229 G~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 291 (307)
T cd05098 229 GVLLWEIFTLGGSPYPGVPVE---ELFKLL----KEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 291 (307)
T ss_pred HHHHHHHHcCCCCCCCcCCHH---HHHHHH----HcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHH
Confidence 999999998 78888543211 111100 0000 00111223568899999999999999999999
Q ss_pred HHHHhCCC
Q 022003 225 VVEALKPL 232 (304)
Q Consensus 225 ll~~l~~~ 232 (304)
+++.|+.+
T Consensus 292 vl~~l~~~ 299 (307)
T cd05098 292 LVEDLDRI 299 (307)
T ss_pred HHHHHHHH
Confidence 99998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=282.69 Aligned_cols=208 Identities=24% Similarity=0.287 Sum_probs=163.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++||||+++++++.+++..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||
T Consensus 92 ~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---IvHr 166 (370)
T cd05621 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LIHR 166 (370)
T ss_pred HHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEec
Confidence 5889999999999999999999999999999999999999998543 5899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC----CCCchhhhHHHHHHHHHHHhCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~tg~~ 157 (304)
||||+|||++.++.+||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 167 DLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~ 245 (370)
T cd05621 167 DVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245 (370)
T ss_pred CCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCC
Confidence 9999999999999999999999987543221 122346799999999998754 37899999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHh
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 229 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~~l 229 (304)
||........ .......... . ... .....+..+.+++.+||+.++.+ |+++.|++++.
T Consensus 246 Pf~~~~~~~~------~~~i~~~~~~---~---~~p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 246 PFYADSLVGT------YSKIMDHKNS---L---NFP--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred CCCCCCHHHH------HHHHHhCCcc---c---CCC--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 9975432110 0000000000 0 000 01123567889999999855543 88999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=281.18 Aligned_cols=208 Identities=27% Similarity=0.350 Sum_probs=165.9
Q ss_pred HhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 022003 6 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 85 (304)
Q Consensus 6 il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp 85 (304)
+++.++||||+++++++..++..++||||+.+++|..++.+. ..+++..+..++.||+.||+|||+.+ |+||||||
T Consensus 49 ~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp 124 (325)
T cd05604 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKP 124 (325)
T ss_pred HHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCH
Confidence 467789999999999999999999999999999999888544 47999999999999999999999988 99999999
Q ss_pred CCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCC
Q 022003 86 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 165 (304)
Q Consensus 86 ~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 165 (304)
+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 125 ~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (325)
T cd05604 125 ENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA 202 (325)
T ss_pred HHeEECCCCCEEEeecCCcccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH
Confidence 99999999999999999987532211 1233457899999999999999999999999999999999999999754321
Q ss_pred CCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCCCcc
Q 022003 166 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 237 (304)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~~~~ 237 (304)
. ......... ....+ ..+..+.+++.+||+.+|.+||++.+.++.+...+.+..
T Consensus 203 ~------~~~~~~~~~----~~~~~--------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 203 E------MYDNILHKP----LVLRP--------GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred H------HHHHHHcCC----ccCCC--------CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 1 111111000 00111 124678899999999999999998765655555555544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=269.81 Aligned_cols=212 Identities=24% Similarity=0.350 Sum_probs=170.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ +
T Consensus 51 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i 127 (267)
T cd08228 51 KEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---V 127 (267)
T ss_pred HHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 589999999999999999999999999999999999999988753 3345899999999999999999999988 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+|+||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 128 ~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p 205 (267)
T cd08228 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred eCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999887543221 12234678899999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
|...... ...+.... . ....+. ......+..+.+++.+||+.+|.+||++.++++.++.+
T Consensus 206 ~~~~~~~----~~~~~~~~-~------~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 206 FYGDKMN----LFSLCQKI-E------QCDYPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred Ccccccc----HHHHHHHH-h------cCCCCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 8643221 11111100 0 000011 11223457899999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=272.00 Aligned_cols=210 Identities=21% Similarity=0.346 Sum_probs=167.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++|+||+++++++... ..+++|||+++|+|.+++..+...+++..+..++.|++.||+|||+.+ ++||
T Consensus 58 ~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~ 133 (279)
T cd05109 58 DEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHR 133 (279)
T ss_pred HHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 588899999999999999998754 578999999999999999776667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+|||++.++.+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||.
T Consensus 134 dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 213 (279)
T cd05109 134 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213 (279)
T ss_pred ccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999987653322211222334678999999998899999999999999999998 888886
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
..... ....+.. .... .. .+...+.++.+++.+||+.||++||++.++++.|+.+
T Consensus 214 ~~~~~---~~~~~~~----~~~~------~~----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 214 GIPAR---EIPDLLE----KGER------LP----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred CCCHH---HHHHHHH----CCCc------CC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 43211 1111111 0000 00 0112356889999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.15 Aligned_cols=210 Identities=29% Similarity=0.449 Sum_probs=167.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++. ....++||||+.+++|.+++.... .+++..+..++.|++.||+|||..+ ++|+
T Consensus 45 ~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~ 119 (257)
T cd05060 45 REASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHR 119 (257)
T ss_pred HHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eecc
Confidence 5899999999999999999876 456899999999999999996654 7899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCccee-eecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||+||+++.++.+||+|||+++.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 120 di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~ 199 (257)
T cd05060 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199 (257)
T ss_pred CcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999999987644332211 111223567999999998899999999999999999998 99998
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
..... .....+... ... .. .+...+..+.++|.+||..+|++||++.++++.|+...
T Consensus 200 ~~~~~---~~~~~~~~~----~~~---~~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 200 GEMKG---AEVIAMLES----GER---LP-------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ccCCH---HHHHHHHHc----CCc---CC-------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 65422 111111111 000 00 11123468899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=273.44 Aligned_cols=216 Identities=25% Similarity=0.470 Sum_probs=167.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHhh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLH 71 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~l~~~~~~~i~~qi~~~l~~LH 71 (304)
+|++++++++|+||+++++++..++..++||||+.+++|.+++.... ..+++..+..++.|++.||+|||
T Consensus 68 ~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 147 (296)
T cd05095 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS 147 (296)
T ss_pred HHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 68999999999999999999999999999999999999999986532 24778899999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHH
Q 022003 72 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 151 (304)
Q Consensus 72 ~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 151 (304)
+.+ ++|+||||+||+++.++.++|+|||+++...............++..|+|||+..++.++.++|||||||++||
T Consensus 148 ~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~e 224 (296)
T cd05095 148 SLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224 (296)
T ss_pred HCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHH
Confidence 988 99999999999999999999999999986543322222223344678999999888899999999999999999
Q ss_pred HHh--CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 152 MLT--GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 152 l~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|++ |..||....... .............. ....+. +..++..+.+++.+||+.||++||++.++++.|
T Consensus 225 l~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 225 ILTLCKEQPYSQLSDEQ---VIENTGEFFRDQGR--QVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred HHHhCCCCCccccChHH---HHHHHHHHHhhccc--cccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 998 667775432211 11100000000000 000010 112346889999999999999999999999987
Q ss_pred C
Q 022003 230 K 230 (304)
Q Consensus 230 ~ 230 (304)
+
T Consensus 295 ~ 295 (296)
T cd05095 295 L 295 (296)
T ss_pred h
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=276.27 Aligned_cols=210 Identities=24% Similarity=0.344 Sum_probs=166.1
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~ 65 (304)
+|+++++++ +||||+++++++...+..++||||+++++|.+++.... ..+++..++.++.|++.
T Consensus 51 ~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 130 (297)
T cd05089 51 GELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVAT 130 (297)
T ss_pred HHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHH
Confidence 588999999 79999999999999999999999999999999986432 35889999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||+|||+.+ ++||||||+|||++.++.+||+|||++...... ........+..|+|||++.+..++.++|||||
T Consensus 131 al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 204 (297)
T cd05089 131 GMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSF 204 (297)
T ss_pred HHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHH
Confidence 999999988 999999999999999999999999998643211 01111223457999999988899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|+|++ |..||....... .. .... ....+. .+...+..+.+|+.+||+.+|.+||++++
T Consensus 205 G~il~el~t~g~~pf~~~~~~~---~~---~~~~-------~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 267 (297)
T cd05089 205 GVLLWEIVSLGGTPYCGMTCAE---LY---EKLP-------QGYRME----KPRNCDDEVYELMRQCWRDRPYERPPFAQ 267 (297)
T ss_pred HHHHHHHHcCCCCCCCCCCHHH---HH---HHHh-------cCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999997 999986543211 11 0000 000011 11123568899999999999999999999
Q ss_pred HHHHhCCCCC
Q 022003 225 VVEALKPLPN 234 (304)
Q Consensus 225 ll~~l~~~~~ 234 (304)
+++.|+.+.+
T Consensus 268 i~~~l~~~~~ 277 (297)
T cd05089 268 ISVQLSRMLE 277 (297)
T ss_pred HHHHHHHHHH
Confidence 9998875544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=271.12 Aligned_cols=208 Identities=25% Similarity=0.386 Sum_probs=164.6
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~ 65 (304)
+|+++++++ +||||+++++++...+..++||||+++++|.+++.... ..+++..+..++.|++.
T Consensus 44 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 123 (270)
T cd05047 44 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 123 (270)
T ss_pred HHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHH
Confidence 589999999 89999999999999999999999999999999986432 24789999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||+|||+.+ ++||||||+||+++.++.+||+|||++...... ........+..|+|||++.+..++.++|||||
T Consensus 124 al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 197 (270)
T cd05047 124 GMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 197 (270)
T ss_pred HHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHH
Confidence 999999988 999999999999999999999999998642211 11111223567999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|+|++ |..||....... ..... ... .....+...+.++.+++.+||..||.+|||+.+
T Consensus 198 G~il~el~~~g~~pf~~~~~~~---~~~~~----~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 260 (270)
T cd05047 198 GVLLWEIVSLGGTPYCGMTCAE---LYEKL----PQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 260 (270)
T ss_pred HHHHHHHHcCCCCCccccCHHH---HHHHH----hCC----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHH
Confidence 999999997 999986532111 11000 000 000011123467899999999999999999999
Q ss_pred HHHHhCCC
Q 022003 225 VVEALKPL 232 (304)
Q Consensus 225 ll~~l~~~ 232 (304)
+++.|+.+
T Consensus 261 il~~l~~~ 268 (270)
T cd05047 261 ILVSLNRM 268 (270)
T ss_pred HHHHHHHh
Confidence 99988654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=269.28 Aligned_cols=211 Identities=25% Similarity=0.419 Sum_probs=169.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++...+..++||||+++++|.+++..+...+++..+..++.|++.||+|||+.+ ++|+
T Consensus 55 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~ 131 (268)
T cd05063 55 SEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHR 131 (268)
T ss_pred HHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 5889999999999999999999999999999999999999999776667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceee-ecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS-TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||+||+++.++.+||+|||++............ .....+..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 132 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~ 211 (268)
T cd05063 132 DLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211 (268)
T ss_pred ccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999865432221111 11223457999999998889999999999999999997 99998
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
...... ...... ..... .+ .....+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 212 ~~~~~~------~~~~~i-~~~~~-----~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 212 WDMSNH------EVMKAI-NDGFR-----LP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CcCCHH------HHHHHH-hcCCC-----CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 654221 111110 00000 00 1112356889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=275.28 Aligned_cols=222 Identities=23% Similarity=0.341 Sum_probs=167.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++..++..++||||+. ++|.+++......+++..+..++.||+.||+|||+.+ |+||
T Consensus 53 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~ 128 (309)
T cd07872 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHR 128 (309)
T ss_pred HHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 69999999999999999999999999999999996 5888888766667899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.+||+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 129 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 206 (309)
T cd07872 129 DLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206 (309)
T ss_pred CCCHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999876433221 1223457889999999875 568999999999999999999999997
Q ss_pred CCCCCCCcchhHhhh--------hhhccccccccccCCccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWAR--------PHLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.....+......... ..+.....+.....+.... ......+.++.+||.+||+.||.+|||+.|++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 207 GSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 654322111110000 0000000000000000000 0011235678999999999999999999999985
Q ss_pred h
Q 022003 229 L 229 (304)
Q Consensus 229 l 229 (304)
.
T Consensus 287 ~ 287 (309)
T cd07872 287 A 287 (309)
T ss_pred h
Confidence 3
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=266.01 Aligned_cols=209 Identities=29% Similarity=0.446 Sum_probs=168.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++......++||||+.+++|.+++......+++..+..++.+++.||+|||+++ ++||
T Consensus 41 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~ 117 (251)
T cd05041 41 QEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117 (251)
T ss_pred HHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eehh
Confidence 5899999999999999999999999999999999999999999776667899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 118 di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~ 197 (251)
T cd05041 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197 (251)
T ss_pred hcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCc
Confidence 9999999999999999999999986543221111112233567999999988899999999999999999999 788886
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
....... ..... ... .. ..+...+..+.+++.+||..+|.+|||+.|+++.|.
T Consensus 198 ~~~~~~~---~~~~~----~~~---~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 198 GMSNQQT---RERIE----SGY---RM-------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHH---HHHHh----cCC---CC-------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 5432111 00000 000 00 011223568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=272.56 Aligned_cols=210 Identities=25% Similarity=0.433 Sum_probs=166.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|+.+++.++|+||+++++++..++..++||||+++|+|.+++.+.. ..++...+..++.||+.||.|||+
T Consensus 58 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (288)
T cd05061 58 NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA 137 (288)
T ss_pred HHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 58889999999999999999999999999999999999999996421 235677889999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
.+ ++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||
T Consensus 138 ~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el 214 (288)
T cd05061 138 KK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214 (288)
T ss_pred CC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHH
Confidence 88 999999999999999999999999999865433222222223456789999999988999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 153 LT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 153 ~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
++ |..||...... ...... . ... . .. .+...+..+.+++.+||+.||++|||+.++++.++.
T Consensus 215 ~~~~~~p~~~~~~~---~~~~~~---~-~~~-~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 277 (288)
T cd05061 215 TSLAEQPYQGLSNE---QVLKFV---M-DGG-Y-----LD----QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277 (288)
T ss_pred HhCCCCCCCCCCHH---HHHHHH---H-cCC-C-----CC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 98 67788643221 111110 0 000 0 00 111224689999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=277.00 Aligned_cols=223 Identities=19% Similarity=0.239 Sum_probs=164.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++.++||||+++++++..++..++||||+++++|.+++..+ ...+++..++.++.|++.||+|||+.+ |+|
T Consensus 48 ~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH 124 (327)
T cd08227 48 GELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVH 124 (327)
T ss_pred HHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---Eec
Confidence 5889999999999999999999999999999999999999998654 345899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCc-c----eeeecccccccccCcchhhc--CCCCchhhhHHHHHHHHHHH
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-T----HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~ 153 (304)
|||||+|||++.++.++++||+.+........ . .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 125 ~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 204 (327)
T cd08227 125 RSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 204 (327)
T ss_pred CCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999986544321111 0 01122346778999999876 46899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhHhhhhhhcc---------------------cccccc---------ccCCccCCCCCHHHHHH
Q 022003 154 TGRRSMDKNRPNGEHNLVEWARPHLGE---------------------RRRFYR---------LIDPRLEGHFSIKGAQK 203 (304)
Q Consensus 154 tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~---------~~~~~~~~~~~~~~~~~ 203 (304)
+|..||........ ........... ...... ..............+..
T Consensus 205 ~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (327)
T cd08227 205 NGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH 282 (327)
T ss_pred HCCCCCCCcchhHH--HHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHH
Confidence 99999975322110 00000000000 000000 00000000112234568
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 204 AAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 204 ~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
+.+|+.+||+.||++|||++|++++.
T Consensus 283 ~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 283 FHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred HHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 99999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=283.48 Aligned_cols=220 Identities=23% Similarity=0.306 Sum_probs=169.7
Q ss_pred hHhhHhhcCC-C-----CcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 2 AEVNFLGDLV-H-----LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 2 ~E~~il~~l~-h-----~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
.|++||..|+ | -|||+++++|...+++|||+|.+ +.+|.++++++ -.+|+...++.++.||+.||.+||+.+
T Consensus 231 ~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~ 309 (586)
T KOG0667|consen 231 IEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG 309 (586)
T ss_pred HHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5999999997 4 48999999999999999999999 67999999776 456999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEECC--CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 75 ERPVIYRDFKTSNILLDA--DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|||+|||||||||.. ...+||+|||.++....... ..+.+..|+|||++.|.+|+.+.||||||||++||
T Consensus 310 ---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL 381 (586)
T KOG0667|consen 310 ---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAEL 381 (586)
T ss_pred ---eeeccCChhheeeccCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhH
Confidence 999999999999954 34799999999997544322 45668889999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhh--------hhhccccccc---------------------------------cccCC-
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWAR--------PHLGERRRFY---------------------------------RLIDP- 190 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~---------------------------------~~~~~- 190 (304)
++|.+.|.+.+..+....+.-.. ........|. +...|
T Consensus 382 ~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~ 461 (586)
T KOG0667|consen 382 FTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPP 461 (586)
T ss_pred hcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCC
Confidence 99999998876544322111000 0000000000 00001
Q ss_pred ---ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 191 ---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 191 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
.+...........+.+++.+||.+||.+|+|..|+++|..
T Consensus 462 ~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpf 504 (586)
T KOG0667|consen 462 GSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPF 504 (586)
T ss_pred CCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcc
Confidence 0011122233567899999999999999999999999754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=292.77 Aligned_cols=207 Identities=27% Similarity=0.334 Sum_probs=166.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC--------eeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD--------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFL 70 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~L 70 (304)
+|+.++..++|+||+++++.+...+ .+++||||+++|+|.+++..+ ...+++..+..++.|++.||.||
T Consensus 80 ~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~l 159 (496)
T PTZ00283 80 AEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV 159 (496)
T ss_pred HHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 5888999999999999988775432 368999999999999998643 34689999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 71 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 71 H~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
|+.+ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|
T Consensus 160 H~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvily 236 (496)
T PTZ00283 160 HSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLY 236 (496)
T ss_pred HhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 9988 9999999999999999999999999998764432222334567999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
||++|..||..... ........... .. ..+...+.++.+++.+||+.||.+||++.+++++
T Consensus 237 eLltG~~Pf~~~~~------~~~~~~~~~~~------~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 237 ELLTLKRPFDGENM------EEVMHKTLAGR------YD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHCCCCCCCCCH------HHHHHHHhcCC------CC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 99999999965321 11111111000 00 0112235689999999999999999999999875
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=288.91 Aligned_cols=203 Identities=29% Similarity=0.413 Sum_probs=173.7
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|++.|++|+|||++.+-|+|......++||||| -||-.|++.-..+++.+.++..|..+.+.||.|||+.+ .||
T Consensus 74 lKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IH 149 (948)
T KOG0577|consen 74 LKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIH 149 (948)
T ss_pred HHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHh
Confidence 57999999999999999999999999999999999 56888988777788999999999999999999999999 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
||||..|||+++.|.|||+|||.|....+ .+.++||+.|||||++. .+.|+-++||||||++..||.-.++
T Consensus 150 RDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkP 223 (948)
T KOG0577|consen 150 RDIKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 223 (948)
T ss_pred hhccccceEecCCCeeeeccccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCC
Confidence 99999999999999999999999976533 45689999999999985 6789999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|+.+.+.......+ . +.-.|.+. ..+.+..+++|+..||+.-|.+|||.++++.|.
T Consensus 224 PlFnMNAMSALYHI-------A------QNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 224 PLFNMNAMSALYHI-------A------QNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CccCchHHHHHHHH-------H------hcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 98776543221111 1 11112222 335678999999999999999999999999764
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=269.97 Aligned_cols=213 Identities=29% Similarity=0.416 Sum_probs=161.4
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
++|+++++.++|+||+++++.+......++||||+++|+|.+++.... ...++..+..++.||+.||+|||+.+
T Consensus 43 ~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-- 120 (269)
T cd05042 43 LQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120 (269)
T ss_pred HHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--
Confidence 368899999999999999999999999999999999999999986542 23567888999999999999999988
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-------CCCCchhhhHHHHHHH
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVL 149 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il 149 (304)
|+||||||+|||++.++.+||+|||++................++..|+|||++.. ..++.++|||||||++
T Consensus 121 -ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05042 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199 (269)
T ss_pred -EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHH
Confidence 99999999999999999999999999876433222222223345678999998753 3568899999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 150 LEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 150 ~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|||++ |..||....... .... .... .......+.. ....+..+.+++..|| .||++|||+++|++.
T Consensus 200 ~el~~~~~~p~~~~~~~~---~~~~---~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 200 WELFTAADQPYPDLSDEQ---VLKQ---VVRE--QDIKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred HHHHhCCCCCCCcCCHHH---HHHH---Hhhc--cCccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 99999 777876442211 1100 0000 0001111211 2233467778999998 599999999999987
Q ss_pred h
Q 022003 229 L 229 (304)
Q Consensus 229 l 229 (304)
|
T Consensus 267 l 267 (269)
T cd05042 267 L 267 (269)
T ss_pred h
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=279.86 Aligned_cols=197 Identities=27% Similarity=0.396 Sum_probs=158.8
Q ss_pred hHhhHhhcCCCC-cccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|++++..+.|+ +|+++++++...+..|+||||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+|
T Consensus 49 ~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---ivH 124 (324)
T cd05587 49 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKG---IIY 124 (324)
T ss_pred HHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEe
Confidence 578888889765 58889999999999999999999999999986543 6899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 125 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 125 RDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred cCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 99999999999999999999999875322111 2234578999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
...... ... ...... .. ++...+.++.+++.+||+.||.+|++.
T Consensus 203 ~~~~~~---~~~---~i~~~~--------~~----~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 203 GEDEDE---LFQ---SIMEHN--------VS----YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCHHH---HHH---HHHcCC--------CC----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 543211 111 000000 01 111235678999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=269.70 Aligned_cols=201 Identities=24% Similarity=0.438 Sum_probs=161.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++..+...++||||+++++|..++.+....+++..+..++.||+.||+|||+.+ |+||
T Consensus 65 ~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~ 141 (274)
T cd05076 65 ETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHG 141 (274)
T ss_pred HHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCC
Confidence 5788999999999999999999999999999999999999998766667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCC-------cEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHH
Q 022003 82 DFKTSNILLDADY-------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 82 dlkp~Nili~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~ 153 (304)
||||+||+++..+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+
T Consensus 142 dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred CCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999997643 4899999988653221 12346778999998875 56899999999999999985
Q ss_pred -hCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 154 -TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 154 -tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
+|..||........ .... ..... ... .....+.++|.+||+.+|++|||++++++.|.
T Consensus 216 ~~g~~p~~~~~~~~~---~~~~----~~~~~--------~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 216 FDGEVPLKERTPSEK---ERFY----EKKHR--------LPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred hCCCCCccccChHHH---HHHH----HhccC--------CCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 68888865432211 1100 00000 000 11347889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=271.86 Aligned_cols=209 Identities=27% Similarity=0.461 Sum_probs=165.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------------CCCCHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------------LPLPWSIRMKIA 60 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------------~~l~~~~~~~i~ 60 (304)
+|+.++++++||||+++++++..+...++||||+++++|.+++.... ..+++..++.++
T Consensus 57 ~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 136 (288)
T cd05050 57 REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIA 136 (288)
T ss_pred HHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHH
Confidence 58999999999999999999999999999999999999999986421 247888999999
Q ss_pred HHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchh
Q 022003 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS 140 (304)
Q Consensus 61 ~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 140 (304)
.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++
T Consensus 137 ~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 213 (288)
T cd05050 137 KQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES 213 (288)
T ss_pred HHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchh
Confidence 99999999999988 999999999999999999999999998765432221112223346679999999988999999
Q ss_pred hhHHHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 022003 141 DVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219 (304)
Q Consensus 141 DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 219 (304)
|||||||++|+|++ |..||....... ..... .... .. ..+...+..+.+|+.+||+.||.+|
T Consensus 214 Dv~slG~il~el~~~~~~p~~~~~~~~---~~~~~----~~~~----~~------~~~~~~~~~l~~li~~~l~~~p~~R 276 (288)
T cd05050 214 DVWAYGVVLWEIFSYGMQPYYGMAHEE---VIYYV----RDGN----VL------SCPDNCPLELYNLMRLCWSKLPSDR 276 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcCC----CC------CCCCCCCHHHHHHHHHHcccCcccC
Confidence 99999999999997 777875432211 11100 0000 00 0111235689999999999999999
Q ss_pred CCHHHHHHHhC
Q 022003 220 PLMSEVVEALK 230 (304)
Q Consensus 220 ps~~ell~~l~ 230 (304)
||+.|+++.|+
T Consensus 277 pt~~el~~~l~ 287 (288)
T cd05050 277 PSFASINRILQ 287 (288)
T ss_pred CCHHHHHHHhh
Confidence 99999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=266.13 Aligned_cols=209 Identities=28% Similarity=0.432 Sum_probs=169.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++++.. ...++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+.+ ++|
T Consensus 45 ~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H 120 (257)
T cd05040 45 KEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIH 120 (257)
T ss_pred HHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 58999999999999999999988 88999999999999999997654 57899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
+||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 121 ~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 200 (257)
T cd05040 121 RDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200 (257)
T ss_pred cccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876543221 11223456788999999998899999999999999999998 9999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
|....... ...... .... .. ..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 201 ~~~~~~~~---~~~~~~---~~~~---~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 201 WAGLSGSQ---ILKKID---KEGE---RL-------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCCHHH---HHHHHH---hcCC---cC-------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 86432211 111100 0000 00 011123568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=267.92 Aligned_cols=201 Identities=22% Similarity=0.392 Sum_probs=161.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++||||+++++++..++..++||||+++|+|..++..+...+++..+..++.||+.||+|||+.+ ++||
T Consensus 48 ~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~ 124 (258)
T cd05078 48 EAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHG 124 (258)
T ss_pred HHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 5788999999999999999999999999999999999999999776667899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCc--------EEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHH
Q 022003 82 DFKTSNILLDADYN--------AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 82 dlkp~Nili~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 152 (304)
||||+||+++.++. ++++|||++...... ....++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 125 dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l 198 (258)
T cd05078 125 NVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEI 198 (258)
T ss_pred CCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHH
Confidence 99999999987765 699999988754321 22457888999999886 4589999999999999999
Q ss_pred HhCC-CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 153 LTGR-RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 153 ~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
++|. .||....... ... ...... . .+.....++.+++.+||+.||++|||++++++.|+
T Consensus 199 ~~g~~~~~~~~~~~~---~~~----~~~~~~--------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 199 FSGGDKPLSALDSQK---KLQ----FYEDRH--------Q----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HcCCCCChhhccHHH---HHH----HHHccc--------c----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 9985 5554322111 000 000000 0 11112357899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=267.37 Aligned_cols=212 Identities=25% Similarity=0.364 Sum_probs=170.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|+++++.++|+||+++++++..++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ +
T Consensus 51 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i 127 (267)
T cd08229 51 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---V 127 (267)
T ss_pred HHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 589999999999999999999999999999999999999998853 2346899999999999999999999988 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+|+||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 128 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p 205 (267)
T cd08229 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred ecCCCCHHHEEEcCCCCEEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543221 12235688899999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
|...... ........ .....+.. .....+..+.+++.+||+.||.+|||+.+|++.++.+
T Consensus 206 ~~~~~~~----~~~~~~~~-------~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 206 FYGDKMN----LYSLCKKI-------EQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred cccccch----HHHHhhhh-------hcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 8643221 11110000 00001111 1123457899999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=267.79 Aligned_cols=211 Identities=26% Similarity=0.423 Sum_probs=163.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEe-CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.+++.++||||+++++++.. ++..++||||+.+++|.+++.+....+++..+..++.|++.||.|||+.+ ++|
T Consensus 45 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H 121 (262)
T cd05058 45 KEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVH 121 (262)
T ss_pred HHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 58889999999999999998764 55689999999999999999776556788888999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcc--eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC-CC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RR 157 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~~ 157 (304)
|||||+|||++.++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++| .+
T Consensus 122 ~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 201 (262)
T cd05058 122 RDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201 (262)
T ss_pred cccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999765332111 111123456789999999888999999999999999999995 55
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
||..... ....... .. .. .+.. +...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 202 ~~~~~~~---~~~~~~~---~~-~~------~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 202 PYPDVDS---FDITVYL---LQ-GR------RLLQ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCCH---HHHHHHH---hc-CC------CCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 5543211 1111111 00 00 0000 111246789999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=265.61 Aligned_cols=209 Identities=26% Similarity=0.383 Sum_probs=169.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++......+++|||+.+++|.+++......+++..++.++.|++.||.|||+.+ ++|+
T Consensus 49 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~ 125 (262)
T cd06613 49 QEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHR 125 (262)
T ss_pred HHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceec
Confidence 5899999999999999999999999999999999999999998776567999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC---CCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~~p 158 (304)
||+|+||+++.++.+||+|||++........ ......++..|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus 126 dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p 203 (262)
T cd06613 126 DIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203 (262)
T ss_pred CCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999876543211 12335678899999998776 889999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|........ ..... ... ...+. .......+.++.+++.+||..+|.+|||+.+++.+
T Consensus 204 ~~~~~~~~~--~~~~~------~~~---~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 204 MFDLHPMRA--LFLIS------KSN---FPPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred CCCCCHHHH--HHHHH------hcc---CCCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 975432111 00000 000 00001 01123446789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=272.72 Aligned_cols=217 Identities=26% Similarity=0.399 Sum_probs=167.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH 80 (304)
+|++++++++||||+++++++..++..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+ ++|
T Consensus 48 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H 123 (308)
T cd06615 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMH 123 (308)
T ss_pred HHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEE
Confidence 6999999999999999999999999999999999999999998655 468999999999999999999997 46 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
+||||+||+++.++.+||+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 124 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred CCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998764322 1234568899999999988889999999999999999999999986
Q ss_pred CCCCCCCcchhHhhhhhhcccc-------------------ccc----cccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERR-------------------RFY----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~-------------------~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
...................... ... .-..+... ....+.++.+++.+||..||+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~ 276 (308)
T cd06615 200 PPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPK 276 (308)
T ss_pred CcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChh
Confidence 5432111100000000000000 000 00001000 001356789999999999999
Q ss_pred CCCCHHHHHHHh
Q 022003 218 ARPLMSEVVEAL 229 (304)
Q Consensus 218 ~Rps~~ell~~l 229 (304)
+|||+.+++++.
T Consensus 277 ~Rpt~~~ll~~~ 288 (308)
T cd06615 277 ERADLKELTKHP 288 (308)
T ss_pred hCcCHHHHhcCh
Confidence 999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=267.37 Aligned_cols=210 Identities=25% Similarity=0.415 Sum_probs=169.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++..++..++||||+++++|.+++.+....+++.++..++.|++.||.|||+.+ ++||
T Consensus 54 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~ 130 (267)
T cd05066 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHR 130 (267)
T ss_pred HHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeeh
Confidence 5889999999999999999999999999999999999999999776667899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceee-ecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS-TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||+||+++.++.++|+|||++............ ....++..|+|||++.+..++.++|||||||++|++++ |..||
T Consensus 131 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~ 210 (267)
T cd05066 131 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210 (267)
T ss_pred hhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCc
Confidence 99999999999999999999999876543221111 11223567999999998899999999999999999886 99998
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ...... +... ... ....+..+.+++.+||+.+|.+||++.++++.|..
T Consensus 211 ~~~~~~~---~~~~~~----~~~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 211 WEMSNQD---VIKAIE----EGYR------LPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ccCCHHH---HHHHHh----CCCc------CCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 6543211 111110 0000 000 11235678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=268.10 Aligned_cols=213 Identities=27% Similarity=0.385 Sum_probs=163.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|+.++++++||||+++++++.+....++||||+++++|.+++... ....++..+..++.|++.||+|||+.+
T Consensus 44 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--- 120 (269)
T cd05087 44 EEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--- 120 (269)
T ss_pred HHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5899999999999999999999988999999999999999998643 224677788899999999999999988
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-------CCCchhhhHHHHHHHH
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-------HLTSRSDVYSFGVVLL 150 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ 150 (304)
++||||||+||+++.++.+||+|||++................++..|+|||++.+. .++.++||||||+++|
T Consensus 121 i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~ 200 (269)
T cd05087 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIW 200 (269)
T ss_pred EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHH
Confidence 999999999999999999999999999764433222222335577889999998642 3688999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 151 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 151 el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
||++ |..||....... ....... ... .....+.... ..+..+.+++..|| .+|++|||++||+..|
T Consensus 201 el~~~g~~p~~~~~~~~---~~~~~~~--~~~---~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 201 ELFELGSQPYRHLSDEQ---VLTYTVR--EQQ---LKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred HHHhCCCCCCCCCChHH---HHHHHhh--ccc---CCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 9996 999996543211 1111000 000 1111122111 12457889999999 6899999999999876
Q ss_pred C
Q 022003 230 K 230 (304)
Q Consensus 230 ~ 230 (304)
.
T Consensus 268 ~ 268 (269)
T cd05087 268 S 268 (269)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=264.50 Aligned_cols=207 Identities=25% Similarity=0.357 Sum_probs=170.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++..+...|+++||+.+++|.+++......+++..++.++.|++.||.|||+.+ ++|+
T Consensus 47 ~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~ 123 (256)
T cd06612 47 KEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHR 123 (256)
T ss_pred HHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 6899999999999999999999999999999999999999999766678999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 124 dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred CCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999887643321 22334578899999999988999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
......... .. ....+. ...+...+..+.++|.+||+.||++|||+.|++++
T Consensus 202 ~~~~~~~~~---~~----------~~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 202 IHPMRAIFM---IP----------NKPPPT--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cchhhhhhh---hc----------cCCCCC--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 432211000 00 000000 00122335688999999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=265.62 Aligned_cols=205 Identities=27% Similarity=0.414 Sum_probs=164.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEe-CCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+.++++++|+|++++++++.. +...++||||+++++|.+++.++. ..+++..++.++.|++.||+|||+.+ ++
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 124 (256)
T cd05082 48 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124 (256)
T ss_pred HHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 58999999999999999997654 457899999999999999987653 34899999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
||||||+||+++.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 125 H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p 199 (256)
T cd05082 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199 (256)
T ss_pred ccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999987643221 12234567999999998899999999999999999997 8888
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
|...... ........ . ..+. .....+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 200 ~~~~~~~---~~~~~~~~---~-------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 200 YPRIPLK---DVVPRVEK---G-------YKMD----APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCHH---HHHHHHhc---C-------CCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 8643211 11111100 0 0011 111235688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=277.58 Aligned_cols=213 Identities=27% Similarity=0.410 Sum_probs=169.2
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~ 65 (304)
+|+++++++ +|+||+++++++..++..++||||+++++|.+++.++. ..+++..+..++.|++.
T Consensus 66 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 145 (334)
T cd05100 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVAR 145 (334)
T ss_pred HHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHH
Confidence 589999999 89999999999999999999999999999999986532 24788899999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||+|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||
T Consensus 146 al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 222 (334)
T cd05100 146 GMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (334)
T ss_pred HHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHH
Confidence 999999988 99999999999999999999999999987544322222222334567999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|||++ |..||...... +..... ..... . ..+...+..+.+++.+||+.+|++|||+.|
T Consensus 223 G~il~el~~~g~~p~~~~~~~------~~~~~~-~~~~~------~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 285 (334)
T cd05100 223 GVLLWEIFTLGGSPYPGIPVE------ELFKLL-KEGHR------M----DKPANCTHELYMIMRECWHAVPSQRPTFKQ 285 (334)
T ss_pred HHHHHHHHhcCCCCCCCCCHH------HHHHHH-HcCCC------C----CCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 999999998 78888653211 111110 00000 0 011123468899999999999999999999
Q ss_pred HHHHhCCCCC
Q 022003 225 VVEALKPLPN 234 (304)
Q Consensus 225 ll~~l~~~~~ 234 (304)
+++.|+.+..
T Consensus 286 ll~~l~~~~~ 295 (334)
T cd05100 286 LVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHhh
Confidence 9999976654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=268.39 Aligned_cols=210 Identities=25% Similarity=0.412 Sum_probs=167.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++..+...++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++|+
T Consensus 54 ~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~ 130 (269)
T cd05065 54 SEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHR 130 (269)
T ss_pred HHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeec
Confidence 5899999999999999999999999999999999999999999776667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeec-c--cccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-V--MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~ 157 (304)
||||+||+++.++.+||+|||++.............. . ..+..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 131 dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~ 210 (269)
T cd05065 131 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210 (269)
T ss_pred ccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCC
Confidence 9999999999999999999999876543222111111 1 12457999999998999999999999999999886 999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
||...... ....+... . .... .+...+..+.+++.+||..+|.+||++.++++.|+.
T Consensus 211 p~~~~~~~---~~~~~i~~----~------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 211 PYWDMSNQ---DVINAIEQ----D------YRLP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred CCCCCCHH---HHHHHHHc----C------CcCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 98654321 11111110 0 0000 111235678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=269.97 Aligned_cols=208 Identities=25% Similarity=0.370 Sum_probs=167.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|+||+++++++..++..++||||+++++|..++.+....+++..+..++.|++.||.|||+.+ ++||
T Consensus 51 ~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~ 127 (282)
T cd06643 51 VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHR 127 (282)
T ss_pred HHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 5899999999999999999999999999999999999999988765567999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+||+++.++.+||+|||++....... .......++..|+|||++. +..++.++|||||||++|+|++|.
T Consensus 128 dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~ 205 (282)
T cd06643 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE 205 (282)
T ss_pred CCCcccEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCC
Confidence 999999999999999999999987653221 1223356889999999874 456788999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
+||....... ....... . ...... .+...+.++.++|.+||+.||.+||++++++++.
T Consensus 206 ~p~~~~~~~~--~~~~~~~---~---~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 206 PPHHELNPMR--VLLKIAK---S---EPPTLA-------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCccccCHHH--HHHHHhh---c---CCCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 9986543211 0111000 0 000000 1122356899999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=272.56 Aligned_cols=207 Identities=31% Similarity=0.411 Sum_probs=167.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.++++++|+||+++++.+..++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|
T Consensus 49 ~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH 125 (285)
T cd05630 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVY 125 (285)
T ss_pred HHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEe
Confidence 5899999999999999999999999999999999999999988543 346999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||+++.++.++|+|||++........ .....|+..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 126 ~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~ 202 (285)
T cd05630 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202 (285)
T ss_pred CCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876543221 123468999999999998899999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~~ 228 (304)
............ ..... ... .+....+.++.+|+.+||+.||++||| ++|++++
T Consensus 203 ~~~~~~~~~~~~---~~~~~-------~~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 203 QRKKKIKREEVE---RLVKE-------VQE----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred CCCccchHHHHH---hhhhh-------hhh----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 643211111000 00000 000 111223467899999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=274.59 Aligned_cols=208 Identities=25% Similarity=0.386 Sum_probs=165.2
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~ 65 (304)
+|++++.++ +|+||+++++++..++..++||||+++++|.+++.+.. ..+++..++.++.|++.
T Consensus 56 ~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 135 (303)
T cd05088 56 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 135 (303)
T ss_pred HHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHH
Confidence 589999999 89999999999999999999999999999999986432 35889999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||+|||+.+ ++||||||+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||
T Consensus 136 al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 209 (303)
T cd05088 136 GMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 209 (303)
T ss_pred HHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhh
Confidence 999999988 9999999999999999999999999986432111 1111233567999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|+|+| |..||....... ..... ... ... ..+...+..+.+|+.+||+.+|++||++++
T Consensus 210 G~il~ellt~g~~p~~~~~~~~---~~~~~----~~~------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 272 (303)
T cd05088 210 GVLLWEIVSLGGTPYCGMTCAE---LYEKL----PQG------YRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQ 272 (303)
T ss_pred hhHHHHHHhcCCCCcccCChHH---HHHHH----hcC------CcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999998 999986443211 11100 000 000 011123467899999999999999999999
Q ss_pred HHHHhCCC
Q 022003 225 VVEALKPL 232 (304)
Q Consensus 225 ll~~l~~~ 232 (304)
+++.|+.+
T Consensus 273 il~~l~~~ 280 (303)
T cd05088 273 ILVSLNRM 280 (303)
T ss_pred HHHHHHHH
Confidence 99988644
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=278.78 Aligned_cols=197 Identities=24% Similarity=0.351 Sum_probs=159.4
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|.+++..+ .|++|+++++++...+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+|
T Consensus 49 ~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH 124 (323)
T cd05616 49 VEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIY 124 (323)
T ss_pred HHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 466777777 5889999999999999999999999999999988654 36899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 125 rDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~ 202 (323)
T cd05616 125 RDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202 (323)
T ss_pred cCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCC
Confidence 9999999999999999999999987543211 12334678999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
...... .. ........ .++...+.++.+++.+||+.||.+|+++
T Consensus 203 ~~~~~~---~~---~~i~~~~~------------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 203 GEDEDE---LF---QSIMEHNV------------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCHHH---HH---HHHHhCCC------------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 543211 11 10000000 1112235688999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=265.47 Aligned_cols=205 Identities=23% Similarity=0.335 Sum_probs=167.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.+++.++|+||+++++.+..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|
T Consensus 47 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H 123 (255)
T cd08219 47 KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLH 123 (255)
T ss_pred HHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---ccc
Confidence 588899999999999999999999999999999999999998865 3456899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
+||||+||+++.++.++|+|||.+........ ......|+..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 124 ~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 201 (255)
T cd08219 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201 (255)
T ss_pred CCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCC
Confidence 99999999999999999999999976543221 1223568889999999998899999999999999999999999996
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
...... ....... .. .. ..+...+..+.++|.+||+.||++|||+.+++..
T Consensus 202 ~~~~~~------~~~~~~~--~~-~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 202 ANSWKN------LILKVCQ--GS-YK--------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCHHH------HHHHHhc--CC-CC--------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 532111 0000000 00 00 0112235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.27 Aligned_cols=223 Identities=22% Similarity=0.322 Sum_probs=159.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLH 71 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~~LH 71 (304)
+|++++++++||||+++++++.. +...++||||+. ++|.+++... ...+++..++.++.||+.||.|||
T Consensus 47 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH 125 (317)
T cd07867 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125 (317)
T ss_pred HHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH
Confidence 69999999999999999998854 457899999995 5887776421 235889999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEE----CCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhc-CCCCchhhhHHH
Q 022003 72 EEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSF 145 (304)
Q Consensus 72 ~~~~~~iiH~dlkp~Nili----~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diwsl 145 (304)
+.+ |+||||||+|||+ +.++.+||+|||+++........ .......||..|+|||++.+ ..++.++|||||
T Consensus 126 ~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 202 (317)
T cd07867 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred hCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhH
Confidence 988 9999999999999 56679999999999876433221 11233568999999999876 458999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcc-------hhHhhhh-------hh---cccccccccc---------CCcc---CCCC
Q 022003 146 GVVLLEMLTGRRSMDKNRPNGEHN-------LVEWARP-------HL---GERRRFYRLI---------DPRL---EGHF 196 (304)
Q Consensus 146 G~il~el~tg~~p~~~~~~~~~~~-------~~~~~~~-------~~---~~~~~~~~~~---------~~~~---~~~~ 196 (304)
||++|||+||.+||.......... ....... .+ .....+.... .... ....
T Consensus 203 G~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (317)
T cd07867 203 GCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKH 282 (317)
T ss_pred HHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcc
Confidence 999999999999997543221100 0000000 00 0000000000 0000 0000
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 197 SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 197 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.......+.+|+.+||+.||.+|||++|++++
T Consensus 283 ~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 283 KVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred cCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 11123568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=269.14 Aligned_cols=227 Identities=25% Similarity=0.324 Sum_probs=165.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++||||+++++++... ...++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ ++
T Consensus 54 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~ 130 (284)
T cd05081 54 REIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YV 130 (284)
T ss_pred HHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ce
Confidence 589999999999999999987643 4678999999999999999766557999999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCccee-eecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||||+||+++.++.+||+|||++........... .....++..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 131 H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 210 (284)
T cd05081 131 HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK 210 (284)
T ss_pred eccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCc
Confidence 999999999999999999999999987644322111 1112234569999999988999999999999999999998776
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
+......-.......... ......+.+.+............+.++.+++.+||..+|++|||+.|+++.|+.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 211 SCSPPAEFMRMMGNDKQG-QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCCcchhhhhhccccccc-ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 543211100000000000 0000000000000000001112356899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=269.70 Aligned_cols=219 Identities=21% Similarity=0.282 Sum_probs=164.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++.+.+..++|+||+. ++|.+++......+++..++.++.||++||.|||+.+ ++||
T Consensus 48 ~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~ 123 (284)
T cd07839 48 REICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHR 123 (284)
T ss_pred HHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 58999999999999999999999999999999995 5888887665567999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.+||+|||+++....... ......++..|+|||++.+. .++.++|||||||++|+|++|..|+.
T Consensus 124 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 124 DLKPQNLLINKNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCCHHHEEEcCCCcEEECccchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 9999999999999999999999986543221 12234568899999998764 47999999999999999999988864
Q ss_pred CCCCCCCcchhHhhh-----------hhhcccccccc--ccCCccC-CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 022003 161 KNRPNGEHNLVEWAR-----------PHLGERRRFYR--LIDPRLE-GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 226 (304)
...... ....... ........... ....... .......+.++.++|.+||+.||.+|||+++++
T Consensus 202 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il 279 (284)
T cd07839 202 PGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279 (284)
T ss_pred CCCCHH--HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHh
Confidence 332211 0000000 00000000000 0000000 001112357889999999999999999999999
Q ss_pred HH
Q 022003 227 EA 228 (304)
Q Consensus 227 ~~ 228 (304)
++
T Consensus 280 ~h 281 (284)
T cd07839 280 QH 281 (284)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=282.57 Aligned_cols=222 Identities=25% Similarity=0.354 Sum_probs=164.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC-----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+++++.++|+||+++++++...+ ..|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||+.+
T Consensus 48 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~-- 123 (372)
T cd07853 48 RELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG-- 123 (372)
T ss_pred HHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 6999999999999999999998776 7899999995 6888877543 47999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhC
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg 155 (304)
++||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+. .++.++|||||||++|||++|
T Consensus 124 -ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 201 (372)
T cd07853 124 -ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201 (372)
T ss_pred -eeCCCCChHHEEECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcC
Confidence 99999999999999999999999999986543221 112234678899999998864 589999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHh----------hhhhhcccccccc-ccC-CccCC--CCCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 156 RRSMDKNRPNGEHNLVEW----------ARPHLGERRRFYR-LID-PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~-~~~-~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
+.||.............. ..........+.. ... +.... ......+.++.+||.+||+.||++|||
T Consensus 202 ~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t 281 (372)
T cd07853 202 RILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS 281 (372)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC
Confidence 999976543221111000 0000000000000 000 00000 011122568899999999999999999
Q ss_pred HHHHHHHh
Q 022003 222 MSEVVEAL 229 (304)
Q Consensus 222 ~~ell~~l 229 (304)
+.|++++.
T Consensus 282 ~~e~l~hp 289 (372)
T cd07853 282 AADALAHP 289 (372)
T ss_pred HHHHhcCH
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=264.44 Aligned_cols=207 Identities=30% Similarity=0.502 Sum_probs=167.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++......++||||+.+++|.+++......++++.++.++.|++.||+|||+.+ ++|+
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~ 124 (256)
T cd05112 48 EEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124 (256)
T ss_pred HHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 5899999999999999999999999999999999999999999776667899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 125 dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 203 (256)
T cd05112 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203 (256)
T ss_pred ccccceEEEcCCCeEEECCCcceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999876543211 11122334678999999998899999999999999999998 888886
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
...... ... . ... ......+.. .+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 204 ~~~~~~---~~~---~-~~~---~~~~~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 204 NRSNSE---VVE---T-INA---GFRLYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred cCCHHH---HHH---H-HhC---CCCCCCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 432211 111 0 000 001111111 246899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=266.43 Aligned_cols=209 Identities=24% Similarity=0.358 Sum_probs=165.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++..++..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||
T Consensus 55 ~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 130 (267)
T cd06646 55 QEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG---KMHR 130 (267)
T ss_pred HHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 5899999999999999999999999999999999999999988654 46899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+||+++.++.+||+|||++........ ......|+..|+|||.+. ...++.++|||||||++|+|++|..|
T Consensus 131 dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p 208 (267)
T cd06646 131 DIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208 (267)
T ss_pred CCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999986532211 122346788999999874 34578899999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|............ .... ...+... .....+..+.++|.+||+.+|++|||+++++++|
T Consensus 209 ~~~~~~~~~~~~~--------~~~~---~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 209 MFDLHPMRALFLM--------SKSN---FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccchhhhheee--------ecCC---CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 8644322110000 0000 0001110 0112356889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.27 Aligned_cols=210 Identities=23% Similarity=0.380 Sum_probs=169.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++|+||+++++++.. ...++||||+++++|.+++......+++..+..++.|++.||+|||+.+ ++||
T Consensus 58 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~ 133 (279)
T cd05057 58 DEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHR 133 (279)
T ss_pred HHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEec
Confidence 58999999999999999999887 7889999999999999999876667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||+++...............++..|+|||.+....++.++|||||||++||+++ |..||.
T Consensus 134 di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 213 (279)
T cd05057 134 DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213 (279)
T ss_pred ccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999987653332222222233567999999988899999999999999999998 999986
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
...... ...... .... ... +..++..+.+++.+||..||++||++.++++.|..+
T Consensus 214 ~~~~~~---~~~~~~----~~~~---~~~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 214 GIPAVE---IPDLLE----KGER---LPQ-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCCHHH---HHHHHh----CCCC---CCC-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 543211 111110 0000 000 111245788999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=282.35 Aligned_cols=213 Identities=25% Similarity=0.408 Sum_probs=168.0
Q ss_pred ChHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-------------------------------
Q 022003 1 MAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------------------- 48 (304)
Q Consensus 1 l~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------------- 48 (304)
++|+++|.++. |||||++++++...+..++|||||.+|+|.+++.+..
T Consensus 88 ~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (401)
T cd05107 88 MSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSH 167 (401)
T ss_pred HHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccc
Confidence 36999999997 9999999999999999999999999999999985431
Q ss_pred ------------------------------------------------------------------CCCCHHHHHHHHHH
Q 022003 49 ------------------------------------------------------------------LPLPWSIRMKIALG 62 (304)
Q Consensus 49 ------------------------------------------------------------------~~l~~~~~~~i~~q 62 (304)
..+++..+..++.|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 247 (401)
T cd05107 168 VSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQ 247 (401)
T ss_pred hhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHH
Confidence 13677788999999
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhh
Q 022003 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 142 (304)
Q Consensus 63 i~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 142 (304)
|+.||+|||+.+ ++||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||
T Consensus 248 i~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 324 (401)
T cd05107 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV 324 (401)
T ss_pred HHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence 999999999988 99999999999999999999999999986533222122223456788999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 143 YSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 143 wslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
|||||++|||++ |..||........ ... ...... . +. .+...+.++.+|+.+||..+|.+||+
T Consensus 325 wslGvil~e~l~~g~~P~~~~~~~~~-----~~~-~~~~~~---~---~~----~p~~~~~~l~~li~~cl~~~P~~RPs 388 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPELPMNEQ-----FYN-AIKRGY---R---MA----KPAHASDEIYEIMQKCWEEKFEIRPD 388 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCchHH-----HHH-HHHcCC---C---CC----CCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 999999999998 8888865422110 000 000000 0 00 11123568999999999999999999
Q ss_pred HHHHHHHhCCC
Q 022003 222 MSEVVEALKPL 232 (304)
Q Consensus 222 ~~ell~~l~~~ 232 (304)
+++|++.|+.+
T Consensus 389 ~~ell~~L~~~ 399 (401)
T cd05107 389 FSQLVHLVGDL 399 (401)
T ss_pred HHHHHHHHHHH
Confidence 99999988653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=264.62 Aligned_cols=205 Identities=28% Similarity=0.477 Sum_probs=167.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.++++++|+||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|
T Consensus 49 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H 125 (256)
T cd05039 49 AEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVH 125 (256)
T ss_pred HHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 68999999999999999999998889999999999999999986553 36899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
+||||+||+++.++.+||+|||.++....... ...++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 126 ~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 200 (256)
T cd05039 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200 (256)
T ss_pred hhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999987632211 2234567999999988889999999999999999997 88888
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... .... ..... .. ..+...+..+.++|.+||..+|++|||+.++++.|+.
T Consensus 201 ~~~~~~~---~~~~----~~~~~------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 201 PRIPLKD---VVPH----VEKGY------RM----EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCHHH---HHHH----HhcCC------CC----CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 6542211 1110 00000 00 0111235788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=270.10 Aligned_cols=216 Identities=29% Similarity=0.449 Sum_probs=167.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++|+||+++++++... ...++||||+++++|.+++.+....+++..+..++.|++.||+|||+.+ ++
T Consensus 55 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~ 131 (284)
T cd05079 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YV 131 (284)
T ss_pred HHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 589999999999999999998875 5688999999999999999766557899999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||||+||+++.++.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|+++..|
T Consensus 132 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~ 211 (284)
T cd05079 132 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS 211 (284)
T ss_pred ecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCC
Confidence 9999999999999999999999999876433221 112234567789999999888899999999999999999998765
Q ss_pred CCCCCCC---------CCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPN---------GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
....... .......... ....... .. .+...+..+.+|+.+||+.||++|||++++++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~------~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 212 ESSPMTLFLKMIGPTHGQMTVTRLVR-VLEEGKR------LP----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred CccccchhhhhcccccccccHHHHHH-HHHcCcc------CC----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 4321100 0000000000 0000000 00 1112357899999999999999999999999988
Q ss_pred CC
Q 022003 230 KP 231 (304)
Q Consensus 230 ~~ 231 (304)
+.
T Consensus 281 ~~ 282 (284)
T cd05079 281 EA 282 (284)
T ss_pred Hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=257.78 Aligned_cols=213 Identities=24% Similarity=0.280 Sum_probs=167.7
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeC----CeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+++.-.. .|||||+++++|+.. +.+.+|||+++||.|...+..++ ..|++.++..|+.||..|+.|||+.+
T Consensus 103 rEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n- 181 (400)
T KOG0604|consen 103 REVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN- 181 (400)
T ss_pred hHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc-
Confidence 577765555 699999999998752 45679999999999999998764 46999999999999999999999998
Q ss_pred CCeEeccCCCCCeEEC---CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 76 RPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|.||||||+|+|.. .|..+||+|||+|+...... ...+.+-|+.|.|||++....|+..+|+||+|+++|-|
T Consensus 182 --IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIl 256 (400)
T KOG0604|consen 182 --IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256 (400)
T ss_pred --hhhccCChhheeeecCCCCcceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHh
Confidence 99999999999995 45679999999998754322 23345679999999999989999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
++|.+||..........-.. .+. +...+++.++.+ ...++++.++|+++|..+|.+|.|+++++++..
T Consensus 257 LCGyPPFYS~hg~aispgMk-~rI----~~gqy~FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 257 LCGYPPFYSNHGLAISPGMK-RRI----RTGQYEFPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred hcCCCcccccCCccCChhHH-hHh----hccCccCCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 99999997654322111100 000 011122333322 244789999999999999999999999998754
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=263.02 Aligned_cols=200 Identities=26% Similarity=0.447 Sum_probs=161.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++|+||+++++++.. ...++||||+++++|.+++......+++..+..++.||+.||+|||+.+ ++||
T Consensus 50 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~ 125 (259)
T cd05037 50 ETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHG 125 (259)
T ss_pred HHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecc
Confidence 58899999999999999999988 7789999999999999999776557999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCC-------cEEEccccCcccCCCCCcceeeecccccccccCcchhhcC--CCCchhhhHHHHHHHHHH
Q 022003 82 DFKTSNILLDADY-------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 82 dlkp~Nili~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el 152 (304)
||||+||+++.++ .+||+|||++..... .....++..|+|||++.+. .++.++|||||||++|+|
T Consensus 126 dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l 199 (259)
T cd05037 126 NVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199 (259)
T ss_pred cCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHH
Confidence 9999999999887 799999999886533 1223456789999998876 789999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 153 LT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 153 ~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
++ |..||........ ..+.. ... ....+ ....+.+++.+||..+|.+|||+.++++.|.
T Consensus 200 ~~~~~~p~~~~~~~~~---~~~~~----~~~---~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 200 CSNGEEPLSTLSSSEK---ERFYQ----DQH---RLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhCCCCCcccCCchhH---HHHHh----cCC---CCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 99 4666655432111 11000 000 00000 0268899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=268.44 Aligned_cols=211 Identities=26% Similarity=0.423 Sum_probs=168.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEe-CCeeEEEEecCCCCCHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|+.++++++|+||+++++++.. +...++++||+++++|.+++.... ..+++..++.++.|++.||+|||+.
T Consensus 57 ~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 136 (280)
T cd05043 57 QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136 (280)
T ss_pred HHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 58899999999999999998876 467899999999999999986531 4589999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 153 (304)
+ ++||||||+||+++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|+++
T Consensus 137 ~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~ 213 (280)
T cd05043 137 G---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213 (280)
T ss_pred C---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHh
Confidence 8 9999999999999999999999999998654433222222344577899999999889999999999999999999
Q ss_pred h-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 154 T-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 154 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
+ |..||...... ....+.. ... ... ....++..+.+++.+||..||++|||+.++++.|+.+
T Consensus 214 ~~g~~p~~~~~~~---~~~~~~~----~~~------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 214 TLGQTPYVEIDPF---EMAAYLK----DGY------RLA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred cCCCCCcCcCCHH---HHHHHHH----cCC------CCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 9 99998654321 1111111 000 000 1112356889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=280.73 Aligned_cols=208 Identities=24% Similarity=0.284 Sum_probs=162.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++||||+++++.+..++..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||
T Consensus 92 ~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHr 166 (371)
T cd05622 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHR 166 (371)
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 5888999999999999999999999999999999999999998654 4899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC----CCCchhhhHHHHHHHHHHHhCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~tg~~ 157 (304)
||||+|||++.++.+||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus 167 DLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 245 (371)
T cd05622 167 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245 (371)
T ss_pred CCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCC
Confidence 9999999999999999999999987543221 122346799999999998754 37899999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHh
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 229 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~~l 229 (304)
||....... .+ ......... ..... ....+..+.++|.+||..++.+ |+++++++++.
T Consensus 246 Pf~~~~~~~-----~~-~~i~~~~~~-~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 246 PFYADSLVG-----TY-SKIMNHKNS-LTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCCCCHHH-----HH-HHHHcCCCc-ccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 997543211 00 000000000 00000 1123568899999999844433 67999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=263.76 Aligned_cols=206 Identities=25% Similarity=0.388 Sum_probs=169.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++++...+..++||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ ++|
T Consensus 48 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h 124 (256)
T cd08221 48 NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILH 124 (256)
T ss_pred HHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 6899999999999999999999999999999999999999999765 456899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
+||+|+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 125 ~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08221 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202 (256)
T ss_pred cCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999986543321 2234568899999999988889999999999999999999999986
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..... +....... ..+ .+ .....+.++.+++.+||..+|.+||+++++++++
T Consensus 203 ~~~~~------~~~~~~~~--~~~----~~-----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 203 ATNPL------NLVVKIVQ--GNY----TP-----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCHH------HHHHHHHc--CCC----CC-----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 53221 11110000 000 00 0122356889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.50 Aligned_cols=207 Identities=25% Similarity=0.379 Sum_probs=165.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|..+. .+++..+..++.|++.||+|||+.+ ++|+
T Consensus 48 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 119 (279)
T cd06619 48 SELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHR 119 (279)
T ss_pred HHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeC
Confidence 6899999999999999999999999999999999999997652 4788999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.++|+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 120 dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 99999999999999999999999865432 12345789999999999988999999999999999999999999975
Q ss_pred CCCCCCcc-hhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 162 NRPNGEHN-LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 162 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
........ ........... ..+.. .....+.++.+++.+||+.+|++||+++|++++..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 196 IQKNQGSLMPLQLLQCIVDE-------DPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred hcccccccchHHHHHHHhcc-------CCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 33222111 11111000000 00110 01123467899999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=282.88 Aligned_cols=208 Identities=26% Similarity=0.363 Sum_probs=162.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++.+++|+||+++++.+.+++..|+||||++||+|.+++.+. ..+++..+..++.|++.||+|||+.+ |+||
T Consensus 50 ~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHr 125 (360)
T cd05627 50 AERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG---FIHR 125 (360)
T ss_pred HHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcc
Confidence 4888999999999999999999999999999999999999998654 36999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcc---------------------------------eeeecccccccccCc
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKT---------------------------------HVSTRVMGTYGYAAP 128 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aP 128 (304)
||||+||||+.++.+||+|||++......... ......+||..|+||
T Consensus 126 DLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 205 (360)
T cd05627 126 DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAP 205 (360)
T ss_pred CCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCH
Confidence 99999999999999999999998754321100 001134799999999
Q ss_pred chhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHH
Q 022003 129 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 208 (304)
Q Consensus 129 E~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 208 (304)
|++.+..++.++|||||||++|||++|..||......... .......... .+.+. ...+.++.++|
T Consensus 206 E~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~------~~i~~~~~~~--~~p~~------~~~s~~~~~li 271 (360)
T cd05627 206 EVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY------RKVMNWKETL--VFPPE------VPISEKAKDLI 271 (360)
T ss_pred HHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHH------HHHHcCCCce--ecCCC------CCCCHHHHHHH
Confidence 9999999999999999999999999999999765332110 0000000000 00110 01246788999
Q ss_pred HHhccCCCCCCCC---HHHHHHH
Q 022003 209 AHCLSRDPKARPL---MSEVVEA 228 (304)
Q Consensus 209 ~~~l~~dp~~Rps---~~ell~~ 228 (304)
.+|+. ||.+|++ +.|+++|
T Consensus 272 ~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 272 LRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHhcc-ChhhcCCCCCHHHHhcC
Confidence 99874 9999985 6676664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=263.11 Aligned_cols=208 Identities=27% Similarity=0.395 Sum_probs=165.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+|++++++++. .+..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|
T Consensus 50 ~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H 125 (260)
T cd05069 50 QEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIH 125 (260)
T ss_pred HHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eee
Confidence 5899999999999999999875 45689999999999999999654 345899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
+||||+||+++.++.++|+|||++......... ......++..|+|||...+..++.++||||||+++|+|++ |..||
T Consensus 126 ~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 204 (260)
T cd05069 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204 (260)
T ss_pred cccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999765432211 1122345678999999988889999999999999999999 88888
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ...... .. ..+. .+...+..+.+++.+||..||++||+++++++.|+.
T Consensus 205 ~~~~~~~---~~~~~~----~~------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 205 PGMVNRE---VLEQVE----RG------YRMP----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCHHH---HHHHHH----cC------CCCC----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 6543211 111100 00 0000 111235689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=279.61 Aligned_cols=218 Identities=24% Similarity=0.316 Sum_probs=161.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+.+++.++||||+++++++.... ..++||||+. ++|.+.+.. .+++..++.++.|++.||.|||+.+
T Consensus 65 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g- 139 (355)
T cd07874 65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG- 139 (355)
T ss_pred HHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 6899999999999999999886543 5799999995 577776643 4889999999999999999999998
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
|+||||||+|||++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 140 --ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 214 (355)
T cd07874 140 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214 (355)
T ss_pred --cccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998654321 12335689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchh-H---------------hhhhhhccccccc-----cccCCcc---CCCCCHHHHHHHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLV-E---------------WARPHLGERRRFY-----RLIDPRL---EGHFSIKGAQKAAQLAAHC 211 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~-~---------------~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~li~~~ 211 (304)
..||............ . ............. ....... ........+..+.+||.+|
T Consensus 215 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 294 (355)
T cd07874 215 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294 (355)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHH
Confidence 9999754321110000 0 0000000000000 0000000 0001112246789999999
Q ss_pred ccCCCCCCCCHHHHHHHh
Q 022003 212 LSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~l 229 (304)
|+.||++|||+.|++++.
T Consensus 295 L~~dP~~Rps~~ell~hp 312 (355)
T cd07874 295 LVIDPAKRISVDEALQHP 312 (355)
T ss_pred hcCCchhcCCHHHHhcCc
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=264.42 Aligned_cols=208 Identities=26% Similarity=0.403 Sum_probs=165.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.++++++|+||+++++++. ....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|
T Consensus 50 ~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H 125 (260)
T cd05070 50 EEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIH 125 (260)
T ss_pred HHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 6899999999999999999875 45689999999999999998654 345899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+||+++.++.++|+|||++......... ......++..|+|||+..+..++.++||||||+++|+|++ |..||
T Consensus 126 ~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~ 204 (260)
T cd05070 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204 (260)
T ss_pred CCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999875432211 1122334567999999988889999999999999999999 88888
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
...... ....... ... .. ..+...+..+.+++.+||..+|.+|||+.++.+.|+.
T Consensus 205 ~~~~~~---~~~~~~~----~~~------~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 205 PGMNNR---EVLEQVE----RGY------RM----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCHH---HHHHHHH----cCC------CC----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 653211 1111110 000 00 1112335689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=272.40 Aligned_cols=210 Identities=23% Similarity=0.392 Sum_probs=167.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++... ..++++||+++|+|.+++..+...+++..+..++.|++.||+|||+.+ ++|+
T Consensus 58 ~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~ 133 (303)
T cd05110 58 DEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHR 133 (303)
T ss_pred HHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eecc
Confidence 588999999999999999988754 567999999999999999776667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 134 dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~ 213 (303)
T cd05110 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213 (303)
T ss_pred ccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987643322222223345678999999998999999999999999999997 888886
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
..... ....+.. .... ... +..++.++.+++.+||..+|++||+++++++.++.+
T Consensus 214 ~~~~~---~~~~~~~----~~~~---~~~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 214 GIPTR---EIPDLLE----KGER---LPQ-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CCCHH---HHHHHHH----CCCC---CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 53211 1111111 1000 000 111245789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=277.55 Aligned_cols=218 Identities=24% Similarity=0.321 Sum_probs=161.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+.+++.++||||+++++++...+ ..|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||+.+
T Consensus 69 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~- 143 (359)
T cd07876 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG- 143 (359)
T ss_pred HHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 6899999999999999999987543 4799999995 467666632 4889999999999999999999998
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
|+||||||+|||++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 144 --ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg 218 (359)
T cd07876 144 --IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218 (359)
T ss_pred --cccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhC
Confidence 9999999999999999999999999997643221 12335689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcch---------hHh-------hhhhhcccccc-----ccccCCcc---CCCCCHHHHHHHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNL---------VEW-------ARPHLGERRRF-----YRLIDPRL---EGHFSIKGAQKAAQLAAHC 211 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~---------~~~-------~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~li~~~ 211 (304)
..||........... ..+ ........... .+...... ........+..+.+||.+|
T Consensus 219 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 298 (359)
T cd07876 219 SVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKM 298 (359)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHH
Confidence 999976532110000 000 00000000000 00000000 0001112246789999999
Q ss_pred ccCCCCCCCCHHHHHHHh
Q 022003 212 LSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~l 229 (304)
|+.||++|||+.|++++.
T Consensus 299 L~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 299 LVIDPDKRISVDEALRHP 316 (359)
T ss_pred hccCcccCCCHHHHhcCc
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=270.51 Aligned_cols=222 Identities=22% Similarity=0.322 Sum_probs=166.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++...+..++||||+. ++|.+++......+++..++.++.||+.||.|||+.+ ++|+
T Consensus 53 ~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~ 128 (301)
T cd07873 53 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHR 128 (301)
T ss_pred HHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCC
Confidence 68999999999999999999999999999999996 6999988776667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.+||+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.
T Consensus 129 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~ 206 (301)
T cd07873 129 DLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206 (301)
T ss_pred CCCHHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999976433221 1223456889999999875 458899999999999999999999997
Q ss_pred CCCCCCCcchhHhh--------hhhhccccccccccCCccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWA--------RPHLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.............. .........+.....+.... ......+..+.+||.+||+.||.+|||++|++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 207 GSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 65321110000000 00000000000000011000 0011235678999999999999999999999985
Q ss_pred h
Q 022003 229 L 229 (304)
Q Consensus 229 l 229 (304)
.
T Consensus 287 ~ 287 (301)
T cd07873 287 P 287 (301)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=266.02 Aligned_cols=206 Identities=25% Similarity=0.400 Sum_probs=167.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++...+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||
T Consensus 55 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~ 130 (267)
T cd06628 55 REIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHR 130 (267)
T ss_pred HHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccc
Confidence 5889999999999999999999999999999999999999999654 46899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCc----ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDK----THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
||+|+||+++.++.++|+|||.++....... ........|+..|+|||.+.+..++.++|||||||++|+|++|..
T Consensus 131 di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~ 210 (267)
T cd06628 131 DIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH 210 (267)
T ss_pred cCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCC
Confidence 9999999999999999999999887642111 111123457889999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
||...... ...... .....+. .+...+..+.++|.+||+.||.+||++.|++++
T Consensus 211 p~~~~~~~-----~~~~~~--------~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 211 PFPDCTQL-----QAIFKI--------GENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCCCccHH-----HHHHHH--------hccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 99753211 000000 0011111 122335788999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.07 Aligned_cols=208 Identities=25% Similarity=0.389 Sum_probs=165.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+
T Consensus 55 ~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 130 (267)
T cd06645 55 QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKG---KMHR 130 (267)
T ss_pred HHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 58899999999999999999999999999999999999999986544 7999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+||+++.++.+||+|||++....... .......|+..|+|||++. ...++.++|||||||++|+|++|..|
T Consensus 131 dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p 208 (267)
T cd06645 131 DIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208 (267)
T ss_pred CCCHHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCC
Confidence 999999999999999999999987654221 1223456899999999874 45688999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|............ .. . ....+.... ....+..+.++|.+||+.+|++|||+++++++
T Consensus 209 ~~~~~~~~~~~~~--~~------~---~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 209 MFDLHPMRALFLM--TK------S---NFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccccchhhHHhh--hc------c---CCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 8654321111000 00 0 000011100 01224578899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=270.70 Aligned_cols=211 Identities=20% Similarity=0.251 Sum_probs=163.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++..++|+||+++++++..++..|+||||+++++|.+++.+....+++..+..++.||+.||+|||+.+ |+||
T Consensus 50 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 126 (331)
T cd05597 50 EERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHR 126 (331)
T ss_pred HHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEC
Confidence 4788999999999999999999999999999999999999999776667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-----CCCCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+|||++.++.+||+|||++........ .......||+.|+|||++.. ..++.++|||||||++|+|++|+
T Consensus 127 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~ 205 (331)
T cd05597 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205 (331)
T ss_pred CCCHHHEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCC
Confidence 9999999999999999999999876543222 11223468999999999873 45788999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~~l 229 (304)
.||...... ............+ . +.+. ....+..+.++|.+||..++++ |+++++++++.
T Consensus 206 ~Pf~~~~~~------~~~~~i~~~~~~~-~-~~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 206 TPFYAESLV------ETYGKIMNHKEHF-Q-FPPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred CCCCCCCHH------HHHHHHHcCCCcc-c-CCCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 999654221 1100010000000 0 0000 0113568899999988654443 78999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=262.70 Aligned_cols=212 Identities=24% Similarity=0.367 Sum_probs=170.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++|+||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ +
T Consensus 51 ~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i 127 (267)
T cd08224 51 KEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---I 127 (267)
T ss_pred HHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 689999999999999999999999999999999999999998854 2446899999999999999999999988 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++|..|
T Consensus 128 ~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p 205 (267)
T cd08224 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred ecCCcChhhEEECCCCcEEEeccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999876543221 12234678899999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
|...... .......... . .. +.. .....+..+.++|.+||..+|.+|||+.++++.|+.+
T Consensus 206 ~~~~~~~----~~~~~~~~~~--~----~~-~~~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 206 FYGDKMN----LYSLCKKIEK--C----DY-PPL---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred cccCCcc----HHHHHhhhhc--C----CC-CCC---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 8643211 1111100000 0 00 000 1113456889999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=268.79 Aligned_cols=205 Identities=24% Similarity=0.355 Sum_probs=166.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|+||+++++.+..+...|+||||+++++|.+++.+. .+++.++..++.|++.||.|||+.+ ++||
T Consensus 66 ~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~ 140 (296)
T cd06654 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHR 140 (296)
T ss_pred HHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 5889999999999999999999999999999999999999998543 5899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.++|||||||++|+|++|..||..
T Consensus 141 dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred CCCHHHEEEcCCCCEEECccccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876533221 12234678899999999988899999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
...... .... ... .. +.. ..+...+..+.+++.+||..||++|||+.+++++
T Consensus 219 ~~~~~~--~~~~----~~~--~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 219 ENPLRA--LYLI----ATN--GT-----PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCHHHh--HHHH----hcC--CC-----CCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 432111 0000 000 00 000 0112334678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=264.67 Aligned_cols=214 Identities=22% Similarity=0.334 Sum_probs=161.8
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
++|+.+++.++||||+++++.+......|+||||+++++|.+++.+. ...+++..++.++.||+.||+|||+.+
T Consensus 43 ~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--- 119 (268)
T cd05086 43 LQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119 (268)
T ss_pred HHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36888999999999999999999999999999999999999998653 234677788899999999999999988
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-------CCCCchhhhHHHHHHHH
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ 150 (304)
++||||||+|||++.++.+||+|||++................++..|+|||++.. ..++.++|||||||++|
T Consensus 120 i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~ 199 (268)
T cd05086 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLW 199 (268)
T ss_pred eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHH
Confidence 99999999999999999999999999864322211122234567889999998753 24578999999999999
Q ss_pred HHHhC-CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 151 EMLTG-RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 151 el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
||+++ ..||...... +....... .......++..... .+..+.+++..|| .+|++||+++++++.|
T Consensus 200 el~~~~~~p~~~~~~~------~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 200 ELFENAAQPYSHLSDR------EVLNHVIK--DQQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred HHHhCCCCCCCCCCHH------HHHHHHHh--hcccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 99974 5677543221 11111111 11112223332222 3467888999999 6899999999999876
Q ss_pred C
Q 022003 230 K 230 (304)
Q Consensus 230 ~ 230 (304)
.
T Consensus 267 ~ 267 (268)
T cd05086 267 T 267 (268)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=265.34 Aligned_cols=219 Identities=22% Similarity=0.277 Sum_probs=163.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+.++++++||||+++++++..++..++||||+. ++|.+++... ...+++..++.++.||+.||+|||+.+ ++
T Consensus 48 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~ 123 (285)
T cd07861 48 REISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VL 123 (285)
T ss_pred HHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 58999999999999999999999999999999996 6898888543 256899999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p 158 (304)
|+||||+||+++.++.+||+|||++........ ......++..|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 124 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~ 201 (285)
T cd07861 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPL 201 (285)
T ss_pred ecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999976543211 12234568899999988754 578999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhh-------hhcc---ccccccccCC---ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 159 MDKNRPNGEHNLVEWARP-------HLGE---RRRFYRLIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~-------~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
|........ ....... .+.. ...+...... ..........+.++.++|.+||+.||.+|||+.++
T Consensus 202 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~l 279 (285)
T cd07861 202 FHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA 279 (285)
T ss_pred CCCCCHHHH--HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 975432110 0000000 0000 0000000000 00000011135688899999999999999999999
Q ss_pred HHH
Q 022003 226 VEA 228 (304)
Q Consensus 226 l~~ 228 (304)
+++
T Consensus 280 l~~ 282 (285)
T cd07861 280 LNH 282 (285)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=306.64 Aligned_cols=208 Identities=29% Similarity=0.391 Sum_probs=170.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|.++|..|+|||+|++||+-.+.+..+|.||||.+|+|.+++. ++.-.++.....+..|++.|+.|||+.| ||||
T Consensus 1283 eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~g---IVHR 1358 (1509)
T KOG4645|consen 1283 EEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHR 1358 (1509)
T ss_pred HHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceec
Confidence 58999999999999999999999999999999999999999984 4445777888889999999999999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcc--eeeecccccccccCcchhhcC---CCCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+||+++.+|.+|++|||.|......... ...+...||+.|||||++.+. +-..+.||||||||+.||+||+
T Consensus 1359 DIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGk 1438 (1509)
T KOG4645|consen 1359 DIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGK 1438 (1509)
T ss_pred CCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCC
Confidence 99999999999999999999999886544211 112346899999999999753 4567999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.||...+.+ |...... .....+..+...+.+..++|..||+.||++|+++.|++++-
T Consensus 1439 rPW~~~dne-------~aIMy~V---------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1439 RPWAELDNE-------WAIMYHV---------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred Cchhhccch-------hHHHhHH---------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 999765332 1111100 01111223344678999999999999999999999999863
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=262.90 Aligned_cols=208 Identities=25% Similarity=0.383 Sum_probs=165.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++++. ....++||||+++++|.+++.+. ...+++..+..++.|++.||+|||+.+ ++|
T Consensus 50 ~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H 125 (262)
T cd05071 50 QEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 125 (262)
T ss_pred HHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 6899999999999999999875 45689999999999999999653 346899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
+||||+||+++.++.+||+|||.++........ ......++..|+|||+..+..++.++|||||||++|+|++ |..||
T Consensus 126 ~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~ 204 (262)
T cd05071 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204 (262)
T ss_pred cccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999999865433221 1122345678999999988899999999999999999999 78888
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ... ... ... .. ......+..+.+++.+||+.||++||++.++++.|+.
T Consensus 205 ~~~~~~~---~~~---~~~-~~~------~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 205 PGMVNRE---VLD---QVE-RGY------RM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCChHH---HHH---HHh-cCC------CC----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 6543211 110 000 000 00 0122345788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=278.59 Aligned_cols=218 Identities=23% Similarity=0.312 Sum_probs=161.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+.+++.++||||+++++++... ...|+||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+
T Consensus 72 ~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~- 146 (364)
T cd07875 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG- 146 (364)
T ss_pred HHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 689999999999999999987643 35799999995 578777743 4889999999999999999999988
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
|+||||||+|||++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 147 --ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 221 (364)
T cd07875 147 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221 (364)
T ss_pred --eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhC
Confidence 9999999999999999999999999998654321 12335689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhH---------h-------hhhhhccccccccc----cCCcc----CCCCCHHHHHHHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLVE---------W-------ARPHLGERRRFYRL----IDPRL----EGHFSIKGAQKAAQLAAHC 211 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~---------~-------~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~~~~li~~~ 211 (304)
+.||............. + ..........+... ..+.. ...........+.+||.+|
T Consensus 222 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m 301 (364)
T cd07875 222 GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301 (364)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHh
Confidence 99997653221100000 0 00000000000000 00000 0001111245789999999
Q ss_pred ccCCCCCCCCHHHHHHHh
Q 022003 212 LSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~l 229 (304)
|+.||.+|||+.|++++.
T Consensus 302 L~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 302 LVIDASKRISVDEALQHP 319 (364)
T ss_pred cCcCcccCCCHHHHhcCc
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=268.86 Aligned_cols=220 Identities=25% Similarity=0.316 Sum_probs=160.9
Q ss_pred hHhhHhhcC---CCCcccceeeEEEeC-----CeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDL---VHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l---~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|+++++.+ +||||+++++++... ...++||||+. ++|.+++... ...+++..+..++.||+.||.|||+
T Consensus 48 ~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 126 (288)
T cd07863 48 REVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126 (288)
T ss_pred HHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467777665 799999999988652 45799999996 5888888654 3458999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
.+ ++||||||+||+++.++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+|
T Consensus 127 ~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 200 (288)
T cd07863 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200 (288)
T ss_pred CC---eecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHH
Confidence 98 99999999999999999999999999986543211 2234678899999999988999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcch-hHhhh----hhhccccccc-cccCCcc---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 022003 153 LTGRRSMDKNRPNGEHNL-VEWAR----PHLGERRRFY-RLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~-~~~~~----~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
++|.+||........... ..... ..+....... ....+.. ........+..+.++|.+||+.||++|||+.
T Consensus 201 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 280 (288)
T cd07863 201 FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAF 280 (288)
T ss_pred HhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHH
Confidence 999999965432211100 00000 0000000000 0000000 0001112356789999999999999999999
Q ss_pred HHHHH
Q 022003 224 EVVEA 228 (304)
Q Consensus 224 ell~~ 228 (304)
|++.+
T Consensus 281 ~~l~h 285 (288)
T cd07863 281 RALQH 285 (288)
T ss_pred HHhcC
Confidence 99975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=270.69 Aligned_cols=219 Identities=29% Similarity=0.398 Sum_probs=178.2
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
|+|-.||.+++.+.||.+--.|++.+.+|+||..|+||+|.-+|.+.+ ..|++..+..++.+|+.||++||+.+ ||
T Consensus 233 LnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iV 309 (591)
T KOG0986|consen 233 LNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IV 309 (591)
T ss_pred hHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---ee
Confidence 578999999999999999999999999999999999999999997764 46999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
+|||||+|||+|+.|+++|+|+|+|..+..+.. ....+||.+|||||++.+..|+...|.|||||++|||+.|+.||
T Consensus 310 YRDLKPeNILLDd~GhvRISDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPF 386 (591)
T KOG0986|consen 310 YRDLKPENILLDDHGHVRISDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPF 386 (591)
T ss_pred eccCChhheeeccCCCeEeeccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCch
Confidence 999999999999999999999999998876543 23348999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHHhCCCCCCccC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLKDM 238 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~~l~~~~~~~~~ 238 (304)
...........++ +..+. ....++...++++.+|.+..|+.||++|..+. +=.+.++..+.++++
T Consensus 387 r~~KeKvk~eEvd--rr~~~------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 387 RQRKEKVKREEVD--RRTLE------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred hhhhhhhhHHHHH--HHHhc------------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 7654332221111 11111 11234445678999999999999999998554 333334444444444
Q ss_pred C
Q 022003 239 A 239 (304)
Q Consensus 239 ~ 239 (304)
+
T Consensus 453 n 453 (591)
T KOG0986|consen 453 N 453 (591)
T ss_pred C
Confidence 3
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=265.78 Aligned_cols=210 Identities=25% Similarity=0.371 Sum_probs=167.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++|+||+++++++.. ...++||||+++++|.+++.+....+++..++.++.|++.||+|||+.+ ++|+
T Consensus 56 ~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~ 131 (270)
T cd05056 56 QEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHR 131 (270)
T ss_pred HHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 58999999999999999998875 4578999999999999999776657899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|+|++ |..||.
T Consensus 132 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 210 (270)
T cd05056 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210 (270)
T ss_pred ccChheEEEecCCCeEEccCceeeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999886543321 11222334567999999988889999999999999999986 999986
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
...... ..... ..... .. .+...+..+.++|.+||..+|.+|||+.++++.|+.+.
T Consensus 211 ~~~~~~---~~~~~----~~~~~------~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 211 GVKNND---VIGRI----ENGER------LP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred CCCHHH---HHHHH----HcCCc------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 543211 11110 00000 00 11123568999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=268.00 Aligned_cols=206 Identities=28% Similarity=0.373 Sum_probs=164.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|++++|+||+++++.+..++..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ |+|
T Consensus 49 ~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH 125 (285)
T cd05632 49 NEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVY 125 (285)
T ss_pred HHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 5899999999999999999999999999999999999999888654 346999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||+++.++.+||+|||++........ .....|+..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 126 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~ 202 (285)
T cd05632 126 RDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202 (285)
T ss_pred cCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876533211 223468999999999998899999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVE 227 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~ 227 (304)
.......... . ....... .. .+....+..+.+|+.+||+.||++||+ +.++++
T Consensus 203 ~~~~~~~~~~--~-~~~~~~~-------~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 203 GRKEKVKREE--V-DRRVLET-------EE----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCCHHHHHHH--H-HHhhhcc-------cc----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 5432111000 0 0000000 00 111223467889999999999999999 555555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=262.43 Aligned_cols=209 Identities=27% Similarity=0.412 Sum_probs=168.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|
T Consensus 50 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h 126 (261)
T cd05034 50 QEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIH 126 (261)
T ss_pred HHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 68999999999999999999998889999999999999999997653 56899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
+||||+||+++.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||
T Consensus 127 ~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 205 (261)
T cd05034 127 RDLAARNILVGENLVCKIADFGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205 (261)
T ss_pred CCcchheEEEcCCCCEEECccccceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999887543211 11112234567999999998899999999999999999998 89998
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
...... ........ . .... .+...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 206 ~~~~~~---~~~~~~~~------~----~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 206 PGMTNR---EVLEQVER------G----YRMP----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHH---HHHHHHHc------C----CCCC----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 653211 11111100 0 0000 011124688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=264.60 Aligned_cols=204 Identities=24% Similarity=0.372 Sum_probs=167.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++..+...++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+
T Consensus 51 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~ 125 (277)
T cd06642 51 QEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHR 125 (277)
T ss_pred HHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eecc
Confidence 589999999999999999999999999999999999999998854 36899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 126 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred CCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999876543221 12234578899999999988899999999999999999999999864
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
...... ... .. ....+ ......+..+.+++.+||+.+|++||++.+++++.
T Consensus 204 ~~~~~~---~~~----~~------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 204 LHPMRV---LFL----IP------KNSPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred cchhhH---Hhh----hh------cCCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 332111 000 00 00011 11223456889999999999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=266.19 Aligned_cols=207 Identities=26% Similarity=0.386 Sum_probs=165.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|+||+++++++..++..++||||+++++|..++.+....+++..+..++.|++.||+|||+.+ ++||
T Consensus 58 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~ 134 (292)
T cd06644 58 VEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHR 134 (292)
T ss_pred HHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeec
Confidence 5889999999999999999999999999999999999999988766667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+||+++.++.+||+|||++....... .......++..|+|||++. ...++.++|||||||++|+|++|.
T Consensus 135 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 212 (292)
T cd06644 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 212 (292)
T ss_pred CCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCC
Confidence 999999999999999999999987643221 1123346788999999884 345788999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||....... ...... ....+.. ..+...+.++.++|.+||..||++||++++++++
T Consensus 213 ~p~~~~~~~~--~~~~~~-----------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 213 PPHHELNPMR--VLLKIA-----------KSEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCCccccHHH--HHHHHh-----------cCCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 9986543211 001000 0000000 0112234678999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=262.07 Aligned_cols=204 Identities=24% Similarity=0.351 Sum_probs=169.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++++.|+||+++++++..+...++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+
T Consensus 51 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~ 125 (277)
T cd06640 51 QEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHR 125 (277)
T ss_pred HHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCc
Confidence 588999999999999999999999999999999999999999854 35899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 126 dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred CCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999977543221 12234578889999999888899999999999999999999999875
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
......... .............+..+.+++.+||+.+|++||++.+++++.
T Consensus 204 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 204 MHPMRVLFL-----------------IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred cChHhHhhh-----------------hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 432211100 000111123335577899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=275.46 Aligned_cols=214 Identities=23% Similarity=0.352 Sum_probs=160.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+++|++++|+||+++++++... ...|++|+++ +++|.+++.. ..+++..+..++.||+.||.|||+.+
T Consensus 63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~- 138 (343)
T cd07878 63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG- 138 (343)
T ss_pred HHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 689999999999999999987643 3568999998 7899887743 36999999999999999999999998
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
|+||||||+||+++.++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 --ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 211 (343)
T cd07878 139 --IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK 211 (343)
T ss_pred --eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHH
Confidence 999999999999999999999999999875432 223468999999999876 578999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhh----------hc--cccccccccCCccCC----CCCHHHHHHHHHHHHHhccCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPH----------LG--ERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKA 218 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~----------~~--~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~ 218 (304)
|..||........ ...+.... .. ....+...+ +.... ......+..+.+||.+||+.||++
T Consensus 212 g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~ 288 (343)
T cd07878 212 GKALFPGNDYIDQ--LKRIMEVVGTPSPEVLKKISSEHARKYIQSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDK 288 (343)
T ss_pred CCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhcchhhHHHHhhcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhh
Confidence 9999975432110 00000000 00 000000000 00000 000012346789999999999999
Q ss_pred CCCHHHHHHHh
Q 022003 219 RPLMSEVVEAL 229 (304)
Q Consensus 219 Rps~~ell~~l 229 (304)
|||+.|++++-
T Consensus 289 R~s~~ell~hp 299 (343)
T cd07878 289 RISASEALAHP 299 (343)
T ss_pred CCCHHHHhcCc
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=258.45 Aligned_cols=224 Identities=24% Similarity=0.324 Sum_probs=166.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEe-CCeeEEEEecCCCCCHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+.+++.|+|+|++.+..++.+ ++..++++||.+ .+|...|.-+ ...++...++.|+.||+.|+.|||++=
T Consensus 76 REiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW-- 152 (438)
T KOG0666|consen 76 REIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW-- 152 (438)
T ss_pred HHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--
Confidence 79999999999999999999988 778999999995 5999988532 346999999999999999999999965
Q ss_pred CeEeccCCCCCeEECCC----CcEEEccccCcccCCCCCcce-eeecccccccccCcchhhcC-CCCchhhhHHHHHHHH
Q 022003 77 PVIYRDFKTSNILLDAD----YNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLL 150 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~----~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ 150 (304)
|+||||||.||||..+ |.|||+|||+++.+...-... .....+-|.||+|||++.|. .|+.+.|||++|||+.
T Consensus 153 -vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfa 231 (438)
T KOG0666|consen 153 -VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFA 231 (438)
T ss_pred -eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHH
Confidence 9999999999999776 999999999999876544332 23345669999999999864 7999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcc-------hhHhhh----h---hhccccccccc------cCCccCCCCCH--------HHHH
Q 022003 151 EMLTGRRSMDKNRPNGEHN-------LVEWAR----P---HLGERRRFYRL------IDPRLEGHFSI--------KGAQ 202 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~-------~~~~~~----~---~~~~~~~~~~~------~~~~~~~~~~~--------~~~~ 202 (304)
||+|..+.|.+........ +..... + .|.......+. +.......... .-++
T Consensus 232 ElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~ 311 (438)
T KOG0666|consen 232 ELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDP 311 (438)
T ss_pred HHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCc
Confidence 9999999887643322111 110000 0 00000011100 00000000000 0123
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 203 KAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 203 ~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
...+|+.++|++||.+|.|+++.+++.
T Consensus 312 ~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 312 SALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred hHHHHHHHHhccCchhhccHHHHhccc
Confidence 488999999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=266.44 Aligned_cols=226 Identities=27% Similarity=0.357 Sum_probs=169.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++|+||+++++++.. ....++||||+++++|.+++......+++..+..++.|++.||+|||+.+ ++
T Consensus 55 ~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~ 131 (284)
T cd05038 55 REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YI 131 (284)
T ss_pred HHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 68999999999999999999887 55789999999999999999776657999999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcce-eeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++|||||||++++|++|..|
T Consensus 132 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p 211 (284)
T cd05038 132 HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP 211 (284)
T ss_pred cCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCC
Confidence 99999999999999999999999998765332211 11123345679999999888999999999999999999999988
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
+............. ... ......+.+.+........+..++.++.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 212 ~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 212 SQSPPAEFLRMIGI-AQG-QMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccccchhcccccc-ccc-cccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 75432211000000 000 0000000000000000011122346899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=264.11 Aligned_cols=204 Identities=26% Similarity=0.403 Sum_probs=168.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|+||+++++++..+...++|+||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+
T Consensus 48 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~ 122 (274)
T cd06609 48 QEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHR 122 (274)
T ss_pred HHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 5889999999999999999999999999999999999999998654 7899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+++.++.++|+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 123 dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 123 DIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred CCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999999999999999998765332 122345678899999999988899999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
...... ..... ....+..... ..+.++.+++.+||..+|++|||+++++++
T Consensus 201 ~~~~~~---~~~~~----------~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 201 LHPMRV---LFLIP----------KNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CchHHH---HHHhh----------hcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 432110 00000 0011111111 135678999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=293.65 Aligned_cols=207 Identities=24% Similarity=0.365 Sum_probs=160.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCC-
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAE- 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~- 75 (304)
+|+.+|++|+|||||+++++|.. ...+||||||+.+++|.++|... ...+++..++.|+.||+.||.|||+.+.
T Consensus 61 ~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~ 140 (1021)
T PTZ00266 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140 (1021)
T ss_pred HHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccc
Confidence 59999999999999999998865 35689999999999999998652 3469999999999999999999998431
Q ss_pred ---CCeEeccCCCCCeEECC-----------------CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc--
Q 022003 76 ---RPVIYRDFKTSNILLDA-----------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 133 (304)
Q Consensus 76 ---~~iiH~dlkp~Nili~~-----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 133 (304)
.+|+||||||+||||+. .+.+||+|||++....... ......||+.|+|||++.+
T Consensus 141 ~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~ 217 (1021)
T PTZ00266 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHET 217 (1021)
T ss_pred cccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccC
Confidence 33999999999999964 2358999999998654322 1234578999999999864
Q ss_pred CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcc
Q 022003 134 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 213 (304)
Q Consensus 134 ~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 213 (304)
..++.++||||||||+|+|++|..||...... ..... .+... +.+. ....+.++.+||.+||+
T Consensus 218 ~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~-----~qli~-~lk~~--------p~lp---i~~~S~eL~dLI~~~L~ 280 (1021)
T PTZ00266 218 KSYDDKSDMWALGCIIYELCSGKTPFHKANNF-----SQLIS-ELKRG--------PDLP---IKGKSKELNILIKNLLN 280 (1021)
T ss_pred CCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH-----HHHHH-HHhcC--------CCCC---cCCCCHHHHHHHHHHhc
Confidence 45899999999999999999999999643221 11111 01000 0000 01124689999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 022003 214 RDPKARPLMSEVVEA 228 (304)
Q Consensus 214 ~dp~~Rps~~ell~~ 228 (304)
.+|.+||++.|++.+
T Consensus 281 ~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 281 LSAKERPSALQCLGY 295 (1021)
T ss_pred CChhHCcCHHHHhcc
Confidence 999999999999954
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=273.27 Aligned_cols=211 Identities=23% Similarity=0.342 Sum_probs=164.0
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|+++++.+. |++|+++++++...+..|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+|
T Consensus 49 ~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivH 124 (323)
T cd05615 49 VEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG---IIY 124 (323)
T ss_pred HHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 4778888885 567888999999999999999999999999998654 36999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 125 rDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (323)
T cd05615 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202 (323)
T ss_pred cCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCC
Confidence 99999999999999999999999875432211 2234568999999999999899999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHHhCCCCCCc
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLK 236 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~~l~~~~~~~ 236 (304)
...... .. ........ .++...+.++.+++.+||+.+|.+|++.. +..+.+...+.+.
T Consensus 203 ~~~~~~---~~---~~i~~~~~------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~ 261 (323)
T cd05615 203 GEDEDE---LF---QSIMEHNV------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFR 261 (323)
T ss_pred CCCHHH---HH---HHHHhCCC------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccC
Confidence 543211 11 10000000 01112346789999999999999999753 2333444444443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=270.46 Aligned_cols=211 Identities=20% Similarity=0.231 Sum_probs=164.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++..++|+||+++++.+...+..++||||+++|+|.+++.+....+++..+..++.||+.||+|||+.+ |+||
T Consensus 50 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHr 126 (332)
T cd05623 50 EERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHR 126 (332)
T ss_pred HHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEec
Confidence 4778899999999999999999999999999999999999999776667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+|||++.++.+||+|||++........ .......||..|+|||++. ...++.++|||||||++|||++|.
T Consensus 127 Dlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~ 205 (332)
T cd05623 127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205 (332)
T ss_pred CCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCC
Confidence 9999999999999999999999876433221 1223457899999999986 346889999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~~l 229 (304)
.||....... ...........+ .-+. .....+.++.+|+.+||..++.+ |++++|++++-
T Consensus 206 ~Pf~~~~~~~------~~~~i~~~~~~~---~~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~ 267 (332)
T cd05623 206 TPFYAESLVE------TYGKIMNHKERF---QFPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP 267 (332)
T ss_pred CCCCCCCHHH------HHHHHhCCCccc---cCCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence 9997542211 111111110000 0000 01123578899999999765544 68999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=277.79 Aligned_cols=218 Identities=27% Similarity=0.452 Sum_probs=180.0
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCC-CHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l-~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
++||++|.+|+|||||.++++|..++.+|+|+||++.|+|.+++.++..+. ..+.-..|+.||+.|++||.+.+ +|
T Consensus 583 ~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fV 659 (807)
T KOG1094|consen 583 LKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FV 659 (807)
T ss_pred HHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hh
Confidence 379999999999999999999999999999999999999999998874443 55566779999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh--CCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRR 157 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t--g~~ 157 (304)
||||.+.|+|++.++++||+|||+++.+..++......+.+-...|||+|.+.-++++.++|+|+||+++||+++ ...
T Consensus 660 Hrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~ 739 (807)
T KOG1094|consen 660 HRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQ 739 (807)
T ss_pred hccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhC
Confidence 999999999999999999999999998877777777777788899999999999999999999999999999755 667
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
||...... +..+.......... .......+..++..+.++|.+||..+-++|||++++..+|..
T Consensus 740 Py~~lt~e---~vven~~~~~~~~~-------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 740 PYSQLTDE---QVVENAGEFFRDQG-------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred chhhhhHH---HHHHhhhhhcCCCC-------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 88654332 22222222221111 111122344567899999999999999999999999988754
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=260.31 Aligned_cols=207 Identities=32% Similarity=0.503 Sum_probs=166.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++.++|+||+++++++.+.+..+++|||+++++|.+++...... +++..++.++.|++.||.|||+.+ ++|
T Consensus 50 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h 126 (258)
T smart00219 50 REARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIH 126 (258)
T ss_pred HHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eee
Confidence 5889999999999999999999999999999999999999999765433 999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
+||||+||+++.++.++|+|||++............ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 127 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~ 205 (258)
T smart00219 127 RDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPY 205 (258)
T ss_pred cccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999876543222111 2236788999999988889999999999999999998 77877
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
...... ....... ... . .. .....+.++.+++.+||..||++|||+.++++.|
T Consensus 206 ~~~~~~---~~~~~~~----~~~---~---~~----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 206 PGMSNE---EVLEYLK----KGY---R---LP----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCHH---HHHHHHh----cCC---C---CC----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 652211 1111100 000 0 00 1112357899999999999999999999999754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=284.85 Aligned_cols=223 Identities=19% Similarity=0.229 Sum_probs=161.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|+++|++++|+|||++++++...+..|+|++++ +++|..++.... .......+..++.||+.||+|||+.+
T Consensus 212 ~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--- 287 (501)
T PHA03210 212 NEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--- 287 (501)
T ss_pred HHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6999999999999999999999999999999999 567777764431 22446677889999999999999988
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
|+||||||+||||+.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..
T Consensus 288 IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~ 366 (501)
T PHA03210 288 LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366 (501)
T ss_pred eecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999987644322 12234578999999999999999999999999999999999875
Q ss_pred C-CCCCCCCCCcchhHhhhhhhcccccc-------ccccCCc----cCCCC-----CHHHHHHHHHHHHHhccCCCCCCC
Q 022003 158 S-MDKNRPNGEHNLVEWARPHLGERRRF-------YRLIDPR----LEGHF-----SIKGAQKAAQLAAHCLSRDPKARP 220 (304)
Q Consensus 158 p-~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~----~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rp 220 (304)
+ +..........+.............+ ...++.. ..... ....+.++.++|.+||+.||++||
T Consensus 367 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp 446 (501)
T PHA03210 367 CPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP 446 (501)
T ss_pred CCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc
Confidence 4 43322211111111111000000000 0000000 00000 001235678899999999999999
Q ss_pred CHHHHHHHh
Q 022003 221 LMSEVVEAL 229 (304)
Q Consensus 221 s~~ell~~l 229 (304)
|+.|++++.
T Consensus 447 sa~elL~hp 455 (501)
T PHA03210 447 GAAELLALP 455 (501)
T ss_pred CHHHHhhCh
Confidence 999999853
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=266.10 Aligned_cols=207 Identities=26% Similarity=0.397 Sum_probs=166.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++..+...++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ ++|+
T Consensus 51 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~ 127 (280)
T cd06611 51 VEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHR 127 (280)
T ss_pred HHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 5899999999999999999999999999999999999999999776667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+||+++.++.++|+|||++........ ......++..|+|||++. ...++.++|||||||++|+|++|.
T Consensus 128 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~ 205 (280)
T cd06611 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205 (280)
T ss_pred CCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999876433211 123356888999999975 345788999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||....... ...... ....+.+. .+...+.++.++|.+||+.+|.+||++++++++
T Consensus 206 ~p~~~~~~~~--~~~~~~-----------~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 206 PPHHELNPMR--VLLKIL-----------KSEPPTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCcccCCHHH--HHHHHh-----------cCCCCCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 9996542211 000000 00000000 111234678899999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=283.79 Aligned_cols=219 Identities=19% Similarity=0.285 Sum_probs=158.1
Q ss_pred hHhhHhhcCCC------CcccceeeEEEeC-CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-C
Q 022003 2 AEVNFLGDLVH------LNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-E 73 (304)
Q Consensus 2 ~E~~il~~l~h------~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~ 73 (304)
.|++++++++| .+++++++++... ++.|+|||++ +++|.+++.++ ..+++..+..++.||+.||+|||+ .
T Consensus 174 ~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ 251 (467)
T PTZ00284 174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTEL 251 (467)
T ss_pred HHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 36777777655 4588888888764 5789999999 78899888655 469999999999999999999997 4
Q ss_pred CCCCeEeccCCCCCeEECCCC----------------cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCC
Q 022003 74 AERPVIYRDFKTSNILLDADY----------------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 137 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 137 (304)
+ |+||||||+|||++.++ .+||+|||.+..... .....+||..|+|||++.+..|+
T Consensus 252 g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~ 323 (467)
T PTZ00284 252 H---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWM 323 (467)
T ss_pred C---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCC
Confidence 7 99999999999998765 499999998764321 12346789999999999999999
Q ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhh----hhcc------cccccc-------ccCCcc-------C
Q 022003 138 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP----HLGE------RRRFYR-------LIDPRL-------E 193 (304)
Q Consensus 138 ~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~------~~~~~~-------~~~~~~-------~ 193 (304)
.++|||||||++|||++|+.||......+....+..... .+.. ...+.. ..++.. .
T Consensus 324 ~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (467)
T PTZ00284 324 YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARAR 403 (467)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhccc
Confidence 999999999999999999999976543211111100000 0000 000000 000000 0
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 194 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 194 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
..........+.+||.+||++||++|||++|+++|..
T Consensus 404 ~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 404 PVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred chhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 0001112457889999999999999999999998654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=264.23 Aligned_cols=210 Identities=30% Similarity=0.483 Sum_probs=167.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++......++||||+.+++|.+++. ....+++..++.++.|+++||.+||+.+ ++|+
T Consensus 47 ~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~ 122 (260)
T PF00069_consen 47 REIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHR 122 (260)
T ss_dssp HHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred hhhhcccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccc---cccc
Confidence 48899999999999999999999999999999999889999997 3346899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-cCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.++|+|||.+..... .........++..|+|||++. +..++.++||||||+++|+|++|..||.
T Consensus 123 dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~ 200 (260)
T PF00069_consen 123 DIKPENILLDENGEVKLIDFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFE 200 (260)
T ss_dssp SBSGGGEEESTTSEEEESSGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSST
T ss_pred cccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999976421 122344567899999999998 8889999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
....... ............. ... .. .......+.++|.+||+.||++|||+++++++
T Consensus 201 ~~~~~~~---~~~~~~~~~~~~~--~~~---~~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 201 ESNSDDQ---LEIIEKILKRPLP--SSS---QQ---SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSSHHHH---HHHHHHHHHTHHH--HHT---TS---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccchhh---hhhhhhccccccc--ccc---cc---cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 6511111 1111000000000 000 00 00012689999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=271.32 Aligned_cols=211 Identities=20% Similarity=0.246 Sum_probs=164.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++..++|+||+++++++...+..|+||||++||+|.+++.+....+++..+..++.|++.||+|||+.+ |+||
T Consensus 50 ~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHr 126 (331)
T cd05624 50 EERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHR 126 (331)
T ss_pred HHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 4788899999999999999999999999999999999999999775567999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-----CCCCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+|||++.++.+||+|||++........ .......||..|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 127 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~ 205 (331)
T cd05624 127 DIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205 (331)
T ss_pred cCchHHEEEcCCCCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCC
Confidence 9999999999999999999999987543222 12233568999999999875 46889999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~~l 229 (304)
.||....... ..........++ . + +.. ....+.++.+++.+||..++.+ |+++++++++.
T Consensus 206 ~Pf~~~~~~~------~~~~i~~~~~~~-~-~-p~~----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 206 TPFYAESLVE------TYGKIMNHEERF-Q-F-PSH----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred CCccCCCHHH------HHHHHHcCCCcc-c-C-CCc----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 9996543211 000000000000 0 0 100 0123568899999999876544 45888888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=260.66 Aligned_cols=205 Identities=24% Similarity=0.336 Sum_probs=165.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEe-CCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++|+|++++++.+.. +...|+||||+++++|.+++... ...+++.+++.++.|++.||.+||+.+ ++
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~ 124 (257)
T cd08223 48 QEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---IL 124 (257)
T ss_pred HHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 58899999999999999998764 44678999999999999998763 446899999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
|+||||+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|||||||++++|++|..||
T Consensus 125 H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~ 202 (257)
T cd08223 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF 202 (257)
T ss_pred ccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999876533211 223456788999999999999999999999999999999999998
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... .......... ..+. .+...+..+.+++.+||+.||++|||+.+++++
T Consensus 203 ~~~~~------~~~~~~~~~~-------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 203 NAKDM------NSLVYRIIEG-------KLPP----MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCH------HHHHHHHHhc-------CCCC----CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 64321 1111111000 0011 122345789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=260.67 Aligned_cols=208 Identities=26% Similarity=0.400 Sum_probs=166.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.++++++|+||+++++++. .+..++||||+.+++|.+++... ...+++..+..++.|++.||+|||+.+ ++|
T Consensus 50 ~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H 125 (260)
T cd05067 50 AEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIH 125 (260)
T ss_pred HHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eec
Confidence 6899999999999999999864 55789999999999999998653 456899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 126 ~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 204 (260)
T cd05067 126 RDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204 (260)
T ss_pred ccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987543221 11222345678999999998889999999999999999999 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ..... ... .... .+...+.++.+++.+||+.+|++|||++++++.|+.
T Consensus 205 ~~~~~~~---~~~~~----~~~------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 205 PGMTNPE---VIQNL----ERG------YRMP----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCChHH---HHHHH----HcC------CCCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 6543211 11100 000 0001 111234689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=263.40 Aligned_cols=212 Identities=26% Similarity=0.446 Sum_probs=169.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH 80 (304)
+|+++++.++||||+++++++...+..++||||+++++|.+++.+. ..+++..+..++.+++.||.|||+ .+ ++|
T Consensus 52 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H 127 (284)
T cd06620 52 RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR---IMH 127 (284)
T ss_pred HHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC---eec
Confidence 6899999999999999999999999999999999999999988654 468999999999999999999997 46 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||+++.++.++|+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 128 ~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~ 203 (284)
T cd06620 128 RDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203 (284)
T ss_pred cCCCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence 999999999999999999999998754221 1223568999999999988899999999999999999999999997
Q ss_pred CCCCCCC-----cchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 161 KNRPNGE-----HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 161 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... .....+......+ ..+... ....+.++.+|+.+||+.||.+|||++|++++..-
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 204 FSNIDDDGQDDPMGILDLLQQIVQE-------PPPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred ccchhhhhhhhhhHHHHHHHHHhhc-------cCCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 5443211 1111111111100 001110 11245688999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=262.87 Aligned_cols=206 Identities=28% Similarity=0.388 Sum_probs=162.6
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeC------CeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|+.+++++ +|+||+++++++... ...++||||+.+++|.+++... ...+++..+..++.|++.||+|||+.
T Consensus 51 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 130 (272)
T cd06637 51 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130 (272)
T ss_pred HHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 578889988 799999999998753 4679999999999999998764 45689999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVV 148 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~i 148 (304)
+ ++|+||||+||++++++.++|+|||++........ ......|+..|+|||++. +..++.++|||||||+
T Consensus 131 ~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~ 205 (272)
T cd06637 131 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 205 (272)
T ss_pred C---CccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHH
Confidence 8 99999999999999999999999999886533211 223456889999999986 3468889999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 149 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+|+|++|..||........ .... . ... .... .....+.++.+|+.+||..||.+|||+.+++++
T Consensus 206 l~el~~g~~p~~~~~~~~~-----~~~~--~-~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 206 AIEMAEGAPPLCDMHPMRA-----LFLI--P-RNP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHHHHhCCCCccccCHHHH-----HHHH--h-cCC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 9999999999964322111 0000 0 000 0000 111234688999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=262.30 Aligned_cols=208 Identities=30% Similarity=0.477 Sum_probs=166.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++...+..++||||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++|+
T Consensus 51 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 126 (265)
T cd06631 51 EEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNC---VVHR 126 (265)
T ss_pred HHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 58999999999999999999999999999999999999999996543 6899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCc----ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDK----THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
||+|+||+++.++.++|+|||++........ ........|+..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 127 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 206 (265)
T cd06631 127 DIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKP 206 (265)
T ss_pred CcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999876432111 111223468889999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
||........ ... .... ....+.. +...+..+.++|.+||+.+|.+||++.+++++
T Consensus 207 p~~~~~~~~~-----~~~--~~~~----~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 207 PLASMDRLAA-----MFY--IGAH----RGLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ccccCChHHH-----HHH--hhhc----cCCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9965322110 000 0000 0001111 11235688999999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=261.96 Aligned_cols=210 Identities=23% Similarity=0.408 Sum_probs=168.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++...+..++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+
T Consensus 52 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~ 127 (268)
T cd06630 52 KEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ---IIHR 127 (268)
T ss_pred HHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 5899999999999999999999999999999999999999998654 36899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCC-cEEEccccCcccCCCCCc--ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADY-NAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||+|+||+++.++ .+||+|||.+........ ........|+..|+|||++.+..++.++|||||||++++|++|..|
T Consensus 128 ~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 207 (268)
T cd06630 128 DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207 (268)
T ss_pred CCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 9999999998775 599999999877643211 1112335678899999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|............. . ..........+...+.++.+++.+||..+|.+||++.+++++
T Consensus 208 ~~~~~~~~~~~~~~--~-----------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 208 WNAEKHSNHLALIF--K-----------IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCCCCcchHHHHH--H-----------HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 86443211111100 0 000001112233456789999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=259.27 Aligned_cols=204 Identities=30% Similarity=0.457 Sum_probs=163.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.++++++||||+++++++..+ ..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|
T Consensus 48 ~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H 123 (254)
T cd05083 48 EETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123 (254)
T ss_pred HHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 689999999999999999998755 5799999999999999997653 35899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+||+++.++.+||+|||++....... .....+..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 124 ~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 198 (254)
T cd05083 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198 (254)
T ss_pred cccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987643211 12233567999999988899999999999999999998 89988
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ..... .... . +. .....+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 199 ~~~~~~~---~~~~~----~~~~---~---~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 199 PKMSLKE---VKECV----EKGY---R---ME----PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ccCCHHH---HHHHH----hCCC---C---CC----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 6543211 11110 0000 0 00 111235688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=265.11 Aligned_cols=219 Identities=24% Similarity=0.336 Sum_probs=163.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++..++..++||||+. ++|.+++.+....+++..++.++.|+++||.|||+.+ ++||
T Consensus 52 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~ 127 (291)
T cd07844 52 REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHR 127 (291)
T ss_pred HHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 69999999999999999999999999999999996 5999988776667899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.+||+|||+++....... ......++..|+|||++.+ ..++.++||||+|+++|+|++|..||.
T Consensus 128 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 128 DLKPQNLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred cCCHHHEEEcCCCCEEECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999876432111 1122346788999999875 568999999999999999999999996
Q ss_pred CCCCCCCcchhHhhhhhhc-----------ccccccc----ccC-CccCCCC-CHHHHHHHHHHHHHhccCCCCCCCCHH
Q 022003 161 KNRPNGEHNLVEWARPHLG-----------ERRRFYR----LID-PRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~----~~~-~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
....... .......... ....... ... ....... ......++.+++.+||+.+|++|||+.
T Consensus 206 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~ 283 (291)
T cd07844 206 GSTDVED--QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAA 283 (291)
T ss_pred CCccHHH--HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHH
Confidence 5431110 0000000000 0000000 000 0000000 000126788999999999999999999
Q ss_pred HHHHH
Q 022003 224 EVVEA 228 (304)
Q Consensus 224 ell~~ 228 (304)
|++++
T Consensus 284 e~l~~ 288 (291)
T cd07844 284 EAMKH 288 (291)
T ss_pred HHhcC
Confidence 99874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=266.40 Aligned_cols=205 Identities=24% Similarity=0.364 Sum_probs=166.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|+||+++++++...+..++||||+++++|..++... .+++.++..++.|++.||.|||+.+ ++|+
T Consensus 65 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~---i~H~ 139 (296)
T cd06655 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ---VIHR 139 (296)
T ss_pred HHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 5899999999999999999999999999999999999999988543 5899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++|..||..
T Consensus 140 dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~ 217 (296)
T cd06655 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (296)
T ss_pred CCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876543221 12234678899999999988899999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
....... ... ..... +.. ..+...+..+.++|.+||..||.+|||+.+++++
T Consensus 218 ~~~~~~~--~~~----~~~~~-------~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 218 ENPLRAL--YLI----ATNGT-------PEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCHHHHH--HHH----HhcCC-------ccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 4321110 000 00000 000 0111234678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=264.51 Aligned_cols=221 Identities=26% Similarity=0.326 Sum_probs=165.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++......++||||+++++|..++.. ...+++..+..++.||+.||+|||+.+ ++|+
T Consensus 49 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~ 124 (286)
T cd07847 49 REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHR 124 (286)
T ss_pred HHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 589999999999999999999999999999999998888776643 346999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.+||+|||++........ ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 125 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 125 DVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred CCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987644321 1223457889999999876 568899999999999999999999997
Q ss_pred CCCCCCCcchhHhh-hhhhc------cccccc-cccCCccCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 161 KNRPNGEHNLVEWA-RPHLG------ERRRFY-RLIDPRLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 161 ~~~~~~~~~~~~~~-~~~~~------~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
.....+........ ..... ....+. ....+...... ....+..+.+|+.+||+.+|++|||+.|++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 203 GKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 65432111000000 00000 000000 00000000000 0122567899999999999999999999987
Q ss_pred H
Q 022003 228 A 228 (304)
Q Consensus 228 ~ 228 (304)
+
T Consensus 283 ~ 283 (286)
T cd07847 283 H 283 (286)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=260.38 Aligned_cols=207 Identities=25% Similarity=0.376 Sum_probs=164.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++|+||+++++++..++..++||||+++++|.+++......+ ++..+..++.||+.||.|||+.+ |+
T Consensus 54 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~ 130 (268)
T cd06624 54 EEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IV 130 (268)
T ss_pred HHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 68999999999999999999999999999999999999999997654455 88889999999999999999988 99
Q ss_pred eccCCCCCeEECC-CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC--CCCchhhhHHHHHHHHHHHhCC
Q 022003 80 YRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 80 H~dlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~ 156 (304)
||||||+||+++. ++.++|+|||++........ ......|+..|+|||++.+. .++.++||||||+++|+|++|.
T Consensus 131 h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~ 208 (268)
T cd06624 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208 (268)
T ss_pred ecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCC
Confidence 9999999999976 67999999999876543221 12234578899999998754 4889999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||........ ..+...... ..+ ..+...+.++.+++.+||+.+|.+|||+.|++++
T Consensus 209 ~p~~~~~~~~~---~~~~~~~~~--------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 209 PPFIELGEPQA---AMFKVGMFK--------IHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCccccChhh---hHhhhhhhc--------cCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 99865322111 111100000 001 1122335688999999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=261.52 Aligned_cols=209 Identities=30% Similarity=0.439 Sum_probs=169.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH 80 (304)
+|++++++++||||+++++.+..++..++|+||+.+++|.+++......+++..+..++.|++.||+|||+ .+ ++|
T Consensus 48 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H 124 (265)
T cd06605 48 RELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIH 124 (265)
T ss_pred HHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eec
Confidence 68999999999999999999999999999999999999999997665689999999999999999999999 88 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
+||||+||+++.++.++|+|||.+........ ....++..|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 125 ~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 200 (265)
T cd06605 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200 (265)
T ss_pred CCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876532211 12567889999999998899999999999999999999999996
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
....... ........... ...+... ....+.++.++|.+||..||++|||+.+++.+
T Consensus 201 ~~~~~~~-~~~~~~~~~~~-------~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 201 PENDPPD-GIFELLQYIVN-------EPPPRLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ccccccc-cHHHHHHHHhc-------CCCCCCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 5432111 11111111100 0001111 11145789999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=259.61 Aligned_cols=208 Identities=27% Similarity=0.410 Sum_probs=166.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++++.. ...++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|
T Consensus 50 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H 125 (260)
T cd05073 50 AEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 125 (260)
T ss_pred HHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 68999999999999999999887 7789999999999999999653 456889999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
+||||+||+++.++.+||+|||.+......... ......++..|+|||++....++.++|||||||++|++++ |..||
T Consensus 126 ~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~ 204 (260)
T cd05073 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204 (260)
T ss_pred cccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999865432211 1222345677999999998889999999999999999998 88898
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ...... ... ... .....+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 205 ~~~~~~~---~~~~~~----~~~------~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 205 PGMSNPE---VIRALE----RGY------RMP----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCHHH---HHHHHh----CCC------CCC----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 6532211 111100 000 000 011234689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=265.42 Aligned_cols=223 Identities=22% Similarity=0.299 Sum_probs=167.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++++..++..+++|||+++++|.+++.+. ...+++..+..++.|++.||+|||+.+ |+|
T Consensus 48 ~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH 124 (314)
T cd08216 48 QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIH 124 (314)
T ss_pred HHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 5899999999999999999999999999999999999999999754 446899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCc-----ceeeecccccccccCcchhhc--CCCCchhhhHHHHHHHHHHH
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~ 153 (304)
|||||+||+++.++.+||+|||.+........ ........++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 125 ~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~ 204 (314)
T cd08216 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELA 204 (314)
T ss_pred CCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHH
Confidence 99999999999999999999998875432211 111123456778999999875 45889999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhHhhhhhhc---cccc-------ccc----ccC----CccCCCCCHHHHHHHHHHHHHhccCC
Q 022003 154 TGRRSMDKNRPNGEHNLVEWARPHLG---ERRR-------FYR----LID----PRLEGHFSIKGAQKAAQLAAHCLSRD 215 (304)
Q Consensus 154 tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~-------~~~----~~~----~~~~~~~~~~~~~~~~~li~~~l~~d 215 (304)
+|..||....... ...+....... .... ... ... ...........+.++.+++.+||+.|
T Consensus 205 ~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 282 (314)
T cd08216 205 NGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRD 282 (314)
T ss_pred hCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcC
Confidence 9999997543211 00000000000 0000 000 000 00111123344678999999999999
Q ss_pred CCCCCCHHHHHHHh
Q 022003 216 PKARPLMSEVVEAL 229 (304)
Q Consensus 216 p~~Rps~~ell~~l 229 (304)
|++|||+++++++.
T Consensus 283 P~~Rpt~~~ll~~p 296 (314)
T cd08216 283 PESRPSASQLLNHS 296 (314)
T ss_pred CCcCcCHHHHhcCc
Confidence 99999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=264.16 Aligned_cols=205 Identities=23% Similarity=0.349 Sum_probs=166.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++|+||+++++++..++..++||||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||
T Consensus 65 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~ 139 (297)
T cd06656 65 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQ---VIHR 139 (297)
T ss_pred HHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 5889999999999999999999999999999999999999998543 5889999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++|..||..
T Consensus 140 dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred CCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876543221 12234678899999999988899999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.......... .. .. .+. ...+...+..+.+++.+||+.||++||++++++++
T Consensus 218 ~~~~~~~~~~------~~--~~-----~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 218 ENPLRALYLI------AT--NG-----TPE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCcchheeee------cc--CC-----CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4332111000 00 00 000 00112235678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=264.86 Aligned_cols=207 Identities=27% Similarity=0.428 Sum_probs=164.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHE-EAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i 78 (304)
+|++++++++|+||+++++.+..++..++||||+++++|..++... ...+++..+..++.|++.||.|||+ .+ +
T Consensus 48 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i 124 (286)
T cd06622 48 MELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---I 124 (286)
T ss_pred HHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---E
Confidence 6899999999999999999999999999999999999999988653 3368999999999999999999996 46 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC------CCCchhhhHHHHHHHHHH
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el 152 (304)
+|+||||+||+++.++.+||+|||++....... .....++..|+|||++.+. .++.++|||||||++|+|
T Consensus 125 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l 200 (286)
T cd06622 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200 (286)
T ss_pred eeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHH
Confidence 999999999999999999999999987653321 2234578899999998643 358899999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
++|..||............ . ..... .....+...+.++.++|.+||+.+|.+||++++++++.
T Consensus 201 ~~g~~pf~~~~~~~~~~~~---~----------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 201 ALGRYPYPPETYANIFAQL---S----------AIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred HhCCCCCCCcchhhHHHHH---H----------HHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 9999999654221110000 0 00000 00112223567899999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.32 Aligned_cols=211 Identities=26% Similarity=0.449 Sum_probs=166.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++...+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+
T Consensus 57 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 132 (272)
T cd06629 57 SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHR 132 (272)
T ss_pred HHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeec
Confidence 4889999999999999999999999999999999999999998665 47999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC--CCchhhhHHHHHHHHHHHhCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||+|+||+++.++.++|+|||++................|+..|+|||++.... ++.++|+||||+++|+|++|..||
T Consensus 133 dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 212 (272)
T cd06629 133 DLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212 (272)
T ss_pred CCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999997654322222223356788999999987654 899999999999999999999998
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
...... ....... .. ...+..........+..+.+++.+||..+|.+|||+++++++
T Consensus 213 ~~~~~~-----~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 213 SDEEAI-----AAMFKLG--NK-----RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCcchH-----HHHHHhh--cc-----ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 543211 1110000 00 000111111112235789999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=271.07 Aligned_cols=213 Identities=31% Similarity=0.435 Sum_probs=164.0
Q ss_pred ChHhhHhhcC-CCCcccceeeEEEeC-CeeEEEEecCCCCCHHHHhhcCC------------------------------
Q 022003 1 MAEVNFLGDL-VHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRS------------------------------ 48 (304)
Q Consensus 1 l~E~~il~~l-~h~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------------------------------ 48 (304)
++|+++|.++ +|+||+++++++... ...++|||||++|+|.+++....
T Consensus 58 ~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (343)
T cd05103 58 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRR 137 (343)
T ss_pred HHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhh
Confidence 3699999999 689999999988654 46789999999999999985421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC
Q 022003 49 ------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 92 (304)
Q Consensus 49 ------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~ 92 (304)
..+++..+..++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~ 214 (343)
T cd05103 138 LDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 214 (343)
T ss_pred ccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcC
Confidence 23678888999999999999999988 999999999999999
Q ss_pred CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcchh
Q 022003 93 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV 171 (304)
Q Consensus 93 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~ 171 (304)
++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 215 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~ 292 (343)
T cd05103 215 NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC 292 (343)
T ss_pred CCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH
Confidence 99999999999987533222222222345677999999998899999999999999999997 888886532211 010
Q ss_pred HhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 172 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
. ....... .... ...+.++.+++.+||+.||++|||+.|++++|+.+
T Consensus 293 ~----~~~~~~~------~~~~----~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 293 R----RLKEGTR------MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred H----HHhccCC------CCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0000000 0000 11235789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=264.87 Aligned_cols=220 Identities=24% Similarity=0.328 Sum_probs=167.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++|+||+++++++..+...++||||+ +++|.+++......+++..++.++.||+.||+|||+.+ ++|+
T Consensus 48 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 123 (286)
T cd07832 48 REIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHR 123 (286)
T ss_pred HHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 6899999999999999999999999999999999 99999999776677999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.++|+|||++........ .......|+..|+|||++.+. .++.++|||||||++|+|++|.++|.
T Consensus 124 dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 124 DLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred CcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 9999999999999999999999987654322 112234688899999998654 56899999999999999999988876
Q ss_pred CCCCCCCcchhHhhhhhhcc-----cccc------ccccCCccC----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGE-----RRRF------YRLIDPRLE----GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~-----~~~~------~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
....... .......... ...+ .....+... .......+..+.++|.+||+.||++|||++++
T Consensus 203 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 279 (286)
T cd07832 203 GENDIEQ---LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA 279 (286)
T ss_pred CCCHHHH---HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHH
Confidence 5432110 0000000000 0000 000000000 00011234789999999999999999999999
Q ss_pred HHHh
Q 022003 226 VEAL 229 (304)
Q Consensus 226 l~~l 229 (304)
+++.
T Consensus 280 l~h~ 283 (286)
T cd07832 280 LRHP 283 (286)
T ss_pred hhCc
Confidence 9863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=273.53 Aligned_cols=210 Identities=25% Similarity=0.414 Sum_probs=176.9
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
|.|+-+|+.++|||||+++|+|.+. ..+||||+++-|.|..+++++...++......++.||+.||.|||+.. +||
T Consensus 439 lqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVH 514 (974)
T KOG4257|consen 439 LQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVH 514 (974)
T ss_pred HHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhh
Confidence 5799999999999999999999866 579999999999999999998889999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||...|||+.....+||+|||+++...+...+. .....-...|||||.+.-..++.++|||.||+++||++. |..||
T Consensus 515 RDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPf 593 (974)
T KOG4257|consen 515 RDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPF 593 (974)
T ss_pred hhhhhhheeecCcceeeecccchhhhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcc
Confidence 9999999999999999999999999987654433 223344678999999999999999999999999999765 88999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
.+....+....++ ++. + -..+..++..+..|+.+||.++|.+||.++|+...|..+
T Consensus 594 qgvkNsDVI~~iE-------nGe---R-------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 594 QGVKNSDVIGHIE-------NGE---R-------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred ccccccceEEEec-------CCC---C-------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 8754433322111 111 1 113445678999999999999999999999999887644
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.79 Aligned_cols=209 Identities=25% Similarity=0.424 Sum_probs=166.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--------LPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|++++++++|+||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.
T Consensus 57 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~ 136 (275)
T cd05046 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA 136 (275)
T ss_pred HHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc
Confidence 58999999999999999999999889999999999999999986543 1589999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 153 (304)
+ ++||||||+||+++.++.++++|||++....... ........++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 137 ~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~ 212 (275)
T cd05046 137 R---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212 (275)
T ss_pred C---cccCcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 8 9999999999999999999999999987543221 11122335577899999998888999999999999999999
Q ss_pred h-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 154 T-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 154 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
+ |..||....... ....... ... .. ......+..+.+++.+||+.+|.+|||+.|+++.|.
T Consensus 213 ~~~~~p~~~~~~~~---~~~~~~~-----~~~-~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 213 TQGELPFYGLSDEE---VLNRLQA-----GKL-EL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred hCCCCCccccchHH---HHHHHHc-----CCc-CC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 8 777885432211 1111000 000 00 001123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=266.67 Aligned_cols=205 Identities=26% Similarity=0.399 Sum_probs=165.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++|+||+++++.+..++..++||||+++++|.+++.. ..+++..++.++.||+.||+|||+.+ ++||
T Consensus 68 ~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~ 142 (292)
T cd06658 68 NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHR 142 (292)
T ss_pred HHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---Eeec
Confidence 688999999999999999999999999999999999999998744 35899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++||||||+++|||++|..||..
T Consensus 143 dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred CCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876432221 12335688999999999888899999999999999999999999865
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... ...... ....+.... ....+..+.+++.+||..||.+|||+++++++
T Consensus 221 ~~~~~---~~~~~~----------~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 221 EPPLQ---AMRRIR----------DNLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCHHH---HHHHHH----------hcCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 32211 000000 001111110 11235678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=261.81 Aligned_cols=200 Identities=29% Similarity=0.428 Sum_probs=165.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..++..++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+
T Consensus 50 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~ 125 (290)
T cd05580 50 NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYR 125 (290)
T ss_pred HHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 5899999999999999999999999999999999999999998655 47999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+|+.++.+||+|||++...... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 126 dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 126 DLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred CCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999875433 2334688999999999888899999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~ 228 (304)
.... .... . ..... .. .+...+..+.++|.+||+.||.+|+ +++|++++
T Consensus 201 ~~~~---~~~~--~-~~~~~--------~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 201 DNPI---QIYE--K-ILEGK--------VR----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCHH---HHHH--H-HhcCC--------cc----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 4311 0000 0 00000 01 1112256889999999999999999 66777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=263.93 Aligned_cols=222 Identities=26% Similarity=0.334 Sum_probs=166.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++..++..++||||++++.+..+. .+...+++..++.++.||+.||.|||+.+ ++|+
T Consensus 49 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~ 124 (288)
T cd07833 49 REVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHR 124 (288)
T ss_pred HHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 6899999999999999999999999999999999876666555 44456999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||+|+||+++.++.+||+|||++......... ......++..|+|||++.+. .++.++||||||+++|+|++|..||.
T Consensus 125 dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 125 DIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred CCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999998876543321 12335678899999999887 88999999999999999999999987
Q ss_pred CCCCCCCcchhHhhhhh--------hcccc-----ccccccCCc-cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 022003 161 KNRPNGEHNLVEWARPH--------LGERR-----RFYRLIDPR-LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~--------~~~~~-----~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 226 (304)
.....+........... ..... .+.....+. ....++...+.++.++|.+||..+|++|||+++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 283 (288)
T cd07833 204 GDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283 (288)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence 54321110000000000 00000 000000000 00011222367899999999999999999999998
Q ss_pred HH
Q 022003 227 EA 228 (304)
Q Consensus 227 ~~ 228 (304)
++
T Consensus 284 ~~ 285 (288)
T cd07833 284 QH 285 (288)
T ss_pred cC
Confidence 74
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=290.34 Aligned_cols=212 Identities=22% Similarity=0.317 Sum_probs=164.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHhh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIRMKIALGAAKGLAFLH 71 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~~l~~~~~~~i~~qi~~~l~~LH 71 (304)
+|++++++++||||+++++++.+++..++||||++|++|.+++... ...+++..+..++.||+.||+|||
T Consensus 51 rEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH 130 (932)
T PRK13184 51 REAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH 130 (932)
T ss_pred HHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH
Confidence 6899999999999999999999999999999999999999988531 123566788899999999999999
Q ss_pred cCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCc----------------ceeeecccccccccCcchhhcCC
Q 022003 72 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK----------------THVSTRVMGTYGYAAPEYVMTGH 135 (304)
Q Consensus 72 ~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~ 135 (304)
+.+ |+||||||+||+++.++.+||+|||+++....... ........||+.|+|||++.+..
T Consensus 131 s~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~ 207 (932)
T PRK13184 131 SKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP 207 (932)
T ss_pred HCC---ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC
Confidence 988 99999999999999999999999999986521100 01112356999999999999999
Q ss_pred CCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCC
Q 022003 136 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 215 (304)
Q Consensus 136 ~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 215 (304)
++.++|||||||++|||+||..||......... .. . ....+.... .....+..+.+++.+||+.|
T Consensus 208 ~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~----~~-~---------~i~~P~~~~-p~~~iP~~L~~LI~rcL~~D 272 (932)
T PRK13184 208 ASESTDIYALGVILYQMLTLSFPYRRKKGRKIS----YR-D---------VILSPIEVA-PYREIPPFLSQIAMKALAVD 272 (932)
T ss_pred CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh----hh-h---------hccChhhcc-ccccCCHHHHHHHHHHccCC
Confidence 999999999999999999999999653221110 00 0 000000000 01123567889999999999
Q ss_pred CCCCC-CHHHHHHHhCC
Q 022003 216 PKARP-LMSEVVEALKP 231 (304)
Q Consensus 216 p~~Rp-s~~ell~~l~~ 231 (304)
|++|+ +++++++.|+.
T Consensus 273 P~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 273 PAERYSSVQELKQDLEP 289 (932)
T ss_pred hhhCcCHHHHHHHHHHH
Confidence 99997 56667766653
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=258.74 Aligned_cols=206 Identities=25% Similarity=0.386 Sum_probs=161.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+.++++++||||+++++++.. +...+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++
T Consensus 53 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~---i~ 128 (266)
T cd06651 53 CEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNM---IV 128 (266)
T ss_pred HHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 58899999999999999998875 357889999999999999986543 5899999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|+||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 129 H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~p 208 (266)
T cd06651 129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208 (266)
T ss_pred eCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999998764321111 111234578899999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|....... .... ... ....+ ..+...+..+.+++ +||..+|++||+++|++++
T Consensus 209 f~~~~~~~-----~~~~-~~~------~~~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 209 WAEYEAMA-----AIFK-IAT------QPTNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ccccchHH-----HHHH-Hhc------CCCCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 96532110 0000 000 00011 12223345677787 6888999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=262.32 Aligned_cols=219 Identities=24% Similarity=0.321 Sum_probs=165.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++...+..++||||+ +++|.+++......+++..+..++.||++||.|||+.+ ++|+
T Consensus 51 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 126 (298)
T cd07841 51 REIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHR 126 (298)
T ss_pred HHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 5889999999999999999999999999999999 89999999765557999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.++|+|||+++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|.++|.
T Consensus 127 dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~ 204 (298)
T cd07841 127 DLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204 (298)
T ss_pred CCChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence 9999999999999999999999987644321 1222346788999998864 467899999999999999999988776
Q ss_pred CCCCCCCcchhHhhhhh-------hccccccccccC-----CccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPH-------LGERRRFYRLID-----PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
....... ........ +........... +..........+..+.++|.+||+.||++|||++|++++
T Consensus 205 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 205 GDSDIDQ--LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred CCccHHH--HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 5432111 00000000 000000000000 000000112235788999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=265.65 Aligned_cols=208 Identities=27% Similarity=0.347 Sum_probs=165.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++.++|+||+++++++..++..|+||||+.+++|.+++.+. ...+++..+..++.|++.||+|||+.+ ++|
T Consensus 50 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H 126 (316)
T cd05574 50 TEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVY 126 (316)
T ss_pred HHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 5889999999999999999999999999999999999999998654 457999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcc---------------------------eeeecccccccccCcchhhc
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT---------------------------HVSTRVMGTYGYAAPEYVMT 133 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~ 133 (304)
+||||+||+++.++.++|+|||++......... .......|+..|+|||++.+
T Consensus 127 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 206 (316)
T cd05574 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206 (316)
T ss_pred cCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC
Confidence 999999999999999999999998754322110 01123467889999999998
Q ss_pred CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhcc
Q 022003 134 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 213 (304)
Q Consensus 134 ~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 213 (304)
..++.++||||||+++|+|++|..||........ +.. ....... ... ....+..+.+++.+||+
T Consensus 207 ~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-----~~~-~~~~~~~--------~~~--~~~~~~~~~~li~~~l~ 270 (316)
T cd05574 207 DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET-----FSN-ILKKEVT--------FPG--SPPVSSSARDLIRKLLV 270 (316)
T ss_pred CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH-----HHH-HhcCCcc--------CCC--ccccCHHHHHHHHHHcc
Confidence 8899999999999999999999999975432110 000 0000000 000 11146789999999999
Q ss_pred CCCCCCCC----HHHHHHH
Q 022003 214 RDPKARPL----MSEVVEA 228 (304)
Q Consensus 214 ~dp~~Rps----~~ell~~ 228 (304)
.||++||| ++|++++
T Consensus 271 ~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 271 KDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCHhHCCCchhhHHHHHcC
Confidence 99999999 6666663
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=264.25 Aligned_cols=221 Identities=25% Similarity=0.356 Sum_probs=165.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++||||+++++++... ...|+||||+. ++|.+++......+++..++.++.||+.||+|||+.+ ++
T Consensus 53 ~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~ 128 (293)
T cd07843 53 REINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---IL 128 (293)
T ss_pred HHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 589999999999999999998877 78999999996 5999988766657999999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p 158 (304)
|+||||+||+++.++.+||+|||++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..|
T Consensus 129 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 206 (293)
T cd07843 129 HRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPL 206 (293)
T ss_pred eccCCHHHEEECCCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987654321 12234568889999988754 468999999999999999999999
Q ss_pred CCCCCCCCCcchh----------Hhhhh-hhc--cccccccccCCccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 159 MDKNRPNGEHNLV----------EWARP-HLG--ERRRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 159 ~~~~~~~~~~~~~----------~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
|............ .|... .+. ....+...........++.. .+..+.++|.+||+.||++|||++|
T Consensus 207 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~e 286 (293)
T cd07843 207 FPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286 (293)
T ss_pred CCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHH
Confidence 9754322111000 00000 000 00000000000111111111 3567899999999999999999999
Q ss_pred HHHH
Q 022003 225 VVEA 228 (304)
Q Consensus 225 ll~~ 228 (304)
++++
T Consensus 287 ll~~ 290 (293)
T cd07843 287 ALKH 290 (293)
T ss_pred HhcC
Confidence 9975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=265.58 Aligned_cols=205 Identities=24% Similarity=0.397 Sum_probs=165.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++||||+++++++..++..++||||+++++|..++.. ..+++..++.++.|++.||+|||+.+ ++||
T Consensus 67 ~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~ 141 (297)
T cd06659 67 NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHR 141 (297)
T ss_pred HHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 688999999999999999999999999999999999999998754 35899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++....... .......|+..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 142 dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred CCCHHHeEEccCCcEEEeechhHhhccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987543321 112335688999999999988899999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... ...... ... .+... .....+..+.++|.+||+.+|++||++++++++
T Consensus 220 ~~~~~---~~~~~~----~~~------~~~~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 220 DSPVQ---AMKRLR----DSP------PPKLK--NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHH---HHHHHh----ccC------CCCcc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 33211 110000 000 00000 011224678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=257.78 Aligned_cols=211 Identities=28% Similarity=0.414 Sum_probs=169.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++++.++|+||+++++.+......++|||++++++|.+++... ...+++..+..++.|++.||.|||+.+ ++
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~ 124 (267)
T cd06610 48 KEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QI 124 (267)
T ss_pred HHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 5889999999999999999999999999999999999999999654 246899999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcce--eeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~ 156 (304)
|+||+|+||++++++.++|+|||++.......... ......|+..|+|||++... .++.++|+|||||++|+|++|.
T Consensus 125 h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~ 204 (267)
T cd06610 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204 (267)
T ss_pred cCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCC
Confidence 99999999999999999999999988765433221 22345688999999998876 7899999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||....... ........ . .+...... ....+..+.+++.+||+.||++|||+++++++
T Consensus 205 ~p~~~~~~~~--~~~~~~~~---~--------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 205 APYSKYPPMK--VLMLTLQN---D--------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCccccChhh--hHHHHhcC---C--------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 9997543321 11111100 0 00111000 11335788999999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=260.96 Aligned_cols=206 Identities=29% Similarity=0.388 Sum_probs=164.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++||||+++++++...+..|+||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.+ ++|
T Consensus 42 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H 118 (277)
T cd05577 42 NEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVY 118 (277)
T ss_pred HHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 58999999999999999999999999999999999999999986543 36999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
+||+|+||+++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 119 ~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 195 (277)
T cd05577 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR 195 (277)
T ss_pred CCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 9999999999999999999999987654311 1223457788999999988889999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVE 227 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~ 227 (304)
........... ....... . ...+...+..+.++|.+||+.||.+|| ++.++++
T Consensus 196 ~~~~~~~~~~~--~~~~~~~--------~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 196 QRKEKVEKEEL--KRRTLEM--------A----VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCcccccHHHH--Hhccccc--------c----ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 54432111110 0000000 0 011122357889999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=258.59 Aligned_cols=206 Identities=26% Similarity=0.340 Sum_probs=166.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|+||+++++++.++...++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+
T Consensus 42 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~ 117 (262)
T cd05572 42 SEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYR 117 (262)
T ss_pred HHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccC
Confidence 5889999999999999999999999999999999999999999654 35899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 118 dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred CCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 999999999999999999999998764432 12234678899999999888899999999999999999999999976
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~~ 228 (304)
..... ......... ......++...+.++.++|.+||+.+|.+||+ ++|++++
T Consensus 195 ~~~~~----~~~~~~~~~----------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 195 DDEDP----MEIYNDILK----------GNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCCCH----HHHHHHHhc----------cCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 54211 111110000 00001112222578999999999999999999 7777763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=261.78 Aligned_cols=205 Identities=26% Similarity=0.397 Sum_probs=166.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++|+||+++++++...+..++|+||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||
T Consensus 65 ~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~ 139 (285)
T cd06648 65 NEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHR 139 (285)
T ss_pred HHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 588999999999999999999999999999999999999999866 46899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+++.++.++|+|||.+........ ......|+..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 140 dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred CCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 9999999999999999999998875433211 12335688999999999888899999999999999999999999865
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.... ........ ...+... .....+..+.+++.+||+.+|++|||+.+++++
T Consensus 218 ~~~~------~~~~~~~~-------~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 218 EPPL------QAMKRIRD-------NLPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCHH------HHHHHHHh-------cCCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 3221 11110000 0001110 011134689999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=258.44 Aligned_cols=207 Identities=25% Similarity=0.393 Sum_probs=165.6
Q ss_pred hHhhHhhc-CCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhc-CCCC
Q 022003 2 AEVNFLGD-LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHE-EAER 76 (304)
Q Consensus 2 ~E~~il~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~ 76 (304)
+|+.++.+ ++|+||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+
T Consensus 57 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-- 134 (269)
T cd08528 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR-- 134 (269)
T ss_pred HHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--
Confidence 46776764 7999999999999999999999999999999988743 34569999999999999999999996 56
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCC
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 156 (304)
++|+||+|+||+++.++.+||+|||.+....... ......|+..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 135 -i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~ 210 (269)
T cd08528 135 -IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210 (269)
T ss_pred -eeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998754332 233456888999999999888999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
.||....... ...... . .. ..+. .....+..+.++|.+||+.||++||++.|+.++++
T Consensus 211 ~p~~~~~~~~---~~~~~~----~-~~----~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 211 PPFYSTNMLS---LATKIV----E-AV----YEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcccccCHHH---HHHHHh----h-cc----CCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 9986432111 000000 0 00 0000 01123468899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=257.24 Aligned_cols=214 Identities=27% Similarity=0.343 Sum_probs=166.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|++++++++||||+++++++... +.+++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+
T Consensus 48 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~-- 125 (287)
T cd06621 48 RELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK-- 125 (287)
T ss_pred HHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 689999999999999999988654 468999999999999887643 3456899999999999999999999988
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCC
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 156 (304)
++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|||||||++|+|++|.
T Consensus 126 -i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 200 (287)
T cd06621 126 -IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200 (287)
T ss_pred -cccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987643221 12345788899999999899999999999999999999999
Q ss_pred CCCCCCCCCCC--cchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 157 RSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 157 ~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
.||........ .....+.... ... .. .... ......+..+.+++.+||..+|.+|||+.|++++-.
T Consensus 201 ~p~~~~~~~~~~~~~~~~~~~~~--~~~---~~-~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 201 FPFPPEGEPPLGPIELLSYIVNM--PNP---EL-KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred CCCCcccCCCCChHHHHHHHhcC--Cch---hh-ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 99976532111 1111111100 000 00 0000 001123578999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=260.78 Aligned_cols=208 Identities=29% Similarity=0.386 Sum_probs=161.9
Q ss_pred hHhhHhhcC-CCCcccceeeEEE-----eCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|+++++++ +|+||+++++++. .++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+
T Consensus 63 ~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 142 (286)
T cd06638 63 AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142 (286)
T ss_pred HHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh
Confidence 488899999 6999999999874 34568999999999999998753 34568999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-----CCCCchhhhHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGV 147 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~ 147 (304)
.+ ++||||||+||+++.++.+||+|||+++....... ......|+..|+|||++.. ..++.++|||||||
T Consensus 143 ~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv 217 (286)
T cd06638 143 NK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217 (286)
T ss_pred CC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHH
Confidence 88 99999999999999999999999999886543211 1223468899999998753 45789999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 148 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 148 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
++|+|++|..||........ .... . .........+ ...+.++.++|.+||+.||++|||+.|+++
T Consensus 218 i~~el~~g~~p~~~~~~~~~--~~~~-----~-~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 218 TAIELGDGDPPLADLHPMRA--LFKI-----P-RNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred HHHHHhcCCCCCCCCchhHH--Hhhc-----c-ccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 99999999999865432111 0000 0 0000011111 112457899999999999999999999998
Q ss_pred Hh
Q 022003 228 AL 229 (304)
Q Consensus 228 ~l 229 (304)
++
T Consensus 283 ~~ 284 (286)
T cd06638 283 HV 284 (286)
T ss_pred cc
Confidence 75
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=256.88 Aligned_cols=205 Identities=25% Similarity=0.347 Sum_probs=165.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhh-----
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLH----- 71 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH----- 71 (304)
+|++++++++|+||+++++++.. +...+++|||+++++|.+++... ...+++..++.++.||+.||.|||
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~ 127 (265)
T cd08217 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127 (265)
T ss_pred HHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccc
Confidence 58899999999999999998764 44679999999999999998653 457999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHH
Q 022003 72 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 151 (304)
Q Consensus 72 ~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 151 (304)
+.+ ++|+||||+||+++.++.+||+|||++........ ......++..|+|||++.+..++.++||||||+++++
T Consensus 128 ~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~ 202 (265)
T cd08217 128 GNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE 202 (265)
T ss_pred cCc---ceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHH
Confidence 666 99999999999999999999999999987654322 1223468899999999998889999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 152 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 152 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|++|..||..... ........ . . .....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 203 l~~g~~p~~~~~~---~~~~~~~~----~-~---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 203 LCALSPPFTARNQ---LQLASKIK----E-G---------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHCCCcccCcCH---HHHHHHHh----c-C---------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 9999999975431 11111100 0 0 0011222345789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=263.70 Aligned_cols=209 Identities=22% Similarity=0.285 Sum_probs=162.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++||||+++++.+..++..++||||++|++|.+++... ..+++..+..++.|++.||.|||+.+ ++||
T Consensus 50 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 125 (305)
T cd05609 50 VERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHR 125 (305)
T ss_pred HHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 5889999999999999999999999999999999999999999655 46899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCc-------------ceeeecccccccccCcchhhcCCCCchhhhHHHHHH
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDK-------------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 148 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 148 (304)
||||+||+++.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||+
T Consensus 126 dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~v 205 (305)
T cd05609 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGII 205 (305)
T ss_pred CCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHH
Confidence 9999999999999999999999864211000 001112457888999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 149 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+|+|++|..||.+.... +........ ....+... ...+.++.++|.+||+.||++||++.++.+.
T Consensus 206 l~el~~g~~pf~~~~~~------~~~~~~~~~-----~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~l 270 (305)
T cd05609 206 LYEFLVGCVPFFGDTPE------ELFGQVISD-----DIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEV 270 (305)
T ss_pred HHHHHhCCCCCCCCCHH------HHHHHHHhc-----ccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHH
Confidence 99999999999654221 111100000 00011110 1235678999999999999999985444443
Q ss_pred h
Q 022003 229 L 229 (304)
Q Consensus 229 l 229 (304)
|
T Consensus 271 l 271 (305)
T cd05609 271 K 271 (305)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=255.78 Aligned_cols=204 Identities=27% Similarity=0.406 Sum_probs=165.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++.+..++..++||||+++++|.+++.+. ...+++..+..++.|++.||+|||+.+ ++|
T Consensus 48 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h 124 (256)
T cd08220 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILH 124 (256)
T ss_pred HHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 5899999999999999999999999999999999999999999764 345899999999999999999999988 999
Q ss_pred ccCCCCCeEECCC-CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
+||+|+||+++.+ +.+||+|||.+........ .....|+..|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 125 ~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~ 201 (256)
T cd08220 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF 201 (256)
T ss_pred CCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence 9999999999755 4689999999987643221 22346788999999999888999999999999999999999998
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
....... ...... . ... .. .+...+.++.+++.+||..+|.+|||+.|++++
T Consensus 202 ~~~~~~~---~~~~~~---~--~~~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 202 EAANLPA---LVLKIM---S--GTF-----AP----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ccCchHH---HHHHHH---h--cCC-----CC----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 6543211 111000 0 000 00 111235688999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=283.77 Aligned_cols=213 Identities=25% Similarity=0.426 Sum_probs=177.4
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
|.|+.||.+++||||+++.|+....+...||+|||++|+|+.+|+++...|.+.++..+++.|+.|++||-..+ +||
T Consensus 678 L~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVH 754 (996)
T KOG0196|consen 678 LSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVH 754 (996)
T ss_pred hhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chh
Confidence 57999999999999999999999999999999999999999999999888999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCccee-eecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
|||...||||+.+-.+|++|||+++.+.+...... .....-...|.|||.+..+.++.++||||+|+++||.++ |..|
T Consensus 755 RDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERP 834 (996)
T KOG0196|consen 755 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 834 (996)
T ss_pred hhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCc
Confidence 99999999999999999999999998765432211 111122568999999999999999999999999999654 8888
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
|-..... +++..+. +-+++. -+.+++..+.+|+..||++|..+||.+.+|+..|.++.
T Consensus 835 YWdmSNQ---dVIkaIe-------~gyRLP-------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 835 YWDMSNQ---DVIKAIE-------QGYRLP-------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred ccccchH---HHHHHHH-------hccCCC-------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 8655322 2221111 111221 23467889999999999999999999999999987553
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.29 Aligned_cols=205 Identities=23% Similarity=0.369 Sum_probs=167.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++++...+..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h 124 (256)
T cd08218 48 KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILH 124 (256)
T ss_pred HHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 5889999999999999999999999999999999999999998654 346899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
+||+|+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++++|++|..||.
T Consensus 125 ~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred CCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCcc
Confidence 99999999999999999999999986543221 1223457888999999998889999999999999999999999986
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... ......... . .+. .+...+.++.++|.+||+.+|.+||++.+++++
T Consensus 203 ~~~~~------~~~~~~~~~--~-----~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 203 AGNMK------NLVLKIIRG--S-----YPP----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCHH------HHHHHHhcC--C-----CCC----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 43211 111111000 0 000 112335688999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=256.11 Aligned_cols=207 Identities=23% Similarity=0.313 Sum_probs=163.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++|+||+++++++.+. ..+++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++
T Consensus 53 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~ 128 (265)
T cd06652 53 CEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IV 128 (265)
T ss_pred HHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 489999999999999999988764 4678999999999999998654 35889999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|+||||+||+++.++.++|+|||+++........ .......|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 129 H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 208 (265)
T cd06652 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208 (265)
T ss_pred cCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCC
Confidence 9999999999999999999999998865321111 112234578899999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|...... ..... . .........+...+..+.+++.+||. +|++||++++++++.
T Consensus 209 ~~~~~~~-----~~~~~-~----------~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 209 WAEFEAM-----AAIFK-I----------ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred CCccchH-----HHHHH-H----------hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 8643211 11000 0 00001112233446788899999995 999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=261.33 Aligned_cols=223 Identities=25% Similarity=0.325 Sum_probs=162.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC--------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|++++++++||||+++++++...+ ..++||||+. ++|.+.+......+++.+++.++.||+.||.|||+.
T Consensus 60 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 138 (310)
T cd07865 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN 138 (310)
T ss_pred HHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 6899999999999999999987654 4599999995 588888876666799999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcc--eeeecccccccccCcchhhcC-CCCchhhhHHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLL 150 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ 150 (304)
+ ++|+||||+||+++.++.+||+|||++......... .......++..|+|||++.+. .++.++||||||+++|
T Consensus 139 ~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~ 215 (310)
T cd07865 139 K---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMA 215 (310)
T ss_pred C---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHH
Confidence 8 999999999999999999999999999865432211 112234578889999988764 4789999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhhhc-----cccc---cccccCCc-----cCCC-CCHHHHHHHHHHHHHhccCCC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPHLG-----ERRR---FYRLIDPR-----LEGH-FSIKGAQKAAQLAAHCLSRDP 216 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~---~~~~~~~~-----~~~~-~~~~~~~~~~~li~~~l~~dp 216 (304)
+|++|..||.................... .... +.....+. .... .....+..+.++|.+||..||
T Consensus 216 el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P 295 (310)
T cd07865 216 EMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDP 295 (310)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCCh
Confidence 99999999875433211111111000000 0000 00000000 0000 000113567899999999999
Q ss_pred CCCCCHHHHHHH
Q 022003 217 KARPLMSEVVEA 228 (304)
Q Consensus 217 ~~Rps~~ell~~ 228 (304)
.+|||++|++++
T Consensus 296 ~~R~t~~e~l~h 307 (310)
T cd07865 296 AKRIDADTALNH 307 (310)
T ss_pred hhccCHHHHhcC
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=248.04 Aligned_cols=226 Identities=25% Similarity=0.316 Sum_probs=170.3
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeC--------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIED--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
++|+++|..|+|+|++.+++.|... ..+|+||++|+ .+|..++.....+++..++.+++.++..||.|+|+
T Consensus 64 lreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr 142 (376)
T KOG0669|consen 64 LREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR 142 (376)
T ss_pred HHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH
Confidence 5899999999999999999988642 35899999995 59999998887899999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcce--eeecccccccccCcchhhc-CCCCchhhhHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVL 149 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il 149 (304)
.. |+|||+|++|+||+.+|.+||+|||+++.+....... ..+..+-|.+|++||.+.| ..|+++.|||+.|||+
T Consensus 143 ~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCim 219 (376)
T KOG0669|consen 143 NK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIM 219 (376)
T ss_pred hh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHH
Confidence 88 9999999999999999999999999998765433221 1223445999999998875 5799999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhHhhhh-----hhcccc--cccccc-CCccCCCC---------CHHHHHHHHHHHHHhc
Q 022003 150 LEMLTGRRSMDKNRPNGEHNLVEWARP-----HLGERR--RFYRLI-DPRLEGHF---------SIKGAQKAAQLAAHCL 212 (304)
Q Consensus 150 ~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~--~~~~~~-~~~~~~~~---------~~~~~~~~~~li~~~l 212 (304)
.||+|+.+.+.++........+...-. .|.+.. ++++.+ .+.+.... +---.+++.+|+.++|
T Consensus 220 aeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll 299 (376)
T KOG0669|consen 220 AEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLL 299 (376)
T ss_pred HHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHh
Confidence 999999999987654332222211110 000000 001111 00000000 0001357889999999
Q ss_pred cCCCCCCCCHHHHHHHhC
Q 022003 213 SRDPKARPLMSEVVEALK 230 (304)
Q Consensus 213 ~~dp~~Rps~~ell~~l~ 230 (304)
..||.+|+++++++.+-.
T Consensus 300 ~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 300 KLDPTKRIDADQALNHDF 317 (376)
T ss_pred ccCcccCcchHhhhchhh
Confidence 999999999999998754
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=263.04 Aligned_cols=223 Identities=22% Similarity=0.284 Sum_probs=163.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+.++++++||||+++++++... +..++||||+. ++|.+++... ...+++..++.++.||+.||.|||+.+
T Consensus 51 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~- 128 (316)
T cd07842 51 REIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW- 128 (316)
T ss_pred HHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 589999999999999999999988 78999999995 5777766432 236899999999999999999999988
Q ss_pred CCeEeccCCCCCeEECC----CCcEEEccccCcccCCCCCc-ceeeecccccccccCcchhhc-CCCCchhhhHHHHHHH
Q 022003 76 RPVIYRDFKTSNILLDA----DYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVL 149 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~----~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il 149 (304)
++||||||+||+++. ++.+||+|||++........ ........++..|+|||++.+ ..++.++|||||||++
T Consensus 129 --i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 206 (316)
T cd07842 129 --VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIF 206 (316)
T ss_pred --EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 999999999999999 99999999999987543322 112233467889999998876 4689999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcc-------hhHhhhhh----------hcccccccc---ccC-CccC-----CCCCH--HHH
Q 022003 150 LEMLTGRRSMDKNRPNGEHN-------LVEWARPH----------LGERRRFYR---LID-PRLE-----GHFSI--KGA 201 (304)
Q Consensus 150 ~el~tg~~p~~~~~~~~~~~-------~~~~~~~~----------~~~~~~~~~---~~~-~~~~-----~~~~~--~~~ 201 (304)
|+|++|.+||.......... ........ ......+.. ... .... ..... ..+
T Consensus 207 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (316)
T cd07842 207 AELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPD 286 (316)
T ss_pred HHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCC
Confidence 99999999997654432100 00000000 000000000 000 0000 00000 234
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 202 QKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 202 ~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..+.+++.+||+.||++|||+.|++++
T Consensus 287 ~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 287 SQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 578999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=273.94 Aligned_cols=211 Identities=24% Similarity=0.387 Sum_probs=173.7
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
|+|+.+|+.++|||+|+++++|.....+|||+|||..|+|.++|++.. ..++.-....++-||..|++||..++ +|
T Consensus 311 LkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FI 387 (1157)
T KOG4278|consen 311 LKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FI 387 (1157)
T ss_pred HHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hh
Confidence 579999999999999999999999999999999999999999997753 34677777899999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
||||...|+|+.++..+|++|||+++.+...... ....-.-...|.|||-+....++.|+|||+||++|||+.| |..|
T Consensus 388 HRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsP 466 (1157)
T KOG4278|consen 388 HRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 466 (1157)
T ss_pred hhhhhhhhccccccceEEeeccchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999987653221 1111112467999999999999999999999999999977 7778
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
|.+.+... .+.++...+.-.-+..|++.+++||+.||++.|.+||++.|+-+.++.+
T Consensus 467 YPGidlSq-----------------VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 467 YPGIDLSQ-----------------VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred CCCccHHH-----------------HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 87653211 1223333333334456688999999999999999999999999877644
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=257.53 Aligned_cols=211 Identities=24% Similarity=0.425 Sum_probs=163.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC------eeEEEEecCCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFL 70 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~~L 70 (304)
+|++++++++||||+++++++...+ ..+++++|+.+++|.+++... ...+++..++.++.|++.||+||
T Consensus 50 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l 129 (273)
T cd05074 50 REAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL 129 (273)
T ss_pred HHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 6899999999999999999887542 247889999999998887421 22478999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 71 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 71 H~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
|+.+ ++||||||+||+++.++.+||+|||+++...............++..|++||.+.+..++.++|||||||++|
T Consensus 130 H~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~ 206 (273)
T cd05074 130 SSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW 206 (273)
T ss_pred HhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHH
Confidence 9988 9999999999999999999999999998754332222222334567899999999889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 151 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 151 el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
+|++ |..||...... ....+.. .... .. .....+..+.+++.+||+.+|++|||+.++++.|
T Consensus 207 el~~~g~~p~~~~~~~---~~~~~~~----~~~~------~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 207 EIMTRGQTPYAGVENS---EIYNYLI----KGNR------LK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred HHhhCCCCCCCCCCHH---HHHHHHH----cCCc------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999 88888643221 1111111 0000 00 0112346899999999999999999999999998
Q ss_pred CCC
Q 022003 230 KPL 232 (304)
Q Consensus 230 ~~~ 232 (304)
+.+
T Consensus 270 ~~~ 272 (273)
T cd05074 270 ELI 272 (273)
T ss_pred Hhh
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=264.72 Aligned_cols=223 Identities=22% Similarity=0.262 Sum_probs=163.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.+++.++||||+++++++..++..++||||+.+++|.+++.+. ...+++..+..++.|++.||+|||+.+ ++|
T Consensus 48 ~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH 124 (328)
T cd08226 48 NEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIH 124 (328)
T ss_pred HHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 4788888899999999999999999999999999999999998764 345899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcce-----eeecccccccccCcchhhcC--CCCchhhhHHHHHHHHHHH
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~ 153 (304)
|||||+||+++.++.++++||+.+.......... ......++..|+|||++.+. .++.++|||||||++|+|+
T Consensus 125 rDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~ 204 (328)
T cd08226 125 RNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA 204 (328)
T ss_pred CCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999998654332111100 01112345679999998763 5789999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhHhhhh---------hhccc--------ccc--------------ccccCCccCCCCCHHHHH
Q 022003 154 TGRRSMDKNRPNGEHNLVEWARP---------HLGER--------RRF--------------YRLIDPRLEGHFSIKGAQ 202 (304)
Q Consensus 154 tg~~p~~~~~~~~~~~~~~~~~~---------~~~~~--------~~~--------------~~~~~~~~~~~~~~~~~~ 202 (304)
+|..||........ ....... ..... ..+ ................+.
T Consensus 205 ~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (328)
T cd08226 205 TGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSP 282 (328)
T ss_pred hCCCCCCCcChHHH--HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhH
Confidence 99999975432110 0000000 00000 000 000001111112234567
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 203 KAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 203 ~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.+.+|+.+||+.||++|||++|++++.
T Consensus 283 ~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 283 AFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 899999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=271.40 Aligned_cols=203 Identities=25% Similarity=0.347 Sum_probs=171.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|..|+|||||+++.+......+|+||||+.+|.+.+++.+++ ...+..+..++.|++.|++|||+++ |+||
T Consensus 104 rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~---ivHr 179 (596)
T KOG0586|consen 104 REVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN---IVHR 179 (596)
T ss_pred HHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc---eecc
Confidence 69999999999999999999999999999999999999999998776 5666999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||++|+|++.+-.+||+|||++..+..+ ......+|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||+
T Consensus 180 dLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD 256 (596)
T KOG0586|consen 180 DLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD 256 (596)
T ss_pred ccchhhcccccccceeeeccccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence 99999999999999999999999987643 34566899999999999998877 689999999999999999999998
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
+........-. +..+-+ .+.-.+.++.++|+++|..+|.+|++++++.++-
T Consensus 257 G~~lk~Lr~rv------l~gk~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 257 GQNLKELRPRV------LRGKYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred Ccccccccchh------eeeeec------------ccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 76543322110 000000 0111245788999999999999999999998754
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=260.63 Aligned_cols=206 Identities=30% Similarity=0.395 Sum_probs=161.5
Q ss_pred hHhhHhhcC-CCCcccceeeEEEe------CCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
.|+.+++++ +|+||+++++++.. ....|+||||+.+++|.+++... ...+++..++.++.||+.||.|||+.
T Consensus 61 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~ 140 (282)
T cd06636 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140 (282)
T ss_pred HHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 477888888 79999999999863 45789999999999999998653 44688999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVV 148 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~i 148 (304)
+ ++|+||||+||+++.++.++|+|||++........ ......|+..|+|||++. ...++.++|||||||+
T Consensus 141 ~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~ 215 (282)
T cd06636 141 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGIT 215 (282)
T ss_pred C---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHH
Confidence 8 99999999999999999999999999876432111 123356888999999875 3468889999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 149 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+|+|++|..||............ . ....+.. .....+.++.++|.+||..||.+|||+.|++++
T Consensus 216 l~el~~g~~p~~~~~~~~~~~~~-------~------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 216 AIEMAEGAPPLCDMHPMRALFLI-------P------RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred HHHHHhCCCCccccCHHhhhhhH-------h------hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 99999999999654321111000 0 0000111 111235689999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=260.60 Aligned_cols=221 Identities=22% Similarity=0.300 Sum_probs=162.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|+||+++++++..++..++||||+. ++|.+.+......+++..+..++.||+.||.|||+.+ ++|+
T Consensus 52 ~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~ 127 (291)
T cd07870 52 REASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHR 127 (291)
T ss_pred HHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 68999999999999999999999999999999995 6887777665556889999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.+||+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 128 dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred CCChHHEEEcCCCcEEEeccccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999876432211 1223456889999999875 458899999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhh---------hccccccc-cccCCccCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 161 KNRPNGEHNLVEWARPH---------LGERRRFY-RLIDPRLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~---------~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
............+.... ......+. ........... ....+..+.+++.+||+.||++|||++|+
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~ 285 (291)
T cd07870 206 GVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285 (291)
T ss_pred CchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHH
Confidence 54321110000000000 00000000 00000000000 00114578899999999999999999999
Q ss_pred HHH
Q 022003 226 VEA 228 (304)
Q Consensus 226 l~~ 228 (304)
+.+
T Consensus 286 l~h 288 (291)
T cd07870 286 LLH 288 (291)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=257.61 Aligned_cols=207 Identities=29% Similarity=0.404 Sum_probs=162.7
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCC------eeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhh
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLH 71 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH 71 (304)
+|+++++++ +|+||+++++++.... ..++||||+++++|.+++... ...+++..++.++.|++.||.|||
T Consensus 51 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH 130 (275)
T cd06608 51 EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130 (275)
T ss_pred HHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 588999999 7999999999997644 489999999999999988542 357999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-----CCCCchhhhHHHH
Q 022003 72 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFG 146 (304)
Q Consensus 72 ~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG 146 (304)
+.+ ++|+||+|+||+++.++.+||+|||++....... .......|+..|+|||++.. ..++.++||||||
T Consensus 131 ~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 205 (275)
T cd06608 131 ENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG 205 (275)
T ss_pred cCC---cccCCCCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhH
Confidence 988 9999999999999999999999999987653322 11233568889999998753 3578899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 022003 147 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226 (304)
Q Consensus 147 ~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 226 (304)
|++|+|++|..||....... ..... . ....+.. ......+..+.++|.+||..||++|||+.+++
T Consensus 206 ~il~~l~~g~~p~~~~~~~~--~~~~~----~-------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll 270 (275)
T cd06608 206 ITAIELADGKPPLCDMHPMR--ALFKI----P-------RNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELL 270 (275)
T ss_pred HHHHHHHhCCCCccccchHH--HHHHh----h-------ccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 99999999999996432211 00000 0 0000111 11123457899999999999999999999999
Q ss_pred HH
Q 022003 227 EA 228 (304)
Q Consensus 227 ~~ 228 (304)
++
T Consensus 271 ~~ 272 (275)
T cd06608 271 EH 272 (275)
T ss_pred cC
Confidence 75
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=252.76 Aligned_cols=204 Identities=28% Similarity=0.444 Sum_probs=166.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++..+...++||||+++++|.+++.+. ..+++..+..++.||+.||+|||+.+ ++|+
T Consensus 51 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 126 (258)
T cd06632 51 QEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHR 126 (258)
T ss_pred HHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 5889999999999999999999999999999999999999998654 36899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC-CCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||+|+||+++.++.+||+|||++....... ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||.
T Consensus 127 dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~ 203 (258)
T cd06632 127 DIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203 (258)
T ss_pred CCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 999999999999999999999988754322 223456888999999987766 8999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
...... .... .. ..... +. .+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 204 ~~~~~~--~~~~--~~---~~~~~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 204 QLEGVA--AVFK--IG---RSKEL-----PP----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCcHHH--HHHH--HH---hcccC-----CC----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 543111 0000 00 00000 11 111234678899999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=260.63 Aligned_cols=221 Identities=27% Similarity=0.326 Sum_probs=164.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++||||+++++++..++..++||||+++++|..+.... ..+++..++.++.||+.||+|||+.+ ++|+
T Consensus 49 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~ 124 (286)
T cd07846 49 REIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN---IIHR 124 (286)
T ss_pred HHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 5899999999999999999999999999999999998888876443 35899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||+|+||++++++.++|+|||++........ ......++..|+|||++.+ ..++.++||||||+++|+|++|.+||.
T Consensus 125 ~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 125 DIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred CCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999886543221 1223457889999999875 457889999999999999999999886
Q ss_pred CCCCCCCcchhHhhhhhhcc--------ccccccccCCccCCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGE--------RRRFYRLIDPRLEGH-----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
.................... .........+..... .....+..+.+++.+||+.+|++||++.++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 203 GDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 54321100000000000000 000000000000000 01123568999999999999999999999987
Q ss_pred H
Q 022003 228 A 228 (304)
Q Consensus 228 ~ 228 (304)
+
T Consensus 283 ~ 283 (286)
T cd07846 283 H 283 (286)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=271.67 Aligned_cols=200 Identities=27% Similarity=0.310 Sum_probs=162.4
Q ss_pred HhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 3 EVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 3 E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
|+.++... +|+||+++.+++.++.+.|+|||.+.|+-|.+.+.... .....+..|+++|+.|+.|||++| ++||
T Consensus 365 e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g---vvhR 439 (612)
T KOG0603|consen 365 EIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG---VVHR 439 (612)
T ss_pred ccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC---eeec
Confidence 55555555 79999999999999999999999999998888875543 233777789999999999999999 9999
Q ss_pred cCCCCCeEE-CCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILL-DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||+ +..+.++|+|||.++..... ....+-|..|.|||++....|++++||||||++||+|++|+.||.
T Consensus 440 DLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~ 514 (612)
T KOG0603|consen 440 DLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFA 514 (612)
T ss_pred CCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccc
Confidence 999999999 68899999999999876543 122345888999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
..... ..+.. ++..+. +....+..+.+|+.+||+.||.+|+++.++..+-..
T Consensus 515 ~~P~~--~ei~~-------------~i~~~~----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 515 AHPAG--IEIHT-------------RIQMPK----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cCCch--HHHHH-------------hhcCCc----cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 65433 11110 111111 123446899999999999999999999999986543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=254.53 Aligned_cols=204 Identities=27% Similarity=0.359 Sum_probs=170.3
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
|.|-++|+..+||.+..+--.|..++.+|+||||..||.|.-++.+ ...|++.....+-..|+.||.|||+++ ||+
T Consensus 216 lTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~---ivY 291 (516)
T KOG0690|consen 216 LTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRN---IVY 291 (516)
T ss_pred hhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCC---eee
Confidence 3577899999999999998899999999999999999999999855 447999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||.+|+|++.+|++||+|||+++.-.. ......++|||+.|.|||++....|+.++|.|.+|+++|||++|+.||.
T Consensus 292 RDlKLENLlLDkDGHIKitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 292 RDLKLENLLLDKDGHIKITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred eechhhhheeccCCceEeeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 99999999999999999999999986322 2234567899999999999999999999999999999999999999998
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~ 228 (304)
..+......++. .+..+ ++...++++..|+..+|..||++|. .+.|+.++
T Consensus 370 n~dh~kLFeLIl------~ed~k------------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 370 NKDHEKLFELIL------MEDLK------------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ccchhHHHHHHH------hhhcc------------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 764432222211 11111 3334467899999999999999995 46666553
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=258.37 Aligned_cols=199 Identities=26% Similarity=0.335 Sum_probs=159.0
Q ss_pred hcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 022003 8 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 87 (304)
Q Consensus 8 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~N 87 (304)
....|+||+.+++++...+..++||||+++++|.+++..+. .+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~N 127 (279)
T cd05633 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPAN 127 (279)
T ss_pred hhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHH
Confidence 33479999999999999999999999999999999886543 6999999999999999999999998 9999999999
Q ss_pred eEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 022003 88 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 166 (304)
Q Consensus 88 ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 166 (304)
|+++.++.++|+|||++....... .....|+..|+|||++. +..++.++||||+||++|+|++|..||.......
T Consensus 128 il~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 203 (279)
T cd05633 128 ILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203 (279)
T ss_pred EEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC
Confidence 999999999999999987653321 22346899999999986 4568999999999999999999999997543322
Q ss_pred CcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 022003 167 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 229 (304)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~l 229 (304)
...... ... .... ..+...+.++.++|.+||..||.+|| |++|++++.
T Consensus 204 ~~~~~~---~~~--------~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 204 KHEIDR---MTL--------TVNV----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred HHHHHH---Hhh--------cCCc----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 111110 000 0011 11223457889999999999999999 588888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=257.29 Aligned_cols=204 Identities=25% Similarity=0.322 Sum_probs=167.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++.+..+...++||||+.+++|.+++... ..+++..+..++.||++||.|||+.+ ++|+
T Consensus 49 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~ 124 (258)
T cd05578 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHR 124 (258)
T ss_pred HHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 5899999999999999999999999999999999999999998665 47999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||++++++.++|+|||++....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||..
T Consensus 125 dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 125 DIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred CCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999988754332 12335678899999999888899999999999999999999999976
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH--HHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM--SEVVE 227 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--~ell~ 227 (304)
...... ..... .... . ....+...+..+.++|.+||+.||.+||++ +|+++
T Consensus 202 ~~~~~~---~~~~~-~~~~-------~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 202 HSRTIR---DQIRA-KQET-------A----DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred CCccHH---HHHHH-Hhcc-------c----cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 543211 11111 0000 0 011122235789999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=260.69 Aligned_cols=202 Identities=29% Similarity=0.415 Sum_probs=163.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++||||+++++++..++..++||||+. |+|.+++......+++..+..++.|++.||.|||+.+ ++|+
T Consensus 64 ~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~ 139 (307)
T cd06607 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHR 139 (307)
T ss_pred HHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 68899999999999999999999999999999995 6887877665567999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||+|+||+++.++.++|+|||++...... ....++..|+|||++. ...++.++||||||+++|+|++|..|
T Consensus 140 dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p 213 (307)
T cd06607 140 DIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213 (307)
T ss_pred CCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCC
Confidence 99999999999999999999998764322 2345788899999874 45688999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|........ .. ..... ..+. ......+..+.++|.+||..||++||++.+++.+.
T Consensus 214 ~~~~~~~~~---~~----~~~~~------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 214 LFNMNAMSA---LY----HIAQN------DSPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CCCccHHHH---HH----HHhcC------CCCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 865422110 00 00000 0011 11223467899999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=255.50 Aligned_cols=204 Identities=25% Similarity=0.386 Sum_probs=164.6
Q ss_pred hHhhHhhcCC---CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLV---HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++ |||++++++++..+...++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ +
T Consensus 48 ~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~---i 122 (277)
T cd06917 48 REVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG---V 122 (277)
T ss_pred HHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 4788888886 999999999999999999999999999999998553 6899999999999999999999988 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~ 157 (304)
+|+||+|+||+++.++.++|+|||++........ ......|+..|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 123 ~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~ 200 (277)
T cd06917 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200 (277)
T ss_pred ccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999987654332 1233468889999998874 457999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
||.......... . .. ....+.+... ..+.++.+++.+||+.||++||++.+++.+
T Consensus 201 p~~~~~~~~~~~---~----~~------~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 201 PYSDVDAFRAMM---L----IP------KSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCChhhhhh---c----cc------cCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 997543211100 0 00 0001111110 134688999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=265.76 Aligned_cols=218 Identities=24% Similarity=0.310 Sum_probs=162.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|++++++++|+||+++++++.... ..|+||||+. ++|.+.+... +++..+..++.|++.||+|||+.+
T Consensus 64 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g- 138 (353)
T cd07850 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG- 138 (353)
T ss_pred HHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5899999999999999999886443 5699999994 5888887543 889999999999999999999998
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
++||||||+||+++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++|
T Consensus 139 --i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 213 (353)
T cd07850 139 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213 (353)
T ss_pred --eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHC
Confidence 99999999999999999999999999987543221 2234578899999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcch---------hHhh-------hhhhcccc-----ccccccC----CccCCCCCHHHHHHHHHHHHH
Q 022003 156 RRSMDKNRPNGEHNL---------VEWA-------RPHLGERR-----RFYRLID----PRLEGHFSIKGAQKAAQLAAH 210 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~---------~~~~-------~~~~~~~~-----~~~~~~~----~~~~~~~~~~~~~~~~~li~~ 210 (304)
..||........... ..+. ........ .+.+... +..........+..+.++|.+
T Consensus 214 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 293 (353)
T cd07850 214 TVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSK 293 (353)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHH
Confidence 999975432110000 0000 00000000 0001100 000000112335678999999
Q ss_pred hccCCCCCCCCHHHHHHHh
Q 022003 211 CLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 211 ~l~~dp~~Rps~~ell~~l 229 (304)
||+.||.+|||+.|++++-
T Consensus 294 ~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 294 MLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HcCCChhhCcCHHHHhcCh
Confidence 9999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=260.51 Aligned_cols=222 Identities=27% Similarity=0.317 Sum_probs=163.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++|+||+++++++... +..++||||+. ++|.+++......+++..++.++.|++.||+|||+.+ ++
T Consensus 55 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~ 130 (309)
T cd07845 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---II 130 (309)
T ss_pred HHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 699999999999999999998765 46899999995 5898888766567999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||||+||+++.++.+||+|||++......... .....++..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 131 H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~ 208 (309)
T cd07845 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPL 208 (309)
T ss_pred cCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876533211 122345778999999875 5689999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhh-----h---hccccc--cccccCCccCC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARP-----H---LGERRR--FYRLIDPRLEG--HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~-----~---~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 226 (304)
|................. . ...... ........... ......+..+.++|.+||+.||++|||+++++
T Consensus 209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 209 LPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred CCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 975433221110000000 0 000000 00000000000 00011256788999999999999999999999
Q ss_pred HHh
Q 022003 227 EAL 229 (304)
Q Consensus 227 ~~l 229 (304)
.+.
T Consensus 289 ~h~ 291 (309)
T cd07845 289 ESS 291 (309)
T ss_pred cCh
Confidence 753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=257.22 Aligned_cols=216 Identities=25% Similarity=0.332 Sum_probs=162.8
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|+.++.++. |+||+++++++.++ +..++||||+. ++|.+.+......+++..++.++.|++.||+|||+.+ +
T Consensus 46 ~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i 121 (282)
T cd07831 46 REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---I 121 (282)
T ss_pred HHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5888888885 99999999999987 88999999996 5888888765567999999999999999999999988 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~ 157 (304)
+||||+|+||+++. +.+||+|||++........ .....++..|+|||++.. ..++.++|||||||++|||++|..
T Consensus 122 ~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~ 197 (282)
T cd07831 122 FHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197 (282)
T ss_pred eecccCHHHEEEcC-CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCc
Confidence 99999999999999 9999999999987543221 122457889999997754 567899999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhcc-------ccc---cccccCCccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGE-------RRR---FYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~-------~~~---~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
||......+. .......... ... ......+.... ......+..+.++|.+||+.+|++||+++
T Consensus 198 p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 274 (282)
T cd07831 198 LFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK 274 (282)
T ss_pred CCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHH
Confidence 9976433211 1110000000 000 00000000000 00113367899999999999999999999
Q ss_pred HHHHH
Q 022003 224 EVVEA 228 (304)
Q Consensus 224 ell~~ 228 (304)
+++++
T Consensus 275 ~~l~~ 279 (282)
T cd07831 275 QALRH 279 (282)
T ss_pred HHhhC
Confidence 99985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=251.30 Aligned_cols=206 Identities=27% Similarity=0.407 Sum_probs=169.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+|++++++++..+...++++||+++++|.+++......+++..+..++.|++.||.+||..+ ++|+
T Consensus 46 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~ 122 (253)
T cd05122 46 NEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHR 122 (253)
T ss_pred HHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecC
Confidence 6899999999999999999999999999999999999999999776567999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 123 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 199 (253)
T cd05122 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSE 199 (253)
T ss_pred CCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654321 2345678899999999988899999999999999999999999875
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
...... ..... . ........ ....+..+.++|.+||+.||++|||+.+++++
T Consensus 200 ~~~~~~---~~~~~--~---~~~~~~~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 200 LPPMKA---LFKIA--T---NGPPGLRN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CchHHH---HHHHH--h---cCCCCcCc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 432111 00000 0 00001100 11124679999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=257.58 Aligned_cols=207 Identities=29% Similarity=0.388 Sum_probs=161.8
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeC-----CeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|+.+++++ +|||++++++++... +..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+
T Consensus 67 ~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 146 (291)
T cd06639 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146 (291)
T ss_pred HHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 588899998 899999999998754 358999999999999998753 34578999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-----CCCchhhhHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTSRSDVYSFGV 147 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~ 147 (304)
.+ ++|+||||+||+++.++.+||+|||++........ ......|+..|+|||++... .++.++|||||||
T Consensus 147 ~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGv 221 (291)
T cd06639 147 NR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGI 221 (291)
T ss_pred CC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHH
Confidence 88 99999999999999999999999999886543221 12234678899999987643 3689999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 148 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 148 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
++|+|++|+.||........ ...+.. .......+ +......+.++|.+||+.+|++||++.|+++
T Consensus 222 i~~el~~g~~p~~~~~~~~~--~~~~~~------~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 222 TAIELGDGDPPLFDMHPVKT--LFKIPR------NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHhhCCCCCCCCcHHHH--HHHHhc------CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 99999999999975432111 111000 00000111 1123457899999999999999999999998
Q ss_pred H
Q 022003 228 A 228 (304)
Q Consensus 228 ~ 228 (304)
+
T Consensus 287 ~ 287 (291)
T cd06639 287 H 287 (291)
T ss_pred C
Confidence 6
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=257.16 Aligned_cols=205 Identities=25% Similarity=0.378 Sum_probs=166.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++...+..++|+||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+
T Consensus 65 ~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g---i~H~ 139 (293)
T cd06647 65 NEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHR 139 (293)
T ss_pred HHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---Eeec
Confidence 5889999999999999999999999999999999999999998653 4889999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 140 dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~ 217 (293)
T cd06647 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (293)
T ss_pred cCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876543322 12334678899999999888899999999999999999999999976
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.......... . .... +.. ......+..+.++|.+||..+|.+||++++++.+
T Consensus 218 ~~~~~~~~~~--~---~~~~--------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 218 ENPLRALYLI--A---TNGT--------PEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CChhhheeeh--h---cCCC--------CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4332211100 0 0000 000 0111234678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=253.08 Aligned_cols=207 Identities=26% Similarity=0.380 Sum_probs=169.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH 80 (304)
+|++++.+++|+||+++++++...+..++||||+++++|.+++.+. ..+++..++.++.|++.||+|||+ .+ ++|
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H 123 (264)
T cd06623 48 RELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIH 123 (264)
T ss_pred HHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---Ccc
Confidence 5889999999999999999999999999999999999999999665 479999999999999999999999 88 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 124 ~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 201 (264)
T cd06623 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFL 201 (264)
T ss_pred CCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 999999999999999999999999876432221 123457889999999998899999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
............... ....+. .... .+..+.++|.+||..+|++|||+.+++++
T Consensus 202 ~~~~~~~~~~~~~~~----------~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 202 PPGQPSFFELMQAIC----------DGPPPS----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccccCHHHHHHHHh----------cCCCCC----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 654311111111111 000011 1112 45789999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=256.18 Aligned_cols=218 Identities=24% Similarity=0.349 Sum_probs=163.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++||||+++++++..++..++||||+. ++|..++... ...+++..+..++.|++.||+|||+.+ ++|
T Consensus 48 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H 123 (284)
T cd07860 48 REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLH 123 (284)
T ss_pred HHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 59999999999999999999999999999999995 6898888553 456899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
+||+|+||+++.++.+||+|||++........ ......++..|+|||++.+. .++.++|||||||++|+|+||..||
T Consensus 124 ~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~ 201 (284)
T cd07860 124 RDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201 (284)
T ss_pred CCCCHHHEEECCCCCEEEeeccchhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999876543221 12233567889999988764 4688999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhc----------c----ccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 160 DKNRPNGEHNLVEWARPHLG----------E----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~----------~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
....... ........... . ...+......... ......+..+.++|.+||+.||.+|||++++
T Consensus 202 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 278 (284)
T cd07860 202 PGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278 (284)
T ss_pred CCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHH
Confidence 6543211 11100000000 0 0000000000000 0001124578899999999999999999999
Q ss_pred HHH
Q 022003 226 VEA 228 (304)
Q Consensus 226 l~~ 228 (304)
+++
T Consensus 279 l~~ 281 (284)
T cd07860 279 LAH 281 (284)
T ss_pred hcC
Confidence 975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=252.06 Aligned_cols=194 Identities=22% Similarity=0.277 Sum_probs=158.4
Q ss_pred CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 022003 11 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 90 (304)
Q Consensus 11 ~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili 90 (304)
+|+||+++++.+..++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~ 142 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLY 142 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEE
Confidence 79999999999999999999999999999999996654 7999999999999999999999998 9999999999999
Q ss_pred CCCC-cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 022003 91 DADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 169 (304)
Q Consensus 91 ~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 169 (304)
+.++ .++|+|||++...... ....|+..|+|||++.+..++.++||||||+++|+|++|..||....... ..
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~ 215 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LD 215 (267)
T ss_pred eCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hh
Confidence 9988 9999999998765422 12357889999999998899999999999999999999999997443221 11
Q ss_pred hhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 022003 170 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEA 228 (304)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~ell~~ 228 (304)
...+.... . .. .......+..+.++|.+||+.+|.+||+ ++|++++
T Consensus 216 ~~~~~~~~-~------~~------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 216 LESLLKRQ-Q------KK------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHhh-c------cc------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 11111110 0 00 0011134578999999999999999995 6999874
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=259.23 Aligned_cols=206 Identities=29% Similarity=0.424 Sum_probs=165.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+|++++++++..+...++||||+. |+|.+.+......+++..+..++.|++.||.|||+.+ ++||
T Consensus 74 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~ 149 (317)
T cd06635 74 KEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHR 149 (317)
T ss_pred HHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 58999999999999999999999999999999996 5888887666667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||+|+||+++.++.+||+|||++..... .....|+..|+|||++. ...++.++|||||||++|+|++|..|
T Consensus 150 dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p 223 (317)
T cd06635 150 DIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223 (317)
T ss_pred CCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999875432 22345788999999874 45689999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
|........ ...+.. .. .+. ......+..+.+++.+||+.+|.+||++.++++++....
T Consensus 224 ~~~~~~~~~--~~~~~~----~~-------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 224 LFNMNAMSA--LYHIAQ----NE-------SPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCCccHHHH--HHHHHh----cc-------CCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 865321110 000000 00 000 011123567899999999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=255.79 Aligned_cols=208 Identities=27% Similarity=0.420 Sum_probs=168.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++...+..++|+||+++++|.+++..+...+++..+..++.|++.||.|||+.+ ++|+
T Consensus 64 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~ 140 (286)
T cd06614 64 NEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHR 140 (286)
T ss_pred HHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeC
Confidence 6899999999999999999999999999999999999999999776557999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 141 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred CCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876543211 12234578889999999888899999999999999999999999864
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
...... ..... . ... +... .....+..+.++|.+||+.+|.+||++.+++++.
T Consensus 219 ~~~~~~--~~~~~-----~-~~~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 219 EPPLRA--LFLIT-----T-KGI-----PPLK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred CCHHHH--HHHHH-----h-cCC-----CCCc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 322110 00000 0 000 0000 0112356889999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=250.51 Aligned_cols=208 Identities=28% Similarity=0.413 Sum_probs=170.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++|+||+++++.+... ...++||||+++++|.+++.+.. .+++..++.++.|++.||.|||+.+ ++
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~ 123 (260)
T cd06606 48 REIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IV 123 (260)
T ss_pred HHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 589999999999999999999988 88999999999999999987655 8999999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++++|++|..||
T Consensus 124 h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 203 (260)
T cd06606 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203 (260)
T ss_pred ccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765443211133456788999999998888999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... . ....+. . .........+...+..+.++|.+||+.||.+||++.+++.+
T Consensus 204 ~~~~~--~-~~~~~~---~---------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 204 SELGN--P-MAALYK---I---------GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCCc--h-HHHHHh---c---------cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 76541 0 000000 0 00001111222336789999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=253.86 Aligned_cols=203 Identities=25% Similarity=0.395 Sum_probs=165.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++..++..++||||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+
T Consensus 51 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~ 125 (277)
T cd06641 51 QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEK---KIHR 125 (277)
T ss_pred HHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCC---eecC
Confidence 5889999999999999999999999999999999999999988543 5899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++|..||..
T Consensus 126 dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred CCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999999999999876543211 12234678899999999888899999999999999999999999864
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... .... .... ..+ ......+..+.+++.+||+.+|.+||++.+++++
T Consensus 204 ~~~~~---~~~~----~~~~------~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 204 LHPMK---VLFL----IPKN------NPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cchHH---HHHH----HhcC------CCC----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 32211 0000 0000 001 1122335678999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=252.51 Aligned_cols=203 Identities=25% Similarity=0.370 Sum_probs=168.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++|+||+++++++......++||||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+ +
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i 124 (256)
T cd08530 48 NEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---I 124 (256)
T ss_pred HHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---c
Confidence 6889999999999999999999999999999999999999988652 346899999999999999999999988 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+|+||+|+||+++.++.+||+|||++...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|
T Consensus 125 ~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p 200 (256)
T cd08530 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200 (256)
T ss_pred ccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999876543 12234578899999999998999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|...... ...... .... ........+.++.+++.+||+.+|++||++.+++++
T Consensus 201 ~~~~~~~---~~~~~~-----~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 201 FEARSMQ---DLRYKV-----QRGK---------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCHH---HHHHHH-----hcCC---------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 9654321 000000 0000 011122446789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=256.97 Aligned_cols=209 Identities=29% Similarity=0.353 Sum_probs=160.9
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhh----cCCCCCCHHHHHHHHHHHHHHHHHhhcC-CC
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEE-AE 75 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~ 75 (304)
+|+.++.++. |+||+++++++...+..+++|||+. ++|.++.. .....+++..+..++.|++.||+|||+. +
T Consensus 51 ~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~- 128 (288)
T cd06616 51 MDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK- 128 (288)
T ss_pred HHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC-
Confidence 5888999996 9999999999999999999999994 56655432 2235799999999999999999999974 6
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC---CCCchhhhHHHHHHHHHH
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el 152 (304)
++||||||+||+++.++.+||+|||+++....... .....|+..|+|||++.+. .++.++|||||||++|+|
T Consensus 129 --i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 203 (288)
T cd06616 129 --IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203 (288)
T ss_pred --eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHH
Confidence 99999999999999999999999999976543211 2234578899999998865 689999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
++|..||..... .......... ...+..........+.++.+||.+||+.||++|||+++++++-
T Consensus 204 ~~g~~p~~~~~~-----~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 204 ATGKFPYPKWNS-----VFDQLTQVVK-------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred HhCCCCchhcch-----HHHHHhhhcC-------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 999999975431 1110000000 0011111111123457899999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=257.10 Aligned_cols=217 Identities=26% Similarity=0.354 Sum_probs=167.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++..+...++||||++ ++|.+++......+++..+..++.||+.||.|||+.+ ++|+
T Consensus 47 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~ 122 (283)
T cd05118 47 REIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHR 122 (283)
T ss_pred HHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 58899999999999999999999999999999996 5898888776668999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.
T Consensus 123 dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 123 DLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred CcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987654321 12224578889999998876 78999999999999999999999996
Q ss_pred CCCCCCCcchhHhhhhhhcc-----cccc-----------ccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGE-----RRRF-----------YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~-----~~~~-----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
.....+.... ....... ...+ ........ .......+.++.++|.+||+.||.+||++.+
T Consensus 201 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 276 (283)
T cd05118 201 GKSEIDQLFK---IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276 (283)
T ss_pred CCCHHHHHHH---HHHHcCCCchHhcccchhhhhhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHH
Confidence 5432211000 0000000 0000 00000000 1112234678999999999999999999999
Q ss_pred HHHH
Q 022003 225 VVEA 228 (304)
Q Consensus 225 ll~~ 228 (304)
++.+
T Consensus 277 ll~~ 280 (283)
T cd05118 277 ALAH 280 (283)
T ss_pred HhhC
Confidence 9975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=266.27 Aligned_cols=216 Identities=23% Similarity=0.282 Sum_probs=178.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
.|-+||.+.+.|.||++|--|.+++..|++||-|-||.|+..++.++ .|+..+...++..+++|++|||+++ ||+|
T Consensus 469 sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~---iIYR 544 (732)
T KOG0614|consen 469 SERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKG---IIYR 544 (732)
T ss_pred hHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcC---ceec
Confidence 47889999999999999999999999999999999999999997665 7999999999999999999999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|++++.+|.+||.|||+|+....+.+ ..+++||+.|.|||++.....+.++|.||||+++|||++|.+||.+
T Consensus 545 DLKPENllLd~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~ 621 (732)
T KOG0614|consen 545 DLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG 621 (732)
T ss_pred cCChhheeeccCCceEEeehhhHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999999876654 4468999999999999999999999999999999999999999988
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHhCCCCCCccCCC
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALKPLPNLKDMAS 240 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~ell~~l~~~~~~~~~~~ 240 (304)
.++....+.+.-... ...++......+.+||++++..+|.+|.. -..=++.++.+.++....+
T Consensus 622 ~dpmktYn~ILkGid----------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 622 VDPMKTYNLILKGID----------------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred CchHHHHHHHHhhhh----------------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 765433222211110 01233344567889999999999999984 2223333444455544443
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=254.24 Aligned_cols=200 Identities=26% Similarity=0.337 Sum_probs=160.3
Q ss_pred HhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 022003 6 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 85 (304)
Q Consensus 6 il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp 85 (304)
+++...||||+++++++...+..++||||+.|++|..++... ..+++..+..++.|++.||.|||+.+ ++||||||
T Consensus 50 ~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p 125 (278)
T cd05606 50 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKP 125 (278)
T ss_pred HHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCH
Confidence 445568999999999999999999999999999999988654 47999999999999999999999988 99999999
Q ss_pred CCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Q 022003 86 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 164 (304)
Q Consensus 86 ~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~ 164 (304)
+||+++.++.+||+|||++....... .....|+..|+|||++.++ .++.++||||+||++|+|++|..||.....
T Consensus 126 ~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~ 201 (278)
T cd05606 126 ANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (278)
T ss_pred HHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999999987653221 2234689999999998754 689999999999999999999999976432
Q ss_pred CCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 022003 165 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 228 (304)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~ 228 (304)
........ ... ..... .+...+.++.+++.+||..+|.+|| ++.+++++
T Consensus 202 ~~~~~~~~---~~~--------~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 202 KDKHEIDR---MTL--------TMAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred cchHHHHH---Hhh--------ccCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 22111110 000 00111 1112357899999999999999999 99999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=247.36 Aligned_cols=217 Identities=25% Similarity=0.332 Sum_probs=167.3
Q ss_pred ChHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
++|++++.+. .|+||++++++|++++.+|+|||-+.||+|..+|.++. .|++.++..+..+|+.||.|||.+| |.
T Consensus 123 fREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kg---IA 198 (463)
T KOG0607|consen 123 FREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKG---IA 198 (463)
T ss_pred HHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcC---cc
Confidence 3789998888 59999999999999999999999999999999996654 7999999999999999999999999 99
Q ss_pred eccCCCCCeEECCCCc---EEEccccCcccCCCC-----CcceeeecccccccccCcchhh-----cCCCCchhhhHHHH
Q 022003 80 YRDFKTSNILLDADYN---AKLSDFGLAKDGPEG-----DKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFG 146 (304)
Q Consensus 80 H~dlkp~Nili~~~~~---~kl~Dfg~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG 146 (304)
||||||+|||....+. +|||||.+..-.... .......+.+|+..|||||++. ...|+.++|.||||
T Consensus 199 HRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLG 278 (463)
T KOG0607|consen 199 HRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLG 278 (463)
T ss_pred cccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHH
Confidence 9999999999965543 799999887543211 1111223467899999999874 24689999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCC-------cc--hhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 147 VVLLEMLTGRRSMDKNRPNGE-------HN--LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 147 ~il~el~tg~~p~~~~~~~~~-------~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
+|+|-|++|.+||.+....+. -. ....... + ....+++.+.. -...+.+..+++..+|..|+.
T Consensus 279 vIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes-I--QEGkYeFPdkd-----WahIS~eakdlisnLlvrda~ 350 (463)
T KOG0607|consen 279 VILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES-I--QEGKYEFPDKD-----WAHISSEAKDLISNLLVRDAK 350 (463)
T ss_pred HHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH-H--hccCCcCChhh-----hHHhhHHHHHHHHHHHhccHH
Confidence 999999999999987554321 00 0000000 0 01111222221 124578899999999999999
Q ss_pred CCCCHHHHHHHh
Q 022003 218 ARPLMSEVVEAL 229 (304)
Q Consensus 218 ~Rps~~ell~~l 229 (304)
+|.++.+++.+.
T Consensus 351 ~rlsa~~vlnhP 362 (463)
T KOG0607|consen 351 QRLSAAQVLNHP 362 (463)
T ss_pred hhhhhhhccCCc
Confidence 999999999854
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=256.93 Aligned_cols=218 Identities=24% Similarity=0.339 Sum_probs=163.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++++..++..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|
T Consensus 47 ~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H 122 (283)
T cd07835 47 REISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLH 122 (283)
T ss_pred HHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeC
Confidence 5899999999999999999999999999999999 468999886543 46899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
+||+|+||+++.++.++|+|||++......... .....++..|+|||++.+. .++.++||||||+++|+|++|..||
T Consensus 123 ~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 200 (283)
T cd07835 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200 (283)
T ss_pred CCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999765332111 1223467889999987654 5799999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhh----------hccccc----cccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 160 DKNRPNGEHNLVEWARPH----------LGERRR----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~----------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
........ ........ ...... +........ .......+..+.++|.+||+.||.+|||++|+
T Consensus 201 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i 277 (283)
T cd07835 201 PGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA 277 (283)
T ss_pred CCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 75432111 00000000 000000 000000000 00111234678899999999999999999999
Q ss_pred HHH
Q 022003 226 VEA 228 (304)
Q Consensus 226 l~~ 228 (304)
+++
T Consensus 278 l~~ 280 (283)
T cd07835 278 LQH 280 (283)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=255.02 Aligned_cols=219 Identities=22% Similarity=0.313 Sum_probs=164.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++|+||+++++++...+..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++
T Consensus 47 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 122 (284)
T cd07836 47 REISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VL 122 (284)
T ss_pred HHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 68999999999999999999999999999999996 58888886543 46899999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||||+||+++.++.++|+|||++........ ......++..|++||++.+ ..++.++|||||||++|+|++|..|
T Consensus 123 h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~ 200 (284)
T cd07836 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL 200 (284)
T ss_pred eCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999976533211 1223456888999998865 4578999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhh----------hhccccccccccCCc---cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 159 MDKNRPNGEHNLVEWARP----------HLGERRRFYRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
|......... ...... .+.....+....... .........+..+.+++.+||+.||.+||++.++
T Consensus 201 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 278 (284)
T cd07836 201 FPGTNNEDQL--LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA 278 (284)
T ss_pred CCCCCcHHHH--HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence 9765332110 000000 000000000000000 0000111235688999999999999999999999
Q ss_pred HHH
Q 022003 226 VEA 228 (304)
Q Consensus 226 l~~ 228 (304)
+++
T Consensus 279 l~~ 281 (284)
T cd07836 279 LQH 281 (284)
T ss_pred hcC
Confidence 874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=254.22 Aligned_cols=206 Identities=27% Similarity=0.396 Sum_probs=163.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++.+..++..|+||||+.+++|.+++.+.. .+++..++.++.||++||+|||+.+ ++|+
T Consensus 42 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~ 117 (265)
T cd05579 42 TERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHR 117 (265)
T ss_pred HHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecC
Confidence 58899999999999999999999999999999999999999986654 7999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCc------ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDK------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
||+|+||+++.++.++|+|||++........ ........++..|+|||......++.++||||||+++|+|++|
T Consensus 118 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g 197 (265)
T cd05579 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197 (265)
T ss_pred CCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence 9999999999999999999999876433211 1122335678899999999888899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
..||....... ...........+ +. .. ..+..+.+++.+||+.+|.+|||+.++.+
T Consensus 198 ~~p~~~~~~~~------~~~~~~~~~~~~-----~~---~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 198 IPPFHGETPEE------IFQNILNGKIEW-----PE---DV--EVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred CCCCCCCCHHH------HHHHHhcCCcCC-----Cc---cc--cCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 99996543211 111000000000 00 00 12578899999999999999999944443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=250.08 Aligned_cols=205 Identities=26% Similarity=0.406 Sum_probs=169.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++|+|++++++.+......++|+||+++++|.+++.+. ...+++..+..++.+++.||.|||+.+ +
T Consensus 48 ~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~ 124 (258)
T cd08215 48 NEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---I 124 (258)
T ss_pred HHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 5899999999999999999999999999999999999999999764 367999999999999999999999998 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+|+||+|+||+++.++.++|+|||.+....... .......|+..|+|||.+.+..++.++|+||+|+++++|++|..|
T Consensus 125 ~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 202 (258)
T cd08215 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202 (258)
T ss_pred ecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999998764432 123345688899999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|...... ......... . .+.+ +...+..+.+++.+||..+|.+|||+.+++++
T Consensus 203 ~~~~~~~------~~~~~~~~~--~-----~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 203 FEGENLL------ELALKILKG--Q-----YPPI----PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCcHH------HHHHHHhcC--C-----CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 8654311 111110000 0 0111 11234688999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=251.42 Aligned_cols=205 Identities=23% Similarity=0.388 Sum_probs=165.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++.+..+...++|+||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ ++|
T Consensus 48 ~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H 124 (257)
T cd08225 48 KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILH 124 (257)
T ss_pred HHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 6899999999999999999999999999999999999999998654 335899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCC-cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
+||||+||+++.++ .+||+|||.+........ ......|+..|+|||++.+..++.++|+||||+++++|++|..||
T Consensus 125 ~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 202 (257)
T cd08225 125 RDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF 202 (257)
T ss_pred ccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999998875 469999999887643221 122345788999999998888999999999999999999999998
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
...... ......... ...+ .....+.++.+++.+||..+|++|||+.+++++
T Consensus 203 ~~~~~~------~~~~~~~~~------~~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 203 EGNNLH------QLVLKICQG------YFAP-----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCccHH------HHHHHHhcc------cCCC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 644211 111111100 0000 011224689999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=270.27 Aligned_cols=207 Identities=26% Similarity=0.417 Sum_probs=172.2
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
++|+.+|.+|+|+|++++||+..+ ....||||+++.|||.+.|.+ ....|.......++.||+.|+.||.+++ +|
T Consensus 159 lrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lv 234 (1039)
T KOG0199|consen 159 LREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LV 234 (1039)
T ss_pred HHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hh
Confidence 479999999999999999999887 678999999999999999987 4567999999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCccee-eecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~ 157 (304)
||||...|+|+.....|||+|||+.+-++..+.... .....-...|+|||.++...++.++|||++|+++|||+| |..
T Consensus 235 HRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEe 314 (1039)
T KOG0199|consen 235 HRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEE 314 (1039)
T ss_pred hhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCC
Confidence 999999999999999999999999998876554332 222333567999999999999999999999999999998 678
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
||.+.........+ .++. ++ ..+..+++++++++..||..+|.+|||+..|.+.
T Consensus 315 PW~G~~g~qIL~~i-------D~~e---rL-------pRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 315 PWVGCRGIQILKNI-------DAGE---RL-------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCCCHHHHHHhc-------cccc---cC-------CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 88776432211111 1111 11 1244568999999999999999999999999743
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=252.21 Aligned_cols=197 Identities=26% Similarity=0.329 Sum_probs=156.0
Q ss_pred hhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 022003 7 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 86 (304)
Q Consensus 7 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~ 86 (304)
...++|+||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~ 126 (260)
T cd05611 51 MIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPE 126 (260)
T ss_pred hhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 34458999999999999999999999999999999998654 36899999999999999999999988 999999999
Q ss_pred CeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 022003 87 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 166 (304)
Q Consensus 87 Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 166 (304)
||+++.++.+||+|||++..... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 127 nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 200 (260)
T cd05611 127 NLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200 (260)
T ss_pred HeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999999999999999876432 223457889999999988889999999999999999999999996542211
Q ss_pred CcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 167 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
. +.. ....... .........+..+.+++.+||+.+|++||++.++.+
T Consensus 201 ---~--~~~-~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 201 ---V--FDN-ILSRRIN--------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred ---H--HHH-HHhcccC--------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 0 000 0000000 000111123578999999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.40 Aligned_cols=204 Identities=26% Similarity=0.411 Sum_probs=158.0
Q ss_pred HhhH-hhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCC
Q 022003 3 EVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AERP 77 (304)
Q Consensus 3 E~~i-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ 77 (304)
|+.+ ++.++||||+++++++..++..++||||++ ++|.+++.. ....+++..++.++.||+.||+|||++ +
T Consensus 49 e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--- 124 (283)
T cd06617 49 DLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--- 124 (283)
T ss_pred HHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---
Confidence 4454 566789999999999999999999999995 688877753 245699999999999999999999986 7
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc----CCCCchhhhHHHHHHHHHHH
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~ 153 (304)
++||||||+||+++.++.+||+|||++....... ......|+..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 125 i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~ 201 (283)
T cd06617 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELA 201 (283)
T ss_pred eecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHH
Confidence 9999999999999999999999999998654321 1223457889999998864 45789999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 154 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 154 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+|..||...... ...... ... ...+... ....+.++.++|.+||..+|.+||++.+++++
T Consensus 202 ~g~~p~~~~~~~----~~~~~~-~~~-------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 202 TGRFPYDSWKTP----FQQLKQ-VVE-------EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred hCCCCCCccccC----HHHHHH-HHh-------cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999998643211 000000 000 0001110 11235789999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=256.90 Aligned_cols=206 Identities=29% Similarity=0.400 Sum_probs=164.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|+|++++++++......++||||+. ++|.+.+......+++..+..++.|++.||.|||+.+ ++||
T Consensus 64 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~ 139 (308)
T cd06634 64 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHR 139 (308)
T ss_pred HHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 58999999999999999999999999999999995 6888877655567899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||+|+||+++.++.++|+|||++..... .....++..|+|||++. ...++.++|||||||++|+|++|..|
T Consensus 140 dl~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 213 (308)
T cd06634 140 DVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213 (308)
T ss_pred CCCHHhEEECCCCcEEECCcccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999876432 12345788999999975 35688999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
|........ ...+. . .. .+.. .....+..+.++|.+||+.+|++||++.+++++.....
T Consensus 214 ~~~~~~~~~--~~~~~-----~-~~-----~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 214 LFNMNAMSA--LYHIA-----Q-NE-----SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CccccHHHH--HHHHh-----h-cC-----CCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 865321110 00000 0 00 0110 11133567899999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=290.29 Aligned_cols=219 Identities=32% Similarity=0.550 Sum_probs=171.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|||||++++++.+.+..++||||+++|+|.+++. .+++..+..++.|++.||+|||.....+|+||
T Consensus 732 ~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~ 807 (968)
T PLN00113 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807 (968)
T ss_pred HHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence 47889999999999999999999999999999999999999984 38899999999999999999995533449999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++..++. ||....... .....||..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 808 dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 999999999998888775 665543211 1123578999999999999999999999999999999999999954
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG--HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
... ......+|....... .......++.... ........++.+++.+||+.||++|||++|+++.|+.+.
T Consensus 881 ~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 881 EFG-VHGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred ccC-CCCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 322 223344444432211 1122334444322 233455668899999999999999999999999997653
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=249.65 Aligned_cols=209 Identities=31% Similarity=0.447 Sum_probs=166.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++...+..++|+||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+
T Consensus 48 ~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~ 123 (264)
T cd06626 48 DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHR 123 (264)
T ss_pred HHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 5899999999999999999999999999999999999999998654 35899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCccee--eecccccccccCcchhhcCC---CCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV--STRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg~ 156 (304)
||+|+||+++.++.+||+|||++........... .....++..|+|||++.+.. ++.++||||||+++|+|++|.
T Consensus 124 dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~ 203 (264)
T cd06626 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203 (264)
T ss_pred CCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCC
Confidence 9999999999999999999999987644322111 11345788999999998766 899999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||....... ...+.... . ..+.... ....+..+.++|.+||+.+|.+|||+.+++.+
T Consensus 204 ~pf~~~~~~~---~~~~~~~~-~--------~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 204 RPWSELDNEF---QIMFHVGA-G--------HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCccCCcchH---HHHHHHhc-C--------CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 9996542110 01100000 0 0011111 11225678899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=255.66 Aligned_cols=201 Identities=29% Similarity=0.430 Sum_probs=162.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|+|++++++++.+....++||||+. ++|.+++......+++..+..++.|++.||.|||+.+ ++|+
T Consensus 70 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~ 145 (313)
T cd06633 70 KEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHR 145 (313)
T ss_pred HHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 58899999999999999999999999999999995 5888888666667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||+|+||+++.++.+||+|||++..... .....|+..|+|||++. ...++.++|||||||++|+|++|..|
T Consensus 146 dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p 219 (313)
T cd06633 146 DIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219 (313)
T ss_pred CCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999865322 22356788999999974 45688999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|.......... .. . .... +.. .....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 220 ~~~~~~~~~~~---~~---~--~~~~-----~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 220 LFNMNAMSALY---HI---A--QNDS-----PTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCChHHHHH---HH---H--hcCC-----CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 86543211100 00 0 0000 100 011224578899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=254.46 Aligned_cols=205 Identities=26% Similarity=0.395 Sum_probs=164.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++|+||+++++++..++..++||||+++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+
T Consensus 66 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~ 140 (292)
T cd06657 66 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQG---VIHR 140 (292)
T ss_pred HHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 5889999999999999999999999999999999999999987443 5899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++||||+|+++|+|++|..||..
T Consensus 141 dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred CCCHHHEEECCCCCEEEcccccceeccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987653321 112335678899999999888899999999999999999999999865
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
...... ...... ...+.... ....+..+.+++.+||+.||.+||++.+++++
T Consensus 219 ~~~~~~---~~~~~~----------~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 219 EPPLKA---MKMIRD----------NLPPKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHH---HHHHHh----------hCCcccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 322111 000000 00011000 01124578899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=248.35 Aligned_cols=189 Identities=24% Similarity=0.268 Sum_probs=152.7
Q ss_pred HhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 82 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d 82 (304)
|...+....||||+++++++...+..++||||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++|||
T Consensus 35 ~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~d 110 (237)
T cd05576 35 ERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREG---IVCRD 110 (237)
T ss_pred HHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4444555679999999999999999999999999999999986543 6999999999999999999999988 99999
Q ss_pred CCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 022003 83 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 162 (304)
Q Consensus 83 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 162 (304)
|||+||+++.++.++++|||.+...... .....++..|+|||.+.+..++.++||||+|+++|+|++|..++...
T Consensus 111 lkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 111 LNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred CCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 9999999999999999999987665332 12234567799999998888999999999999999999999887532
Q ss_pred CCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 163 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
..... ... .. ..+...+..+.++|.+||+.||++||++
T Consensus 186 ~~~~~------------~~~---~~-------~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 186 PSGIN------------THT---TL-------NIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred chhcc------------ccc---cc-------CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 21100 000 00 0111234678999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=254.52 Aligned_cols=222 Identities=24% Similarity=0.321 Sum_probs=165.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++|+|++++++++... +..++||||++ ++|.+++.+....+++..++.++.||+.||+|||+.+ ++
T Consensus 47 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~ 122 (287)
T cd07840 47 REIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---IL 122 (287)
T ss_pred HHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ce
Confidence 589999999999999999999988 78999999996 5999988776567999999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|+||+|+||+++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus 123 h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p 201 (287)
T cd07840 123 HRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPI 201 (287)
T ss_pred eccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543211 1222456788999998765 4689999999999999999999999
Q ss_pred CCCCCCCCCcchhHh-hh-hhhcccccc-----cccc------CCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 159 MDKNRPNGEHNLVEW-AR-PHLGERRRF-----YRLI------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~-~~-~~~~~~~~~-----~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
|.............. .. ........+ .... .......+...++..+.+++.+||..+|.+||++.++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 281 (287)
T cd07840 202 FQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281 (287)
T ss_pred CCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 975443211000000 00 000000000 0000 0000001111126788999999999999999999999
Q ss_pred HHH
Q 022003 226 VEA 228 (304)
Q Consensus 226 l~~ 228 (304)
+++
T Consensus 282 l~~ 284 (287)
T cd07840 282 LQH 284 (287)
T ss_pred hhC
Confidence 875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=251.63 Aligned_cols=210 Identities=17% Similarity=0.175 Sum_probs=156.0
Q ss_pred hHhhcCCCCcccceeeEEEeCC----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 5 NFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 5 ~il~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
..+..+.|+||+++++++.... ..+++++++ ..++.+.+... ..+++..+..++.|++.||+|||+.+ ++|
T Consensus 75 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH 149 (294)
T PHA02882 75 KNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG---ISH 149 (294)
T ss_pred HHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 3455678999999999776543 347888988 45777766443 34678889999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcc-----eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
|||||+|||++.++.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 150 rDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred CCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999875432211 112234689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..||............. ...... ++...... ....+..+.+++..||..+|++||+++++++.+
T Consensus 230 ~~P~~~~~~~~~~~~~~-~~~~~~------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 230 KLPWKGFGHNGNLIHAA-KCDFIK------RLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCCccccchHHHHHh-HHHHHH------Hhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 99997653322110000 000000 00000000 011256899999999999999999999999865
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=229.42 Aligned_cols=222 Identities=23% Similarity=0.282 Sum_probs=171.4
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++||-+|+.|+|.|||+++++...++.+-+|+||| +.+|+.+...-+..++.+.+..++.|++.||.|+|+++ +.|
T Consensus 49 lreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlh 124 (292)
T KOG0662|consen 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLH 124 (292)
T ss_pred HHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhh
Confidence 58999999999999999999999999999999999 67999999777778999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t-g~~p 158 (304)
|||||.|+||+.+|.+||+|||+++-++-... .....+-|.+|++|.++.+. -|+...|+||.||++.|+.. |++.
T Consensus 125 rdlkpqnllin~ngelkladfglarafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred ccCCcceEEeccCCcEEecccchhhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 99999999999999999999999998765432 33445669999999999876 48999999999999999976 6666
Q ss_pred CCCCCCCCCcchhHhhhh--hhccccccccccCCccCCCCC---------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARP--HLGERRRFYRLIDPRLEGHFS---------IKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
|.+.+..++...+-+... .-.++.....+.|-.....++ ......-++++.+.|.-+|.+|.++++.++
T Consensus 203 fpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 203 FPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 766544332211111111 111111111221211111111 122345589999999999999999999987
Q ss_pred H
Q 022003 228 A 228 (304)
Q Consensus 228 ~ 228 (304)
+
T Consensus 283 h 283 (292)
T KOG0662|consen 283 H 283 (292)
T ss_pred C
Confidence 5
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=250.96 Aligned_cols=219 Identities=22% Similarity=0.294 Sum_probs=160.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+||+++++++..+...++||||++ ++|.+++... ...+++..++.++.||+.||+|||+.+ ++|
T Consensus 50 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H 125 (294)
T PLN00009 50 REISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLH 125 (294)
T ss_pred HHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeC
Confidence 58999999999999999999999999999999995 5888877554 334688899999999999999999988 999
Q ss_pred ccCCCCCeEECC-CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 81 RDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 81 ~dlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+||+|+||+++. ++.+||+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|+||..|
T Consensus 126 ~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~p 203 (294)
T PLN00009 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPL 203 (294)
T ss_pred CCCCcceEEEECCCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999985 56799999999976543211 1123456889999998876 4679999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhcccccc-------cc--ccCCccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRF-------YR--LIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~--~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
|......+.. .............. .. ...+.... ......+..+.+++.+||+.+|++||++.++
T Consensus 204 f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~ 281 (294)
T PLN00009 204 FPGDSEIDEL--FKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281 (294)
T ss_pred CCCCCHHHHH--HHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH
Confidence 9754321110 00000000000000 00 00000000 0011224678999999999999999999999
Q ss_pred HHH
Q 022003 226 VEA 228 (304)
Q Consensus 226 l~~ 228 (304)
+++
T Consensus 282 l~~ 284 (294)
T PLN00009 282 LEH 284 (294)
T ss_pred hcC
Confidence 974
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=254.56 Aligned_cols=219 Identities=22% Similarity=0.307 Sum_probs=160.0
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCe-----eEEEEecCCCCCHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhh
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQ-----RLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLH 71 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~~LH 71 (304)
+|+.+++++. |+||+++++++..... .|+||||+++ +|.+++... ...+++..++.++.||++||.|||
T Consensus 49 ~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH 127 (295)
T cd07837 49 REISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127 (295)
T ss_pred HHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5899999995 6999999999987665 8999999975 888887543 245899999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEECC-CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHH
Q 022003 72 EEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVL 149 (304)
Q Consensus 72 ~~~~~~iiH~dlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il 149 (304)
+.+ ++||||||+||+++. ++.+||+|||++......... .....++..|+|||++.+ ..++.++||||||+++
T Consensus 128 ~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l 202 (295)
T cd07837 128 KHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIF 202 (295)
T ss_pred HCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHH
Confidence 988 999999999999998 899999999998865332111 122346788999998865 4679999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhHhhhhh----------hcccccccccc--CCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 150 LEMLTGRRSMDKNRPNGEHNLVEWARPH----------LGERRRFYRLI--DPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 150 ~el~tg~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
|+|++|..||........ ........ ........+.. .+..........+..+.++|.+||..||.
T Consensus 203 ~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 280 (295)
T cd07837 203 AEMSRKQPLFPGDSELQQ--LLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA 280 (295)
T ss_pred HHHHcCCCCCCCCCHHHH--HHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence 999999999975432111 00000000 00000000000 00000000112356789999999999999
Q ss_pred CCCCHHHHHHH
Q 022003 218 ARPLMSEVVEA 228 (304)
Q Consensus 218 ~Rps~~ell~~ 228 (304)
+||+++|++.+
T Consensus 281 ~R~~~~eil~~ 291 (295)
T cd07837 281 KRISAKAALTH 291 (295)
T ss_pred hcCCHHHHhcC
Confidence 99999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=248.58 Aligned_cols=207 Identities=22% Similarity=0.299 Sum_probs=163.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++|+||+++++++... +.+++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++
T Consensus 53 ~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~---i~ 128 (264)
T cd06653 53 CEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM---IV 128 (264)
T ss_pred HHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 589999999999999999998764 46889999999999999986544 5899999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCc-ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|+||||+||+++.++.++|+|||+++....... ........|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 129 H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 208 (264)
T cd06653 129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208 (264)
T ss_pred cCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999986532111 1111234678899999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|...... ..... .. ........+...+..+.+++.+||+ +|..||++.+++.+.
T Consensus 209 ~~~~~~~-----~~~~~-~~----------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 209 WAEYEAM-----AAIFK-IA----------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred CCccCHH-----HHHHH-HH----------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 9643211 11000 00 0001111223345789999999999 579999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=258.71 Aligned_cols=220 Identities=29% Similarity=0.361 Sum_probs=162.4
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|+.+++++ +|+||+++++++... ...++||||+. ++|..++... .+++..++.++.|++.||+|||+.+ +
T Consensus 55 ~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i 128 (337)
T cd07852 55 REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---V 128 (337)
T ss_pred HHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 589999999 999999999998654 36899999996 5999988654 6889999999999999999999988 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcc---eeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
+||||||+||+++.++.+||+|||++......... .......|+..|+|||++.+ ..++.++||||||+++|+|++
T Consensus 129 ~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~t 208 (337)
T cd07852 129 IHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208 (337)
T ss_pred ecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHh
Confidence 99999999999999999999999999875443221 12233568899999998764 567899999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhh--------hh--cccccccccc----CCccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARP--------HL--GERRRFYRLI----DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~--------~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 220 (304)
|+.||................. .+ .....+.... ...... .....+.++.++|.+||+.||.+||
T Consensus 209 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rp 287 (337)
T cd07852 209 GKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRL 287 (337)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCccccc
Confidence 9999965432211000000000 00 0000000000 000000 0111357889999999999999999
Q ss_pred CHHHHHHH
Q 022003 221 LMSEVVEA 228 (304)
Q Consensus 221 s~~ell~~ 228 (304)
|+.+++++
T Consensus 288 s~~~il~~ 295 (337)
T cd07852 288 TAEEALEH 295 (337)
T ss_pred CHHHHhhC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=247.67 Aligned_cols=204 Identities=29% Similarity=0.462 Sum_probs=167.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+|++++++++......++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++||
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 123 (254)
T cd06627 48 QEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHR 123 (254)
T ss_pred HHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccC
Confidence 6899999999999999999999999999999999999999998665 57999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 124 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 124 DIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred CCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876543321 2335678899999999888899999999999999999999999864
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.... ...+.. .. .. .+. .+...+..+.+++.+||..+|++|||+.+++.+
T Consensus 202 ~~~~----~~~~~~-~~---~~-----~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 202 LNPM----AALFRI-VQ---DD-----HPP----LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ccHH----HHHHHH-hc---cC-----CCC----CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 3211 111110 00 00 011 111225688999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=257.68 Aligned_cols=220 Identities=23% Similarity=0.296 Sum_probs=164.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++...+..++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+
T Consensus 69 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~ 143 (335)
T PTZ00024 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWY---FMHR 143 (335)
T ss_pred HHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 58999999999999999999999999999999995 6999988554 46899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCC------------cceeeecccccccccCcchhhcC-CCCchhhhHHHHHH
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGD------------KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVV 148 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~i 148 (304)
||+|+||+++.++.++|+|||++....... .........++..|+|||++.+. .++.++|||||||+
T Consensus 144 dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~ 223 (335)
T PTZ00024 144 DLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCI 223 (335)
T ss_pred cccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHH
Confidence 999999999999999999999998654110 00111223467889999998764 47999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhHhhhhhh--------cccccc------ccccCCccCCCCCHHHHHHHHHHHHHhccC
Q 022003 149 LLEMLTGRRSMDKNRPNGEHNLVEWARPHL--------GERRRF------YRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 214 (304)
Q Consensus 149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 214 (304)
+|+|++|..||........ ........ ...... .....+... ......+.++.++|.+||+.
T Consensus 224 l~el~tg~~p~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~ 299 (335)
T PTZ00024 224 FAELLTGKPLFPGENEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKL 299 (335)
T ss_pred HHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCC
Confidence 9999999999976543211 10000000 000000 000000000 00112256789999999999
Q ss_pred CCCCCCCHHHHHHHhC
Q 022003 215 DPKARPLMSEVVEALK 230 (304)
Q Consensus 215 dp~~Rps~~ell~~l~ 230 (304)
+|++|||++|++.+..
T Consensus 300 ~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 300 NPLERISAKEALKHEY 315 (335)
T ss_pred CchhccCHHHHhcCcc
Confidence 9999999999998543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=243.20 Aligned_cols=199 Identities=30% Similarity=0.451 Sum_probs=161.7
Q ss_pred CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 022003 11 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 90 (304)
Q Consensus 11 ~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili 90 (304)
..|+||+.+|+|..+...++.||.| +..++.++++-..++++..+-++...++.||.||..+.. |+|||+||+|||+
T Consensus 149 dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILl 225 (391)
T KOG0983|consen 149 DCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILL 225 (391)
T ss_pred CCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEE
Confidence 4699999999999999999999999 668888887777889999999999999999999987543 9999999999999
Q ss_pred CCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 022003 91 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 167 (304)
Q Consensus 91 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 167 (304)
|+.|.+||||||++-++.+.. ......|-+.|||||.+. ...|+..+||||||+.++||.||+.||.+....
T Consensus 226 De~GniKlCDFGIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-- 300 (391)
T KOG0983|consen 226 DERGNIKLCDFGISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-- 300 (391)
T ss_pred ccCCCEEeecccccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--
Confidence 999999999999998765432 234456888999999886 347899999999999999999999999875331
Q ss_pred cchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 168 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
......+. .-..|.+..... .++++.+++..||++|+.+||-..+++++-
T Consensus 301 Fe~ltkvl----------n~ePP~L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 301 FEVLTKVL----------NEEPPLLPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred HHHHHHHH----------hcCCCCCCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 11111111 111133332222 578999999999999999999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=259.81 Aligned_cols=218 Identities=23% Similarity=0.325 Sum_probs=160.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC-----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+.++++++|+||+++++++.... ..++|+||+. ++|.+++.. ..+++..++.++.|++.||+|||+.+
T Consensus 52 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~-- 126 (336)
T cd07849 52 REIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN-- 126 (336)
T ss_pred HHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5899999999999999999876543 5799999995 588887744 36999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
++||||||+||+++.++.+||+|||++......... .......|+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 127 -ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~ 205 (336)
T cd07849 127 -VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205 (336)
T ss_pred -eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999998865432211 11223567899999998764 568999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhcc-------------ccccccccCCccCCC---CCHHHHHHHHHHHHHhccCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGE-------------RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKA 218 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~ 218 (304)
|+.||........ .......... ...+........... .....+.++.++|.+||+.||++
T Consensus 206 G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 282 (336)
T cd07849 206 NRPLFPGKDYLHQ---LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHK 282 (336)
T ss_pred CCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhh
Confidence 9999965422110 0000000000 000000000000000 00112467899999999999999
Q ss_pred CCCHHHHHHH
Q 022003 219 RPLMSEVVEA 228 (304)
Q Consensus 219 Rps~~ell~~ 228 (304)
|||+.|++++
T Consensus 283 Rpt~~e~l~h 292 (336)
T cd07849 283 RITVEEALAH 292 (336)
T ss_pred CcCHHHHhcC
Confidence 9999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=256.80 Aligned_cols=219 Identities=24% Similarity=0.330 Sum_probs=162.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC-----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+.+++.++|+||+++++++... ...|+||||+ +++|.+++... ..+++..+..++.|++.||.|||+.+
T Consensus 53 ~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~-- 128 (337)
T cd07858 53 REIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN-- 128 (337)
T ss_pred HHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 589999999999999999988654 3479999999 57898888654 47999999999999999999999988
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhC
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg 155 (304)
++||||||+||+++.++.+||+|||++....... .......++..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 129 -i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 205 (337)
T cd07858 129 -VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR 205 (337)
T ss_pred -EecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcC
Confidence 9999999999999999999999999998754322 11233467889999998875 5689999999999999999999
Q ss_pred CCCCCCCCCCCCcchhH----------hhhhhhccccccc----cccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 156 RRSMDKNRPNGEHNLVE----------WARPHLGERRRFY----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~----------~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
..||............. +............ ....+.... .....+.++.++|.+||+.+|++|||
T Consensus 206 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps 284 (337)
T cd07858 206 KPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRIT 284 (337)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccC
Confidence 99996542111000000 0000000000000 000000000 01123578899999999999999999
Q ss_pred HHHHHHH
Q 022003 222 MSEVVEA 228 (304)
Q Consensus 222 ~~ell~~ 228 (304)
+++++++
T Consensus 285 ~~ell~h 291 (337)
T cd07858 285 VEEALAH 291 (337)
T ss_pred HHHHHcC
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=259.85 Aligned_cols=223 Identities=22% Similarity=0.319 Sum_probs=162.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEe----CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|+.+|++++||||+++++++.. ....++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+
T Consensus 53 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--- 127 (334)
T cd07855 53 RELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN--- 127 (334)
T ss_pred HHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 58999999999999999998763 346899999994 6899988554 45999999999999999999999988
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcccCCCCCcc--eeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
++||||||+||+++.++.+||+|||++......... .......|+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 128 ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~ 207 (334)
T cd07855 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLG 207 (334)
T ss_pred eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHc
Confidence 999999999999999999999999999765332211 11223568899999999865 468999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhh---------hhhhcc-ccccccccCCccC---CCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWA---------RPHLGE-RRRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~---------~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
|+.||............... ...... ............. .......+.++.++|.+||+.+|.+|||
T Consensus 208 g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 287 (334)
T cd07855 208 RRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT 287 (334)
T ss_pred CCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC
Confidence 99999654321110000000 000000 0000000000000 0001123578999999999999999999
Q ss_pred HHHHHHHh
Q 022003 222 MSEVVEAL 229 (304)
Q Consensus 222 ~~ell~~l 229 (304)
+++++.+.
T Consensus 288 ~~~~l~~~ 295 (334)
T cd07855 288 VEQALQHP 295 (334)
T ss_pred HHHHHhCh
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=262.90 Aligned_cols=221 Identities=27% Similarity=0.347 Sum_probs=168.1
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCC------eeEEEEecCCCCCHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~--~~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
++|+++|++|+|+|||+++++-.+.. ...+|||||.||||...+.+ +...+++.++..++.++..||.|||+
T Consensus 59 ~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE 138 (732)
T KOG4250|consen 59 CREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE 138 (732)
T ss_pred HHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47999999999999999999865543 45899999999999999975 35679999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEE--CCCC--cEEEccccCcccCCCCCcceeeecccccccccCcchhh-cCCCCchhhhHHHHH
Q 022003 73 EAERPVIYRDFKTSNILL--DADY--NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGV 147 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili--~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ 147 (304)
++ |+||||||.||++ ..+| ..||+|||.|+...++. .....+||..|.+||++. ...|+..+|.|||||
T Consensus 139 n~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gv 212 (732)
T KOG4250|consen 139 NG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGV 212 (732)
T ss_pred cC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhh
Confidence 88 9999999999999 3334 36999999999887654 456689999999999998 588999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccc-----------cc--cccccCCccCCCCCHHHHHHHHHHHHHhccC
Q 022003 148 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-----------RR--FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 214 (304)
Q Consensus 148 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 214 (304)
++|+++||..||.............|........ ++ +...+ |. ...........+-.++..+|..
T Consensus 213 tlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~l-P~-p~~Ls~~l~~~~~kwLa~~L~~ 290 (732)
T KOG4250|consen 213 TLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTL-PQ-PNHLSRGLATRLTKWLASMLEW 290 (732)
T ss_pred HHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccC-CC-cccccHHHHhhhhHHHHHHHhh
Confidence 9999999999997654332222222222111110 00 10111 11 2233344455677888899999
Q ss_pred CCCCCC--CHHHHHHHh
Q 022003 215 DPKARP--LMSEVVEAL 229 (304)
Q Consensus 215 dp~~Rp--s~~ell~~l 229 (304)
+|++|. ...+..+.+
T Consensus 291 ~~~~~~~~~~~~~Fa~~ 307 (732)
T KOG4250|consen 291 NPRKRGHEGFDRFFAEV 307 (732)
T ss_pred hHHHhCCCCcchHHHHH
Confidence 999998 555555444
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=255.65 Aligned_cols=222 Identities=27% Similarity=0.310 Sum_probs=161.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC--------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|++++++++|+||+++++++.... .+++||||+. ++|...+......+++..+..++.|+++||+|||+.
T Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~ 134 (311)
T cd07866 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN 134 (311)
T ss_pred HHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5899999999999999999876433 4699999995 578887766666799999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcce---------eeecccccccccCcchhhc-CCCCchhhhH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH---------VSTRVMGTYGYAAPEYVMT-GHLTSRSDVY 143 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 143 (304)
+ ++|+||||+||+++.++.++|+|||+++......... ......++..|+|||++.+ ..++.++|||
T Consensus 135 ~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 211 (311)
T cd07866 135 H---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIW 211 (311)
T ss_pred C---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhH
Confidence 8 9999999999999999999999999998654322111 1122356888999998865 4589999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhh-----hhcccccccc--------ccCCccCCCCCHHHHHHHHHHHHH
Q 022003 144 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-----HLGERRRFYR--------LIDPRLEGHFSIKGAQKAAQLAAH 210 (304)
Q Consensus 144 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~ 210 (304)
||||++|+|++|.+||................. .+........ ...+..... .......+.++|.+
T Consensus 212 slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~ 290 (311)
T cd07866 212 GIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSK 290 (311)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHH
Confidence 999999999999999975433211110000000 0000000000 000000000 01123578899999
Q ss_pred hccCCCCCCCCHHHHHHH
Q 022003 211 CLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 211 ~l~~dp~~Rps~~ell~~ 228 (304)
||+.||.+|||+.|++.+
T Consensus 291 ~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 291 LLSLDPYKRLTASDALEH 308 (311)
T ss_pred HcccCcccCcCHHHHhcC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=248.09 Aligned_cols=204 Identities=22% Similarity=0.321 Sum_probs=164.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++||||+++++++......++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ +
T Consensus 51 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i 127 (260)
T cd08222 51 QEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---I 127 (260)
T ss_pred HHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---c
Confidence 478899999999999999999999999999999999999998853 3456999999999999999999999988 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+|+||+|+||+++. +.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 128 ~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~ 204 (260)
T cd08222 128 LHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA 204 (260)
T ss_pred cccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999975 5799999999876543221 22335678899999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|..... ........ ....+ ..+...+.++.++|.+||+.+|++||++.|++++
T Consensus 205 ~~~~~~------~~~~~~~~-------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 205 FEGQNF------LSVVLRIV-------EGPTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCccH------HHHHHHHH-------cCCCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 854321 11111000 00011 1223456789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=250.92 Aligned_cols=214 Identities=24% Similarity=0.341 Sum_probs=167.1
Q ss_pred ChHhhHhhcCCCCcccceeeEEEe-CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
++|.+|.+.|+||.||++|+++.- .+.+|-|+|||+|.+|+-++.++. .+++.++..|+.||+.||.||.... .+||
T Consensus 515 cREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEik-pPII 592 (775)
T KOG1151|consen 515 CREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIK-PPII 592 (775)
T ss_pred HHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccC-CCee
Confidence 579999999999999999999865 557899999999999999997654 6999999999999999999999877 6799
Q ss_pred eccCCCCCeEECC---CCcEEEccccCcccCCCCCcc-----eeeecccccccccCcchhhcC----CCCchhhhHHHHH
Q 022003 80 YRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGV 147 (304)
Q Consensus 80 H~dlkp~Nili~~---~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~ 147 (304)
|-||||.|||+-. -|.+||+|||+++.+.+.... .......||.||.+||.+.-+ .++.|+||||+|+
T Consensus 593 HYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGV 672 (775)
T KOG1151|consen 593 HYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGV 672 (775)
T ss_pred eeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeeh
Confidence 9999999999943 478999999999987654322 233457899999999987633 4789999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 148 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 148 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
|+|.++.|+.||+.+... ..+...-..... .+.-.|... -.+.++.++|++||++.-++|....++..
T Consensus 673 IFyQClYGrKPFGhnqsQ--QdILqeNTIlkA-----tEVqFP~KP-----vVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 673 IFYQCLYGRKPFGHNQSQ--QDILQENTILKA-----TEVQFPPKP-----VVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhhhhhccCCCCCCchhH--HHHHhhhchhcc-----eeccCCCCC-----ccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 999999999999865321 111111000000 011111111 12468899999999999999999888775
Q ss_pred H
Q 022003 228 A 228 (304)
Q Consensus 228 ~ 228 (304)
+
T Consensus 741 d 741 (775)
T KOG1151|consen 741 D 741 (775)
T ss_pred C
Confidence 3
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=247.21 Aligned_cols=217 Identities=24% Similarity=0.328 Sum_probs=162.3
Q ss_pred hHhhHhhcC---CCCcccceeeEEEeCCe-----eEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDL---VHLNLVKLIGYCIEDDQ-----RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l---~h~niv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|+.+++++ +|+||+++++++...+. .+++|||+. ++|.+++.... ..+++..++.++.|++.||.|||+
T Consensus 47 ~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~ 125 (287)
T cd07838 47 REIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125 (287)
T ss_pred HHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 466666655 69999999999998776 899999996 58988886543 368999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
.+ ++|+||+|+||+++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|
T Consensus 126 ~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l 199 (287)
T cd07838 126 HR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199 (287)
T ss_pred CC---eeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHH
Confidence 88 99999999999999999999999999987643321 1223468889999999998999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhh-------cc-----ccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHL-------GE-----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~-------~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 220 (304)
++|.+||......+. ...+..... .. ...+........ .......+..+.++|.+||+.||.+||
T Consensus 200 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (287)
T cd07838 200 FRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRI 276 (287)
T ss_pred HhCCCcccCCChHHH--HHHHHHHcCCCChHhcCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCC
Confidence 999999875432211 111100000 00 000000000000 111123357889999999999999999
Q ss_pred CHHHHHHH
Q 022003 221 LMSEVVEA 228 (304)
Q Consensus 221 s~~ell~~ 228 (304)
++.+++.+
T Consensus 277 ~~~~il~~ 284 (287)
T cd07838 277 SAFEALQH 284 (287)
T ss_pred CHHHHhcC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=255.32 Aligned_cols=221 Identities=25% Similarity=0.322 Sum_probs=159.5
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeC----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+++++++ +|+||+++++++... ...++++||+ +++|.+.+.. ...+++..++.++.||+.||+|||+.+
T Consensus 50 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g-- 125 (332)
T cd07857 50 RELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN-- 125 (332)
T ss_pred HHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 589999999 599999999976533 4578899999 4689988854 347999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcc--eeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHH
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~ 153 (304)
++||||||+||+++.++.+||+|||+++........ .......|+..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 126 -ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~ 204 (332)
T cd07857 126 -VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204 (332)
T ss_pred -cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999865432211 11223568999999998775 56899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchh---------Hhhhhhhccc-ccccccc----CCccCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 022003 154 TGRRSMDKNRPNGEHNLV---------EWARPHLGER-RRFYRLI----DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219 (304)
Q Consensus 154 tg~~p~~~~~~~~~~~~~---------~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 219 (304)
+|..||............ .......... ..+.... ...+. ......+..+.+++.+||+.||++|
T Consensus 205 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R 283 (332)
T cd07857 205 GRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKR 283 (332)
T ss_pred hCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccC
Confidence 999998754321100000 0000000000 0000000 00000 0000124678999999999999999
Q ss_pred CCHHHHHHH
Q 022003 220 PLMSEVVEA 228 (304)
Q Consensus 220 ps~~ell~~ 228 (304)
||+.+++++
T Consensus 284 ~t~~~ll~~ 292 (332)
T cd07857 284 ISVEEALEH 292 (332)
T ss_pred CCHHHHhcC
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=251.26 Aligned_cols=219 Identities=21% Similarity=0.269 Sum_probs=165.6
Q ss_pred hHhhHhhcCCC--C----cccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 2 AEVNFLGDLVH--L----NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 2 ~E~~il~~l~h--~----niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
-|+++|.+|.+ | -+|++.++|...++.|||+|.+ |-|+.+++..+ ..+++...+..+.+||+++++|||+.+
T Consensus 134 iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k 212 (415)
T KOG0671|consen 134 IEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK 212 (415)
T ss_pred HHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc
Confidence 48999999943 3 3788889999999999999999 77999999774 567999999999999999999999988
Q ss_pred CCCeEeccCCCCCeEECC--------------------CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC
Q 022003 75 ERPVIYRDFKTSNILLDA--------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 134 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~--------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 134 (304)
++|.||||+|||+.+ +-.++|+|||.|+...... ...+.|..|+|||++.+.
T Consensus 213 ---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL 284 (415)
T KOG0671|consen 213 ---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL 284 (415)
T ss_pred ---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc
Confidence 999999999999932 3358999999998754433 345678999999999999
Q ss_pred CCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhcc----cc---------cc-----------ccccCC
Q 022003 135 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE----RR---------RF-----------YRLIDP 190 (304)
Q Consensus 135 ~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~---------~~-----------~~~~~~ 190 (304)
+++..+||||+||||+|+.||...|......+...+++........ +. ++ ....++
T Consensus 285 GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ 364 (415)
T KOG0671|consen 285 GWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEP 364 (415)
T ss_pred CcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcC
Confidence 9999999999999999999999999876533322222111110000 00 00 000000
Q ss_pred cc----CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 191 RL----EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 191 ~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.. .......+..++++||++||..||.+|+|+.|++.+.
T Consensus 365 ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 365 CKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHP 407 (415)
T ss_pred CccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCH
Confidence 00 0001223456899999999999999999999999853
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=243.36 Aligned_cols=203 Identities=32% Similarity=0.415 Sum_probs=165.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++.+..++..++||||+.+++|.+++.... .+++..++.++.|+++||.|||+.+ ++|+
T Consensus 42 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~ 117 (250)
T cd05123 42 TERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLG---IIYR 117 (250)
T ss_pred HHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 58899999999999999999999999999999999999999996553 6899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 118 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 118 DLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred CCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999998754321 123345678899999999888899999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH---HHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM---SEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~ell~~ 228 (304)
... .... ....... .. ++...+..+.+++.+||..||++||++ ++++++
T Consensus 196 ~~~---~~~~---~~~~~~~--------~~----~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 196 EDR---KEIY---EKILKDP--------LR----FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCH---HHHH---HHHhcCC--------CC----CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 432 1111 1000000 01 111225688999999999999999999 566553
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=249.10 Aligned_cols=208 Identities=28% Similarity=0.367 Sum_probs=163.1
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++++ +|+||+++++.+..+...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|
T Consensus 53 ~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H 128 (290)
T cd05613 53 TERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIY 128 (290)
T ss_pred HHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 488999999 6899999999999999999999999999999998654 46899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc--CCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|||+|+||+++.++.+||+|||++........ .......|+..|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus 129 ~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p 207 (290)
T cd05613 129 RDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207 (290)
T ss_pred cCCCHHHeEECCCCCEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999987543221 11223568889999999875 3578899999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~ 228 (304)
|....... ............ .+. ++...+..+.+++.+||+.||++|| ++++++++
T Consensus 208 ~~~~~~~~--~~~~~~~~~~~~--------~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 208 FTVDGEKN--SQAEISRRILKS--------EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCcCCccc--cHHHHHHHhhcc--------CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 86432211 111111111110 011 1122356788999999999999997 66777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=251.33 Aligned_cols=205 Identities=26% Similarity=0.346 Sum_probs=167.1
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++++. |+||+++++++..++..++|||++.+++|.+++.+.. .+++..++.++.|++.||.|||+.+ ++|
T Consensus 50 ~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H 125 (280)
T cd05581 50 IEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKG---IIH 125 (280)
T ss_pred HHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 5788999998 9999999999999999999999999999999996654 7999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcc------------------eeeecccccccccCcchhhcCCCCchhhh
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDV 142 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 142 (304)
+||+|+||+++.++.++|+|||++......... .......++..|+|||+..+..++.++||
T Consensus 126 ~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di 205 (280)
T cd05581 126 RDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDL 205 (280)
T ss_pred cCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhH
Confidence 999999999999999999999998875432211 12233567889999999988889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 143 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 143 wslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
||||++++++++|..||....... ... ..... ....+...+..+.++|.+||+.+|.+|||+
T Consensus 206 ~slG~~l~~l~~g~~p~~~~~~~~---~~~---~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 206 WALGCIIYQMLTGKPPFRGSNEYL---TFQ---KILKL------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHH---HHH---HHHhc------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 999999999999999997553111 000 00000 001112225688999999999999999999
Q ss_pred ----HHHHHH
Q 022003 223 ----SEVVEA 228 (304)
Q Consensus 223 ----~ell~~ 228 (304)
++++++
T Consensus 268 ~~~~~~ll~~ 277 (280)
T cd05581 268 NEGYDELKAH 277 (280)
T ss_pred ccCHHHHhcC
Confidence 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=247.77 Aligned_cols=210 Identities=28% Similarity=0.352 Sum_probs=164.7
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++.++ +|+||+++++.+..++..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|
T Consensus 53 ~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H 128 (288)
T cd05583 53 TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIY 128 (288)
T ss_pred HHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 588899999 5999999999999999999999999999999998654 46899999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC--CCchhhhHHHHHHHHHHHhCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p 158 (304)
+||+|+||+++.++.++|+|||+++........ ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..|
T Consensus 129 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p 207 (288)
T cd05583 129 RDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207 (288)
T ss_pred cCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCC
Confidence 999999999999999999999998765433211 122345788999999987654 78899999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
|....... ............ .+.. +...+..+.+++.+||+.||++|||+.++.+.|+
T Consensus 208 ~~~~~~~~--~~~~~~~~~~~~--------~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 208 FTVDGEQN--SQSEISRRILKS--------KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred cccCcccc--hHHHHHHHHHcc--------CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 86432211 111111111110 0111 1123467889999999999999999877766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=250.91 Aligned_cols=221 Identities=26% Similarity=0.313 Sum_probs=162.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC----------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD----------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 71 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~----------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH 71 (304)
+|++++++++||||+++++++.+.. ..++||||+++ +|...+......+++..+..++.|++.||+|||
T Consensus 55 ~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH 133 (302)
T cd07864 55 REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH 133 (302)
T ss_pred HHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5889999999999999999987654 78999999965 787877666567999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHH
Q 022003 72 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 72 ~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ 150 (304)
+.+ ++|+||||+||+++.++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||+++
T Consensus 134 ~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~ 209 (302)
T cd07864 134 KKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 209 (302)
T ss_pred hCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHH
Confidence 988 999999999999999999999999999875433221 1122345778999998865 45789999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhh--------hhcccccccc-----ccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARP--------HLGERRRFYR-----LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
+|++|++||................. ...+...+.. .......... ...+..+.+++.+||+.||.
T Consensus 210 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~ 288 (302)
T cd07864 210 ELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPS 288 (302)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChh
Confidence 99999999975432111100000000 0000000000 0000000000 01256889999999999999
Q ss_pred CCCCHHHHHHH
Q 022003 218 ARPLMSEVVEA 228 (304)
Q Consensus 218 ~Rps~~ell~~ 228 (304)
+|||+++++++
T Consensus 289 ~Rp~~~~il~~ 299 (302)
T cd07864 289 KRCTAEEALNS 299 (302)
T ss_pred hCCCHHHHhcC
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=247.67 Aligned_cols=220 Identities=27% Similarity=0.391 Sum_probs=165.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|+||+++++++...+..++||||+. ++|.+++.+....+++..+..++.|++.||.|||+.+ ++||
T Consensus 47 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~ 122 (282)
T cd07829 47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHR 122 (282)
T ss_pred HHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 58899999999999999999999999999999996 5999999776557999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++|||||||++++|++|..||.
T Consensus 123 ~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 123 DLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred CCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999887543221 12223457789999998766 78999999999999999999999986
Q ss_pred CCCCCCCcchh----------Hhhhhh-hc-cccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLV----------EWARPH-LG-ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~----------~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
........... .|.... .. ....+............ ...+..+.++|.+||..||++||++.+++.+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 201 GDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred CccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 64321110000 000000 00 00000000000000001 1125689999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=253.32 Aligned_cols=222 Identities=25% Similarity=0.339 Sum_probs=165.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC-----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+++++.++|+||+++++++...+ ..|+||||+. ++|.+++.+.. .+++..++.++.||+.||+|||+.+
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g-- 123 (330)
T cd07834 48 REIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN-- 123 (330)
T ss_pred HHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5899999999999999999988775 7899999996 58998886544 7999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHh
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t 154 (304)
++|+||||+||+++.++.++|+|||++......... .......++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 124 -i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~ 202 (330)
T cd07834 124 -VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202 (330)
T ss_pred -eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHc
Confidence 999999999999999999999999999876543210 112334678899999999877 88999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhH----------hhhhhhccccccccccCCcc---CCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVE----------WARPHLGERRRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
|..||............. +..........+........ ........+..+.++|.+||+.+|.+|||
T Consensus 203 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 282 (330)
T cd07834 203 RKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282 (330)
T ss_pred CCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC
Confidence 999997654211100000 00000000000000000000 00001123568899999999999999999
Q ss_pred HHHHHHH
Q 022003 222 MSEVVEA 228 (304)
Q Consensus 222 ~~ell~~ 228 (304)
+++++++
T Consensus 283 ~~~ll~~ 289 (330)
T cd07834 283 ADEALAH 289 (330)
T ss_pred HHHHHhC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=250.53 Aligned_cols=207 Identities=30% Similarity=0.446 Sum_probs=159.1
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeE
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ii 79 (304)
+|+.++.++ .|+||+++++++......++||||+ +++|.+++......+++..+..++.|++.||+|||+ .+ ++
T Consensus 62 ~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~ 137 (296)
T cd06618 62 MDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VI 137 (296)
T ss_pred HHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---Ee
Confidence 356656666 5999999999999999999999999 558888876655579999999999999999999997 47 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC----CCCchhhhHHHHHHHHHHHhC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~tg 155 (304)
||||+|+||+++.++.+||+|||++........ .....++..|+|||++.+. .++.++||||||+++|+|++|
T Consensus 138 H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g 214 (296)
T cd06618 138 HRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG 214 (296)
T ss_pred cCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhC
Confidence 999999999999999999999999876543221 1223567889999998754 388999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
+.||...... ...... ...... +.... ....+.++.+++.+||..||.+||++++++++.
T Consensus 215 ~~p~~~~~~~--~~~~~~---~~~~~~-------~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 215 QFPYKNCKTE--FEVLTK---ILQEEP-------PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCCCcchhH--HHHHHH---HhcCCC-------CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 9999643211 011100 000000 00000 012346789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=247.08 Aligned_cols=219 Identities=28% Similarity=0.420 Sum_probs=164.3
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+..+++++ |+||+++++++..++..++||||+ +++|.+++.... ..+++..+..++.|++.+|.|||+.+ ++
T Consensus 46 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~ 121 (283)
T cd07830 46 REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FF 121 (283)
T ss_pred HHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 5888999998 999999999999999999999999 789998886653 57899999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-cCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|+||+|+||+++.++.++|+|||++........ .....++..|+|||++. +..++.++||||||+++++|++|..|
T Consensus 122 H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~ 198 (283)
T cd07830 122 HRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPL 198 (283)
T ss_pred cCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCc
Confidence 999999999999999999999999986543221 12345788999999875 45689999999999999999999999
Q ss_pred CCCCCCCCCcch----------hHhhhhh-hcccc--ccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 159 MDKNRPNGEHNL----------VEWARPH-LGERR--RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 159 ~~~~~~~~~~~~----------~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
|......+.... ..|.... ..... .+......... ......+.++.++|.+||+.||++|||++|+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 277 (283)
T cd07830 199 FPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQA 277 (283)
T ss_pred cCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHH
Confidence 965533211000 0000000 00000 00000000000 0001114689999999999999999999999
Q ss_pred HHH
Q 022003 226 VEA 228 (304)
Q Consensus 226 l~~ 228 (304)
+.+
T Consensus 278 ~~~ 280 (283)
T cd07830 278 LQH 280 (283)
T ss_pred hhC
Confidence 875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=271.28 Aligned_cols=212 Identities=29% Similarity=0.456 Sum_probs=171.7
Q ss_pred ChHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHH
Q 022003 1 MAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAA 64 (304)
Q Consensus 1 l~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~ 64 (304)
+.|+++|+.+ +|+||+.+++.|...+..++|+||+..|+|.++++++. ..++......++.||+
T Consensus 349 ~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa 428 (609)
T KOG0200|consen 349 MSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIA 428 (609)
T ss_pred HHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHH
Confidence 3689999999 69999999999999999999999999999999997765 3488999999999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeee-cccccccccCcchhhcCCCCchhhhH
Q 022003 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTSRSDVY 143 (304)
Q Consensus 65 ~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Diw 143 (304)
.|++||++.. ++||||...||||.++..+||+|||+++............ ...-...|||||.+....|+.++|||
T Consensus 429 ~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVW 505 (609)
T KOG0200|consen 429 NGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVW 505 (609)
T ss_pred HHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhh
Confidence 9999999988 9999999999999999999999999999755433332221 11124569999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 144 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 144 slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
|+|+++|||+| |..||.+..... .+.+ .+. .......+..+..+++++++.||+.+|++||++
T Consensus 506 SfGI~L~EifsLG~~PYp~~~~~~--~l~~----~l~----------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F 569 (609)
T KOG0200|consen 506 SFGILLWEIFTLGGTPYPGIPPTE--ELLE----FLK----------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTF 569 (609)
T ss_pred HHHHHHHHHhhCCCCCCCCCCcHH--HHHH----HHh----------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence 99999999998 678886622111 1111 111 111222334456899999999999999999999
Q ss_pred HHHHHHhCC
Q 022003 223 SEVVEALKP 231 (304)
Q Consensus 223 ~ell~~l~~ 231 (304)
.++.+.+..
T Consensus 570 ~~~~~~~~~ 578 (609)
T KOG0200|consen 570 SECVEFFEK 578 (609)
T ss_pred HHHHHHHHH
Confidence 999998876
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=256.43 Aligned_cols=217 Identities=24% Similarity=0.336 Sum_probs=161.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCe------eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+.++++++|+||+++++++...+. .++|+||+ +++|.+++.. ..+++..++.++.|++.||+|||+.+
T Consensus 63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g- 138 (343)
T cd07851 63 RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG- 138 (343)
T ss_pred HHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 58999999999999999998876554 89999999 7799998865 36999999999999999999999988
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
++||||||+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 139 --i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt 211 (343)
T cd07851 139 --IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211 (343)
T ss_pred --eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHh
Confidence 999999999999999999999999999875432 223457888999999865 468899999999999999999
Q ss_pred CCCCCCCCCCCCCcchh-H--------hhhhhhcc-ccccccccCCccCCCC---CHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLV-E--------WARPHLGE-RRRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~-~--------~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
|..||............ . +....... ...+...........+ ....+..+.++|.+||+.||++|||
T Consensus 212 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt 291 (343)
T cd07851 212 GKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT 291 (343)
T ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC
Confidence 99999754321110000 0 00000000 0000000000000000 0112568999999999999999999
Q ss_pred HHHHHHHh
Q 022003 222 MSEVVEAL 229 (304)
Q Consensus 222 ~~ell~~l 229 (304)
+.|++++-
T Consensus 292 ~~ell~h~ 299 (343)
T cd07851 292 AAEALAHP 299 (343)
T ss_pred HHHHhcCC
Confidence 99999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=247.26 Aligned_cols=197 Identities=26% Similarity=0.390 Sum_probs=165.4
Q ss_pred ChHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
|.|-++|... +-|.+++++..|.+-+.+|+||||+.||+|.-+|++-+ ++.+..+..++..|+-||-+||++| ||
T Consensus 397 m~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kg---Ii 472 (683)
T KOG0696|consen 397 MVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKG---II 472 (683)
T ss_pred ehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCC---ee
Confidence 4566777666 45788899999999999999999999999999997765 6889999999999999999999999 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
+||||.+|||++.+|.+||+|||+++.-.... .+..+++||+.|+|||++...+|+.++|.||+|++||||+.|++||
T Consensus 473 YRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPF 550 (683)
T KOG0696|consen 473 YRDLKLDNVMLDSEGHIKIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 550 (683)
T ss_pred eeeccccceEeccCCceEeeecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999998643322 3456789999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
++.+..+.... +.+. .-.++...+.++.+++...|...|.+|..
T Consensus 551 dGeDE~elF~a----------------I~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 551 DGEDEDELFQA----------------IMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CCCCHHHHHHH----------------HHHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 87654322111 1111 12355566789999999999999999963
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=253.55 Aligned_cols=214 Identities=24% Similarity=0.363 Sum_probs=157.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|++++++++|+||+++++++.... ..++||||+. .+|..++ ...+++..+..++.|++.||+|||+.+
T Consensus 63 ~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~- 137 (342)
T cd07879 63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG- 137 (342)
T ss_pred HHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 6899999999999999999987543 4699999995 5777765 235899999999999999999999988
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
++||||||+||+++.++.+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 138 --i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~ 210 (342)
T cd07879 138 --IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210 (342)
T ss_pred --cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHh
Confidence 999999999999999999999999998764322 123456888999999876 568999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhh--------hhhcc--cccccc----ccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWAR--------PHLGE--RRRFYR----LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 220 (304)
|+.||................ ..... ...+.. .........+ ...+..+.++|.+||+.||++||
T Consensus 211 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 211 GKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCc
Confidence 999997543211100000000 00000 000000 0000000000 01245788999999999999999
Q ss_pred CHHHHHHH
Q 022003 221 LMSEVVEA 228 (304)
Q Consensus 221 s~~ell~~ 228 (304)
++.+++.+
T Consensus 290 ~~~e~l~h 297 (342)
T cd07879 290 TATEALEH 297 (342)
T ss_pred CHHHHhcC
Confidence 99999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=241.16 Aligned_cols=218 Identities=24% Similarity=0.324 Sum_probs=166.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|..++..++|+||++++.++.-.+ +.|+|||++ ..+|...+. ..++-+.+..++.|++.|++|||+.+
T Consensus 64 rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~- 138 (369)
T KOG0665|consen 64 RELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG- 138 (369)
T ss_pred hhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc-
Confidence 6899999999999999999987543 569999999 679999886 35788999999999999999999999
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
|+||||||+||++..++.+||.|||+|+.-... ...+..+.|..|+|||++.+..|.+.+||||+||++.||++|
T Consensus 139 --IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~ 213 (369)
T KOG0665|consen 139 --IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILG 213 (369)
T ss_pred --eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhc
Confidence 999999999999999999999999999874332 234446678899999999998899999999999999999999
Q ss_pred CCCCCCCCCCCCcchh----------------Hhhhhhhccc-----ccccccc-CCccCC--CCCHHHHHHHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLV----------------EWARPHLGER-----RRFYRLI-DPRLEG--HFSIKGAQKAAQLAAHC 211 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~----------------~~~~~~~~~~-----~~~~~~~-~~~~~~--~~~~~~~~~~~~li~~~ 211 (304)
...|.+....++-... ..++...... ..+.+.+ |..+.. ..+......+++++.+|
T Consensus 214 ~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~M 293 (369)
T KOG0665|consen 214 TVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKM 293 (369)
T ss_pred eEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHh
Confidence 9988754332211000 0000000000 1111111 111111 11122356889999999
Q ss_pred ccCCCCCCCCHHHHHHHh
Q 022003 212 LSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~l 229 (304)
|..||++|.|++++|.|.
T Consensus 294 Lvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 294 LVIDPEKRISVDDALRHP 311 (369)
T ss_pred hccChhhcccHHHHhcCC
Confidence 999999999999999874
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=253.27 Aligned_cols=221 Identities=22% Similarity=0.307 Sum_probs=157.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--------------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 67 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--------------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l 67 (304)
+|++++++++||||+++++++... ...++||||+. ++|.+++... .+++..++.++.||++||
T Consensus 51 ~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL 127 (342)
T cd07854 51 REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGL 127 (342)
T ss_pred HHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHH
Confidence 589999999999999999876654 35789999995 5898887543 589999999999999999
Q ss_pred HHhhcCCCCCeEeccCCCCCeEECC-CCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhc-CCCCchhhhHH
Q 022003 68 AFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYS 144 (304)
Q Consensus 68 ~~LH~~~~~~iiH~dlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 144 (304)
.|||+.+ ++||||||+||+++. ++.+||+|||+++........ .......++..|+|||++.+ ..++.++||||
T Consensus 128 ~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwS 204 (342)
T cd07854 128 KYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 204 (342)
T ss_pred HHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHH
Confidence 9999988 999999999999974 567899999999765322111 11122357889999998754 56889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhc--ccccccc----ccC-CccCC-----CCCHHHHHHHHHHHHHhc
Q 022003 145 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--ERRRFYR----LID-PRLEG-----HFSIKGAQKAAQLAAHCL 212 (304)
Q Consensus 145 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----~~~-~~~~~-----~~~~~~~~~~~~li~~~l 212 (304)
|||++|+|++|+.||.................... ....+.. ... ..... ......+.++.+||.+||
T Consensus 205 lGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 284 (342)
T cd07854 205 AGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQIL 284 (342)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHh
Confidence 99999999999999975533211100000000000 0000000 000 00000 000123467889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 022003 213 SRDPKARPLMSEVVEA 228 (304)
Q Consensus 213 ~~dp~~Rps~~ell~~ 228 (304)
+.||++|||+.|++++
T Consensus 285 ~~dP~~R~t~~ell~h 300 (342)
T cd07854 285 TFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCchhccCHHHHhCC
Confidence 9999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=251.95 Aligned_cols=214 Identities=23% Similarity=0.323 Sum_probs=159.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|++++++++|+||+++++++... ...+++++++ +++|.+++... .+++..++.++.|++.||+|||+.+
T Consensus 65 ~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~- 140 (345)
T cd07877 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD- 140 (345)
T ss_pred HHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 589999999999999999988643 3468888888 78998887543 5899999999999999999999988
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
++||||||+||+++.++.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 141 --ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 213 (345)
T cd07877 141 --IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213 (345)
T ss_pred --eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999998864322 223467889999998876 568999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccc------------ccccccc----CCccCCCCCHHHHHHHHHHHHHhccCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGER------------RRFYRLI----DPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 218 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 218 (304)
|..||......... ........... ..+...+ ..... ......+.++.++|.+||+.||.+
T Consensus 214 g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~ 290 (345)
T cd07877 214 GRTLFPGTDHIDQL--KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDK 290 (345)
T ss_pred CCCCCCCCCHHHHH--HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhh
Confidence 99999654321110 00000000000 0000000 00000 000012467899999999999999
Q ss_pred CCCHHHHHHHh
Q 022003 219 RPLMSEVVEAL 229 (304)
Q Consensus 219 Rps~~ell~~l 229 (304)
||++.+++.+-
T Consensus 291 R~t~~e~l~h~ 301 (345)
T cd07877 291 RITAAQALAHA 301 (345)
T ss_pred cCCHHHHhcCh
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=251.45 Aligned_cols=216 Identities=24% Similarity=0.331 Sum_probs=159.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+++|++++|+||+++++++..+. ..++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+.+
T Consensus 63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g- 138 (343)
T cd07880 63 RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG- 138 (343)
T ss_pred HHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 6899999999999999999987654 458999999 7899988754 36899999999999999999999988
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
|+||||||+||+++.++.++|+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 --i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~ 211 (343)
T cd07880 139 --IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211 (343)
T ss_pred --eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999865332 123456889999999876 468999999999999999999
Q ss_pred CCCCCCCCCCCCCcchh---------Hhhhhhhcc-ccccccccCCccC---CCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLV---------EWARPHLGE-RRRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~---------~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
|..||............ .+....... ...+...+..... .......+.++.++|.+||+.||.+|||
T Consensus 212 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t 291 (343)
T cd07880 212 GKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT 291 (343)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC
Confidence 99999754321100000 000000000 0000000000000 0001123457899999999999999999
Q ss_pred HHHHHHH
Q 022003 222 MSEVVEA 228 (304)
Q Consensus 222 ~~ell~~ 228 (304)
+.+++++
T Consensus 292 ~~~~l~~ 298 (343)
T cd07880 292 AAEALAH 298 (343)
T ss_pred HHHHhcC
Confidence 9999974
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=249.07 Aligned_cols=215 Identities=25% Similarity=0.355 Sum_probs=160.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEe-CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++||||+++++++.. ....++||||+ +++|.+++... .+++..+..++.|+++||.|||+.+ ++|
T Consensus 58 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---iiH 131 (328)
T cd07856 58 RELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG---VVH 131 (328)
T ss_pred HHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 58999999999999999999876 55789999999 67998887543 5888999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
|||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||
T Consensus 132 ~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f 206 (328)
T cd07856 132 RDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206 (328)
T ss_pred CCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998754321 122456788999998765 57899999999999999999999999
Q ss_pred CCCCCCCCcch---------hHhhhhhhc-cccccccccCCccCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 160 DKNRPNGEHNL---------VEWARPHLG-ERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 160 ~~~~~~~~~~~---------~~~~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
........... .++...... ...++..... .....+ ...+..+.++|.+||+.+|++|||+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e 284 (328)
T cd07856 207 PGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP--KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284 (328)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcc--ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 65432110000 000000000 0000000000 000000 112468899999999999999999999
Q ss_pred HHHHh
Q 022003 225 VVEAL 229 (304)
Q Consensus 225 ll~~l 229 (304)
++.+-
T Consensus 285 ll~~~ 289 (328)
T cd07856 285 ALAHP 289 (328)
T ss_pred HhcCC
Confidence 99863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=265.36 Aligned_cols=207 Identities=24% Similarity=0.255 Sum_probs=165.1
Q ss_pred HhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 82 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d 82 (304)
|-.||.--+.+-|++++-.|.++.++|+||||++||+|-.++.+.. ++++..++.++..|+.||..||+.| +||||
T Consensus 125 ERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRD 200 (1317)
T KOG0612|consen 125 ERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRD 200 (1317)
T ss_pred HhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceecc
Confidence 4556666667889999999999999999999999999999998777 8999999999999999999999999 99999
Q ss_pred CCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh----c-CCCCchhhhHHHHHHHHHHHhCCC
Q 022003 83 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----T-GHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 83 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~el~tg~~ 157 (304)
|||+|||||..|++||+|||.+-.+...+.. ....-+|||.|++||++. + +.|+..+|.||+|+++|||++|..
T Consensus 201 iKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~T 279 (1317)
T KOG0612|consen 201 IKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGET 279 (1317)
T ss_pred CCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCC
Confidence 9999999999999999999999887654333 344568999999999986 3 579999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHHh
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEAL 229 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~~l 229 (304)
||......+....+. ...+.-.|+.. .+.+.++.+||.+.+. +|+.|.. ++++..|.
T Consensus 280 PFYadslveTY~KIm----~hk~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 280 PFYADSLVETYGKIM----NHKESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred cchHHHHHHHHHHHh----chhhhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 997543221111110 11111111111 1246789999999876 6788886 88877754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=250.28 Aligned_cols=199 Identities=26% Similarity=0.384 Sum_probs=159.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
.|-.||..-+.+-||++|-.|.+.+.+|+||+|++||++..+|.+.+ -|+++.++.++..|.+|+++.|+.| +|||
T Consensus 678 AERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIHR 753 (1034)
T KOG0608|consen 678 AERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIHR 753 (1034)
T ss_pred hhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---ceec
Confidence 37789999999999999999999999999999999999999998876 5999999999999999999999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccC---------CCCCc-------------------------------ceeeecccc
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDG---------PEGDK-------------------------------THVSTRVMG 121 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~---------~~~~~-------------------------------~~~~~~~~g 121 (304)
||||+|||||.+|++||+|||++.-+ ..++- .......+|
T Consensus 754 DiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvg 833 (1034)
T KOG0608|consen 754 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVG 833 (1034)
T ss_pred ccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcC
Confidence 99999999999999999999998621 11000 000112579
Q ss_pred cccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcc-hhHhhhhhhccccccccccCCccCCCCCHHH
Q 022003 122 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRRFYRLIDPRLEGHFSIKG 200 (304)
Q Consensus 122 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (304)
|+.|+|||++....|+..+|.||.|+|||||+.|++||....+.+... ++.|.. .++-... .+.
T Consensus 834 t~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~-----------~l~~~~~----~~l 898 (1034)
T KOG0608|consen 834 TPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN-----------FLHIPYQ----GNL 898 (1034)
T ss_pred CCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh-----------ccccccc----ccc
Confidence 999999999999999999999999999999999999998877765432 222221 1111111 233
Q ss_pred HHHHHHHHHHhccCCCCCCC
Q 022003 201 AQKAAQLAAHCLSRDPKARP 220 (304)
Q Consensus 201 ~~~~~~li~~~l~~dp~~Rp 220 (304)
+.++.+||.+++. ++++|.
T Consensus 899 s~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 899 SKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred CHHHHHHHHHHhc-Chhhhh
Confidence 5678888888543 566776
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=256.84 Aligned_cols=207 Identities=29% Similarity=0.362 Sum_probs=171.1
Q ss_pred HhhHhhcC-CCCcccceeeEEEe-----CCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 3 EVNFLGDL-VHLNLVKLIGYCIE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 3 E~~il~~l-~h~niv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
|++||+.+ .|||++.+|++|.. ++.++||||||.|||.-|+++.- +..+.|+.+..|++.++.||.+||+..
T Consensus 65 eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk- 143 (953)
T KOG0587|consen 65 EYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK- 143 (953)
T ss_pred HHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc-
Confidence 67788888 69999999999875 45799999999999999998653 667999999999999999999999988
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-----CCCCchhhhHHHHHHHH
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ 150 (304)
++|||||-.|||++.++.|||.|||++..... .....++.+||+.|||||++.. ..|+..+|+||||++..
T Consensus 144 --viHRDikG~NiLLT~e~~VKLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaI 219 (953)
T KOG0587|consen 144 --VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAI 219 (953)
T ss_pred --eeeecccCceEEEeccCcEEEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceee
Confidence 99999999999999999999999999987643 2233556789999999999864 35788999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
||.-|.+|+....+.-.... ..-+|...-..+...++++.++|..||..|.++||++.++++|.
T Consensus 220 EladG~PPl~DmHPmraLF~---------------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 220 EMAEGAPPLCDMHPMRALFL---------------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred hhcCCCCCccCcchhhhhcc---------------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 99999999976654321110 01112222223556789999999999999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=263.64 Aligned_cols=100 Identities=28% Similarity=0.339 Sum_probs=93.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|+||+++++++......|+||||+.+++|.+++... ..+++..++.++.||+.||+|||..+ |+||
T Consensus 53 ~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHr 128 (669)
T cd05610 53 AERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHR 128 (669)
T ss_pred HHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeC
Confidence 4788999999999999999999999999999999999999998654 36899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcc
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAK 105 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~ 105 (304)
||||+||||+.++.+||+|||+++
T Consensus 129 DLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 129 DLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=231.25 Aligned_cols=206 Identities=31% Similarity=0.415 Sum_probs=166.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++.+++++|+||+++++++......+++|||+.+++|.+++.... .+++..++.++.+++.++.+||+.+ ++|+
T Consensus 36 ~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~ 111 (244)
T smart00220 36 REISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNG---IIHR 111 (244)
T ss_pred HHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecC
Confidence 58899999999999999999999999999999999889999986544 3899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|.||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++||||||+++++|++|..||..
T Consensus 112 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 112 DLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998765432 22345678899999999988899999999999999999999999865
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.... ........ .... . .. ......+.++.+++.+||..+|++||++.+++++
T Consensus 189 ~~~~--~~~~~~~~---~~~~---~---~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 189 DDQL--LELFKKIG---KPKP---P---FP---PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CCcH--HHHHHHHh---ccCC---C---Cc---cccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 3111 11111100 0000 0 00 0000034688999999999999999999999973
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-33 Score=253.73 Aligned_cols=207 Identities=27% Similarity=0.381 Sum_probs=160.1
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCC---CHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l---~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+||..|+.- +|||||++|+.-.+.+..||..|.| ..+|.+++......+ .....+.++.|++.||++||+.+
T Consensus 551 rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--- 626 (903)
T KOG1027|consen 551 REIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--- 626 (903)
T ss_pred HHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---
Confidence 689988887 7999999999999999999999999 579999997741111 11345778999999999999988
Q ss_pred eEeccCCCCCeEECC---C--CcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHH
Q 022003 78 VIYRDFKTSNILLDA---D--YNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 151 (304)
Q Consensus 78 iiH~dlkp~Nili~~---~--~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 151 (304)
||||||||.||||+. + .+++|+|||++++...+... .......||.+|+|||++....-+.++||||||||+|+
T Consensus 627 iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyY 706 (903)
T KOG1027|consen 627 IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYY 706 (903)
T ss_pred cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEE
Confidence 999999999999965 2 46899999999998655432 22345679999999999998888889999999999999
Q ss_pred HHhC-CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 152 MLTG-RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 152 l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.++| ..||+..-..+..- +........+ .+ ..+ .++.+||.+|+..+|..||++.+++.|.
T Consensus 707 vltgG~HpFGd~~~R~~NI--------l~~~~~L~~L-~~------~~d--~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 707 VLTGGSHPFGDSLERQANI--------LTGNYTLVHL-EP------LPD--CEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred EecCCccCCCchHHhhhhh--------hcCccceeee-cc------Cch--HHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 8886 88997643221100 0000000000 00 001 1788999999999999999999999865
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-33 Score=269.24 Aligned_cols=201 Identities=19% Similarity=0.227 Sum_probs=145.5
Q ss_pred hhcCCC-CcccceeeEE-------EeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 7 LGDLVH-LNLVKLIGYC-------IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 7 l~~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
.+.++| .||++++++| .....++++|||+ +++|.+++......+++..++.++.||+.||.|||+++ |
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 455677 6888999987 3334677889988 67999999766667999999999999999999999988 9
Q ss_pred EeccCCCCCeEECCC-------------------CcEEEccccCcccCCCCCc--------------ceeeecccccccc
Q 022003 79 IYRDFKTSNILLDAD-------------------YNAKLSDFGLAKDGPEGDK--------------THVSTRVMGTYGY 125 (304)
Q Consensus 79 iH~dlkp~Nili~~~-------------------~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y 125 (304)
+||||||+||||+.. +.+|++|||+++....... ........||++|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4556666666654211000 0001124578999
Q ss_pred cCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHH
Q 022003 126 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA 205 (304)
Q Consensus 126 ~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (304)
||||++.+..|+.++|||||||++|||++|.+|+..... ....... ....+... .......
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~----------~~~~~~~~-----~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH----------RVLPPQIL-----LNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH----------hhcChhhh-----hcCHHHH
Confidence 999999999999999999999999999998887642110 0000000 01111110 1123567
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 206 QLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 206 ~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
+++.+||+.+|.+||++.|++++..
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhchh
Confidence 8999999999999999999998643
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-34 Score=230.63 Aligned_cols=204 Identities=27% Similarity=0.353 Sum_probs=157.9
Q ss_pred hcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 022003 8 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 83 (304)
Q Consensus 8 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dl 83 (304)
+.=+.||||++||.+...+..+|.||+| +.||+.+... ....+++..+-.|....+.||.||.+.-. |||||+
T Consensus 118 ks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDv 194 (361)
T KOG1006|consen 118 KSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDV 194 (361)
T ss_pred hhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccC
Confidence 3346799999999999999999999999 6788887643 24569999999999999999999987543 999999
Q ss_pred CCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh--cCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 84 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 84 kp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||+|||++..|.+||||||++-.+.+. ...+...|-..|||||.+. +..|+-++||||||+++||+.||+.||.+
T Consensus 195 KPSNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 195 KPSNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred ChhheEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 999999999999999999998765432 2233456778899999886 34699999999999999999999999988
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+.. ..+... ....++. ..+.. .......+..+..+|.-||.+|..+||...+++++
T Consensus 272 w~s--vfeql~--~Vv~gdp---p~l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 272 WDS--VFEQLC--QVVIGDP---PILLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHH--HHHHHH--HHHcCCC---CeecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 754 111111 1111111 11111 11123456789999999999999999999998874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=223.56 Aligned_cols=199 Identities=28% Similarity=0.401 Sum_probs=157.5
Q ss_pred HhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 022003 6 FLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 84 (304)
Q Consensus 6 il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlk 84 (304)
+..+- +||.+|-++.+|.+...+++|.||++||+|.-++++ ..+++++.+..+...|+.||.|||+.| ||+||||
T Consensus 303 vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rg---iiyrdlk 378 (593)
T KOG0695|consen 303 VFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLK 378 (593)
T ss_pred HHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeecc
Confidence 34433 789999999999999999999999999999888854 447999999999999999999999999 9999999
Q ss_pred CCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Q 022003 85 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 164 (304)
Q Consensus 85 p~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 164 (304)
.+|||++..|.+||+|+|+++.-... .....+++||+.|+|||++++..|+..+|.|+||++++||+.|+.||.-..-
T Consensus 379 ldnvlldaeghikltdygmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm 456 (593)
T KOG0695|consen 379 LDNVLLDAEGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGM 456 (593)
T ss_pred ccceEEccCCceeecccchhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecC
Confidence 99999999999999999999864322 2235578999999999999999999999999999999999999999974321
Q ss_pred CC-CcchhHhhhhhhcc-ccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 165 NG-EHNLVEWARPHLGE-RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 165 ~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
.. ..+..++.-..+-+ .-++ +...+-.+..+++..|.+||++|..+
T Consensus 457 ~n~d~ntedylfqvilekqiri------------prslsvkas~vlkgflnkdp~erlgc 504 (593)
T KOG0695|consen 457 DNPDMNTEDYLFQVILEKQIRI------------PRSLSVKASHVLKGFLNKDPKERLGC 504 (593)
T ss_pred CCcccchhHHHHHHHhhhcccc------------cceeehhhHHHHHHhhcCCcHHhcCC
Confidence 11 11222222221111 1111 11223456688999999999999643
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-33 Score=242.42 Aligned_cols=207 Identities=23% Similarity=0.257 Sum_probs=168.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.||+.+.||.||.+...|++.+..|.|||-+.|.-|.-.+.....++++..-+.++.||+.||.|||-++ |+|+
T Consensus 612 ~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHC 688 (888)
T KOG4236|consen 612 NEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHC 688 (888)
T ss_pred HHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeec
Confidence 5999999999999999999999999999999999554444444445668999999999999999999999998 9999
Q ss_pred cCCCCCeEECCC---CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDAD---YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+|||+... -.+||||||+|+.+++.. .....+||+.|.|||+++...|+..-|+||+|+|+|--++|..|
T Consensus 689 DLKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 689 DLKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred cCCchheeeccCCCCCceeeccccceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEeccccc
Confidence 999999999654 469999999999987543 24457899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
|....+. .+..+. ..+.-|.- --.+.+..+.+||..+|++.-.+|.|.++.+.+.+
T Consensus 766 FNEdEdI-----ndQIQN--------AaFMyPp~---PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 766 FNEDEDI-----NDQIQN--------AAFMYPPN---PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred CCCccch-----hHHhhc--------cccccCCC---chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 9654321 111110 01111111 11244678999999999999999999999998754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=249.97 Aligned_cols=209 Identities=26% Similarity=0.380 Sum_probs=176.6
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
|+|+-+|.+|+|||++++++++.... +-||++|+++|+|.++++.+...+.......|..||++|+.|||.+. ++|
T Consensus 746 LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVH 821 (1177)
T KOG1025|consen 746 LDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVH 821 (1177)
T ss_pred HHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhh
Confidence 46889999999999999999999876 88999999999999999988888999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||...||||.+-..+|++|||+++...............-.+.|||-|.+....|+.++||||+|+++||++| |..|+
T Consensus 822 rdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py 901 (1177)
T KOG1025|consen 822 RDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPY 901 (1177)
T ss_pred hhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCcc
Confidence 99999999999999999999999998776555444433334567999999999999999999999999999887 88898
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
.+....+..+..+... ++ ..+..++.++..++.+||..|++.||+++++.+.+.
T Consensus 902 ~gi~~~eI~dlle~ge----------RL-------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 902 DGIPAEEIPDLLEKGE----------RL-------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS 955 (1177)
T ss_pred CCCCHHHhhHHHhccc----------cC-------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence 8765544333322111 11 123456789999999999999999999999987654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=227.37 Aligned_cols=223 Identities=22% Similarity=0.303 Sum_probs=163.6
Q ss_pred ChHhhHhhcCC-----C---CcccceeeEEEeC----CeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHH
Q 022003 1 MAEVNFLGDLV-----H---LNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGL 67 (304)
Q Consensus 1 l~E~~il~~l~-----h---~niv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l 67 (304)
|.||++|++++ | .+||+++++|... .+.|||+|++ |.+|..+|... .+.++...++.|++||+.||
T Consensus 122 lDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GL 200 (590)
T KOG1290|consen 122 LDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGL 200 (590)
T ss_pred HHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHH
Confidence 57999999983 3 4799999999864 4899999999 77888888654 66799999999999999999
Q ss_pred HHhhcCCCCCeEeccCCCCCeEECCC------------------------------------------------------
Q 022003 68 AFLHEEAERPVIYRDFKTSNILLDAD------------------------------------------------------ 93 (304)
Q Consensus 68 ~~LH~~~~~~iiH~dlkp~Nili~~~------------------------------------------------------ 93 (304)
.|||++.. |||.||||+|||+..+
T Consensus 201 dYLH~ecg--IIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~ 278 (590)
T KOG1290|consen 201 DYLHRECG--IIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLK 278 (590)
T ss_pred HHHHHhcC--ccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHh
Confidence 99999764 9999999999999400
Q ss_pred --------------------------------------------------------------------------------
Q 022003 94 -------------------------------------------------------------------------------- 93 (304)
Q Consensus 94 -------------------------------------------------------------------------------- 93 (304)
T Consensus 279 r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~ 358 (590)
T KOG1290|consen 279 RQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSA 358 (590)
T ss_pred hhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhccccc
Confidence
Q ss_pred --------------------------------CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhh
Q 022003 94 --------------------------------YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSD 141 (304)
Q Consensus 94 --------------------------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 141 (304)
-++||+|||-|++.... .+....|..|+|||++.+..|++.+|
T Consensus 359 t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~AD 433 (590)
T KOG1290|consen 359 TPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSAD 433 (590)
T ss_pred ccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchh
Confidence 01466666666654221 22235688899999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCC---CcchhHhhhhhhc------------------cccccccccCCcc--------
Q 022003 142 VYSFGVVLLEMLTGRRSMDKNRPNG---EHNLVEWARPHLG------------------ERRRFYRLIDPRL-------- 192 (304)
Q Consensus 142 iwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~------------------~~~~~~~~~~~~~-------- 192 (304)
|||++|++|||+||...|......+ ..+.+......++ .++.+..+-.-..
T Consensus 434 iWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~ 513 (590)
T KOG1290|consen 434 IWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLI 513 (590)
T ss_pred HHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHH
Confidence 9999999999999999886543322 1111111111111 1111111100000
Q ss_pred -CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 193 -EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 193 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
.-.++.+.+.++.+|+.-||+.+|++||||.+++++...
T Consensus 514 eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwL 553 (590)
T KOG1290|consen 514 EKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWL 553 (590)
T ss_pred HHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccc
Confidence 013567778999999999999999999999999997553
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=225.74 Aligned_cols=225 Identities=30% Similarity=0.427 Sum_probs=164.7
Q ss_pred hHhhHhhc--CCCCcccceeeEEEeCC----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGD--LVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~--l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|-+|++. ++|+||+++++.-+... .++||++|.+.|+|.++|..+ .++|....+++..+++||+|||+.-+
T Consensus 251 ~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p 328 (534)
T KOG3653|consen 251 NEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELP 328 (534)
T ss_pred hHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCC
Confidence 45666664 58999999999887766 789999999999999999776 49999999999999999999998643
Q ss_pred ------CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCC-----chhhhH
Q 022003 76 ------RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLT-----SRSDVY 143 (304)
Q Consensus 76 ------~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~Diw 143 (304)
.+|+|||||..||||..|++.-|+|||+|.++..+....-....+||..|||||++.+. .+. ...|||
T Consensus 329 ~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvY 408 (534)
T KOG3653|consen 329 RGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVY 408 (534)
T ss_pred cCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHH
Confidence 34999999999999999999999999999987654433333347899999999999764 232 369999
Q ss_pred HHHHHHHHHHhCCCCCCC-CCCCCC----------cchhHhhhhhhccccccccccCCccCCCC-CHHHHHHHHHHHHHh
Q 022003 144 SFGVVLLEMLTGRRSMDK-NRPNGE----------HNLVEWARPHLGERRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHC 211 (304)
Q Consensus 144 slG~il~el~tg~~p~~~-~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~ 211 (304)
|+|.|+|||++.-.-+.. ..+.-. ..+.+.......+ ...|.+...+ .-.....+++.+..|
T Consensus 409 amgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~k------K~RP~~p~~W~~h~~~~~l~et~EeC 482 (534)
T KOG3653|consen 409 AMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRK------KQRPKIPDAWRKHAGMAVLCETIEEC 482 (534)
T ss_pred HHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhh------ccCCCChhhhhcCccHHHHHHHHHHH
Confidence 999999999996544421 111111 0111111111111 1112221111 113356889999999
Q ss_pred ccCCCCCCCCHHHHHHHhCCCCC
Q 022003 212 LSRDPKARPLMSEVVEALKPLPN 234 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~l~~~~~ 234 (304)
|..|++.|.|+.=+-+.+..+..
T Consensus 483 WDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 483 WDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCCchhhhhhhHHHHHHHHHHhc
Confidence 99999999998888777655443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=236.48 Aligned_cols=220 Identities=24% Similarity=0.267 Sum_probs=168.2
Q ss_pred ChHhhHhhcCCC------CcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 1 MAEVNFLGDLVH------LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 1 l~E~~il~~l~h------~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
++|++||++|+. -|+++++-+|...+++|||+|-+ .-+|.++|.+. ...|....+..++.|++.||..|..
T Consensus 476 l~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~ 554 (752)
T KOG0670|consen 476 LKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK 554 (752)
T ss_pred hHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh
Confidence 579999999953 48999999999999999999999 67999999764 4568899999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCC-CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 151 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 151 (304)
.| |+|.||||+|||+++. ..+||||||.|........+ + ..-+..|+|||++.|.+|+...|+||+||+|||
T Consensus 555 c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit---P-YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYE 627 (752)
T KOG0670|consen 555 CG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEIT---P-YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYE 627 (752)
T ss_pred cC---eeecccCccceEeccCcceeeeccCcccccccccccc---H-HHHHHhccCcceeecCcccCCccceeeceeeEE
Confidence 88 9999999999999875 56899999999876544322 1 223567999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhHh---------------hhhhhcccccccc----------------ccCC----------
Q 022003 152 MLTGRRSMDKNRPNGEHNLVEW---------------ARPHLGERRRFYR----------------LIDP---------- 190 (304)
Q Consensus 152 l~tg~~p~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~----------------~~~~---------- 190 (304)
|.||+-.|.+...+....+.+- ...+......|+. .+.|
T Consensus 628 lYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~ 707 (752)
T KOG0670|consen 628 LYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA 707 (752)
T ss_pred eeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc
Confidence 9999999987654432221111 1111111111110 0111
Q ss_pred --ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 191 --RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 191 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.+. .-.......+.+|+.+||..||++|.|..++|+|.
T Consensus 708 ~q~~~-deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 708 VQRLP-DEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred cCCCC-chhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 111 11223457889999999999999999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=209.63 Aligned_cols=212 Identities=20% Similarity=0.291 Sum_probs=162.6
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++||..|. ||||++++++..+. +...+|+||+...+...+. ..++.-.+..++.+++.||.|+|+.| |
T Consensus 81 REikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---I 153 (338)
T KOG0668|consen 81 REIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---I 153 (338)
T ss_pred HHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---c
Confidence 6999999996 99999999998764 4678999999888877765 35788889999999999999999999 9
Q ss_pred EeccCCCCCeEECC-CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCC
Q 022003 79 IYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 79 iH~dlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~ 156 (304)
+|||+||.|++|+. ...++|+|+|+|..+..+... +-.+.+..|.-||++.. ..|+..-|+|||||++..|++.+
T Consensus 154 mHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrk 230 (338)
T KOG0668|consen 154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 230 (338)
T ss_pred ccccCCcceeeechhhceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhcc
Confidence 99999999999985 467999999999987665432 22456778899998874 56899999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhh-------------hh------------ccccccccccCCccCCCCCHHHHHHHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARP-------------HL------------GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 211 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~-------------~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 211 (304)
.||.....+..+ +...... .+ ..+..+..++.+.-.. -.++++.+|+.++
T Consensus 231 epFFhG~dN~DQ-LVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h----l~~peaiDlldkl 305 (338)
T KOG0668|consen 231 EPFFHGHDNYDQ-LVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQH----LVSPEAIDLLDKL 305 (338)
T ss_pred CcccCCCCCHHH-HHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccc----cCChHHHHHHHHH
Confidence 999765544221 1111110 00 0111112222211111 1247899999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 022003 212 LSRDPKARPLMSEVVEA 228 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~ 228 (304)
|..|..+|+|++|+.+|
T Consensus 306 LrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 306 LRYDHQERLTAKEAMAH 322 (338)
T ss_pred HhhccccccchHHHhcC
Confidence 99999999999999975
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=248.41 Aligned_cols=182 Identities=28% Similarity=0.437 Sum_probs=133.5
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccC
Q 022003 28 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 107 (304)
Q Consensus 28 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 107 (304)
+||-||||+...|.+++.++...-.....|.++++|++||.|+|+.| +|||||||.||++++++.|||+|||+|...
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhh
Confidence 58999999887777777655422257888999999999999999999 999999999999999999999999999861
Q ss_pred C------C----------CCcceeeecccccccccCcchhhcC---CCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 022003 108 P------E----------GDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 168 (304)
Q Consensus 108 ~------~----------~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 168 (304)
. . +......+..+||.-|+|||++.+. .|+.|+|+||||+|++||+.. |.... +..
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsM--ERa 822 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSM--ERA 822 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchH--HHH
Confidence 1 0 1111133457899999999998754 599999999999999999863 43221 111
Q ss_pred chhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 169 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..+. .+. ...+... ..+....-..-..+|++||+.||.+||||.|+|..
T Consensus 823 ~iL~----~LR-~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 823 SILT----NLR-KGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHH----hcc-cCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 1111 111 1111111 11222223456789999999999999999999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=206.52 Aligned_cols=165 Identities=25% Similarity=0.244 Sum_probs=125.5
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeee
Q 022003 38 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117 (304)
Q Consensus 38 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 117 (304)
|+|.+++..++..+++..++.++.||+.||+|||+.+ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-------
Confidence 6899999876667999999999999999999999854 999999999999999 9998765432
Q ss_pred cccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCC
Q 022003 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 197 (304)
Q Consensus 118 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (304)
...||..|+|||++.+..++.++|||||||++|||++|..||....... ........... . ..+... ...
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~------~-~~~~~~-~~~ 132 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMP------A-DDPRDR-SNL 132 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhc------c-CCcccc-ccH
Confidence 1257899999999999999999999999999999999999986432211 11111100000 0 000000 011
Q ss_pred HHHHH--HHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 198 IKGAQ--KAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 198 ~~~~~--~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
..... .+.+++.+||..||++||++.|+++++.
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 12223 6899999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=206.93 Aligned_cols=156 Identities=27% Similarity=0.375 Sum_probs=131.5
Q ss_pred hHhhHhh-cCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLG-DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|+++.. ....|.+|.+||...+.+..++.||.| ..||+.+.. +++..+++..+-+|+..++.||.|||++-+
T Consensus 93 ~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~-- 169 (282)
T KOG0984|consen 93 MDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS-- 169 (282)
T ss_pred HhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--
Confidence 4555433 346899999999999999999999999 679988764 357789999999999999999999999754
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh----cCCCCchhhhHHHHHHHHHHH
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TGHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~ 153 (304)
+||||+||+||||+.+|++|+||||++-.+.+.. ..+...|-..|||||.+. ...|+-++||||||+.++||.
T Consensus 170 vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA 246 (282)
T KOG0984|consen 170 VIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA 246 (282)
T ss_pred hhhccCCcceEEEccCCcEEEcccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhh
Confidence 9999999999999999999999999998765432 122245677899999875 347999999999999999999
Q ss_pred hCCCCCCCCC
Q 022003 154 TGRRSMDKNR 163 (304)
Q Consensus 154 tg~~p~~~~~ 163 (304)
+++.||..+.
T Consensus 247 ~lr~PY~~w~ 256 (282)
T KOG0984|consen 247 ILRFPYESWG 256 (282)
T ss_pred hccccccccC
Confidence 9999998763
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=219.81 Aligned_cols=223 Identities=22% Similarity=0.300 Sum_probs=165.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC-----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+++|.-++|.|++..++...-.. .+|.|+|++ ..+|...|. ..+.++...++-++.||+.||+|||+.+
T Consensus 101 re~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~-- 176 (449)
T KOG0664|consen 101 REIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTAN-- 176 (449)
T ss_pred HHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-Hhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcc--
Confidence 6899999999999999998765332 468889999 568888774 4557999999999999999999999999
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhC
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg 155 (304)
|.||||||.|+|++.|..+||||||+++.....+... .+..+-|..|+|||++.| ..|+.++||||+|||+.||+..
T Consensus 177 -ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgR 254 (449)
T KOG0664|consen 177 -ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQR 254 (449)
T ss_pred -hhhccCCCccEEeccCceEEecccccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhh
Confidence 9999999999999999999999999999865543332 333455889999999986 5799999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhh--------hhccccccc---cc-cCCccCCCC----CHHHHHHHHHHHHHhccCCCCCC
Q 022003 156 RRSMDKNRPNGEHNLVEWARP--------HLGERRRFY---RL-IDPRLEGHF----SIKGAQKAAQLAAHCLSRDPKAR 219 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~---~~-~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~R 219 (304)
+-.|....+....+++.-... ...++.+-+ .- -.|.+.-.+ +.....+...++.++|..||.+|
T Consensus 255 rILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkr 334 (449)
T KOG0664|consen 255 KILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKR 334 (449)
T ss_pred hhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccc
Confidence 888887666543332211100 000000000 00 001111000 11223467889999999999999
Q ss_pred CCHHHHHHHhC
Q 022003 220 PLMSEVVEALK 230 (304)
Q Consensus 220 ps~~ell~~l~ 230 (304)
.+.++.+.++-
T Consensus 335 is~~~A~~~~~ 345 (449)
T KOG0664|consen 335 ISVEEALQHRY 345 (449)
T ss_pred ccHhhhccccc
Confidence 99999988753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=218.95 Aligned_cols=224 Identities=27% Similarity=0.356 Sum_probs=169.8
Q ss_pred hHhhHhhcC--CCCcccceeeEEEeCC----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC--
Q 022003 2 AEVNFLGDL--VHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-- 73 (304)
Q Consensus 2 ~E~~il~~l--~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-- 73 (304)
+|.+|++.+ +|+||+.+++.-..+. .++||++|-+.|||.|+|.+. .++.+...+++..++.||++||.+
T Consensus 252 rEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~ 329 (513)
T KOG2052|consen 252 RETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIV 329 (513)
T ss_pred hHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHh
Confidence 688888875 9999999999876654 679999999999999999763 699999999999999999999954
Q ss_pred ---CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCC--cceeeecccccccccCcchhhcC----CC-C-chhhh
Q 022003 74 ---AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHVSTRVMGTYGYAAPEYVMTG----HL-T-SRSDV 142 (304)
Q Consensus 74 ---~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~----~~-~-~~~Di 142 (304)
|+..|.|||||..||||.++|..-|+|+|+|....... .....+..+||..|||||++... .+ + ..+||
T Consensus 330 GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADI 409 (513)
T KOG2052|consen 330 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADI 409 (513)
T ss_pred cCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHH
Confidence 55569999999999999999999999999998765432 12234457899999999998642 12 2 36999
Q ss_pred HHHHHHHHHHHhC----------CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCC-CCHHHHHHHHHHHHHh
Q 022003 143 YSFGVVLLEMLTG----------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHC 211 (304)
Q Consensus 143 wslG~il~el~tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~ 211 (304)
||||.|+||+... +.||....+.+.....+ ... -..+.+.|.+... .....-..+.+||+.|
T Consensus 410 YafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM-rkV------VCv~~~RP~ipnrW~s~~~l~~m~klMkeC 482 (513)
T KOG2052|consen 410 YAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM-RKV------VCVQKLRPNIPNRWKSDPALRVMAKLMKEC 482 (513)
T ss_pred HHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH-hcc------eeecccCCCCCcccccCHHHHHHHHHHHHh
Confidence 9999999998763 46776655544322111 110 1112223333322 2334456888999999
Q ss_pred ccCCCCCCCCHHHHHHHhCCCCC
Q 022003 212 LSRDPKARPLMSEVVEALKPLPN 234 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~l~~~~~ 234 (304)
|..||.-|.|+-.+.+.|..+.+
T Consensus 483 W~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 483 WYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred hcCCchhhhHHHHHHHHHHHHhc
Confidence 99999999999999988876554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=240.30 Aligned_cols=200 Identities=21% Similarity=0.260 Sum_probs=132.6
Q ss_pred EeCCeeEEEEecCCCCCHHHHhhcCCCC-------------------CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 022003 23 IEDDQRLLVYEFMPRGSLENHLFRRSLP-------------------LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 83 (304)
Q Consensus 23 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dl 83 (304)
..+...++||||+.+++|.+++...... .....+..++.||+.||.|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 3456789999999999999998654311 123446789999999999999988 999999
Q ss_pred CCCCeEECC-CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC----------------------CCCchh
Q 022003 84 KTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----------------------HLTSRS 140 (304)
Q Consensus 84 kp~Nili~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~ 140 (304)
||+|||++. ++.+||+|||+++....... .......+++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 57999999999986543222 223456789999999976422 234567
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCC----CC--HHHHHHHHHHHHHhccC
Q 022003 141 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH----FS--IKGAQKAAQLAAHCLSR 214 (304)
Q Consensus 141 DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~~~li~~~l~~ 214 (304)
|||||||++|||+++..++.... ................+.....+..... +. ........+||.+||+.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999998765433210 0000000000000000000111110000 00 00123566899999999
Q ss_pred CCCCCCCHHHHHHHhC
Q 022003 215 DPKARPLMSEVVEALK 230 (304)
Q Consensus 215 dp~~Rps~~ell~~l~ 230 (304)
||++|||++|+++|..
T Consensus 437 dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 437 KGRQRISAKAALAHPY 452 (566)
T ss_pred CcccCCCHHHHhCCcC
Confidence 9999999999999743
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=216.53 Aligned_cols=209 Identities=25% Similarity=0.332 Sum_probs=169.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC-eeEEEEecCCCCCHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFR-------RSLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
.|.-.|..+.|||+.++.+++.++. ..+.++.+..-|+|+.++.. ..+.++..+...++.|++.|++|||+.
T Consensus 336 ~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~ 415 (563)
T KOG1024|consen 336 QESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH 415 (563)
T ss_pred HHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc
Confidence 4566677789999999999987654 56888999988999999972 234577778889999999999999999
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 153 (304)
+ +||.||...|++|++.-++||+|-.+++..-..+.............||++|.+....|+.++|+||||+++|||+
T Consensus 416 ~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELm 492 (563)
T KOG1024|consen 416 G---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELM 492 (563)
T ss_pred C---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHH
Confidence 9 9999999999999999999999999999866555544444445577899999999999999999999999999998
Q ss_pred h-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 154 T-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 154 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
| |+.|+...++.+..... .++. .-..+..++++++.++.-||..+|++||+++|+..-|.
T Consensus 493 tlg~~PyaeIDPfEm~~yl-------kdGy----------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 493 TLGKLPYAEIDPFEMEHYL-------KDGY----------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred hcCCCCccccCHHHHHHHH-------hccc----------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 8 78888765543322111 1111 11224467899999999999999999999999998775
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=202.18 Aligned_cols=174 Identities=35% Similarity=0.560 Sum_probs=154.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|++|+++++++......+++||++.+++|.+++......+++..++.++.+++.+|++||+.+ ++|+
T Consensus 40 ~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~ 116 (215)
T cd00180 40 REIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHR 116 (215)
T ss_pred HHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 6899999999999999999999999999999999989999998765456899999999999999999999998 9999
Q ss_pred cCCCCCeEECC-CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 82 DFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||+|.||+++. ++.++|+|||.+........ ......+...|++||..... .++.++|+|++|+++++|
T Consensus 117 dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------- 187 (215)
T cd00180 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------- 187 (215)
T ss_pred CCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------
Confidence 99999999999 89999999999987644321 12234567889999998877 889999999999999998
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..+.+++.+|++.||.+||++.++++++
T Consensus 188 ------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2567999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=227.92 Aligned_cols=152 Identities=25% Similarity=0.360 Sum_probs=135.6
Q ss_pred hHhhHhhcCC---CCcccceeeEEEeCCeeEEEEecC-CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLV---HLNLVKLIGYCIEDDQRLLVYEFM-PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~---h~niv~~~~~~~~~~~~~lv~e~~-~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
-||.||..|+ |+||++++++|++++++||+||-- +|-+|.++|..+ ..+++.++..|++||+.|+++||+.|
T Consensus 615 ~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~--- 690 (772)
T KOG1152|consen 615 SEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG--- 690 (772)
T ss_pred hhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC---
Confidence 3899999997 999999999999999999999975 334999999554 47999999999999999999999999
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCC
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~ 156 (304)
|||||||-+||.++.+|.+||+|||.+.....+ ....++||..|.|||++.|..| +..-|||+||+++|-++...
T Consensus 691 ivhrdikdenvivd~~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyke 766 (772)
T KOG1152|consen 691 IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKE 766 (772)
T ss_pred ceecccccccEEEecCCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEecc
Confidence 999999999999999999999999999875433 2345789999999999999887 56799999999999999988
Q ss_pred CCCCC
Q 022003 157 RSMDK 161 (304)
Q Consensus 157 ~p~~~ 161 (304)
.||.+
T Consensus 767 npyyn 771 (772)
T KOG1152|consen 767 NPYYN 771 (772)
T ss_pred CCCcC
Confidence 88853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=227.05 Aligned_cols=213 Identities=20% Similarity=0.270 Sum_probs=147.5
Q ss_pred HhhHhhcCCCCcc-----cceeeEEEe--------CCeeEEEEecCCCCCHHHHhhcCC---------------------
Q 022003 3 EVNFLGDLVHLNL-----VKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFRRS--------------------- 48 (304)
Q Consensus 3 E~~il~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~--------------------- 48 (304)
|+.++.+++|.++ ++++++|.. .+..++||||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6667777766554 677777653 346799999999999999885421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeeccccccccc
Q 022003 49 --LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 126 (304)
Q Consensus 49 --~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 126 (304)
..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+++.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 12466788899999999999999988 999999999999999999999999999765332211 111233478999
Q ss_pred CcchhhcCC--------------------C--CchhhhHHHHHHHHHHHhCCC-CCCCCCCCCC------cchhHhhhhh
Q 022003 127 APEYVMTGH--------------------L--TSRSDVYSFGVVLLEMLTGRR-SMDKNRPNGE------HNLVEWARPH 177 (304)
Q Consensus 127 aPE~~~~~~--------------------~--~~~~DiwslG~il~el~tg~~-p~~~~~~~~~------~~~~~~~~~~ 177 (304)
|||++.... | ..+.||||+||++|+|+++.. ||........ .....|...
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~- 456 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY- 456 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-
Confidence 999875322 1 235799999999999999874 6643211110 011111110
Q ss_pred hccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCC---CCCCCHHHHHHHhC
Q 022003 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP---KARPLMSEVVEALK 230 (304)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rps~~ell~~l~ 230 (304)
.... .+-. .....+....+|+.+||..+| .+|+|++|+++|..
T Consensus 457 ~~~~------~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 457 KGQK------YDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred cccC------CCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 0000 0000 011235788999999999866 68999999999754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=207.36 Aligned_cols=199 Identities=23% Similarity=0.328 Sum_probs=146.9
Q ss_pred CCCcccceeeE-EEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 022003 11 VHLNLVKLIGY-CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 89 (304)
Q Consensus 11 ~h~niv~~~~~-~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nil 89 (304)
.|.||+.-|++ |++.+.+++++||++.|+|..-+... .+.+..-+.++.|++.||.|+|+++ +||||||.+|||
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiL 153 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENIL 153 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEE
Confidence 48899988875 66777888999999999999988664 4888889999999999999999998 999999999999
Q ss_pred EC--CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc---C--CCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 022003 90 LD--ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---G--HLTSRSDVYSFGVVLLEMLTGRRSMDKN 162 (304)
Q Consensus 90 i~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~il~el~tg~~p~~~~ 162 (304)
|- +.-++||||||+++..+.- .....-+..|.|||+... + ...+.+|||.||+++|.++||..||...
T Consensus 154 if~~df~rvKlcDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 154 IFDADFYRVKLCDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred EecCCccEEEeeecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 93 3348999999999875432 122223567999998753 2 3478899999999999999999999854
Q ss_pred CCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHHh
Q 022003 163 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR---PLMSEVVEAL 229 (304)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~ell~~l 229 (304)
.. .......|...........++.+. ..++.+.++.++-|..++++| .+++.....+
T Consensus 229 ~~-~d~~Y~~~~~w~~rk~~~~P~~F~---------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 229 SI-MDKPYWEWEQWLKRKNPALPKKFN---------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred hc-cCchHHHHHHHhcccCccCchhhc---------ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 32 233333333322222122222221 235688899999999999999 4544444433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=228.73 Aligned_cols=208 Identities=24% Similarity=0.331 Sum_probs=166.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+-+++..+|||||.+++.+...+.++++||||.||+|++... -..++++.++....+..++||+|||+.+ -+||
T Consensus 61 qei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~g---k~hR 136 (829)
T KOG0576|consen 61 QEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHR 136 (829)
T ss_pred cceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCC---cccc
Confidence 47778889999999999999999999999999999999999753 3457999999999999999999999999 8999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|||-.||++++.|.+|++|||.+..++... .....+.||+.|||||+.. .+.|..++|||++|+...|+--.++|
T Consensus 137 diKGanilltd~gDvklaDfgvsaqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 137 DIKGANILLTDEGDVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred cccccceeecccCceeecccCchhhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 999999999999999999999998765422 2344578999999999864 57899999999999999999888887
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.....+..... +.... .++|.... -....++.+.+|++.+|..+|++|||++.++.|
T Consensus 215 lfdlhpmr~l~--------LmTkS----~~qpp~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 215 LFDLHPMRALF--------LMTKS----GFQPPTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccccchHHHHH--------Hhhcc----CCCCCccc-CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 65433221111 00000 11111111 112336788999999999999999999988864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=199.66 Aligned_cols=220 Identities=26% Similarity=0.313 Sum_probs=159.9
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|..+ -+.||+++.+++..++..++||||++.....+++. .++...+..+++.++.||.++|.+| |||
T Consensus 83 ~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvH 155 (418)
T KOG1167|consen 83 NELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVH 155 (418)
T ss_pred HHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccc
Confidence 688999988 58999999999999999999999999988888874 3678999999999999999999999 999
Q ss_pred ccCCCCCeEECC-CCcEEEccccCcccCCCC---------------------------------Ccc---------eeee
Q 022003 81 RDFKTSNILLDA-DYNAKLSDFGLAKDGPEG---------------------------------DKT---------HVST 117 (304)
Q Consensus 81 ~dlkp~Nili~~-~~~~kl~Dfg~a~~~~~~---------------------------------~~~---------~~~~ 117 (304)
|||||.|+|.+. .+.-.|.|||+|...... ... ...-
T Consensus 156 RDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~a 235 (418)
T KOG1167|consen 156 RDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERA 235 (418)
T ss_pred cCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceec
Confidence 999999999964 477889999998721000 000 0011
Q ss_pred cccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhh-----------hh-----hcc
Q 022003 118 RVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-----------PH-----LGE 180 (304)
Q Consensus 118 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~-----------~~-----~~~ 180 (304)
...||++|+|||++.. ...++++||||.|+|+.-++++..||........ .+.+... .. +.+
T Consensus 236 nrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ 314 (418)
T KOG1167|consen 236 NRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQ 314 (418)
T ss_pred ccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeec
Confidence 2469999999999874 5678999999999999999999999876433211 1111000 00 000
Q ss_pred c----------cccccc----cCC--c--cC-CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 181 R----------RRFYRL----IDP--R--LE-GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 181 ~----------~~~~~~----~~~--~--~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
+ ..|... +.+ . .. .......+..+.+|+.+||+.||.+|.|+++.|+|.
T Consensus 315 ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 315 KSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred cccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 0 000000 000 0 00 011112245889999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=189.14 Aligned_cols=156 Identities=31% Similarity=0.381 Sum_probs=136.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++.+++++|+|++++++++......++++|++.+++|.+++......+++..+..++.+++.+|.+||+.+ ++|+
T Consensus 46 ~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~ 122 (225)
T smart00221 46 REIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHR 122 (225)
T ss_pred HHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 5889999999999999999999989999999999998999998665433899999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchh-hcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||+|.||+++.++.++|+|||.+........ .......++..|++||++ ....++.++|||+||+++++|++|+.||.
T Consensus 123 di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 123 DLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred CCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 9999999999999999999999987654320 012334678889999998 66778889999999999999999999995
Q ss_pred C
Q 022003 161 K 161 (304)
Q Consensus 161 ~ 161 (304)
.
T Consensus 202 ~ 202 (225)
T smart00221 202 G 202 (225)
T ss_pred c
Confidence 4
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-27 Score=220.11 Aligned_cols=211 Identities=20% Similarity=0.237 Sum_probs=165.4
Q ss_pred HhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 82 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d 82 (304)
|+-+-..|.|+|++..+..+.+.....-+||||++ +|..++... ..+....+..++.|++.||+|+|..| +.|||
T Consensus 371 E~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrd 445 (601)
T KOG0590|consen 371 EFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRD 445 (601)
T ss_pred heeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceecc
Confidence 55566778999999888877776666666999998 999998665 36888999999999999999999999 99999
Q ss_pred CCCCCeEECCCCcEEEccccCcccCCCCCcc--eeeecccccccccCcchhhcCCCCc-hhhhHHHHHHHHHHHhCCCCC
Q 022003 83 FKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 83 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tg~~p~ 159 (304)
||++|+++..+|.+||+|||.+..+...... ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||
T Consensus 446 lK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~W 525 (601)
T KOG0590|consen 446 LKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPW 525 (601)
T ss_pred CccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcc
Confidence 9999999999999999999999876544443 4556688999999999999999976 699999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
......+...... .... +.. . ..-........+...+.+|.+||+.||.+|.|+++|++
T Consensus 526 k~a~~~~~~~~~~-~~~~--~~~----~--~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 526 KVAKKSDNSFKTN-NYSD--QRN----I--FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccccchhhh-cccc--ccc----c--ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 7665443321000 0000 000 0 00001122234667889999999999999999999997
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-24 Score=188.33 Aligned_cols=218 Identities=25% Similarity=0.396 Sum_probs=168.5
Q ss_pred hhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe-EeccCCC
Q 022003 7 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV-IYRDFKT 85 (304)
Q Consensus 7 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i-iH~dlkp 85 (304)
|+.+.|.|+.+++|.+..+...+.|.+||..|+|.+.+......+++.....++++|+.||+|||... | .|+.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence 56789999999999999999999999999999999999888888999999999999999999999976 4 9999999
Q ss_pred CCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-------CCCchhhhHHHHHHHHHHHhCCCC
Q 022003 86 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-------HLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 86 ~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~el~tg~~p 158 (304)
.|++++....+||+|||+.................-...|.|||.+.+. ..+.+.||||+|++++|+++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998776431111111222235579999998763 146779999999999999999999
Q ss_pred CCCCCCCCCc-chhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCCC
Q 022003 159 MDKNRPNGEH-NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 235 (304)
Q Consensus 159 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~~ 235 (304)
|......... ........ .....+.|.+.... +...++..++..||..+|.+||+++++...++.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9875444332 12221111 01122223322111 3344789999999999999999999999988766543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-22 Score=174.53 Aligned_cols=218 Identities=32% Similarity=0.430 Sum_probs=165.0
Q ss_pred hHhhHhhcCCCC-cccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|+.+++.+.|+ +|+++++++......+++++++.+++|.+++.... ..+....+..++.|++.++.|+|+.+ +
T Consensus 46 ~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~ 122 (384)
T COG0515 46 REIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122 (384)
T ss_pred HHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 588899999988 79999999977777899999999999997775544 26999999999999999999999999 9
Q ss_pred EeccCCCCCeEECCCC-cEEEccccCcccCCCCCcce----eeecccccccccCcchhhc---CCCCchhhhHHHHHHHH
Q 022003 79 IYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTH----VSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 79 iH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ 150 (304)
+|||+||+||+++..+ .++++|||.+.......... ......|+..|+|||.+.+ ..++...|+|++|++++
T Consensus 123 ~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~ 202 (384)
T COG0515 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLY 202 (384)
T ss_pred eccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHH
Confidence 9999999999999988 79999999998654433221 2355789999999999987 57899999999999999
Q ss_pred HHHhCCCCCCCCCCC-CCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 151 EMLTGRRSMDKNRPN-GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 151 el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
++++|..||...... ............ ... .................+.+++.+|+..+|..|.+..+....
T Consensus 203 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 203 ELLTGLPPFEGEKNSSATSQTLKIILEL---PTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHhCCCCCCCCCccccHHHHHHHHHhc---CCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 999999996654321 001111111100 000 000000000001223578899999999999999988887764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-22 Score=174.90 Aligned_cols=213 Identities=23% Similarity=0.244 Sum_probs=161.3
Q ss_pred hHhhHhhcCCC----CcccceeeEE-EeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVH----LNLVKLIGYC-IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h----~niv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
.|..++..+.+ +++..+++.+ ..+...|+||+.+ |.+|.++..... ..++..++..++.|++.+|++||+.|
T Consensus 65 ~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G- 142 (322)
T KOG1164|consen 65 IEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG- 142 (322)
T ss_pred hHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC-
Confidence 37888888873 6899999999 4777889999999 889999886554 78999999999999999999999999
Q ss_pred CCeEeccCCCCCeEECCC-----CcEEEccccCcc--cCCCCCcc----e-e-eecccccccccCcchhhcCCCCchhhh
Q 022003 76 RPVIYRDFKTSNILLDAD-----YNAKLSDFGLAK--DGPEGDKT----H-V-STRVMGTYGYAAPEYVMTGHLTSRSDV 142 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~-----~~~kl~Dfg~a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Di 142 (304)
++||||||+|+++... ..+.|.|||+++ .+...... . . ...+.||..|+++.++.+...+.+.|+
T Consensus 143 --~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl 220 (322)
T KOG1164|consen 143 --FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL 220 (322)
T ss_pred --cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh
Confidence 9999999999999754 469999999999 43222111 1 1 223569999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 143 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 143 wslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
||++.++.+++.|..||......... .......... .... .....+..+.++...+-..+..++|..
T Consensus 221 es~~Y~l~el~~g~LPW~~~~~~~~~--~~~~~~~~~~------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy 287 (322)
T KOG1164|consen 221 ESLFYMLLELLKGSLPWEALEMTDLK--SKFEKDPRKL------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDY 287 (322)
T ss_pred hhHHHHHHHHhcCCCCCccccccchH--HHHHHHhhhh------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCH
Confidence 99999999999999999655432221 1111100000 0000 111124566777777777999999999
Q ss_pred HHHHHHhCC
Q 022003 223 SEVVEALKP 231 (304)
Q Consensus 223 ~ell~~l~~ 231 (304)
..+...++.
T Consensus 288 ~~~~~~l~~ 296 (322)
T KOG1164|consen 288 EKLAELLKD 296 (322)
T ss_pred HHHHHHHHH
Confidence 999887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-23 Score=196.60 Aligned_cols=209 Identities=22% Similarity=0.273 Sum_probs=151.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
.|++ ...++|||++.+.-+-.+++..|||-+|. ..+|.|.+..+. .+...+.++|+.||+.||.-+|+.| |+|+
T Consensus 71 ~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~g---VcHG 144 (1431)
T KOG1240|consen 71 EEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLG---VCHG 144 (1431)
T ss_pred HHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcC---cccc
Confidence 4555 56679999999998888888899999999 569999986654 5788888999999999999999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCC-CCCc----ceeeecccccccccCcchhhc----------CC-CCchhhhHHH
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGP-EGDK----THVSTRVMGTYGYAAPEYVMT----------GH-LTSRSDVYSF 145 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~-~~~~----~~~~~~~~gt~~y~aPE~~~~----------~~-~~~~~Diwsl 145 (304)
|||.+||||+.-+.+.|+||...+... ..+. .....+-..-.+|.|||-+.. .. .+++-||||+
T Consensus 145 DIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~ 224 (1431)
T KOG1240|consen 145 DIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSA 224 (1431)
T ss_pred ccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhh
Confidence 999999999999999999998765421 1111 111111222347999998753 12 5779999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||+++||++ |+++|.-. ++..+............+.+ ....++.||..|++.||.+|.||++
T Consensus 225 GCViaELf~Eg~PlF~LS------QL~aYr~~~~~~~e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAed 287 (1431)
T KOG1240|consen 225 GCVIAELFLEGRPLFTLS------QLLAYRSGNADDPEQLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAED 287 (1431)
T ss_pred hHHHHHHHhcCCCcccHH------HHHhHhccCccCHHHHHHhC-----------cCccHHHHHHHHHccCchhccCHHH
Confidence 999999988 57777421 12222221111111111111 1236789999999999999999999
Q ss_pred HHHHhCCCC
Q 022003 225 VVEALKPLP 233 (304)
Q Consensus 225 ll~~l~~~~ 233 (304)
.|+.-.+..
T Consensus 288 yL~~yrG~~ 296 (1431)
T KOG1240|consen 288 YLQKYRGLV 296 (1431)
T ss_pred HHHhhhccc
Confidence 998755443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=166.94 Aligned_cols=197 Identities=22% Similarity=0.262 Sum_probs=140.0
Q ss_pred CCCcccceeeEEEeC---------------------------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHH
Q 022003 11 VHLNLVKLIGYCIED---------------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 63 (304)
Q Consensus 11 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi 63 (304)
+|||||+++++|.+. ..+|+||.-+ ..+|..++-.+ ..+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC--CCchHHHHHHHHHH
Confidence 699999999887632 3579999988 56999998654 36667778899999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEC--CC--CcEEEccccCcccCCCCCc-cee---eecccccccccCcchhhcCC
Q 022003 64 AKGLAFLHEEAERPVIYRDFKTSNILLD--AD--YNAKLSDFGLAKDGPEGDK-THV---STRVMGTYGYAAPEYVMTGH 135 (304)
Q Consensus 64 ~~~l~~LH~~~~~~iiH~dlkp~Nili~--~~--~~~kl~Dfg~a~~~~~~~~-~~~---~~~~~gt~~y~aPE~~~~~~ 135 (304)
++|+.|||++| |.|||||.+||||. ++ -.+.|+|||.+--.....- ... .-..-|...-||||+....+
T Consensus 351 LEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999999 99999999999993 33 3579999998754322110 000 11234667789999886421
Q ss_pred -----C-CchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHH
Q 022003 136 -----L-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 209 (304)
Q Consensus 136 -----~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 209 (304)
. -.|+|.|+.|.+.||+++...||....... .+... +.+.--|. ++..++..+++++.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~-----------Yqe~qLPa----lp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRT-----------YQESQLPA----LPSRVPPVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhh-----------hhhhhCCC----CcccCChHHHHHHH
Confidence 1 348999999999999999999998732211 11111 11111122 23344678999999
Q ss_pred HhccCCCCCCCCHHHHHHHh
Q 022003 210 HCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 210 ~~l~~dp~~Rps~~ell~~l 229 (304)
..|+.||.+|++..=....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999866555444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=180.16 Aligned_cols=187 Identities=29% Similarity=0.351 Sum_probs=156.1
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|..++..++ ||.+|++.-.++.+...++++++..||+|...+.+.. .+.+..+..+...++.+++++|+.+ ++|
T Consensus 45 ~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~---iiy 120 (612)
T KOG0603|consen 45 QERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLG---IAY 120 (612)
T ss_pred cHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhH---HHH
Confidence 3667788886 9999999999999999999999999999999885544 6888888899999999999999999 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||+|++||+++.+|++++.|||+++....... .+||..|||||++. .....+|.||+|++++||+||..||.
T Consensus 121 rd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 121 RDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred hcccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 99999999999999999999999987544322 28999999999988 67889999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
.. .. .... ...-.++...+..+.+++..++..+|.+|...
T Consensus 193 ~~-------~~---~~Il------------~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 193 GD-------TM---KRIL------------KAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hH-------HH---HHHh------------hhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 61 00 0000 01112345567889999999999999999744
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-22 Score=177.47 Aligned_cols=173 Identities=25% Similarity=0.407 Sum_probs=130.5
Q ss_pred eeEEEEecCCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCc
Q 022003 27 QRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 104 (304)
Q Consensus 27 ~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a 104 (304)
.+||.|++|...+|.++|.++ ....+......++.|++.|++| ++ .+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999644 4557888899999999999999 56 999999999999999999999999999
Q ss_pred ccCCCCC----cceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhc
Q 022003 105 KDGPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 179 (304)
Q Consensus 105 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 179 (304)
....... .........||.+||+||.+.+..|+.|+||||||++++|+++ -...+........ .
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d-----~------ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTD-----I------ 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhh-----h------
Confidence 8765433 1223445789999999999999999999999999999999998 2222221110000 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
.. ..++|.....+ ++-..|+.++|...|.+||++.+.
T Consensus 473 r~----g~ip~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RD----GIIPPEFLQDY-----PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hc----CCCChHHhhcC-----cHHHHHHHHhcCCCcccCchHHHH
Confidence 00 11122222222 244589999999999999955544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=158.47 Aligned_cols=204 Identities=23% Similarity=0.361 Sum_probs=154.0
Q ss_pred HhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
|.--|+-+.||||+.+++.|....++.++..|++.|||...+... +...+..++.+++.+++.|++|||+..+ -|..-
T Consensus 237 efp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~ 315 (448)
T KOG0195|consen 237 EFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRF 315 (448)
T ss_pred hCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhh
Confidence 444567789999999999999999999999999999999999664 3447788899999999999999999873 24445
Q ss_pred cCCCCCeEECCCCcEEEc--cccCcccCCCCCcceeeecccccccccCcchhhcCCC---CchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLS--DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL---TSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~tg~ 156 (304)
-|....|+|+++-+.+|. |--++.. .....-.+.||+||.+...+- -.++|+|||++++|||.|..
T Consensus 316 ~lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~tre 386 (448)
T KOG0195|consen 316 YLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTRE 386 (448)
T ss_pred hcccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccc
Confidence 688899999998776653 3222221 111223678999999986654 35799999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
.||....+.+.--.+. .+ .+....+...+..+..|+.-|+.-||.+||.++.++-.|+.+
T Consensus 387 vpfadlspmecgmkia------------le----glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 387 VPFADLSPMECGMKIA------------LE----GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccccCCchhhhhhhh------------hc----cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 9998776543321111 01 111122333456888999999999999999999988877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=156.36 Aligned_cols=214 Identities=18% Similarity=0.196 Sum_probs=167.7
Q ss_pred HhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 3 EVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 3 E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
|.+.++.|. .++|-++|-+..++.+..||||++ |.||.|++.-.+..|+..++..++.|++.-++|+|++. +|+|
T Consensus 73 EYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYR 148 (449)
T KOG1165|consen 73 EYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYR 148 (449)
T ss_pred HHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeec
Confidence 777777774 589999999999999999999999 89999999777888999999999999999999999988 9999
Q ss_pred cCCCCCeEECC-----CCcEEEccccCcccCCCCCc-----ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHH
Q 022003 82 DFKTSNILLDA-----DYNAKLSDFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 151 (304)
Q Consensus 82 dlkp~Nili~~-----~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 151 (304)
||||+|+||.. ...+.++|||+|+.+.+... ........||..||+-..+.|...+...|+-|||-|+++
T Consensus 149 DIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmY 228 (449)
T KOG1165|consen 149 DIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 228 (449)
T ss_pred ccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhh
Confidence 99999999964 34689999999998765433 223345679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 152 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 152 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
.+-|..||.+.......... . .+++..+.. -..++-...+.++...++-.-..+..+-|..+-+...+.
T Consensus 229 FLRGsLPWQGLKA~tnK~kY--e--KIGe~Kr~T------~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 229 FLRGSLPWQGLKADTNKEKY--E--KIGETKRST------PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD 297 (449)
T ss_pred hccCCCccccccCcchHHHH--H--HhccccccC------CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 99999999876544332211 1 111111100 000111123567888888888888889998877766543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8e-21 Score=151.49 Aligned_cols=215 Identities=19% Similarity=0.163 Sum_probs=166.4
Q ss_pred hHhhHhhcCCC-CcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|.++.+.|++ ..|..+..++.+.....+||+++ |.||.+++.-....|+..++.-++-|++.-++|+|.++ +||
T Consensus 59 yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiH 134 (341)
T KOG1163|consen 59 YESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIH 134 (341)
T ss_pred HHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---ccc
Confidence 47888888876 56777777788888889999999 89999998766678999999999999999999999999 999
Q ss_pred ccCCCCCeEECCC---CcEEEccccCcccCCCCCc-----ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 81 RDFKTSNILLDAD---YNAKLSDFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 81 ~dlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|||||+|+|..-+ ..+.|+|||+++.+-+... ........||..|.+-..+.+...+...|+-|+|.++.++
T Consensus 135 RDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYf 214 (341)
T KOG1163|consen 135 RDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYF 214 (341)
T ss_pred ccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeee
Confidence 9999999999643 5789999999998755332 2223346799999999988888899999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
.-|..||.+.......+..+.... ..-....+..-...+.++.-.+.-|-..-.++-|...-+.+...
T Consensus 215 nrG~LPWQglka~tk~QKyEkI~E----------kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 215 NRGSLPWQGLKAATKKQKYEKISE----------KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred ecCCCcccccchhhHHHHHHHHHH----------hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 999999998766544333221111 00000111111123568888999999999999998777666544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=164.38 Aligned_cols=116 Identities=20% Similarity=0.154 Sum_probs=91.5
Q ss_pred hHhhHhhcCCCCcccc-eeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVK-LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|++++|+|++. +++ .+..|+||||++|++|.. +... . ...++.|++++|.|||+.+ |+|
T Consensus 70 ~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH~~g---IiH 134 (365)
T PRK09188 70 REIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLHRAG---ITH 134 (365)
T ss_pred HHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHHHCC---Cee
Confidence 6999999999999985 443 245799999999999973 2111 1 1467899999999999998 999
Q ss_pred ccC-CCCCeEECCCCcEEEccccCcccCCCCCccee------eecccccccccCcchhh
Q 022003 81 RDF-KTSNILLDADYNAKLSDFGLAKDGPEGDKTHV------STRVMGTYGYAAPEYVM 132 (304)
Q Consensus 81 ~dl-kp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~ 132 (304)
||| ||+|||++.++.+||+|||+++.+........ .....++..|+|||++.
T Consensus 135 rDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 135 NDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999 99999999999999999999997654321111 12456788899999885
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-20 Score=154.70 Aligned_cols=161 Identities=22% Similarity=0.338 Sum_probs=108.7
Q ss_pred eEEEEecCCCCCHHHHhhc---CC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccc
Q 022003 28 RLLVYEFMPRGSLENHLFR---RS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 101 (304)
Q Consensus 28 ~~lv~e~~~~~sL~~~l~~---~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Df 101 (304)
.+++|+-+ .++|.+++.. .. ..+.......+..|+++.+++||+.| ++|+||+|+|++++++|.++|+||
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcCh
Confidence 47788888 5699888642 11 12344455677799999999999999 999999999999999999999999
Q ss_pred cCcccCCCCCcceeeecccccccccCcchhhc--------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHh
Q 022003 102 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 173 (304)
Q Consensus 102 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~ 173 (304)
+.....+.. . .. ...+..|.+||.... ..++.+.|.|+||+++|.|+++..||...........
T Consensus 190 ~~~~r~g~~--~--~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--- 261 (288)
T PF14531_consen 190 SSLVRAGTR--Y--RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--- 261 (288)
T ss_dssp GGEEETTEE--E--EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---
T ss_pred HHHeecCce--e--ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---
Confidence 988775431 1 11 233577999997754 2578999999999999999999999976533222110
Q ss_pred hhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 022003 174 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219 (304)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 219 (304)
.+ .... ..++.+..||..+|+.||.+|
T Consensus 262 -----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 -----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred -----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 01 1122 557899999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=144.54 Aligned_cols=146 Identities=20% Similarity=0.155 Sum_probs=110.6
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|++|. |+++.+++++ ...+++|||+.|.+|...+.. . ...++.|++.+|.++|+.| |+|
T Consensus 50 rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~G---IvH 114 (218)
T PRK12274 50 REALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCG---VAH 114 (218)
T ss_pred HHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCc---Ccc
Confidence 6999999995 4789999886 346999999999998754311 1 1357889999999999999 999
Q ss_pred ccC-CCCCeEECCCCcEEEccccCcccCCCCCcc---ee--------eecccccccccCcchhhcC-CCC-chhhhHHHH
Q 022003 81 RDF-KTSNILLDADYNAKLSDFGLAKDGPEGDKT---HV--------STRVMGTYGYAAPEYVMTG-HLT-SRSDVYSFG 146 (304)
Q Consensus 81 ~dl-kp~Nili~~~~~~kl~Dfg~a~~~~~~~~~---~~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG 146 (304)
||| ||+|||++.++.++|+|||++......... .. ......++.|+.|+...-. ..+ ...+.++.|
T Consensus 115 rDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g 194 (218)
T PRK12274 115 NDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATG 194 (218)
T ss_pred CCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhc
Confidence 999 799999999999999999999865432210 00 1112356778888865432 344 567888999
Q ss_pred HHHHHHHhCCCCCCCC
Q 022003 147 VVLLEMLTGRRSMDKN 162 (304)
Q Consensus 147 ~il~el~tg~~p~~~~ 162 (304)
+-+|.++|+..+.-..
T Consensus 195 ~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 195 KPVYRFVTRRVLHWED 210 (218)
T ss_pred chHHHHHhccCCcccc
Confidence 9999999998776443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.2e-20 Score=149.05 Aligned_cols=126 Identities=10% Similarity=0.163 Sum_probs=99.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|++.+.++.|++|..+.+++... +..++||||++|.+|.+.. .+++ ..+.+++.+|..+|+.
T Consensus 84 ~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~ 154 (232)
T PRK10359 84 NLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQH 154 (232)
T ss_pred HHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHc
Confidence 578899999999999999986643 3578999999999998873 2333 2466999999999999
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 153 (304)
| ++|||+||+|++++.+| ++|+|||........... ..++....|+.++|||+||+.+..+.
T Consensus 155 g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 155 G---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9 99999999999999988 999999988654221100 01344566778999999999987654
Q ss_pred h
Q 022003 154 T 154 (304)
Q Consensus 154 t 154 (304)
.
T Consensus 217 ~ 217 (232)
T PRK10359 217 K 217 (232)
T ss_pred H
Confidence 3
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.5e-18 Score=136.62 Aligned_cols=99 Identities=18% Similarity=0.207 Sum_probs=80.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~iiH 80 (304)
+|++++.++.++++.....+... ..+|||||++|++|...+.+ ...++...+..++.|++.+|.++ |+.+ |+|
T Consensus 68 ~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiH 141 (190)
T cd05147 68 KEMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR---LVH 141 (190)
T ss_pred HHHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 38899999988887544433222 23899999988777655333 34689999999999999999999 7888 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDG 107 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~ 107 (304)
|||||+|||++ ++.++|+|||++...
T Consensus 142 rDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 142 ADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCCCHHHEEEE-CCcEEEEEccccccC
Confidence 99999999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.9e-18 Score=136.53 Aligned_cols=97 Identities=15% Similarity=0.152 Sum_probs=78.9
Q ss_pred hHhhHhhcC-----CCCcccceeeEEEeCC---eeE-EEEec--CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HH
Q 022003 2 AEVNFLGDL-----VHLNLVKLIGYCIEDD---QRL-LVYEF--MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL-AF 69 (304)
Q Consensus 2 ~E~~il~~l-----~h~niv~~~~~~~~~~---~~~-lv~e~--~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l-~~ 69 (304)
+|+++++++ +||||++++++++++. ..+ +|||| +.+++|.+++.+. .+++. ..++.|++.++ +|
T Consensus 45 rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~y 120 (210)
T PRK10345 45 RELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRY 120 (210)
T ss_pred HHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHH
Confidence 699999999 5799999999999874 333 78999 5578999999653 36655 35688888888 99
Q ss_pred hhcCCCCCeEeccCCCCCeEECC----CCcEEEccccCcc
Q 022003 70 LHEEAERPVIYRDFKTSNILLDA----DYNAKLSDFGLAK 105 (304)
Q Consensus 70 LH~~~~~~iiH~dlkp~Nili~~----~~~~kl~Dfg~a~ 105 (304)
||+++ |+||||||+|||++. ++.++|+||+.+.
T Consensus 121 Lh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 121 LLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred HHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 99999 999999999999974 3479999955443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-18 Score=162.86 Aligned_cols=139 Identities=25% Similarity=0.393 Sum_probs=107.1
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCc-------------ceeeecccccccccCcch
Q 022003 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-------------THVSTRVMGTYGYAAPEY 130 (304)
Q Consensus 64 ~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~ 130 (304)
+.+++|||+.+ |+|||+||+|++|+.-|++|++|||+.+....... .....+.+||+.|+|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 67999999999 99999999999999999999999999875322110 011224689999999999
Q ss_pred hhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHH
Q 022003 131 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 210 (304)
Q Consensus 131 ~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 210 (304)
+....|+..+|.|++|+|+||.+-|..||.+..+.+... ..+.+...+.+- + ...+.++.++|.+
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~visd~i~wpE~-d--------ea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVISDDIEWPEE-D--------EALPPEAQDLIEQ 294 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hhhhhhcccccc-C--------cCCCHHHHHHHHH
Confidence 999999999999999999999999999998876543221 112222222221 1 1224689999999
Q ss_pred hccCCCCCCC
Q 022003 211 CLSRDPKARP 220 (304)
Q Consensus 211 ~l~~dp~~Rp 220 (304)
+|+.+|..|.
T Consensus 295 LL~qnp~~Rl 304 (1205)
T KOG0606|consen 295 LLRQNPLCRL 304 (1205)
T ss_pred HHHhChHhhc
Confidence 9999999996
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=3e-17 Score=132.66 Aligned_cols=100 Identities=17% Similarity=0.152 Sum_probs=80.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH 80 (304)
+|++.+.++.|+++.....+.... .++||||++|+++....... ..++...+..++.|++.+|.++|+ .| |+|
T Consensus 68 ~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivH 141 (190)
T cd05145 68 KEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAG---LVH 141 (190)
T ss_pred HHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 478889999999876555443332 48999999887554432222 357888999999999999999999 88 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGP 108 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 108 (304)
|||||+||+++ ++.++|+|||++....
T Consensus 142 rDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 142 GDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999998 8899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.6e-18 Score=161.47 Aligned_cols=210 Identities=28% Similarity=0.320 Sum_probs=162.4
Q ss_pred HhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeE
Q 022003 3 EVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH-EEAERPVI 79 (304)
Q Consensus 3 E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l-~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~ii 79 (304)
|..+-..+. |.|++.+++........+++++|..|+++.+.+ .......+......++.|+..++.|+| ..+ +.
T Consensus 70 e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~ 146 (601)
T KOG0590|consen 70 ETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VT 146 (601)
T ss_pred cccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cc
Confidence 444555565 999999999999999999999999999999988 433336777788889999999999999 877 99
Q ss_pred eccCCCCCeEECCCC-cEEEccccCcccCCC-CCcceeeecccc-cccccCcchhhcC-CCCchhhhHHHHHHHHHHHhC
Q 022003 80 YRDFKTSNILLDADY-NAKLSDFGLAKDGPE-GDKTHVSTRVMG-TYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 80 H~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg 155 (304)
||||||+|.+++.++ .++++|||+|..+.. ..........+| +..|+|||...+. ...+..|+||.|+++.-+++|
T Consensus 147 h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g 226 (601)
T KOG0590|consen 147 HRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTG 226 (601)
T ss_pred cCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccC
Confidence 999999999999999 999999999998766 444445556778 9999999998885 557899999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..|+......... ...|... ...+. ............+++.+++..+|..|.+.+++...
T Consensus 227 ~~p~~~~~~~~~~-~~~~~~~----~~~~~--------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 227 ELPWDFPSRKDGR-YSSWKSN----KGRFT--------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred CCCcccccccccc-ceeeccc----ccccc--------cCccccCChhhhhcccccccCCchhcccccccccc
Confidence 9998765443311 1111110 00000 01111224577899999999999999998887653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=150.68 Aligned_cols=149 Identities=19% Similarity=0.178 Sum_probs=122.1
Q ss_pred hHhhcCC---CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 5 NFLGDLV---HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 5 ~il~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+++.+|+ -+-|..+...+.-.+.-++|+||.+-|+|.+++. ..+..++..++.+..|++.-|+.||..+ |||+
T Consensus 743 q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHg 818 (974)
T KOG1166|consen 743 QVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHG 818 (974)
T ss_pred HHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecc
Confidence 3455555 2345555666666777899999999999999996 5557999999999999999999999999 9999
Q ss_pred cCCCCCeEECC-------CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh
Q 022003 82 DFKTSNILLDA-------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 82 dlkp~Nili~~-------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 154 (304)
||||+|+||.. +..++|+|||.+..+.--.........++|-.+-.+|+..|.+|++.+|.|.|+.+++-|++
T Consensus 819 DiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLF 898 (974)
T KOG1166|consen 819 DIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLF 898 (974)
T ss_pred cCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHH
Confidence 99999999942 34689999999876432222233445678999999999999999999999999999999999
Q ss_pred CCC
Q 022003 155 GRR 157 (304)
Q Consensus 155 g~~ 157 (304)
|+.
T Consensus 899 G~y 901 (974)
T KOG1166|consen 899 GKY 901 (974)
T ss_pred HHH
Confidence 864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.4e-17 Score=134.13 Aligned_cols=201 Identities=23% Similarity=0.287 Sum_probs=140.7
Q ss_pred hhcCCCCcccceeeEEEeCC-----eeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 7 LGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 7 l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
|-++.|.|||+++.|+.+.+ ...+++||+..|+|..+|++. ...+....-.+|+-||+.||.|||+.. .+|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccc
Confidence 44567999999999987654 357889999999999999653 456888888999999999999999987 679
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCC---CcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEG---DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
+|+++..+-|++..+|-+|+.- +........ ..........+.++|.|||.-.....+..+|||++|.+..+|..+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999998742 211111000 001112224567899999987767778899999999999999887
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..--....... ......... ....-+ ..-++++.+|++..|..||++.+++-|.
T Consensus 279 Eiq~tnseS~~--~~ee~ia~~------i~~len------------~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 279 EIQSTNSESKV--EVEENIANV------IIGLEN------------GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eeccCCCccee--ehhhhhhhh------eeeccC------------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 53211111100 000000000 000001 1123789999999999999999998764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.2e-15 Score=123.83 Aligned_cols=96 Identities=20% Similarity=0.305 Sum_probs=85.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++..+.|++|.....++...+..++||||++|++|.+.+.... . .+..++.+++.+|.++|+.+ ++|+
T Consensus 48 ~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~ 119 (211)
T PRK14879 48 REARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHG 119 (211)
T ss_pred HHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccC
Confidence 58889999999999888877777788899999999999999985432 2 78899999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCccc
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
|++|.|||++ ++.++|+|||.+..
T Consensus 120 Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 120 DLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999 78999999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.8e-15 Score=122.07 Aligned_cols=94 Identities=22% Similarity=0.342 Sum_probs=80.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.+.|+++....-++......++||||++|++|.+++..... .++.+++.+|.+||+.+ ++|+
T Consensus 46 ~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~ 114 (199)
T TIGR03724 46 NEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHG 114 (199)
T ss_pred HHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecC
Confidence 589999999998876666666667778999999999999998754321 78999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDG 107 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~ 107 (304)
|++|+||+++ ++.++++|||++...
T Consensus 115 Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 115 DLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999999 889999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.8e-15 Score=139.83 Aligned_cols=92 Identities=24% Similarity=0.346 Sum_probs=83.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|++++....++......++||||++|++|.+++. ....++.+++.+|.+||+.+ ++||
T Consensus 385 ~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHr 452 (535)
T PRK09605 385 AEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHG 452 (535)
T ss_pred HHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccC
Confidence 58999999999999988888777778899999999999999874 35678999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCccc
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
||||+|||+ .++.++|+|||+++.
T Consensus 453 Dlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 453 DLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999 678999999999876
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=9.7e-15 Score=121.95 Aligned_cols=97 Identities=25% Similarity=0.224 Sum_probs=78.6
Q ss_pred hHhhHhhcCCCCcc--cceeeEEEeCCe----eEEEEecCCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 2 AEVNFLGDLVHLNL--VKLIGYCIEDDQ----RLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 2 ~E~~il~~l~h~ni--v~~~~~~~~~~~----~~lv~e~~~~-~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
+|++++.+|.|++| ++.+++...... .++|||+++| .+|.+++... .++... +.+|+.+|.+||+.|
T Consensus 89 rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~lH~~G 162 (239)
T PRK01723 89 AEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARFHDAG 162 (239)
T ss_pred HHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHHHHCC
Confidence 59999999998875 677776544322 2599999997 6999887543 355443 578999999999999
Q ss_pred CCCeEeccCCCCCeEECCCCcEEEccccCcccC
Q 022003 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 107 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 107 (304)
|+||||||+|||++.++.++|+|||.+...
T Consensus 163 ---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 163 ---VYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred ---CCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 999999999999999999999999998763
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.6e-14 Score=120.46 Aligned_cols=99 Identities=19% Similarity=0.213 Sum_probs=76.9
Q ss_pred hHhhHhhcCCCCc--ccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++.++.+.. +.++++. . ..++||||+.|.+|....... ..+....+..++.|++.+|.+||..+. ++
T Consensus 99 ~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~--ii 171 (237)
T smart00090 99 KEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGE--LV 171 (237)
T ss_pred HHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCC--EE
Confidence 4888899887532 3344432 2 358999999888887654332 346666778999999999999998653 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGP 108 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 108 (304)
||||||+||+++ ++.++|+|||.+....
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999999 8899999999987543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.5e-14 Score=128.40 Aligned_cols=204 Identities=25% Similarity=0.310 Sum_probs=153.6
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCC
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK----GLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~ 76 (304)
+|+.-..++ .|+|.++.+..+...+..|+-+|+| +.+|..+.......++...++..+.+... ||.++|+.+
T Consensus 166 ~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~-- 242 (524)
T KOG0601|consen 166 REFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN-- 242 (524)
T ss_pred chhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--
Confidence 444445555 5899999999999999999999999 68999998777777999999999999999 999999988
Q ss_pred CeEeccCCCCCeEECCC-CcEEEccccCcccCCCCCcc---eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 77 PVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
++|-|+||+||+...+ ...+++|||++..+..+... ....+..|..-|++||.. .+-++.+.|||++|.++.+-
T Consensus 243 -~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~ 320 (524)
T KOG0601|consen 243 -IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEA 320 (524)
T ss_pred -ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhh
Confidence 9999999999999999 88999999999988765422 222233577789999965 45678999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
.++........-. .|. +.... . +...+-...+..+...+..|++.+|..|+++..+.+
T Consensus 321 ~l~~~~~~~g~~~------~W~-----~~r~~---~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 321 ILGSHLPSVGKNS------SWS-----QLRQG---Y---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred HhhcccccCCCCC------Ccc-----ccccc---c---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 8876554322000 010 00000 0 011111112345566999999999999999888775
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.7e-13 Score=123.25 Aligned_cols=141 Identities=17% Similarity=0.212 Sum_probs=111.9
Q ss_pred HhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 82 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d 82 (304)
-++-|+.|+||||+++++.++..+.+|+|+|-+ ..|..++.+. ....+..-+.||+.||.|||..+. ++|++
T Consensus 59 A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l----~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgN 130 (690)
T KOG1243|consen 59 AVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL----GKEEVCLGLFQILAALSFLNDDCN--LVHGN 130 (690)
T ss_pred HHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh----HHHHHHHHHHHHHHHHHHHhccCC--eeecc
Confidence 467889999999999999999999999999998 5788877553 377788889999999999986553 99999
Q ss_pred CCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 83 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 83 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
|.-..|+|+..|..||++|.++........ .......-..|..|+.+.... ...|.|.|||++++++.|
T Consensus 131 v~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 131 VCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred EeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 999999999999999999998876443221 111122233466676544322 567999999999999998
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.7e-14 Score=114.33 Aligned_cols=94 Identities=17% Similarity=0.111 Sum_probs=75.5
Q ss_pred hHhhHhhcCCCCc--ccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+.++.++.|++ +...++ ....++||||++|++|...... .....++.+++.++.++|+.+ ++
T Consensus 82 ~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~ 147 (198)
T cd05144 82 KEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---II 147 (198)
T ss_pred HHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CC
Confidence 4777888887774 444443 2345899999999998775421 335678899999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPE 109 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 109 (304)
||||||+||+++.++.++|+|||++.....
T Consensus 148 H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 148 HGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.9e-13 Score=103.35 Aligned_cols=97 Identities=25% Similarity=0.215 Sum_probs=82.7
Q ss_pred hHhhHhhcCCC--CcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+.+++.++| .++.+++++....+..+++|||+.++.+..+ +......++.+++++|.++|......++
T Consensus 40 ~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~ 111 (155)
T cd05120 40 REVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLC 111 (155)
T ss_pred HHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEE
Confidence 58889999976 5888999888877889999999988777654 5566678899999999999986333499
Q ss_pred eccCCCCCeEECCCCcEEEccccCccc
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
|+|++|+||++++.+.++++|||.++.
T Consensus 112 H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCCcceEEEECCcEEEEEecccccC
Confidence 999999999999989999999998875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-12 Score=123.48 Aligned_cols=192 Identities=23% Similarity=0.233 Sum_probs=140.2
Q ss_pred CcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC
Q 022003 13 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 92 (304)
Q Consensus 13 ~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~ 92 (304)
|-++...--+.-....++|++|+.+++|...+...+ ..+.+........+.+++++||+.. +.|+|++|.|.++..
T Consensus 864 P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~ 939 (1205)
T KOG0606|consen 864 PAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAY 939 (1205)
T ss_pred CceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcc
Confidence 444444433444567899999999999999886554 4666666777788899999999977 899999999999999
Q ss_pred CCcEEEccccCcccCCCC---------------------C--------cceeeecccccccccCcchhhcCCCCchhhhH
Q 022003 93 DYNAKLSDFGLAKDGPEG---------------------D--------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 143 (304)
Q Consensus 93 ~~~~kl~Dfg~a~~~~~~---------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 143 (304)
+|..+++|||.....+.. . .........||+.|.+||...+..-...+|+|
T Consensus 940 ~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~ 1019 (1205)
T KOG0606|consen 940 DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWW 1019 (1205)
T ss_pred cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhh
Confidence 999999999843321110 0 00112335789999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 022003 144 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 144 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
++|++++|.++|.+||....+......+...... ...-+...+..+.+++...+..++.+|..+.
T Consensus 1020 ~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~---------------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQQIFENILNRDIP---------------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhhhcCCCCCCCcchhhhhhccccCCCC---------------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999999765543322111100000 0111223356788999999999999998766
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=5e-12 Score=101.84 Aligned_cols=75 Identities=20% Similarity=0.164 Sum_probs=59.0
Q ss_pred eeEEEEecCCCCCHHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEECCCCcEEEccccCc
Q 022003 27 QRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLA 104 (304)
Q Consensus 27 ~~~lv~e~~~~~sL~~-~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a 104 (304)
..++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .+ ++|+||||+||+++ ++.++|+|||.+
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDfg~a 161 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDVPQA 161 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEECccc
Confidence 4689999998843321 111111 11 5678899999999999999 88 99999999999999 899999999999
Q ss_pred ccCC
Q 022003 105 KDGP 108 (304)
Q Consensus 105 ~~~~ 108 (304)
....
T Consensus 162 ~~~~ 165 (187)
T cd05119 162 VEID 165 (187)
T ss_pred cccc
Confidence 7643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.6e-11 Score=92.97 Aligned_cols=93 Identities=25% Similarity=0.346 Sum_probs=76.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++.++.--.|...+=+..+.....|+|||++|..|++.+... ...++..+-.-+.-||..| |+|+
T Consensus 48 ~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHG 116 (204)
T COG3642 48 REARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHG 116 (204)
T ss_pred HHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecC
Confidence 6899999886655555555556677778999999999999888654 2566777888889999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCccc
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
||.++|++++.++ +.++|||++..
T Consensus 117 DLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 117 DLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCccceEEEeCCc-EEEEECCcccc
Confidence 9999999997665 99999999875
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.2e-11 Score=95.08 Aligned_cols=97 Identities=14% Similarity=0.131 Sum_probs=73.2
Q ss_pred hHhhHhhcCCC--CcccceeeEEEeCCeeEEEEecCCCCCHHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCC
Q 022003 2 AEVNFLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~ 77 (304)
+|++.|+++.. -++-+.+++ ..-+|||||+.++.+.. .+.. ..++......++.+++.+|..| |+.+
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--- 145 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--- 145 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence 68999999853 455666654 35689999996643322 2211 2355666778889999999999 8888
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcccCC
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDGP 108 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 108 (304)
++|+||++.||++. ++.+.|+|||.+....
T Consensus 146 lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 146 LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999999996 4689999999887643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-11 Score=111.47 Aligned_cols=199 Identities=22% Similarity=0.164 Sum_probs=142.6
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|+-+...+ .|.+++.++..+....+.|+=-|||.++++...+ .-...+.+..++.+..|++.++.++|+.. ++|
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~ 389 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVH 389 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhc
Confidence 455555555 6889999888888888889999999999887766 22345888899999999999999999988 999
Q ss_pred ccCCCCCeEECCC-CcEEEccccCcccCCCCCcceeeeccccccccc--CcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 81 RDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA--APEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 81 ~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
+|+||+||++..+ +..++.|||....+.... ......-++. +++......+..++|++|||.-+.+.+++..
T Consensus 390 ~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 390 LDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ccccccceeeccchhhhhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 9999999999876 788999999886532111 1112223344 4555556788999999999999999998765
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
.-..... |. . +........+.. ..++..+...+...++..||++.++..+..
T Consensus 465 ls~~~~~--------~~-----------~-i~~~~~p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 465 LSESGVQ--------SL-----------T-IRSGDTPNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cCccccc--------ce-----------e-eecccccCCCch-HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 3322110 00 0 000000111111 267778899999999999999988876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.1e-11 Score=94.31 Aligned_cols=93 Identities=23% Similarity=0.120 Sum_probs=69.0
Q ss_pred hHhhHhhcCCCCccc-ceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCe
Q 022003 2 AEVNFLGDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--ERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~i 78 (304)
+|+++++.+.+.+++ +++.+. ....++||||++|.++...- .....++.+++++|+.||+.+ ...+
T Consensus 41 ~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~ 109 (170)
T cd05151 41 NEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVP 109 (170)
T ss_pred HHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccccc---------ccCHHHHHHHHHHHHHHhCCCCCCcee
Confidence 588889988665554 455443 33458999999998876530 112345789999999999977 1224
Q ss_pred EeccCCCCCeEECCCCcEEEccccCccc
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
+|+|++|.||+++ ++.++++|||.+..
T Consensus 110 ~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 110 CHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9999999999998 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.6e-10 Score=104.82 Aligned_cols=102 Identities=20% Similarity=0.142 Sum_probs=69.9
Q ss_pred hHhhHhhcC----CCCcccceeeEE-EeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHH-HHHHhhcCCC
Q 022003 2 AEVNFLGDL----VHLNLVKLIGYC-IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK-GLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~-~l~~LH~~~~ 75 (304)
+|++.+.++ +|.+-+.+-.++ ...+..++||||++|++|.++........+ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC-
Confidence 355555555 233323332222 223457999999999999887643221222 2345555555 467889888
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCC
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 109 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 109 (304)
++|+|+||.||+++.++.++++|||++.....
T Consensus 278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.2e-11 Score=108.97 Aligned_cols=160 Identities=21% Similarity=0.272 Sum_probs=110.0
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeee-------ccccccc
Q 022003 52 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-------RVMGTYG 124 (304)
Q Consensus 52 ~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~-------~~~gt~~ 124 (304)
.-+....-+.+++.|+.|+|...+ +||++|.|++|.++.++..||+.|+.+............. -......
T Consensus 97 aTe~~f~nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~ 174 (700)
T KOG2137|consen 97 ATEDGFANLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLN 174 (700)
T ss_pred cccHhhhhhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcc
Confidence 334445556677799999998654 9999999999999999999999999887654422211111 1123567
Q ss_pred ccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHH
Q 022003 125 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK 203 (304)
Q Consensus 125 y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (304)
|.|||++.+..-+.++|+||+|+++|.+.. |+..+............ ...+..-...+....+.+
T Consensus 175 f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~~~s~~~p~e 240 (700)
T KOG2137|consen 175 FLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAFGYSNNLPSE 240 (700)
T ss_pred cccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccccccccCcHH
Confidence 999999999888999999999999999984 44444332111110000 001111111122345689
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHH
Q 022003 204 AAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 204 ~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
+++=+.+++..+..-||++.++..
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhc
Confidence 999999999999999998887765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.9e-10 Score=86.25 Aligned_cols=102 Identities=23% Similarity=0.240 Sum_probs=76.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCC-CCHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++|.++.--.|.-..=++.+...-+|+|||++| .++.+++...... ........++..|-+.+.-||.++ |+
T Consensus 59 ~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---ii 135 (229)
T KOG3087|consen 59 QEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---II 135 (229)
T ss_pred HHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---ee
Confidence 588888887654555444456666677899999966 3888888654322 333333788999999999999999 99
Q ss_pred eccCCCCCeEECCCC---cEEEccccCccc
Q 022003 80 YRDFKTSNILLDADY---NAKLSDFGLAKD 106 (304)
Q Consensus 80 H~dlkp~Nili~~~~---~~kl~Dfg~a~~ 106 (304)
|+||..+||++..++ .+.++|||++..
T Consensus 136 HGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 136 HGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cccccccceEEecCCCcCceEEEeecchhc
Confidence 999999999996554 347999999865
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.7e-09 Score=91.47 Aligned_cols=102 Identities=16% Similarity=0.138 Sum_probs=78.4
Q ss_pred hHhhHhhcCCCC--cccceeeEEEe-----CCeeEEEEecCCCC-CHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDLVHL--NLVKLIGYCIE-----DDQRLLVYEFMPRG-SLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l~h~--niv~~~~~~~~-----~~~~~lv~e~~~~~-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|.+.+.+|..- ...+.+++++. ....+||||++++. +|.+++... ....+......++.+++..+.-||.
T Consensus 77 rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~ 156 (268)
T PRK15123 77 REWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA 156 (268)
T ss_pred HHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 577777777432 33455666543 23468999999876 899988532 2345677788999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECC-------CCcEEEccccCccc
Q 022003 73 EAERPVIYRDFKTSNILLDA-------DYNAKLSDFGLAKD 106 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~-------~~~~kl~Dfg~a~~ 106 (304)
.| |+|+||++.|||++. +..+.|+||+.++.
T Consensus 157 ~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 157 AG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred Cc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99 999999999999975 46899999998754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-08 Score=88.25 Aligned_cols=197 Identities=16% Similarity=0.173 Sum_probs=128.8
Q ss_pred eeEEEEecCCCC-CHHHHh-----hcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEcc
Q 022003 27 QRLLVYEFMPRG-SLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 100 (304)
Q Consensus 27 ~~~lv~e~~~~~-sL~~~l-----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~D 100 (304)
...++|..+.|. .+..++ ++......|......++.|+.+.+.||+.| .+-+|+.++|+|+++++.+.|.|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEc
Confidence 367788888664 233333 123455899999999999999999999999 99999999999999999999998
Q ss_pred ccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCCCCCc-chh--
Q 022003 101 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGEH-NLV-- 171 (304)
Q Consensus 101 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg-~~p~~~~~~~~~~-~~~-- 171 (304)
-........+. .....+|...|.+||.-. +..-+...|-|.||+++++++.| +.||.+....... .-.
T Consensus 161 sDsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 161 SDSFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred ccceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 66544432221 122357889999999754 33457789999999999998886 8999764332211 000
Q ss_pred Hhhhhhhccccc-cccccCCccCCCCCHHHHHHHHHHHHHhccC--CCCCCCCHHHHHHHhC
Q 022003 172 EWARPHLGERRR-FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR--DPKARPLMSEVVEALK 230 (304)
Q Consensus 172 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--dp~~Rps~~ell~~l~ 230 (304)
.+.......... -.....+.. ..--...+.++..|..+|+.. ++.-|||++..+..|.
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~-~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~ 298 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPR-SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD 298 (637)
T ss_pred hhhcceeeechhccCCCCCCCC-CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence 111000000000 000111111 111123457888999999864 3678999988776654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.2e-08 Score=90.97 Aligned_cols=180 Identities=17% Similarity=0.263 Sum_probs=126.4
Q ss_pred hhHhhcCCCCcccceeeEEEe----CCeeEEEEecCCCC-CHHHHhhcC--------------CCCCCHHHHHHHHHHHH
Q 022003 4 VNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRG-SLENHLFRR--------------SLPLPWSIRMKIALGAA 64 (304)
Q Consensus 4 ~~il~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~-sL~~~l~~~--------------~~~l~~~~~~~i~~qi~ 64 (304)
++.++++.|.|||++.+++.+ +..+++|++|+++. +|.++.... +.+.+++.+|.++.||.
T Consensus 324 ve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLt 403 (655)
T KOG3741|consen 324 VEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLT 403 (655)
T ss_pred HHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHH
Confidence 678899999999999999874 33679999998874 777765331 23578899999999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHH
Q 022003 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 144 (304)
Q Consensus 65 ~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 144 (304)
.||.++|+.| +.=+-|.+.+|+++.+-+++|...|..-....... |.+.+ -.+-|.=.
T Consensus 404 aaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~----------------~~le~---~Qq~D~~~ 461 (655)
T KOG3741|consen 404 AALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT----------------EPLES---QQQNDLRD 461 (655)
T ss_pred HHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCC----------------cchhH---HhhhhHHH
Confidence 9999999999 87799999999999888899887776544322110 11111 23578889
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 145 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 145 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||.+++.|.||..--... +. .... . .......++.++++++.-....++++ -++.+
T Consensus 462 lG~ll~aLAt~~~ns~~~---d~--~~~s---~---------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ 517 (655)
T KOG3741|consen 462 LGLLLLALATGTENSNRT---DS--TQSS---H---------------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQD 517 (655)
T ss_pred HHHHHHHHhhcccccccc---cc--hHHH---H---------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHH
Confidence 999999999985421000 00 0000 0 00112244678888888888888886 56777
Q ss_pred HHHHh
Q 022003 225 VVEAL 229 (304)
Q Consensus 225 ll~~l 229 (304)
++.++
T Consensus 518 llp~~ 522 (655)
T KOG3741|consen 518 LLPMI 522 (655)
T ss_pred HHHHH
Confidence 76543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.4e-09 Score=85.47 Aligned_cols=102 Identities=25% Similarity=0.252 Sum_probs=80.6
Q ss_pred hHhhHhhcCCC--CcccceeeEEEeCC----eeEEEEecCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 2 AEVNFLGDLVH--LNLVKLIGYCIEDD----QRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 2 ~E~~il~~l~h--~niv~~~~~~~~~~----~~~lv~e~~~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
+|.+.+..|.. -...+.+++.+... ..++|+|++++. +|.+++..... .+......++.+++..+.-||..|
T Consensus 60 ~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH~~g 138 (206)
T PF06293_consen 60 REWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLHDAG 138 (206)
T ss_pred HHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHHHCc
Confidence 46676666643 33456677666532 358999999875 89998865332 667778899999999999999999
Q ss_pred CCCeEeccCCCCCeEECCCC---cEEEccccCcccC
Q 022003 75 ERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDG 107 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~~~---~~kl~Dfg~a~~~ 107 (304)
|+|+|+++.|||++.++ .+.++||+.++..
T Consensus 139 ---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 139 ---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred ---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999998887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.89 E-value=8e-10 Score=101.77 Aligned_cols=75 Identities=15% Similarity=0.048 Sum_probs=55.8
Q ss_pred CCeeEEEEecCCCCCHHHHh--hcCCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC----c
Q 022003 25 DDQRLLVYEFMPRGSLENHL--FRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 95 (304)
Q Consensus 25 ~~~~~lv~e~~~~~sL~~~l--~~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~----~ 95 (304)
....+|||||+.|+.|.++- .+.+. .+.+..+..++.|++ ..| ++|+|+||.||+++.+| .
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~ 302 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDG---FFHADMHPGNIFVSYDPPENPR 302 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC---eeeCCCChHHeEEecCCCCCCe
Confidence 34568999999999998742 22221 244444555566654 356 99999999999999888 9
Q ss_pred EEEccccCcccCCC
Q 022003 96 AKLSDFGLAKDGPE 109 (304)
Q Consensus 96 ~kl~Dfg~a~~~~~ 109 (304)
++++|||++.....
T Consensus 303 i~llDFGivg~l~~ 316 (537)
T PRK04750 303 YIALDFGIVGSLNK 316 (537)
T ss_pred EEEEecceEEECCH
Confidence 99999999987654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.2e-08 Score=81.51 Aligned_cols=96 Identities=22% Similarity=0.245 Sum_probs=63.6
Q ss_pred hHhhHhhcCCCC--cccceeeEEEeCCeeEEEEecCC--CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCC
Q 022003 2 AEVNFLGDLVHL--NLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~--niv~~~~~~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~~~ 76 (304)
+|++.|.++..- ++-+++++. .-+|||||+. |..+..+.... ++.+....++.+++..+.. +|+.|
T Consensus 57 ~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g-- 127 (188)
T PF01163_consen 57 KEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG-- 127 (188)
T ss_dssp HHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT--
T ss_pred HHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC--
Confidence 599999999765 455666542 3479999997 55554433221 2234456677788885555 57888
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCC
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 108 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 108 (304)
++|+||.+.||+++++ .+.|+|||.+....
T Consensus 128 -ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 128 -IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp -EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred -ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 9999999999999877 89999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.8e-08 Score=83.10 Aligned_cols=103 Identities=23% Similarity=0.285 Sum_probs=78.2
Q ss_pred hHhhHhhcCCCC--cccceeeEEEeC---CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC--
Q 022003 2 AEVNFLGDLVHL--NLVKLIGYCIED---DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-- 74 (304)
Q Consensus 2 ~E~~il~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-- 74 (304)
+|+++++.+.+. ++.+++.+.... +..++||||++|.++.+.+.. ..++......++.+++++|..||+..
T Consensus 44 ~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 121 (223)
T cd05154 44 REYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPA 121 (223)
T ss_pred HHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChh
Confidence 588899998763 456777776553 256899999999888775532 24677777788888888888888531
Q ss_pred ---------------------------------------------------CCCeEeccCCCCCeEECC--CCcEEEccc
Q 022003 75 ---------------------------------------------------ERPVIYRDFKTSNILLDA--DYNAKLSDF 101 (304)
Q Consensus 75 ---------------------------------------------------~~~iiH~dlkp~Nili~~--~~~~kl~Df 101 (304)
...++|+|+++.||+++. ++.+.|+||
T Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~ 201 (223)
T cd05154 122 AVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDW 201 (223)
T ss_pred hcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEec
Confidence 123799999999999988 667899999
Q ss_pred cCccc
Q 022003 102 GLAKD 106 (304)
Q Consensus 102 g~a~~ 106 (304)
+.+..
T Consensus 202 e~~~~ 206 (223)
T cd05154 202 ELATL 206 (223)
T ss_pred ccccc
Confidence 98764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=1e-06 Score=71.21 Aligned_cols=101 Identities=17% Similarity=0.170 Sum_probs=76.6
Q ss_pred hHhhHhhcCCC--CcccceeeEEEe---C--CeeEEEEecCCC-CCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDLVH--LNLVKLIGYCIE---D--DQRLLVYEFMPR-GSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l~h--~niv~~~~~~~~---~--~~~~lv~e~~~~-~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|+..|.+|.. -.+.++. ++.. . -..+||+|-+.| .+|.+++.+.. .+.+......++.+++..+.-||.
T Consensus 68 rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~ 146 (216)
T PRK09902 68 REVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS 146 (216)
T ss_pred HHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH
Confidence 68888888843 2244444 3321 1 135799998754 48988885542 356788888999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCc--EEEccccCccc
Q 022003 73 EAERPVIYRDFKTSNILLDADYN--AKLSDFGLAKD 106 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~--~kl~Dfg~a~~ 106 (304)
.| +.|+|+.+.||+++.+|. ++++||.-++.
T Consensus 147 ~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 147 VN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99 999999999999986667 99999987765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.6e-08 Score=90.04 Aligned_cols=147 Identities=20% Similarity=0.187 Sum_probs=110.3
Q ss_pred HhhHhhcCCCCc-ccceeeEEEeCCeeEEEEecCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 3 EVNFLGDLVHLN-LVKLIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 3 E~~il~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++++|.+++||| .+..++-+..+....++|+++.++ +...........+..-+...+.+.-+.+++++|+.. -+|
T Consensus 283 ~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~ 359 (829)
T KOG0576|consen 283 AIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVH 359 (829)
T ss_pred HHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccC
Confidence 678999999999 677777777777889999999777 332222111122344445566777778999999965 589
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
+| ||+..+ +..+.+||+....+.... ......+++.++|||+.....+..+.|+|++|.-..+|--|.+|-.
T Consensus 360 ~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 360 RD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 98 777655 678999999987765432 3445678999999999999999999999999987777777766643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.45 E-value=6.4e-07 Score=87.10 Aligned_cols=194 Identities=21% Similarity=0.235 Sum_probs=136.7
Q ss_pred HhhHhhcCCCCcccceeeEEEeCCee----EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDDQR----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
|.+.+.++.|+|++.++.|....... .+..++|...++...+.. ...++.+.++.+..++++||.|+|+.. .
T Consensus 232 e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~---l 307 (1351)
T KOG1035|consen 232 ELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLS---L 307 (1351)
T ss_pred HHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhc---c
Confidence 56677888999999999998765433 244578888888888744 447899999999999999999999976 6
Q ss_pred EeccCCCC---CeEECCCCcEEEc--cccCcccCCCCCcceeeecccccccccCcchhhcCCCCc--hhhhHHHHHHHHH
Q 022003 79 IYRDFKTS---NILLDADYNAKLS--DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS--RSDVYSFGVVLLE 151 (304)
Q Consensus 79 iH~dlkp~---Nili~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiwslG~il~e 151 (304)
.|.-|... +.-++.++.+.++ ||+.+......... .....+..+.|+|......+.. ..|+|.+|.....
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 66665555 4444566677777 99888876543321 1123355678888877665554 4799999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 152 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 152 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
+..|..+-...... ..+++. .......++..+|+.-+.++|+++.+++.+..
T Consensus 385 ~~~~~~i~~~~~~~-------------------~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 385 LSQGEDISEKSAVP-------------------VSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhcCcccccccch-------------------hhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 98876543211100 000100 00115678999999999999999999998653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.1e-06 Score=70.59 Aligned_cols=102 Identities=28% Similarity=0.265 Sum_probs=81.8
Q ss_pred hHhhHhhcCCC-CcccceeeEEEeCCeeEEEEecCCCCCHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|.-+|+.+.+ +++.+++|+| ..++|.||...+++..... ......+|..+.+++.++++.+.+|+......+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888999976 6999999998 3477899997666643210 111247899999999999999999998654558
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDG 107 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 107 (304)
.-.|++++|+-|+.+|++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999877653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.6e-06 Score=72.03 Aligned_cols=92 Identities=18% Similarity=0.149 Sum_probs=66.8
Q ss_pred hHhhHhhcCCCC--cccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHL--NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|.++|.+|.-. .+-+.+++ +.-++|||+++|-.|... +++.+....++..|++-+.-+-..| ||
T Consensus 158 rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~G---iV 224 (304)
T COG0478 158 REFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRG---IV 224 (304)
T ss_pred HHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcC---cc
Confidence 588888888644 66666664 234789999988666543 1234444455556666665555777 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCccc
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
|+|+.+-||+++++|.+.++||--+..
T Consensus 225 HGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 225 HGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred ccCCchheEEEecCCCEEEEeCccccc
Confidence 999999999999999999999966544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.5e-06 Score=70.44 Aligned_cols=67 Identities=15% Similarity=0.168 Sum_probs=52.6
Q ss_pred eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 27 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 27 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
..++||||++|..|.+... +++ .+...+.+++.-||+.| +.|+|.+|.|++++.+ .++++||+..+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccccc
Confidence 4568999999988876531 222 24456778899999999 9999999999999865 499999976653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.8e-05 Score=65.64 Aligned_cols=103 Identities=15% Similarity=0.127 Sum_probs=60.2
Q ss_pred hHhhHhhcCCCCc--ccceeeEEEeCCeeEEEEecCCCCC-HHHHh--------------hc-----CC---CCCCHHHH
Q 022003 2 AEVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGS-LENHL--------------FR-----RS---LPLPWSIR 56 (304)
Q Consensus 2 ~E~~il~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~s-L~~~l--------------~~-----~~---~~l~~~~~ 56 (304)
+|.++++.+..-. +.+.+++....+...+|||+++|.. +...+ .+ +. ........
T Consensus 41 ~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~ 120 (226)
T TIGR02172 41 REFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY 120 (226)
T ss_pred HHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH
Confidence 5888888886433 4677888877888899999998863 21111 00 00 01111110
Q ss_pred H-HHHHH----------HHHH-HHHh--hcCCCCCeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 57 M-KIALG----------AAKG-LAFL--HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 57 ~-~i~~q----------i~~~-l~~L--H~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
. .+..+ +... ..+| +... ..++|+|+.|.||++++++ +.|+||+.+..
T Consensus 121 ~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~-~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 121 KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT-STCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC-CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 0 00000 0011 1111 1212 3379999999999999888 99999988753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.1e-05 Score=64.98 Aligned_cols=42 Identities=21% Similarity=0.231 Sum_probs=31.8
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHH
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 43 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~ 43 (304)
+|+++++.+. +--+.+++++...++..++|||+++|.+|...
T Consensus 40 ~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 40 REAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred HHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 5888888884 33455778877776678999999999877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=1.8e-05 Score=72.93 Aligned_cols=82 Identities=18% Similarity=0.161 Sum_probs=58.8
Q ss_pred eCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccC
Q 022003 24 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 103 (304)
Q Consensus 24 ~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~ 103 (304)
..+...|+|||+.|-.+.+....+...++...+...+.++.-- -+-..| ++|.|.+|.||+++.+|++.+.|||+
T Consensus 237 ~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~--q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi 311 (517)
T COG0661 237 YTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLR--QLLRDG---FFHADPHPGNILVRSDGRIVLLDFGI 311 (517)
T ss_pred ccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHH--HHHhcC---ccccCCCccceEEecCCcEEEEcCcc
Confidence 3456789999999988888753333456655544433333222 222245 99999999999999999999999999
Q ss_pred cccCCCC
Q 022003 104 AKDGPEG 110 (304)
Q Consensus 104 a~~~~~~ 110 (304)
.......
T Consensus 312 ~g~l~~~ 318 (517)
T COG0661 312 VGRLDPK 318 (517)
T ss_pred eecCCHH
Confidence 9876543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=2.4e-06 Score=85.39 Aligned_cols=155 Identities=15% Similarity=0.025 Sum_probs=115.3
Q ss_pred HhhHhhcCCCCcccceeeEEE--eCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCC--
Q 022003 3 EVNFLGDLVHLNLVKLIGYCI--EDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAE-- 75 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~-- 75 (304)
|.+-+++..|++++..+.-.. ++...+.+++|+.+|.+.+.|.+. ...+....+.....+.+.+..-+|+..+
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 444556678888877665443 234568999999999999998664 2345555555555554666666665432
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
.-.+|++||+-|.+|..+-.+|++++|+.+..... ....+...+++-|+++++.....++.++|||..|+-+|+..-|
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 33799999999999999999999999999832221 1223445678889999998888999999999999999999888
Q ss_pred CCCC
Q 022003 156 RRSM 159 (304)
Q Consensus 156 ~~p~ 159 (304)
..+|
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 7766
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.77 E-value=9.2e-05 Score=61.02 Aligned_cols=97 Identities=20% Similarity=0.224 Sum_probs=65.4
Q ss_pred hHhhHhhcCC--CCcccceeeEEEeCCeeEEEEecCCCCCH-HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCC
Q 022003 2 AEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERP 77 (304)
Q Consensus 2 ~E~~il~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~sL-~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ 77 (304)
+|++-|+++. +-.+-+-+++. +..|||||+....+ .-.| +...+..+....+..++++.+.-|-. .+
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~a~--- 187 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKEAG--- 187 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHhcC---
Confidence 4666666663 33334444432 34789999944310 0011 11233444677788888888888877 56
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcccCC
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDGP 108 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 108 (304)
+||+||..-|||+. ++.+.++|||-+....
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999998 8899999999887643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00026 Score=57.16 Aligned_cols=90 Identities=19% Similarity=0.226 Sum_probs=64.0
Q ss_pred hHhhHhhcCC------CCcccceeeEEEeCCeeEEEEecCCCC------CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLV------HLNLVKLIGYCIEDDQRLLVYEFMPRG------SLENHLFRRSLPLPWSIRMKIALGAAKGLAF 69 (304)
Q Consensus 2 ~E~~il~~l~------h~niv~~~~~~~~~~~~~lv~e~~~~~------sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~ 69 (304)
+|++-...+. +.+|.+++|+.+++....+|+|.+.+. +|.+++.+. .++. .....+.++. +|
T Consensus 60 ~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~L~~f~---~~ 133 (199)
T PF10707_consen 60 RELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQALDEFK---RY 133 (199)
T ss_pred HHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHHHHHHH---HH
Confidence 3555555444 789999999999999999999976442 788888544 3555 4455555444 45
Q ss_pred hhcCCCCCeEeccCCCCCeEECCC--C--cEEEcc
Q 022003 70 LHEEAERPVIYRDFKTSNILLDAD--Y--NAKLSD 100 (304)
Q Consensus 70 LH~~~~~~iiH~dlkp~Nili~~~--~--~~kl~D 100 (304)
|-... |+.+||+|.||++..+ + .+.|+|
T Consensus 134 l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 134 LLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence 55655 9999999999999533 2 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00024 Score=70.14 Aligned_cols=38 Identities=18% Similarity=0.354 Sum_probs=29.5
Q ss_pred hHhhHhhcCC-CCcc--cceeeEEEeC---CeeEEEEecCCCCC
Q 022003 2 AEVNFLGDLV-HLNL--VKLIGYCIED---DQRLLVYEFMPRGS 39 (304)
Q Consensus 2 ~E~~il~~l~-h~ni--v~~~~~~~~~---~~~~lv~e~~~~~s 39 (304)
+|+++|+.|. |.++ .+++.++.+. +..|+||||++|..
T Consensus 87 rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 87 REYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred HHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 6899999995 6665 6778877654 46789999998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00015 Score=60.48 Aligned_cols=30 Identities=20% Similarity=0.233 Sum_probs=25.4
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
.++|+|+.+.||+++.++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 389999999999998766567999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00016 Score=66.54 Aligned_cols=79 Identities=18% Similarity=0.098 Sum_probs=55.3
Q ss_pred CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC----CCcEEEccc
Q 022003 26 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA----DYNAKLSDF 101 (304)
Q Consensus 26 ~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~----~~~~kl~Df 101 (304)
....|+||||+|..+.+.-.-....++...+..-+.+...-+-+.| | ++|+|=+|.||+|+. ++.+.+.||
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~--G---ffHaDPHPGNilv~~~~~~~~~ivllDh 349 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT--G---FFHADPHPGNILVRPNPEGDEEIVLLDH 349 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc--C---CccCCCCCCcEEEecCCCCCccEEEEcc
Confidence 4569999999998666553323334666655554444443333333 4 999999999999984 678999999
Q ss_pred cCcccCCC
Q 022003 102 GLAKDGPE 109 (304)
Q Consensus 102 g~a~~~~~ 109 (304)
|+......
T Consensus 350 Gl~~~is~ 357 (538)
T KOG1235|consen 350 GLYAVISH 357 (538)
T ss_pred cccccccH
Confidence 99987644
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00065 Score=56.16 Aligned_cols=31 Identities=32% Similarity=0.326 Sum_probs=21.2
Q ss_pred CCeEeccCCCCCeEEC-CCCcEEEccccCccc
Q 022003 76 RPVIYRDFKTSNILLD-ADYNAKLSDFGLAKD 106 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~-~~~~~kl~Dfg~a~~ 106 (304)
..++|+|+.+.||+++ .++.+-|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 3399999999999999 667778999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00095 Score=55.58 Aligned_cols=30 Identities=20% Similarity=0.286 Sum_probs=26.2
Q ss_pred CeEeccCCCCCeEECC-CCcEEEccccCccc
Q 022003 77 PVIYRDFKTSNILLDA-DYNAKLSDFGLAKD 106 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~-~~~~kl~Dfg~a~~ 106 (304)
.++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 3999999999999997 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00076 Score=57.05 Aligned_cols=28 Identities=25% Similarity=0.329 Sum_probs=25.2
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
++|+|+.|.||++++++ +.|+||..+..
T Consensus 148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 148 PLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 89999999999999877 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00019 Score=65.01 Aligned_cols=44 Identities=25% Similarity=0.367 Sum_probs=34.3
Q ss_pred hhHhhcCCCCcccceeeEEEeC-CeeEEEEecCCCCCHHHHhhcCC
Q 022003 4 VNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRS 48 (304)
Q Consensus 4 ~~il~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~ 48 (304)
..+++.+.|+|.+.++++.+.. ....+|||++ +.||.+.+..+.
T Consensus 33 ~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 33 FQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred hHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 4567788999999999987643 3467889999 679999886543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0075 Score=52.21 Aligned_cols=39 Identities=18% Similarity=0.172 Sum_probs=29.3
Q ss_pred hHhhHhhcCCC---CcccceeeEEEe---CCeeEEEEecCCCCCH
Q 022003 2 AEVNFLGDLVH---LNLVKLIGYCIE---DDQRLLVYEFMPRGSL 40 (304)
Q Consensus 2 ~E~~il~~l~h---~niv~~~~~~~~---~~~~~lv~e~~~~~sL 40 (304)
+|++.|+.|.- -.+.++++++.. .+..+||||+++|.++
T Consensus 56 ~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 56 QEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred HHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 58888888843 357788887754 3568999999988654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0052 Score=53.26 Aligned_cols=30 Identities=23% Similarity=0.502 Sum_probs=27.5
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcccC
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDG 107 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 107 (304)
++|+|+++.|++|+.++-+-|.||+++..-
T Consensus 200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 200 LVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 899999999999999888999999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0071 Score=52.90 Aligned_cols=73 Identities=18% Similarity=0.127 Sum_probs=56.5
Q ss_pred eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 27 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 27 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
..|++|++- |++|.-. .-..++++..++++.+.-+.-+...-+ .-|||+.-.||||+ +|.+.|+||-+++.
T Consensus 300 y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~--fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKKFP--FEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCC--cccccccccceeee-cCceEEEEeeeeec
Confidence 557788875 5555431 124578888999988887777776543 88999999999999 99999999999985
Q ss_pred CC
Q 022003 107 GP 108 (304)
Q Consensus 107 ~~ 108 (304)
..
T Consensus 371 ~~ 372 (488)
T COG5072 371 SY 372 (488)
T ss_pred cc
Confidence 43
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.021 Score=50.23 Aligned_cols=29 Identities=17% Similarity=0.284 Sum_probs=25.5
Q ss_pred eEeccCCCCCeEECC-CCcEEEccccCccc
Q 022003 78 VIYRDFKTSNILLDA-DYNAKLSDFGLAKD 106 (304)
Q Consensus 78 iiH~dlkp~Nili~~-~~~~kl~Dfg~a~~ 106 (304)
.+|.|+.+.||++++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999974 57899999988754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.0087 Score=51.63 Aligned_cols=90 Identities=19% Similarity=0.117 Sum_probs=60.8
Q ss_pred hHhhHhhcCCC-C-cccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVH-L-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h-~-niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+..|+.|.. . -+.+.+++. .-|+|||++.|-.|...-. ..+..++..- +..-+.-|-.+| +|
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~----v~d~~~ly~~---lm~~Iv~la~~G---lI 224 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRH----VEDPPTLYDD---LMGLIVRLANHG---LI 224 (465)
T ss_pred HHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeee----cCChHHHHHH---HHHHHHHHHHcC---ce
Confidence 57777877742 2 234555543 3478999998877765421 2333444333 333345566777 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcc
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAK 105 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~ 105 (304)
|+|..-=||+|.+++.++++||--..
T Consensus 225 HgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 225 HGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred ecccchheeEEecCCCEEEeechHhh
Confidence 99999999999999999999996443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.027 Score=49.58 Aligned_cols=100 Identities=15% Similarity=0.095 Sum_probs=65.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++-|.+|..-.|...--+... .-.|||+|+ |.+=+..=.-+...++...+..+-.|++.-+.-|...+. +||.
T Consensus 215 KE~RNLkRl~~aGIP~PePIlLk--~hVLVM~Fl-Grdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHA 289 (520)
T KOG2270|consen 215 KEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFL-GRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHA 289 (520)
T ss_pred HHHHHHHHHHhcCCCCCCceeee--cceEeeeec-cCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eecc
Confidence 46666666655443322222222 237899999 433222111123357777788888888888888876543 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDG 107 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~ 107 (304)
||.--|+|+ .+|.+.++|.+-+...
T Consensus 290 DLSEfN~Ly-hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 290 DLSEFNLLY-HDGKLYIIDVSQSVEH 314 (520)
T ss_pred chhhhhheE-ECCEEEEEEccccccC
Confidence 999999999 5678999999877653
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.034 Score=48.19 Aligned_cols=31 Identities=29% Similarity=0.230 Sum_probs=26.8
Q ss_pred CCeEeccCCCCCeEECCC----CcEEEccccCccc
Q 022003 76 RPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 106 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~----~~~kl~Dfg~a~~ 106 (304)
..++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 448999999999999875 8899999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.034 Score=47.32 Aligned_cols=52 Identities=17% Similarity=0.095 Sum_probs=39.5
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 54 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 54 ~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
..+.+.+..+-.++.-.+... .-++|+|+.|+|++.++.+.++|+||..|..
T Consensus 132 ~~~~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 132 HLLRKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 334445666666666666651 2289999999999999989999999988764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.026 Score=49.05 Aligned_cols=31 Identities=35% Similarity=0.412 Sum_probs=27.0
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
..++|+|+++.|++++.++.+.|+||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 4499999999999999888778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.072 Score=47.80 Aligned_cols=27 Identities=26% Similarity=0.173 Sum_probs=23.1
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcc
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAK 105 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~ 105 (304)
.+|.|+.+.||+.+. +.+.++||..|.
T Consensus 229 fCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 229 FCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeccCCcccEEecC-CCEEEEEecccc
Confidence 899999999999754 469999997764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.041 Score=48.06 Aligned_cols=31 Identities=32% Similarity=0.421 Sum_probs=26.1
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
..+||+|+++.||+++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4499999999999998765568999998754
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.016 Score=46.23 Aligned_cols=28 Identities=25% Similarity=0.318 Sum_probs=25.3
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
.+|+|+.|.|++++++| ++|+||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 79999999999998877 99999998864
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.33 Score=40.06 Aligned_cols=39 Identities=31% Similarity=0.479 Sum_probs=29.9
Q ss_pred HhhHhhcC---CCCcccceeeEEEeCCeeEEEEecCCCCCHH
Q 022003 3 EVNFLGDL---VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE 41 (304)
Q Consensus 3 E~~il~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 41 (304)
|+.-|+.| +--++.+++.+....++.|+||||++-+.+.
T Consensus 58 Ea~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 58 EADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred HHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 55555554 4456778999999999999999999887665
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.07 Score=42.06 Aligned_cols=89 Identities=16% Similarity=0.134 Sum_probs=59.6
Q ss_pred hHhhHhhcCCCCccc-ceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.|+++|..++--++- ++|.+.. .++.|||+.|-.|.+....- + .+-+..+++.---|-..| |-|
T Consensus 64 kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~G---I~H 128 (201)
T COG2112 64 KEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLG---IEH 128 (201)
T ss_pred HHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhhhhhcc----c----HHHHHHHHHHHHHHHHhc---cch
Confidence 588888888776654 4555433 35569999888888765321 2 223445556655566666 889
Q ss_pred ccCCC--CCeEECCCCcEEEccccCccc
Q 022003 81 RDFKT--SNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 81 ~dlkp--~Nili~~~~~~kl~Dfg~a~~ 106 (304)
..|.- .||++.. +.+.|+||.-|+.
T Consensus 129 ~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 129 GELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhcCCceeEEecC-CcEEEEEccchhh
Confidence 88875 4666644 4899999998874
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.054 Score=47.03 Aligned_cols=30 Identities=27% Similarity=0.344 Sum_probs=25.3
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
..++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 34899999999999987 6788999987653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.043 Score=47.30 Aligned_cols=31 Identities=35% Similarity=0.408 Sum_probs=26.8
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999887778999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.14 Score=41.32 Aligned_cols=80 Identities=31% Similarity=0.412 Sum_probs=53.6
Q ss_pred HhhHhhcC---CCCcc--cceeeEEEeC------------------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHH
Q 022003 3 EVNFLGDL---VHLNL--VKLIGYCIED------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59 (304)
Q Consensus 3 E~~il~~l---~h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i 59 (304)
|-+...+| .+.++ |+++|+..-. ....||.||++... .+....
T Consensus 104 ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~---- 169 (207)
T PF13095_consen 104 ECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD---- 169 (207)
T ss_pred HHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----
Confidence 44444444 45566 8888887432 12367888876543 233333
Q ss_pred HHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCc
Q 022003 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 104 (304)
Q Consensus 60 ~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a 104 (304)
+.++..-|..+|..| |+-+|+++.|.. +| ||+|||.+
T Consensus 170 ~~~~~~dl~~~~k~g---I~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILHKLG---IVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHCC---eeeccCcccccc---CC--EEEecccC
Confidence 456677788999999 999999999985 33 78899864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.047 Score=44.62 Aligned_cols=29 Identities=34% Similarity=0.438 Sum_probs=20.8
Q ss_pred eEeccCCCCCeEE-CCCCcEEEccccCccc
Q 022003 78 VIYRDFKTSNILL-DADYNAKLSDFGLAKD 106 (304)
Q Consensus 78 iiH~dlkp~Nili-~~~~~~kl~Dfg~a~~ 106 (304)
++|+||.+.||++ +.++.++|+||..+..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 8999999999999 8889999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.062 Score=46.58 Aligned_cols=79 Identities=18% Similarity=0.110 Sum_probs=45.1
Q ss_pred eEEEEecCCCCCHHHH----hhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCCeEECCCC--------
Q 022003 28 RLLVYEFMPRGSLENH----LFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADY-------- 94 (304)
Q Consensus 28 ~~lv~e~~~~~sL~~~----l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~dlkp~Nili~~~~-------- 94 (304)
..+|+.++.. +-... ..+.+-.--.+-++.++.|++.-.-.+-+. +....+|-||||+||||-+..
T Consensus 250 nIIIfPLArc-Sadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~ 328 (444)
T PHA03111 250 NIIIFPLARC-SADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLK 328 (444)
T ss_pred cEEEEehhhc-ccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEEC
Confidence 4577877633 22221 112222234455677888886544233222 123389999999999993322
Q ss_pred ----------cEEEccccCcccC
Q 022003 95 ----------NAKLSDFGLAKDG 107 (304)
Q Consensus 95 ----------~~kl~Dfg~a~~~ 107 (304)
.++|.||.+++..
T Consensus 329 ~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 329 DATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred CeEEEeccchhhhhcccCHHHHc
Confidence 2467777777653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.11 Score=45.64 Aligned_cols=29 Identities=31% Similarity=0.468 Sum_probs=25.7
Q ss_pred eEeccCCCCCeEECCCCc-EEEccccCccc
Q 022003 78 VIYRDFKTSNILLDADYN-AKLSDFGLAKD 106 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~-~kl~Dfg~a~~ 106 (304)
+||+|+.|.||+++.+.. +.++||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 899999999999998874 88999998753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.05 Score=44.53 Aligned_cols=40 Identities=28% Similarity=0.181 Sum_probs=33.9
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCc
Q 022003 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 104 (304)
Q Consensus 64 ~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a 104 (304)
+.+|...|+.. ...+|+|..|+||+-+..|.+||.|-+..
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 36788889665 45999999999999999999999997653
|
The function of this family is unknown. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.089 Score=46.57 Aligned_cols=30 Identities=20% Similarity=0.304 Sum_probs=25.9
Q ss_pred CeEeccCCCCCeEECC-CCcEEEccccCccc
Q 022003 77 PVIYRDFKTSNILLDA-DYNAKLSDFGLAKD 106 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~-~~~~kl~Dfg~a~~ 106 (304)
.++|+|+++.||++++ ++.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 3899999999999976 47899999988754
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.088 Score=45.88 Aligned_cols=77 Identities=18% Similarity=0.181 Sum_probs=44.7
Q ss_pred EEEEecCCCCCHHHHhh----cCCCCCCHHHHHHHHHHHHHHHHH--hhcC-CCCCeEeccCCCCCeEECCCC-------
Q 022003 29 LLVYEFMPRGSLENHLF----RRSLPLPWSIRMKIALGAAKGLAF--LHEE-AERPVIYRDFKTSNILLDADY------- 94 (304)
Q Consensus 29 ~lv~e~~~~~sL~~~l~----~~~~~l~~~~~~~i~~qi~~~l~~--LH~~-~~~~iiH~dlkp~Nili~~~~------- 94 (304)
.+|+.++.. +-+..-. +.+-..-.+-++.++.|++ |-| +-+. +....+|-||||+||||-+..
T Consensus 247 IIIfPLA~~-Sadkv~~~~~~e~GF~s~~~YvkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~ 323 (434)
T PF05445_consen 247 IIIFPLARC-SADKVTESNAAELGFKSNVEYVKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKF 323 (434)
T ss_pred EEEEehhhc-chhhcCHHHHHhcCchhHHHHHHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEE
Confidence 578887633 3222211 1222233445677788885 444 2222 123389999999999993221
Q ss_pred -----------cEEEccccCcccCC
Q 022003 95 -----------NAKLSDFGLAKDGP 108 (304)
Q Consensus 95 -----------~~kl~Dfg~a~~~~ 108 (304)
.++|.||.+++..+
T Consensus 324 ~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 324 GNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred CCeEEEecccceeeecccCHHHhcc
Confidence 35788888887643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.49 E-value=0.19 Score=40.53 Aligned_cols=30 Identities=27% Similarity=0.326 Sum_probs=25.1
Q ss_pred CeEeccCCCCCeEECCCC-----cEEEccccCccc
Q 022003 77 PVIYRDFKTSNILLDADY-----NAKLSDFGLAKD 106 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~-----~~kl~Dfg~a~~ 106 (304)
-++|||+.+.|+++..++ .+.++||..++.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 399999999999997543 589999988764
|
subfamily of choline kinases |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.82 E-value=0.26 Score=42.39 Aligned_cols=36 Identities=31% Similarity=0.439 Sum_probs=21.5
Q ss_pred HhhHhhcC---CCCcccceeeEEEeCCeeEEEEecCCCC
Q 022003 3 EVNFLGDL---VHLNLVKLIGYCIEDDQRLLVYEFMPRG 38 (304)
Q Consensus 3 E~~il~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~~ 38 (304)
|++-|+.| .--.+.+++++....+..+|||||++.+
T Consensus 59 Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 59 EAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp HHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred HHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 66667777 2345679999988888889999998766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.78 E-value=0.18 Score=43.92 Aligned_cols=30 Identities=17% Similarity=0.177 Sum_probs=27.3
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
.++|+|+.++|++++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.75 E-value=0.093 Score=44.91 Aligned_cols=29 Identities=31% Similarity=0.436 Sum_probs=24.8
Q ss_pred eEeccCCCCCeEECCCCc-EEEccccCccc
Q 022003 78 VIYRDFKTSNILLDADYN-AKLSDFGLAKD 106 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~-~kl~Dfg~a~~ 106 (304)
++|+|+++.||+++.++. .-|+||+.+..
T Consensus 187 lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 187 LVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 899999999999987555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.54 E-value=0.25 Score=50.21 Aligned_cols=31 Identities=45% Similarity=0.493 Sum_probs=26.0
Q ss_pred CCeEeccCCCCCeEECCCC--cEE-EccccCccc
Q 022003 76 RPVIYRDFKTSNILLDADY--NAK-LSDFGLAKD 106 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~--~~k-l~Dfg~a~~ 106 (304)
..+||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4499999999999998775 555 999998765
|
|
| >PF10140 YukC: WXG100 protein secretion system (Wss), protein YukC; InterPro: IPR018778 Members of this family are associated with type VII secretion of WXG100 family targets in the Firmicutes, but not in the Actinobacteria | Back alignment and domain information |
|---|
Probab=91.56 E-value=0.43 Score=42.19 Aligned_cols=84 Identities=14% Similarity=0.178 Sum_probs=45.3
Q ss_pred CCCcccceeeEEEeCCeeEEEEecCCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 022003 11 VHLNLVKLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 89 (304)
Q Consensus 11 ~h~niv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nil 89 (304)
.||++++. .+-.+++.+.+-++.-+. -++.. + ..++...++.++.+|..--.++++ -+|--|+|+|++
T Consensus 21 ~~~~f~~~-~i~~~ed~~~~~y~~~~~~~~f~~-i----~~~~~~eklr~~~ni~~l~~~~~~-----~~~f~l~P~Nl~ 89 (359)
T PF10140_consen 21 HDPYFLPQ-EIEEDEDELTFTYQIPESYQSFEE-I----KKLDKSEKLRLLINIAALKEHLNS-----RYTFILHPENLV 89 (359)
T ss_dssp --TTB--E-EEEE-SSEEEEEE---TTSEEGGG-G----GGS-HHHHHHHHHHGGGGGGGGGS-----SEE---SGGGEE
T ss_pred cCcccCCc-eEEEeCCEEEEEEEcCcccCcHHH-H----HhcCHHHHHHHHHHHHHHHHHhcC-----ceeEEEechheE
Confidence 78999985 555666766665554332 23333 2 246778888888885443333343 688999999999
Q ss_pred ECCCCcEEEccccCcc
Q 022003 90 LDADYNAKLSDFGLAK 105 (304)
Q Consensus 90 i~~~~~~kl~Dfg~a~ 105 (304)
++.++.+++.-.|+-.
T Consensus 90 fd~~~~p~i~hrGi~~ 105 (359)
T PF10140_consen 90 FDKNLMPKILHRGIKE 105 (359)
T ss_dssp E-TTS-EEES--EETT
T ss_pred EcCCCCEEEEEcCCcC
Confidence 9999999998777643
|
This protein is designated YukC in Bacillus subtilis and EssB is Staphylococcus aureus. ; PDB: 4ANN_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 304 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-43 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-42 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-31 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 448 bits (1155), Expect = e-160
Identities = 85/234 (36%), Positives = 132/234 (56%), Gaps = 9/234 (3%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMK 58
E+ + H NLV+L+G+ + D LVY +MP GSL + L + PL W +R K
Sbjct: 78 DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
IA GAA G+ FLHE I+RD K++NILLD + AK+SDFGLA+ + +T +++R
Sbjct: 138 IAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 178
++GT Y APE + G +T +SD+YSFGVVLLE++TG ++D++R L++
Sbjct: 195 IVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIKEEIE 251
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
E + ID ++ + +A+ CL RP + +V + L+ +
Sbjct: 252 DEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 423 bits (1089), Expect = e-150
Identities = 91/241 (37%), Positives = 142/241 (58%), Gaps = 7/241 (2%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMK 58
E+ L H +LV LIG+C E ++ +L+Y++M G+L+ HL+ ++ + W R++
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
I +GAA+GL +LH +I+RD K+ NILLD ++ K++DFG++K G E D+TH+ST
Sbjct: 144 ICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 178
V GT GY PEY + G LT +SDVYSFGVVL E+L R ++ ++ P NL EWA
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 238
+ +++DP L + +K A CL+ + RP M +V+ L+ L++
Sbjct: 261 -NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319
Query: 239 A 239
Sbjct: 320 V 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 382 bits (984), Expect = e-134
Identities = 95/234 (40%), Positives = 145/234 (61%), Gaps = 7/234 (2%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMK 58
EV + VH NL++L G+C+ +RLLVY +M GS+ + L R PL W R +
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
IALG+A+GLA+LH+ + +I+RD K +NILLD ++ A + DFGLAK D THV+T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTA 194
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWARP 176
V GT G+ APEY+ TG + ++DV+ +GV+LLE++TG+R+ D R + L++W +
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 177 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230
L + ++ L+D L+G++ + ++ Q+A C P RP MSEVV L+
Sbjct: 255 LL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 2e-75
Identities = 63/257 (24%), Positives = 103/257 (40%), Gaps = 23/257 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 58
EV L + H N+++ IG L+ F +GSL + L + W+
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCH 125
Query: 59 IALGAAKGLAFLHEEAER-------PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 111
IA A+GLA+LHE+ + +RD K+ N+LL + A ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 112 KTHVSTRVMGTYGYAAPEYVMTGHLTS-----RSDVYSFGVVLLEMLTGRRSMDKNRPNG 166
+ +GT Y APE + R D+Y+ G+VL E+ + + D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 167 EHNLVE--WARPHLGERRRF--YRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPL 221
E P L + + ++ P L ++ G + C D +AR
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 222 MSEVVEALKPLPNLKDM 238
V E + + L ++
Sbjct: 306 AGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 1e-54
Identities = 53/264 (20%), Positives = 96/264 (36%), Gaps = 36/264 (13%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIR 56
+ + + H N+ + I + LLV E+ P GSL +L + W
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD--WVSS 113
Query: 57 MKIALGAAKGLAFLHEEAER------PVIYRDFKTSNILLDADYNAKLSDFGLAK----- 105
++A +GLA+LH E R + +RD + N+L+ D +SDFGL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 106 -DGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTSRSDVYSFGVVLLEMLTGRR 157
G++ + + +GT Y APE + + D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 158 SMDKNRPNGEHNL----VEWARPHLGERRRF-----YRLIDPRLEGHFSIKGAQKAAQLA 208
+ E+ + P + + R P S+ + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL-AVRSLKETI 292
Query: 209 AHCLSRDPKARPLMSEVVEALKPL 232
C +D +AR E + L
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAEL 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-54
Identities = 66/236 (27%), Positives = 101/236 (42%), Gaps = 31/236 (13%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIA 60
E+ L + H N+VKL G C+ LV E+ GSL N H + M
Sbjct: 51 ELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTHVSTRV 119
L ++G+A+LH + +I+RD K N+LL A K+ DFG A D T
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNN 163
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--- 176
G+ + APE + + + DV+S+G++L E++T R +P E +
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFRIMWAV 217
Query: 177 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
H G R + + + L C S+DP RP M E+V+ + L
Sbjct: 218 HNGTRPPLIKNLPKPI------------ESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-53
Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 25/234 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIA 60
EV + L H N+V +G + +V E++ RGSL L + L R+ +A
Sbjct: 84 EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
AKG+ +LH P+++R+ K+ N+L+D Y K+ DFGL++ + S
Sbjct: 144 YDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAA 200
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE--WARPHL 178
GT + APE + +SDVYSFGV+L E+ T + +P G N + A
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQVVAAVGFK 254
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
+R R ++P++ A + C + +P RP + +++ L+PL
Sbjct: 255 CKRLEIPRNLNPQV------------AAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-53
Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 39/242 (16%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
EV + +L H N+VKL G +V EF+P G L + L ++ P+ WS+++++ L
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLD-----ADYNAKLSDFGLAKDGPEGDKTHVST 117
A G+ ++ + P+++RD ++ NI L A AK++DFGL++ H +
Sbjct: 131 IALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVS 184
Query: 118 RVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRP----NGEHNL 170
++G + + APE + T ++D YSF ++L +LTG P +
Sbjct: 185 GLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYSYGKIK 237
Query: 171 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230
G R PRL + C S DPK RP S +V+ L
Sbjct: 238 FINMIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIVKELS 285
Query: 231 PL 232
L
Sbjct: 286 EL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-51
Identities = 57/249 (22%), Positives = 98/249 (39%), Gaps = 40/249 (16%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ EV + L H N++K IG +D + + E++ G+L + PWS R+ A
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------------DGP 108
A G+A+LH +I+RD + N L+ + N ++DFGLA+
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 109 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 168
+ V+G + APE + + DV+SFG+VL E++ + P+
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLP 227
Query: 169 NLVEWARPHLGERRRFYRL-----IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223
+++ R F P + C DP+ RP
Sbjct: 228 RTMDFGLNV----RGFLDRYCPPNCPPSF------------FPITVRCCDLDPEKRPSFV 271
Query: 224 EVVEALKPL 232
++ L+ L
Sbjct: 272 KLEHWLETL 280
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-50
Identities = 68/240 (28%), Positives = 108/240 (45%), Gaps = 34/240 (14%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E L H N++ L G C+++ LV EF G L L + +P I + A+
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQ 113
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLD--------ADYNAKLSDFGLAKDGPEGDKTH 114
A+G+ +LH+EA P+I+RD K+SNIL+ ++ K++DFGLA+ E +T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTT 170
Query: 115 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNL-VE 172
+ G Y + APE + + SDV+S+GV+L E+LTG P G L V
Sbjct: 171 KMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVA 223
Query: 173 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
+ A+L C + DP +RP + +++ L +
Sbjct: 224 YGVAMNKLALPIPSTCPEPF------------AKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-50
Identities = 54/245 (22%), Positives = 95/245 (38%), Gaps = 48/245 (19%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFR-RSLPLPWSIRMKI 59
E L H N++ ++G C + +MP GSL N L + + S +K
Sbjct: 57 ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
AL A+G+AFLH E + + ++++D D A++S + + S
Sbjct: 117 ALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGR 168
Query: 120 MGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA- 174
M + APE + +D++SF V+L E++T P + + +E
Sbjct: 169 MYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGM 221
Query: 175 -------RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
RP + I P + ++L C++ DP RP +V
Sbjct: 222 KVALEGLRPTIPPG------ISPHV------------SKLMKICMNEDPAKRPKFDMIVP 263
Query: 228 ALKPL 232
L+ +
Sbjct: 264 ILEKM 268
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-50
Identities = 56/260 (21%), Positives = 103/260 (39%), Gaps = 27/260 (10%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 57
E+ + H N++ I I+ Q L+ ++ GSL ++L +S L +
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSML 137
Query: 58 KIALGAAKGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEG 110
K+A + GL LH E + +RD K+ NIL+ + ++D GLA
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNR 163
+ +GT Y PE V+ L +D+YSFG++L E+ R
Sbjct: 198 EVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIV 255
Query: 164 PNGE--HNLVEWARPHLGERRRF--YRLIDPRLEGHFSIKGAQKA-AQLAAHCLSRDPKA 218
+ ++ + + P + R + + P +S + +L C + +P +
Sbjct: 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315
Query: 219 RPLMSEVVEALKPLPNLKDM 238
R V + L + +D+
Sbjct: 316 RLTALRVKKTLAKMSESQDI 335
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-49
Identities = 58/258 (22%), Positives = 94/258 (36%), Gaps = 35/258 (13%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 57
E+ L H N++ I + Q L+ + GSL ++L + L +
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCL 108
Query: 58 KIALGAAKGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEG 110
+I L A GLA LH E + +RD K+ NIL+ + ++D GLA
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNR 163
+ +GT Y APE V+ + R D+++FG+VL E+ S
Sbjct: 169 QLDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
Query: 164 P--------NGEHNLVEWARPHLGERRRFYRL-IDPRLEGHFSIKGAQKAAQLAAHCLSR 214
E R + ++ R I R A+L C +
Sbjct: 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQ--RPNIPNRWFSD---PTLTSLAKLMKECWYQ 282
Query: 215 DPKARPLMSEVVEALKPL 232
+P AR + + L +
Sbjct: 283 NPSARLTALRIKKTLTKI 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-49
Identities = 43/255 (16%), Positives = 90/255 (35%), Gaps = 40/255 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
EV H N+V +G C+ ++ +L + + + L + +IA
Sbjct: 79 EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRV 119
KG+ +LH + ++++D K+ N+ D + ++DFGL G +
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 120 MGTYGYAAPEYVMTG---------HLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGE 167
G + APE + + SDV++ G + E+ ++
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---- 250
Query: 168 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+ W + ++ I + C + + + RP +++++
Sbjct: 251 ---IIWQ------MGTGMKPNLSQIGMGKEIS------DILLFCWAFEQEERPTFTKLMD 295
Query: 228 ALKPLPNLKDMASSS 242
L+ LP K S
Sbjct: 296 MLEKLP--KRNRRLS 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-49
Identities = 59/234 (25%), Positives = 104/234 (44%), Gaps = 19/234 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
EV L H+N++ +GY Q +V ++ SL +HL + IA
Sbjct: 70 EVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
A+G+ +LH + +I+RD K++NI L D K+ DFGLA + +H ++ G+
Sbjct: 129 TARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 123 YGYAAPE---YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+ APE + + +SDVY+FG+VL E++TG+ P N + +G
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVG 239
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233
++ + ++ +L A CL + RP ++ ++ L
Sbjct: 240 RGSL--SPDLSKVRSNCP----KRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-48
Identities = 61/264 (23%), Positives = 103/264 (39%), Gaps = 35/264 (13%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 57
AE+ L H N++ I +D+ Q LV ++ GSL ++L + +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMI 142
Query: 58 KIALGAAKGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEG 110
K+AL A GLA LH E + +RD K+ NIL+ + ++D GLA D
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNR 163
+GT Y APE V+ + R+D+Y+ G+V E+ +
Sbjct: 203 TIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 164 P--------NGEHNLVEWARPHLGERRRFYRL-IDPRLEGHFSIKGAQKAAQLAAHCLSR 214
VE R + E++ R I R + +++ A++ C
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKL--RPNIPNRWQSCEALR---VMAKIMRECWYA 316
Query: 215 DPKARPLMSEVVEALKPLPNLKDM 238
+ AR + + L L + +
Sbjct: 317 NGAARLTALRIKKTLSQLSQQEGI 340
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 21/233 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E L H N+V+LIG C + +V E + G L L +++
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
AA G+ +L + I+RD N L+ K+SDFG++++ +G
Sbjct: 220 GDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQ 276
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLG 179
+ APE + G +S SDV+SFG++L E + S N N + VE
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE------- 329
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
+ RL P E +L C + +P RP S + + L+ +
Sbjct: 330 ---KGGRL--PCPELC-----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 56/258 (21%), Positives = 110/258 (42%), Gaps = 29/258 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKI 59
+ E + ++ H NLV+L+G C + ++ EFM G+L ++L + + + +
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A + + +L ++ I+R+ N L+ ++ K++DFGL++ GD
Sbjct: 324 ATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGA 379
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHL 178
+ APE + + +SDV++FGV+L E+ T S + + L+E
Sbjct: 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------ 433
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 237
+ YR+ P G + +L C +P RP +E+ +A + +
Sbjct: 434 ----KDYRMERPE--------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ--- 478
Query: 238 MASSSYYFQTMQAERIGS 255
SS + + G+
Sbjct: 479 -ESSISDEVEKELGKRGT 495
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 31/228 (13%)
Query: 10 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 69
L H N+V +I EDD LV E++ +L ++ PL + G+
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKH 126
Query: 70 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 129
H+ +++RD K NIL+D++ K+ DFG+AK E T + V+GT Y +PE
Sbjct: 127 AHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPE 182
Query: 130 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGE-----RRR 183
+D+YS G+VL EML G P NGE V A H+ +
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE------PPFNGE-TAVSIAIKHIQDSVPNVTTD 235
Query: 184 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 230
+ I L + +D R + E+ + L
Sbjct: 236 VRKDIPQSLS------------NVILRATEKDKANRYKTIQEMKDDLS 271
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-29
Identities = 51/225 (22%), Positives = 86/225 (38%), Gaps = 27/225 (12%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCI---EDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIR 56
E L L H N+V+ + + +++ E M G+L+ +L +R + +
Sbjct: 73 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVL 131
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHV 115
KGL FLH P+I+RD K NI + + K+ D GLA +
Sbjct: 132 RSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASF 186
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 175
+ V+GT + APE + DVY+FG+ +LEM T E+ E
Sbjct: 187 AKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMAT-----------SEYPYSECQN 234
Query: 176 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
RR + + + ++ C+ ++ R
Sbjct: 235 AAQIYRRVTSGVKPASFDKVAI----PEVKEIIEGCIRQNKDERY 275
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-29
Identities = 52/230 (22%), Positives = 77/230 (33%), Gaps = 32/230 (13%)
Query: 1 MAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
+AEV + H V+L E L E SL+ H LP +
Sbjct: 104 LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGY 162
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
LA LH + +++ D K +NI L KL DFGL + V
Sbjct: 163 LRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---Q 216
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
G Y APE + + + +DV+S G+ +LE+ PH G
Sbjct: 217 EGDPRYMAPELLQGSY-GTAADVFSLGLTILEVACNME-----------------LPHGG 258
Query: 180 ERRR--FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
E + + P S + + L DPK R ++
Sbjct: 259 EGWQQLRQGYLPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 67/247 (27%), Positives = 99/247 (40%), Gaps = 38/247 (15%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMK 58
E++ L L H +++K G C + LV E++P GSL ++L R S+ L +
Sbjct: 81 KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF- 139
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST- 117
A +G+A+LH + I+RD N+LLD D K+ DFGLAK PEG + +
Sbjct: 140 -AQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 195
Query: 118 ------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 170
APE + SDV+SFGV L E+LT S E
Sbjct: 196 DGDSPVFWY------APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249
Query: 171 VEWARPHLGERRRF----YRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223
+ + + RL P E + L +C + RP
Sbjct: 250 IAQGQMTVLRLTELLERGERLPRPDKCPAEVY----------HLMKNCWETEASFRPTFE 299
Query: 224 EVVEALK 230
++ LK
Sbjct: 300 NLIPILK 306
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 52/258 (20%), Positives = 94/258 (36%), Gaps = 59/258 (22%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-------------LVYEFMPRGSLENHLFRR 47
++EV L L H +V+ +E + + E+ G+L + +
Sbjct: 50 LSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE 109
Query: 48 SLPLP----WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 103
+L W + +I L+++H + +I+RD K NI +D N K+ DFGL
Sbjct: 110 NLNQQRDEYWRLFRQILEA----LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGL 162
Query: 104 AK-------------DGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVV 148
AK G ++++ + GT Y A E V+ TGH + D+YS G++
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGII 220
Query: 149 LLEMLTGRRSMDKNRPNGEHNLVE-WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 207
EM+ + V + P + + + ++
Sbjct: 221 FFEMIYP--------FSTGMERVNILKKLRSVSIE-----FPPDFDDNKM----KVEKKI 263
Query: 208 AAHCLSRDPKARPLMSEV 225
+ DP RP +
Sbjct: 264 IRLLIDHDPNKRPGARTL 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 56/292 (19%), Positives = 108/292 (36%), Gaps = 26/292 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKI 59
EV L ++ H N+V+ E+ +V ++ G L + ++ + +
Sbjct: 71 RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
+ L +H+ R +++RD K+ NI L D +L DFG+A+ +
Sbjct: 131 FVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI 186
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
GT Y +PE ++SD+++ G VL E+ T + + + +
Sbjct: 187 -GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--- 242
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE---ALKPLPNLK 236
P + H+S L + R+P+ RP ++ ++E K +
Sbjct: 243 ----------PPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFL 288
Query: 237 DMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASP 288
+ F + GS P + S+S + ++ P Y P
Sbjct: 289 SPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIP 340
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 60/253 (23%), Positives = 91/253 (35%), Gaps = 45/253 (17%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL----------------LVYEFMPRGSLENHL-F 45
EV L L H+N+V G D + EF +G+LE +
Sbjct: 54 EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 46 RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 105
RR L + +++ KG+ ++H + +I RD K SNI L K+ DFGL
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 106 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 165
TR GT Y +PE + + D+Y+ G++L E+L
Sbjct: 171 ---SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAF 222
Query: 166 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225
F L D + F +K L LS+ P+ RP SE+
Sbjct: 223 ETSKF-------------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265
Query: 226 VEALKPLPNLKDM 238
+ L +
Sbjct: 266 LRTLTVWKKSPEK 278
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 38/158 (24%), Positives = 79/158 (50%), Gaps = 5/158 (3%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + + + ++ +L+G C+ L+ + MP G L +++ + +
Sbjct: 65 LDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ AKG+ +L +R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 124 VQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ A E ++ T +SDV+S+GV + E++T G +
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 45/148 (30%), Positives = 61/148 (41%), Gaps = 5/148 (3%)
Query: 10 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 69
L ++V + + D Q + + L L RR PL + I L
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDA 149
Query: 70 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 129
H +RD K NIL+ AD A L DFG+A + T + +GT Y APE
Sbjct: 150 AHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPE 205
Query: 130 YVMTGHLTSRSDVYSFGVVLLEMLTGRR 157
H T R+D+Y+ VL E LTG
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSP 233
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 62/249 (24%), Positives = 97/249 (38%), Gaps = 36/249 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMK 58
E+ L +L H N+VK G C ED L+ EF+P GSL+ +L + + ++K
Sbjct: 71 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST- 117
A+ KG+ +L R ++RD N+L+++++ K+ DFGL K + +
Sbjct: 131 YAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 118 ------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 170
APE +M SDV+SFGV L E+LT +
Sbjct: 188 DRDSPVFWY------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
Query: 171 V---EWARPHLGER-RRFYRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223
+ L + RL P E + QL C P R
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY----------QLMRKCWEFQPSNRTSFQ 291
Query: 224 EVVEALKPL 232
++E + L
Sbjct: 292 NLIEGFEAL 300
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMK 58
E + L H LVK G C ++ +V E++ G L N+L + L + M
Sbjct: 51 FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM- 109
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
+G+AFL I+RD N L+D D K+SDFG+ + +
Sbjct: 110 -CYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVS 161
Query: 119 VMGT---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+GT ++APE +S+SDV++FG+++ E+ + G+
Sbjct: 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 26/235 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKI 59
+ E + L H LV+L E+ +V E+M +GSL + L L + +
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A A G+A++ ++RD + +NIL+ + K++DFGLA+ E ++
Sbjct: 286 AAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGA 341
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHL 178
+ APE + G T +SDV+SFG++L E+ T R N E + VE
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------ 395
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPL 232
R YR+ P ++ L C ++P+ RP + L+
Sbjct: 396 ----RGYRMPCPP--------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMK 58
+ E + L H LV+L G C+E LV EFM G L ++L R + M
Sbjct: 51 IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM- 109
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVST 117
L +G+A+L E VI+RD N L+ + K+SDFG+ + + + T
Sbjct: 110 -CLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165
Query: 118 RV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ +PE +S+SDV+SFGV++ E+ + G+
Sbjct: 166 KFPVKWA------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 37/166 (22%), Positives = 70/166 (42%), Gaps = 21/166 (12%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-------FRRSLPLPWS 54
E+ + D+ + + G I + + ++YE+M S+ + +P
Sbjct: 93 ELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 55 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KT 113
+ I +++H E+ + +RD K SNIL+D + KLSDFG ++ + K
Sbjct: 152 VIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 156
GTY + PE + + ++ D++S G+ L M
Sbjct: 210 -----SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 38/236 (16%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRM 57
+ E++ L L H N++K IED++ +V E G L + ++ +P
Sbjct: 80 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
K + L +H R V++RD K +N+ + A KL D GL + T +
Sbjct: 140 KYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHS 195
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
V GT Y +PE + +SD++S G +L EM + P
Sbjct: 196 LV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPF 236
Query: 178 LGERRRFYRLI--------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225
G++ Y L P H+S ++ QL C++ DP+ RP ++ V
Sbjct: 237 YGDKMNLYSLCKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDVTYV 288
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 45/159 (28%), Positives = 80/159 (50%), Gaps = 5/159 (3%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
++E + +G H N+++L G ++V E+M GSL+ L + +
Sbjct: 98 LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRV 119
G G+ +L ++ ++RD N+L+D++ K+SDFGL++ + D + +T
Sbjct: 158 RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ APE + +S SDV+SFGVV+ E+L G R
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-27
Identities = 40/163 (24%), Positives = 78/163 (47%), Gaps = 15/163 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMK 58
+ E + +L H LV+L G C + ++ E+M G L N+L R + M
Sbjct: 67 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM- 125
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
+ + +L + ++RD N L++ K+SDFGL++ + + T
Sbjct: 126 -CKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTS 177
Query: 119 VMGT---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+G+ ++ PE +M +S+SD+++FGV++ E+ + G+
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 24/169 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPL 51
+ E + + + ++V+L+G + L++ E M RG L+++L P
Sbjct: 76 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 52 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 111
S +++A A G+A+L ++RD N ++ D+ K+ DFG+ +D E D
Sbjct: 136 SLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 112 KTHVSTRV------MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ M +PE + G T+ SDV+SFGVVL E+ T
Sbjct: 193 YYRKGGKGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-27
Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 16/164 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
M E + L + +V+LIG C + + +LV E G L L + +P S ++
Sbjct: 58 MREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 116
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ G+ +L E+ ++RD N+LL + AK+SDFGL+K D + +
Sbjct: 117 HQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-- 171
Query: 121 GTYG------YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ APE + +SRSDV+S+GV + E L+ G++
Sbjct: 172 ---AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 38/158 (24%), Positives = 79/158 (50%), Gaps = 5/158 (3%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + + + ++ +L+G C+ L+ + MP G L +++ + +
Sbjct: 65 LDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ AKG+ +L +R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 124 VQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ A E ++ T +SDV+S+GV + E++T G +
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 44/158 (27%), Positives = 81/158 (51%), Gaps = 5/158 (3%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ +G L H ++V+L+G C LV +++P GSL +H+ + L + +
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG 121
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ AKG+ +L E +++R+ N+LL + +++DFG+A P DK + +
Sbjct: 122 VQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK 178
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ A E + G T +SDV+S+GV + E++T G
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 58/255 (22%), Positives = 90/255 (35%), Gaps = 39/255 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L +V L G E + E + GSL L ++ LP +
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQ 158
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAK---DGPEGDKTHVSTR 118
A +GL +LH +++ D K N+LL +D A L DFG A G
Sbjct: 159 ALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 119 VMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
+ GT + APE VM ++ D++S ++L ML G P W
Sbjct: 216 IPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCH------P--------WT--Q 258
Query: 178 LGERRRFYRL-----IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVVEA 228
++ + + AQ L ++P R L +V +A
Sbjct: 259 YFRGPLCLKIASEPPPIREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
Query: 229 LKPLPNLKDMASSSY 243
L+ + LK Y
Sbjct: 315 LQEVGGLKSPWKGEY 329
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
+ E + D H N++ L+G C+ + L+V +M G L N + + +
Sbjct: 74 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
L AKG+ +L A + ++RD N +LD + K++DFGLA+D + + V +
Sbjct: 134 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 120 MG------TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
A E + T T++SDV+SFGV+L E++T
Sbjct: 191 GAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 50/160 (31%), Positives = 86/160 (53%), Gaps = 11/160 (6%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMK 58
+AE + + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
+L + + +L ++RD N+L+ D AK+SDFGL K+ T + +
Sbjct: 294 FSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGK 347
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ + APE + +++SDV+SFG++L E+ + GR
Sbjct: 348 L--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 385
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMK 58
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST- 117
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ +
Sbjct: 119 YTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 118 ------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
APE + + SDV+SFGVVL E+ T
Sbjct: 176 PGESPIFWY------APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 10/161 (6%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ EVN + L H NL++L G + +V E P GSL + L + + A
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ A+G+ +L + I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 128 VQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-- 182
Query: 121 GT---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ + APE + T + SD + FGV L EM T G+
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 53/255 (20%), Positives = 91/255 (35%), Gaps = 54/255 (21%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDD---------QRLLVY---EFMPRGSLENHLFRR- 47
M EV L L H +V+ +E + ++ +Y + + +L++ + R
Sbjct: 51 MREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC 110
Query: 48 -SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK- 105
S+ + I L A+ + FLH + +++RD K SNI D K+ DFGL
Sbjct: 111 TIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167
Query: 106 ---------DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
T +GT Y +PE + + + D++S G++L E+L
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225
Query: 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLID----PRLEGHFSIKGAQKAAQLAAHCL 212
+ + ER R + P L + L
Sbjct: 226 ------PFSTQM-----------ERVRTLTDVRNLKFPPLFTQKY----PCEYVMVQDML 264
Query: 213 SRDPKARPLMSEVVE 227
S P RP ++E
Sbjct: 265 SPSPMERPEAINIIE 279
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 48/174 (27%), Positives = 70/174 (40%), Gaps = 29/174 (16%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---- 56
E L L H ++V+ G C E L+V+E+M G L L
Sbjct: 91 QREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150
Query: 57 ----------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106
+ +A A G+ +L A ++RD T N L+ K+ DFG+++D
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 207
Query: 107 GPEGDKTHVSTRV------MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
D V R M PE ++ T+ SDV+SFGVVL E+ T
Sbjct: 208 IYSTDYYRVGGRTMLPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 17/165 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + +G H N+++L G + ++V E+M GSL++ L + + +
Sbjct: 94 LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVST 117
G A G+ +L ++ ++RD NIL++++ K+SDFGL +D PE T
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 118 RV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
++ +PE + TS SDV+S+G+VL E+++ G R
Sbjct: 211 KIPIRWT------SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 65/249 (26%), Positives = 97/249 (38%), Gaps = 36/249 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMK 58
E+ L L +VK G ++ LV E++P G L + L R L S +
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST- 117
+ KG+ +L R ++RD NIL++++ + K++DFGLAK P +V
Sbjct: 132 YSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 118 ------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 170
APE + + +SDV+SFGVVL E+ T +S +
Sbjct: 189 PGQSPIFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242
Query: 171 VEWARPHLGERRRF----YRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223
E P L RL P E H +L C + P+ RP S
Sbjct: 243 CERDVPALSRLLELLEEGQRLPAPPACPAEVH----------ELMKLCWAPSPQDRPSFS 292
Query: 224 EVVEALKPL 232
+ L L
Sbjct: 293 ALGPQLDML 301
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 18/163 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHL--FRRSLPLPWSIRM 57
+ E + L H N++ LIG + + ++ +M G L + +R+ + I
Sbjct: 70 LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
L A+G+ +L AE+ ++RD N +LD + K++DFGLA+D + + V
Sbjct: 130 --GLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ 184
Query: 118 RVMG------TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
T A E + T T++SDV+SFGV+L E+LT
Sbjct: 185 HRHARLPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 55/235 (23%), Positives = 98/235 (41%), Gaps = 30/235 (12%)
Query: 10 LVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 65
L H +V + + +V E++ +L + + P+ +++ A +
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQ 127
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGTYG 124
L F H+ +I+RD K +NI++ A K+ DFG+A+ + + T V+GT
Sbjct: 128 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 125 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRR 183
Y +PE + +RSDVYS G VL E+LTG P G+ + V A H+ E
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGD-SPVSVAYQHVREDPI 237
Query: 184 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALKPLP 233
L + + L+++P+ R + +++V P
Sbjct: 238 PPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 26/235 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKI 59
+ E + L H LV+L E+ +V E+M +GSL + L L + +
Sbjct: 310 LQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A A G+A++ ++RD + +NIL+ + K++DFGLA+ E ++
Sbjct: 369 AAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGA 424
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHL 178
+ APE + G T +SDV+SFG++L E+ T R N E + VE
Sbjct: 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------ 478
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPL 232
R YR+ P ++ L C ++P+ RP + L+
Sbjct: 479 ----RGYRMPCPP--------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMK 58
E+ L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 90 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 149
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST- 117
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ + +
Sbjct: 150 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 206
Query: 118 ------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
APE + + SDV+SFGVVL E+ T
Sbjct: 207 PGESPIFWY------APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 58/255 (22%), Positives = 90/255 (35%), Gaps = 39/255 (15%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR----LLVYEFMPRGSLENHLFRRSL---PLPW 53
E + H N+++L+ YC+ + L+ F RG+L N + R L
Sbjct: 74 QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133
Query: 54 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 113
+ + LG +GL +H + +RD K +NILL + L D G +
Sbjct: 134 DQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 114 HVSTRVM-------GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 163
+ T Y APE + R+DV+S G VL M+ G D
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250
Query: 164 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP--- 220
G+ L + + P S QL ++ DP RP
Sbjct: 251 QKGDSVA-------LAVQNQLSIPQSP----RHS----SALWQLLNSMMTVDPHQRPHIP 295
Query: 221 -LMSEVVEALKPLPN 234
L+S++ P P
Sbjct: 296 LLLSQLEALQPPAPG 310
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 33/229 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---IRM 57
E+ L H N+V+ +G E+ + E +P GSL L + PL + I
Sbjct: 67 HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG- 125
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVS 116
+GL +LH+ +++RD K N+L++ K+SDFG +K + +
Sbjct: 126 FYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
Query: 117 TRVMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 173
GT Y APE + G+ +D++S G ++EM TG+ P + L E
Sbjct: 183 --FTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGK------PPF--YELGEP 231
Query: 174 ARP--HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
+G + + P + S +A C DP R
Sbjct: 232 QAAMFKVGMFK-----VHPEIPESMS----AEAKAFILKCFEPDPDKRA 271
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 50/164 (30%), Positives = 85/164 (51%), Gaps = 19/164 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMK 58
+AE + + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K
Sbjct: 62 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
+L + + +L ++RD N+L+ D AK+SDFGL K+ T + +
Sbjct: 122 FSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGK 175
Query: 119 V----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ APE + +++SDV+SFG++L E+ + GR
Sbjct: 176 LPVKWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-26
Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 25/170 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHL-FRRSLPLPWS 54
++E + D H N+++L+G CIE + +++ FM G L +L + R P
Sbjct: 84 LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143
Query: 55 IRMK----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 110
I ++ + A G+ +L + R ++RD N +L D ++DFGL+K G
Sbjct: 144 IPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200
Query: 111 D--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
D + ++ + A E + TS+SDV++FGV + E+ T
Sbjct: 201 DYYRQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
+ E + D H N++ L+G C+ + L+V +M G L N + + +
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
L AKG+ FL A + ++RD N +LD + K++DFGLA+D + + V +
Sbjct: 198 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 254
Query: 120 MG------TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
A E + T T++SDV+SFGV+L E++T
Sbjct: 255 GAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 19/165 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKI 59
+AE N + L + +V++IG C E + +LV E G L +L R + I +
Sbjct: 66 LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL-- 122
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
+ G+ +L E ++RD N+LL + AK+SDFGL+K + + +
Sbjct: 123 VHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT- 178
Query: 120 MGTYG------YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ APE + +S+SDV+SFGV++ E + G++
Sbjct: 179 ----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-26
Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 9/160 (5%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKI 59
+AE N + L H LV+L ++ ++ E+M GSL + L + L + + +
Sbjct: 56 LAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTR 118
A A+G+AF+ ER I+RD + +NIL+ + K++DFGLA+ + + +
Sbjct: 115 AAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ APE + G T +SDV+SFG++L E++T GR
Sbjct: 172 FP--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 7/159 (4%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKI 59
+AE N + L H LVKL ++ ++ EFM +GSL + L P +
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 289
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
+ A+G+AF+ +R I+RD + +NIL+ A K++DFGLA+ E ++
Sbjct: 290 SAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGA 345
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ APE + G T +SDV+SFG++L+E++T GR
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-26
Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 17/165 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E +G H N+++L G + +++ E+M G+L+ L + + +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVST 117
G A G+ +L A ++RD NIL++++ K+SDFGL+ +D PE T
Sbjct: 154 RGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 118 RV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
++ APE + TS SDV+SFG+V+ E++T G R
Sbjct: 211 KIPIRWT------APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 40/164 (24%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKI 59
+ E + ++ H NLV+L+G C + ++ EFM G+L ++L + + + +
Sbjct: 57 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTR 118
A + + +L ++ I+RD N L+ ++ K++DFGL++ H +
Sbjct: 117 ATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 119 V----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
APE + + +SDV++FGV+L E+ T G
Sbjct: 174 FPIKWT------APESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 23/169 (13%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMK 58
+ + L H +LV G C+ D+ +LV EF+ GSL+ +L + + + W + +
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV- 118
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDGPEG 110
A A + FL E +I+ + NILL + + KLSD G++
Sbjct: 119 -AKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT-GRR 157
D + PE + +L +D +SFG L E+ + G +
Sbjct: 175 DILQERIPWV------PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 49/175 (28%), Positives = 75/175 (42%), Gaps = 30/175 (17%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---- 56
E L +L H ++VK G C + D ++V+E+M G L L +
Sbjct: 65 QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 57 -----------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 105
+ IA A G+ +L A + ++RD T N L+ A+ K+ DFG+++
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 106 DGPEGDKTHVSTRV------MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
D D V M PE +M T+ SDV+SFGV+L E+ T
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 54/162 (33%), Positives = 70/162 (43%), Gaps = 17/162 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK- 58
+ E L + +V L Y E L LV M G L+ H++ R
Sbjct: 232 LNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 59 ----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 114
I G L LH E ++YRD K NILLD + ++SD GLA PEG
Sbjct: 291 YAAEICCG----LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343
Query: 115 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
RV GT GY APE V T D ++ G +L EM+ G+
Sbjct: 344 --GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMK 58
M+E + +L H ++VKLIG E+ ++ E P G L ++L + SL + +
Sbjct: 61 MSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY- 118
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST- 117
+L K +A+L ++RD NIL+ + KL DFGL++ + D S
Sbjct: 119 -SLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 174
Query: 118 ----RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ M +PE + T+ SDV+ F V + E+L+ G++
Sbjct: 175 RLPIKWM------SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 39/171 (22%), Positives = 77/171 (45%), Gaps = 26/171 (15%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHL-FRRSLPLPW 53
+ E + + H ++ KL+G + + +++ FM G L L R P+
Sbjct: 73 LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 54 SIRMK----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 109
++ ++ + A G+ +L + R I+RD N +L D ++DFGL++
Sbjct: 133 NLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189
Query: 110 GD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
GD + ++++ + A E + T SDV++FGV + E++T
Sbjct: 190 GDYYRQGCASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
M E + L + +V+LIG C + + +LV E G L L + +P S ++
Sbjct: 384 MREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ G+ +L E+ ++R+ N+LL + AK+SDFGL+K D + +
Sbjct: 443 HQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-- 497
Query: 121 GT---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ APE + +SRSDV+S+GV + E L+ G++
Sbjct: 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 43/175 (24%), Positives = 73/175 (41%), Gaps = 30/175 (17%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---- 56
E L H N+V L+G +D +++ + G L L RS
Sbjct: 60 RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 57 -----------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 105
+ + A G+ +L + V+++D T N+L+ N K+SD GL +
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 106 DGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ D K ++ + M APE +M G + SD++S+GVVL E+ +
Sbjct: 177 EVYAADYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-25
Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 20/165 (12%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMK 58
+ E + H ++VKLIG E+ ++ E G L + L + SL L I
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY- 121
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST- 117
A + LA+L + ++RD N+L+ ++ KL DFGL++ + S
Sbjct: 122 -AYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 118 ----RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157
+ M APE + TS SDV+ FGV + E+L G +
Sbjct: 178 KLPIKWM------APESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-24
Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 26/234 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSI 55
++EVN L +L H N+V+ + L +V E+ G L + + + L
Sbjct: 53 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 56 RMKIALGAAKGLAFLHE--EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 113
+++ L H + V++RD K +N+ LD N KL DFGLA+ D +
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTS 171
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 173
T V GT Y +PE + +SD++S G +L E+ +
Sbjct: 172 FAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 174 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+ R+ +S + ++ L+ RP + E++E
Sbjct: 231 GKF-------------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 267
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 11/157 (7%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + H ++VKLIG ++ ++ E G L + L R L + + A
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-- 118
+ LA+L + ++RD N+L+ ++ KL DFGL++ + S
Sbjct: 498 YQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 119 -VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ APE + TS SDV+ FGV + E+L
Sbjct: 555 PIKWM----APESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 52/168 (30%), Positives = 69/168 (41%), Gaps = 26/168 (15%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPWS 54
M E L + +V L Y E L LV M G + H++ P
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-- 289
Query: 55 IRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 109
R I G L LH+ +IYRD K N+LLD D N ++SD GLA +
Sbjct: 290 -RAIFYTAQIVSG----LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 110 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
G GT G+ APE ++ G S D ++ GV L EM+ R
Sbjct: 342 GQTK-TKGYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 38/183 (20%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---- 56
E + + + N+VKL+G C L++E+M G L L S S+
Sbjct: 98 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 57 -------------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 97
+ IA A G+A+L +ER ++RD T N L+ + K
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVK 214
Query: 98 LSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 151
++DFGL+++ D K + + M PE + T+ SDV+++GVVL E
Sbjct: 215 IADFGLSRNIYSADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWE 268
Query: 152 MLT 154
+ +
Sbjct: 269 IFS 271
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 48/150 (32%), Positives = 68/150 (45%), Gaps = 23/150 (15%)
Query: 15 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGL 67
+V + Y +L + + M G L HL + M+ I LG L
Sbjct: 254 IVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----L 305
Query: 68 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 127
+H V+YRD K +NILLD + ++SD GLA D + K H V GT+GY A
Sbjct: 306 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPH--ASV-GTHGYMA 358
Query: 128 PEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
PE + G S D +S G +L ++L G
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 30/164 (18%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 56
H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTH 114
+ A+G+ +L A + I+RD N+L+ + K++DFGLA+D D K
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 115 VSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ R+ M APE + T +SDV+SFGV++ E+ T
Sbjct: 217 TNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 14/164 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------LPW 53
+ E + H N+V+ IG ++ R ++ E M G L++ L R + P L
Sbjct: 81 LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAM 139
Query: 54 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEG 110
+ +A A G +L E I+RD N LL AK+ DFG+A+D
Sbjct: 140 LDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
M + PE M G TS++D +SFGV+L E+ +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 29/174 (16%)
Query: 1 MAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--- 56
M+E+ + L H N+V L+G C L++ E+ G L N L R+S L
Sbjct: 97 MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 57 ----------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106
+ + A+G+AFL A + I+RD N+LL + AK+ DFGLA+D
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 107 GPEGDKTHVST------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
V + M APE + T +SDV+S+G++L E+ +
Sbjct: 214 IMNDSNYIVKGNARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 50/235 (21%), Positives = 87/235 (37%), Gaps = 44/235 (18%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIR 56
AE FL ++VH ++V++ + D+ +V E++ SL+ + LP+ +I
Sbjct: 128 AERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQKLPVAEAIA 186
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
L L++LH ++Y D K NI+L + KL D G
Sbjct: 187 --YLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSFG 235
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 176
+ GT G+ APE ++ T +D+Y+ G L + + + +G P
Sbjct: 236 Y-LYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----P 289
Query: 177 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 230
L + RL+ + DP+ R E+ L
Sbjct: 290 VLKTYDSYGRLL--------------------RRAIDPDPRQRFTTAEEMSAQLT 324
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-24
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 14/164 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-----PWSI 55
+ E + H N+V+ IG ++ R ++ E M G L++ L R + P ++
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAM 180
Query: 56 R--MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEG 110
+ +A A G +L E I+RD N LL AK+ DFG+A+D
Sbjct: 181 LDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
M + PE M G TS++D +SFGV+L E+ +
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-24
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 32/175 (18%)
Query: 1 MAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--- 56
E+ L L H N++ L+G C L E+ P G+L + L R+S L
Sbjct: 73 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAI 131
Query: 57 -------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 103
+ A A+G+ +L +++ I+RD NIL+ +Y AK++DFGL
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL 188
Query: 104 AKDGPEGDKTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
++ K R+ M A E + T+ SDV+S+GV+L E+++
Sbjct: 189 SRGQEVYVKKT-MGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-24
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 30/164 (18%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 56
H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTH 114
+ A+G+ +L A + I+RD N+L+ + K++DFGLA+D D K
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 115 VSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ R+ M APE + T +SDV+SFGV++ E+ T
Sbjct: 263 TNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 6e-24
Identities = 46/244 (18%), Positives = 87/244 (35%), Gaps = 44/244 (18%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------WS 54
++ + N V + + + + +L++ + RR
Sbjct: 109 SVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168
Query: 55 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-------- 106
I ++IA + FLH + +++RD K SNI D K+ DFGL
Sbjct: 169 IFIQIAEA----VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 107 --GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 164
T +GT Y +PE + + + + D++S G++L E+L +
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---- 277
Query: 165 NGEHNLVEWARPHLGERRRFYRLI-DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223
ER R + + + F+ K + + LS P RP +
Sbjct: 278 ---------------ERVRIITDVRNLKFPLLFTQK-YPQEHMMVQDMLSPSPTERPEAT 321
Query: 224 EVVE 227
+++E
Sbjct: 322 DIIE 325
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-24
Identities = 49/234 (20%), Positives = 84/234 (35%), Gaps = 30/234 (12%)
Query: 3 EVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
EV L + H N+++ + + + E +L+ ++ ++ + +
Sbjct: 67 EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ 125
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAK--DGPEGDKTH 114
GLA LH +++RD K NIL+ A +SDFGL K +
Sbjct: 126 QTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 115 VSTRVMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 171
S GT G+ APE + + T D++S G V +++ P G+
Sbjct: 183 RSGVP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQR 236
Query: 172 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225
+ L E H A +L ++ DP+ RP V
Sbjct: 237 Q-----ANILLGACSLDCLHPEKHED----VIARELIEKMIAMDPQKRPSAKHV 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-24
Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
EV L H N+++L GY D R+ L+ E+ P G++ L ++
Sbjct: 59 EVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 116
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 121
A L++ H + VI+RD K N+LL + K++DFG + P + G
Sbjct: 117 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---G 169
Query: 122 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 181
T Y PE + + D++S GV+ E L G+ P + E
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQE--------- 214
Query: 182 RRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
Y+ I + + +GA+ L + L +P RP++ EV+E
Sbjct: 215 --TYKRISRVEFTFPDFVT-EGARD---LISRLLKHNPSQRPMLREVLE 257
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-24
Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 40/184 (21%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---- 56
++E N L + H +++KL G C +D LL+ E+ GSL L R S +
Sbjct: 74 LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGG 132
Query: 57 --------------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 96
+ A ++G+ +L AE +++RD NIL+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKM 189
Query: 97 KLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150
K+SDFGL++D E D R+ M A E + T++SDV+SFGV+L
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLW 243
Query: 151 EMLT 154
E++T
Sbjct: 244 EIVT 247
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 1e-23
Identities = 32/245 (13%), Positives = 69/245 (28%), Gaps = 49/245 (20%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYC--IEDDQRLLVYEFMP-----RGSLENHLFRRSLPLPW 53
+ + + D ++++ + R +Y M G + L
Sbjct: 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 205
Query: 54 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 113
R+++ L + LA LH +++ + +I+LD L+ F +
Sbjct: 206 HARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV------RD 256
Query: 114 HVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLTGRRSMDKN 162
+ G+ PE +T D ++ G+V+ +
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD------ 310
Query: 163 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222
P + + + R + Q L L + R L
Sbjct: 311 LPITKDAALGGSEWIF------------RSCKNIP----QPVRALLEGFLRYPKEDRLLP 354
Query: 223 SEVVE 227
+ +E
Sbjct: 355 LQAME 359
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 30/164 (18%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----------FRRSLPLPWSIRMK-- 58
H N++ L+G C +D ++ E+ +G+L +L + S + K
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 59 --IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTH 114
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D K
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 115 VSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ R+ M APE + T +SDV+SFGV+L E+ T
Sbjct: 251 TNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 2e-23
Identities = 39/241 (16%), Positives = 71/241 (29%), Gaps = 52/241 (21%)
Query: 9 DLVHLNLVKLIGYCIEDDQRLLV---YEFMPRGSLENHLFRRSL--------PLPWSIRM 57
DLV K + D++ + V + PR F L L R+
Sbjct: 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 214
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
++ L + LA LH +++ + +I+LD L+ F +G S
Sbjct: 215 QLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA----SA 265
Query: 118 RVMGTYGYAAPEYVM----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 167
G+A PE +T D ++ G+ + + PN +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------LPNTD 319
Query: 168 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+ + + P+ L L + R L + +E
Sbjct: 320 DAALGGSEWIFRSCKNI-----PQP-----------VRALLEGFLRYPKEDRLLPLQAME 363
Query: 228 A 228
Sbjct: 364 T 364
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 10/155 (6%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
E+ L H N++++ Y D +R+ L+ EF PRG L L ++
Sbjct: 64 EIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFME 121
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 121
A L + HE R VI+RD K N+L+ K++DFG + P + G
Sbjct: 122 ELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---G 174
Query: 122 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
T Y PE + + D++ GV+ E L G
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 48/166 (28%), Positives = 69/166 (41%), Gaps = 32/166 (19%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 56
H+N+V L+G C L++ E+ G L N L R+ S
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 57 --MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 114
+ + AKG+AFL A + I+RD NILL K+ DFGLA+D
Sbjct: 146 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 115 VST------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
V + M APE + T SDV+S+G+ L E+ +
Sbjct: 203 VKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-23
Identities = 46/154 (29%), Positives = 82/154 (53%), Gaps = 7/154 (4%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L + +V G D + + E M GSL+ + +++ +P I K+++
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIA 139
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
KGL +L E+ +++RD K SNIL+++ KL DFG++ + + ++ V GT
Sbjct: 140 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GT 193
Query: 123 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 26/168 (15%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 58
E+ + L H LV L Y +D++ + +V + + G L HL + +K
Sbjct: 63 FKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVK 118
Query: 59 -----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 113
+ + L +L + +I+RD K NILLD + ++DF +A P +
Sbjct: 119 LFICELVMA----LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI 171
Query: 114 HVSTRVMGTYGYAAPEYVM----TGHLTSRSDVYSFGVVLLEMLTGRR 157
T + GT Y APE G+ + D +S GV E+L GRR
Sbjct: 172 ---TTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRR 215
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-23
Identities = 49/166 (29%), Positives = 72/166 (43%), Gaps = 33/166 (19%)
Query: 12 HLNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSLPLPWSIR-------------- 56
HLN+V L+G C + +++ EF G+L +L R +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 57 --MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--K 112
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 149 HLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 113 THVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
R+ M APE + T +SDV+SFGV+L E+ +
Sbjct: 206 RKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-23
Identities = 69/232 (29%), Positives = 94/232 (40%), Gaps = 50/232 (21%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 58
+ E L + H L L Y + RL V E+ G L HL R R R +
Sbjct: 53 VTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RAR 108
Query: 59 -----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 113
I L +LH R V+YRD K N++LD D + K++DFGL K+G T
Sbjct: 109 FYGAEIVSA----LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161
Query: 114 HVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 171
+ GT Y APE V+ + R+ D + GVV+ EM+ G R
Sbjct: 162 ---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCG-------RL------- 203
Query: 172 EWARPHLGE-RRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219
P + R + LI + R S +A L A L +DPK R
Sbjct: 204 ----PFYNQDHERLFELILMEEIRFPRTLS----PEAKSLLAGLLKKDPKQR 247
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 30/226 (13%), Positives = 56/226 (24%), Gaps = 26/226 (11%)
Query: 27 QRLLVYEFM-----PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81
LL+ S + ++ + + A L + +++
Sbjct: 162 NYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHG 218
Query: 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSR 139
F N+ + D L D YA E++ T
Sbjct: 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHA 273
Query: 140 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 199
+ + G+ + + P + W RP L +
Sbjct: 274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKG---SWKRPSLRVPGTDS--LAFGSCTPLP-- 326
Query: 200 GAQKAAQLAAHCLSRDPKARPLMSEVVE--ALKPLPNLKDMASSSY 243
L L+ D + R L E +E L N + S+
Sbjct: 327 --DFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTG 370
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 37/171 (21%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 56
H N+V L+G C L++E+ G L N+L +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 57 -------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 109
+ A AKG+ FL + ++RD N+L+ K+ DFGLA+D
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 110 GD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
+ R+ M APE + G T +SDV+S+G++L E+ +
Sbjct: 225 DSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-22
Identities = 53/240 (22%), Positives = 91/240 (37%), Gaps = 38/240 (15%)
Query: 1 MAEVNFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 57
E+ +L L + ++L Y DQ + +V E L + L ++ + R
Sbjct: 74 RNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERK 130
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
+ + +H+ +++ D K +N L+ D KL DFG+A + V
Sbjct: 131 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD 186
Query: 118 RVMGTYGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-N 165
+GT Y PE + ++ +SDV+S G +L M G+ P
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------PFQ 240
Query: 166 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225
N + + + +IDP E F + + CL RDPK R + E+
Sbjct: 241 QIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 58/298 (19%), Positives = 110/298 (36%), Gaps = 42/298 (14%)
Query: 1 MAEVNFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 57
E+ +L L + ++L Y DQ + +V E L + L ++ + R
Sbjct: 55 RNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERK 111
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
+ + +H+ +++ D K +N L+ D KL DFG+A + V
Sbjct: 112 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD 167
Query: 118 RVMGTYGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-N 165
+GT Y PE + ++ +SDV+S G +L M G+ P
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------PFQ 221
Query: 166 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225
N + + + +IDP E F + + CL RDPK R + E+
Sbjct: 222 QIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
Query: 226 VE----ALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLS 279
+ ++ P + ++ + + + +G + A+ +G S +
Sbjct: 272 LAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHN 329
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 4e-22
Identities = 55/245 (22%), Positives = 83/245 (33%), Gaps = 33/245 (13%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFR--RSLPLP 52
E+ + L H N+V + D + LL E+ G L +L + L
Sbjct: 62 EIQIMKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 53 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA---KLSDFGLAKDGPE 109
+ + L +LHE +I+RD K NI+L K+ D G AK+ +
Sbjct: 120 EGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 110 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR---------SMD 160
G+ V GT Y APE + T D +SFG + E +TG R
Sbjct: 177 GELCT--EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233
Query: 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
+ + G + L P H S A K + L + R
Sbjct: 234 GKVREKSNEHIVVYDDLTGAVKFSSVLPTPN---HLSGILAGKLERWLQCMLMWHQRQRG 290
Query: 221 LMSEV 225
+
Sbjct: 291 TDPQN 295
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-22
Identities = 55/165 (33%), Positives = 82/165 (49%), Gaps = 24/165 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 58
E + L ++ H +VKL Y + + +L L+ +F+ G L L + +K
Sbjct: 74 KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVK 129
Query: 59 -----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 113
+AL L LH +IYRD K NILLD + + KL+DFGL+K+ + +K
Sbjct: 130 FYLAELALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182
Query: 114 HVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
GT Y APE V+ ++S D +SFGV++ EMLTG
Sbjct: 183 ---AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-22
Identities = 54/161 (33%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 58
+ E L + H L L Y + RL V E+ G L HL R R R +
Sbjct: 196 LTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RAR 251
Query: 59 I-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
L +LH +E+ V+YRD K N++LD D + K++DFGL K+G + T
Sbjct: 252 FYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---M 306
Query: 118 RVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
+ GT Y APE V+ + R+ D + GVV+ EM+ GR
Sbjct: 307 KTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 7e-22
Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 24/165 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 58
AE N L ++ H +V LI Y + +L L+ E++ G L L R
Sbjct: 69 KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---TAC 124
Query: 59 -----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 113
I++ L LH++ +IYRD K NI+L+ + KL+DFGL K+
Sbjct: 125 FYLAEISMA----LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177
Query: 114 HVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
T GT Y APE ++ +R+ D +S G ++ +MLTG
Sbjct: 178 ---THTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-21
Identities = 52/240 (21%), Positives = 90/240 (37%), Gaps = 38/240 (15%)
Query: 1 MAEVNFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 57
E+ +L L + ++L Y DQ + +V E L + L ++ + R
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERK 158
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
+ + +H+ +++ D K +N L+ D KL DFG+A + V
Sbjct: 159 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 118 RVMGTYGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-N 165
+G Y PE + ++ +SDV+S G +L M G+ P
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQ 268
Query: 166 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225
N + + + +IDP E F + + CL RDPK R + E+
Sbjct: 269 QIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 56/290 (19%), Positives = 90/290 (31%), Gaps = 41/290 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSI 55
M E L L H N+VKL E+ EF P GSL L + LP S
Sbjct: 55 MREFEVLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGD 111
+ + G+ L E +++R+ K NI+ D KL+DFG A++ + +
Sbjct: 114 FLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 112 KTHVSTRVMGTYGYAAPEYVMTGHLTSRS--------DVYSFGVVLLEMLTGRR------ 157
+ + GT Y P+ L D++S GV TG
Sbjct: 171 QFV--SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 158 -------SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 210
M K + + + D + S + A+
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLAN 285
Query: 211 CLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTR 260
L D + + + + + + Q M A +I
Sbjct: 286 ILEADQEKCWGFDQFFAETSDILHRMVIH--VFSLQQMTAHKIYIHSYNT 333
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 50/224 (22%), Positives = 82/224 (36%), Gaps = 44/224 (19%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGAAKGLA 68
V G + + E M SL+ + + +P I KIA+ K L
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 69 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 128
LH + VI+RD K SN+L++A K+ DFG++ G Y AP
Sbjct: 124 HLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAP 178
Query: 129 EYVMTGHL----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 184
E + + +SD++S G+ ++E+ R W P
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR-----------FPYDSWGTP-------- 219
Query: 185 YRLID-------PRL-EGHFSIKGAQKAAQLAAHCLSRDPKARP 220
++ + P+L FS + + CL ++ K RP
Sbjct: 220 FQQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERP 259
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
EV L H ++++L Y ED + LV E G + +L R P +
Sbjct: 61 EVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVM 120
G+ +LH +++RD SN+LL + N K++DFGLA + +K +
Sbjct: 120 QIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--- 173
Query: 121 GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
GT Y +PE + H SDV+S G + +L GR
Sbjct: 174 GTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 2e-21
Identities = 30/169 (17%), Positives = 55/169 (32%), Gaps = 18/169 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----PLPWSIRMK 58
+ L + +K + + +LV E G+L N + +P + +
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILL-----------DADYNAKLSDFGLAKDG 107
A+ + +H+ +I+ D K N +L D L D G + D
Sbjct: 177 FAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 108 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
K + T T G+ E + + D + + ML G
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-21
Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 58
E + + L H VKL + +DD++L + G L ++ + S +
Sbjct: 78 TRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---CTR 133
Query: 59 -----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 113
I L +LH + +I+RD K NILL+ D + +++DFG AK K
Sbjct: 134 FYTAEIVSA----LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 114 HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 156
+ +GT Y +PE + SD+++ G ++ +++ G
Sbjct: 187 ARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGL 229
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 61/236 (25%), Positives = 91/236 (38%), Gaps = 50/236 (21%)
Query: 1 MAEVNFLGDLVHLN-LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM 57
E L + LV L Y + + +L L+ +++ G L HL + +
Sbjct: 106 RTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EV 161
Query: 58 K-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
+ I L L LH+ +IYRD K NILLD++ + L+DFGL+K+ +
Sbjct: 162 QIYVGEIVLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 214
Query: 113 THVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNG 166
GT Y AP+ V +GH + D +S GV++ E+LTG +
Sbjct: 215 ERAYDFC-GTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQA 272
Query: 167 EHNLVEWARPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219
E R I +P S A L L +DPK R
Sbjct: 273 E----------------ISRRILKSEPPYPQEMS----ALAKDLIQRLLMKDPKKR 308
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-21
Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 43/219 (19%)
Query: 15 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM---KIALGAAKGLAF 69
LV L C + + RL V E++ G L H+ R R LP + R +I+L L +
Sbjct: 72 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISLA----LNY 125
Query: 70 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAP 128
LHE R +IYRD K N+LLD++ + KL+D+G+ K+G T T GT Y AP
Sbjct: 126 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAP 179
Query: 129 EYVMTGHLTSRS-DVYSFGVVLLEMLTGR----RSMDKNRPNGEHNLVEWARPHLGERRR 183
E ++ G S D ++ GV++ EM+ GR + P+
Sbjct: 180 E-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------------TEDY 226
Query: 184 FYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219
+++I R+ S KAA + L++DPK R
Sbjct: 227 LFQVILEKQIRIPRSLS----VKAASVLKSFLNKDPKER 261
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 58/166 (34%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 1 MAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM 57
M+E N L V H LV L + + +L V +++ G L HL R R P R
Sbjct: 86 MSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RA 141
Query: 58 K-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
+ IA L +LH ++YRD K NILLD+ + L+DFGL K+ E +
Sbjct: 142 RFYAAEIASA----LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194
Query: 113 THVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
T T GT Y APE V+ R+ D + G VL EML G
Sbjct: 195 T---TSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 52/151 (34%), Positives = 72/151 (47%), Gaps = 24/151 (15%)
Query: 15 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGL 67
L + + + L V E++ G L H+ L R I LG L
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIILG----L 131
Query: 68 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYA 126
FLH + ++YRD K NILLD D + K++DFG+ K+ GD T GT Y
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYI 185
Query: 127 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
APE ++ G + S D +SFGV+L EML G+
Sbjct: 186 APE-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-20
Identities = 65/231 (28%), Positives = 95/231 (41%), Gaps = 36/231 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
E++ L H ++V G+ ED+ + +V E R SL RR R
Sbjct: 65 EISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLR 122
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVM 120
G +LH VI+RD K N+ L+ D K+ DFGLA K +G++ V
Sbjct: 123 QIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--- 176
Query: 121 GTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
GT Y APE V++ S DV+S G ++ +L G+ P L E
Sbjct: 177 GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKE------- 222
Query: 180 ERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
Y I + + H + AA L L DP ARP ++E++
Sbjct: 223 ----TYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 265
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 40/167 (23%), Positives = 65/167 (38%), Gaps = 19/167 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 57
E + L + + +L + +D+ L LV E+ G L L + +P + R
Sbjct: 109 REERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RF 166
Query: 58 KIA-LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
+A + A + +H ++RD K NILLD + +L+DFG
Sbjct: 167 YLAEIVMA--IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVY-------SFGVVLLEMLTGR 156
V GT Y +PE + + Y + GV EM G+
Sbjct: 222 VAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 15 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGL 67
L +L C + RL V E++ G L H+ + P IA+G L
Sbjct: 83 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIG----L 134
Query: 68 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYA 126
FL + +IYRD K N++LD++ + K++DFG+ K+ T T+ GT Y
Sbjct: 135 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYI 188
Query: 127 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
APE ++ +S D ++FGV+L EML G+
Sbjct: 189 APE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 52/249 (20%), Positives = 81/249 (32%), Gaps = 39/249 (15%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSI 55
M E L L H N+VKL E+ EF P GSL L + LP S
Sbjct: 55 MREFEVLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGD 111
+ + G+ L E +++R+ K NI+ D KL+DFG A++ + +
Sbjct: 114 FLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 112 KTHVSTRVMGTYGYAAPEYVMTGHL--------TSRSDVYSFGVVLLEMLTGRR------ 157
+ + GT Y P+ L + D++S GV TG
Sbjct: 171 QFV--SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 158 -------SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 210
M K + + + D + S + A+
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLAN 285
Query: 211 CLSRDPKAR 219
L D +
Sbjct: 286 ILEADQEKC 294
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 56/216 (25%), Positives = 83/216 (38%), Gaps = 29/216 (13%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 71
+V+ G I + + E M E R P+P I K+ + K L +L
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 72 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 131
E+ VI+RD K SNILLD KL DFG++ R G Y APE +
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERI 196
Query: 132 MTGHL-----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRF 184
R+DV+S G+ L+E+ TG+ + + E +++ P L
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG---- 252
Query: 185 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
FS CL++D + RP
Sbjct: 253 --------HMGFS----GDFQSFVKDCLTKDHRKRP 276
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 47/221 (21%)
Query: 15 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGL 67
LV L C + + RL V E++ G L H+ R R LP + I+L L
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA----L 166
Query: 68 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYA 126
+LHE R +IYRD K N+LLD++ + KL+D+G+ K+G T T GT Y
Sbjct: 167 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYI 220
Query: 127 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR----RSMDKNRPNGEHNLVEWARPHLGER 181
APE ++ G S D ++ GV++ EM+ GR + P+
Sbjct: 221 APE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------------TE 267
Query: 182 RRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219
+++I R+ S KAA + L++DPK R
Sbjct: 268 DYLFQVILEKQIRIPRSLS----VKAASVLKSFLNKDPKER 304
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 65/231 (28%), Positives = 95/231 (41%), Gaps = 36/231 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
E++ L H ++V G+ ED+ + +V E R SL RR R
Sbjct: 91 EISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLR 148
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVM 120
G +LH VI+RD K N+ L+ D K+ DFGLA K +G++ V
Sbjct: 149 QIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--- 202
Query: 121 GTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
GT Y APE V++ S DV+S G ++ +L G+ P L E
Sbjct: 203 GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKE------- 248
Query: 180 ERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
Y I + + H + AA L L DP ARP ++E++
Sbjct: 249 ----TYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 291
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-20
Identities = 51/162 (31%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
E + + +V+L Y +DD+ L +V E+MP G L N + +P W+ R
Sbjct: 117 WEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYT 174
Query: 60 A-LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
A + A L +H I+RD K N+LLD + KL+DFG + T
Sbjct: 175 AEVVLA--LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 229
Query: 119 VMGTYGYAAPEYVMT----GHLTSRSDVYSFGVVLLEMLTGR 156
V GT Y +PE + + G+ D +S GV L EML G
Sbjct: 230 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-20
Identities = 45/245 (18%), Positives = 79/245 (32%), Gaps = 55/245 (22%)
Query: 1 MAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIR 56
+ EV L H ++V+ EDD L+ E+ GSL + + +R +
Sbjct: 58 LREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-------------------YNAK 97
+ L +GL ++H +++ D K SNI + K
Sbjct: 118 KDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 98 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTG 155
+ D G V G + A E + HL +D+++ + ++
Sbjct: 175 IGDLGHVT---RISSPQVEE---GDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGA 227
Query: 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 215
P +W G PR+ S Q+ +L + D
Sbjct: 228 EPL-----PRNGD---QWHEIRQGRL--------PRIPQVLS----QEFTELLKVMIHPD 267
Query: 216 PKARP 220
P+ RP
Sbjct: 268 PERRP 272
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-20
Identities = 51/151 (33%), Positives = 72/151 (47%), Gaps = 24/151 (15%)
Query: 15 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGL 67
L +L C + RL V EF+ G L H+ + R R + I L
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAEIISA----L 137
Query: 68 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYA 126
FLH+ + +IYRD K N+LLD + + KL+DFG+ K+G T T GT Y
Sbjct: 138 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYI 191
Query: 127 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
APE ++ L + D ++ GV+L EML G
Sbjct: 192 APE-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 8e-20
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 27/165 (16%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 58
E L + H ++++ +D Q++ ++ +++ G L + L + + P P K
Sbjct: 54 NDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAK 109
Query: 59 -----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 113
+ L L +LH + +IYRD K NILLD + + K++DFG AK P+ T
Sbjct: 110 FYAAEVCLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162
Query: 114 HVSTRVMGTYGYAAPEYVMT-GHLTSRS-DVYSFGVVLLEMLTGR 156
+ GT Y APE V T + ++S D +SFG+++ EML G
Sbjct: 163 -----LCGTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGY 200
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 60/262 (22%), Positives = 100/262 (38%), Gaps = 66/262 (25%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+ L + K G ++D + ++ E++ GS + L L IA
Sbjct: 68 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IA 122
Query: 61 L---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
KGL +LH E I+RD K +N+LL KL+DFG+A G T
Sbjct: 123 TILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQI 174
Query: 118 R---VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR---------RSM---DKN 162
+ +GT + APE + S++D++S G+ +E+ G + + KN
Sbjct: 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN 234
Query: 163 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222
P P LEG++S + + CL+++P RP
Sbjct: 235 NP-------------------------PTLEGNYS----KPLKEFVEACLNKEPSFRPTA 265
Query: 223 SE------VVEALKPLPNLKDM 238
E ++ K L ++
Sbjct: 266 KELLKHKFILRNAKKTSYLTEL 287
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 46/165 (27%), Positives = 69/165 (41%), Gaps = 17/165 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL--FRRSLPLPWSIRM 57
E + L + + L Y +DD L LV ++ G L L F LP + R
Sbjct: 122 REERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RF 179
Query: 58 KIA-LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
+A + A + +H+ ++RD K NIL+D + + +L+DFG E S
Sbjct: 180 YLAEMVIA--IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGR 156
V GT Y +PE + D +S GV + EML G
Sbjct: 235 VAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 48/147 (32%), Positives = 73/147 (49%), Gaps = 16/147 (10%)
Query: 15 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGAAKGLAFLH 71
L +L C + RL V E++ G L H+ + P A A GL FL
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIGLFFLQ 459
Query: 72 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEY 130
+ +IYRD K N++LD++ + K++DFG+ K+ T T+ GT Y APE
Sbjct: 460 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE- 512
Query: 131 VMTGHLTSRS-DVYSFGVVLLEMLTGR 156
++ +S D ++FGV+L EML G+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 59/262 (22%), Positives = 92/262 (35%), Gaps = 65/262 (24%)
Query: 3 EVNFLGDLV-HLNLVKLIGYCIEDDQRL--LVYEFMPRGSL-----ENHLFRRSLPLPWS 54
E+ L + H N+++ YC E R + E +L ++ +L L
Sbjct: 58 EIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKE 114
Query: 55 IRMKIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLD-------------ADYNAKLSD 100
L A G+A LH +I+RD K NIL+ + +SD
Sbjct: 115 YNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 101 FGLAK---DGPEGDKTHVSTRVMGTYGYAAPE-------YVMTGHLTSRSDVYSFGVVLL 150
FGL K G +T+++ GT G+ APE LT D++S G V
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 151 EMLTG-------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK 203
+L+ + S + N G +L E H + +
Sbjct: 231 YILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLH---------------DRSLI----AE 271
Query: 204 AAQLAAHCLSRDPKARPLMSEV 225
A L + + DP RP +V
Sbjct: 272 ATDLISQMIDHDPLKRPTAMKV 293
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 5e-19
Identities = 56/286 (19%), Positives = 103/286 (36%), Gaps = 53/286 (18%)
Query: 3 EVNFLGDLV-HLNLVKLIGYCIEDDQR-------LLVYEFMPRGSLENHLFRRSL--PLP 52
EV F+ L H N+V+ + L+ + +G L L + PL
Sbjct: 75 EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS 134
Query: 53 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPE 109
+KI + + +H + P+I+RD K N+LL KL DFG A P+
Sbjct: 135 CDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193
Query: 110 GDKTHVSTRVM-------GTYGYAAPEYV-MTGHL--TSRSDVYSFGVVLLEMLTGRRSM 159
+ ++ T Y PE + + + + D+++ G +L + +
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ--- 250
Query: 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI----KGAQKAAQLAAHCLSRD 215
P + + I + G +SI L L +
Sbjct: 251 ---HPFEDGAKLR---------------I---VNGKYSIPPHDTQYTVFHSLIRAMLQVN 289
Query: 216 PKARPLMSEVVEALKPLPNLKDMASSSYYFQTM-QAERIGSSPNTR 260
P+ R ++EVV L+ + +++ S + + Q GS+ +R
Sbjct: 290 PEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-19
Identities = 59/228 (25%), Positives = 80/228 (35%), Gaps = 48/228 (21%)
Query: 12 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL----FRRSLPLPWSIRMKIALGAAKGL 67
+V+ G + + E M S + +P I KI L K L
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 68 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 127
L E +I+RD K SNILLD N KL DFG++ + + TR G Y A
Sbjct: 139 NHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMA 193
Query: 128 PEYVMTGHL----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 183
PE + RSDV+S G+ L E+ TGR K
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS------------------- 234
Query: 184 FYRLID-------PRL----EGHFSIKGAQKAAQLAAHCLSRDPKARP 220
+ + P+L E FS CL++D RP
Sbjct: 235 VFDQLTQVVKGDPPQLSNSEEREFS----PSFINFVNLCLTKDESKRP 278
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-19
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 23/163 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM- 57
+ E L + LVKL + +D+ L +V E++ G + +HL R P + R
Sbjct: 89 LNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFY 146
Query: 58 --KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 115
+I L +LH +IYRD K N+L+D +++DFG AK T
Sbjct: 147 AAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-- 197
Query: 116 STRVMGTYGYAAPEYVMT-GHLTSRS-DVYSFGVVLLEMLTGR 156
+ GT APE +++ G+ +++ D ++ GV++ EM G
Sbjct: 198 ---LCGTPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGY 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 2e-18
Identities = 49/263 (18%), Positives = 81/263 (30%), Gaps = 53/263 (20%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E++ H N+V I D++ +V FM GS + L + + IA
Sbjct: 74 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMN-ELAIA 131
Query: 61 L---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG-LAKDGPEGDKTHV- 115
G K L ++H ++R K S+IL+ D LS G + V
Sbjct: 132 YILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 116 ---STRVMGTYGYAAPEYVMTGHL---TSRSDVYSFGVVLLEMLTGR------------- 156
+ + +PE V+ +L ++SD+YS G+ E+ G
Sbjct: 189 HDFPKYSVKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247
Query: 157 -------------------RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 197
+ ++ + + R FS
Sbjct: 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307
Query: 198 IKGAQKAAQLAAHCLSRDPKARP 220
CL R+P ARP
Sbjct: 308 ----PHFHHFVEQCLQRNPDARP 326
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 38/226 (16%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ + + + N+V + + D+ +V E++ GSL + + + I +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-I-AAVCRE 124
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMG 121
+ L FLH VI+RD K+ NILL D + KL+DFG A+ PE K T V G
Sbjct: 125 CLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-G 178
Query: 122 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 181
T + APE V + D++S G++ +EM+ G P P+L E
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-------EP-----------PYLNEN 220
Query: 182 --RRFYRLID---PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 220
R Y + P L+ S CL D + R
Sbjct: 221 PLRALYLIATNGTPELQNPEKLS----AIFRDFLNRCLEMDVEKRG 262
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-18
Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L L H NLV L+ + LV+E+ ++ + L R +P + I
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VSTRV 119
+ + F H+ I+RD K NIL+ KL DFG A+ GP V+TR
Sbjct: 111 TLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR- 166
Query: 120 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
Y +PE ++ DV++ G V E+L+G
Sbjct: 167 ----WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 38/227 (16%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E++ + ++VK G ++ +V E+ GS+ + + R+ L I
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMG 121
KGL +LH I+RD K NILL+ + +AKL+DFG+ + K + V+G
Sbjct: 134 TLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIG 187
Query: 122 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 181
T + APE + +D++S G+ +EM G +P P+
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG-------KP-----------PYADIH 229
Query: 182 --RRFYRLID----PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 220
R + +I P +S CL + P+ R
Sbjct: 230 PMRAIF-MIPTNPPPTFRKPELWS----DNFTDFVKQCLVKSPEQRA 271
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-18
Identities = 58/239 (24%), Positives = 94/239 (39%), Gaps = 51/239 (21%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 56
E++ L L H N++KL ED + LV EF G L + R +
Sbjct: 96 EISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANI 151
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 113
MK L + +LH + +++RD K NILL ++ N K+ DFGL+ + K
Sbjct: 152 MKQILSG---ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVE 172
+GT Y APE V+ + DV+S GV++ +L G P G+++
Sbjct: 206 R---DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY------PPFGGQND--- 252
Query: 173 WARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 225
+ + + +G + +A +L L+ D R E
Sbjct: 253 ---------QDIIKKV---EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 38/226 (16%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
EV + D H N+V++ + ++ ++ EF+ G+L + + + L +
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEA 149
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMG 121
+ LA+LH + VI+RD K+ +ILL D KLSDFG A+ + K + V G
Sbjct: 150 VLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-G 203
Query: 122 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 181
T + APE + + D++S G++++EM+ G P P+ +
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG-------EP-----------PYFSDS 245
Query: 182 --RRFYRLID---PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 220
+ RL D P+L+ S L RDP+ R
Sbjct: 246 PVQAMKRLRDSPPPKLKNSHKVS----PVLRDFLERMLVRDPQERA 287
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-17
Identities = 52/237 (21%), Positives = 91/237 (38%), Gaps = 49/237 (20%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E+ L H +VKL+G D + ++ EF P G+++ + L +
Sbjct: 64 IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVC 123
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-- 118
+ L FLH + +I+RD K N+L+ + + +L+DFG++ +
Sbjct: 124 RQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRD 175
Query: 119 -VMGTYGYAAPEYVMTGHLT-----SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 172
+GT + APE VM + ++D++S G+ L+EM P
Sbjct: 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-------EP-------- 220
Query: 173 WARPHLGE---RRRFYRLID----PRLE--GHFSIKGAQKAAQLAAHCLSRDPKARP 220
PH R I P L +S + L ++P+ RP
Sbjct: 221 ---PHHELNPMRVLL--KIAKSDPPTLLTPSKWS----VEFRDFLKIALDKNPETRP 268
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 46/158 (29%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L L H NLV L+ C + + LV+EF+ ++ + L L + + K
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VSTRV 119
G+ F H +I+RD K NIL+ KL DFG A+ P V+TR
Sbjct: 133 IINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR- 188
Query: 120 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
Y APE ++ DV++ G ++ EM G
Sbjct: 189 ----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 57/239 (23%), Positives = 92/239 (38%), Gaps = 51/239 (21%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 56
EV L L H N++KL + ED + LV E G L + + R ++
Sbjct: 86 EVAVLKLLDHPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVI 141
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 113
+K L + +LH+ +++RD K N+LL + D K+ DFGL+ K
Sbjct: 142 IKQVLSG---VTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVE 172
+GT Y APE V+ + DV+S GV+L +L G P G+ +
Sbjct: 196 K---ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------PPFGGQTD--- 242
Query: 173 WARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 225
+ R + +G ++ + A L L D + R +
Sbjct: 243 ---------QEILRKV---EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-17
Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 51/239 (21%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 56
EV L L H N++KL + ED LV E G L + + R +S
Sbjct: 76 EVQLLKQLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARI 131
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 113
++ L + ++H+ +++RD K N+LL D N ++ DFGL+ K
Sbjct: 132 IRQVLSG---ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 173
+GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 186 K---DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC----------------- 224
Query: 174 ARPHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 225
P G + + +G ++ + + A L L+ P R +
Sbjct: 225 -PPFNGANEYDILKKV---EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-17
Identities = 58/239 (24%), Positives = 94/239 (39%), Gaps = 42/239 (17%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK---- 58
E+ + H N+V + D+ LV + + GS+ + + +
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDES 121
Query: 59 -IAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKT 113
IA +GL +LH+ I+RD K NILL D + +++DFG+ A GD T
Sbjct: 122 TIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178
Query: 114 HVSTR--VMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 170
R +GT + APE + ++D++SFG+ +E+ TG K P
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM----- 233
Query: 171 VEWARPHLGERRRFYRLI----DPRLEGHFSIKGAQKA-----AQLAAHCLSRDPKARP 220
+ L P LE K K ++ + CL +DP+ RP
Sbjct: 234 ------------KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-16
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L +L H N+V+L D + LV+EF + L+ + + L I
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVM 120
KGL F H R V++RD K N+L++ + KL++FGLA+ P + V+
Sbjct: 110 LLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV 163
Query: 121 GTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRR 157
T Y P+ V+ G ++ D++S G + E+ R
Sbjct: 164 -TLWYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 48/237 (20%)
Query: 3 EVNFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
EV + L H N+VKL + IE ++ L L+ E+ G + ++L RMK
Sbjct: 64 EVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHG-------RMKEK 114
Query: 61 LGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 114
+K + + H+ + +++RD K N+LLDAD N K++DFG + + G K
Sbjct: 115 EARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171
Query: 115 VSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 172
G YAAPE + G DV+S GV+L +++G D NL E
Sbjct: 172 AFC---GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKE 221
Query: 173 WARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLMSEVVE 227
+ L G + I + L L +P R + ++++
Sbjct: 222 -----------LRERV---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 13/158 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E++ L +L H N+VKL + +LV+E + + L+ L L L
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVM 120
G+A+ H+ R V++RD K N+L++ + K++DFGLA+ P TH ++
Sbjct: 109 LLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV 162
Query: 121 GTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 156
T Y AP+ V+ G ++ D++S G + EM+ G
Sbjct: 163 -TLWYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-16
Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E++ L +L H N+V LI + LV+EFM + L+ L L S
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVM 120
+G+A H+ +++RD K N+L+++D KL+DFGLA+ P TH V+
Sbjct: 128 LLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV 181
Query: 121 GTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 156
T Y AP+ V+ G ++ D++S G + EM+TG+
Sbjct: 182 -TLWYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
EV+ L DL H N+V L + LV+E++ + L+ +L +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVSTRVM 120
+GLA+ H + V++RD K N+L++ KL+DFGLA K P + V+
Sbjct: 109 LLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV 162
Query: 121 GTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 156
T Y P+ ++ G +++ D++ G + EM TGR
Sbjct: 163 -TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-16
Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 51/239 (21%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 56
EV L L H N++KL ED +V E G L + + +R +S
Sbjct: 71 EVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARI 126
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 113
+K + ++H+ +++RD K NILL + D + K+ DFGL+ + K
Sbjct: 127 IKQVFSG---ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 173
+GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 181 K---DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT----------------- 219
Query: 174 ARPHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 225
P G+ + + G ++ A L L+ P R ++
Sbjct: 220 -PPFYGKNEYDILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 36/114 (31%), Positives = 50/114 (43%), Gaps = 3/114 (2%)
Query: 41 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 100
E L + + AKG+ FL A R I+RD NILL K+ D
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 101 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154
FGLA+D + + APE + T +SDV+SFGV+L E+ +
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 51/158 (32%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L +L H N++ L+ LV++FM LE + SL L S L
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTH-VSTRV 119
+GL +LH+ +++RD K +N+LLD + KL+DFGLAK P TH V TR
Sbjct: 121 TLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR- 176
Query: 120 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 156
Y APE + + D+++ G +L E+L
Sbjct: 177 ----WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-15
Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 16/162 (9%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRS-LPLPWSIRMK 58
E++ + +L H N+V+L +++ LV+EFM + +++ + L ++
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVS 116
+GLAF HE +++RD K N+L++ KL DFGLA P +
Sbjct: 113 FQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS-- 167
Query: 117 TRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 156
V+ T Y AP+ V+ G ++ D++S G +L EM+TG+
Sbjct: 168 -EVV-TLWYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 65/252 (25%), Positives = 97/252 (38%), Gaps = 50/252 (19%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
EV FL L H N ++ G + + LV E+ GS + L PL + G
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHG 162
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR--VM 120
A +GLA+LH +I+RD K NILL KL DFG A + ++ +
Sbjct: 163 ALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFV 211
Query: 121 GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
GT + APE ++ G + DV+S G+ +E+ +P P
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-------KP-----------PL 253
Query: 178 LGER-RRFYRLID----PRLE-GHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVV 226
I P L+ GH+S + CL + P+ RP L V
Sbjct: 254 FNMNAMSALYHIAQNESPALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309
Query: 227 EALKPLPNLKDM 238
+P + D+
Sbjct: 310 LRERPPTVIMDL 321
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-15
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 54/240 (22%)
Query: 3 EVNFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+ L H +++KL Y I +V E++ G L +++ + R++
Sbjct: 61 EIQNLKLFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG-------RVEEM 111
Query: 61 LGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 114
+ + H V++RD K N+LLDA NAK++DFGL+ +G+
Sbjct: 112 EARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168
Query: 115 VSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 172
S G+ YAAPE V++G L D++S GV+L +L G D + ++
Sbjct: 169 TSC---GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHV-- 216
Query: 173 WARPHLGERRRFYRLIDPRLEGHFSI-----KGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
++ I G F I + L H L DP R + ++ E
Sbjct: 217 ---------PTLFKKI---RGGVFYIPEYLNRSVAT---LLMHMLQVDPLKRATIKDIRE 261
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 62/252 (24%), Positives = 99/252 (39%), Gaps = 43/252 (17%)
Query: 3 EVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR---- 56
EV L H N+++LI + E++ R LV+E M GS+ +H+ +R ++
Sbjct: 60 EVEMLYQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASV 115
Query: 57 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKD-GPEGD 111
++ A L FLH + + +RD K NIL + K+ DF L GD
Sbjct: 116 VVQDVASA---LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 112 KTHVSTRVM----GTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGRRSMDKN 162
+ +ST + G+ Y APE V + D++S GV+L +L+G
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------ 223
Query: 163 RP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRD 215
P G L + EG + A L + L RD
Sbjct: 224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRD 283
Query: 216 PKARPLMSEVVE 227
K R ++V++
Sbjct: 284 AKQRLSAAQVLQ 295
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 59/242 (24%), Positives = 92/242 (38%), Gaps = 48/242 (19%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW------SI 55
E + L H ++V+L+ D L +V+EFM L + +R+ S
Sbjct: 76 EASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDK 112
M+ L A L + H + +I+RD K +LL + KL FG+A E
Sbjct: 135 YMRQILEA---LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188
Query: 113 THVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 171
RV GT + APE V+ + DV+ GV+L +L+G
Sbjct: 189 V-AGGRV-GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGC--------------- 230
Query: 172 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQ------KAAQLAAHCLSRDPKARPLMSEV 225
P G + R + I ++G + + Q A L L DP R + E
Sbjct: 231 ---LPFYGTKERLFEGI---IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284
Query: 226 VE 227
+
Sbjct: 285 LN 286
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-14
Identities = 46/163 (28%), Positives = 67/163 (41%), Gaps = 21/163 (12%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
E+ L H N+VK G + L E+ G L + + I M
Sbjct: 55 EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD 106
Query: 62 GAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 115
G+ +LH + +RD K N+LLD N K+SDFGLA ++ +
Sbjct: 107 AQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 116 STRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 156
++ GT Y APE ++ DV+S G+VL ML G
Sbjct: 164 LNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 19/164 (11%)
Query: 3 EVNFLGDLVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLE--NHLFRRSLPLPWSIRMK 58
E+ L L H N+++L+ E+ Q++ +V E+ G E + + + P+ +
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHV 115
L GL +LH + ++++D K N+LL K+S G+A D
Sbjct: 116 CQL--IDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 116 STRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 156
S G+ + PE + G T + D++S GV L + TG
Sbjct: 171 SQ---GSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 20/163 (12%)
Query: 3 EVNFLGDLVHLNLVKLIGYCI----EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM- 57
E+ L L H N+VKL + +D +V+E + +G + + L +
Sbjct: 86 EIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYF 143
Query: 58 -KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 116
+ G + +LH + +I+RD K SN+L+ D + K++DFG++ + +G +S
Sbjct: 144 QDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSDALLS 195
Query: 117 TRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 156
V GT + APE + DV++ GV L + G+
Sbjct: 196 NTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 45/170 (26%), Positives = 68/170 (40%), Gaps = 36/170 (21%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L L H ++K+ + + + +V E M G E LF + + L
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LFDK-------VVGNKRLK 237
Query: 63 ---AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPE 109
+ +LHE +I+RD K N+LL + D K++DFG +K E
Sbjct: 238 EATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294
Query: 110 GDKTHVSTRVMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTG 155
T GT Y APE V+ D +S GV+L L+G
Sbjct: 295 TSLM--RTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 57/303 (18%), Positives = 100/303 (33%), Gaps = 60/303 (19%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGS-LENHLFRRSLPLPWSIRMKIA 60
E+ L + H N++K++ E+ LV E G L + R R+
Sbjct: 79 EIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHP-------RLDEP 130
Query: 61 LGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 114
L + + +L + +I+RD K NI++ D+ KL DFG A G +
Sbjct: 131 LASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY 187
Query: 115 VSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNL 170
GT Y APE V+ G+ +++S GV L ++ +
Sbjct: 188 TFC---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAA--- 240
Query: 171 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA-- 228
P S ++ L + L P+ R + ++V
Sbjct: 241 --------------IHP--PY---LVS----KELMSLVSGLLQPVPERRTTLEKLVTDPW 277
Query: 229 LKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASP 288
+ NL D Y ++ + S G + ++ + G
Sbjct: 278 VTQPVNLAD-----YTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEGHHH 332
Query: 289 YHH 291
+HH
Sbjct: 333 HHH 335
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 66/355 (18%), Positives = 120/355 (33%), Gaps = 71/355 (20%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIED-DQRL-LVYEFMP---RGSLENH----LFRRSLPLPW 53
E+ L +L H N++ L + D+++ L++++ ++ H ++ + LP
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 54 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DG 107
+ + G+ +LH V++RD K +NIL+ + K++D G A+ +
Sbjct: 128 GMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 108 PEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR-----RSMD 160
P + V+ T+ Y APE ++ G H T D+++ G + E+LT R D
Sbjct: 185 PLKPLADLDPVVV-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 161 KNRPNGEH--------------NLVEW-----------ARPHLGERRRFYRLIDPRLEGH 195
N H +W + +E H
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 196 FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK-------PLPNLKDMASSSYYFQTM 248
+ KA L L+ DP R +A++ PLP A +
Sbjct: 303 KVKPDS-KAFHLLQKLLTMDPIKRITSE---QAMQDPYFLEDPLPTSDVFAGCQIPYP-K 357
Query: 249 QAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASPYHHQFPHPSPKPNGK 303
+ P+ + + Q N P + H P K
Sbjct: 358 REFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPG-------NQDSSHTQGPPLKK 405
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 47/164 (28%), Positives = 69/164 (42%), Gaps = 23/164 (14%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
E+ L H N+VK G + L E+ G L + + I M
Sbjct: 55 EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD 106
Query: 62 GAAK-------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 114
A + G+ +LH + +RD K N+LLD N K+SDFGLA ++
Sbjct: 107 -AQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 115 VSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 156
+ ++ GT Y APE ++ DV+S G+VL ML G
Sbjct: 163 LLNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 19/163 (11%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
EV+ L +L H N+++L + + L++E+ L+ ++ ++ + +
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQ 140
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKD--GPEGDKTHV 115
G+ F H R ++RD K N+LL + K+ DFGLA+ P TH
Sbjct: 141 LINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH- 196
Query: 116 STRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 156
++ T Y PE ++ G H ++ D++S + EML
Sbjct: 197 --EII-TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-14
Identities = 47/202 (23%), Positives = 72/202 (35%), Gaps = 54/202 (26%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
EV + L H N+ +L ED+Q + LV E G L + L M +
Sbjct: 78 EVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 62 G--------------------------------AAK-------GLAFLHEEAERPVIYRD 82
+ L +LH + + +RD
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRD 193
Query: 83 FKTSNILLDADYNA--KLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 137
K N L + + KL DFGL+K G+ ++T+ GT + APE V+
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE-VLNTTNE 251
Query: 138 S---RSDVYSFGVVLLEMLTGR 156
S + D +S GV+L +L G
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGA 273
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 24/168 (14%)
Query: 3 EVNFLGDLVHLNLVKLIGYCI------EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPW 53
E+ + + H N+V L +D+ L LV E++P H + +P
Sbjct: 82 ELQIMRIVKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM 140
Query: 54 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK 112
+ + LA++H + +RD K N+LLD KL DFG AK G+
Sbjct: 141 LLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
Query: 113 -TH-VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 156
+ +R Y Y APE ++ G + T+ D++S G V+ E++ G+
Sbjct: 198 NVSYICSR----Y-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-14
Identities = 64/253 (25%), Positives = 91/253 (35%), Gaps = 66/253 (26%)
Query: 1 MAEVNFLGDLV-HLNLVKLIG------YCIEDDQRLLVYEFMPRGSLE---NHLFRRSLP 50
E+N L H N+ G DDQ LV EF GS+ + +L
Sbjct: 68 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 127
Query: 51 LPWSIRMKIAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 107
W IA +GL+ LH+ VI+RD K N+LL + KL DFG++
Sbjct: 128 EEW-----IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--- 176
Query: 108 PEGDKTHVSTR---VMGTYGYAAPEYVMTGHLT-----SRSDVYSFGVVLLEMLTGRRSM 159
R +GT + APE + +SD++S G+ +EM G
Sbjct: 177 --AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG---- 230
Query: 160 DKNRPNGEHNLVEWARPHLGE---RRRFYRLID----PRLEG-HFSIKGAQKAAQLAAHC 211
P P R F LI PRL+ +S +K C
Sbjct: 231 ---AP-----------PLCDMHPMRALF--LIPRNPAPRLKSKKWS----KKFQSFIESC 270
Query: 212 LSRDPKARPLMSE 224
L ++ RP +
Sbjct: 271 LVKNHSQRPATEQ 283
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-14
Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 41/241 (17%)
Query: 3 EVNFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR---- 56
E+ L H N+VKL D LV E + G L + ++ +S
Sbjct: 55 EITALKLCEGHPNIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKK---HFSETEASY 110
Query: 57 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDK 112
M+ + A ++ +H+ V++RD K N+L + + K+ DFG A+ P ++
Sbjct: 111 IMRKLVSA---VSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 113 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 172
+ T T YAAPE + D++S GV+L ML+G+ P
Sbjct: 165 P-LKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ------VPF------- 209
Query: 173 WARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVV 226
+ ++ +G FS +G Q+A L L+ DP R MS +
Sbjct: 210 QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269
Query: 227 E 227
Sbjct: 270 Y 270
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-14
Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 21/164 (12%)
Query: 7 LGDLVHLNLVKLI------GYCIEDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRM 57
L L H N+V+L G D L +V E++P + +RR + P +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKD-GPEGDKTH- 114
+ + LH + V +RD K N+L++ AD KL DFG AK P
Sbjct: 133 VFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 115 VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 156
+ +R Y Y APE ++ G H T+ D++S G + EM+ G
Sbjct: 192 ICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 46/170 (27%), Positives = 70/170 (41%), Gaps = 36/170 (21%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ L L H ++K+ + + + +V E M G E LF + + L
Sbjct: 65 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LFDK-------VVGNKRLK 112
Query: 63 ---AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPE 109
+ +LHE +I+RD K N+LL + D K++DFG +K E
Sbjct: 113 EATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 110 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSR----SDVYSFGVVLLEMLTG 155
T GT Y APE V+ T+ D +S GV+L L+G
Sbjct: 170 TSLM--RTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 38/172 (22%)
Query: 3 EVNFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
EV+ L + H N+++L E + LV++ M +G E LF + K+
Sbjct: 73 EVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKG--E--LFDY-------LTEKVT 120
Query: 61 LG---AAK-------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 110
L K + LH+ +++RD K NILLD D N KL+DFG + G
Sbjct: 121 LSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-------DVYSFGVVLLEMLTG 155
+K GT Y APE ++ + D++S GV++ +L G
Sbjct: 178 EKL--REVC-GTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 22/167 (13%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL------LVYEFMPR--GSLENHLFRRSLPLPWS 54
E+ + L H N+V+L + ++ LV +++P + H R LP
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 55 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK- 112
+ LA++H + +RD K N+LLD D KL DFG AK G+
Sbjct: 157 YVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 113 TH-VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 156
+ +R Y Y APE ++ G TS DV+S G VL E+L G+
Sbjct: 214 VSYICSR----Y-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 48/237 (20%)
Query: 3 EVNFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+ L H +++KL Y I + +V E++ G L +++ + R+
Sbjct: 66 EIQNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG-------RLDEK 116
Query: 61 LGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 114
G+ + H V++RD K N+LLDA NAK++DFGL+ +G+
Sbjct: 117 ESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173
Query: 115 VSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 172
S G+ YAAPE V++G L D++S GV+L +L G D + ++
Sbjct: 174 TSC---GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD------DDHV-- 221
Query: 173 WARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLMSEVVE 227
++ I +G F L H L DP R + ++ E
Sbjct: 222 ---------PTLFKKI---CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 37/169 (21%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 125
+ + H +++RD K N+LLD + N K++DFGL+ +G+ S G+ Y
Sbjct: 120 AIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 173
Query: 126 AAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 183
AAPE V+ G L DV+S G+VL ML GR D + +
Sbjct: 174 AAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFI-----------PN 215
Query: 184 FYRLIDPRLEGHFSI-----KGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
++ + + + GAQ L + DP R + E+
Sbjct: 216 LFKKV---NSCVYVMPDFLSPGAQS---LIRRMIVADPMQRITIQEIRR 258
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 29/172 (16%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL--------LVYEFMP---RGSLENHLFRRSLPL 51
E+ L L H N+V LI C LV++F G L N L + +L
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125
Query: 52 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA------K 105
+ M++ L GL ++H +++RD K +N+L+ D KL+DFGLA K
Sbjct: 126 IKRV-MQMLL---NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 106 DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 156
+ T+ RV+ T Y PE ++ D++ G ++ EM T
Sbjct: 179 NSQPNRYTN---RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-13
Identities = 59/249 (23%), Positives = 91/249 (36%), Gaps = 67/249 (26%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 56
EV L L H N++KL ED +V E G E LF I
Sbjct: 71 EVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGG--E--LFDE-------IIKRKRF 118
Query: 57 --------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAK 105
+K + ++H+ +++RD K NILL + D + K+ DFGL+
Sbjct: 119 SEHDAARIIKQVFSG---ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 106 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 165
+ K R+ GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 173 CFQQNTKM--KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT--------- 219
Query: 166 GEHNLVEWARPHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKA 218
P G+ + + G ++ A L L+ P
Sbjct: 220 ---------PPFYGKNEYDILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 219 RPLMSEVVE 227
R ++ +E
Sbjct: 268 RITATQCLE 276
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-13
Identities = 58/243 (23%), Positives = 90/243 (37%), Gaps = 56/243 (23%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 56
E+ L L H N++K+ ED + +V E G E L R + +
Sbjct: 70 EIEVLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEG 124
Query: 57 -----MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGP 108
MK + A LA+ H + V+++D K NIL K+ DFGLA+
Sbjct: 125 YVAELMKQMMNA---LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 109 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 168
+ + GT Y APE V +T + D++S GVV+ +LTG
Sbjct: 179 SDEH--STNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGC------------ 222
Query: 169 NLVEWARPHLGE-RRRFYRLIDPRLEGHFSIKGA-----QKAAQLAAHCLSRDPKARPLM 222
P G + + +A L L++DP+ RP
Sbjct: 223 ------LPFTGTSLEEVQQKA---TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSA 273
Query: 223 SEV 225
++V
Sbjct: 274 AQV 276
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-13
Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 22/166 (13%)
Query: 3 EVNFLGDL---VHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPL 51
EV L L H N+V+L + + +L LV+E + L+ +
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGV 117
Query: 52 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEG 110
P + +GL FLH V++RD K NIL+ + KL+DFGLA+ +
Sbjct: 118 PTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
T V+ T Y APE ++ + D++S G + EM +
Sbjct: 175 ALTS---VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 10/94 (10%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGT 122
G+ LH +I+RD K SNI++ +D K+ DFGLA+ +V TR
Sbjct: 175 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 228
Query: 123 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
Y APE ++ D++S G ++ EM+ +
Sbjct: 229 --YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 10/94 (10%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGT 122
G+ LH +I+RD K SNI++ +D K+ DFGLA+ +V TR
Sbjct: 138 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 191
Query: 123 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
Y APE ++ D++S G ++ EM+ G
Sbjct: 192 --YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 8e-13
Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 22/166 (13%)
Query: 3 EVNFLGDL---VHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPL 51
EV L L H N+V+L+ + + ++ LV+E + R L+ L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGL 117
Query: 52 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEG 110
P + +GL FLH +++RD K NIL+ + KL+DFGLA+ +
Sbjct: 118 PAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156
T V+ T Y APE ++ + D++S G + EM +
Sbjct: 175 ALTP---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 9e-13
Identities = 61/247 (24%), Positives = 87/247 (35%), Gaps = 67/247 (27%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 56
E+ + L H N+++L ED+ + LV E G E LF R +
Sbjct: 56 EIEIMKSLDHPNIIRLYET-FEDNTDIYLVMELCTGG--E--LFER-------VVHKRVF 103
Query: 57 --------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAK 105
MK L A +A+ H+ V +RD K N L D KL DFGLA
Sbjct: 104 RESDAARIMKDVLSA---VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157
Query: 106 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 165
G + T+V GT Y +P+ V+ G D +S GV++ +L G
Sbjct: 158 RFKPGKM--MRTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY--------- 204
Query: 166 GEHNLVEWARPHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKA 218
P I EG F+ +A L L++ PK
Sbjct: 205 ---------PPFSAPTDSEVMLKI---REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQ 252
Query: 219 RPLMSEV 225
R +
Sbjct: 253 RITSLQA 259
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 49/235 (20%), Positives = 84/235 (35%), Gaps = 47/235 (20%)
Query: 12 HLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIAL 61
++V ++ E+ L++ E M G L + + R ++ R M+
Sbjct: 81 GPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIG 138
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTR 118
A + FLH + +RD K N+L + D KL+DFG AK+ + + T
Sbjct: 139 TA---IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTP 189
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 178
T Y APE + D++S GV++ +L G ++
Sbjct: 190 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------------YSNTGQ 235
Query: 179 GERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 227
R I G + + A QL L DP R +++ +
Sbjct: 236 AISPGMKRRI---RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 25/164 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSI 55
EV+ L ++H N++ L E+ + L+ E + G L + L +
Sbjct: 65 EVSILRQVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TS 119
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGD 111
+K L G+ +LH + + + D K NI+L + KL DFGLA + +G
Sbjct: 120 FIKQILD---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 112 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
+ + GT + APE V L +D++S GV+ +L+G
Sbjct: 174 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 47/172 (27%), Positives = 75/172 (43%), Gaps = 38/172 (22%)
Query: 3 EVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E + L + H +++ LI E + LV++ M +G E LF + K+A
Sbjct: 149 ETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG--E--LFDY-------LTEKVA 196
Query: 61 LG---AAK-------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 110
L ++FLH +++RD K NILLD + +LSDFG + G
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-------DVYSFGVVLLEMLTG 155
+K GT GY APE ++ + D+++ GV+L +L G
Sbjct: 254 EKL--RELC-GTPGYLAPE-ILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 36/168 (21%), Positives = 60/168 (35%), Gaps = 41/168 (24%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLA---KDGPEGDKTHVSTRVMG 121
+ H V++RD K NIL+D + KL DFG KD G
Sbjct: 161 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFD-----G 210
Query: 122 TYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
T Y+ PE++ H + V+S G++L +M+ G + + ++
Sbjct: 211 TRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRG------ 258
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
++ + S + L CL+ P RP E+
Sbjct: 259 ------QVFFRQ---RVS----SECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 39/169 (23%), Positives = 60/169 (35%), Gaps = 43/169 (25%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLA---KDGPEGDKTHVSTRVMG 121
+ H R V++RD K NIL+D KL DFG D P G
Sbjct: 151 AIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFD-----G 200
Query: 122 TYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
T Y+ PE++ + V+S G++L +M+ G P +
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD------------------IPFERD 242
Query: 181 RRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLMSEVVE 227
+ I LE + L CL+ P +RP + E++
Sbjct: 243 QE-----I---LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 44/170 (25%), Positives = 69/170 (40%), Gaps = 39/170 (22%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
E+ L + H N+V L E LV + + G E LF R I +
Sbjct: 56 EIAVLKKIKHENIVTLEDI-YESTTHYYLVMQLVSGG--E--LFDR-------I---LER 100
Query: 62 G------AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAK 105
G A+ + +LHE +++RD K N+L + + ++DFGL+K
Sbjct: 101 GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157
Query: 106 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
G + + GT GY APE + + D +S GV+ +L G
Sbjct: 158 MEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 16/159 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E+ + L H LV L +D++ +++YEFM G E LF + + A+
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHNKMSEDEAVE 259
Query: 63 AAK----GLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGPEGDKTHVS 116
+ GL +HE ++ D K NI+ KL DFGL V
Sbjct: 260 YMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV- 315
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
GT +AAPE + +D++S GV+ +L+G
Sbjct: 316 --TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-12
Identities = 29/224 (12%), Positives = 60/224 (26%), Gaps = 47/224 (20%)
Query: 10 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 69
+ + +++ L+V E++ GSL+ + P P ++ A
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGA-IRAMQSLAAAADA 144
Query: 70 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 129
H V S + + D + L+
Sbjct: 145 AHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA 179
Query: 130 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 189
+ D+ G L +L R + + G + + A + ID
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPE---AGVRSGLAPAERDTAGQPIEPADID 229
Query: 190 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233
+ S +AA + D R S ++ ++
Sbjct: 230 RDIPFQIS--------AVAARSVQGDGGIRSA-STLLNLMQQAT 264
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 25/164 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSI 55
EV+ L ++H N++ L E+ + L+ E + G L + L +
Sbjct: 65 EVSILRQVLHHNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TS 119
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGD 111
+K L G+ +LH + + + D K NI+L + KL DFGLA + +G
Sbjct: 120 FIKQILD---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 112 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
+ + GT + APE V L +D++S GV+ +L+G
Sbjct: 174 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-12
Identities = 31/95 (32%), Positives = 43/95 (45%), Gaps = 11/95 (11%)
Query: 66 GLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDKTHVSTRVMGTY 123
G+++ H + +RD K N LLD K+ DFG +K + + V GT
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTP 181
Query: 124 GYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 156
Y APE V+ +DV+S GV L ML G
Sbjct: 182 AYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 35/95 (36%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKT-HVSTRVMGT 122
GL LHE A V++RD NILL + + + DF LA +D + +KT +V+ R
Sbjct: 145 LGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW--- 198
Query: 123 YGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 156
Y APE VM T D++S G V+ EM +
Sbjct: 199 --YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 40/159 (25%), Positives = 68/159 (42%), Gaps = 16/159 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMK 58
E++ + L H L+ L ED + L+ EF+ G L + + + M+
Sbjct: 98 EISIMNQLHHPKLINLHDA-FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGPEGDKTHVS 116
A GL +HE +++ D K NI+ + K+ DFGLA + V
Sbjct: 157 QACE---GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV- 209
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
T +AAPE V + +D+++ GV+ +L+G
Sbjct: 210 --TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 32/159 (20%), Positives = 67/159 (42%), Gaps = 16/159 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMK 58
E++ L H N++ L E + L +++EF+ + + + L +
Sbjct: 51 EISILNIARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH 109
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVS 116
+ L FLH + + D + NI+ ++ K+ +FG A+ GD +
Sbjct: 110 QVC---EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL- 162
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
+ Y APE +++ +D++S G ++ +L+G
Sbjct: 163 --LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-12
Identities = 58/246 (23%), Positives = 89/246 (36%), Gaps = 54/246 (21%)
Query: 3 EVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR---- 56
E+ L H N++ L +D + + +V E M G L + + R+ +S R
Sbjct: 65 EIEILLRYGQHPNIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQK---FFSEREASA 120
Query: 57 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA---KLSDFGLAKDGPEGD 111
+ + +LH + V++RD K SNIL D N ++ DFG AK +
Sbjct: 121 VLFTITKT---VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 112 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG----RRSMDKNRPNGE 167
+ T T + APE + + D++S GV+L MLTG D
Sbjct: 175 GL-LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--- 229
Query: 168 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPL 221
I G FS+ G A L + L DP R
Sbjct: 230 ---------------EILARI---GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT 271
Query: 222 MSEVVE 227
+ V+
Sbjct: 272 AALVLR 277
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 1e-11
Identities = 44/170 (25%), Positives = 71/170 (41%), Gaps = 38/170 (22%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
E L H N+V+L E+ LV++ + G E LF I +A
Sbjct: 55 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG--E--LFED-------I---VARE 100
Query: 63 ------AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKD 106
A+ +A+ H +++R+ K N+LL KL+DFGLA +
Sbjct: 101 FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157
Query: 107 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 155
+ + H GT GY +PE V+ + D+++ GV+L +L G
Sbjct: 158 VNDSEAWH--GFA-GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 11/94 (11%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTY 123
KGL ++H V++RD K N+ ++ D K+ DFGLA+ + + T V TR
Sbjct: 137 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTRW---- 188
Query: 124 GYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 156
Y APE +++ H D++S G ++ EMLTG+
Sbjct: 189 -YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 25/164 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSI 55
EVN L ++ H N++ L E+ + L+ E + G L + L +
Sbjct: 58 EVNILREIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEA----TQ 112
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGD 111
+K L G+ +LH + + + D K NI+L + KL DFG+A G+
Sbjct: 113 FLKQILD---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
Query: 112 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
+ + GT + APE V L +D++S GV+ +L+G
Sbjct: 167 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 11/94 (11%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTY 123
+GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + T +V+TR
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYVATRW---- 194
Query: 124 GYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 156
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 195 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 11/94 (11%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTY 123
KGL ++H A +I+RD K N+ ++ D K+ DFGLA+ + + T +V TR
Sbjct: 139 KGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVVTRW---- 190
Query: 124 GYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 156
Y APE ++ T D++S G ++ EM+TG+
Sbjct: 191 -YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 56
E L H N+V+L I+++ LV++ + G L + R +S
Sbjct: 78 EARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHC 133
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 113
++ L + +A+ H +++R+ K N+LL KL+DFGLA + + +
Sbjct: 134 IQQILES---IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
H GT GY +PE + + D+++ GV+L +L G
Sbjct: 188 H--GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 37/165 (22%), Positives = 69/165 (41%), Gaps = 25/165 (15%)
Query: 3 EVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW-------- 53
E+ L ++ L + +L+ E+ G E +F LP
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDV 133
Query: 54 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEG 110
+K L G+ +LH + +++ D K NILL + K+ DFG+++
Sbjct: 134 IRLIKQILE---GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 111 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
+ +MGT Y APE + +T+ +D+++ G++ +LT
Sbjct: 188 CELRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 26/164 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLF--RRSLPLPW 53
E++ + L H NL++L E + LV E++ G L E++ ++
Sbjct: 136 EISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-- 192
Query: 54 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGPEGD 111
MK G+ +H+ +++ D K NIL K+ DFGLA+ +
Sbjct: 193 ---MKQICE---GIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 112 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
K V GT + APE V ++ +D++S GV+ +L+G
Sbjct: 244 KLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 25/164 (15%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSI 55
EV+ L ++ H N++ L E+ + L+ E + G L + L +
Sbjct: 64 EVSILKEIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEA----TE 118
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGD 111
+K L + +LH + + D K NI+L K+ DFGLA G+
Sbjct: 119 FLKQILNG---VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 112 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155
+ + GT + APE V L +D++S GV+ +L+G
Sbjct: 173 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 58/248 (23%), Positives = 85/248 (34%), Gaps = 63/248 (25%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 61
E+ L L H N++KL E + LV E + G L F R I +
Sbjct: 98 EIGVLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGEL----FDR-------I---VEK 142
Query: 62 G------AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAK 105
G AA +A+LHE +++RD K N+L D K++DFGL+K
Sbjct: 143 GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199
Query: 106 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 165
V GT GY APE + D++S G++ +L G
Sbjct: 200 IVEHQVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF--------- 247
Query: 166 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKAR 219
P ER + L + A L + DPK R
Sbjct: 248 ---------EPFYDERGD-QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKR 297
Query: 220 PLMSEVVE 227
+ ++
Sbjct: 298 LTTFQALQ 305
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 34/135 (25%), Positives = 61/135 (45%), Gaps = 18/135 (13%)
Query: 30 LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAFLHEEAERPVIYRDFKTS 86
++ E++P + R +P + I + + + F+H + +RD K
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQ 170
Query: 87 NILLDA-DYNAKLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPEYVMTG--HLTSRSD 141
N+L+++ D KL DFG AK + + +R + Y APE +M G T D
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE-LMLGATEYTPSID 224
Query: 142 VYSFGVVLLEMLTGR 156
++S G V E++ G+
Sbjct: 225 LWSIGCVFGELILGK 239
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTY 123
+GL ++H A V++RD K SN+LL+ + K+ DFGLA+ P+ D T T + T
Sbjct: 139 RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 124 GYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 156
Y APE ++ T D++S G +L EML+ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-11
Identities = 51/245 (20%), Positives = 89/245 (36%), Gaps = 47/245 (19%)
Query: 3 EVNFLGDLV-HLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR 56
EV ++V+++ E+ L+V E + G L + + R ++ R
Sbjct: 104 EVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTER 161
Query: 57 -----MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDGP 108
MK A + +LH + +RD K N+L NA KL+DFG AK+
Sbjct: 162 EASEIMKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 109 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 168
+ ++T T Y APE + D++S GV++ +L G P
Sbjct: 216 SHNS--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPF--- 263
Query: 169 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLM 222
++ L I G + ++ L + L +P R +
Sbjct: 264 ----YSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 316
Query: 223 SEVVE 227
+E +
Sbjct: 317 TEFMN 321
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 23/163 (14%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 56
E L H N+V+L I ++ L+++ + G L + R +S
Sbjct: 60 EARICRLLKHPNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHC 115
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 113
++ L A + H+ V++R+ K N+LL KL+DFGLA + EG++
Sbjct: 116 IQQILEA---VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQ 168
Query: 114 HVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 155
GT GY +PE V+ D+++ GV+L +L G
Sbjct: 169 AWFGFA-GTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA----KDGPEGDKTHVSTRVM 120
+ + LH + VI+RD K SN+L++++ + K+ DFGLA + + + M
Sbjct: 123 RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 121 GTY----GYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 156
+ Y APE ++T + DV+S G +L E+ R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 24/97 (24%), Positives = 48/97 (49%), Gaps = 12/97 (12%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDG-PEGDKTH-VSTRVMG 121
K L + H +++RD K N+++D ++ +L D+GLA+ P + V++R
Sbjct: 141 KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195
Query: 122 TYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRR 157
+ PE ++ + S D++S G +L M+ +
Sbjct: 196 ---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 5e-10
Identities = 28/95 (29%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAK-DGPEGDKTHVSTRVMGT 122
+GL ++H A V++RD K +N+ ++ D K+ DFGLA+ P + + T
Sbjct: 131 RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 123 YGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 156
Y +P +++ + T D+++ G + EMLTG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 28/112 (25%), Positives = 51/112 (45%), Gaps = 23/112 (20%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRVMG 121
K + +LH +++RD K SNILL+A+ + K++DFGL+ + +
Sbjct: 120 KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 122 TYGYAAPEYVMTGH------------LTSRS-----DVYSFGVVLLEMLTGR 156
T + + ++T + L S D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 28/122 (22%), Positives = 48/122 (39%), Gaps = 24/122 (19%)
Query: 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA----KDGPEGDKTHVSTRVM 120
G F+HE + +I+RD K +N LL+ D + K+ DFGLA + +
Sbjct: 140 LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 121 GTYGYAAPEYVMTGHLTSR-----------------SDVYSFGVVLLEMLTGRRSMDKNR 163
+ +T H+ +R D++S G + E+L +S +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 164 PN 165
N
Sbjct: 257 TN 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 31/153 (20%), Positives = 64/153 (41%), Gaps = 24/153 (15%)
Query: 30 LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 86
+V+E + +L + + R +PL ++ +I+ GL ++H +I+ D K
Sbjct: 107 MVFEVL-GENLLALIKKYEHRGIPLI-YVK-QISKQLLLGLDYMHRRCG--IIHTDIKPE 161
Query: 87 NILLD------ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS 140
N+L++ K++D G A E + TR Y +PE ++ +
Sbjct: 162 NVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE-----YRSPEVLLGAPWGCGA 216
Query: 141 DVYSFGVVLLEMLTGR-----RSMDKNRPNGEH 168
D++S ++ E++TG + +H
Sbjct: 217 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 38/205 (18%), Positives = 69/205 (33%), Gaps = 56/205 (27%)
Query: 3 EVNFLGDLVHLNLVKL----IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 57
E+ L L H ++VK+ I +E L +V E ++ + R
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKK-------LFRT 149
Query: 58 KIALGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--- 104
+ L G+ ++H A +++RD K +N L++ D + K+ DFGLA
Sbjct: 150 PVYLTELHIKTLLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
Query: 105 ------KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH------------LTSRS-----D 141
++ + +TGH L + D
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAID 266
Query: 142 VYSFGVVLLEMLTGRRSMDKNRPNG 166
V+S G + E+L + +
Sbjct: 267 VWSIGCIFAELLNMIKENVAYHADR 291
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 41/278 (14%), Positives = 76/278 (27%), Gaps = 88/278 (31%)
Query: 30 LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 88
+V+E + L + + LP KI +GL +LH + +I+ D K NI
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178
Query: 89 LLDAD-------------------------------------------------YNAKLS 99
LL + K++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 100 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159
D G A + + TR Y + E ++ + +D++S + E+ TG
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293
Query: 160 DKNRPNGEHN-------------------LVEWARPHL-----GERRRFYRLIDPRLEG- 194
+ + +V G+ + +L L
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353
Query: 195 -----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+S + A L P+ R +E +
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 35/128 (27%), Positives = 57/128 (44%), Gaps = 18/128 (14%)
Query: 31 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 90
+YE + + + LP +R K A + L LH+ +I+ D K NILL
Sbjct: 185 LYELIKKNKF------QGFSLP-LVR-KFAHSILQCLDALHKNR---IIHCDLKPENILL 233
Query: 91 -DADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 148
+ K+ DFG + + T++ +R Y APE ++ D++S G +
Sbjct: 234 KQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCI 288
Query: 149 LLEMLTGR 156
L E+LTG
Sbjct: 289 LAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 35/129 (27%), Positives = 56/129 (43%), Gaps = 18/129 (13%)
Query: 31 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 90
+Y+ L N FR + ++ K A L FL +I+ D K NILL
Sbjct: 142 LYDL-----LRNTNFR---GVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILL 192
Query: 91 DADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGV 147
+ K+ DFG + + ++ +R Y +PE V+ G + D++S G
Sbjct: 193 CNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPE-VLLGMPYDLAIDMWSLGC 246
Query: 148 VLLEMLTGR 156
+L+EM TG
Sbjct: 247 ILVEMHTGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 37/159 (23%), Positives = 62/159 (38%), Gaps = 32/159 (20%)
Query: 17 KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE 73
+ + E +LV + + SLE L R + ++ M A + +HE
Sbjct: 70 NVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVK-TVAM-AAKQMLARVQSIHE- 124
Query: 74 AERPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DGPEGDKTHVSTR----VMG 121
+ ++YRD K N L+ + + DFG+ K D K H+ R + G
Sbjct: 125 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQHIPYREKKNLSG 180
Query: 122 TYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 156
T Y + + HL + R D+ + G V + L G
Sbjct: 181 TARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 45/253 (17%), Positives = 80/253 (31%), Gaps = 84/253 (33%)
Query: 3 EVNFLGDLV-HLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR 56
EV ++V+++ E+ L+V E + G E LF R I+
Sbjct: 60 EVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGG--E--LFSR-------IQ 107
Query: 57 MKIALG-----AA-------KGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 101
+ A+ + + +LH + +RD K N+L + KL+DF
Sbjct: 108 DRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 102 GLAKDGPEGDKTHVSTRVMGT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160
G A E G Y + D++S GV++ +L G
Sbjct: 165 GFA---KE---------TTGEKYDKSC-------------DMWSLGVIMYILLCGY---- 195
Query: 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSR 214
P ++ L I G + ++ L + L
Sbjct: 196 --PPF-------YSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKT 243
Query: 215 DPKARPLMSEVVE 227
+P R ++E +
Sbjct: 244 EPTQRMTITEFMN 256
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 40/155 (25%), Positives = 62/155 (40%), Gaps = 26/155 (16%)
Query: 17 KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE 73
+ E D ++V E + SLE LF R L ++ + +A + ++H
Sbjct: 69 TIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLK-TVLL-LADQMISRIEYIHS- 123
Query: 74 AERPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-GPEGDKTHVSTR----VMGTYGY 125
+ I+RD K N L+ + DFGLAK H+ R + GT Y
Sbjct: 124 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 126 AAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 156
A+ + HL + R D+ S G VL+ G
Sbjct: 182 AS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 38/170 (22%), Positives = 62/170 (36%), Gaps = 35/170 (20%)
Query: 7 LGDLVHLNLVKLIGY-CIEDDQRLLVYEFMPR--GSLENHLFRRSLPLPWSIRM--KIAL 61
L L + +G+ +D R LV +P SL+ S S R ++A
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQ-SALDVSPKHVLSERSVLQVAC 166
Query: 62 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAK---DGPEGDKTHVS 116
L FLHE ++ + NI +D + ++ L+ +G A HV+
Sbjct: 167 RLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP----SGKHVA 219
Query: 117 TR------VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 156
G + + M H + RSD+ S G +L+ L G
Sbjct: 220 YVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 7e-05
Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 32/159 (20%)
Query: 17 KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE 73
++ + +V E + SLE LF R+ L ++ M IA+ + ++H
Sbjct: 69 QVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLK-TVLM-IAIQLISRMEYVHS- 123
Query: 74 AERPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DGPEGDKTHVSTR----VMG 121
+ +IYRD K N L+ N + DF LAK D K H+ R + G
Sbjct: 124 --KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKHIPYREHKSLTG 179
Query: 122 TYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 156
T Y + + HL + R D+ + G + + L G
Sbjct: 180 TARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 1e-04
Identities = 18/82 (21%), Positives = 25/82 (30%), Gaps = 4/82 (4%)
Query: 24 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 83
+DDQ +V EF G + + + I LA +RD
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLR--FEHRDL 188
Query: 84 KTSNILLDADYNAKLSDFGLAK 105
N+LL KL K
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGK 210
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 37/145 (25%), Positives = 55/145 (37%), Gaps = 37/145 (25%)
Query: 31 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 90
+EF L+ + F+ P P +A L FLHE + + D K NIL
Sbjct: 108 TFEF-----LKENNFQ---PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILF 156
Query: 91 -DADYNA------------------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 131
++++ +++DFG A E T V+TR Y PE V
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH-----YRPPE-V 210
Query: 132 MTGHL-TSRSDVYSFGVVLLEMLTG 155
+ DV+S G +L E G
Sbjct: 211 ILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 39/144 (27%), Positives = 55/144 (38%), Gaps = 35/144 (24%)
Query: 31 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 90
Y+F ++ + F P K+A K + FLH + + D K NIL
Sbjct: 103 TYDF-----IKENGFL---PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILF 151
Query: 91 -DADYNA------------------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 131
+DY K+ DFG A E T VSTR Y APE +
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVI 206
Query: 132 MTGHLTSRSDVYSFGVVLLEMLTG 155
+ + DV+S G +L+E G
Sbjct: 207 LALGWSQPCDVWSIGCILIEYYLG 230
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 30/144 (20%), Positives = 57/144 (39%), Gaps = 20/144 (13%)
Query: 24 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 83
R +V E + L+ + ++ S +++ + L ++HE ++ D
Sbjct: 123 GRSYRFMVMERLGI-DLQ-KISGQNGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDI 177
Query: 84 KTSNILLDADYNAK--LSDFGLAKD-GPEGDKTHVSTRV----MGTYGYAAPEYVMTGHL 136
K +N+LL + L+D+GL+ P G+ GT + + + H
Sbjct: 178 KAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS----LDAHK 233
Query: 137 ----TSRSDVYSFGVVLLEMLTGR 156
+ RSDV G +L L G+
Sbjct: 234 GVALSRRSDVEILGYCMLRWLCGK 257
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 24/154 (15%)
Query: 17 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM--KIALGAAKGLAFLHEEA 74
+ + +E D +LV + + SLE LF S++ +A + F+H
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGP-SLE-DLFN-FCSRKLSLKTVLMLADQMINRVEFVHS-- 121
Query: 75 ERPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-GPEGDKTHVSTR----VMGTYGYA 126
+ ++RD K N L+ A + DFGLAK H+ R + GT YA
Sbjct: 122 -KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 127 APEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 156
+ + HL + R D+ S G VL+ L G
Sbjct: 181 S----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 26/101 (25%), Positives = 43/101 (42%), Gaps = 18/101 (17%)
Query: 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAKD-GPEGDKTHVSTR----V 119
L ++HE ++ D K SN+LL+ + L D+GLA PEG +
Sbjct: 165 LEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221
Query: 120 MGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 156
GT + + + H + R D+ G +++ LTG
Sbjct: 222 DGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 304 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.33 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.92 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.26 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.0 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.98 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.95 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.03 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.87 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.86 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.78 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.5 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.91 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.65 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 95.08 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 94.6 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.08 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.96 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.37 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 92.92 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.26 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 91.43 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.61 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 85.84 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 83.97 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=378.72 Aligned_cols=216 Identities=22% Similarity=0.282 Sum_probs=178.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++|+|||||++++++.+++.+|||||||+||+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+||
T Consensus 81 ~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~---IiHR 156 (311)
T 4aw0_A 81 RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG---IIHR 156 (311)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CccC
Confidence 69999999999999999999999999999999999999999997654 6999999999999999999999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||||+.+|.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|+|++|..||..
T Consensus 157 DlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 236 (311)
T 4aw0_A 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236 (311)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999987654444445567999999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hCCCCCCccCC
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKDMA 239 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~--l~~~~~~~~~~ 239 (304)
.+.. ............ + +...+.++.+||.+||+.||++|||++|++.+ +..++++++..
T Consensus 237 ~~~~------~~~~~i~~~~~~--------~----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 237 GNEG------LIFAKIIKLEYD--------F----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp SSHH------HHHHHHHHTCCC--------C----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred CCHH------HHHHHHHcCCCC--------C----CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 4221 111111111111 1 11235688999999999999999999997543 34455555543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=373.60 Aligned_cols=215 Identities=27% Similarity=0.465 Sum_probs=169.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++. ++.++||||||++|+|.+++......+++..+..|+.||+.||+|||+.+ ||||
T Consensus 81 ~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHR 156 (307)
T 3omv_A 81 NEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHR 156 (307)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCS
T ss_pred HHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCC
Confidence 6999999999999999999875 45789999999999999999877778999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc---CCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+||||+.++.+||+|||+|+..............+||+.|||||++.+ ..|+.++|||||||++|||+||+.|
T Consensus 157 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~P 236 (307)
T 3omv_A 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236 (307)
T ss_dssp CCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCC
Confidence 9999999999999999999999987654333334455789999999999974 4699999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
|....... .... ..... ...|.. ...+..++.++.+||.+||+.||++|||+.||+++|+.+
T Consensus 237 f~~~~~~~---~~~~---~~~~~-----~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 237 YSHINNRD---QIIF---MVGRG-----YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TTTCCCHH---HHHH---HHHTT-----CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCCCChHH---HHHH---HHhcC-----CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 97543211 1111 11110 111111 112223467899999999999999999999999988643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-55 Score=382.25 Aligned_cols=205 Identities=22% Similarity=0.378 Sum_probs=171.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|++|+|||||++++++.+++.+|||||||+||+|.++|..+ ...+++..++.|+.||+.||+|||+++ |+|
T Consensus 72 ~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiH 148 (350)
T 4b9d_A 72 REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILH 148 (350)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEE
T ss_pred HHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 7999999999999999999999999999999999999999999654 456899999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||||+.+|.+||+|||+|+..... .......+||+.|||||++.+..|+.++|||||||++|||+||+.||.
T Consensus 149 RDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~ 226 (350)
T 4b9d_A 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226 (350)
T ss_dssp TTCCGGGEEECTTCCEEECSTTEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCHHHEEECCCCCEEEcccccceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999999875421 122345689999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... +........ .+ +.. +...+.++.+||.+||+.||++|||++|++++
T Consensus 227 ~~~~~------~~~~~i~~~--~~-----~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 227 AGSMK------NLVLKIISG--SF-----PPV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CSSHH------HHHHHHHHT--CC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CcCHH------HHHHHHHcC--CC-----CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 54321 111111100 00 111 11235789999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=376.26 Aligned_cols=211 Identities=24% Similarity=0.237 Sum_probs=172.8
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++|+|||||++++++.+++.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||+++ |||
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~---IiH 173 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRR---ILH 173 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT---EEC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 379999999999999999999999999999999999999999997654 6999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCC-cEEEccccCcccCCCCCc---ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCC
Q 022003 81 RDFKTSNILLDADY-NAKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 81 ~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 156 (304)
|||||+||||+.+| .+||+|||+|+....... .......+||+.|||||++.+..|+.++|||||||++|||+||.
T Consensus 174 RDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~ 253 (336)
T 4g3f_A 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253 (336)
T ss_dssp SCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCc
Confidence 99999999999987 699999999987654321 11233468999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
.||...........+. .....+. ..+...+.++.+||.+||+.||++|||+.|++++|.
T Consensus 254 ~Pf~~~~~~~~~~~i~------~~~~~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 254 HPWTQYFRGPLCLKIA------SEPPPIR---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp CSSTTTCCSCCHHHHH------HSCCGGG---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHH------cCCCCch---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 9997654433211110 0111111 112233578999999999999999999999998874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=375.14 Aligned_cols=214 Identities=26% Similarity=0.392 Sum_probs=178.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKG 66 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~ 66 (304)
+|+++|++|+|||||+++|+|.+++.++||||||++|+|.++|..+. ..+++..+..++.||+.|
T Consensus 78 ~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 157 (308)
T 4gt4_A 78 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 157 (308)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHH
Confidence 69999999999999999999999999999999999999999996532 358999999999999999
Q ss_pred HHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHH
Q 022003 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 146 (304)
Q Consensus 67 l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 146 (304)
|+|||+.+ ||||||||+||||+.++.+||+|||+++...............||+.|||||++.+..|+.++||||||
T Consensus 158 l~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfG 234 (308)
T 4gt4_A 158 MEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 234 (308)
T ss_dssp HHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHH
Confidence 99999988 999999999999999999999999999876443333334456799999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 147 VVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 147 ~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
|++|||+| |..||...... .+..... .... +. .+..++..+.+||.+||+.||++|||+.||
T Consensus 235 vvl~El~t~g~~Pf~~~~~~---~~~~~i~----~~~~------~~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei 297 (308)
T 4gt4_A 235 VVLWEVFSYGLQPYCGYSNQ---DVVEMIR----NRQV------LP----CPDDCPAWVYALMIECWNEFPSRRPRFKDI 297 (308)
T ss_dssp HHHHHHHTTTCCTTTTCCHH---HHHHHHH----TTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCCC------CC----CcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999998 89999765321 1111111 1110 01 122346789999999999999999999999
Q ss_pred HHHhCCCCCC
Q 022003 226 VEALKPLPNL 235 (304)
Q Consensus 226 l~~l~~~~~~ 235 (304)
++.|+.+.++
T Consensus 298 ~~~L~a~~nl 307 (308)
T 4gt4_A 298 HSRLRAWGNL 307 (308)
T ss_dssp HHHHHTSCC-
T ss_pred HHHHHhccCC
Confidence 9999876553
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=375.70 Aligned_cols=205 Identities=26% Similarity=0.389 Sum_probs=171.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++|+|||||++++++.+++.+|||||||+||+|.+++.+. .+++..++.++.||+.||+|||+++ |+||
T Consensus 120 ~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHR 194 (346)
T 4fih_A 120 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHR 194 (346)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 7999999999999999999999999999999999999999998653 5999999999999999999999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||||+.+|.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|..||..
T Consensus 195 DlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 195 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999987654322 23457899999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... ....... ...+... .....+.++.+||.+||+.||++|||++|+++|
T Consensus 273 ~~~~~---~~~~i~~----------~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 273 EPPLK---AMKMIRD----------NLPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCHHH---HHHHHHH----------SSCCCCS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCHHH---HHHHHHc----------CCCCCCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 43211 1111110 0011110 111235789999999999999999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=374.54 Aligned_cols=211 Identities=29% Similarity=0.473 Sum_probs=176.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR------------SLPLPWSIRMKIALGAAKGLAF 69 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------------~~~l~~~~~~~i~~qi~~~l~~ 69 (304)
+|+++|++|+|||||+++++|.+++.+|||||||++|+|.++|.+. ...+++..+..++.||+.||+|
T Consensus 64 ~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y 143 (299)
T 4asz_A 64 REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVY 143 (299)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 7999999999999999999999999999999999999999999653 2469999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHH
Q 022003 70 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 149 (304)
Q Consensus 70 LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 149 (304)
||+++ |+||||||+||||+.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++
T Consensus 144 LH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl 220 (299)
T 4asz_A 144 LASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 220 (299)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence 99988 999999999999999999999999999876544333334446789999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 150 LEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 150 ~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|||+| |+.||...... .+..... .... +. .+..++.++.+||.+||+.||++|||++|+++.
T Consensus 221 ~Ellt~G~~Pf~~~~~~---~~~~~i~----~~~~------~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~ 283 (299)
T 4asz_A 221 WEIFTYGKQPWYQLSNN---EVIECIT----QGRV------LQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTL 283 (299)
T ss_dssp HHHHTTTCCTTTTSCHH---HHHHHHH----HTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCCCCHH---HHHHHHH----cCCC------CC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99998 89999764321 1111111 1000 11 122345789999999999999999999999988
Q ss_pred hCCC
Q 022003 229 LKPL 232 (304)
Q Consensus 229 l~~~ 232 (304)
|+.+
T Consensus 284 L~~~ 287 (299)
T 4asz_A 284 LQNL 287 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-54 Score=374.95 Aligned_cols=211 Identities=27% Similarity=0.451 Sum_probs=167.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAKGL 67 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~l 67 (304)
+|+++|++|+|||||+++++|.+++.+|||||||++|+|.+++.+.. .++++.++..|+.||+.||
T Consensus 92 ~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl 171 (329)
T 4aoj_A 92 REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171 (329)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHH
Confidence 79999999999999999999999999999999999999999996532 3599999999999999999
Q ss_pred HHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHH
Q 022003 68 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 147 (304)
Q Consensus 68 ~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 147 (304)
+|||+.+ ||||||||+||||+.++.+||+|||+++...............||+.|||||++.+..|+.++|||||||
T Consensus 172 ~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gv 248 (329)
T 4aoj_A 172 VYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248 (329)
T ss_dssp HHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred HHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHH
Confidence 9999988 9999999999999999999999999998765444444445567999999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 022003 148 VLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226 (304)
Q Consensus 148 il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 226 (304)
++|||+| |+.||...... ....... ... + +. .+..++.++.+||.+||+.||++|||++||+
T Consensus 249 vl~Ellt~G~~Pf~~~~~~---~~~~~i~----~g~---~---~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 311 (329)
T 4aoj_A 249 VLWEIFTYGKQPWYQLSNT---EAIDCIT----QGR---E---LE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVH 311 (329)
T ss_dssp HHHHHHTTSCCTTCSSCHH---HHHHHHH----HTC---C---CC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred HHHHHHcCCCCCCCCCCHH---HHHHHHH----cCC---C---CC----CcccccHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 9999999 89999754321 1111111 111 0 11 1223457899999999999999999999999
Q ss_pred HHhCCC
Q 022003 227 EALKPL 232 (304)
Q Consensus 227 ~~l~~~ 232 (304)
++|+.+
T Consensus 312 ~~L~~l 317 (329)
T 4aoj_A 312 ARLQAL 317 (329)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=364.55 Aligned_cols=206 Identities=24% Similarity=0.369 Sum_probs=165.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEe----CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|+++|++|+|||||++++++.+ ++.+|||||||+||+|.+++.+. ..+++..+..|+.||+.||+|||+++ .+
T Consensus 74 ~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~-~~ 151 (290)
T 3fpq_A 74 EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PP 151 (290)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SC
T ss_pred HHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-CC
Confidence 69999999999999999999875 34689999999999999999654 47999999999999999999999976 45
Q ss_pred eEeccCCCCCeEEC-CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCC
Q 022003 78 VIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 78 iiH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 156 (304)
|+||||||+||||+ .+|.+||+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+
T Consensus 152 IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~ 226 (290)
T 3fpq_A 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 226 (290)
T ss_dssp CCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCC
Confidence 99999999999997 4799999999999864322 2345689999999998865 6999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.||...... ..+.... ..... .+.. +...++++.+||.+||+.||++|||++|+++|.
T Consensus 227 ~Pf~~~~~~--~~~~~~i----~~~~~-----~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp 284 (290)
T 3fpq_A 227 YPYSECQNA--AQIYRRV----TSGVK-----PASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp CTTTTCSSH--HHHHHHH----TTTCC-----CGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCCCCCCcH--HHHHHHH----HcCCC-----CCCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 999653221 1111100 00000 0011 111245789999999999999999999999853
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=378.96 Aligned_cols=205 Identities=26% Similarity=0.389 Sum_probs=171.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++|+|||||++++++.+++.+|||||||+||+|.+++... .+++..+..++.||+.||+|||+++ ||||
T Consensus 197 ~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~---IiHR 271 (423)
T 4fie_A 197 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHR 271 (423)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 7999999999999999999999999999999999999999998653 5999999999999999999999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||||+.+|.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+
T Consensus 272 DiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 272 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp CCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999987654322 23457899999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... ....... ...+... .....+.++.+||.+||+.||++|||++|+++|
T Consensus 350 ~~~~~---~~~~i~~----------~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 350 EPPLK---AMKMIRD----------NLPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCHHH---HHHHHHH----------SCCCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCHHH---HHHHHHc----------CCCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 43211 1111110 0011111 011235789999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=356.91 Aligned_cols=202 Identities=25% Similarity=0.338 Sum_probs=160.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+++.+|+||||| +|+|.+++.+++ .+++..+..++.||+.||+|||+++ |+||
T Consensus 62 ~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~---IiHR 136 (275)
T 3hyh_A 62 REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHK---IVHR 136 (275)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 6999999999999999999999999999999999 789999997654 7999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||++.++.+||+|||+|+...... .....+||+.|||||++.+..| +.++|||||||++|+|+||+.||.
T Consensus 137 DiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~ 213 (275)
T 3hyh_A 137 DLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213 (275)
T ss_dssp CCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999998754322 2345789999999999998876 589999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.... ............ .+ +...+.++.+||.+||+.||++|||++|+++|-
T Consensus 214 ~~~~------~~~~~~i~~~~~--------~~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 214 DESI------PVLFKNISNGVY--------TL----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp CSSH------HHHHHHHHHTCC--------CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred CCCH------HHHHHHHHcCCC--------CC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 5321 111111111111 11 112356889999999999999999999999853
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=365.58 Aligned_cols=203 Identities=29% Similarity=0.352 Sum_probs=165.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+++.+|||||||+||+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||
T Consensus 75 ~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~---IiHR 150 (304)
T 3ubd_A 75 MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLG---IIYR 150 (304)
T ss_dssp ---CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCC
Confidence 69999999999999999999999999999999999999999996654 7999999999999999999999999 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.+|.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||..
T Consensus 151 DlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~ 228 (304)
T 3ubd_A 151 DLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228 (304)
T ss_dssp SCCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987543222 23457899999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~~ 228 (304)
.+.. +........... ++...+.++.+||.+||+.||++|||+ +|+++|
T Consensus 229 ~~~~------~~~~~i~~~~~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 229 KDRK------ETMTMILKAKLG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp SSHH------HHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred cCHH------HHHHHHHcCCCC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 4321 111111111111 111235789999999999999999985 566653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=365.82 Aligned_cols=213 Identities=29% Similarity=0.404 Sum_probs=174.8
Q ss_pred ChHhhHhhcCCC-CcccceeeEEEeC-CeeEEEEecCCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHH
Q 022003 1 MAEVNFLGDLVH-LNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGA 63 (304)
Q Consensus 1 l~E~~il~~l~h-~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi 63 (304)
++|+++|++++| ||||+++++|.+. +.++||||||++|+|.++|... ...+++..+..++.||
T Consensus 115 ~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 194 (353)
T 4ase_A 115 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 194 (353)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHH
Confidence 369999999976 8999999999764 5689999999999999999643 2348999999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhH
Q 022003 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 143 (304)
Q Consensus 64 ~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 143 (304)
+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||
T Consensus 195 a~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVw 271 (353)
T 4ase_A 195 AKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 271 (353)
T ss_dssp HHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEe
Confidence 99999999988 999999999999999999999999999977554444445567899999999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 144 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 144 slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
||||++|||+| |..||....... .+.... .... .+.. +..++.++.++|.+||+.||++|||+
T Consensus 272 S~Gv~l~El~t~G~~Pf~~~~~~~--~~~~~i----~~g~------~~~~----p~~~~~~~~~li~~c~~~dP~~RPt~ 335 (353)
T 4ase_A 272 SFGVLLWEIFSLGASPYPGVKIDE--EFCRRL----KEGT------RMRA----PDYTTPEMYQTMLDCWHGEPSQRPTF 335 (353)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSH--HHHHHH----HHTC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ehHHHHHHHHhCCCCCCCCCCHHH--HHHHHH----HcCC------CCCC----CccCCHHHHHHHHHHcCcChhHCcCH
Confidence 99999999998 899997653221 111111 1111 1111 12235789999999999999999999
Q ss_pred HHHHHHhCCC
Q 022003 223 SEVVEALKPL 232 (304)
Q Consensus 223 ~ell~~l~~~ 232 (304)
.||+++|+.+
T Consensus 336 ~eil~~L~~l 345 (353)
T 4ase_A 336 SELVEHLGNL 345 (353)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=345.92 Aligned_cols=222 Identities=25% Similarity=0.310 Sum_probs=167.0
Q ss_pred HhhHhhcCCCCcccceeeEEEeCC----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC----
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA---- 74 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---- 74 (304)
|+.++.+++|||||++++++.+++ .+|||||||++|+|.+++.+. .+++..+..++.|++.||+|||++.
T Consensus 47 Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~ 124 (303)
T 3hmm_A 47 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124 (303)
T ss_dssp HHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred HHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhcc
Confidence 666778899999999999998764 579999999999999999764 5899999999999999999999871
Q ss_pred -CCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcc--eeeecccccccccCcchhhcC------CCCchhhhHHH
Q 022003 75 -ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSF 145 (304)
Q Consensus 75 -~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Diwsl 145 (304)
..+|+||||||+||||+.++.+||+|||+++........ ......+||+.|||||++.+. .|+.++|||||
T Consensus 125 ~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~ 204 (303)
T 3hmm_A 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp CBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred CCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence 123999999999999999999999999999876443322 122346799999999999754 46789999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCc---------chhHhhhhhhccccccccccCCccCCC-CCHHHHHHHHHHHHHhccCC
Q 022003 146 GVVLLEMLTGRRSMDKNRPNGEH---------NLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRD 215 (304)
Q Consensus 146 G~il~el~tg~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~d 215 (304)
||++|||+||.+||......... .......... ....+|.+... .....+..+.+|+.+||+.|
T Consensus 205 Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~------~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~d 278 (303)
T 3hmm_A 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT------TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSS
T ss_pred HHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHh------cccCCCCCCccccchHHHHHHHHHHHHHcccC
Confidence 99999999998887543322111 0111111000 01122222211 12345678999999999999
Q ss_pred CCCCCCHHHHHHHhCCC
Q 022003 216 PKARPLMSEVVEALKPL 232 (304)
Q Consensus 216 p~~Rps~~ell~~l~~~ 232 (304)
|++|||+.||++.|+.+
T Consensus 279 P~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 279 GAARLTALRIKKTLSQL 295 (303)
T ss_dssp GGGSCCHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHH
Confidence 99999999999988654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=346.00 Aligned_cols=206 Identities=24% Similarity=0.386 Sum_probs=154.3
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCC------------eeEEEEecCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHH
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDD------------QRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKG 66 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~------------~~~lv~e~~~~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~~ 66 (304)
++|+++|++|+|||||++++++.+.+ .+|+|||||+||+|.+++..+.. ..++..++.++.||++|
T Consensus 51 ~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~a 130 (299)
T 4g31_A 51 MREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130 (299)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHH
Confidence 37999999999999999999987654 36999999999999999976532 35667789999999999
Q ss_pred HHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcc----------eeeecccccccccCcchhhcCCC
Q 022003 67 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT----------HVSTRVMGTYGYAAPEYVMTGHL 136 (304)
Q Consensus 67 l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~ 136 (304)
|+|||+++ |+||||||+||||+.+|.+||+|||+|+........ ......+||+.|||||++.+..|
T Consensus 131 l~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y 207 (299)
T 4g31_A 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY 207 (299)
T ss_dssp HHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCC
T ss_pred HHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC
Confidence 99999998 999999999999999999999999999876543211 11234679999999999999999
Q ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCC
Q 022003 137 TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 216 (304)
Q Consensus 137 ~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 216 (304)
+.++|||||||++|||++ ||.... ........ .. ...+ |. .....++.+.+||.+||+.||
T Consensus 208 ~~~~DiwSlGvilyell~---Pf~~~~-----~~~~~~~~-~~-~~~~-----p~----~~~~~~~~~~~li~~~L~~dP 268 (299)
T 4g31_A 208 SHKVDIFSLGLILFELLY---PFSTQM-----ERVRTLTD-VR-NLKF-----PP----LFTQKYPCEYVMVQDMLSPSP 268 (299)
T ss_dssp CTHHHHHHHHHHHHHHHS---CCSSHH-----HHHHHHHH-HH-TTCC-----CH----HHHHHCHHHHHHHHHHTCSSG
T ss_pred CCHHHHHHHHHHHHHHcc---CCCCcc-----HHHHHHHH-Hh-cCCC-----CC----CCcccCHHHHHHHHHHcCCCh
Confidence 999999999999999996 564210 00000000 00 0000 00 111234567899999999999
Q ss_pred CCCCCHHHHHHH
Q 022003 217 KARPLMSEVVEA 228 (304)
Q Consensus 217 ~~Rps~~ell~~ 228 (304)
++|||+.|++++
T Consensus 269 ~~Rps~~eil~h 280 (299)
T 4g31_A 269 MERPEAINIIEN 280 (299)
T ss_dssp GGSCCHHHHHTS
T ss_pred hHCcCHHHHhcC
Confidence 999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=346.01 Aligned_cols=224 Identities=22% Similarity=0.306 Sum_probs=166.8
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeC------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
++|+++|++|+|||||++++++... +.+|||||||. |+|.+++.++ ..+++..++.++.||+.||+|||+++
T Consensus 101 ~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~ 178 (398)
T 4b99_A 101 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ 178 (398)
T ss_dssp HHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 3799999999999999999987643 57899999995 6899998654 47999999999999999999999999
Q ss_pred CCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCC--cceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHH
Q 022003 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLE 151 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~e 151 (304)
|+||||||+|||++.+|.+||+|||+|+.+.... ........+||+.|||||++.+. .|+.++||||+||++||
T Consensus 179 ---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~e 255 (398)
T 4b99_A 179 ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGE 255 (398)
T ss_dssp ---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred ---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHH
Confidence 9999999999999999999999999998764321 12223457899999999998875 57999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhHhhhhhhc----------cccccccccCCccCCC---CCHHHHHHHHHHHHHhccCCCCC
Q 022003 152 MLTGRRSMDKNRPNGEHNLVEWARPHLG----------ERRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKA 218 (304)
Q Consensus 152 l~tg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~ 218 (304)
|++|++||.+.+.......+........ ....+...+.+..... .....+.++.+||.+||+.||++
T Consensus 256 ll~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 335 (398)
T 4b99_A 256 MLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSA 335 (398)
T ss_dssp HHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTT
T ss_pred HHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhH
Confidence 9999999976533221111100000000 0000000000000000 00112468899999999999999
Q ss_pred CCCHHHHHHHh
Q 022003 219 RPLMSEVVEAL 229 (304)
Q Consensus 219 Rps~~ell~~l 229 (304)
|||++|+++|-
T Consensus 336 R~ta~e~L~Hp 346 (398)
T 4b99_A 336 RISAAAALRHP 346 (398)
T ss_dssp SCCHHHHTTSG
T ss_pred CcCHHHHhcCH
Confidence 99999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=338.85 Aligned_cols=154 Identities=26% Similarity=0.350 Sum_probs=134.7
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|+.+ +|||||++++++.+++++|+|||||+||+|.+++. .+++.+++.++.||+.||+|||++| |+|
T Consensus 68 ~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiH 140 (361)
T 4f9c_A 68 AELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVH 140 (361)
T ss_dssp HHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEe
Confidence 699999998 69999999999999999999999999999999983 4899999999999999999999999 999
Q ss_pred ccCCCCCeEECCC-CcEEEccccCcccCCCCCcc--------------------------eeeecccccccccCcchhhc
Q 022003 81 RDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKT--------------------------HVSTRVMGTYGYAAPEYVMT 133 (304)
Q Consensus 81 ~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~ 133 (304)
|||||+|||++.+ +.+||+|||+|+........ ......+||++|+|||++.+
T Consensus 141 RDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 220 (361)
T 4f9c_A 141 RDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK 220 (361)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT
T ss_pred CcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence 9999999999876 89999999999865432110 11223579999999999987
Q ss_pred C-CCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 022003 134 G-HLTSRSDVYSFGVVLLEMLTGRRSMDKN 162 (304)
Q Consensus 134 ~-~~~~~~DiwslG~il~el~tg~~p~~~~ 162 (304)
. .|+.++||||+||++|||++|+.||...
T Consensus 221 ~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 221 CPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 5 5899999999999999999999999654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=361.27 Aligned_cols=209 Identities=22% Similarity=0.288 Sum_probs=173.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|+.|+|||||++++++.+++.+|||||||+||+|.++|.++...+++..+..++.||+.||+|||+++ |+||
T Consensus 203 ~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHR 279 (573)
T 3uto_A 203 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHL 279 (573)
T ss_dssp HHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 6999999999999999999999999999999999999999999777678999999999999999999999998 9999
Q ss_pred cCCCCCeEECCC--CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 82 DFKTSNILLDAD--YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||||+|||++.+ +.+||+|||+++...... .....+||+.|||||++.+..|+.++|||||||++|+|++|..||
T Consensus 280 DlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf 356 (573)
T 3uto_A 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356 (573)
T ss_dssp CCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred cCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999754 899999999999875433 234468999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
....... .... .......+ .... ....+.++.+||.+||+.||.+|||+.|+++|-.
T Consensus 357 ~~~~~~~---~~~~---i~~~~~~~----~~~~----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 357 GGENDDE---TLRN---VKSCDWNM----DDSA----FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp CCSSHHH---HHHH---HHTTCCCC----CSGG----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCcCHHH---HHHH---HHhCCCCC----Cccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 7643211 1110 00000000 0111 1122568899999999999999999999999743
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=355.71 Aligned_cols=204 Identities=26% Similarity=0.320 Sum_probs=167.8
Q ss_pred HhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 82 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d 82 (304)
++++++.++|||||+++++|.+.+.+|||||||+||+|.++|.+.+ .+++..++.++.||+.||+|||+++ |||||
T Consensus 242 ~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRD 317 (689)
T 3v5w_A 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRF---VVYRD 317 (689)
T ss_dssp HHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 4667788899999999999999999999999999999999997654 6999999999999999999999999 99999
Q ss_pred CCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-cCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 83 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 83 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
|||+||||+.+|.+||+|||+|+...... ....+||+.|||||++. +..|+.++|||||||++|||++|.+||..
T Consensus 318 LKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 318 LKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred CchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998765432 34568999999999996 46899999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~~l 229 (304)
....... .......... .. ++...+.++.+||.+||+.||++|++ ++||++|.
T Consensus 394 ~~~~~~~---~i~~~i~~~~--------~~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 394 HKTKDKH---EIDRMTLTMA--------VE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp GGCCCHH---HHHHHHHHCC--------CC----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred CChHHHH---HHHHhhcCCC--------CC----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 4332211 1111111111 11 11223578999999999999999997 67877653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=317.23 Aligned_cols=227 Identities=40% Similarity=0.730 Sum_probs=192.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |
T Consensus 84 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i 160 (321)
T 2qkw_B 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---I 160 (321)
T ss_dssp HHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---e
Confidence 68999999999999999999999999999999999999999986543 35899999999999999999999988 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+||||||+||+++.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 161 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p 240 (321)
T 2qkw_B 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240 (321)
T ss_dssp ECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTT
T ss_pred ecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCc
Confidence 99999999999999999999999999875443333333445689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
|.............|..... ....+...+++..........+..+.+++.+||+.||++|||+.|++++|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 241 IVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CSCSSSSSCCCHHHHTHHHH-TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCcHHHHHHHHHhhhcc-ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 98776655555555443222 22334455566666667788899999999999999999999999999998744
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=321.16 Aligned_cols=211 Identities=25% Similarity=0.404 Sum_probs=174.2
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~ 65 (304)
+|+++|+++ +||||+++++++...+.+|+||||+++|+|.+++.... ..+++..++.++.||+.
T Consensus 135 ~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 214 (370)
T 2psq_A 135 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 214 (370)
T ss_dssp HHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHH
Confidence 699999999 89999999999999999999999999999999997643 35899999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||+|||+.+ |+||||||+||||+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||
T Consensus 215 aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl 291 (370)
T 2psq_A 215 GMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291 (370)
T ss_dssp HHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred HHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHH
Confidence 999999998 99999999999999999999999999987654433333334567889999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|||++ |..||....... ...... .. ..+. .+..++..+.++|.+||+.||.+|||+.|
T Consensus 292 G~il~ellt~g~~p~~~~~~~~---~~~~~~----~~------~~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~e 354 (370)
T 2psq_A 292 GVLMWEIFTLGGSPYPGIPVEE---LFKLLK----EG------HRMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQ 354 (370)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGG---HHHHHH----TT------CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHcCCCCCCCCCCHHH---HHHHHh----cC------CCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999999 999997643211 111110 00 0011 12233568999999999999999999999
Q ss_pred HHHHhCCC
Q 022003 225 VVEALKPL 232 (304)
Q Consensus 225 ll~~l~~~ 232 (304)
+++.|+.+
T Consensus 355 ll~~L~~i 362 (370)
T 2psq_A 355 LVEDLDRI 362 (370)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=309.28 Aligned_cols=227 Identities=41% Similarity=0.728 Sum_probs=188.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhcC---CC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEE---AE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~---~~ 75 (304)
+|++++++++||||+++++++...+..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+. +
T Consensus 76 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~- 154 (326)
T 3uim_A 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK- 154 (326)
T ss_dssp HHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC-
T ss_pred HHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-
Confidence 68999999999999999999999999999999999999999997643 3499999999999999999999998 7
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
|+||||||+|||++.++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 155 --ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (326)
T 3uim_A 155 --IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231 (326)
T ss_dssp --EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred --eEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence 99999999999999999999999999987654322 223445699999999999999999999999999999999999
Q ss_pred CCCCCCCC--CCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 156 RRSMDKNR--PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 156 ~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
..||.... .........|...... ........+......+....+..+.+++.+||+.||.+|||+.|++++|+...
T Consensus 232 ~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 232 QRAFDLARLANDDDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp CCSBCHHHHTTTSCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred CCcccccccccccchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 99996321 1122233333332222 23334555666666778888999999999999999999999999999998643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=311.78 Aligned_cols=227 Identities=27% Similarity=0.349 Sum_probs=173.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC----
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE---- 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---- 73 (304)
+|+.++++++|||||++++++.... .+++||||+++|+|.+++... .+++..++.++.|++.||+|||+.
T Consensus 67 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l 144 (322)
T 3soc_A 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGL 144 (322)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEE
T ss_pred HHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 4888999999999999999998754 469999999999999999664 499999999999999999999998
Q ss_pred ------CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-----CCCCchhhh
Q 022003 74 ------AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDV 142 (304)
Q Consensus 74 ------~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di 142 (304)
+ |+||||||+|||++.++.+||+|||+++...............||..|+|||++.+ ..++.++||
T Consensus 145 ~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di 221 (322)
T 3soc_A 145 KDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221 (322)
T ss_dssp TTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHH
T ss_pred ccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchh
Confidence 7 99999999999999999999999999987654433333344678999999999986 355678999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhc--cc--cccccccCCccCCC-CCHHHHHHHHHHHHHhccCCCC
Q 022003 143 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--ER--RRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 143 wslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~ 217 (304)
|||||++|||++|..||.................... .. ........+..... .....+..+.+||.+||+.||+
T Consensus 222 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 301 (322)
T 3soc_A 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301 (322)
T ss_dssp HHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChh
Confidence 9999999999999999987554332222111000000 00 00000111111111 1224567799999999999999
Q ss_pred CCCCHHHHHHHhCCCC
Q 022003 218 ARPLMSEVVEALKPLP 233 (304)
Q Consensus 218 ~Rps~~ell~~l~~~~ 233 (304)
+|||+.|+++.|+.+.
T Consensus 302 ~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 302 ARLSAGCVGERITQMQ 317 (322)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=306.39 Aligned_cols=214 Identities=26% Similarity=0.390 Sum_probs=174.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+++..++||||+++++|.+++......+++..+..++.||+.||+|||+.+ |+||
T Consensus 56 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~ 132 (310)
T 3s95_A 56 KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHR 132 (310)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCC
Confidence 6999999999999999999999999999999999999999999887778999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcce------------eeecccccccccCcchhhcCCCCchhhhHHHHHHH
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH------------VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 149 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 149 (304)
||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++
T Consensus 133 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 212 (310)
T 3s95_A 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVL 212 (310)
T ss_dssp CCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHH
Confidence 999999999999999999999998764332211 11145799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 150 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 150 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|+|++|..||................ . ...... ..++..+.+++.+||+.||++|||+.++++.|
T Consensus 213 ~el~~g~~~~~~~~~~~~~~~~~~~~-~------~~~~~~--------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 213 CEIIGRVNADPDYLPRTMDFGLNVRG-F------LDRYCP--------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp HHHHHTCCSSTTTSCBCTTSSBCHHH-H------HHHTCC--------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCCCCCcchhhhHHHHhhhhhc-c------ccccCC--------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99999999987654332211110000 0 000011 12235788999999999999999999999988
Q ss_pred CCCC
Q 022003 230 KPLP 233 (304)
Q Consensus 230 ~~~~ 233 (304)
+.+.
T Consensus 278 ~~l~ 281 (310)
T 3s95_A 278 ETLR 281 (310)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=306.77 Aligned_cols=206 Identities=23% Similarity=0.323 Sum_probs=170.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++...+..++||||+.+++|.+++.+. .+++..++.++.|++.||+|||+.+ |+||
T Consensus 66 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 140 (297)
T 3fxz_A 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHR 140 (297)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeC
Confidence 6899999999999999999999999999999999999999999764 5999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 141 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654322 23346799999999999999999999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
...... . .. ..... ..... .+...+..+.+||.+||+.||++|||++|++++.
T Consensus 219 ~~~~~~---~--~~-~~~~~--~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 219 ENPLRA---L--YL-IATNG--TPELQ-------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp SCHHHH---H--HH-HHHHC--SCCCS-------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCHHHH---H--HH-HHhCC--CCCCC-------CccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 432110 0 00 00000 00000 1112356889999999999999999999999853
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=311.16 Aligned_cols=209 Identities=26% Similarity=0.396 Sum_probs=170.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++||||+++++++.+++..++|||||++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||
T Consensus 54 ~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~ 129 (323)
T 3tki_A 54 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHR 129 (323)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 6899999999999999999999999999999999999999998554 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||++.++.+||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 130 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 209 (323)
T 3tki_A 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209 (323)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred ccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987543333333445679999999999988775 789999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
....... ....+... . ....+ ....+..+.+||.+||+.||++|||++|++++.
T Consensus 210 ~~~~~~~-~~~~~~~~-----~---~~~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 210 QPSDSCQ-EYSDWKEK-----K---TYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp SSCTTSH-HHHHHHTT-----C---TTSTT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CCchHHH-HHHHHhcc-----c---ccCCc------cccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 6433211 11111110 0 00000 012246788999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=312.75 Aligned_cols=203 Identities=25% Similarity=0.372 Sum_probs=169.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|+.++||||+++++++...+..|+||||+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+||
T Consensus 63 ~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~---ivHr 138 (328)
T 3fe3_A 63 REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKR---IVHR 138 (328)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---Eecc
Confidence 69999999999999999999999999999999999999999986653 6999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCC-chhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||++.++.+||+|||++........ ....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.
T Consensus 139 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 215 (328)
T 3fe3_A 139 DLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215 (328)
T ss_dssp CCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHEEEcCCCCEEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987644322 3446799999999999988775 79999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..... ............ .+...+.++.+||.+||+.||.+|||++|++++.
T Consensus 216 ~~~~~------~~~~~i~~~~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 216 GQNLK------ELRERVLRGKYR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp CSSHH------HHHHHHHHCCCC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred CCCHH------HHHHHHHhCCCC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 54321 111111111000 1112356889999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=312.19 Aligned_cols=211 Identities=26% Similarity=0.414 Sum_probs=171.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+++..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||
T Consensus 99 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 175 (325)
T 3kul_A 99 SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHR 175 (325)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCC
Confidence 6999999999999999999999999999999999999999999777678999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCc-ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||+|||++.++.+||+|||+++....... ........+|..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 176 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~ 255 (325)
T 3kul_A 176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255 (325)
T ss_dssp CCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999999987654322 122233456788999999999999999999999999999999 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
....... ...... .. .... .+...+..+.+||.+||+.||++|||+.++++.|+.+
T Consensus 256 ~~~~~~~---~~~~~~----~~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 256 WNMTNRD---VISSVE----EG------YRLP----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp TTSCHHH---HHHHHH----TT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHH---HHHHHH----cC------CCCC----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 6542211 111000 00 0011 1123357899999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=320.74 Aligned_cols=212 Identities=25% Similarity=0.422 Sum_probs=172.8
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++++||||+++++++...+..++||||+++|+|.+++......+++..+..++.||+.||+|||+.+ |+|
T Consensus 160 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH 236 (377)
T 3cbl_A 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIH 236 (377)
T ss_dssp THHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCC
Confidence 47999999999999999999999999999999999999999999776667999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 237 rDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~ 316 (377)
T 3cbl_A 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316 (377)
T ss_dssp SCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987543221111122345778999999998999999999999999999998 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
...... ....... ... .. . .+..++..+.+||.+||+.||++|||++++++.|+.+
T Consensus 317 ~~~~~~---~~~~~~~----~~~---~~---~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 317 PNLSNQ---QTREFVE----KGG---RL---P----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp TTSCHH---HHHHHHH----TTC---CC---C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHH---HHHHHHH----cCC---CC---C----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 754321 1111110 000 00 0 1112356889999999999999999999999988643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=306.01 Aligned_cols=209 Identities=18% Similarity=0.259 Sum_probs=172.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|+.++||||+++++++.+.+..++|||||+|++|.+++......+++..++.++.||+.||.|||+.+ |+||
T Consensus 50 ~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~ 126 (321)
T 1tki_A 50 KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHF 126 (321)
T ss_dssp HHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcC
Confidence 6999999999999999999999999999999999999999999777668999999999999999999999998 9999
Q ss_pred cCCCCCeEECC--CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 82 DFKTSNILLDA--DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||||+|||++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 127 Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 203 (321)
T 1tki_A 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203 (321)
T ss_dssp CCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999987 78999999999988654332 33457899999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
...... ... .........+. ..... ..+.++.+||.+||+.||.+|||+.|++++..
T Consensus 204 ~~~~~~---~~~---~~i~~~~~~~~----~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 204 LAETNQ---QII---ENIMNAEYTFD----EEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp CCSSHH---HHH---HHHHHTCCCCC----HHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred cCCCHH---HHH---HHHHcCCCCCC----hhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 754221 111 11100000000 00000 12468899999999999999999999999653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=313.87 Aligned_cols=208 Identities=23% Similarity=0.323 Sum_probs=170.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++.+.+..++||||++|++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 64 ~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHr 139 (361)
T 2yab_A 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IAHF 139 (361)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 6999999999999999999999999999999999999999999654 47999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCC----cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 82 DFKTSNILLDADY----NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 82 dlkp~Nili~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
||||+|||++.++ .+||+|||++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 140 Dlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~ 216 (361)
T 2yab_A 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216 (361)
T ss_dssp CCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred CCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 9999999998776 799999999987654322 234679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
||....... .. .........+ ++... ...+..+.+||.+||..||.+|||+.|++++..
T Consensus 217 Pf~~~~~~~---~~---~~i~~~~~~~----~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 217 PFLGDTKQE---TL---ANITAVSYDF----DEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp SSCCSSHHH---HH---HHHHTTCCCC----CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CCCCCCHHH---HH---HHHHhcCCCC----Cchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 997542211 11 1000000000 00000 012467899999999999999999999998643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=310.57 Aligned_cols=212 Identities=26% Similarity=0.431 Sum_probs=171.7
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+.++++++||||+++++++. ++..++||||+.+++|.+++......+++..++.++.||+.||+|||+.+ |+|
T Consensus 63 ~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH 138 (325)
T 3kex_A 63 TDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVH 138 (325)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCC
Confidence 36899999999999999999886 55689999999999999999877667999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+|||++.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 139 ~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 218 (325)
T 3kex_A 139 RNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218 (325)
T ss_dssp SCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCc
Confidence 99999999999999999999999998765444444445677889999999999999999999999999999999 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
........ ...... .. ....+ ...+.++.++|.+||+.||.+|||+.+++++|+.+.
T Consensus 219 ~~~~~~~~---~~~~~~--~~-----~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 219 AGLRLAEV---PDLLEK--GE-----RLAQP-------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp TTSCTTHH---HHHHHT--TC-----BCCCC-------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred cccCHHHH---HHHHHc--CC-----CCCCC-------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 76543221 111110 00 00001 112346779999999999999999999999987553
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=311.59 Aligned_cols=210 Identities=21% Similarity=0.337 Sum_probs=171.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..+. .++|+||+.+|+|.+++.+....+++..++.++.||+.||.|||+.+ |+||
T Consensus 66 ~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~ 141 (327)
T 3poz_A 66 DEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHR 141 (327)
T ss_dssp HHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCC
Confidence 6999999999999999999998764 78899999999999999887778999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 142 Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp CCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 9999999999999999999999987655444333444567889999999999999999999999999999999 999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
...... ....... ... . ..+..++.++.+++.+||+.||.+|||+.|++++|+.+
T Consensus 222 ~~~~~~---~~~~~~~----~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 222 GIPASE---ISSILEK----GER------L----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp TCCGGG---HHHHHHT----TCC------C----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred CCCHHH---HHHHHHc----CCC------C----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 643321 1111110 000 0 01112346899999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=300.36 Aligned_cols=224 Identities=37% Similarity=0.625 Sum_probs=181.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++
T Consensus 79 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~ 155 (307)
T 2nru_A 79 QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HI 155 (307)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---ee
Confidence 6899999999999999999999999999999999999999998643 346999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||||||+||+++.++.+||+|||++................||..|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 156 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~ 234 (307)
T 2nru_A 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV 234 (307)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred cCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCc
Confidence 999999999999999999999999987654433333445678999999998865 5899999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
......... ..+..........+...+++.. .......+..+.+++.+||+.||.+|||+++++++|+.+
T Consensus 235 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 235 DEHREPQLL--LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp CTTBSSSBT--THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ccCcchHHH--HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 865433221 1111111111222223333333 234567788999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=318.72 Aligned_cols=212 Identities=26% Similarity=0.406 Sum_probs=175.5
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~ 65 (304)
+|+++++++ +||||+++++++..++..++||||+++++|.+++.... ..+++..++.++.||+.
T Consensus 123 ~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 202 (382)
T 3tt0_A 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 202 (382)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHH
Confidence 699999999 99999999999999999999999999999999997643 35999999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||+|||+.+ |+||||||+||||+.++.+||+|||+++...............+|..|+|||++.+..++.++|||||
T Consensus 203 aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 279 (382)
T 3tt0_A 203 GMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279 (382)
T ss_dssp HHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred HHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHH
Confidence 999999998 99999999999999999999999999987655433333444567889999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|+|++ |..||...... ....... ... ... .+...+.++.+||.+||+.||++|||++|
T Consensus 280 G~il~ellt~g~~p~~~~~~~---~~~~~~~----~~~------~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~e 342 (382)
T 3tt0_A 280 GVLLWEIFTLGGSPYPGVPVE---ELFKLLK----EGH------RMD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQ 342 (382)
T ss_dssp HHHHHHHHTTSCCSSTTCCHH---HHHHHHH----TTC------CCC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCC------CCC----CCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999999 99999754321 1111110 000 011 11123568999999999999999999999
Q ss_pred HHHHhCCCC
Q 022003 225 VVEALKPLP 233 (304)
Q Consensus 225 ll~~l~~~~ 233 (304)
++++|+.+.
T Consensus 343 ll~~L~~~~ 351 (382)
T 3tt0_A 343 LVEDLDRIV 351 (382)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999997654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=308.83 Aligned_cols=204 Identities=30% Similarity=0.365 Sum_probs=169.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|+.++||||+++++++.+.+..|+||||++||+|..++.+. ..+++..++.++.||+.||+|||+.+ |+||
T Consensus 54 ~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHr 129 (337)
T 1o6l_A 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYR 129 (337)
T ss_dssp HHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCC
T ss_pred HHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 6899999999999999999999999999999999999999998654 36999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 130 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence 9999999999999999999999986432221 23456799999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~l 229 (304)
.... ............ ++...+.++.+||.+||+.||++|| +++|+++|.
T Consensus 208 ~~~~------~~~~~i~~~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 208 QDHE------RLFELILMEEIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp SSHH------HHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CCHH------HHHHHHHcCCCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 4211 111111111111 1112356889999999999999999 899999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=300.90 Aligned_cols=224 Identities=23% Similarity=0.254 Sum_probs=175.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC--eeEEEEecCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|+++|++++||||+++++++...+ ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+
T Consensus 56 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--- 132 (319)
T 4euu_A 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132 (319)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 6999999999999999999998765 7799999999999999997643 33999999999999999999999998
Q ss_pred eEeccCCCCCeEE----CCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh--------cCCCCchhhhHHH
Q 022003 78 VIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TGHLTSRSDVYSF 145 (304)
Q Consensus 78 iiH~dlkp~Nili----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Diwsl 145 (304)
|+||||||+|||+ +.++.+||+|||+++....... .....||..|+|||++. +..++.++|||||
T Consensus 133 ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 209 (319)
T 4euu_A 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (319)
T ss_dssp EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHH
T ss_pred EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHH
Confidence 9999999999999 7888899999999987654332 23356899999999986 5788999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccc---ccc--------ccCCccCCCCCHHHHHHHHHHHHHhccC
Q 022003 146 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR---FYR--------LIDPRLEGHFSIKGAQKAAQLAAHCLSR 214 (304)
Q Consensus 146 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~ 214 (304)
||++|||++|..||........................ ... ..............+..+.++|.+||+.
T Consensus 210 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 289 (319)
T 4euu_A 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (319)
T ss_dssp HHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccC
Confidence 99999999999999754432221111111000000000 000 0011122345677889999999999999
Q ss_pred CCCCCCCHHHHHHHhCC
Q 022003 215 DPKARPLMSEVVEALKP 231 (304)
Q Consensus 215 dp~~Rps~~ell~~l~~ 231 (304)
||++|||++|++++...
T Consensus 290 dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 290 DQEKCWGFDQFFAETSD 306 (319)
T ss_dssp CTTTSCCHHHHHHHHHH
T ss_pred ChhhhccHHHhhhccHH
Confidence 99999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=304.61 Aligned_cols=221 Identities=24% Similarity=0.301 Sum_probs=169.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+.+..++||||++ ++|.+++......+++..++.++.||+.||+|||+.+ |+||
T Consensus 68 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~ 143 (311)
T 3niz_A 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHR 143 (311)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 69999999999999999999999999999999996 5898888777777999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||++.++.+||+|||+++....... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 144 Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (311)
T 3niz_A 144 DLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221 (311)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987643222 2334578999999999876 568999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhh-----hhccccc-------cccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARP-----HLGERRR-------FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~-----~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
................ .+..... .................+.++.+||.+||+.||++|||++|++++
T Consensus 222 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 222 GVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 6544332111100000 0000000 000000000000011124688999999999999999999999985
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=306.97 Aligned_cols=211 Identities=27% Similarity=0.423 Sum_probs=174.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-----------------------CCCCHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMK 58 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~~l~~~~~~~ 58 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++.... ..+++..++.
T Consensus 75 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (314)
T 2ivs_A 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154 (314)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHH
T ss_pred HHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHH
Confidence 69999999999999999999999999999999999999999997643 2389999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCc
Q 022003 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 138 (304)
Q Consensus 59 i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 138 (304)
++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.
T Consensus 155 i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 231 (314)
T 2ivs_A 155 FAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTT 231 (314)
T ss_dssp HHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECH
T ss_pred HHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCc
Confidence 9999999999999998 9999999999999999999999999998765544433344456788999999999999999
Q ss_pred hhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 139 RSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 139 ~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
++|||||||++|+|++ |..||....... ....... . .... .+...+..+.++|.+||+.||.
T Consensus 232 ~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~----~------~~~~----~~~~~~~~~~~li~~~l~~dp~ 294 (314)
T 2ivs_A 232 QSDVWSFGVLLWEIVTLGGNPYPGIPPER---LFNLLKT----G------HRME----RPDNCSEEMYRLMLQCWKQEPD 294 (314)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHT----T------CCCC----CCTTCCHHHHHHHHHHTCSSGG
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHhhc----C------CcCC----CCccCCHHHHHHHHHHccCChh
Confidence 9999999999999999 999997653321 1111100 0 0011 1122357899999999999999
Q ss_pred CCCCHHHHHHHhCCC
Q 022003 218 ARPLMSEVVEALKPL 232 (304)
Q Consensus 218 ~Rps~~ell~~l~~~ 232 (304)
+|||+.+++++|+.+
T Consensus 295 ~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 295 KRPVFADISKDLEKM 309 (314)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999988643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=299.77 Aligned_cols=212 Identities=26% Similarity=0.424 Sum_probs=174.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||
T Consensus 52 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~ 128 (268)
T 3sxs_A 52 QEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHR 128 (268)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred HHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 6999999999999999999999999999999999999999999776667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||++........ .......+|..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 129 dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (268)
T 3sxs_A 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207 (268)
T ss_dssp SCSGGGEEECTTCCEEECCTTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CcCcceEEECCCCCEEEccCccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987654332 22233456778999999999899999999999999999999 999996
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 234 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~ 234 (304)
...... .. .. ..... ....+ ...+..+.+++.+||+.||.+|||+.|++++|+.+..
T Consensus 208 ~~~~~~---~~---~~-~~~~~---~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 208 LYTNSE---VV---LK-VSQGH---RLYRP-------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TSCHHH---HH---HH-HHTTC---CCCCC-------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ccChHH---HH---HH-HHcCC---CCCCC-------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 543211 00 00 00000 01111 1124688999999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=306.61 Aligned_cols=212 Identities=29% Similarity=0.457 Sum_probs=164.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++|++++||||+++++++...+..++||||+++++|.+++.+... .+++..++.++.||+.||+|||+.+ .+|+
T Consensus 83 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~iv 161 (309)
T 3p86_A 83 REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIV 161 (309)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCC
T ss_pred HHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEE
Confidence 699999999999999999999999999999999999999999976542 3999999999999999999999976 4599
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||||||+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 162 H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf 239 (309)
T 3p86_A 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239 (309)
T ss_dssp CTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998643321 1233467899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
....... ....... .. .... .+...+..+.+||.+||+.||.+|||++++++.|+.+
T Consensus 240 ~~~~~~~---~~~~~~~-~~--------~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 240 GNLNPAQ---VVAAVGF-KC--------KRLE----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp TTSCHHH---HHHHHHH-SC--------CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHHH---HHHHHHh-cC--------CCCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 7543211 1110000 00 0011 1122356899999999999999999999999988654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=317.16 Aligned_cols=208 Identities=22% Similarity=0.286 Sum_probs=170.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++|||||++++++.+.+..|+|||||.||+|.+.+..+. .+++..+..++.||+.||.|||+.+ |+||
T Consensus 59 ~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~g---ivHr 134 (444)
T 3soa_A 59 REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMG---VVHR 134 (444)
T ss_dssp HHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTT---CBCC
T ss_pred HHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 69999999999999999999999999999999999999999987654 6999999999999999999999998 9999
Q ss_pred cCCCCCeEEC---CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+|||++ .++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 135 DlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~P 212 (444)
T 3soa_A 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212 (444)
T ss_dssp CCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence 9999999998 568899999999987654322 22346799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|...... .... ....... ....+. ....+.++.+||.+||+.||++|||+.|++++.
T Consensus 213 f~~~~~~---~~~~---~i~~~~~---~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 213 FWDEDQH---RLYQ---QIKAGAY---DFPSPE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp CCCSSHH---HHHH---HHHHTCC---CCCTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred CCCccHH---HHHH---HHHhCCC---CCCccc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 9654211 1111 1000000 011111 012256899999999999999999999999964
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=309.22 Aligned_cols=213 Identities=24% Similarity=0.376 Sum_probs=175.2
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCC----------------------CCCHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------------------PLPWSIRMK 58 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----------------------~l~~~~~~~ 58 (304)
+|+++++++ +||||+++++++...+..++||||+++|+|.+++..... .+++..++.
T Consensus 97 ~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 176 (344)
T 1rjb_A 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176 (344)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHH
T ss_pred HHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHH
Confidence 699999999 999999999999999999999999999999999976542 379999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCc
Q 022003 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 138 (304)
Q Consensus 59 i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 138 (304)
++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.
T Consensus 177 i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 253 (344)
T 1rjb_A 177 FAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 253 (344)
T ss_dssp HHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCCh
Confidence 9999999999999998 9999999999999999999999999998765444333444566788999999999999999
Q ss_pred hhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 139 RSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 139 ~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
++|||||||++|+|+| |..||....... ........ . .... .+...+..+.+||.+||+.||.
T Consensus 254 ~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~----~------~~~~----~~~~~~~~l~~li~~~l~~dp~ 317 (344)
T 1rjb_A 254 KSDVWSYGILLWEIFSLGVNPYPGIPVDA--NFYKLIQN----G------FKMD----QPFYATEEIYIIMQSCWAFDSR 317 (344)
T ss_dssp HHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHT----T------CCCC----CCTTCCHHHHHHHHHHTCSSGG
T ss_pred hHhHHHHHHHHHHHHcCCCCCcccCCcHH--HHHHHHhc----C------CCCC----CCCCCCHHHHHHHHHHcCCCch
Confidence 9999999999999998 999997653221 11111110 0 0011 1112357899999999999999
Q ss_pred CCCCHHHHHHHhCCCC
Q 022003 218 ARPLMSEVVEALKPLP 233 (304)
Q Consensus 218 ~Rps~~ell~~l~~~~ 233 (304)
+|||+.+++++|+.+.
T Consensus 318 ~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 318 KRPSFPNLTSFLGCQL 333 (344)
T ss_dssp GSCCHHHHHHHHHHHC
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999987543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=299.92 Aligned_cols=210 Identities=29% Similarity=0.466 Sum_probs=173.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.|++.||+|||+.+ ++||
T Consensus 54 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~ 130 (269)
T 4hcu_A 54 EEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 130 (269)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 6999999999999999999999999999999999999999999877778999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||+++...... ........+|..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 131 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~ 209 (269)
T 4hcu_A 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 209 (269)
T ss_dssp CCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CcchheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999998654321 112223456778999999999999999999999999999999 899997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
...... ...... .. ..... +...+..+.+++.+||+.||++|||+.+++++|+.+
T Consensus 210 ~~~~~~---~~~~~~----~~---~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 210 NRSNSE---VVEDIS----TG---FRLYK-------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp TCCHHH---HHHHHH----TT---CCCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHHH---HHHHHh----cC---ccCCC-------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 543211 111000 00 00111 112246899999999999999999999999998643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=312.58 Aligned_cols=209 Identities=20% Similarity=0.292 Sum_probs=171.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++.+.+..++||||+.+++|.+++......+++..++.++.||+.||+|||+.+ |+||
T Consensus 97 ~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHr 173 (387)
T 1kob_A 97 NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHL 173 (387)
T ss_dssp HHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 6999999999999999999999999999999999999999999777667999999999999999999999998 9999
Q ss_pred cCCCCCeEECC--CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 82 DFKTSNILLDA--DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||||+|||++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 174 Dlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf 250 (387)
T 1kob_A 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250 (387)
T ss_dssp CCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred ccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCC
Confidence 99999999974 57899999999987654322 23357899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
...... .... ........ .++.. ....+.++.+||.+||+.||++|||+.|++++..
T Consensus 251 ~~~~~~---~~~~---~i~~~~~~----~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 251 AGEDDL---ETLQ---NVKRCDWE----FDEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp CCSSHH---HHHH---HHHHCCCC----CCSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred CCCCHH---HHHH---HHHhCCCC----CCccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 754221 1111 00000000 11111 1123568999999999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=317.77 Aligned_cols=211 Identities=25% Similarity=0.380 Sum_probs=170.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+.++++++||||+++++++...+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+
T Consensus 123 ~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~- 201 (367)
T 3l9p_A 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH- 201 (367)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 68999999999999999999999999999999999999999996532 45999999999999999999999998
Q ss_pred CCeEeccCCCCCeEECCCC---cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 76 RPVIYRDFKTSNILLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|+||||||+||||+.++ .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||
T Consensus 202 --ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el 279 (367)
T 3l9p_A 202 --FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279 (367)
T ss_dssp --CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred --eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999998555 5999999999754322222223345678999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 153 LT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 153 ~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
++ |..||...... ....... ... ... .+...+..+.+||.+||+.||++|||+.+++++|+.
T Consensus 280 lt~g~~pf~~~~~~---~~~~~i~----~~~------~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 280 FSLGYMPYPSKSNQ---EVLEFVT----SGG------RMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HTTSCCSSTTCCHH---HHHHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHH---HHHHHHH----cCC------CCC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 98 99999754321 1111111 000 000 111234678999999999999999999999999864
Q ss_pred C
Q 022003 232 L 232 (304)
Q Consensus 232 ~ 232 (304)
+
T Consensus 343 ~ 343 (367)
T 3l9p_A 343 C 343 (367)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=297.19 Aligned_cols=215 Identities=26% Similarity=0.386 Sum_probs=169.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||
T Consensus 60 ~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 135 (294)
T 4eqm_A 60 REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMR---IVHR 135 (294)
T ss_dssp HHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 68999999999999999999999999999999999999999996554 6999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 136 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 214 (294)
T 4eqm_A 136 DIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214 (294)
T ss_dssp CCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCCHHHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987643321 223345789999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhCCCCC
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPN 234 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~ell~~l~~~~~ 234 (304)
..... .......... +..........+..+.++|.+||+.||.+|| +++++.+.|+.+..
T Consensus 215 ~~~~~------~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 215 ETAVS------IAIKHIQDSV-------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp SCHHH------HHHHHHSSCC-------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred CChHH------HHHHHhhccC-------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 43211 0000000000 0000011112356899999999999999999 89999998876554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=307.12 Aligned_cols=208 Identities=23% Similarity=0.300 Sum_probs=169.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 63 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~ 138 (326)
T 2y0a_A 63 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHF 138 (326)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcC
Confidence 6999999999999999999999999999999999999999999654 47999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCC----cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 82 DFKTSNILLDADY----NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 82 dlkp~Nili~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
||||+|||++.++ .+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 139 Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 215 (326)
T 2y0a_A 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215 (326)
T ss_dssp CCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred CCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence 9999999998887 899999999987643322 234578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
||....... ..... ......+. ... ....+..+.+||.+||+.||++|||+.|++++..
T Consensus 216 pf~~~~~~~---~~~~~---~~~~~~~~----~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 216 PFLGDTKQE---TLANV---SAVNYEFE----DEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp SSCCSSHHH---HHHHH---HHTCCCCC----HHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred CCCCCCHHH---HHHHH---HhcCCCcC----ccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 996542211 11000 00000000 000 0112467899999999999999999999999643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=313.04 Aligned_cols=212 Identities=29% Similarity=0.410 Sum_probs=172.1
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCe-eEEEEecCCCCCHHHHhhcCCC------------------------------
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSL------------------------------ 49 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~------------------------------ 49 (304)
+|+++++++ +||||+++++++...+. .++|||||++|+|.+++.....
T Consensus 74 ~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (359)
T 3vhe_A 74 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRL 153 (359)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------
T ss_pred HHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccc
Confidence 699999999 78999999999987654 8999999999999999976432
Q ss_pred -----------------------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC
Q 022003 50 -----------------------------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 94 (304)
Q Consensus 50 -----------------------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~ 94 (304)
.+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~ 230 (359)
T 3vhe_A 154 DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKN 230 (359)
T ss_dssp ------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred cccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCC
Confidence 1899999999999999999999998 99999999999999999
Q ss_pred cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcchhHh
Q 022003 95 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 173 (304)
Q Consensus 95 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~ 173 (304)
.+||+|||+++...............||..|+|||++.+..++.++|||||||++|+|++ |..||........ ....
T Consensus 231 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~ 308 (359)
T 3vhe_A 231 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRR 308 (359)
T ss_dssp CEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHH
T ss_pred cEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHH
Confidence 999999999987655444444455678999999999999999999999999999999998 9999976533211 1111
Q ss_pred hhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 174 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
.. ... ... .+...+.++.++|.+||+.||.+|||+.|++++|+.+
T Consensus 309 ~~----~~~------~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 309 LK----EGT------RMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp HH----HTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----cCC------CCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 10 000 011 1112346899999999999999999999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.96 Aligned_cols=205 Identities=24% Similarity=0.335 Sum_probs=168.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+.+..|+||||+.||+|..++.+. ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 64 ~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHr 139 (384)
T 4fr4_A 64 KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR---IIHR 139 (384)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 6999999999999999999999999999999999999999999664 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc---CCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+||||+.+|.+||+|||++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 140 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~P 216 (384)
T 4fr4_A 140 DMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216 (384)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCC
Confidence 999999999999999999999998764332 2345679999999999863 4689999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~ell~~ 228 (304)
|................ ... .. ++...+..+.+||.+||+.||.+||+ +++++++
T Consensus 217 f~~~~~~~~~~~~~~~~---~~~--------~~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 217 YHIRSSTSSKEIVHTFE---TTV--------VT----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp SCCCTTSCHHHHHHHHH---HCC--------CC----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred CCCCCCccHHHHHHHHh---hcc--------cC----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 97544332211111110 000 01 11223578999999999999999998 7777754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=310.50 Aligned_cols=213 Identities=25% Similarity=0.419 Sum_probs=173.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-----------------------CCCCHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMK 58 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~~l~~~~~~~ 58 (304)
+|++++++++||||+++++++..++..++||||+++++|.+++.... ..+++..++.
T Consensus 99 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 178 (343)
T 1luf_A 99 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178 (343)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHH
T ss_pred HHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHH
Confidence 69999999999999999999999999999999999999999997642 5699999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCc
Q 022003 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 138 (304)
Q Consensus 59 i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 138 (304)
++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.
T Consensus 179 i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 255 (343)
T 1luf_A 179 IARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 255 (343)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCc
Confidence 9999999999999998 9999999999999999999999999998654332222334456789999999999999999
Q ss_pred hhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 139 RSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 139 ~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
++|||||||++|+|++ |..||...... ....... .. .. +. .+...+..+.++|.+||+.||.
T Consensus 256 ~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~----~~-~~-----~~----~~~~~~~~l~~li~~~l~~~p~ 318 (343)
T 1luf_A 256 ESDVWAYGVVLWEIFSYGLQPYYGMAHE---EVIYYVR----DG-NI-----LA----CPENCPLELYNLMRLCWSKLPA 318 (343)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH----TT-CC-----CC----CCTTCCHHHHHHHHHHTCSSGG
T ss_pred ccccHHHHHHHHHHHhcCCCcCCCCChH---HHHHHHh----CC-Cc-----CC----CCCCCCHHHHHHHHHHcccCcc
Confidence 9999999999999999 99999754221 1111000 00 00 01 1122356899999999999999
Q ss_pred CCCCHHHHHHHhCCCCC
Q 022003 218 ARPLMSEVVEALKPLPN 234 (304)
Q Consensus 218 ~Rps~~ell~~l~~~~~ 234 (304)
+|||+.++++.|+.+..
T Consensus 319 ~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 319 DRPSFCSIHRILQRMCE 335 (343)
T ss_dssp GSCCHHHHHHHHHHTTC
T ss_pred cCCCHHHHHHHHHHHHh
Confidence 99999999999976543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=299.89 Aligned_cols=220 Identities=22% Similarity=0.267 Sum_probs=167.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+++..++||||+.+ +|.+.+......+++..++.++.||+.||+|||+.+ |+||
T Consensus 50 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~ 125 (292)
T 3o0g_A 50 REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHR 125 (292)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 699999999999999999999999999999999964 777777666668999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC-CCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||++.++.+||+|||+++....... ......||..|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 126 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 126 DLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred CCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 9999999999999999999999987643222 233457899999999998765 8999999999999999999888864
Q ss_pred CCCCCCCcchhHhhhhhhcc-----cccccc---------ccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGE-----RRRFYR---------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 226 (304)
...... ............ ...... ..............+..+.+||.+||+.||++|||++|++
T Consensus 204 ~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 204 PGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp CCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCHH--HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 332211 111100000000 000000 0000000111123457889999999999999999999999
Q ss_pred HHh
Q 022003 227 EAL 229 (304)
Q Consensus 227 ~~l 229 (304)
++.
T Consensus 282 ~hp 284 (292)
T 3o0g_A 282 QHP 284 (292)
T ss_dssp TSG
T ss_pred cCc
Confidence 853
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=311.90 Aligned_cols=203 Identities=25% Similarity=0.367 Sum_probs=164.4
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|+.+ +||||+++++++.+.+..|+|||||+||+|..++.+. ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 72 ~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH 147 (353)
T 3txo_A 72 TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIY 147 (353)
T ss_dssp HHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBC
T ss_pred HHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 588899988 7999999999999999999999999999999999654 36999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||||+.+|.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 148 rDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 225 (353)
T 3txo_A 148 RDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225 (353)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCC
Confidence 9999999999999999999999998643222 22345689999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~~ 228 (304)
...... ........... ++...+.++.+||.+||+.||.+||++ +|+++|
T Consensus 226 ~~~~~~------~~~~i~~~~~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 226 AENEDD------LFEAILNDEVV------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CSSHHH------HHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCCHHH------HHHHHHcCCCC------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 543211 11111111111 111234688999999999999999998 777764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=313.02 Aligned_cols=211 Identities=26% Similarity=0.435 Sum_probs=162.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++...+..++||||+++++|.+++.+....+++..++.++.||+.||+|||+.+ |+||
T Consensus 95 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 171 (373)
T 2qol_A 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHR 171 (373)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCC
Confidence 6999999999999999999999999999999999999999999877778999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||+|||++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 172 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~ 251 (373)
T 2qol_A 172 DLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251 (373)
T ss_dssp CCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTT
T ss_pred CCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876443221 11222345778999999999999999999999999999998 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
...... ....... .... . ..+..++..+.++|.+||+.||++||++.++++.|+.+
T Consensus 252 ~~~~~~---~~~~~i~----~~~~---~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 252 WEMSNQ---DVIKAVD----EGYR---L-------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp TTCCHH---HHHHHHH----TTEE---C-------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHH---HHHHHHH----cCCC---C-------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 654221 1111110 0000 0 01112357899999999999999999999999988654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=306.65 Aligned_cols=202 Identities=24% Similarity=0.332 Sum_probs=167.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++||||+++++++.+.+..++||||+ +|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||
T Consensus 58 ~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~ 132 (336)
T 3h4j_B 58 REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHK---IVHR 132 (336)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHT---CCCC
T ss_pred HHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEec
Confidence 6999999999999999999999999999999999 789999886543 6999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||++.++.+||+|||++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 133 Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 209 (336)
T 3h4j_B 133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209 (336)
T ss_dssp CCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSB
T ss_pred CCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987654322 234579999999999988776 789999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
............ . ... ..+...+..+.+||.+||+.||.+|||++|++++.
T Consensus 210 ~~~~~~~~~~i~----------~----~~~----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 210 DEFIPNLFKKVN----------S----CVY----VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp CSSSTTCBCCCC----------S----SCC----CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred CccHHHHHHHHH----------c----CCC----CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 643322111000 0 000 01112356889999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=309.31 Aligned_cols=207 Identities=22% Similarity=0.313 Sum_probs=168.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+.+..|+||||+.+++|.+++..+ ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 77 ~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~ 152 (362)
T 2bdw_A 77 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHR 152 (362)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCC
T ss_pred HHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEec
Confidence 6999999999999999999999999999999999999999998655 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECCC---CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDAD---YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+|||++.+ +.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 153 Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P 229 (362)
T 2bdw_A 153 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229 (362)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999765 4599999999987653322 2346799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|...... ...... ...... ...+. ....+.++.+||.+||+.||++|||+.|++++.
T Consensus 230 f~~~~~~---~~~~~i---~~~~~~---~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 230 FWDEDQH---RLYAQI---KAGAYD---YPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp SCCSSHH---HHHHHH---HHTCCC---CCTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred CCCCCHH---HHHHHH---HhCCCC---CCccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 9754211 111100 000000 00000 012246889999999999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=309.18 Aligned_cols=210 Identities=27% Similarity=0.398 Sum_probs=168.0
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|..+|.++ +|||||++++++.+.+.+|+||||++||+|..++.+. ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 101 ~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH 176 (396)
T 4dc2_A 101 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIY 176 (396)
T ss_dssp HHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBC
T ss_pred HHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 578888877 8999999999999999999999999999999998654 36999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||||+.+|.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 177 rDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 177 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred ccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999998633221 22445789999999999999999999999999999999999999996
Q ss_pred CCCCCCCc--chhH-hhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHHh
Q 022003 161 KNRPNGEH--NLVE-WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~~l 229 (304)
........ .... .......... . ++...+.++.+||.+||+.||++||++ +|+++|.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~i~~~~~--------~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 255 IVGSSDNPDQNTEDYLFQVILEKQI--------R----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp TTTC------CCHHHHHHHHHHCCC--------C----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred ccccccccchhhHHHHHHHHhcccc--------C----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 54322111 0111 1111111111 1 112235688999999999999999985 6777653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=306.86 Aligned_cols=211 Identities=20% Similarity=0.327 Sum_probs=166.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..+. .++|+||+.+++|.+++......+++..++.++.||+.||.|||+.+ |+||
T Consensus 66 ~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 141 (327)
T 3lzb_A 66 DEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHR 141 (327)
T ss_dssp HHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCC
Confidence 6999999999999999999998765 78899999999999999887778999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 142 Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp CCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999987654443333344567889999999999999999999999999999999 999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
...... ....... .. ... .+...+.++.++|.+||+.||.+|||+.|+++.|+.+.
T Consensus 222 ~~~~~~---~~~~~~~----~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 222 GIPASE---ISSILEK----GE------RLP----QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp TCCGGG---HHHHHHT----TC------CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHHH---HHHHHHc----CC------CCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 653321 1111110 00 000 11123468899999999999999999999999887544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=303.96 Aligned_cols=211 Identities=27% Similarity=0.412 Sum_probs=174.6
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCC-----------------CCCHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------------PLPWSIRMKIALGA 63 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------------~l~~~~~~~i~~qi 63 (304)
+|+++++++ +||||+++++++...+..++||||+++++|.+++..... .+++..++.++.||
T Consensus 75 ~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi 154 (313)
T 1t46_A 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQV 154 (313)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHH
T ss_pred HHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHH
Confidence 699999999 999999999999999999999999999999999976532 48999999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhH
Q 022003 64 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 143 (304)
Q Consensus 64 ~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 143 (304)
+.||.|||+.+ ++||||||+||+++.++.+||+|||+++...............||..|+|||++.+..++.++|||
T Consensus 155 ~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 231 (313)
T 1t46_A 155 AKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231 (313)
T ss_dssp HHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHH
Confidence 99999999998 999999999999999999999999999887654443344455678899999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 144 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 144 slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
||||++|+|++ |..||....... ........ . ..... +...+..+.++|.+||+.||.+|||+
T Consensus 232 slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~----~------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~ 295 (313)
T 1t46_A 232 SYGIFLWELFSLGSSPYPGMPVDS--KFYKMIKE----G------FRMLS----PEHAPAEMYDIMKTCWDADPLKRPTF 295 (313)
T ss_dssp HHHHHHHHHHTTTCCSSTTCCSSH--HHHHHHHH----T------CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHhCCCCCCCcccchh--HHHHHhcc----C------CCCCC----cccCCHHHHHHHHHHcCCCchhCcCH
Confidence 99999999999 999997653221 11111110 0 00111 11235689999999999999999999
Q ss_pred HHHHHHhCC
Q 022003 223 SEVVEALKP 231 (304)
Q Consensus 223 ~ell~~l~~ 231 (304)
.|+++.|+.
T Consensus 296 ~ell~~L~~ 304 (313)
T 1t46_A 296 KQIVQLIEK 304 (313)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=297.54 Aligned_cols=201 Identities=27% Similarity=0.390 Sum_probs=168.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.+++.++||||+++++++.+.+..|+||||++||+|.+++.+.. .+++..++.++.||+.||+|||+.+ |+||
T Consensus 55 ~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHr 130 (318)
T 1fot_A 55 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKD---IIYR 130 (318)
T ss_dssp HHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTT---EECC
T ss_pred HHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 58899999999999999999999999999999999999999996643 6999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.+|.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 131 Dlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 131 DLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp CCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999875432 2346799999999999999999999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~l 229 (304)
.... ............ ++...+.++.++|.+||+.||++|| +++++++|.
T Consensus 206 ~~~~------~~~~~i~~~~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 206 SNTM------KTYEKILNAELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp SSHH------HHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCHH------HHHHHHHhCCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 4211 111111111111 1112246889999999999999999 888888753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=302.46 Aligned_cols=208 Identities=25% Similarity=0.343 Sum_probs=167.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++||||+++++++..++..|+|||||++++|.+++.+. ...+++..++.++.||+.||+|||+.+ |
T Consensus 75 ~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i 151 (351)
T 3c0i_A 75 REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---I 151 (351)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 6999999999999999999999999999999999999998887543 345899999999999999999999998 9
Q ss_pred EeccCCCCCeEECCCCc---EEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 79 IYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
+||||||+|||++.++. +||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 152 vHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (351)
T 3c0i_A 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229 (351)
T ss_dssp ECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred eeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHC
Confidence 99999999999976654 99999999987654322 23345799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..||..... .... ........ ..+.... ..+.++.+||.+||+.||++|||+.|++++.
T Consensus 230 ~~pf~~~~~----~~~~---~i~~~~~~----~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 230 CLPFYGTKE----RLFE---GIIKGKYK----MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp SCSSCSSHH----HHHH---HHHHTCCC----CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCCCCCcHH----HHHH---HHHcCCCC----CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 999975311 1110 00000000 0000000 1246889999999999999999999999853
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=306.74 Aligned_cols=201 Identities=23% Similarity=0.287 Sum_probs=168.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|+.++||||+++++++.+.+..|+||||++|++|.+++.+.. .+++..++.++.||+.||+|||+.+ |+||
T Consensus 90 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHr 165 (350)
T 1rdq_E 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD---LIYR 165 (350)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 58999999999999999999999999999999999999999996643 6999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.+|.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 166 Dlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence 99999999999999999999999875432 2345789999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~~l 229 (304)
.... ............ ++...+.++.++|.+||+.||.+||+ +++++++.
T Consensus 241 ~~~~------~~~~~i~~~~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 241 DQPI------QIYEKIVSGKVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp SSHH------HHHHHHHHCCCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCHH------HHHHHHHcCCCC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 4221 111111111111 11123568999999999999999998 78887753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=298.77 Aligned_cols=218 Identities=24% Similarity=0.318 Sum_probs=165.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+. ++|.+++......+++..++.++.||+.||+|||+.+ |+||
T Consensus 49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 124 (288)
T 1ob3_A 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124 (288)
T ss_dssp HHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 69999999999999999999999999999999996 4999999777678999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.+||+|||+++....... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 125 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (288)
T 1ob3_A 125 DLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (288)
T ss_dssp CCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999986543211 1233568999999999976 458999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhh-------hccccccccccCCcc-------CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 022003 161 KNRPNGEHNLVEWARPH-------LGERRRFYRLIDPRL-------EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 226 (304)
....... ........ +....... ..++.. ........+.++.+||.+||+.||++|||++|++
T Consensus 203 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 279 (288)
T 1ob3_A 203 GVSEADQ--LMRIFRILGTPNSKNWPNVTELP-KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (288)
T ss_dssp CSSHHHH--HHHHHHHHCCCCTTTSTTGGGST-TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCHHHH--HHHHHHHHCCCChhhchhhhccc-ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 5432111 00000000 00000000 000000 0011112356889999999999999999999999
Q ss_pred HH
Q 022003 227 EA 228 (304)
Q Consensus 227 ~~ 228 (304)
++
T Consensus 280 ~h 281 (288)
T 1ob3_A 280 EH 281 (288)
T ss_dssp TS
T ss_pred cC
Confidence 85
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=299.70 Aligned_cols=216 Identities=17% Similarity=0.193 Sum_probs=174.2
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++| +||||+++++++..++..++||||+ +++|.+++......+++..++.++.||+.||+|||+.+ |+|
T Consensus 53 ~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiH 128 (330)
T 2izr_A 53 LEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIY 128 (330)
T ss_dssp HHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 699999999 9999999999999999999999999 99999999876668999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCc-----EEEccccCcccCCCCCcce-----eeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 81 RDFKTSNILLDADYN-----AKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 81 ~dlkp~Nili~~~~~-----~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
|||||+|||++.++. +||+|||+++......... ......||..|+|||++.+..++.++|||||||++|
T Consensus 129 rDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 208 (330)
T 2izr_A 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFM 208 (330)
T ss_dssp CCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred cCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHH
Confidence 999999999998887 9999999998764432211 123567999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
||++|..||.................. ......... . ...+ ++.+++.+||+.||.+||++++|++.|+
T Consensus 209 ell~g~~Pf~~~~~~~~~~~~~~i~~~--~~~~~~~~~----~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 209 YFLRGSLPWQGLKADTLKERYQKIGDT--KRATPIEVL----C----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HHHHSSCTTTTCCCSSHHHHHHHHHHH--HHHSCHHHH----T----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHhcCCCCccccccccHHHHHHHHHhh--hccCCHHHH----h----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 999999999876433221111111000 000000000 0 0123 8999999999999999999999999886
Q ss_pred CC
Q 022003 231 PL 232 (304)
Q Consensus 231 ~~ 232 (304)
.+
T Consensus 278 ~~ 279 (330)
T 2izr_A 278 DL 279 (330)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=310.24 Aligned_cols=207 Identities=22% Similarity=0.287 Sum_probs=170.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++...+..++||||+++++|.+++......+++..++.++.||+.||+|||+.+ |+||
T Consensus 135 ~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 211 (373)
T 2x4f_A 135 NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHL 211 (373)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 6999999999999999999999999999999999999999998776667999999999999999999999998 9999
Q ss_pred cCCCCCeEE--CCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 82 DFKTSNILL--DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 82 dlkp~Nili--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 212 Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 288 (373)
T 2x4f_A 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288 (373)
T ss_dssp CCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 999999999 6678999999999987654322 23356899999999999899999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
....... ...........+ ..... ...+.++.+||.+||+.||.+|||+.|++++
T Consensus 289 ~~~~~~~------~~~~i~~~~~~~----~~~~~----~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 289 LGDNDAE------TLNNILACRWDL----EDEEF----QDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CCSSHHH------HHHHHHHTCCCS----CSGGG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHH------HHHHHHhccCCC----Chhhh----ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 7543211 111111000000 00000 1224689999999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=298.36 Aligned_cols=209 Identities=24% Similarity=0.370 Sum_probs=160.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++. ++..++||||+++++|.+++..+...+++..++.++.|++.||.|||+.+ ++||
T Consensus 65 ~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 140 (281)
T 1mp8_A 65 QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHR 140 (281)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 6899999999999999999874 56789999999999999999877667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+|||++.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 141 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 141 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp CCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccHHHEEECCCCCEEECccccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999987644322 12233456788999999999999999999999999999997 999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
...... ...... ... ... .+...+..+.++|.+||+.||++|||+.|+++.|+.+
T Consensus 220 ~~~~~~---~~~~i~----~~~------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 220 GVKNND---VIGRIE----NGE------RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp TCCGGG---HHHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCHHH---HHHHHH----cCC------CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 643221 111110 000 001 1122357899999999999999999999999988643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=310.59 Aligned_cols=220 Identities=18% Similarity=0.209 Sum_probs=170.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
.|+..++.++||||+++++++... ...++||||+ +++|.+++......+++..++.++.||+.||+|||+.+
T Consensus 97 ~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--- 172 (364)
T 3op5_A 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--- 172 (364)
T ss_dssp HHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 456677888999999999998875 4589999999 99999999887678999999999999999999999998
Q ss_pred eEeccCCCCCeEEC--CCCcEEEccccCcccCCCCCcc-----eeeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 78 VIYRDFKTSNILLD--ADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 78 iiH~dlkp~Nili~--~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
|+||||||+|||++ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|
T Consensus 173 iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~ 252 (364)
T 3op5_A 173 YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMI 252 (364)
T ss_dssp EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHH
Confidence 99999999999998 8899999999999875432111 1113355999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
||++|..||....... .......... .......+++.+. ....+.++.+++.+||+.||.+||++.+|++.|+
T Consensus 253 el~~g~~Pf~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~ 325 (364)
T 3op5_A 253 QWLTGHLPWEDNLKDP--KYVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325 (364)
T ss_dssp HHHHSCCTTGGGTTCH--HHHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHhCCCCccccccCH--HHHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence 9999999997532221 1111111100 0111111111110 0112468999999999999999999999999886
Q ss_pred CC
Q 022003 231 PL 232 (304)
Q Consensus 231 ~~ 232 (304)
.+
T Consensus 326 ~~ 327 (364)
T 3op5_A 326 QG 327 (364)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=298.72 Aligned_cols=216 Identities=27% Similarity=0.497 Sum_probs=161.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++ ..+..++||||+.+++|.+++......+++..++.++.||+.||.|||+.+ |+||
T Consensus 69 ~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~ 144 (289)
T 3og7_A 69 NEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144 (289)
T ss_dssp HHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 699999999999999999965 566789999999999999999777778999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+||+++.++.+||+|||+++...............||..|+|||++. +..++.++|||||||++|+|++|..|
T Consensus 145 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (289)
T 3og7_A 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224 (289)
T ss_dssp CCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCT
T ss_pred cCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCC
Confidence 999999999999999999999998654433333334467899999999986 66789999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
|....... ........ .. ..+.. ......++..+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 225 ~~~~~~~~--~~~~~~~~-----~~----~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 225 YSNINNRD--QIIEMVGR-----GS----LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TSSCCCHH--HHHHHHHH-----TS----CCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccchHH--HHHHHhcc-----cc----cCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 97543211 11111110 00 00111 1112233578999999999999999999999999987553
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=307.72 Aligned_cols=222 Identities=19% Similarity=0.240 Sum_probs=167.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|||||++++++..++..++|||||++++|.+++... ...+++..++.++.||+.||+|||+.+ |+|
T Consensus 75 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH 151 (389)
T 3gni_B 75 GELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVH 151 (389)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 5999999999999999999999999999999999999999999764 356999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCc-----ceeeecccccccccCcchhhc--CCCCchhhhHHHHHHHHHHH
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~ 153 (304)
|||||+||||+.++.+||+|||.+........ ........||..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 152 rDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 231 (389)
T 3gni_B 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231 (389)
T ss_dssp CCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHH
Confidence 99999999999999999999999875432211 111223478999999999987 67999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhHhhhhhhccc--------cc-------------ccccc---------CCccCCCCCHHHHHH
Q 022003 154 TGRRSMDKNRPNGEHNLVEWARPHLGER--------RR-------------FYRLI---------DPRLEGHFSIKGAQK 203 (304)
Q Consensus 154 tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~-------------~~~~~---------~~~~~~~~~~~~~~~ 203 (304)
+|..||......... ........... .. ..... .......+....+..
T Consensus 232 ~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 309 (389)
T 3gni_B 232 NGHVPFKDMPATQML--LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH 309 (389)
T ss_dssp HSSCTTTTCCSTTHH--HHC--------------------------------------------------------CCHH
T ss_pred HCCCCCCCCCHHHHH--HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHH
Confidence 999999764432211 10000000000 00 00000 000000122234578
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 204 AAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 204 ~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+.+||.+||+.||++|||++|++++
T Consensus 310 ~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 310 FHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHhhcCcccCCCHHHHhcC
Confidence 9999999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=298.15 Aligned_cols=209 Identities=20% Similarity=0.364 Sum_probs=172.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+.+..++||||+.+++|.+++......+++..++.++.|++.||.|||+.+ |+||
T Consensus 68 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~ 144 (283)
T 3gen_A 68 EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHR 144 (283)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCC
Confidence 6999999999999999999999999999999999999999999876667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||+++...... ........+|..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 145 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~ 223 (283)
T 3gen_A 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223 (283)
T ss_dssp SCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 999999999999999999999998754321 111223456788999999999999999999999999999998 999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
...... .... .... ..... +...+..+.++|.+||+.||.+|||+++++++|+.
T Consensus 224 ~~~~~~---~~~~----~~~~------~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 224 RFTNSE---TAEH----IAQG------LRLYR----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp TSCHHH---HHHH----HHTT------CCCCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ccChhH---HHHH----Hhcc------cCCCC----CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 543211 1110 0000 00111 11224688999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=303.57 Aligned_cols=211 Identities=23% Similarity=0.397 Sum_probs=160.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCee------EEEEecCCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFL 70 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~~L 70 (304)
+|++++++++||||+++++++...+.. ++||||+.+++|.+++... ...+++..++.++.||+.||+||
T Consensus 74 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L 153 (323)
T 3qup_A 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL 153 (323)
T ss_dssp HHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHH
Confidence 699999999999999999999887655 9999999999999998542 22599999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 71 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 71 H~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
|+.+ |+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|
T Consensus 154 H~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 230 (323)
T 3qup_A 154 SSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMW 230 (323)
T ss_dssp HHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHH
Confidence 9998 9999999999999999999999999998765443333333455688999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 151 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 151 el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
+|++ |..||....... ...... . .. ... .+...+..+.+||.+||+.||++|||+.++++.|
T Consensus 231 ell~~g~~p~~~~~~~~---~~~~~~---~-~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 293 (323)
T 3qup_A 231 EIMTRGQTPYAGIENAE---IYNYLI---G-GN------RLK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293 (323)
T ss_dssp HHHTTSCCTTTTCCGGG---HHHHHH---T-TC------CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCccccChHH---HHHHHh---c-CC------CCC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9999 899997643221 111100 0 00 000 1112346899999999999999999999999888
Q ss_pred CCC
Q 022003 230 KPL 232 (304)
Q Consensus 230 ~~~ 232 (304)
+.+
T Consensus 294 ~~~ 296 (323)
T 3qup_A 294 ENI 296 (323)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=312.30 Aligned_cols=211 Identities=20% Similarity=0.228 Sum_probs=171.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++..++||||+++++++.+.+.+|+|||||+||+|.+++.+....+++..++.++.||+.||+|||+.+ |+||
T Consensus 123 ~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHr 199 (437)
T 4aw2_A 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHR 199 (437)
T ss_dssp HHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEec
Confidence 5889999999999999999999999999999999999999999876668999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+||||+.++.+||+|||+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++|.
T Consensus 200 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~ 278 (437)
T 4aw2_A 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278 (437)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred ccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence 9999999999999999999999987654322 2234468999999999987 457899999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~~l 229 (304)
.||........ ......... ....|.... ..+.++.+||.+||+.+|++ |++++|+++|.
T Consensus 279 ~Pf~~~~~~~~------~~~i~~~~~---~~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 279 TPFYAESLVET------YGKIMNHKE---RFQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp CTTCCSSHHHH------HHHHHTHHH---HCCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred CCCCCCChhHH------HHhhhhccc---cccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 99975432111 110100000 011111111 12468899999999998888 99999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.85 Aligned_cols=212 Identities=22% Similarity=0.352 Sum_probs=174.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|++++|||||++++++...+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+|
T Consensus 265 ~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH 341 (495)
T 1opk_A 265 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341 (495)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 6999999999999999999999999999999999999999999764 456999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+||||+.++.+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 342 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~ 420 (495)
T 1opk_A 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420 (495)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998764322 222223456788999999999999999999999999999999 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 234 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~ 234 (304)
...... ........ . .....+..++..+.+||.+||+.||++|||+.++++.|+.+..
T Consensus 421 ~~~~~~---~~~~~~~~----~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 421 PGIDLS---QVYELLEK----D----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TTCCGG---GHHHHHHT----T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCHH---HHHHHHHc----C----------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 765322 11111110 0 0001122335789999999999999999999999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=298.76 Aligned_cols=206 Identities=26% Similarity=0.398 Sum_probs=169.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ |+||
T Consensus 91 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 165 (321)
T 2c30_A 91 NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG---VIHR 165 (321)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 6999999999999999999999999999999999999999998643 5999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 166 Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987644221 23346799999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.... ....... ....+... .....+..+.++|.+||+.||++|||+.|++++.
T Consensus 244 ~~~~---~~~~~~~----------~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 244 DSPV---QAMKRLR----------DSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp SCHH---HHHHHHH----------HSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCHH---HHHHHHh----------cCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 4221 1111000 00011110 0112346789999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=293.67 Aligned_cols=208 Identities=28% Similarity=0.539 Sum_probs=168.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+.. ++||||+++++|.+++.+....+++..++.++.|++.||+|||+.+ .+|+||
T Consensus 72 ~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~ 148 (287)
T 4f0f_A 72 REVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHR 148 (287)
T ss_dssp HHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCS
T ss_pred HHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecC
Confidence 5899999999999999999986654 7999999999999999887778999999999999999999999976 459999
Q ss_pred cCCCCCeEECCCCc-----EEEccccCcccCCCCCcceeeecccccccccCcchhh--cCCCCchhhhHHHHHHHHHHHh
Q 022003 82 DFKTSNILLDADYN-----AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 82 dlkp~Nili~~~~~-----~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~t 154 (304)
||||+||+++.++. +||+|||+++.... ......||..|+|||++. ...++.++|||||||++|+|++
T Consensus 149 dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~ 223 (287)
T 4f0f_A 149 DLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223 (287)
T ss_dssp CCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH
T ss_pred CCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc
Confidence 99999999988776 99999999985432 233467899999999984 4567899999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
|..||................ ....+. .+...+..+.++|.+||+.||.+|||++|+++.|+.
T Consensus 224 g~~pf~~~~~~~~~~~~~~~~----------~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 224 GEGPFDEYSYGKIKFINMIRE----------EGLRPT----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp SSCTTTTCCCCHHHHHHHHHH----------SCCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCccccccHHHHHHHHhc----------cCCCCC----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 999997653321110110000 001111 122335789999999999999999999999999865
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=307.18 Aligned_cols=212 Identities=21% Similarity=0.264 Sum_probs=162.3
Q ss_pred hHhhHhh-cCCCCcccceeeEEEe----CCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLG-DLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~-~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|++++. ..+||||+++++++.. .+.+|+|||||+||+|.+++..+. ..+++..++.++.||+.||.|||+.+
T Consensus 103 ~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 181 (400)
T 1nxk_A 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 181 (400)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5788774 4589999999999876 567899999999999999997753 46999999999999999999999988
Q ss_pred CCeEeccCCCCCeEECC---CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 76 RPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|+||||||+|||++. ++.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 182 --ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 256 (400)
T 1nxk_A 182 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256 (400)
T ss_dssp --EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHH
T ss_pred --ccccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHH
Confidence 999999999999987 7899999999998754322 23346789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcc-hhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 153 LTGRRSMDKNRPNGEHN-LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
++|..||.......... ....... ... ....+. ....+.++.+||.+||+.||++|||+.|++++..
T Consensus 257 l~g~~pf~~~~~~~~~~~~~~~i~~---~~~---~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 257 LCGYPPFYSNHGLAISPGMKTRIRM---GQY---EFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp HHSSCSCCCCTTCSSCCSHHHHHHH---TCC---CCCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HhCCCCCCCCccccccHHHHHHHHc---Ccc---cCCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 99999997654432211 1111110 000 000110 0123568999999999999999999999999753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=304.19 Aligned_cols=221 Identities=18% Similarity=0.171 Sum_probs=170.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEe----CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|+.+++.++||||+++++++.. ....|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+
T Consensus 97 ~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--- 171 (345)
T 2v62_A 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE--- 171 (345)
T ss_dssp HHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 57788889999999999999988 67899999999 999999986654 7999999999999999999999998
Q ss_pred eEeccCCCCCeEECCCC--cEEEccccCcccCCCCCcc-----eeeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 78 VIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
|+||||||+|||++.++ .+||+|||+++........ .......||..|+|||++.+..++.++|||||||++|
T Consensus 172 ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 251 (345)
T 2v62_A 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCML 251 (345)
T ss_dssp EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHH
Confidence 99999999999998877 9999999999875432111 1113457899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
+|++|..||........ ........... .+...+..... ....+.++.++|.+||+.||++|||++++++.|+
T Consensus 252 ell~g~~pf~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 324 (345)
T 2v62_A 252 RWLCGKLPWEQNLKDPV-AVQTAKTNLLD---ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN 324 (345)
T ss_dssp HHHHSSCTTGGGTTCHH-HHHHHHHHHHH---TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred HHHhCCCCccccccccH-HHHHHHHhhcc---cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 99999999964322111 01110000000 00000000000 0012468999999999999999999999999998
Q ss_pred CCCC
Q 022003 231 PLPN 234 (304)
Q Consensus 231 ~~~~ 234 (304)
.+..
T Consensus 325 ~~~~ 328 (345)
T 2v62_A 325 PHGI 328 (345)
T ss_dssp TTCC
T ss_pred ccCC
Confidence 7543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=300.96 Aligned_cols=209 Identities=27% Similarity=0.413 Sum_probs=166.7
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++++ +||||+++++++.+.+..|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 58 ~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH 133 (345)
T 3a8x_A 58 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIY 133 (345)
T ss_dssp HHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBC
T ss_pred HHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 588899888 8999999999999999999999999999999998654 36999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 134 rDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 211 (345)
T 3a8x_A 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211 (345)
T ss_dssp CCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcC
Confidence 9999999999999999999999998643222 12345689999999999999999999999999999999999999996
Q ss_pred CCCCCCCc--chhHhh-hhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 022003 161 KNRPNGEH--NLVEWA-RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~~ 228 (304)
........ ...... ........ . ++...+.++.+||.+||+.||.+||++ +|+++|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~i~~~~~--------~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 212 IVGSSDNPDQNTEDYLFQVILEKQI--------R----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp TTTC-------CHHHHHHHHHHCCC--------C----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CcccccccccccHHHHHHHHHcCCC--------C----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 53222111 001111 11111110 1 111235688999999999999999986 566654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=305.23 Aligned_cols=209 Identities=22% Similarity=0.315 Sum_probs=158.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++.+.+..++||||+.+++|.+++.... .+++..++.++.||+.||+|||+.+ |+||
T Consensus 65 ~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~ 140 (361)
T 3uc3_A 65 REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQ---ICHR 140 (361)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCSC
T ss_pred HHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 68999999999999999999999999999999999999999986543 6999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCc--EEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCch-hhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p 158 (304)
||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..|
T Consensus 141 Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~P 217 (361)
T 3uc3_A 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217 (361)
T ss_dssp CCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCC
Confidence 99999999987765 9999999997533221 2234579999999999998888765 9999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|......... .............+ +. ....+..+.+||.+||+.||++|||+.|+++|.
T Consensus 218 f~~~~~~~~~--~~~~~~~~~~~~~~-----~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 218 FEDPEEPRDY--RKTIQRILSVKYSI-----PD-----DIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp CC----CCCH--HHHHHHHHTTCCCC-----CT-----TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CCCCccHHHH--HHHHHHHhcCCCCC-----CC-----cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 9765432221 11111111111000 00 001246889999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=292.48 Aligned_cols=217 Identities=16% Similarity=0.134 Sum_probs=174.7
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++++ +|+|++++++++......++||||+ +++|.+++......+++..++.++.||+.||+|||+.+ |+|
T Consensus 54 ~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 129 (298)
T 1csn_A 54 DEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVY 129 (298)
T ss_dssp HHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EEC
T ss_pred HHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 589999999 8999999999999999999999999 99999999877667999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCc-----EEEccccCcccCCCCCcc-----eeeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 81 RDFKTSNILLDADYN-----AKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 81 ~dlkp~Nili~~~~~-----~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
|||||+||+++.++. +||+|||+++........ .......||..|+|||++.+..++.++|||||||++|
T Consensus 130 ~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 209 (298)
T 1csn_A 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFM 209 (298)
T ss_dssp CCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHH
Confidence 999999999987766 999999999876543221 1233467899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
+|++|..||.................... ....... . ...+.++.+++.+||+.||++|||++++++.|+
T Consensus 210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~ 279 (298)
T 1csn_A 210 YFLRGSLPWQGLKAATNKQKYERIGEKKQ-STPLREL-----C----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279 (298)
T ss_dssp HHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSCHHHH-----T----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHHcCCCCcchhhccccHHHHHHHHhhcc-CccHHHH-----H----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 99999999987543322221111110000 0000000 0 012468999999999999999999999999887
Q ss_pred CC
Q 022003 231 PL 232 (304)
Q Consensus 231 ~~ 232 (304)
.+
T Consensus 280 ~~ 281 (298)
T 1csn_A 280 KV 281 (298)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=306.84 Aligned_cols=203 Identities=28% Similarity=0.403 Sum_probs=166.9
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|.++++.+ +||||+++++++.+.+..|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 66 ~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH 141 (345)
T 1xjd_A 66 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVY 141 (345)
T ss_dssp HHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBC
T ss_pred HHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEe
Confidence 578888876 9999999999999999999999999999999999654 36999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 142 rDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (345)
T 1xjd_A 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 219 (345)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999999986432221 2345689999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~~ 228 (304)
..... ... ....... +.. +...+.++.+||.+||+.||++||++. ++++|
T Consensus 220 ~~~~~---~~~---~~i~~~~--------~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 220 GQDEE---ELF---HSIRMDN--------PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp CSSHH---HHH---HHHHHCC--------CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCCHH---HHH---HHHHhCC--------CCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 54321 111 1111110 111 112346889999999999999999997 66654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=307.28 Aligned_cols=211 Identities=27% Similarity=0.445 Sum_probs=161.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEe-CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++||||+++++++.. ++..++||||+++++|.+++.+....+++..++.++.||+.||+|||+.+ |+|
T Consensus 139 ~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH 215 (373)
T 3c1x_A 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVH 215 (373)
T ss_dssp HHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---Eec
Confidence 68999999999999999998764 45789999999999999999887778999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcc--eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~ 157 (304)
|||||+|||++.++.+||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 216 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~ 295 (373)
T 3c1x_A 216 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295 (373)
T ss_dssp SCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCC
Confidence 999999999999999999999999865432211 11233457789999999999999999999999999999999 677
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
||....... ....... .. .... +..++..+.++|.+||+.||++|||+.|+++.|+.+
T Consensus 296 p~~~~~~~~---~~~~~~~----~~---~~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 296 PYPDVNTFD---ITVYLLQ----GR---RLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp SCTTSCSSC---HHHHHHT----TC---CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHHH---HHHHHHc----CC---CCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 776543322 1111110 00 0111 112346899999999999999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=302.15 Aligned_cols=214 Identities=25% Similarity=0.303 Sum_probs=150.5
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++.+. ||||+++++++.+.+..|+||||+++++|.+++.+. ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 54 ~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH 129 (325)
T 3kn6_A 54 KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVH 129 (325)
T ss_dssp HHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---Cee
Confidence 5899999997 999999999999999999999999999999999765 47999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCC---cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 81 RDFKTSNILLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 81 ~dlkp~Nili~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
|||||+|||++.++ .+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 130 ~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 207 (325)
T 3kn6_A 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQV 207 (325)
T ss_dssp CCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCC
Confidence 99999999997765 899999999987543322 2334568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcc-hhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 158 SMDKNRPNGEHN-LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 158 p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
||.......... ............. ..........+.++.+||.+||+.||.+|||++|++++.
T Consensus 208 pf~~~~~~~~~~~~~~~~~~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 208 PFQSHDRSLTCTSAVEIMKKIKKGDF--------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp TTC-------CCCHHHHHHHHTTTCC--------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred CCCCCccccccccHHHHHHHHHcCCC--------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 997654322111 1111111000000 000000012357899999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=292.59 Aligned_cols=208 Identities=31% Similarity=0.503 Sum_probs=161.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++||||+++++++..++..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+..+++||
T Consensus 55 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~ 132 (271)
T 3dtc_A 55 QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132 (271)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCS
T ss_pred HHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeec
Confidence 589999999999999999999999999999999999999999854 369999999999999999999999874448899
Q ss_pred cCCCCCeEECC--------CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHH
Q 022003 82 DFKTSNILLDA--------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 82 dlkp~Nili~~--------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 153 (304)
||||+||+++. ++.+||+|||++....... .....||..|+|||++.+..++.++||||||+++|+|+
T Consensus 133 dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 208 (271)
T 3dtc_A 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL 208 (271)
T ss_dssp CCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred CCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 99999999986 7789999999998654322 22356899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 154 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 154 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
+|..||....... . ....... ......+...+..+.++|.+||+.||.+|||+.|++++|+.
T Consensus 209 ~g~~p~~~~~~~~----~--~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 209 TGEVPFRGIDGLA----V--AYGVAMN----------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HCCCTTTTSCHHH----H--HHHHHTS----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred hCCCCCCCCCHHH----H--HHhhhcC----------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 9999997542110 0 0000000 00011122335689999999999999999999999999865
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=301.92 Aligned_cols=212 Identities=25% Similarity=0.402 Sum_probs=172.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------SLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+
T Consensus 77 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 156 (322)
T 1p4o_A 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 156 (322)
T ss_dssp HHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 6999999999999999999999999999999999999999998642 1457999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
.+ |+||||||+||+++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|+|
T Consensus 157 ~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 233 (322)
T 1p4o_A 157 NK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233 (322)
T ss_dssp TT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHH
Confidence 98 999999999999999999999999999865433222223345678899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 153 LT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 153 ~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
++ |..||...... ....... .. .. .. .+...+..+.++|.+||+.||.+|||+.|++++|+.
T Consensus 234 ~~~g~~p~~~~~~~---~~~~~~~----~~-~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~ 296 (322)
T 1p4o_A 234 ATLAEQPYQGLSNE---QVLRFVM----EG-GL-----LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296 (322)
T ss_dssp HHTSCCTTTTSCHH---HHHHHHH----TT-CC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred HhcCCCccccCCHH---HHHHHHH----cC-Cc-----CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 99 88888654221 1111100 00 00 00 111235689999999999999999999999999976
Q ss_pred CC
Q 022003 232 LP 233 (304)
Q Consensus 232 ~~ 233 (304)
..
T Consensus 297 ~~ 298 (322)
T 1p4o_A 297 EM 298 (322)
T ss_dssp GS
T ss_pred hh
Confidence 53
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=306.17 Aligned_cols=211 Identities=25% Similarity=0.390 Sum_probs=172.3
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-------------SLPLPWSIRMKIALGAAKGL 67 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------------~~~l~~~~~~~i~~qi~~~l 67 (304)
+|+++++++ +||||+++++++...+..++||||+++|+|.+++... ...+++..++.++.||+.||
T Consensus 98 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l 177 (333)
T 2i1m_A 98 SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGM 177 (333)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 699999999 8999999999999999999999999999999998643 34589999999999999999
Q ss_pred HHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHH
Q 022003 68 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 147 (304)
Q Consensus 68 ~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 147 (304)
.|||+.+ |+||||||+|||++.++.+||+|||+++...............||..|+|||++.+..++.++|||||||
T Consensus 178 ~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 254 (333)
T 2i1m_A 178 AFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254 (333)
T ss_dssp HHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHH
Confidence 9999998 9999999999999999999999999998754433333344456788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 022003 148 VLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226 (304)
Q Consensus 148 il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 226 (304)
++|+|++ |..||....... ........ . .... .+...+..+.++|.+||+.||.+|||+.|++
T Consensus 255 il~el~t~g~~p~~~~~~~~--~~~~~~~~----~------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 318 (333)
T 2i1m_A 255 LLWEIFSLGLNPYPGILVNS--KFYKLVKD----G------YQMA----QPAFAPKNIYSIMQACWALEPTHRPTFQQIC 318 (333)
T ss_dssp HHHHHTTTSCCSSTTCCSSH--HHHHHHHH----T------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHcCCCCCCcccchhH--HHHHHHhc----C------CCCC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 9999998 899997643221 11111110 0 0000 1112246889999999999999999999999
Q ss_pred HHhCC
Q 022003 227 EALKP 231 (304)
Q Consensus 227 ~~l~~ 231 (304)
+.|+.
T Consensus 319 ~~L~~ 323 (333)
T 2i1m_A 319 SFLQE 323 (333)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=300.60 Aligned_cols=217 Identities=23% Similarity=0.333 Sum_probs=166.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|++++++++||||+++++++..++..++||||+. ++|.+++... ...+++..++.++.||+.||.|||+.+
T Consensus 52 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-- 128 (317)
T 2pmi_A 52 REISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-- 128 (317)
T ss_dssp HHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 69999999999999999999999999999999996 6999988543 245999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhC
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg 155 (304)
|+||||||+|||++.++.+||+|||+++....... ......||..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 129 -ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 205 (317)
T 2pmi_A 129 -ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205 (317)
T ss_dssp -EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred -eeeCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999987643221 2234578999999999976 4689999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhh-----hhccc---ccc------------ccccCCccCCCCCHHHHHHHHHHHHHhccCC
Q 022003 156 RRSMDKNRPNGEHNLVEWARP-----HLGER---RRF------------YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 215 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~-----~~~~~---~~~------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 215 (304)
..||................. .+... ..+ .+.+.+... ...+.++.+||.+||+.|
T Consensus 206 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~d 281 (317)
T 2pmi_A 206 KPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTK----EPLDGNLMDFLHGLLQLN 281 (317)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCS----SCCCHHHHHHHHHHSCSS
T ss_pred CCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhccccc----ccCCHHHHHHHHHHCCCC
Confidence 999976432211100000000 00000 000 000000011 112468999999999999
Q ss_pred CCCCCCHHHHHHH
Q 022003 216 PKARPLMSEVVEA 228 (304)
Q Consensus 216 p~~Rps~~ell~~ 228 (304)
|++|||++|++++
T Consensus 282 P~~Rpt~~e~l~h 294 (317)
T 2pmi_A 282 PDMRLSAKQALHH 294 (317)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=302.11 Aligned_cols=211 Identities=25% Similarity=0.406 Sum_probs=173.4
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~ 65 (304)
+|+++++++ +||||+++++++...+..++||||+++++|.+++.... ..+++..++.++.||+.
T Consensus 89 ~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 168 (334)
T 2pvf_A 89 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 168 (334)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHH
Confidence 689999999 89999999999999999999999999999999997653 24899999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||.|||+.+ |+||||||+||+++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||
T Consensus 169 aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 245 (334)
T 2pvf_A 169 GMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245 (334)
T ss_dssp HHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHH
Confidence 999999998 99999999999999999999999999987655433333344567889999999999899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|+|++ |..||...... ....... .. .... .+...+..+.++|.+||+.||.+|||+.|
T Consensus 246 G~il~ellt~g~~p~~~~~~~---~~~~~~~----~~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e 308 (334)
T 2pvf_A 246 GVLMWEIFTLGGSPYPGIPVE---ELFKLLK----EG------HRMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQ 308 (334)
T ss_dssp HHHHHHHHTTSCCSSTTCCHH---HHHHHHH----HT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhCCCCCcCcCCHH---HHHHHHh----cC------CCCC----CCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999 99999754221 1111100 00 0011 11123568999999999999999999999
Q ss_pred HHHHhCCC
Q 022003 225 VVEALKPL 232 (304)
Q Consensus 225 ll~~l~~~ 232 (304)
+++.|+.+
T Consensus 309 ll~~L~~l 316 (334)
T 2pvf_A 309 LVEDLDRI 316 (334)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=302.19 Aligned_cols=211 Identities=23% Similarity=0.329 Sum_probs=168.0
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++.++ +||||+++++++.+++..|+|||||.||+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+|
T Consensus 64 ~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivH 139 (342)
T 2qr7_A 64 EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG---VVH 139 (342)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEe
Confidence 588899888 7999999999999999999999999999999999665 46999999999999999999999998 999
Q ss_pred ccCCCCCeEECCC----CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCC
Q 022003 81 RDFKTSNILLDAD----YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 81 ~dlkp~Nili~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 156 (304)
|||||+|||+..+ +.+||+|||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 140 rDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 217 (342)
T 2qr7_A 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY 217 (342)
T ss_dssp SCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSS
T ss_pred ccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCC
Confidence 9999999998433 3599999999987543322 233467899999999999888999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.||................ .... ..........+.++.+||.+||+.||++|||+.+++++.
T Consensus 218 ~Pf~~~~~~~~~~~~~~i~---~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 218 TPFANGPDDTPEEILARIG---SGKF--------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp CSSCSSTTSCHHHHHHHHH---HCCC--------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred CCCCCCCcCCHHHHHHHHc---cCCc--------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 9997543222111111111 0000 001111112357899999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=303.49 Aligned_cols=207 Identities=25% Similarity=0.373 Sum_probs=160.5
Q ss_pred hHhhHhhcCCC--CcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++|++++| +||+++++++..++..++|||+. +++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+
T Consensus 56 ~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ii 130 (343)
T 3dbq_A 56 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IV 130 (343)
T ss_dssp HHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 59999999987 99999999999999999999955 88999999765 47999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-----------CCCCchhhhHHHHHH
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVV 148 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~i 148 (304)
||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||+
T Consensus 131 HrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~i 209 (343)
T 3dbq_A 131 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 209 (343)
T ss_dssp CCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHH
T ss_pred cCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHH
Confidence 999999999996 67899999999987654433333445679999999999875 678999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 149 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+|+|++|..||...... ..... ...++.....++...+..+.+||.+||+.||.+|||+.|++++
T Consensus 210 l~ell~g~~pf~~~~~~-----~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 210 LYYMTYGKTPFQQIINQ-----ISKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHHSSCTTTTCCSH-----HHHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCCCcchhhhhH-----HHHHH----------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 99999999999643211 11000 1111111111122224678999999999999999999999986
Q ss_pred h
Q 022003 229 L 229 (304)
Q Consensus 229 l 229 (304)
.
T Consensus 275 p 275 (343)
T 3dbq_A 275 P 275 (343)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=295.35 Aligned_cols=210 Identities=25% Similarity=0.385 Sum_probs=172.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++ ..+..++||||+.+++|.+++......+++..++.++.||+.||.|||+.+ ++||
T Consensus 59 ~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 134 (287)
T 1u59_A 59 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHR 134 (287)
T ss_dssp HHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeC
Confidence 699999999999999999998 556789999999999999999777777999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||+||+++.++.+||+|||++......... .......+|..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 135 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 214 (287)
T 1u59_A 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214 (287)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999876543322 11223456889999999998899999999999999999998 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
...... ........ .. .+. .+...+..+.++|.+||+.||++|||+.+++++|+.+
T Consensus 215 ~~~~~~---~~~~~i~~----~~------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 215 KKMKGP---EVMAFIEQ----GK------RME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp TTCCTH---HHHHHHHT----TC------CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHH---HHHHHHhc----CC------cCC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 764321 11111110 00 011 1123357899999999999999999999999998644
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=295.97 Aligned_cols=204 Identities=25% Similarity=0.375 Sum_probs=163.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++|++++||||+++++++.. .+..++||||+++++|.+++. ...+++..++.++.||+.||+|||+.+ |+
T Consensus 85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iv 159 (298)
T 2zv2_A 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK---II 159 (298)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 59999999999999999999987 568899999999999988653 346999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC---CCchhhhHHHHHHHHHHHhCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg~ 156 (304)
||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 160 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 999999999999999999999999987654322 233457899999999987655 478999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||..... .............+ +. .. ..+.++.+||.+||+.||++|||+.|++++
T Consensus 238 ~pf~~~~~------~~~~~~~~~~~~~~-----~~-~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 238 CPFMDERI------MCLHSKIKSQALEF-----PD-QP----DIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CSSCCSSH------HHHHHHHHHCCCCC-----CS-SS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCCccH------HHHHHHHhcccCCC-----CC-cc----ccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99965321 11111110000000 00 01 124688999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=311.60 Aligned_cols=207 Identities=27% Similarity=0.419 Sum_probs=169.0
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCC-eeEEEEecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
++|+++|++++|||||++++++...+ ..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |
T Consensus 234 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i 310 (450)
T 1k9a_A 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 310 (450)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 36999999999999999999988765 78999999999999999976543 4799999999999999999999998 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~ 157 (304)
+||||||+|||++.++.+||+|||+++..... .....++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 311 vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~ 385 (450)
T 1k9a_A 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 385 (450)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999864321 122356889999999999999999999999999999998 999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
||........ ..... ... . .. .+..++..+.+||.+||+.||++|||+.++++.|+.+
T Consensus 386 P~~~~~~~~~---~~~i~----~~~---~---~~----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 386 PYPRIPLKDV---VPRVE----KGY---K---MD----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp SSTTSCTTTH---HHHHH----TTC---C---CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHH---HHHHH----cCC---C---CC----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 9976543221 11111 000 0 11 1223357899999999999999999999999988643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=305.80 Aligned_cols=208 Identities=24% Similarity=0.278 Sum_probs=169.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++|||||++++++.+.+.+|+|||||+||+|.+++.+. .+++..++.++.||+.||+|||+.+ |+||
T Consensus 118 ~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHr 192 (410)
T 3v8s_A 118 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHR 192 (410)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEec
Confidence 6899999999999999999999999999999999999999998654 5899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC----CCchhhhHHHHHHHHHHHhCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~tg~~ 157 (304)
||||+|||++.+|.+||+|||+++...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|..
T Consensus 193 DLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 271 (410)
T 3v8s_A 193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271 (410)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSC
T ss_pred cCCHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCC
Confidence 999999999999999999999998765432 22234578999999999998665 8899999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHh
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 229 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~~l 229 (304)
||........ .......... ...+.. . ..+.++.+||.+||+.+|.+ ||+++|+++|.
T Consensus 272 Pf~~~~~~~~------~~~i~~~~~~---~~~p~~-~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 272 PFYADSLVGT------YSKIMNHKNS---LTFPDD-N----DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp TTCCSSHHHH------HHHHHTHHHH---CCCCTT-C----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred CCCCCChhhH------HHHHHhcccc---ccCCCc-c----cccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 9975432111 1111000000 000100 0 12468999999999999988 99999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=295.08 Aligned_cols=211 Identities=27% Similarity=0.435 Sum_probs=168.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEe-CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++||||+++++++.. ++..++||||+.+++|.+++.+....+++..++.++.|++.||+|||+.+ |+|
T Consensus 75 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H 151 (298)
T 3f66_A 75 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVH 151 (298)
T ss_dssp HHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccC
Confidence 68999999999999999998654 55789999999999999999877778999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCc--ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 157 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~ 157 (304)
|||||+||+++.++.+||+|||+++....... ........||..|+|||++.+..++.++|||||||++|+|++ |.+
T Consensus 152 ~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~ 231 (298)
T 3f66_A 152 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231 (298)
T ss_dssp SCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987643321 112233567889999999999999999999999999999999 556
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
||........ ...... .. .... +...+..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 232 ~~~~~~~~~~---~~~~~~---~~----~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 232 PYPDVNTFDI---TVYLLQ---GR----RLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp SSTTSCTTTH---HHHHHT---TC----CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCCHHHH---HHHHhc---CC----CCCC-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 6654432211 111100 00 0011 112246899999999999999999999999988654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=301.43 Aligned_cols=211 Identities=24% Similarity=0.404 Sum_probs=166.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||
T Consensus 95 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 171 (333)
T 1mqb_A 95 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHR 171 (333)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCC
Confidence 6999999999999999999999999999999999999999999877678999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||+||+++.++.+||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 172 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf 251 (333)
T 1mqb_A 172 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251 (333)
T ss_dssp CCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999876433221 11223446788999999999999999999999999999999 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
...... ...... ..... .. .+...+..+.++|.+||+.||++||++.++++.|+.+
T Consensus 252 ~~~~~~---~~~~~~----~~~~~------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 252 WELSNH---EVMKAI----NDGFR------LP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp TTCCHH---HHHHHH----HTTCC------CC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ccCCHH---HHHHHH----HCCCc------CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 654221 111110 00000 00 1112356899999999999999999999999988654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=300.24 Aligned_cols=204 Identities=27% Similarity=0.352 Sum_probs=164.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++...+..|+||||+++++|.+++.+.. .+++..++.++.||+.||.|||+.+ |+||
T Consensus 70 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---ivH~ 145 (327)
T 3a62_A 70 AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKG---IIYR 145 (327)
T ss_dssp -HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEcc
Confidence 59999999999999999999999999999999999999999986543 6899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 146 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 146 DLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp CCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999997643221 123346799999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~l 229 (304)
.... ........... . ++...+..+.+||.+||+.||.+|| ++.|+++|.
T Consensus 224 ~~~~------~~~~~i~~~~~--------~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 224 ENRK------KTIDKILKCKL--------N----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp SSHH------HHHHHHHHTCC--------C----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred CCHH------HHHHHHHhCCC--------C----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 4221 11111111100 1 1112246889999999999999999 788998854
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=303.44 Aligned_cols=203 Identities=24% Similarity=0.353 Sum_probs=167.1
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|.++|..+ +||||+++++++.+.+..|+||||++||+|.+++.+.. .+++..++.++.||+.||+|||+.+ |+|
T Consensus 69 ~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g---ivH 144 (353)
T 2i0e_A 69 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG---IIY 144 (353)
T ss_dssp HHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CBC
T ss_pred HHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 588899888 89999999999999999999999999999999996543 6999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 145 rDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 222 (353)
T 2i0e_A 145 RDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222 (353)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCC
Confidence 9999999999999999999999998643221 12345689999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~~ 228 (304)
..... ............ ++...+.++.+||.+||+.||.+||+ ++++++|
T Consensus 223 ~~~~~------~~~~~i~~~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 223 GEDED------ELFQSIMEHNVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CSSHH------HHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCHH------HHHHHHHhCCCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 54221 111111111111 11123578999999999999999995 5777765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=307.46 Aligned_cols=213 Identities=27% Similarity=0.311 Sum_probs=167.8
Q ss_pred hHhhH-hhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~i-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|..+ ++.++||||+++++++.+.+..|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 87 ~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH 162 (373)
T 2r5t_A 87 SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVY 162 (373)
T ss_dssp ----CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 45555 56789999999999999999999999999999999998654 36899999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 163 rDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 240 (373)
T 2r5t_A 163 RDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240 (373)
T ss_dssp CCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999998643221 12345689999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCCCccC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 238 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~~~~~ 238 (304)
..... ............ . +...+..+.+||.+||+.||.+||++.+.++.+...+++...
T Consensus 241 ~~~~~------~~~~~i~~~~~~--------~----~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 241 SRNTA------EMYDNILNKPLQ--------L----KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp CSBHH------HHHHHHHHSCCC--------C----CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred CCCHH------HHHHHHHhcccC--------C----CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 54221 111111111100 1 112246889999999999999999986555555555555444
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=317.31 Aligned_cols=208 Identities=30% Similarity=0.400 Sum_probs=172.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|++++|||||++++++.+.+..|+||||++||+|.+++.... ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 233 ~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvH 309 (576)
T 2acx_A 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVY 309 (576)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eec
Confidence 69999999999999999999999999999999999999999997653 35999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||||+.+|.+||+|||+++....... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 310 rDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~ 386 (576)
T 2acx_A 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386 (576)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSS
T ss_pred cCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999987654322 234589999999999999899999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~l 229 (304)
........... ....... ... ++...+.++.+||.+||+.||.+|| +++|+++|.
T Consensus 387 ~~~~~~~~~~i--~~~i~~~--------~~~----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 387 QRKKKIKREEV--ERLVKEV--------PEE----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp CSSSCCCHHHH--HHHHHHC--------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred ccccchhHHHH--HHHhhcc--------ccc----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 65432221111 1111000 011 1122357899999999999999999 789998763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=298.29 Aligned_cols=209 Identities=25% Similarity=0.319 Sum_probs=159.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 97 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 172 (349)
T 2w4o_A 97 TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG---IVHR 172 (349)
T ss_dssp --CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEec
Confidence 6999999999999999999999999999999999999999998654 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECC---CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+|||++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 173 Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 249 (349)
T 2w4o_A 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249 (349)
T ss_dssp CCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 99999999975 8899999999998754321 22345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
|....... ... ........ ....+ .....+.++.+||.+||+.||++|||+.|++++..
T Consensus 250 f~~~~~~~--~~~---~~i~~~~~---~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 250 FYDERGDQ--FMF---RRILNCEY---YFISP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp TCCTTCHH--HHH---HHHHTTCC---CCCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCCCcccH--HHH---HHHHhCCC---ccCCc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 96543211 000 00000000 00011 11123568899999999999999999999999643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=291.31 Aligned_cols=205 Identities=27% Similarity=0.390 Sum_probs=150.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||
T Consensus 60 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 136 (278)
T 3cok_A 60 NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHR 136 (278)
T ss_dssp HHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 5899999999999999999999999999999999999999999877678999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 137 dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp SCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987643221 12235689999999999998999999999999999999999999976
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.......... . ..+.. .+...+.++.++|.+||+.||++|||+++++++.
T Consensus 215 ~~~~~~~~~~------~--------~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 215 DTVKNTLNKV------V--------LADYE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp CSCC-----C------C--------SSCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred hhHHHHHHHH------h--------hcccC----CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 4332211000 0 00001 1112346889999999999999999999999853
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.43 Aligned_cols=205 Identities=28% Similarity=0.364 Sum_probs=165.1
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeE
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ii 79 (304)
++|+++++.++||||+++++++...+..|+||||+++++|.+++.+. ..+++..+..++.||+.||+|||+ .+ |+
T Consensus 196 ~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---ii 271 (446)
T 4ejn_A 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VV 271 (446)
T ss_dssp -----CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CC
T ss_pred HHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EE
Confidence 36889999999999999999999999999999999999999998654 379999999999999999999998 88 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||||||+||||+.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 272 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 349 (446)
T 4ejn_A 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349 (446)
T ss_dssp CCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ECCCCHHHEEECCCCCEEEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCC
Confidence 99999999999999999999999998643322 2234468999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 229 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~l 229 (304)
...... ............ ++...+.++.+||.+||+.||.+|| |++|+++|.
T Consensus 350 ~~~~~~------~~~~~i~~~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 350 YNQDHE------KLFELILMEEIR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp CCSSHH------HHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CCCCHH------HHHHHHHhCCCC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 654221 111111111111 1112346889999999999999999 999999853
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=311.25 Aligned_cols=203 Identities=25% Similarity=0.354 Sum_probs=169.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|+.++||||+++++++...+..++||||+++++|.+++.++ ..+++..++.++.||+.||+|||+.+ |+||
T Consensus 65 ~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHr 140 (476)
T 2y94_A 65 REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM---VVHR 140 (476)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECS
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcc
Confidence 6999999999999999999999999999999999999999999654 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 141 DLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 217 (476)
T 2y94_A 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217 (476)
T ss_dssp CCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC
Confidence 999999999999999999999998765432 2334579999999999988765 789999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..... ..... ..... . . .+...+.++.+||.+||+.||.+|||++|++++.
T Consensus 218 ~~~~~---~~~~~---i~~~~-----~---~----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 218 DDHVP---TLFKK---ICDGI-----F---Y----TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp CSSSH---HHHHH---HHTTC-----C---C----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred CCCHH---HHHHH---HhcCC-----c---C----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 54321 11110 00000 0 0 0111246789999999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=306.51 Aligned_cols=207 Identities=24% Similarity=0.374 Sum_probs=161.2
Q ss_pred hHhhHhhcCC--CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++|++++ ||||+++++++...+..|+|||+ .+++|.+++.+.. .+++..++.++.||+.||.|||+.+ |+
T Consensus 103 ~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---iv 177 (390)
T 2zmd_A 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---IV 177 (390)
T ss_dssp HHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT---CC
T ss_pred HHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 6999999996 59999999999999999999995 5889999997654 7899999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-----------CCCCchhhhHHHHHH
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVV 148 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~i 148 (304)
||||||+|||++ ++.+||+|||+++..............+||+.|+|||++.+ ..++.++|||||||+
T Consensus 178 HrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvi 256 (390)
T 2zmd_A 178 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256 (390)
T ss_dssp CCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHH
T ss_pred ecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHH
Confidence 999999999995 58999999999987654433333445679999999999875 468999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 149 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+|+|++|..||...... ..... ..+++.....++...+.++.+||.+||+.||.+|||+.|++++
T Consensus 257 l~ell~G~~Pf~~~~~~-----~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 257 LYYMTYGKTPFQQIINQ-----ISKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHHSSCTTTTCCCH-----HHHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHCCCcchhhhHH-----HHHHH----------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 99999999999653211 11111 1111111111111124688999999999999999999999986
Q ss_pred h
Q 022003 229 L 229 (304)
Q Consensus 229 l 229 (304)
.
T Consensus 322 p 322 (390)
T 2zmd_A 322 P 322 (390)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=299.05 Aligned_cols=198 Identities=24% Similarity=0.305 Sum_probs=167.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|++++||||+++++++.+.+..++||||+.+| +|.+++.... .+++..++.++.||+.||.|||+.+ |+|
T Consensus 78 ~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---ivH 153 (335)
T 3dls_A 78 LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKD---IIH 153 (335)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eEE
Confidence 5999999999999999999999999999999999776 9999986553 6999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~ 159 (304)
|||||+|||++.++.+||+|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus 154 ~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 230 (335)
T 3dls_A 154 RDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230 (335)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCch
Confidence 99999999999999999999999987654332 233578999999999988876 88999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
........ ....+ +...+.++.+||.+||+.||++|||+++++++..
T Consensus 231 ~~~~~~~~------------------~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 231 CELEETVE------------------AAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp SSGGGGTT------------------TCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred hhHHHHHh------------------hccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 64211000 00000 0012468999999999999999999999999743
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=297.17 Aligned_cols=218 Identities=24% Similarity=0.345 Sum_probs=167.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++||||+++++++... ...++||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+
T Consensus 60 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iv 136 (295)
T 3ugc_A 60 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YI 136 (295)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cc
Confidence 699999999999999999998653 4689999999999999999877667999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 137 H~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 216 (295)
T 3ugc_A 137 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216 (295)
T ss_dssp CSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCT
T ss_pred cCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccc
Confidence 9999999999999999999999999876443221 222334577889999999999999999999999999999999988
Q ss_pred CCCCCCC---------CCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPN---------GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
+...... ............... ......+..++.++.++|.+||+.||++|||+.|+++.|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 217 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKN----------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp TCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT----------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cCCChHHHHhhhcCccccchhHHHHHHHHhc----------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 8642110 000000000000000 001111223457899999999999999999999999988
Q ss_pred CCC
Q 022003 230 KPL 232 (304)
Q Consensus 230 ~~~ 232 (304)
+.+
T Consensus 287 ~~l 289 (295)
T 3ugc_A 287 DQI 289 (295)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=313.29 Aligned_cols=222 Identities=22% Similarity=0.300 Sum_probs=158.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC-----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+++|++++|||||++++++... ..+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||+.+
T Consensus 101 ~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~-- 176 (458)
T 3rp9_A 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG-- 176 (458)
T ss_dssp HHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 699999999999999999998543 5689999998 67999998654 47999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcc-------------------------eeeecccccccccCcchh
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-------------------------HVSTRVMGTYGYAAPEYV 131 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~ 131 (304)
|+||||||+||||+.++.+||+|||+++........ ......+||++|+|||++
T Consensus 177 -iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 255 (458)
T 3rp9_A 177 -ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI 255 (458)
T ss_dssp -CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHH
T ss_pred -cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHh
Confidence 999999999999999999999999999876432110 122346789999999986
Q ss_pred -hcCCCCchhhhHHHHHHHHHHHh-----------CCCCCCCCCCCCCc-----------------chhHhhhhhhcc--
Q 022003 132 -MTGHLTSRSDVYSFGVVLLEMLT-----------GRRSMDKNRPNGEH-----------------NLVEWARPHLGE-- 180 (304)
Q Consensus 132 -~~~~~~~~~DiwslG~il~el~t-----------g~~p~~~~~~~~~~-----------------~~~~~~~~~~~~-- 180 (304)
.+..|+.++|||||||++|||++ |.++|.+....... .........++.
T Consensus 256 ~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~ 335 (458)
T 3rp9_A 256 LLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS 335 (458)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCC
T ss_pred hCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCC
Confidence 46679999999999999999999 55666543211000 000000000000
Q ss_pred -----------ccccccccC----CccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 181 -----------RRRFYRLID----PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 181 -----------~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
...+...+. ..+.. .....+.++.+||.+||+.||++|||++|+++|.
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 336 EEDIEALEKEDAKRYIRIFPKREGTDLAE-RFPASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp HHHHHTSSCHHHHHHHTTSCCCCCCCGGG-GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHhhcCCHHHHHHHHhcCCCCCCCHHH-HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 000000000 00000 0112257899999999999999999999999964
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=294.03 Aligned_cols=218 Identities=26% Similarity=0.330 Sum_probs=166.1
Q ss_pred hHhhHhhc--CCCCcccceeeEEEeC----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh----
Q 022003 2 AEVNFLGD--LVHLNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH---- 71 (304)
Q Consensus 2 ~E~~il~~--l~h~niv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH---- 71 (304)
+|.+++.. ++||||+++++++... ...++||||+++|+|.+++... .+++..++.++.||+.||+|||
T Consensus 49 ~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~ 126 (301)
T 3q4u_A 49 RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIF 126 (301)
T ss_dssp HHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBC
T ss_pred HHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhh
Confidence 36666666 7999999999987653 4589999999999999999543 6999999999999999999999
Q ss_pred ----cCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcce--eeecccccccccCcchhhcC------CCCch
Q 022003 72 ----EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTSR 139 (304)
Q Consensus 72 ----~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~ 139 (304)
+.+ |+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+. .++.+
T Consensus 127 ~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 203 (301)
T 3q4u_A 127 GTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR 203 (301)
T ss_dssp STTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHH
T ss_pred hccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCch
Confidence 777 9999999999999999999999999997654332221 12234789999999999876 45579
Q ss_pred hhhHHHHHHHHHHHhC----------CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccC-CCCCHHHHHHHHHHH
Q 022003 140 SDVYSFGVVLLEMLTG----------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE-GHFSIKGAQKAAQLA 208 (304)
Q Consensus 140 ~DiwslG~il~el~tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li 208 (304)
+|||||||++|||++| ..||............ ........ ...+... .......+..+.+||
T Consensus 204 ~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li 276 (301)
T 3q4u_A 204 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED-MRKVVCVD------QQRPNIPNRWFSDPTLTSLAKLM 276 (301)
T ss_dssp HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH-HHHHHTTS------CCCCCCCGGGGGSHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhh-hhHHHhcc------CCCCCCChhhccCccHHHHHHHH
Confidence 9999999999999999 7777654433322111 11100000 0011111 112335678999999
Q ss_pred HHhccCCCCCCCCHHHHHHHhCC
Q 022003 209 AHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 209 ~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
.+||+.||++|||+.|+++.|+.
T Consensus 277 ~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 277 KECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp HHHCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhhcChhhCCCHHHHHHHHhc
Confidence 99999999999999999998864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=294.57 Aligned_cols=212 Identities=24% Similarity=0.357 Sum_probs=169.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCee-EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~-~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++||||+++++++...+.. ++||||+.+++|.+++......+++..++.++.|++.||+|||+.+ ++|
T Consensus 71 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H 147 (298)
T 3pls_A 71 REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVH 147 (298)
T ss_dssp HHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 689999999999999999999876655 9999999999999999887778999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCc--ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|||||+||+++.++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 148 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~ 227 (298)
T 3pls_A 148 RDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227 (298)
T ss_dssp SCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred CCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCC
Confidence 99999999999999999999999986543221 1122335678899999999999999999999999999999996555
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
+...... .......... . ... .+...+..+.+++.+||+.||.+|||++++++.|+.+
T Consensus 228 ~~~~~~~--~~~~~~~~~~----~------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 228 PYRHIDP--FDLTHFLAQG----R------RLP----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp TTTTSCG--GGHHHHHHTT----C------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCCH--HHHHHHhhcC----C------CCC----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 4332211 1111111100 0 000 1112246899999999999999999999999988654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=292.73 Aligned_cols=206 Identities=24% Similarity=0.375 Sum_probs=167.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..++..++||||+.+++|.+++.+....+++..++.++.||+.||.|||+.+ |+||
T Consensus 61 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 137 (289)
T 4fvq_A 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHG 137 (289)
T ss_dssp HHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECC
Confidence 6899999999999999999999999999999999999999999877666999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCc--------EEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHH
Q 022003 82 DFKTSNILLDADYN--------AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 82 dlkp~Nili~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 152 (304)
||||+|||++.++. +||+|||++..... .....||..|+|||++.+ ..++.++|||||||++|+|
T Consensus 138 Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 211 (289)
T 4fvq_A 138 NVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211 (289)
T ss_dssp CCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHH
T ss_pred CcCcceEEEecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHH
Confidence 99999999988877 99999999876432 223457899999999987 7799999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
++|..|+....... .... .......+ ... .+.++.++|.+||+.||++|||+.+++++|+.+
T Consensus 212 ~~g~~~~~~~~~~~--~~~~----~~~~~~~~----~~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l 273 (289)
T 4fvq_A 212 CSGGDKPLSALDSQ--RKLQ----FYEDRHQL----PAP--------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273 (289)
T ss_dssp HTTTCCTTTTSCHH--HHHH----HHHTTCCC----CCC--------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred HcCCCCCccccchH--HHHH----HhhccCCC----CCC--------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 99654443221110 0000 00011111 111 134678999999999999999999999999877
Q ss_pred CC
Q 022003 233 PN 234 (304)
Q Consensus 233 ~~ 234 (304)
..
T Consensus 274 ~~ 275 (289)
T 4fvq_A 274 FT 275 (289)
T ss_dssp C-
T ss_pred cC
Confidence 65
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=322.58 Aligned_cols=210 Identities=25% Similarity=0.392 Sum_probs=168.4
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++++|||||++++++.. +..++|||||.+|+|.+++......+++..+..++.||+.||+|||+.+ |+|
T Consensus 384 ~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH 459 (613)
T 2ozo_A 384 MREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 459 (613)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEc
Confidence 369999999999999999999876 5689999999999999999877777999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
|||||+||||+.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 460 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~P 539 (613)
T 2ozo_A 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539 (613)
T ss_dssp SCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999999876433221 11222345688999999999999999999999999999998 9999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
|....... ...... ... . ...+..++.++.+||.+||+.||++|||+.++++.|+.
T Consensus 540 f~~~~~~~---~~~~i~----~~~---~-------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 540 YKKMKGPE---VMAFIE----QGK---R-------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp TTTCCSHH---HHHHHH----TTC---C-------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCHHH---HHHHHH----cCC---C-------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 97653321 111111 000 0 01122345789999999999999999999999998863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=306.09 Aligned_cols=210 Identities=20% Similarity=0.214 Sum_probs=168.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++..++||||+++++++.+.+.+|+||||++||+|.+++.+....+++..++.++.||+.||+|||+.+ |+||
T Consensus 110 ~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHr 186 (412)
T 2vd5_A 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHR 186 (412)
T ss_dssp HHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 5889999999999999999999999999999999999999999776667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-------cCCCCchhhhHHHHHHHHHHHh
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~t 154 (304)
||||+||||+.+|.+||+|||+++....... ......+||+.|+|||++. +..|+.++|||||||++|||++
T Consensus 187 DLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt 265 (412)
T 2vd5_A 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265 (412)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH
T ss_pred ccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh
Confidence 9999999999999999999999987654322 2233468999999999987 3568999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHHh
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR---PLMSEVVEAL 229 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~ell~~l 229 (304)
|..||........ ......... ....+.. ....+.++.+||.+||+ +|.+| |+++|+++|-
T Consensus 266 G~~Pf~~~~~~~~------~~~i~~~~~---~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 266 GQTPFYADSTAET------YGKIVHYKE---HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp SSCTTCCSSHHHH------HHHHHTHHH---HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred CCCCCCCCCHHHH------HHHHHhccc---CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 9999975432111 000000000 0001111 11235789999999999 99998 5899998864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=291.95 Aligned_cols=210 Identities=29% Similarity=0.445 Sum_probs=172.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||
T Consensus 52 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 128 (267)
T 3t9t_A 52 EEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128 (267)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 6999999999999999999999999999999999999999999877667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 129 dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (267)
T 3t9t_A 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 207 (267)
T ss_dssp SCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCchheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCC
Confidence 999999999999999999999998754321 111223456788999999999999999999999999999999 899987
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
..... ...... .... .... +...+..+.+++.+||+.||++|||+.+++++|+.+
T Consensus 208 ~~~~~---~~~~~i----~~~~---~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 208 NRSNS---EVVEDI----STGF---RLYK-------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp TCCHH---HHHHHH----HTTC---CCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHH---HHHHHH----hcCC---cCCC-------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 54221 111100 0000 0001 112246889999999999999999999999988643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=298.03 Aligned_cols=208 Identities=26% Similarity=0.402 Sum_probs=168.9
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~ 65 (304)
+|+++++++ +||||+++++++...+..++||||+++++|.+++.... ..+++..++.++.||+.
T Consensus 74 ~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 153 (327)
T 1fvr_A 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 153 (327)
T ss_dssp HHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHH
Confidence 589999999 99999999999999999999999999999999997653 46999999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||.|||+.+ |+||||||+||+++.++.+||+|||+++..... .......++..|+|||++.+..++.++|||||
T Consensus 154 aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 227 (327)
T 1fvr_A 154 GMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 227 (327)
T ss_dssp HHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHH
Confidence 999999998 999999999999999999999999999753221 11223456889999999999899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|+|++ |..||....... ... ..... .... .+...+..+.+||.+||+.||.+|||++|
T Consensus 228 G~il~ellt~g~~pf~~~~~~~---~~~----~~~~~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e 290 (327)
T 1fvr_A 228 GVLLWEIVSLGGTPYCGMTCAE---LYE----KLPQG------YRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQ 290 (327)
T ss_dssp HHHHHHHHTTSCCTTTTCCHHH---HHH----HGGGT------CCCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHcCCCCCCCCCcHHH---HHH----HhhcC------CCCC----CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999998 999996543211 110 00000 0011 11223568999999999999999999999
Q ss_pred HHHHhCCC
Q 022003 225 VVEALKPL 232 (304)
Q Consensus 225 ll~~l~~~ 232 (304)
++++|+.+
T Consensus 291 ll~~L~~~ 298 (327)
T 1fvr_A 291 ILVSLNRM 298 (327)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99988643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=299.82 Aligned_cols=220 Identities=22% Similarity=0.327 Sum_probs=165.0
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++++||||+++++++...+..++||||+. ++|.+++......+++..++.++.||+.||.|||+.+ |+|
T Consensus 48 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH 123 (324)
T 3mtl_A 48 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLH 123 (324)
T ss_dssp CCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred HHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccC
Confidence 369999999999999999999999999999999996 6999999877778999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
|||||+|||++.++.+||+|||+++...... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 124 ~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 201 (324)
T 3mtl_A 124 RDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201 (324)
T ss_dssp SSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcCHHHEEECCCCCEEEccCcccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998654322 12234568999999999876 57899999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhcc-----------ccccccccCCccCCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 160 DKNRPNGEHNLVEWARPHLGE-----------RRRFYRLIDPRLEGH----FSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
......... ......... ...+.....+..... .....+.++.+||.+||+.||.+|||++|
T Consensus 202 ~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 278 (324)
T 3mtl_A 202 PGSTVEEQL---HFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAED 278 (324)
T ss_dssp CCSSHHHHH---HHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCHHHHH---HHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHH
Confidence 764322111 100000000 000000000000000 00122467899999999999999999999
Q ss_pred HHHHh
Q 022003 225 VVEAL 229 (304)
Q Consensus 225 ll~~l 229 (304)
++++.
T Consensus 279 ~l~hp 283 (324)
T 3mtl_A 279 AMKHP 283 (324)
T ss_dssp HTTSG
T ss_pred HhcCh
Confidence 99853
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=299.29 Aligned_cols=216 Identities=27% Similarity=0.416 Sum_probs=171.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++||||+++++++... ...++||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+
T Consensus 72 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 148 (302)
T 4e5w_A 72 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YV 148 (302)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cc
Confidence 699999999999999999999876 5689999999999999999766667999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||||+||+++.++.+||+|||++......... .......||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 149 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (302)
T 4e5w_A 149 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDS 228 (302)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred cCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999876544322 223345688899999999999999999999999999999999988
Q ss_pred CCCCCC---------CCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRP---------NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
+..... .......... .... .......+...+..+.+||.+||+.||.+|||+.++++.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 229 DSSPMALFLKMIGPTHGQMTVTRLV-NTLK----------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp GGSHHHHHHHHHCSCCGGGHHHHHH-HHHH----------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CcchhhHHhhccCCcccccCHHHHH-HHHh----------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 643210 0000000000 0000 0001111223357899999999999999999999999988
Q ss_pred CC
Q 022003 230 KP 231 (304)
Q Consensus 230 ~~ 231 (304)
+.
T Consensus 298 ~~ 299 (302)
T 4e5w_A 298 EA 299 (302)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=299.18 Aligned_cols=212 Identities=29% Similarity=0.414 Sum_probs=172.4
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCC-eeEEEEecCCCCCHHHHhhcCCCC---------------CCHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRMKIALGAA 64 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~---------------l~~~~~~~i~~qi~ 64 (304)
+|+++++++ +||||+++++++...+ ..++||||+++++|.+++...... +++..++.++.||+
T Consensus 79 ~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~ 158 (316)
T 2xir_A 79 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 158 (316)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHH
T ss_pred HHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHH
Confidence 689999999 7899999999988755 489999999999999999765432 89999999999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHH
Q 022003 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 144 (304)
Q Consensus 65 ~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 144 (304)
.||.|||+.+ |+||||||+||+++.++.+||+|||+++...............||..|+|||++.+..++.++||||
T Consensus 159 ~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s 235 (316)
T 2xir_A 159 KGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235 (316)
T ss_dssp HHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHH
Confidence 9999999998 9999999999999999999999999998765544434444567889999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 022003 145 FGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 145 lG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
|||++|+|++ |..||....... ....... ... .... +...+..+.++|.+||+.||.+|||+.
T Consensus 236 lG~il~~l~t~g~~p~~~~~~~~--~~~~~~~----~~~------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ 299 (316)
T 2xir_A 236 FGVLLWEIFSLGASPYPGVKIDE--EFCRRLK----EGT------RMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFS 299 (316)
T ss_dssp HHHHHHHHHTTSCCSSTTCCCSH--HHHHHHH----HTC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHhCCCCCCcccchhH--HHHHHhc----cCc------cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 9999999998 999997643221 1111100 000 0011 112246889999999999999999999
Q ss_pred HHHHHhCCC
Q 022003 224 EVVEALKPL 232 (304)
Q Consensus 224 ell~~l~~~ 232 (304)
|++++|+.+
T Consensus 300 ell~~L~~~ 308 (316)
T 2xir_A 300 ELVEHLGNL 308 (316)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.79 Aligned_cols=211 Identities=25% Similarity=0.391 Sum_probs=162.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC-----eeEEEEecCCCCCHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHhh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLH 71 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~-----~~~~l~~~~~~~i~~qi~~~l~~LH 71 (304)
+|++++++++||||+++++++...+ ..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||
T Consensus 85 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 164 (313)
T 3brb_A 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS 164 (313)
T ss_dssp HHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH
Confidence 6899999999999999999998755 34999999999999999842 3356999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHH
Q 022003 72 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 151 (304)
Q Consensus 72 ~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 151 (304)
+.+ |+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+
T Consensus 165 ~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 241 (313)
T 3brb_A 165 NRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWE 241 (313)
T ss_dssp TTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHH
T ss_pred hCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHH
Confidence 998 99999999999999999999999999987654333233334567889999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 152 MLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 152 l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
|++ |..||....... ....... . ..+.. +...+..+.++|.+||+.||.+|||+.+++++|+
T Consensus 242 l~~~g~~p~~~~~~~~---~~~~~~~----~------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 304 (313)
T 3brb_A 242 IATRGMTPYPGVQNHE---MYDYLLH----G------HRLKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304 (313)
T ss_dssp HHTTSCCSSTTCCGGG---HHHHHHT----T------CCCCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcCCCCCccCCHHH---HHHHHHc----C------CCCCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999 888887543221 1111100 0 00111 1123468999999999999999999999999986
Q ss_pred CC
Q 022003 231 PL 232 (304)
Q Consensus 231 ~~ 232 (304)
.+
T Consensus 305 ~l 306 (313)
T 3brb_A 305 KL 306 (313)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=293.37 Aligned_cols=209 Identities=23% Similarity=0.352 Sum_probs=173.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++||||+++++++...+..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ |+|
T Consensus 58 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H 134 (288)
T 3kfa_A 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 134 (288)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCC
T ss_pred HHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccC
Confidence 6899999999999999999999999999999999999999999764 456999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+||+++.++.+||+|||++........ .......+|..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 135 ~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~ 213 (288)
T 3kfa_A 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213 (288)
T ss_dssp SCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654332 22334557889999999999999999999999999999999 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ....... ..... .+...+..+.+++.+||+.||.+|||++++++.|+.
T Consensus 214 ~~~~~~~---~~~~~~~----------~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 214 PGIDLSQ---VYELLEK----------DYRME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp TTCCGGG---HHHHHHT----------TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCHHH---HHHHHhc----------cCCCC----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 7643221 1111110 00011 112235789999999999999999999999998864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=314.61 Aligned_cols=212 Identities=26% Similarity=0.416 Sum_probs=171.4
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
++|+++|++++|||||++++++. .+..++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+
T Consensus 231 ~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---iv 306 (454)
T 1qcf_A 231 LAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YI 306 (454)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 36999999999999999999886 66789999999999999999754 236899999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
||||||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 307 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P 385 (454)
T 1qcf_A 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385 (454)
T ss_dssp CSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998754321 111222346788999999999999999999999999999999 9999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 234 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~ 234 (304)
|...... ....... ... ... .+..++.++.+||.+||+.||++|||+++|++.|+.+..
T Consensus 386 ~~~~~~~---~~~~~i~----~~~---~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 386 YPGMSNP---EVIRALE----RGY---RMP-------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp STTCCHH---HHHHHHH----HTC---CCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCHH---HHHHHHH----cCC---CCC-------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 9754321 1111111 000 111 112235789999999999999999999999999987654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=303.25 Aligned_cols=225 Identities=23% Similarity=0.245 Sum_probs=174.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC--eeEEEEecCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|+++|++++||||+++++++...+ ..++|||||++++|.+++.... ..+++..++.++.||+.||+|||+.+
T Consensus 56 ~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 132 (396)
T 4eut_A 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132 (396)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 6999999999999999999998765 7799999999999999997642 34999999999999999999999998
Q ss_pred eEeccCCCCCeEE----CCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc--------CCCCchhhhHHH
Q 022003 78 VIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------GHLTSRSDVYSF 145 (304)
Q Consensus 78 iiH~dlkp~Nili----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Diwsl 145 (304)
|+||||||+|||+ +.++.+||+|||+++...... ......||..|+|||++.+ ..++.++|||||
T Consensus 133 ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSl 209 (396)
T 4eut_A 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (396)
T ss_dssp EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHH
T ss_pred EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHH
Confidence 9999999999999 778889999999998764432 1234568999999999875 567889999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhcccc-----------ccccccCCccCCCCCHHHHHHHHHHHHHhccC
Q 022003 146 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR-----------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 214 (304)
Q Consensus 146 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 214 (304)
||++|+|++|..||....................... .+.-..............+..+.+++.+||+.
T Consensus 210 G~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~ 289 (396)
T 4eut_A 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (396)
T ss_dssp HHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhcc
Confidence 9999999999999975443222111111100000000 00000011122345577889999999999999
Q ss_pred CCCCCCCHHHHHHHhCCC
Q 022003 215 DPKARPLMSEVVEALKPL 232 (304)
Q Consensus 215 dp~~Rps~~ell~~l~~~ 232 (304)
||++|||++|+++.+..+
T Consensus 290 dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 290 DQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp CTTTSCCHHHHHHHHHHH
T ss_pred ChhhhccHHHHHHHHHHH
Confidence 999999999999887643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=297.29 Aligned_cols=200 Identities=23% Similarity=0.270 Sum_probs=159.3
Q ss_pred HhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 3 EVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 3 E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
|+..+.++ +||||+++++++.+++..++||||+ +++|.+++......+++..++.++.||+.||+|||+.+ |+||
T Consensus 106 e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 181 (311)
T 3p1a_A 106 EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHL 181 (311)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 45555544 8999999999999999999999999 77999998777778999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..++..
T Consensus 182 Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 182 DVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp CCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998764322 2334568999999998876 799999999999999999999776643
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.. .+... .. ....+.. ....+.++.++|.+||+.||++|||++|++++.
T Consensus 258 ~~--------~~~~~--~~-----~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 258 GE--------GWQQL--RQ-----GYLPPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp HH--------HHHHH--TT-----TCCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred cc--------HHHHH--hc-----cCCCccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 21 01000 00 0000111 111246899999999999999999999999853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=297.27 Aligned_cols=207 Identities=22% Similarity=0.318 Sum_probs=169.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||
T Consensus 64 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~ 139 (321)
T 2a2a_A 64 REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IAHF 139 (321)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 6899999999999999999999999999999999999999999654 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCC----cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 82 DFKTSNILLDADY----NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 82 dlkp~Nili~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
||||+||+++.++ .+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 140 dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 216 (321)
T 2a2a_A 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216 (321)
T ss_dssp CCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred CCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCC
Confidence 9999999999887 799999999987654322 234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
||....... .. ......... .++... ...+..+.+||.+||+.||++|||+.|++++.
T Consensus 217 pf~~~~~~~---~~---~~i~~~~~~----~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 217 PFLGDTKQE---TL---ANITSVSYD----FDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp SSCCSSHHH---HH---HHHHTTCCC----CCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred CCCCCCHHH---HH---HHHHhcccc----cChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 996542211 11 100000000 000000 11246789999999999999999999999964
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.77 Aligned_cols=206 Identities=22% Similarity=0.355 Sum_probs=161.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC-------------------------------------------------------
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD------------------------------------------------------- 26 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~------------------------------------------------------- 26 (304)
+|+++|++++||||+++++++.+..
T Consensus 53 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (332)
T 3qd2_B 53 REVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132 (332)
T ss_dssp HHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------C
T ss_pred HHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCC
Confidence 6999999999999999999986643
Q ss_pred --eeEEEEecCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEcccc
Q 022003 27 --QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 102 (304)
Q Consensus 27 --~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg 102 (304)
..++|||||++++|.+++.+.. ...++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 133 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 209 (332)
T 3qd2_B 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG 209 (332)
T ss_dssp CCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred CceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecC
Confidence 2799999999999999997653 23566778999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcc----------eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhH
Q 022003 103 LAKDGPEGDKT----------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 172 (304)
Q Consensus 103 ~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~ 172 (304)
+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..|+... ..
T Consensus 210 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~ 281 (332)
T 3qd2_B 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VR 281 (332)
T ss_dssp TCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HH
T ss_pred cccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HH
Confidence 99876543211 1223457999999999999999999999999999999999986654210 00
Q ss_pred hhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 173 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
...... . .. ........+.++.+||.+||+.||++|||++|++++.
T Consensus 282 ~~~~~~-------~---~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 282 IITDVR-------N---LK-FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHHHH-------T---TC-CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred HHHHhh-------c---cC-CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence 000000 0 00 0001123346789999999999999999999999853
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=303.28 Aligned_cols=227 Identities=25% Similarity=0.301 Sum_probs=173.2
Q ss_pred hHhhHhhcCCCCcccceeeEEE--eCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCI--EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++||||+++++++. ..+..++||||+++++|.+++......+++..++.++.||+.||+|||+.+ |+
T Consensus 73 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iv 149 (327)
T 3lxl_A 73 REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CV 149 (327)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 6999999999999999999987 455689999999999999999775557999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||||+|||++.++.+||+|||+++........ .......||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 150 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p 229 (327)
T 3lxl_A 150 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229 (327)
T ss_dssp CSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred CCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543322 222335678889999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhh-hhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCC
Q 022003 159 MDKNRPNGEHNLVEWAR-PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 234 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~ 234 (304)
|........ ..+.. ..........+..........+...+..+.+||.+||+.||.+|||+.|++++|+.+..
T Consensus 230 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 230 SCSPSAEFL---RMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp GGSHHHHHH---HHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred Cccccchhh---hhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 864321000 00000 00000000000000111111122345789999999999999999999999999976543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=301.64 Aligned_cols=203 Identities=28% Similarity=0.378 Sum_probs=166.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++..++..++||||+. |+|.+++......+++..++.++.|++.||.|||+.+ |+||
T Consensus 103 ~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 178 (348)
T 1u5q_A 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHR 178 (348)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCC
T ss_pred HHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeC
Confidence 69999999999999999999999999999999996 6888888665667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+|||++.++.+||+|||++..... .....||+.|+|||++. +..++.++|||||||++|||++|..|
T Consensus 179 Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 252 (348)
T 1u5q_A 179 DVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252 (348)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999987543 22357899999999985 56789999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
|....... ........ ..+... ....+..+.+||.+||+.||++|||+++++++..
T Consensus 253 ~~~~~~~~------~~~~~~~~-------~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 253 LFNMNAMS------ALYHIAQN-------ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp TTTSCHHH------HHHHHHHS-------CCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCCCChHH------HHHHHHhc-------CCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 96542211 10000000 001110 1122467899999999999999999999998653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=292.60 Aligned_cols=209 Identities=25% Similarity=0.336 Sum_probs=167.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.. +..++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ ++||
T Consensus 62 ~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 137 (281)
T 3cc6_A 62 SEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHR 137 (281)
T ss_dssp HHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 59999999999999999998764 4578999999999999999776667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 138 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp CCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCccceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999987644322 11233456889999999999999999999999999999998 999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
...... ....... .. .... +...+..+.++|.+||+.||++|||+.|++++|+.+
T Consensus 217 ~~~~~~---~~~~~~~----~~------~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 217 WLENKD---VIGVLEK----GD------RLPK----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp TSCGGG---HHHHHHH----TC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCChHH---HHHHHhc----CC------CCCC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 543221 1111100 00 0001 112246899999999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=289.14 Aligned_cols=209 Identities=26% Similarity=0.396 Sum_probs=169.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++||||+++++++.+++..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++||
T Consensus 54 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 129 (276)
T 2yex_A 54 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHR 129 (276)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 5899999999999999999999999999999999999999998544 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.+||+|||++................||..|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 130 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 209 (276)
T 2yex_A 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209 (276)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCS
T ss_pred CCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987543332223344678999999999987765 789999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
....... ....+... .. ...+ ....+..+.++|.+||+.||.+|||++|++++.
T Consensus 210 ~~~~~~~-~~~~~~~~-----~~---~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 210 QPSDSCQ-EYSDWKEK-----KT---YLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp CSCTTSH-HHHHHHTT-----CT---TSTT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CCchHHH-HHHHhhhc-----cc---ccCc------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 6433211 11111110 00 0000 012246889999999999999999999999853
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=291.39 Aligned_cols=202 Identities=26% Similarity=0.408 Sum_probs=165.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+.+..++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 58 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~ 133 (279)
T 3fdn_A 58 REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHR 133 (279)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEEC
T ss_pred HHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---Eecc
Confidence 5899999999999999999999999999999999999999998654 36999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++...... ......||..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 134 dlkp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 134 DIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp CCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cCChHhEEEcCCCCEEEEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999998654332 12345789999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..... ....... ..... +...+..+.+||.+||+.||++|||++|++++.
T Consensus 210 ~~~~~------~~~~~~~--------~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 210 NTYQE------TYKRISR--------VEFTF----PDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp SSHHH------HHHHHHH--------TCCCC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CcHHH------HHHHHHh--------CCCCC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 42111 0000000 00111 112246889999999999999999999999853
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=306.59 Aligned_cols=219 Identities=23% Similarity=0.335 Sum_probs=162.9
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCC--eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|+.+|+++. ||||+++++++...+ ..|+|||||. ++|.+++... .+++..+..++.||+.||+|||+.+ |
T Consensus 57 ~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i 130 (388)
T 3oz6_A 57 REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGG---L 130 (388)
T ss_dssp HHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 6899999997 999999999998654 6899999995 6999988653 6999999999999999999999998 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCC-------------------cceeeecccccccccCcchhhc-CCCCc
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-------------------KTHVSTRVMGTYGYAAPEYVMT-GHLTS 138 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~ 138 (304)
+||||||+|||++.++.+||+|||+++...... ........+||++|+|||++.+ ..++.
T Consensus 131 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 210 (388)
T 3oz6_A 131 LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTK 210 (388)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCT
T ss_pred EeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCC
Confidence 999999999999999999999999998653211 1112234679999999999986 67999
Q ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccc-cc-cccc---------------c---CCccCCCC--
Q 022003 139 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-RR-FYRL---------------I---DPRLEGHF-- 196 (304)
Q Consensus 139 ~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~---------------~---~~~~~~~~-- 196 (304)
++|||||||++|||++|.+||.+.........+ . ...... .. .... . .......+
T Consensus 211 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i--~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (388)
T 3oz6_A 211 GIDMWSLGCILGEILCGKPIFPGSSTMNQLERI--I-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK 287 (388)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--H-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcc
Confidence 999999999999999999999765322111100 0 000000 00 0000 0 00000000
Q ss_pred ----------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 197 ----------SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 197 ----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
....+.++.+||.+||+.||++|||++|+++|.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHP 330 (388)
T ss_dssp HHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTST
T ss_pred hhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCH
Confidence 001246889999999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=294.69 Aligned_cols=221 Identities=25% Similarity=0.309 Sum_probs=165.5
Q ss_pred hHhhHhhcCC---CCcccceeeEEEeCC-----eeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDLV---HLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l~---h~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|++++++++ ||||+++++++.... ..++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+
T Consensus 60 ~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 138 (308)
T 3g33_A 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 138 (308)
T ss_dssp HHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 5777777764 999999999998765 5799999995 69999997654 349999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
.+ |+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 139 ~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 212 (308)
T 3g33_A 139 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212 (308)
T ss_dssp TT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHT
T ss_pred CC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHH
Confidence 99 9999999999999999999999999998764322 23446789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhh-----hhcccccccc-ccCCccC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARP-----HLGERRRFYR-LIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
++|..||................. .+.....+.. .+.+... .......+..+.+||.+||+.||++|||+.
T Consensus 213 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 292 (308)
T 3g33_A 213 FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292 (308)
T ss_dssp TTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHH
Confidence 999999976432211100000000 0000000000 0000000 000112346889999999999999999999
Q ss_pred HHHHHh
Q 022003 224 EVVEAL 229 (304)
Q Consensus 224 ell~~l 229 (304)
|++++.
T Consensus 293 e~l~h~ 298 (308)
T 3g33_A 293 RALQHS 298 (308)
T ss_dssp HHHTST
T ss_pred HHhcCc
Confidence 999853
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=309.65 Aligned_cols=208 Identities=25% Similarity=0.353 Sum_probs=170.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|+++|++++||||+++++++.+.+.+|+||||++||+|.+++... ...+++..++.++.||+.||+|||+.+ |
T Consensus 234 ~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---I 310 (543)
T 3c4z_A 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---I 310 (543)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---C
Confidence 6899999999999999999999999999999999999999998654 346999999999999999999999998 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+||||||+||||+.+|.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 311 vHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~P 388 (543)
T 3c4z_A 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388 (543)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCC
Confidence 9999999999999999999999999987654322 12345899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~~ 228 (304)
|......... ............. ++...+..+.+||.+||+.||.+||++ +++++|
T Consensus 389 F~~~~~~~~~--~~~~~~i~~~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 389 FRARGEKVEN--KELKQRVLEQAVT------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp SCCTTCCCCH--HHHHHHHHHCCCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CCCCccchhH--HHHHHHHhhcccC------------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 9765332211 1111111111111 112235788999999999999999965 566653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=299.94 Aligned_cols=211 Identities=25% Similarity=0.385 Sum_probs=168.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+.++++++||||+++++++...+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+
T Consensus 82 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~- 160 (327)
T 2yfx_A 82 MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH- 160 (327)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-
Confidence 68999999999999999999999999999999999999999997653 35899999999999999999999998
Q ss_pred CCeEeccCCCCCeEECC---CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 76 RPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|+||||||+|||++. +..+||+|||++................||..|+|||++.+..++.++|||||||++|+|
T Consensus 161 --i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 238 (327)
T 2yfx_A 161 --FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238 (327)
T ss_dssp --CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred --eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHH
Confidence 999999999999984 446999999999764333322233445678999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 153 LT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 153 ~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
++ |..||...... ........ .. ... .+...+..+.++|.+||+.||.+|||+.+++++|+.
T Consensus 239 lt~g~~p~~~~~~~---~~~~~~~~----~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 239 FSLGYMPYPSKSNQ---EVLEFVTS----GG------RMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HTTSCCSSTTCCHH---HHHHHHHT----TC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HcCCCCCCCCcCHH---HHHHHHhc----CC------CCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 98 88998654221 11111110 00 001 111234688999999999999999999999999864
Q ss_pred C
Q 022003 232 L 232 (304)
Q Consensus 232 ~ 232 (304)
+
T Consensus 302 ~ 302 (327)
T 2yfx_A 302 C 302 (327)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=291.46 Aligned_cols=208 Identities=25% Similarity=0.368 Sum_probs=168.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++ ..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ ++||
T Consensus 67 ~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~ 141 (291)
T 1xbb_A 67 AEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHR 141 (291)
T ss_dssp HHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcC
Confidence 689999999999999999998 567789999999999999999764 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcce-eeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 142 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 221 (291)
T 1xbb_A 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221 (291)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999998765433321 1222446788999999998889999999999999999999 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ...... ... .+. .+...+..+.++|.+||+.||.+|||+.++++.|+.
T Consensus 222 ~~~~~~~---~~~~~~----~~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 222 RGMKGSE---VTAMLE----KGE------RMG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp TTCCHHH---HHHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCHHH---HHHHHH----cCC------CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 7543211 111110 000 011 112335789999999999999999999999998864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=294.25 Aligned_cols=209 Identities=24% Similarity=0.361 Sum_probs=157.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCe----eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQ----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|++++++++||||+++++++..... .|+||||+++++|.+++.... .+++..++.++.||+.||+|||+.+
T Consensus 61 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--- 136 (311)
T 3ork_A 61 REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--- 136 (311)
T ss_dssp HHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 68999999999999999999886553 499999999999999996543 6999999999999999999999998
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCC
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 156 (304)
|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 137 ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~ 216 (311)
T 3ork_A 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216 (311)
T ss_dssp CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999876443221 2233457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||....... ................ ....+.++.++|.+||+.||++||++.+++.+
T Consensus 217 ~pf~~~~~~~------~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 217 PPFTGDSPVS------VAYQHVREDPIPPSAR--------HEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp CSCCCSSHHH------HHHHHHHCCCCCHHHH--------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCCCCChHH------HHHHHhcCCCCCcccc--------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 9997543211 1111111100000000 01124688999999999999999977776653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=306.12 Aligned_cols=219 Identities=24% Similarity=0.283 Sum_probs=160.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+++|+.++||||+++++++... ...|+||||+.+ +|.+.+.. .+++..++.++.||+.||+|||+.+
T Consensus 110 ~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~- 184 (464)
T 3ttj_A 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG- 184 (464)
T ss_dssp HHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 699999999999999999999755 357999999965 67776643 4899999999999999999999998
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
|+||||||+||||+.++.+||+|||+++...... .....+||++|+|||++.+..|+.++|||||||++|||++|
T Consensus 185 --iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 259 (464)
T 3ttj_A 185 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259 (464)
T ss_dssp --CCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred --cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998764322 23446799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHh----------------hhhhhccc-----cccccccCCccC---CCCCHHHHHHHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLVEW----------------ARPHLGER-----RRFYRLIDPRLE---GHFSIKGAQKAAQLAAHC 211 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~----------------~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~ 211 (304)
+.||.+....+....+.. ........ ..+...+..... .......+.++.+||.+|
T Consensus 260 ~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m 339 (464)
T 3ttj_A 260 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 339 (464)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHH
Confidence 999976532111000000 00000000 000001100000 001112367899999999
Q ss_pred ccCCCCCCCCHHHHHHHhC
Q 022003 212 LSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~l~ 230 (304)
|+.||++|||++|+++|..
T Consensus 340 L~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 340 LVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp SCSSTTTSCCHHHHHTSTT
T ss_pred cCCChhhCCCHHHHhcChh
Confidence 9999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=293.49 Aligned_cols=222 Identities=23% Similarity=0.285 Sum_probs=164.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||
T Consensus 51 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~ 126 (311)
T 4agu_A 51 REIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN---CIHR 126 (311)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCC
Confidence 6999999999999999999999999999999999998998887544 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.+||+|||++........ ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 127 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 204 (311)
T 4agu_A 127 DVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204 (311)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCChhhEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987653222 2234578999999999986 678999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhh--------hcccccc--ccccCCccCCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPH--------LGERRRF--YRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
................. ......+ ....++..... .....+..+.+||.+||+.||.+|||++|+++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 205 GKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 65332211111000000 0000000 00000000000 00123567899999999999999999999998
Q ss_pred Hh
Q 022003 228 AL 229 (304)
Q Consensus 228 ~l 229 (304)
+.
T Consensus 285 hp 286 (311)
T 4agu_A 285 HP 286 (311)
T ss_dssp SG
T ss_pred Ch
Confidence 63
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=311.05 Aligned_cols=212 Identities=25% Similarity=0.388 Sum_probs=166.8
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
++|+++|++++||||+++++++.. +..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+
T Consensus 227 ~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iv 302 (452)
T 1fmk_A 227 LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 302 (452)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 369999999999999999999875 6789999999999999999653 346999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 303 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P 381 (452)
T 1fmk_A 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381 (452)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCCCChhhEEECCCCCEEECCCccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987643221 12223456788999999999999999999999999999999 8999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 234 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~ 234 (304)
|...... ....... ... . .. .+..++..+.+||.+||+.||++|||++++++.|+.+..
T Consensus 382 ~~~~~~~---~~~~~i~----~~~---~---~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 382 YPGMVNR---EVLDQVE----RGY---R---MP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp STTCCHH---HHHHHHH----TTC---C---CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCHH---HHHHHHH----cCC---C---CC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 9754321 1111110 000 0 01 112335789999999999999999999999999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=290.32 Aligned_cols=205 Identities=25% Similarity=0.338 Sum_probs=161.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|+++|++++||||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |
T Consensus 69 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i 145 (285)
T 3is5_A 69 AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---V 145 (285)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 6999999999999999999999999999999999999999988542 457999999999999999999999998 9
Q ss_pred EeccCCCCCeEE---CCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 79 IYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 79 iH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
+||||||+||++ +.++.+||+|||++....... ......||..|+|||++. ..++.++|||||||++|+|++|
T Consensus 146 vH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g 221 (285)
T 3is5_A 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221 (285)
T ss_dssp CCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHS
T ss_pred EECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhC
Confidence 999999999999 456889999999998654322 233457899999999875 5789999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..||....... ...........+. .. .. ..+.++.+||.+||+.||++|||+.|++++
T Consensus 222 ~~pf~~~~~~~------~~~~~~~~~~~~~----~~-~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 222 CLPFTGTSLEE------VQQKATYKEPNYA----VE-CR----PLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp SCSSCCSSHHH------HHHHHHHCCCCCC----C---C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CCCCCCCCHHH------HHhhhccCCcccc----cc-cC----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99997543211 1000000000000 00 00 124688899999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=303.50 Aligned_cols=153 Identities=29% Similarity=0.388 Sum_probs=129.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC-----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+++|++++||||+++++++... +..|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.+
T Consensus 74 ~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g-- 149 (432)
T 3n9x_A 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG-- 149 (432)
T ss_dssp HHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 699999999999999999999876 57899999994 6999998654 46999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcc--------------------eeeecccccccccCcchh-hcCC
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--------------------HVSTRVMGTYGYAAPEYV-MTGH 135 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~ 135 (304)
|+||||||+||||+.++.+||+|||+++........ ......+||++|+|||++ .+..
T Consensus 150 -ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~ 228 (432)
T 3n9x_A 150 -IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN 228 (432)
T ss_dssp -EECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSC
T ss_pred -CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCC
Confidence 999999999999999999999999999876433211 112456899999999986 4667
Q ss_pred CCchhhhHHHHHHHHHHHhCCCCC
Q 022003 136 LTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 136 ~~~~~DiwslG~il~el~tg~~p~ 159 (304)
++.++|||||||++|||++|..||
T Consensus 229 ~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 229 YTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCcccccchHHHHHHHHHhccccc
Confidence 999999999999999999855444
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=288.59 Aligned_cols=206 Identities=22% Similarity=0.328 Sum_probs=167.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+.+++|.+.+... ..+++..++.++.|++.||.|||+.+ ++||
T Consensus 54 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 129 (284)
T 3kk8_A 54 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHR 129 (284)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcC
Confidence 6899999999999999999999999999999999999999888655 36999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCc---EEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+||+++.++. +||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 130 dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 206 (284)
T 3kk8_A 130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206 (284)
T ss_dssp CCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCC
Confidence 99999999976655 99999999987654322 2345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|...... ....... .... ....+. ....+.++.+||.+||+.||++|||+.|++++
T Consensus 207 f~~~~~~---~~~~~~~---~~~~---~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 207 FWDEDQH---RLYAQIK---AGAY---DYPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp SCCSSHH---HHHHHHH---HTCC---CCCTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCchh---HHHHHHH---hccc---cCCchh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 9653221 1111000 0000 000010 11224688999999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=297.67 Aligned_cols=224 Identities=23% Similarity=0.297 Sum_probs=166.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--------CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|++++++++||||+++++++.. .+..++||||+. ++|.+.+......+++..++.++.||+.||+|||+.
T Consensus 65 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 143 (351)
T 3mi9_A 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 143 (351)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 69999999999999999999987 446899999996 588888877767899999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCc--ceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ 150 (304)
+ |+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|
T Consensus 144 ~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 220 (351)
T 3mi9_A 144 K---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 220 (351)
T ss_dssp T---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHH
T ss_pred C---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHH
Confidence 8 99999999999999999999999999987643221 122234578999999999876 56899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhhh-----ccc--cccccccCCccCCCCCHH-------HHHHHHHHHHHhccCCC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPHL-----GER--RRFYRLIDPRLEGHFSIK-------GAQKAAQLAAHCLSRDP 216 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~--~~~~~~~~~~~~~~~~~~-------~~~~~~~li~~~l~~dp 216 (304)
+|++|..||................... ... .................. .+..+.+||.+||+.||
T Consensus 221 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 300 (351)
T 3mi9_A 221 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 300 (351)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSG
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCCh
Confidence 9999999997643221111110000000 000 000000000000000000 13568899999999999
Q ss_pred CCCCCHHHHHHHh
Q 022003 217 KARPLMSEVVEAL 229 (304)
Q Consensus 217 ~~Rps~~ell~~l 229 (304)
++|||++|++++.
T Consensus 301 ~~R~t~~e~l~hp 313 (351)
T 3mi9_A 301 AQRIDSDDALNHD 313 (351)
T ss_dssp GGSCCHHHHHTSG
T ss_pred hhCCCHHHHhCCC
Confidence 9999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=296.38 Aligned_cols=208 Identities=18% Similarity=0.246 Sum_probs=165.1
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++++++ .||||+++++++...+..++||||+.+++|.+++... ...+++..++.++.||+.||+|||+.+ |+
T Consensus 77 ~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---iv 153 (327)
T 3lm5_A 77 HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IV 153 (327)
T ss_dssp HHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 688999999 5699999999999999999999999999999998654 457999999999999999999999998 99
Q ss_pred eccCCCCCeEECC---CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCC
Q 022003 80 YRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 80 H~dlkp~Nili~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||||+|||++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 H~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 230 (327)
T 3lm5_A 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT 230 (327)
T ss_dssp CSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999987 78999999999987643321 23457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.||........ ..... .... ..........+..+.+||.+||+.||.+|||++|++++.
T Consensus 231 ~pf~~~~~~~~---~~~i~---~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 231 SPFVGEDNQET---YLNIS---QVNV--------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp CSSCCSSHHHH---HHHHH---HTCC--------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred CCCCCCCchHH---HHHHH---hccc--------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 99965432110 00000 0000 001111112356889999999999999999999999853
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=297.42 Aligned_cols=224 Identities=29% Similarity=0.417 Sum_probs=170.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++|++++||||+++++++... ...++||||+++++|.+++.+. .+++..++.++.||+.||.|||+.+ |+
T Consensus 82 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---iv 156 (318)
T 3lxp_A 82 QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YI 156 (318)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 699999999999999999999884 5789999999999999999665 4999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||||+||+++.++.+||+|||++......... .......||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 157 H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p 236 (318)
T 3lxp_A 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS 236 (318)
T ss_dssp CSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred CCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCc
Confidence 9999999999999999999999999887554332 223345678889999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
|........ ....+..... ......+.+........+...+..+.+||.+||+.||++|||+.|+++.|+.+
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 237 SQSPPTKFL-ELIGIAQGQM-TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp GGSHHHHHH-HHHCSCCHHH-HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccchhhh-hhhcccccch-hHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 864211000 0000000000 00000011111111112223457899999999999999999999999988643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=292.74 Aligned_cols=219 Identities=23% Similarity=0.333 Sum_probs=164.8
Q ss_pred HhhHhhc--CCCCcccceeeEEEeC----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC---
Q 022003 3 EVNFLGD--LVHLNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE--- 73 (304)
Q Consensus 3 E~~il~~--l~h~niv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--- 73 (304)
|.+++.. ++||||+++++++... ...++||||+++++|.+++... .+++..++.++.|++.||+|||+.
T Consensus 79 e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~ 156 (337)
T 3mdy_A 79 ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFS 156 (337)
T ss_dssp HHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCS
T ss_pred HHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 4555554 4999999999999987 7889999999999999999654 599999999999999999999998
Q ss_pred -----CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcce--eeecccccccccCcchhhcCCCCch------h
Q 022003 74 -----AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGHLTSR------S 140 (304)
Q Consensus 74 -----~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~ 140 (304)
+ |+||||||+|||++.++.+||+|||+++......... ......||..|+|||++.+..++.. +
T Consensus 157 ~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 233 (337)
T 3mdy_A 157 TQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233 (337)
T ss_dssp TTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHH
T ss_pred hccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCcccc
Confidence 6 9999999999999999999999999998764332211 1224579999999999987766654 9
Q ss_pred hhHHHHHHHHHHHhC----------CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCC-CCHHHHHHHHHHHH
Q 022003 141 DVYSFGVVLLEMLTG----------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAA 209 (304)
Q Consensus 141 DiwslG~il~el~tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~ 209 (304)
|||||||++|||++| ..||.......... ......... ....+..... ....++.++.+||.
T Consensus 234 DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~ 306 (337)
T 3mdy_A 234 DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY-EDMREIVCI------KKLRPSFPNRWSSDECLRQMGKLMT 306 (337)
T ss_dssp HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH-HHHHHHHTT------SCCCCCCCGGGGGSHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch-hhhHHHHhh------hccCccccccchhhHHHHHHHHHHH
Confidence 999999999999999 55554433222111 111100000 0111111111 12256788999999
Q ss_pred HhccCCCCCCCCHHHHHHHhCCCC
Q 022003 210 HCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 210 ~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
+||+.||.+|||+.|++++|+.+.
T Consensus 307 ~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 307 ECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp HHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhhhChhhCCCHHHHHHHHHHHH
Confidence 999999999999999999997554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=288.47 Aligned_cols=207 Identities=23% Similarity=0.326 Sum_probs=166.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++||||+++++++... +..++||||+++++|.+++..... .+++..++.++.||+.||+|||+.+ ..+
T Consensus 56 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i 134 (271)
T 3kmu_A 56 EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLI 134 (271)
T ss_dssp HHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCC
T ss_pred HHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-Cce
Confidence 699999999999999999999887 778999999999999999977543 5999999999999999999999866 459
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCc---hhhhHHHHHHHHHHHhC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~el~tg 155 (304)
+||||||+||+++.++.++|+|||+...... ....||+.|+|||++.+..++. ++|||||||++|+|++|
T Consensus 135 ~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 207 (271)
T 3kmu_A 135 PRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR 207 (271)
T ss_dssp TTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHC
T ss_pred ecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999998888754322 2346799999999998765444 89999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
..||....... ....... ....+.. +...+..+.+++.+||+.||++|||++++++.|+.+
T Consensus 208 ~~p~~~~~~~~------~~~~~~~------~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 208 EVPFADLSNME------IGMKVAL------EGLRPTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp SCTTTTSCHHH------HHHHHHH------SCCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccccChHH------HHHHHHh------cCCCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 99997542211 0000000 0011111 122356899999999999999999999999988654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=293.66 Aligned_cols=215 Identities=19% Similarity=0.324 Sum_probs=166.8
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.+|++++++++||||+++++++...+..++||||+++++|.+++......+++..++.++.||+.||+|||+.+ ++|
T Consensus 77 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H 153 (319)
T 2y4i_B 77 KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILH 153 (319)
T ss_dssp CTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 36999999999999999999999999999999999999999999877668999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCC---cceeeecccccccccCcchhhc---------CCCCchhhhHHHHHH
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTHVSTRVMGTYGYAAPEYVMT---------GHLTSRSDVYSFGVV 148 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~i 148 (304)
|||||+||+++ ++.+||+|||+++...... .........||..|+|||++.+ ..++.++|||||||+
T Consensus 154 ~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i 232 (319)
T 2y4i_B 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232 (319)
T ss_dssp CCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred cCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence 99999999998 6799999999987643211 1112233468999999999874 457999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 149 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+|+|++|..||....... .. .... .. ..+... ....+..+.++|.+||+.||++|||+.++++.
T Consensus 233 l~el~~g~~p~~~~~~~~---~~---~~~~-~~------~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 233 WYELHAREWPFKTQPAEA---II---WQMG-TG------MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHHHHHSSCSSSSCCHHH---HH---HHHH-TT------CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHH---HH---HHhc-cC------CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999997543211 00 0000 00 001110 00123578899999999999999999999999
Q ss_pred hCCCCCC
Q 022003 229 LKPLPNL 235 (304)
Q Consensus 229 l~~~~~~ 235 (304)
|+.+...
T Consensus 297 l~~l~~~ 303 (319)
T 2y4i_B 297 LEKLPKR 303 (319)
T ss_dssp HTTC---
T ss_pred HHHHHHh
Confidence 9987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=293.45 Aligned_cols=211 Identities=23% Similarity=0.252 Sum_probs=162.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC----------------------------------
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------------------------------- 47 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------------------------------- 47 (304)
+|++++++++||||+++++++.+.+..++|||||++++|.+++...
T Consensus 77 ~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (345)
T 3hko_A 77 TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156 (345)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--
T ss_pred HHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccc
Confidence 5999999999999999999999999999999999999999998521
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC--cEEEccccCcccCCCCC--cceeeec
Q 022003 48 -----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGD--KTHVSTR 118 (304)
Q Consensus 48 -----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~--~~kl~Dfg~a~~~~~~~--~~~~~~~ 118 (304)
...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||+++...... .......
T Consensus 157 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 233 (345)
T 3hko_A 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233 (345)
T ss_dssp CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-------
T ss_pred ccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccc
Confidence 112467788999999999999999998 99999999999998776 89999999998653221 1112344
Q ss_pred ccccccccCcchhhc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCC
Q 022003 119 VMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF 196 (304)
Q Consensus 119 ~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (304)
..||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ........... ...+..
T Consensus 234 ~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~---~~~~~~---- 300 (345)
T 3hko_A 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKLC---FENPNY---- 300 (345)
T ss_dssp -CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC---TTSGGG----
T ss_pred cCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcccc---cCCccc----
Confidence 678999999999975 678999999999999999999999997543211 11111111100 000110
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 197 SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 197 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
...+..+.+||.+||+.||.+|||+.|++++.
T Consensus 301 -~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 301 -NVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp -GGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred -ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 11246889999999999999999999999853
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=297.83 Aligned_cols=220 Identities=24% Similarity=0.277 Sum_probs=169.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+.+ +|.+++......+++..++.++.|++.||+|||+.+ |+||
T Consensus 61 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 136 (346)
T 1ua2_A 61 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHR 136 (346)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECC
Confidence 699999999999999999999999999999999965 899998777778999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.
T Consensus 137 Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 137 DLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp CCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999987643322 2334578999999999875 458999999999999999999999987
Q ss_pred CCCCCCCcchhHhhhhh-------hccccccccccCCccCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPH-------LGERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
....... ........ +..................+ ...+.++.+||.+||+.||.+|||++|++++
T Consensus 215 ~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 215 GDSDLDQ--LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CSSHHHH--HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCHHHH--HHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 6432111 01000000 00000000000000000000 1234789999999999999999999999986
Q ss_pred h
Q 022003 229 L 229 (304)
Q Consensus 229 l 229 (304)
.
T Consensus 293 ~ 293 (346)
T 1ua2_A 293 K 293 (346)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=284.69 Aligned_cols=217 Identities=20% Similarity=0.209 Sum_probs=172.4
Q ss_pred hHhhHhhcCCCCcccceeeEE-EeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYC-IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++.++|++++..+..+ ...+..++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+|
T Consensus 53 ~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH 128 (296)
T 4hgt_A 53 IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIH 128 (296)
T ss_dssp HHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 589999999998877766665 5677889999999 99999999866667999999999999999999999998 999
Q ss_pred ccCCCCCeEE---CCCCcEEEccccCcccCCCCCcc-----eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 81 RDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 81 ~dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|||||+|||+ +.++.+||+|||+++........ .......||..|+|||++.+..++.++|||||||++|+|
T Consensus 129 ~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 208 (296)
T 4hgt_A 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 208 (296)
T ss_dssp SCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHH
Confidence 9999999999 78899999999999876543221 122346789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
++|..||...................... ...... . ..+..+.++|.+||+.||++|||++++++.|+.+
T Consensus 209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~----~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 209 NLGSLPWQGLKAATKRQKYERISEKKMST--PIEVLC----K----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHSSCTTSSCCCSSSSSHHHHHHHHHHHS--CHHHHT----T----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hcCCCCCcccchhhhhhhhhhhhcccccc--hhhhhh----c----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 99999998765544333322111110000 000000 1 1246899999999999999999999999988654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.94 Aligned_cols=208 Identities=25% Similarity=0.361 Sum_probs=165.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++. .+..++||||+.+|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||
T Consensus 419 ~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHr 493 (635)
T 4fl3_A 419 AEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHR 493 (635)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCC
Confidence 6999999999999999999986 45689999999999999999654 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||+||||+.++.+||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 494 DLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf 573 (635)
T 4fl3_A 494 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573 (635)
T ss_dssp CCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876543321 22233456789999999999999999999999999999998 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... ...... ... .. ..+..++.++.+||.+||+.||++|||++++++.|+.
T Consensus 574 ~~~~~~~---~~~~i~----~~~------~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 574 RGMKGSE---VTAMLE----KGE------RM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp TTCCHHH---HHHHHH----TTC------CC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCHHH---HHHHHH----cCC------CC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 7643211 111110 000 01 1122335789999999999999999999999998863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=299.16 Aligned_cols=225 Identities=22% Similarity=0.317 Sum_probs=156.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHhh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFR--------RSLPLPWSIRMKIALGAAKGLAFLH 71 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~--------~~~~l~~~~~~~i~~qi~~~l~~LH 71 (304)
+|+++|++++|||||++++++.. +...++||||+. ++|.+++.. ....+++..++.++.||+.||+|||
T Consensus 67 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 145 (405)
T 3rgf_A 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145 (405)
T ss_dssp HHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 69999999999999999999965 668999999995 588887742 1235999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEE----CCCCcEEEccccCcccCCCCCc-ceeeecccccccccCcchhhc-CCCCchhhhHHH
Q 022003 72 EEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSF 145 (304)
Q Consensus 72 ~~~~~~iiH~dlkp~Nili----~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diwsl 145 (304)
+.+ |+||||||+|||| +.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||
T Consensus 146 ~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 222 (405)
T 3rgf_A 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 222 (405)
T ss_dssp HTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHH
T ss_pred hCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHH
Confidence 998 9999999999999 6778999999999987643221 122334678999999999987 459999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCc------chhHhhhhhhc--------cc------cccccccCCccCCCCC--------
Q 022003 146 GVVLLEMLTGRRSMDKNRPNGEH------NLVEWARPHLG--------ER------RRFYRLIDPRLEGHFS-------- 197 (304)
Q Consensus 146 G~il~el~tg~~p~~~~~~~~~~------~~~~~~~~~~~--------~~------~~~~~~~~~~~~~~~~-------- 197 (304)
||++|+|++|..||......... .........+. .. ..+...+.........
T Consensus 223 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (405)
T 3rgf_A 223 GCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302 (405)
T ss_dssp HHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTT
T ss_pred HHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhc
Confidence 99999999999999765432100 00000000000 00 0000000000000000
Q ss_pred -HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 198 -IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 198 -~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
...+..+.+||.+||+.||.+|||++|+++|..
T Consensus 303 ~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 303 KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp TCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 001457889999999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.76 Aligned_cols=216 Identities=26% Similarity=0.292 Sum_probs=162.7
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++.++ +||||+++++++..++..++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 59 ~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 134 (316)
T 2ac3_A 59 REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAH 134 (316)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cee
Confidence 689999885 7999999999999999999999999999999999664 36999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCc---EEEccccCcccCCCCCc-----ceeeecccccccccCcchhhc-----CCCCchhhhHHHHH
Q 022003 81 RDFKTSNILLDADYN---AKLSDFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGV 147 (304)
Q Consensus 81 ~dlkp~Nili~~~~~---~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~ 147 (304)
|||||+|||++.++. +||+|||++........ ........||..|+|||++.+ ..++.++|||||||
T Consensus 135 ~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 214 (316)
T 2ac3_A 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214 (316)
T ss_dssp CCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHH
T ss_pred CCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHH
Confidence 999999999988776 99999999876532211 111223568999999999875 56899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcch---------hHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCC
Q 022003 148 VLLEMLTGRRSMDKNRPNGEHNL---------VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 218 (304)
Q Consensus 148 il~el~tg~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 218 (304)
++|+|++|..||........... .............+. .... ...+..+.+||.+||+.||.+
T Consensus 215 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~----~~~~----~~~~~~~~~li~~~L~~dP~~ 286 (316)
T 2ac3_A 215 ILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP----DKDW----AHISCAAKDLISKLLVRDAKQ 286 (316)
T ss_dssp HHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC----HHHH----TTSCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC----chhc----ccCCHHHHHHHHHHhhCChhh
Confidence 99999999999986543321100 000000000000000 0000 012468899999999999999
Q ss_pred CCCHHHHHHHh
Q 022003 219 RPLMSEVVEAL 229 (304)
Q Consensus 219 Rps~~ell~~l 229 (304)
|||++|++++.
T Consensus 287 Rps~~e~l~hp 297 (316)
T 2ac3_A 287 RLSAAQVLQHP 297 (316)
T ss_dssp SCCHHHHHHST
T ss_pred CCCHHHHhcCh
Confidence 99999999964
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=296.98 Aligned_cols=219 Identities=21% Similarity=0.290 Sum_probs=160.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..++..++||||+. ++|.+++.... .+++..++.++.||+.||+|||+.+ |+||
T Consensus 82 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~ 156 (329)
T 3gbz_A 82 REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR---CLHR 156 (329)
T ss_dssp HHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EECC
Confidence 69999999999999999999999999999999996 59999986654 6999999999999999999999998 9999
Q ss_pred cCCCCCeEE-----CCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhC
Q 022003 82 DFKTSNILL-----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 82 dlkp~Nili-----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg 155 (304)
||||+|||+ +.++.+||+|||+++....... ......||..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 157 Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 234 (329)
T 3gbz_A 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234 (329)
T ss_dssp CCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999 4555699999999987543221 22345689999999999874 589999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhh-hccc---------cc----cccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 156 RRSMDKNRPNGEHNLVEWARPH-LGER---------RR----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~-~~~~---------~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
..||........ ........ .... .. +................+.++.+||.+||+.||++|||
T Consensus 235 ~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 312 (329)
T 3gbz_A 235 TPLFPGDSEIDQ--LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312 (329)
T ss_dssp SCSSCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCcCCCCHHHH--HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC
Confidence 999976432111 00000000 0000 00 00000000000001113468899999999999999999
Q ss_pred HHHHHHHh
Q 022003 222 MSEVVEAL 229 (304)
Q Consensus 222 ~~ell~~l 229 (304)
++|++++.
T Consensus 313 ~~e~l~hp 320 (329)
T 3gbz_A 313 AKNALEHP 320 (329)
T ss_dssp HHHHHTSG
T ss_pred HHHHhCCc
Confidence 99999853
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=282.49 Aligned_cols=205 Identities=23% Similarity=0.291 Sum_probs=165.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++||
T Consensus 55 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~ 130 (277)
T 3f3z_A 55 QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHR 130 (277)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCC
Confidence 6999999999999999999999999999999999999999988654 36999999999999999999999998 9999
Q ss_pred cCCCCCeEE---CCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+||++ +.++.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|..|
T Consensus 131 dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p 206 (277)
T 3f3z_A 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 206 (277)
T ss_dssp CCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCC
Confidence 999999999 788999999999998765432 22345689999999988654 99999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|....... ... ........+.. ... ...+..+.++|.+||+.||++|||+.+++++
T Consensus 207 ~~~~~~~~---~~~---~~~~~~~~~~~----~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 207 FSAPTDSE---VML---KIREGTFTFPE----KDW----LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp SCCSSHHH---HHH---HHHHCCCCCCH----HHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCCHHH---HHH---HHHhCCCCCCc----hhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 97543211 110 00000000000 000 0124688999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=297.16 Aligned_cols=209 Identities=28% Similarity=0.359 Sum_probs=168.1
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|+++ +||||+++++++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+|
T Consensus 107 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivH 182 (355)
T 1vzo_A 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---IIY 182 (355)
T ss_dssp CHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 689999999 69999999999999999999999999999999996543 6999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc--CCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p 158 (304)
|||||+||||+.++.+||+|||+++....... .......||..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 183 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~p 261 (355)
T 1vzo_A 183 RDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261 (355)
T ss_dssp CCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999987543222 12334679999999999985 3578999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~l 229 (304)
|......... .......... .+.. +...+..+.+||.+||+.||++|| |++|++++.
T Consensus 262 f~~~~~~~~~--~~~~~~~~~~--------~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 262 FTVDGEKNSQ--AEISRRILKS--------EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp TSCTTSCCCH--HHHHHHHHHC--------CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CccCCccchH--HHHHHHHhcc--------CCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 9754332221 1111111111 1111 112346789999999999999999 999999865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=298.32 Aligned_cols=221 Identities=25% Similarity=0.390 Sum_probs=163.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 73 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~ 148 (331)
T 4aaa_A 73 REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHN---IIHR 148 (331)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEcc
Confidence 6999999999999999999999999999999999988888876544 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.+||+|||+++....... ......||..|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 149 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (331)
T 4aaa_A 149 DIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226 (331)
T ss_dssp CCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999986543221 22345689999999999875 78999999999999999999999997
Q ss_pred CCCCCCCcchhHhhh--------hhhccccccccccCCccCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 022003 161 KNRPNGEHNLVEWAR--------PHLGERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 227 (304)
............... ........+.....+....... ...+..+.+||.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 227 GDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 653221110000000 0000000000011111111111 123578999999999999999999999997
Q ss_pred H
Q 022003 228 A 228 (304)
Q Consensus 228 ~ 228 (304)
+
T Consensus 307 h 307 (331)
T 4aaa_A 307 H 307 (331)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=288.47 Aligned_cols=201 Identities=25% Similarity=0.383 Sum_probs=167.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++||
T Consensus 63 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 138 (284)
T 2vgo_A 63 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERK---VIHR 138 (284)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT---EECC
T ss_pred HHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 58999999999999999999999999999999999999999986543 6999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++....... .....|+..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 139 dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 139 DIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999987654321 2345689999999999999999999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.... ......... +.. ++...+..+.++|.+||+.||.+|||+++++++
T Consensus 215 ~~~~------~~~~~~~~~--------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 215 PSHT------ETHRRIVNV--------DLK----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp SSHH------HHHHHHHTT--------CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCHh------HHHHHHhcc--------ccC----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 4211 111100000 011 111234688999999999999999999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=298.87 Aligned_cols=218 Identities=24% Similarity=0.310 Sum_probs=165.8
Q ss_pred hHhhHhhcCC-----CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLV-----HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+++++++. ||||+++++++...+..++||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||+.+
T Consensus 80 ~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~- 157 (360)
T 3llt_A 80 IEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS- 157 (360)
T ss_dssp HHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4888999886 999999999999999999999999 899999997653 46999999999999999999999998
Q ss_pred CCeEeccCCCCCeEECC-------------------------CCcEEEccccCcccCCCCCcceeeecccccccccCcch
Q 022003 76 RPVIYRDFKTSNILLDA-------------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 130 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 130 (304)
|+||||||+|||++. ++.+||+|||+++..... .....||+.|+|||+
T Consensus 158 --ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~ 230 (360)
T 3llt_A 158 --LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEV 230 (360)
T ss_dssp --EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHH
T ss_pred --eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHH
Confidence 999999999999975 789999999999875432 234578999999999
Q ss_pred hhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhc----------cccccc-----cccCCccCCC
Q 022003 131 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----------ERRRFY-----RLIDPRLEGH 195 (304)
Q Consensus 131 ~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~-----~~~~~~~~~~ 195 (304)
+.+..++.++|||||||++|+|++|..||.................... ....+. ...-+.....
T Consensus 231 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 310 (360)
T 3llt_A 231 ILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASS 310 (360)
T ss_dssp HTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSC
T ss_pred HcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccc
Confidence 9999999999999999999999999999976432211111000000000 000000 0000000000
Q ss_pred -------------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 196 -------------FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 196 -------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+....+..+.+||.+||+.||++|||++|++++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 311 INSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000012578899999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=290.30 Aligned_cols=216 Identities=25% Similarity=0.384 Sum_probs=161.6
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-------RSLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
++|++++++++||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.
T Consensus 61 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 140 (303)
T 2vwi_A 61 LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140 (303)
T ss_dssp -----CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3689999999999999999999999999999999999999999864 245699999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCc---ceeeecccccccccCcchhhc-CCCCchhhhHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVL 149 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il 149 (304)
+ ++||||||+||+++.++.+||+|||++........ ........||..|+|||++.+ ..++.++|||||||++
T Consensus 141 ~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 217 (303)
T 2vwi_A 141 G---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 217 (303)
T ss_dssp T---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHH
T ss_pred C---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHH
Confidence 8 99999999999999999999999999987543221 112234578999999999875 5789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhHhhhhhhcccccccc-ccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 150 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR-LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 150 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|+|++|..||........ .... .......... ..++.... ..+..+.++|.+||+.||.+|||+.+++++
T Consensus 218 ~~l~~g~~pf~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 218 IELATGAAPYHKYPPMKV---LMLT--LQNDPPSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HHHHHSSCTTTTSCGGGH---HHHH--HTSSCCCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCCCccCchhhH---HHHH--hccCCCccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 999999999976532211 1000 0000000000 00111111 224688999999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=300.37 Aligned_cols=207 Identities=26% Similarity=0.345 Sum_probs=158.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++. .+..++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||
T Consensus 189 ~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHr 263 (419)
T 3i6u_A 189 TEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHR 263 (419)
T ss_dssp HHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 5999999999999999999875 55689999999999999988654 47999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCC---cEEEccccCcccCCCCCcceeeecccccccccCcchhhc---CCCCchhhhHHHHHHHHHHHhC
Q 022003 82 DFKTSNILLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 82 dlkp~Nili~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg 155 (304)
||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg 340 (419)
T 3i6u_A 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340 (419)
T ss_dssp CCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHS
T ss_pred CCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 9999999997544 59999999998764322 2334679999999999853 6788999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..||........ ......... .. ..+.... ..+..+.+||.+||+.||++|||++|++++.
T Consensus 341 ~~pf~~~~~~~~--~~~~i~~~~---~~----~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 341 YPPFSEHRTQVS--LKDQITSGK---YN----FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp SCSSCCCSSSCC--HHHHHHTTC---CC----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCCCCCCcchHH--HHHHHhcCC---CC----CCchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 999976432211 111111000 00 0000000 1246889999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=303.01 Aligned_cols=219 Identities=23% Similarity=0.323 Sum_probs=163.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCe------eEEEEecCCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQ------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|+++|+.++||||+++++++...+. .++||||++++ |...+. .....+++..++.++.||+.||+|||+
T Consensus 81 ~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~ 159 (394)
T 4e7w_A 81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159 (394)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 69999999999999999999976543 78999999764 444332 234579999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEEC-CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLL 150 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ 150 (304)
.+ |+||||||+||||+ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|
T Consensus 160 ~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 233 (394)
T 4e7w_A 160 IG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA 233 (394)
T ss_dssp TT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred CC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHH
Confidence 98 99999999999998 799999999999987644322 2345789999999998765 5999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhh----------hc-c--ccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPH----------LG-E--RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~----------~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
+|++|+.||........ ........ .. . ...+...........+....+.++.+||.+||+.||.
T Consensus 234 ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (394)
T 4e7w_A 234 ELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPS 311 (394)
T ss_dssp HHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChh
Confidence 99999999976532211 11111000 00 0 0000000000000111122357899999999999999
Q ss_pred CCCCHHHHHHHh
Q 022003 218 ARPLMSEVVEAL 229 (304)
Q Consensus 218 ~Rps~~ell~~l 229 (304)
+|||+.|+++|.
T Consensus 312 ~R~t~~e~l~hp 323 (394)
T 4e7w_A 312 ARLTAIEALCHP 323 (394)
T ss_dssp GSCCHHHHHTSG
T ss_pred hCCCHHHHhcCh
Confidence 999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=308.14 Aligned_cols=206 Identities=24% Similarity=0.351 Sum_probs=165.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++...+..++|||||.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||
T Consensus 70 ~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~ 145 (486)
T 3mwu_A 70 REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN---IVHR 145 (486)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEec
Confidence 69999999999999999999999999999999999999999886553 6999999999999999999999998 9999
Q ss_pred cCCCCCeEEC---CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..|
T Consensus 146 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 221 (486)
T 3mwu_A 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221 (486)
T ss_dssp CCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999995 45679999999998764332 2334579999999999875 599999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|....... ...... ..... ...+. ....+.++.+||.+||+.||.+|||+.|++++.
T Consensus 222 f~~~~~~~---~~~~i~---~~~~~---~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 222 FYGKNEYD---ILKRVE---TGKYA---FDLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp SCCSSHHH---HHHHHH---HTCCC---SCSGG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred CCCCCHHH---HHHHHH---hCCCC---CCCcc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 97543211 111000 00000 00000 012256889999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=309.49 Aligned_cols=205 Identities=25% Similarity=0.352 Sum_probs=165.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|+.++|||||++++++...+..|+|||||.+|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 85 ~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 160 (494)
T 3lij_A 85 EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHR 160 (494)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 6999999999999999999999999999999999999999988655 36999999999999999999999998 9999
Q ss_pred cCCCCCeEECCC---CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDAD---YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+|||++.. +.+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..|
T Consensus 161 Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~p 236 (494)
T 3lij_A 161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236 (494)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCC
Confidence 999999999764 559999999998764332 233467999999999876 5699999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|....... .. ........ ....+.. . ..+..+.+||.+||+.||.+|||+.|++++
T Consensus 237 f~~~~~~~---~~---~~i~~~~~---~~~~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 237 FGGQTDQE---IL---RKVEKGKY---TFDSPEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SCCSSHHH---HH---HHHHHTCC---CCCSGGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCCHHH---HH---HHHHhCCC---CCCchhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 97643211 11 11000000 0001110 1 124688999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=291.56 Aligned_cols=210 Identities=32% Similarity=0.477 Sum_probs=160.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++||||+++++++. +..++||||+++++|.+++..... .+++..++.++.|+++||+|||+.+.++|+
T Consensus 50 ~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~iv 127 (307)
T 2eva_A 50 VELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127 (307)
T ss_dssp HHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCC
T ss_pred HHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCee
Confidence 6999999999999999999876 347999999999999999976542 478999999999999999999993222399
Q ss_pred eccCCCCCeEECCCCc-EEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||||+||+++.++. +||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 128 H~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 202 (307)
T 2eva_A 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202 (307)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCT
T ss_pred cCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999988876 799999999765322 2234689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
|........ ...+... .. ..+.... ..+..+.++|.+||+.||++|||++++++.|+.+.
T Consensus 203 ~~~~~~~~~--~~~~~~~-~~--------~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 203 FDEIGGPAF--RIMWAVH-NG--------TRPPLIK----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp TTTTCSSHH--HHHHHHH-TT--------CCCCCBT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred chhhCccHH--HHHHHHh-cC--------CCCCccc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 975432110 0111100 00 0111111 22467899999999999999999999999887543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=310.13 Aligned_cols=206 Identities=25% Similarity=0.360 Sum_probs=168.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++...+..++|||||.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||
T Consensus 75 ~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 150 (484)
T 3nyv_A 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNK---IVHR 150 (484)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeC
Confidence 69999999999999999999999999999999999999999986654 6999999999999999999999998 9999
Q ss_pred cCCCCCeEE---CCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..|
T Consensus 151 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 226 (484)
T 3nyv_A 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 226 (484)
T ss_dssp CCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCC
Confidence 999999999 5678999999999987654322 234579999999999876 699999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|....... ...... ..... ...+. ....+..+.+||.+||+.||.+|||+.|++++.
T Consensus 227 f~~~~~~~---~~~~i~---~~~~~---~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 227 FNGANEYD---ILKKVE---KGKYT---FELPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp SCCSSHHH---HHHHHH---HCCCC---CCSGG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred CCCCCHHH---HHHHHH---cCCCC---CCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 97643211 111110 00000 00010 012356889999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=286.36 Aligned_cols=205 Identities=25% Similarity=0.371 Sum_probs=163.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEe----CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|++++++++||||+++++++.. ....++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ .+
T Consensus 74 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~ 151 (290)
T 1t4h_A 74 EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PP 151 (290)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SC
T ss_pred HHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CC
Confidence 58999999999999999999876 34689999999999999999654 46999999999999999999999976 44
Q ss_pred eEeccCCCCCeEEC-CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCC
Q 022003 78 VIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 78 iiH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 156 (304)
++||||||+||+++ .++.+||+|||++....... .....||..|+|||++. ..++.++|||||||++|+|++|.
T Consensus 152 i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~ 226 (290)
T 1t4h_A 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSE 226 (290)
T ss_dssp CCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCC
Confidence 99999999999997 78999999999997654322 23456899999999876 45999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||...... ......... ... ... .....+.++.++|.+||+.||.+|||++|++++
T Consensus 227 ~pf~~~~~~-----~~~~~~~~~-~~~-----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 227 YPYSECQNA-----AQIYRRVTS-GVK-----PAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CTTTTCSSH-----HHHHHHHTT-TCC-----CGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCcCcH-----HHHHHHHhc-cCC-----ccc----cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 999653221 111110000 000 000 111113578999999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=297.52 Aligned_cols=214 Identities=23% Similarity=0.319 Sum_probs=166.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+++|++++||||+++++++...+ ..|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+
T Consensus 73 ~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~- 148 (367)
T 1cm8_A 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG- 148 (367)
T ss_dssp HHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 6999999999999999999998763 469999999 8899999865 36999999999999999999999998
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
|+||||||+|||++.++.+||+|||+++..... .....||.+|+|||++.+ ..++.++|||||||++|+|++
T Consensus 149 --ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 221 (367)
T 1cm8_A 149 --IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221 (367)
T ss_dssp --EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH
T ss_pred --ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999875432 234578999999999887 689999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccc------------c----ccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGER------------R----RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 218 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~------------~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 218 (304)
|+.||.......... .......... . .+.......+. ......+..+.+||.+||+.||.+
T Consensus 222 g~~pf~~~~~~~~l~--~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~ 298 (367)
T 1cm8_A 222 GKTLFKGSDHLDQLK--EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQ 298 (367)
T ss_dssp SSCSSCCSSHHHHHH--HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTT
T ss_pred CCCCCCCCCHHHHHH--HHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhH
Confidence 999997643221110 0000000000 0 00000000000 011123578999999999999999
Q ss_pred CCCHHHHHHHh
Q 022003 219 RPLMSEVVEAL 229 (304)
Q Consensus 219 Rps~~ell~~l 229 (304)
|||++|+++|.
T Consensus 299 R~t~~e~l~hp 309 (367)
T 1cm8_A 299 RVTAGEALAHP 309 (367)
T ss_dssp SCCHHHHHHSG
T ss_pred CCCHHHHhcCh
Confidence 99999999964
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=282.65 Aligned_cols=217 Identities=20% Similarity=0.213 Sum_probs=171.4
Q ss_pred hHhhHhhcCCCCcccceeeEE-EeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYC-IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++.++|++++..+.++ ..++..++||||+ +++|.+++......+++..++.++.||+.||+|||+.+ |+|
T Consensus 53 ~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 128 (296)
T 3uzp_A 53 IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIH 128 (296)
T ss_dssp HHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 689999999998877666655 5667889999999 89999999766668999999999999999999999998 999
Q ss_pred ccCCCCCeEE---CCCCcEEEccccCcccCCCCCcc-----eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 81 RDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 81 ~dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|||||+|||+ +.++.+||+|||++......... .......||..|+|||++.+..++.++|||||||++|+|
T Consensus 129 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 208 (296)
T 3uzp_A 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 208 (296)
T ss_dssp SCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHH
Confidence 9999999999 47889999999999876543221 112345789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
++|..||...................... . .... . ...+.++.+++.+||+.||.+|||+.++++.|+.+
T Consensus 209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-~~~~----~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 209 NLGSLPWQGLKAATKRQKYERISEKKMST-P-IEVL----C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHSSCTTSSCCCSSSSSHHHHHHHHHHHS-C-HHHH----T----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HhCCCCCCCcCchhhhhhhhhhcccccCC-c-hHHH----H----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 99999998755443333222111110000 0 0000 0 11246899999999999999999999999988754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=300.38 Aligned_cols=220 Identities=23% Similarity=0.342 Sum_probs=166.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH 80 (304)
+|++++++++||||+++++++..++..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+. + |+|
T Consensus 80 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H 155 (360)
T 3eqc_A 80 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK---IMH 155 (360)
T ss_dssp HHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC---CCC
T ss_pred HHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCC---EEc
Confidence 69999999999999999999999999999999999999999996543 699999999999999999999985 7 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||++...... ......||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 156 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp SCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred CCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998754221 1234578999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhh----------------------hhhcccccc----ccccCCccCCCCCHHHHHHHHHHHHHhccC
Q 022003 161 KNRPNGEHNLVEWAR----------------------PHLGERRRF----YRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 214 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~----------------------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 214 (304)
............... ......... ................+.++.+||.+||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 311 (360)
T 3eqc_A 232 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 311 (360)
T ss_dssp CCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCS
T ss_pred CCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhc
Confidence 543211000000000 000000000 000000000001112356899999999999
Q ss_pred CCCCCCCHHHHHHHh
Q 022003 215 DPKARPLMSEVVEAL 229 (304)
Q Consensus 215 dp~~Rps~~ell~~l 229 (304)
||++|||++|++++.
T Consensus 312 dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 312 NPAERADLKQLMVHA 326 (360)
T ss_dssp STTTSCCHHHHHTSH
T ss_pred ChhhCCCHHHHhhCh
Confidence 999999999999853
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.55 Aligned_cols=208 Identities=24% Similarity=0.343 Sum_probs=170.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..++..++||||+.+++|.+++......+++..++.++.||+.||.|||+.+ ++|+
T Consensus 73 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~ 149 (314)
T 3com_A 73 KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHR 149 (314)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCC
Confidence 6999999999999999999999999999999999999999999765667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 150 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 150 DIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987543211 22345689999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..... .... .... ..+.. ..+...+..+.+||.+||+.||.+|||+.+++++.
T Consensus 228 ~~~~~-----~~~~--~~~~------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 228 IHPMR-----AIFM--IPTN------PPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp SCHHH-----HHHH--HHHS------CCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CChHH-----HHHH--HhcC------CCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 42210 0000 0000 00000 01112246889999999999999999999999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=293.50 Aligned_cols=205 Identities=18% Similarity=0.154 Sum_probs=167.3
Q ss_pred hHhhHhhcCC---CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 2 AEVNFLGDLV---HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 2 ~E~~il~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
+|+++++.++ |+||+++++++...+..|+|||||++|+|.+++.. ....+++..++.++.||+.||+|||+.+
T Consensus 113 ~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ 192 (365)
T 3e7e_A 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE 192 (365)
T ss_dssp HHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 4677777776 99999999999999999999999999999999964 3456999999999999999999999988
Q ss_pred CCCeEeccCCCCCeEECC-----------CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhH
Q 022003 75 ERPVIYRDFKTSNILLDA-----------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 143 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~-----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 143 (304)
|+||||||+||||+. ++.+||+|||+++..............+||..|+|||++.+..++.++|||
T Consensus 193 ---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 269 (365)
T 3e7e_A 193 ---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269 (365)
T ss_dssp ---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHH
T ss_pred ---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHH
Confidence 999999999999988 899999999999765432333344557899999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-CH
Q 022003 144 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LM 222 (304)
Q Consensus 144 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~ 222 (304)
||||++|||+||+.||........ .....+. .. ..+..+.+++..||+.+|.+|+ ++
T Consensus 270 slG~il~elltg~~pf~~~~~~~~---------------~~~~~~~-~~------~~~~~~~~~~~~~l~~~p~~r~~~~ 327 (365)
T 3e7e_A 270 GVAATVYCMLFGTYMKVKNEGGEC---------------KPEGLFR-RL------PHLDMWNEFFHVMLNIPDCHHLPSL 327 (365)
T ss_dssp HHHHHHHHHHHSSCCCEEEETTEE---------------EECSCCT-TC------SSHHHHHHHHHHHHCCCCTTCCCCH
T ss_pred HHHHHHHHHHhCCCccccCCCCce---------------eechhcc-cc------CcHHHHHHHHHHHcCCCCCCcchHH
Confidence 999999999999999854322100 0000000 00 1156788999999999999995 77
Q ss_pred HHHHHHhCC
Q 022003 223 SEVVEALKP 231 (304)
Q Consensus 223 ~ell~~l~~ 231 (304)
.++.+.|+.
T Consensus 328 ~~l~~~l~~ 336 (365)
T 3e7e_A 328 DLLRQKLKK 336 (365)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 777777653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=286.98 Aligned_cols=208 Identities=27% Similarity=0.415 Sum_probs=168.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++||||+++++++. .+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|
T Consensus 57 ~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H 132 (279)
T 1qpc_A 57 AEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132 (279)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 6999999999999999999876 456899999999999999986542 36999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 133 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 211 (279)
T 1qpc_A 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (279)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654321 12223456788999999998899999999999999999999 89998
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
...... ....... .. .... .+...+..+.+++.+||+.||++|||++++++.|+.
T Consensus 212 ~~~~~~---~~~~~~~----~~------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 212 PGMTNP---EVIQNLE----RG------YRMV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp TTCCHH---HHHHHHH----TT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccCHH---HHHHHHh----cc------cCCC----CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 754221 1111100 00 0011 111235689999999999999999999999998864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.15 Aligned_cols=213 Identities=25% Similarity=0.364 Sum_probs=162.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++||||+++++++...+..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ +
T Consensus 81 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i 157 (310)
T 2wqm_A 81 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---V 157 (310)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 699999999999999999999999999999999999999999864 3456999999999999999999999998 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
+||||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 158 ~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 235 (310)
T 2wqm_A 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235 (310)
T ss_dssp CCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986543221 22345689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
|...... ......... ...+. +.. ....+.++.++|.+||+.||.+|||+.++++.|+.+.
T Consensus 236 ~~~~~~~----~~~~~~~~~--~~~~~----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 236 FYGDKMN----LYSLCKKIE--QCDYP----PLP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp TC---CC----HHHHHHHHH--TTCSC----CCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Ccccchh----HHHHHHHhh--cccCC----CCc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 9654221 111111000 00000 000 1123468999999999999999999999999886543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=288.79 Aligned_cols=212 Identities=26% Similarity=0.372 Sum_probs=169.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.... .++||||+.+++|.+++......+++..++.++.|++.||.|||+.+ ++||
T Consensus 70 ~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 145 (291)
T 1u46_A 70 REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHR 145 (291)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 6899999999999999999988765 89999999999999999776667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||+||+++.++.+||+|||++......... .......+|..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 146 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 225 (291)
T 1u46_A 146 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225 (291)
T ss_dssp CCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999876543322 12233457888999999998889999999999999999999 99999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
...... ............ .. .+...+..+.++|.+||+.||.+|||+.++++.|+...
T Consensus 226 ~~~~~~------~~~~~~~~~~~~------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 226 IGLNGS------QILHKIDKEGER------LP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp TTCCHH------HHHHHHHTSCCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ccCCHH------HHHHHHHccCCC------CC----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 754321 111111000000 00 11123578999999999999999999999999886543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=287.57 Aligned_cols=206 Identities=24% Similarity=0.330 Sum_probs=164.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ ++||
T Consensus 57 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 132 (283)
T 3bhy_A 57 REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR---IAHF 132 (283)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCC
Confidence 5899999999999999999999999999999999999999999654 36999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCC----cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 82 DFKTSNILLDADY----NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 82 dlkp~Nili~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
||||+||+++.++ .+||+|||++........ .....|+..|+|||++.+..++.++||||||+++|+|++|..
T Consensus 133 dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 209 (283)
T 3bhy_A 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209 (283)
T ss_dssp CCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCC
Confidence 9999999998877 899999999987643321 233568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
||....... ........... ...... ...+..+.++|.+||+.||++|||+.|++++
T Consensus 210 p~~~~~~~~------~~~~~~~~~~~----~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 210 PFLGETKQE------TLTNISAVNYD----FDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp TTCCSSHHH------HHHHHHTTCCC----CCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CCCCcchHH------HHHHhHhcccC----Ccchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 997542211 00000000000 000000 1124678999999999999999999999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=293.52 Aligned_cols=203 Identities=27% Similarity=0.358 Sum_probs=168.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++.+.+..++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 90 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 165 (335)
T 2owb_A 90 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHR 165 (335)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEec
Confidence 5899999999999999999999999999999999999999988654 46999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 166 dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 9999999999999999999999987643221 23345789999999999999999999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.... .......... ... +...+..+.+||.+||+.||++|||++|++++
T Consensus 244 ~~~~------~~~~~~~~~~--------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 244 SCLK------ETYLRIKKNE--------YSI----PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp SSHH------HHHHHHHHTC--------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCHH------HHHHHHhcCC--------CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3211 1100000000 011 11224678899999999999999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=289.64 Aligned_cols=206 Identities=23% Similarity=0.365 Sum_probs=168.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||
T Consensus 55 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 130 (304)
T 2jam_A 55 NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENG---IVHR 130 (304)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 68999999999999999999999999999999999999999986543 6999999999999999999999998 9999
Q ss_pred cCCCCCeEE---CCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+||++ +.++.+||+|||++...... ......||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 131 dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 206 (304)
T 2jam_A 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206 (304)
T ss_dssp SCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999 78899999999998764322 12335689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|...... ... .........+ ... .....+..+.++|.+||+.||++|||++|++++.
T Consensus 207 f~~~~~~---~~~---~~i~~~~~~~----~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 207 FYEETES---KLF---EKIKEGYYEF----ESP----FWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp TTTSCHH---HHH---HHHHHCCCCC----CTT----TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCCCCHH---HHH---HHHHcCCCCC----Ccc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 9654221 111 1000000000 011 1112356899999999999999999999999854
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.86 Aligned_cols=212 Identities=25% Similarity=0.396 Sum_probs=171.2
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
++|+++|++|+|+||+++++++.. +..++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+
T Consensus 310 ~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iv 385 (535)
T 2h8h_A 310 LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 385 (535)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 369999999999999999999865 6789999999999999999653 346999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
||||||+||||+.++.+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 386 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P 464 (535)
T 2h8h_A 386 HRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464 (535)
T ss_dssp CSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCS
T ss_pred CCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998754321 111223446788999999999999999999999999999999 8999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 234 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~~ 234 (304)
|...... ....... ... .. . .+..++..+.+||.+||+.||++|||+++|++.|+.+..
T Consensus 465 ~~~~~~~---~~~~~i~----~~~---~~---~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 465 YPGMVNR---EVLDQVE----RGY---RM---P----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp STTCCHH---HHHHHHH----TTC---CC---C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCHH---HHHHHHH----cCC---CC---C----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 9754321 1111110 000 00 0 112335689999999999999999999999999987644
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=287.48 Aligned_cols=206 Identities=27% Similarity=0.418 Sum_probs=161.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC-CeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++||||+++++++... +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++
T Consensus 63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 139 (278)
T 1byg_A 63 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139 (278)
T ss_dssp HTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 689999999999999999987654 47899999999999999996543 23899999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
||||||+||+++.++.+||+|||++...... .....++..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 140 H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 214 (278)
T 1byg_A 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214 (278)
T ss_dssp CSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998864332 122356889999999999999999999999999999998 9999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
|....... ...... .. .... .+...+..+.++|.+||+.||.+|||+.|+++.|+.+
T Consensus 215 ~~~~~~~~---~~~~~~----~~------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 215 YPRIPLKD---VVPRVE----KG------YKMD----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CTTSCGGG---HHHHHT----TT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHH---HHHHHh----cC------CCCC----CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 97543211 111100 00 0011 1122357899999999999999999999999988643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=300.55 Aligned_cols=219 Identities=27% Similarity=0.351 Sum_probs=162.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC------CeeEEEEecCCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|+++|++++|||||++++++... ..+++||||+++ +|.+.+. .....+++..++.++.||+.||+|||+
T Consensus 96 ~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 174 (420)
T 1j1b_A 96 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174 (420)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 699999999999999999998642 136799999965 6666554 245679999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCC-CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLL 150 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ 150 (304)
.+ |+||||||+||||+.+ +.+||+|||+++....... .....||..|+|||++.+. .++.++|||||||++|
T Consensus 175 ~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 248 (420)
T 1j1b_A 175 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248 (420)
T ss_dssp TT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred CC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHH
Confidence 88 9999999999999865 6789999999987643322 2345789999999998764 7999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhh-------hcc-ccccccccCCccCC-----CCCHHHHHHHHHHHHHhccCCCC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPH-------LGE-RRRFYRLIDPRLEG-----HFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~-------~~~-~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
||++|+.||....... .+....... +.. ...+.+...+.... .+....+.++.+||.+||+.||.
T Consensus 249 ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~ 326 (420)
T 1j1b_A 249 ELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 326 (420)
T ss_dssp HHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGG
T ss_pred HHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChh
Confidence 9999999997643211 111111100 000 00000111111100 01122357899999999999999
Q ss_pred CCCCHHHHHHHh
Q 022003 218 ARPLMSEVVEAL 229 (304)
Q Consensus 218 ~Rps~~ell~~l 229 (304)
+|||+.|+++|.
T Consensus 327 ~R~t~~e~l~hp 338 (420)
T 1j1b_A 327 ARLTPLEACAHS 338 (420)
T ss_dssp GSCCHHHHHTSG
T ss_pred HCCCHHHHhCCH
Confidence 999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=295.97 Aligned_cols=220 Identities=19% Similarity=0.255 Sum_probs=170.7
Q ss_pred hHhhHhhcCCCCcccc---------------eeeEEEe-CCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVK---------------LIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAA 64 (304)
Q Consensus 2 ~E~~il~~l~h~niv~---------------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~ 64 (304)
+|++++++++||||++ +++++.. ++..++||||+ +++|.+++... ...+++..++.++.||+
T Consensus 91 ~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~ 169 (352)
T 2jii_A 91 NEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLL 169 (352)
T ss_dssp HHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHH
Confidence 6999999999999987 6777776 67889999999 99999999765 35799999999999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEECCCC--cEEEccccCcccCCCCCcc-----eeeecccccccccCcchhhcCCCC
Q 022003 65 KGLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLT 137 (304)
Q Consensus 65 ~~l~~LH~~~~~~iiH~dlkp~Nili~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~ 137 (304)
.||.|||+.+ |+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++.+..++
T Consensus 170 ~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 246 (352)
T 2jii_A 170 DALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS 246 (352)
T ss_dssp HHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC
T ss_pred HHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC
Confidence 9999999998 99999999999999998 9999999999875432211 111335789999999999999999
Q ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 138 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 138 ~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
.++|||||||++|+|++|..||....... ............... ........ ....+..+.+||.+||+.||+
T Consensus 247 ~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~~l~~dp~ 319 (352)
T 2jii_A 247 RRSDLQSLGYCMLKWLYGFLPWTNCLPNT-EDIMKQKQKFVDKPG---PFVGPCGH---WIRPSETLQKYLKVVMALTYE 319 (352)
T ss_dssp HHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HHHHHHHHHHHHSCC---CEECTTSC---EECCCHHHHHHHHHHHTCCTT
T ss_pred chhhHHHHHHHHHHHHhCCCCcccCCcCH-HHHHHHHHhccCChh---hhhhhccc---cCCCcHHHHHHHHHHHhCChh
Confidence 99999999999999999999997653221 111111111111111 11110000 001246899999999999999
Q ss_pred CCCCHHHHHHHhCCC
Q 022003 218 ARPLMSEVVEALKPL 232 (304)
Q Consensus 218 ~Rps~~ell~~l~~~ 232 (304)
+|||++++++.|+.+
T Consensus 320 ~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 320 EKPPYAMLRNNLEAL 334 (352)
T ss_dssp CCCCHHHHHHHHHHH
T ss_pred hCCCHHHHHHHHHHH
Confidence 999999999988654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=317.13 Aligned_cols=203 Identities=24% Similarity=0.355 Sum_probs=168.1
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|.++|..+ +||||+++++++.+.+.+||||||++||+|.+++.+.. .+++..++.++.||+.||+|||+.+ |+|
T Consensus 390 ~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g---IiH 465 (674)
T 3pfq_A 390 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG---IIY 465 (674)
T ss_dssp HHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTS---EEC
T ss_pred HHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eEe
Confidence 588888887 79999999999999999999999999999999997654 6999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||||+.+|.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.
T Consensus 466 rDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~ 543 (674)
T 3pfq_A 466 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543 (674)
T ss_dssp CCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCC
Confidence 99999999999999999999999986432221 2345789999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~~ 228 (304)
..... +........... ++...+.++.+||.+||+.||++||++ +||++|
T Consensus 544 ~~~~~------~~~~~i~~~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 544 GEDED------ELFQSIMEHNVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CSSHH------HHHHHHHSSCCC------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CCCHH------HHHHHHHhCCCC------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 64321 111111111111 112235789999999999999999987 666654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=285.11 Aligned_cols=212 Identities=24% Similarity=0.256 Sum_probs=161.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..++..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 83 ~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~ 158 (309)
T 2h34_A 83 REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHR 158 (309)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcC
Confidence 5899999999999999999999999999999999999999999654 36999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++........ .......|+..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 159 dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (309)
T 2h34_A 159 DVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237 (309)
T ss_dssp CCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999987543321 122345689999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhCCCC
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLP 233 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~ell~~l~~~~ 233 (304)
.... ............... .....+..+.++|.+||+.||++|| |++++++.|+...
T Consensus 238 ~~~~-------~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 238 DQLS-------VMGAHINQAIPRPST--------VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp CHHH-------HHHHHHHSCCCCGGG--------TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred chHH-------HHHHHhccCCCCccc--------cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 3211 111111111100011 1112245789999999999999999 9999999887543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=286.57 Aligned_cols=203 Identities=27% Similarity=0.358 Sum_probs=168.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++||
T Consensus 64 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~ 139 (294)
T 2rku_A 64 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHR 139 (294)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 5899999999999999999999999999999999999999988654 36999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++........ ......||..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 140 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987643222 22345689999999999998999999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.... .......... ... +...+..+.++|.+||+.||++|||++|++++
T Consensus 218 ~~~~------~~~~~~~~~~--------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 218 SCLK------ETYLRIKKNE--------YSI----PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp SSHH------HHHHHHHTTC--------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCHH------HHHHHHhhcc--------CCC----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 4211 1000000000 011 11224678999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=286.95 Aligned_cols=205 Identities=28% Similarity=0.413 Sum_probs=168.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEe----------------CCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE----------------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAA 64 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~ 64 (304)
+|++++++++||||+++++++.. ....++||||+++++|.+++... ...+++..++.++.||+
T Consensus 53 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~ 132 (284)
T 2a19_B 53 REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132 (284)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHH
Confidence 69999999999999999998864 44579999999999999999654 35799999999999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHH
Q 022003 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 144 (304)
Q Consensus 65 ~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 144 (304)
.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .....||..|+|||++.+..++.++||||
T Consensus 133 ~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 206 (284)
T 2a19_B 133 KGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYA 206 (284)
T ss_dssp HHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHH
T ss_pred HHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHH
Confidence 9999999998 99999999999999999999999999987654322 23356899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 145 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 145 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
|||++|+|++|..|+... ...... ........ ..+..+.++|.+||+.||.+|||+.|
T Consensus 207 lG~il~~l~~~~~~~~~~--------~~~~~~----------~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e 264 (284)
T 2a19_B 207 LGLILAELLHVCDTAFET--------SKFFTD----------LRDGIISD----IFDKKEKTLLQKLLSKKPEDRPNTSE 264 (284)
T ss_dssp HHHHHHHHHSCCSSHHHH--------HHHHHH----------HHTTCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHhcCCcchhH--------HHHHHH----------hhcccccc----cCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999998876421 000000 00011111 12467889999999999999999999
Q ss_pred HHHHhCCCCC
Q 022003 225 VVEALKPLPN 234 (304)
Q Consensus 225 ll~~l~~~~~ 234 (304)
++++|+.+..
T Consensus 265 ~l~~l~~~~~ 274 (284)
T 2a19_B 265 ILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHHTC
T ss_pred HHHHHHHHhh
Confidence 9999875543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=297.93 Aligned_cols=218 Identities=23% Similarity=0.321 Sum_probs=163.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC--------------------------------------CeeEEEEecCCCCCHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED--------------------------------------DQRLLVYEFMPRGSLENH 43 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~--------------------------------------~~~~lv~e~~~~~sL~~~ 43 (304)
+|+++|+.++|||||++++++... ...++||||++ ++|.+.
T Consensus 49 ~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~ 127 (383)
T 3eb0_A 49 RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKV 127 (383)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHH
T ss_pred HHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHH
Confidence 699999999999999999998543 34889999996 587777
Q ss_pred hhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC-CCCcEEEccccCcccCCCCCcceeeecc
Q 022003 44 LFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRV 119 (304)
Q Consensus 44 l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 119 (304)
+.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++....... ....
T Consensus 128 l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~ 201 (383)
T 3eb0_A 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAY 201 (383)
T ss_dssp HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCc
Confidence 643 4567999999999999999999999988 99999999999997 689999999999987644322 2345
Q ss_pred cccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhc-------------cccccc
Q 022003 120 MGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-------------ERRRFY 185 (304)
Q Consensus 120 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~ 185 (304)
.||..|+|||++.+. .++.++|||||||++|+|++|..||......+. .......... ....+.
T Consensus 202 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 279 (383)
T 3eb0_A 202 ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFP 279 (383)
T ss_dssp CCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCC
T ss_pred ccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCC
Confidence 689999999998865 599999999999999999999999976432211 1111000000 000000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 186 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..........++...+.++.+||.+||+.||.+|||+.|+++|
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 280 TLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000111111222235689999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=308.33 Aligned_cols=206 Identities=25% Similarity=0.329 Sum_probs=167.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++.+.+..++|||||++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||
T Consensus 95 ~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 170 (504)
T 3q5i_A 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHR 170 (504)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeC
Confidence 5999999999999999999999999999999999999999998654 36999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCC---cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+|||++.++ .+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..|
T Consensus 171 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~p 246 (504)
T 3q5i_A 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246 (504)
T ss_dssp CCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCC
Confidence 9999999998776 69999999998765432 233457999999999886 4699999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|....... ...... ..... .+..... ..+.++.+||.+||+.||.+|||++|++++.
T Consensus 247 f~~~~~~~---~~~~i~---~~~~~----~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 247 FGGQNDQD---IIKKVE---KGKYY----FDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp SCCSSHHH---HHHHHH---HCCCC----CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCCCCHHH---HHHHHH---cCCCC----CCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 97643211 111000 00000 0000000 1246899999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=297.34 Aligned_cols=219 Identities=20% Similarity=0.246 Sum_probs=167.0
Q ss_pred hHhhHhhcCC--------CCcccceeeEEE----eCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLV--------HLNLVKLIGYCI----EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLA 68 (304)
Q Consensus 2 ~E~~il~~l~--------h~niv~~~~~~~----~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~ 68 (304)
+|+++|++++ |+||+++++++. .....|+||||+ +++|.+.+.+. ...+++..++.++.||+.||+
T Consensus 82 ~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 160 (397)
T 1wak_A 82 DEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160 (397)
T ss_dssp HHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Confidence 6899999885 788999999988 456789999999 56666666544 467999999999999999999
Q ss_pred HhhcC-CCCCeEeccCCCCCeEECCCC-------------------------------------------------cEEE
Q 022003 69 FLHEE-AERPVIYRDFKTSNILLDADY-------------------------------------------------NAKL 98 (304)
Q Consensus 69 ~LH~~-~~~~iiH~dlkp~Nili~~~~-------------------------------------------------~~kl 98 (304)
|||++ + |+||||||+||||+.++ .+||
T Consensus 161 ~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 237 (397)
T 1wak_A 161 YLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237 (397)
T ss_dssp HHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEE
T ss_pred HHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEe
Confidence 99998 8 99999999999998776 7999
Q ss_pred ccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhh--
Q 022003 99 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-- 176 (304)
Q Consensus 99 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-- 176 (304)
+|||+++..... .....||..|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus 238 ~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 312 (397)
T 1wak_A 238 ADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312 (397)
T ss_dssp CCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHH
T ss_pred cccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHH
Confidence 999999875432 2335789999999999999999999999999999999999999986554332211111000
Q ss_pred -hhcc------------------ccccccccCCc---------cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 177 -HLGE------------------RRRFYRLIDPR---------LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 177 -~~~~------------------~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.... ........... .........+..+.+||.+||+.||++|||++|++++
T Consensus 313 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 313 ELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred HhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000 00000000000 0012356678899999999999999999999999985
Q ss_pred h
Q 022003 229 L 229 (304)
Q Consensus 229 l 229 (304)
.
T Consensus 393 p 393 (397)
T 1wak_A 393 P 393 (397)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=286.97 Aligned_cols=204 Identities=26% Similarity=0.402 Sum_probs=168.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ ++||
T Consensus 69 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 143 (303)
T 3a7i_A 69 QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHR 143 (303)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccC
Confidence 589999999999999999999999999999999999999999854 36999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||+++.++.+||+|||++....... .......||..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 144 dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCChheEEECCCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 999999999999999999999998754322 122345789999999999999999999999999999999999999965
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..... ..... . ....+.... ..+..+.+||.+||+.||.+|||+.+++++.
T Consensus 222 ~~~~~---~~~~~----~------~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 222 LHPMK---VLFLI----P------KNNPPTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp SCHHH---HHHHH----H------HSCCCCCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred cCHHH---HHHHh----h------cCCCCCCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 42211 11000 0 001111111 2246789999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=290.31 Aligned_cols=225 Identities=22% Similarity=0.306 Sum_probs=162.2
Q ss_pred HhhHhhcCCCCcccceeeEEEe-----CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC----
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE---- 73 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---- 73 (304)
|+..+..++||||+++++.+.. ...+++||||+++|+|.+++.... .++..++.++.||+.||+|||+.
T Consensus 57 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~ 134 (336)
T 3g2f_A 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRG 134 (336)
T ss_dssp HHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCG
T ss_pred HHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccc
Confidence 3444556899999999986653 225789999999999999996654 58999999999999999999998
Q ss_pred -----CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCc------ceeeecccccccccCcchhhc-------CC
Q 022003 74 -----AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK------THVSTRVMGTYGYAAPEYVMT-------GH 135 (304)
Q Consensus 74 -----~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~ 135 (304)
+ |+||||||+||||+.++.+||+|||+++....... ........||..|+|||++.+ ..
T Consensus 135 ~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 211 (336)
T 3g2f_A 135 DHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211 (336)
T ss_dssp GGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHH
T ss_pred cccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccc
Confidence 7 99999999999999999999999999987643221 112224579999999999986 45
Q ss_pred CCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchh-Hhhhhhhccccc-----cccccCCccCCC--CCHHHHHHHHHH
Q 022003 136 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARPHLGERRR-----FYRLIDPRLEGH--FSIKGAQKAAQL 207 (304)
Q Consensus 136 ~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~~--~~~~~~~~~~~l 207 (304)
++.++|||||||++|||++|..||............ ............ ......+.+... .....+..+.+|
T Consensus 212 ~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (336)
T 3g2f_A 212 ALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHH
T ss_pred cccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHH
Confidence 678999999999999999997776543332211110 000000000000 000011111111 123467789999
Q ss_pred HHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 208 AAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 208 i~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
|.+||+.||++|||++|+++.|+.+
T Consensus 292 i~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 292 IEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp HHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCChhhCcchHHHHHHHHHH
Confidence 9999999999999999999988754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=301.33 Aligned_cols=217 Identities=21% Similarity=0.219 Sum_probs=171.3
Q ss_pred hHhhHhhcCCC-CcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++.|+| ++|..+..++...+..+|||||+ +++|.+++......+++..++.++.||+.||+|||+.+ |+|
T Consensus 51 ~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvH 126 (483)
T 3sv0_A 51 YESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLH 126 (483)
T ss_dssp HHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---Eee
Confidence 68999999987 55666667777888899999999 99999999876668999999999999999999999998 999
Q ss_pred ccCCCCCeEE---CCCCcEEEccccCcccCCCCCcc-----eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 81 RDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 81 ~dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|||||+|||| +.++.+||+|||+++........ .......||..|+|||++.+..++.++|||||||++|||
T Consensus 127 rDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~el 206 (483)
T 3sv0_A 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYF 206 (483)
T ss_dssp CCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHH
Confidence 9999999999 58899999999999876543321 122356799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
++|..||..................... .....+. . .++.++.+||.+||+.||++||++.+|++.|+.+
T Consensus 207 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~~l~-----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 207 LRGSLPWQGLKAGTKKQKYEKISEKKVA-TSIEALC-----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHSSCTTSSCCCSSHHHHHHHHHHHHHH-SCHHHHH-----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HhCCCCCccccchhHHHHHHHHhhcccc-ccHHHHh-----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 9999999875443322222111110000 0000000 0 1246899999999999999999999999988654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.37 Aligned_cols=207 Identities=26% Similarity=0.414 Sum_probs=166.8
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++++ +||||+++++++...+..++||||++|++|.+++... ..+++..+..++.||+.||.|||+.| ++|
T Consensus 148 ~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H 223 (365)
T 2y7j_A 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVH 223 (365)
T ss_dssp HHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 588999999 8999999999999999999999999999999998654 36999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc------CCCCchhhhHHHHHHHHHHHh
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~t 154 (304)
|||||+|||++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 224 ~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~ 300 (365)
T 2y7j_A 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300 (365)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHH
Confidence 99999999999999999999999987654322 234678999999999864 358899999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|..||...... ....... .....+ ..+.. . ..+..+.++|.+||+.||++|||+.|++++.
T Consensus 301 g~~pf~~~~~~---~~~~~i~---~~~~~~---~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 301 GSPPFWHRRQI---LMLRMIM---EGQYQF---SSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp SSCSSCCSSHH---HHHHHHH---HTCCCC---CHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCCCCCCCCHH---HHHHHHH---hCCCCC---CCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 99999653211 1111000 000000 00000 0 1246789999999999999999999999853
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=289.25 Aligned_cols=213 Identities=21% Similarity=0.283 Sum_probs=164.7
Q ss_pred hHhhHhhcCC-CCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++ ||||+++++++.. ....++||||+.+++|.+++. .+++..++.++.||+.||+|||+.+ |
T Consensus 79 ~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i 151 (330)
T 3nsz_A 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---I 151 (330)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 6999999997 9999999999988 667899999999999999884 3889999999999999999999998 9
Q ss_pred EeccCCCCCeEECCCC-cEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCC
Q 022003 79 IYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 79 iH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~ 156 (304)
+||||||+|||++.++ .+||+|||+++....... .....|+..|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 152 vH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 228 (330)
T 3nsz_A 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228 (330)
T ss_dssp ECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred eeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999776 899999999987654322 234568999999999887 67999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhh----hh----c-----------------cccccccccCCccCCCCCHHHHHHHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARP----HL----G-----------------ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 211 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~----~~----~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 211 (304)
.||........ ........ .. . ....+...... ......+.++.+||.+|
T Consensus 229 ~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~ 303 (330)
T 3nsz_A 229 EPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS----ENQHLVSPEALDFLDKL 303 (330)
T ss_dssp SSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCT----TTGGGCCHHHHHHHHTT
T ss_pred CCcccCCchHH-HHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccc----cccccCCHHHHHHHHHH
Confidence 99954322110 00000000 00 0 00000001111 11112357899999999
Q ss_pred ccCCCCCCCCHHHHHHHh
Q 022003 212 LSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~l 229 (304)
|+.||++|||++|++++.
T Consensus 304 L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 304 LRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp SCSSGGGSCCHHHHHTSG
T ss_pred hcCCcccCCCHHHHhcCc
Confidence 999999999999999853
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=285.08 Aligned_cols=199 Identities=20% Similarity=0.245 Sum_probs=161.2
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|+.++.++ +||||+++++++...+..++||||+++++|.+++.+. ...+++..++.++.||+.||.|||+.+
T Consensus 59 ~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--- 135 (289)
T 1x8b_A 59 REVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--- 135 (289)
T ss_dssp HHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 588888888 9999999999999999999999999999999999654 256999999999999999999999998
Q ss_pred eEeccCCCCCeEECCC-------------------CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCC
Q 022003 78 VIYRDFKTSNILLDAD-------------------YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLT 137 (304)
Q Consensus 78 iiH~dlkp~Nili~~~-------------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 137 (304)
|+||||||+||+++.+ ..+||+|||.+....... ...||..|+|||++.+. .++
T Consensus 136 ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~ 209 (289)
T 1x8b_A 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHL 209 (289)
T ss_dssp EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTH
T ss_pred EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCC
Confidence 9999999999999844 479999999998764322 23589999999999865 667
Q ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 138 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 138 ~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
.++|||||||++|+|++|.+++.... ....... ...+.... ..+..+.++|.+||+.||+
T Consensus 210 ~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~~~-----------~~~~~~~~----~~~~~~~~li~~~l~~dp~ 269 (289)
T 1x8b_A 210 PKADIFALALTVVCAAGAEPLPRNGD-----QWHEIRQ-----------GRLPRIPQ----VLSQEFTELLKVMIHPDPE 269 (289)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCSSSH-----HHHHHHT-----------TCCCCCSS----CCCHHHHHHHHHHTCSSGG
T ss_pred chhhHHHHHHHHHHHhcCCCCCcchh-----HHHHHHc-----------CCCCCCCc----ccCHHHHHHHHHHhCCCcc
Confidence 89999999999999999987764321 1111100 00011111 2246899999999999999
Q ss_pred CCCCHHHHHHHh
Q 022003 218 ARPLMSEVVEAL 229 (304)
Q Consensus 218 ~Rps~~ell~~l 229 (304)
+|||+.|++++.
T Consensus 270 ~Rps~~~ll~h~ 281 (289)
T 1x8b_A 270 RRPSAMALVKHS 281 (289)
T ss_dssp GSCCHHHHHTCT
T ss_pred cCCCHHHHhhCh
Confidence 999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=289.82 Aligned_cols=218 Identities=24% Similarity=0.355 Sum_probs=170.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC--eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++||||+++++++...+ ..++||||+++++|.+++.+....+++..++.++.||+.||.|||+.+ |+
T Consensus 91 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 167 (326)
T 2w1i_A 91 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YI 167 (326)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 6999999999999999999987654 789999999999999999877667999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcce-eeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||||+||+++.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 168 H~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~ 247 (326)
T 2w1i_A 168 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247 (326)
T ss_dssp CSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCG
T ss_pred ccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999998865433221 12234567889999999998899999999999999999999988
Q ss_pred CCCCCC--------CCCcch-hHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 159 MDKNRP--------NGEHNL-VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 159 ~~~~~~--------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|..... ...... ............ .. ..+...+.++.++|.+||+.||++|||+.|+++.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L 317 (326)
T 2w1i_A 248 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG------RL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317 (326)
T ss_dssp GGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC------CC----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHhhccccchhhhHHHHHHHhhcCC------CC----CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 753210 000000 000000000000 00 11123357899999999999999999999999988
Q ss_pred CCC
Q 022003 230 KPL 232 (304)
Q Consensus 230 ~~~ 232 (304)
+.+
T Consensus 318 ~~l 320 (326)
T 2w1i_A 318 DQI 320 (326)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=298.21 Aligned_cols=195 Identities=18% Similarity=0.219 Sum_probs=153.8
Q ss_pred hHh---hHhhcCCCCccccee-------eEEEeCCe-----------------eEEEEecCCCCCHHHHhhcCC------
Q 022003 2 AEV---NFLGDLVHLNLVKLI-------GYCIEDDQ-----------------RLLVYEFMPRGSLENHLFRRS------ 48 (304)
Q Consensus 2 ~E~---~il~~l~h~niv~~~-------~~~~~~~~-----------------~~lv~e~~~~~sL~~~l~~~~------ 48 (304)
+|+ ++|++++|||||+++ +++...+. .|+||||+ +|+|.+++....
T Consensus 122 ~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~ 200 (377)
T 3byv_A 122 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTH 200 (377)
T ss_dssp HHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTT
T ss_pred HHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccccc
Confidence 577 566677899999998 77665542 78999999 689999996542
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCc
Q 022003 49 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 128 (304)
Q Consensus 49 ~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 128 (304)
..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.... ......| ..|+||
T Consensus 201 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aP 271 (377)
T 3byv_A 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPP 271 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCH
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccCh
Confidence 12335888899999999999999998 99999999999999999999999999986432 2334567 999999
Q ss_pred chhhcC-----------CCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCC
Q 022003 129 EYVMTG-----------HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 197 (304)
Q Consensus 129 E~~~~~-----------~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (304)
|++.+. .++.++|||||||++|||++|..||............ .. . ..
T Consensus 272 E~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----------------~~-~-~~--- 330 (377)
T 3byv_A 272 ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------FR-S-CK--- 330 (377)
T ss_dssp HHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG----------------GS-S-CC---
T ss_pred hhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh----------------hh-h-cc---
Confidence 999887 8999999999999999999999999765432221110 00 0 01
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 198 IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 198 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..+.++.+||.+||+.||++|||+.|++++
T Consensus 331 -~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 331 -NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp -CCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred -CCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 124688999999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=287.52 Aligned_cols=219 Identities=26% Similarity=0.351 Sum_probs=169.2
Q ss_pred hHhhHhhc--CCCCcccceeeEEEeCC----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh----
Q 022003 2 AEVNFLGD--LVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH---- 71 (304)
Q Consensus 2 ~E~~il~~--l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH---- 71 (304)
+|++++.. ++||||+++++++.... ..++||||+++++|.+++.+. .+++..++.++.|++.||.|||
T Consensus 83 ~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~ 160 (342)
T 1b6c_B 83 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIV 160 (342)
T ss_dssp HHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBC
T ss_pred HHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHh
Confidence 57888877 79999999999998876 789999999999999999654 5999999999999999999999
Q ss_pred ----cCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcce--eeecccccccccCcchhhcCC------CCch
Q 022003 72 ----EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGH------LTSR 139 (304)
Q Consensus 72 ----~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~ 139 (304)
+.+ |+||||||+||||+.++.+||+|||++.......... ......||..|+|||++.+.. ++.+
T Consensus 161 ~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 237 (342)
T 1b6c_B 161 GTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237 (342)
T ss_dssp STTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHH
T ss_pred hhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCc
Confidence 777 9999999999999999999999999998754433221 223457899999999988652 3478
Q ss_pred hhhHHHHHHHHHHHhC----------CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCC-CCHHHHHHHHHHH
Q 022003 140 SDVYSFGVVLLEMLTG----------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLA 208 (304)
Q Consensus 140 ~DiwslG~il~el~tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li 208 (304)
+|||||||++|+|++| ..||......... ...+...... ....+..... .....+..+.+||
T Consensus 238 ~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li 310 (342)
T 1b6c_B 238 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIM 310 (342)
T ss_dssp HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHHHHHHHTT------SCCCCCCCGGGGTSHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc-HHHHHHHHHH------HHhCCCCcccccchhHHHHHHHHH
Confidence 9999999999999999 6677554332211 1111111100 1111111111 1235677899999
Q ss_pred HHhccCCCCCCCCHHHHHHHhCCC
Q 022003 209 AHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 209 ~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
.+||+.||++|||+.+++++|+.+
T Consensus 311 ~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 311 RECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp HHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhccChhhCCCHHHHHHHHHHH
Confidence 999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=287.26 Aligned_cols=211 Identities=25% Similarity=0.364 Sum_probs=165.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCC--
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEA-- 74 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~-- 74 (304)
+|++++++++||||+++++++.. ++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+
T Consensus 54 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 133 (279)
T 2w5a_A 54 SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133 (279)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCC
Confidence 68999999999999999998854 56889999999999999998653 345999999999999999999999965
Q ss_pred CCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh
Q 022003 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 154 (304)
..+++||||||+||+++.++.+||+|||+++....... ......|+..|+|||++.+..++.++|||||||++|+|++
T Consensus 134 ~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 211 (279)
T 2w5a_A 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211 (279)
T ss_dssp ----CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHH
T ss_pred CCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHH
Confidence 23399999999999999999999999999987643221 1233568999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
|..||...... ....... . ... +.. +...+.++.++|.+||+.||.+|||+.|+++++..
T Consensus 212 g~~p~~~~~~~---~~~~~i~----~-~~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 212 LMPPFTAFSQK---ELAGKIR----E-GKF-----RRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp SSCSSCCSSHH---HHHHHHH----H-TCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCCCcccCHH---HHHHHHh----h-ccc-----ccC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 99999754311 1111000 0 000 111 11235689999999999999999999999997653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=284.78 Aligned_cols=207 Identities=24% Similarity=0.362 Sum_probs=165.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|+++++.++||||+++++++...+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ ++
T Consensus 68 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 144 (295)
T 2clq_A 68 EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144 (295)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EE
Confidence 58999999999999999999999999999999999999999997653 35678999999999999999999998 99
Q ss_pred eccCCCCCeEECC-CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC--CCchhhhHHHHHHHHHHHhCC
Q 022003 80 YRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 80 H~dlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~ 156 (304)
|+||||+||+++. ++.+||+|||++........ ......||..|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 145 H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 222 (295)
T 2clq_A 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222 (295)
T ss_dssp CCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTS
T ss_pred ccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999987 89999999999987643221 223457899999999997653 899999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||...... ....+..... ...+.. +...+.++.++|.+||+.||++|||+++++++
T Consensus 223 ~pf~~~~~~---~~~~~~~~~~--------~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 223 PPFYELGEP---QAAMFKVGMF--------KVHPEI----PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CTTGGGSSH---HHHHHHHHHH--------CCCCCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CCccCCCch---hHHHHhhccc--------cccccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 999643211 1111000000 011111 12235688999999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=288.47 Aligned_cols=215 Identities=26% Similarity=0.385 Sum_probs=167.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEe----CCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
+|++++++++||||+++++++.. ....++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+
T Consensus 75 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 154 (317)
T 2buj_A 75 READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154 (317)
T ss_dssp HHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 69999999999999999999873 3478999999999999999865 3567999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcce-------eeecccccccccCcchhhcCC---CCchhhhHH
Q 022003 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-------VSTRVMGTYGYAAPEYVMTGH---LTSRSDVYS 144 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Diws 144 (304)
|+||||||+||+++.++.+||+|||++.......... ......||..|+|||++.+.. ++.++||||
T Consensus 155 ---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s 231 (317)
T 2buj_A 155 ---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWS 231 (317)
T ss_dssp ---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHH
T ss_pred ---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHH
Confidence 9999999999999999999999999987643211000 011245799999999987554 789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 145 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 145 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
|||++|+|++|..||......... ...... .... . + . ....+..+.++|.+||+.||.+|||+.+
T Consensus 232 lG~il~el~~g~~p~~~~~~~~~~-~~~~~~----~~~~---~--~-~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ 296 (317)
T 2buj_A 232 LGCVLYAMMFGEGPYDMVFQKGDS-VALAVQ----NQLS---I--P-Q----SPRHSSALWQLLNSMMTVDPHQRPHIPL 296 (317)
T ss_dssp HHHHHHHHHHSSCTTHHHHHTTSC-HHHHHH----CC-----C--C-C----CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHhCCCChhhhhcccch-hhHHhh----ccCC---C--C-c----cccCCHHHHHHHHHHhhcChhhCCCHHH
Confidence 999999999999998532111110 110000 0000 0 0 0 1122468999999999999999999999
Q ss_pred HHHHhCCCCC
Q 022003 225 VVEALKPLPN 234 (304)
Q Consensus 225 ll~~l~~~~~ 234 (304)
++++|+.+..
T Consensus 297 ll~~L~~~~~ 306 (317)
T 2buj_A 297 LLSQLEALQP 306 (317)
T ss_dssp HHHHHHHTCC
T ss_pred HHHHhhhcCC
Confidence 9999976653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=287.60 Aligned_cols=207 Identities=27% Similarity=0.367 Sum_probs=164.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++++++..++ .++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 64 ~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 138 (322)
T 2ycf_A 64 TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHR 138 (322)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 5899999999999999999987654 89999999999999988654 47999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCc---EEEccccCcccCCCCCcceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHHHHhC
Q 022003 82 DFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 82 dlkp~Nili~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg 155 (304)
||||+|||++.++. +||+|||+++...... ......||..|+|||++. ...++.++|||||||++|+|++|
T Consensus 139 dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g 215 (322)
T 2ycf_A 139 DLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215 (322)
T ss_dssp CCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHS
T ss_pred CCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999987654 9999999998764321 123456899999999974 46789999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
..||........ ........ ... ..+.... ..+..+.+||.+||+.||++|||+.+++++.
T Consensus 216 ~~pf~~~~~~~~--~~~~~~~~---~~~----~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 216 YPPFSEHRTQVS--LKDQITSG---KYN----FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp SCSSCSTTCSSC--HHHHHHHT---CCC----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCCCcccchHHH--HHHHHHhC---ccc----cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 999976543221 11111100 000 0000000 1246889999999999999999999999853
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=293.58 Aligned_cols=210 Identities=22% Similarity=0.304 Sum_probs=148.9
Q ss_pred hHhhHhhcCC-CCcccceeeEEEe--------CCeeEEEEecCCCCCHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHh
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFL 70 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~--~~~~l~~~~~~~i~~qi~~~l~~L 70 (304)
+|+.+++++. ||||+++++++.. ....++||||+. |+|.+++.. ....+++..++.++.||+.||.||
T Consensus 74 ~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L 152 (337)
T 3ll6_A 74 QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152 (337)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 6899999996 9999999999853 345799999994 799998864 345699999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcce----------eeecccccccccCcchh---hcCCCC
Q 022003 71 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH----------VSTRVMGTYGYAAPEYV---MTGHLT 137 (304)
Q Consensus 71 H~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~ 137 (304)
|+.+ .+|+||||||+|||++.++.+||+|||+++......... ......||..|+|||++ .+..++
T Consensus 153 H~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 231 (337)
T 3ll6_A 153 HRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231 (337)
T ss_dssp HTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSS
T ss_pred HhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCC
Confidence 9976 449999999999999999999999999998765432211 11134689999999998 566789
Q ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 138 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 138 ~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
.++|||||||++|+|++|..||......... . ... .... .. ..+..+.+||.+||+.||.
T Consensus 232 ~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~----~~~---~~~~---~~----~~~~~~~~li~~~l~~~p~ 291 (337)
T 3ll6_A 232 EKQDIWALGCILYLLCFRQHPFEDGAKLRIV------N----GKY---SIPP---HD----TQYTVFHSLIRAMLQVNPE 291 (337)
T ss_dssp HHHHHHHHHHHHHHHHHSSCCC----------------------C---CCCT---TC----CSSGGGHHHHHHHSCSSGG
T ss_pred hHHhHHHHHHHHHHHHhCCCCCcchhHHHhh------c----Ccc---cCCc---cc----ccchHHHHHHHHHccCChh
Confidence 9999999999999999999999654321110 0 000 0000 00 1124578999999999999
Q ss_pred CCCCHHHHHHHhCCCC
Q 022003 218 ARPLMSEVVEALKPLP 233 (304)
Q Consensus 218 ~Rps~~ell~~l~~~~ 233 (304)
+|||+.|++++|+.+.
T Consensus 292 ~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 292 ERLSIAEVVHQLQEIA 307 (337)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999987543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.81 Aligned_cols=206 Identities=13% Similarity=0.029 Sum_probs=147.0
Q ss_pred hhHhhcCCCCccccee-------eEEEeCC-----------------eeEEEEecCCCCCHHHHhhcCCCCCCHHHH---
Q 022003 4 VNFLGDLVHLNLVKLI-------GYCIEDD-----------------QRLLVYEFMPRGSLENHLFRRSLPLPWSIR--- 56 (304)
Q Consensus 4 ~~il~~l~h~niv~~~-------~~~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~--- 56 (304)
+++|+. +||||++++ +++...+ ..|+||||++ ++|.+++......+++..+
T Consensus 116 ~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~ 193 (371)
T 3q60_A 116 AARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGI 193 (371)
T ss_dssp HHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHH
T ss_pred HHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhh
Confidence 445555 799977755 5555433 3799999997 8999999765445666666
Q ss_pred ---HHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc
Q 022003 57 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 133 (304)
Q Consensus 57 ---~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 133 (304)
..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+
T Consensus 194 ~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 194 LALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNA 265 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTC
T ss_pred hhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccC
Confidence 778899999999999998 999999999999999999999999999875321 224557799999999987
Q ss_pred --CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHh
Q 022003 134 --GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 211 (304)
Q Consensus 134 --~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 211 (304)
..++.++|||||||++|+|++|..||................. .... .....+. ....+..+.+||.+|
T Consensus 266 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~-----~~~~~~~~~~li~~~ 336 (371)
T 3q60_A 266 STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLR---VPGT-DSLAFGS-----CTPLPDFVKTLIGRF 336 (371)
T ss_dssp SEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTT---SCCC-CSCCCTT-----SSCCCHHHHHHHHHH
T ss_pred CCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhh---hccc-cccchhh-----ccCCCHHHHHHHHHH
Confidence 7899999999999999999999999987643322111000000 0000 0000010 112357899999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 022003 212 LSRDPKARPLMSEVVEA 228 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~ 228 (304)
|+.||++|||+.+++++
T Consensus 337 L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 337 LNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TCSSTTTCCCHHHHTTS
T ss_pred cCCChhhCCCHHHHhcC
Confidence 99999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=288.01 Aligned_cols=216 Identities=19% Similarity=0.284 Sum_probs=168.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHH------hhcC-CCCCCHHHHHHHHHHHHHHHHHhhc-C
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH------LFRR-SLPLPWSIRMKIALGAAKGLAFLHE-E 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~ 73 (304)
+|++++++++||||+++++++...+..++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ .
T Consensus 92 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 171 (348)
T 2pml_X 92 NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171 (348)
T ss_dssp HHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC
Confidence 689999999999999999999999999999999999999998 5442 5679999999999999999999999 8
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCc-hhhhHHHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTS-RSDVYSFGVVLLE 151 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~e 151 (304)
+ ++||||||+||+++.++.+||+|||++...... ......||..|+|||++.+. .++. ++|||||||++|+
T Consensus 172 ~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 244 (348)
T 2pml_X 172 N---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244 (348)
T ss_dssp C---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHH
T ss_pred C---EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHH
Confidence 8 999999999999999999999999999875432 23446789999999999877 6766 9999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhHhhhhhhcccccccc-------ccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 152 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR-------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 152 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
|++|..||...... ........ .....+.. ..............+..+.+||.+||+.||.+|||+.|
T Consensus 245 l~~g~~pf~~~~~~--~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e 319 (348)
T 2pml_X 245 MFYNVVPFSLKISL--VELFNNIR---TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319 (348)
T ss_dssp HHHSSCSSCCSSCS--HHHHHHHT---SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHhCCCCCCCCCcH--HHHHHHHh---ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999999765331 11111110 00000000 00000000011233578999999999999999999999
Q ss_pred HHHHh
Q 022003 225 VVEAL 229 (304)
Q Consensus 225 ll~~l 229 (304)
++++.
T Consensus 320 ~l~hp 324 (348)
T 2pml_X 320 ALKHE 324 (348)
T ss_dssp HHTSG
T ss_pred HhcCc
Confidence 99853
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=290.69 Aligned_cols=218 Identities=24% Similarity=0.325 Sum_probs=157.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+++++.++||||+++++++...+ ..|+||||+. ++|.+++.. .+++..+..++.||+.||.|||+.+
T Consensus 73 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~- 147 (371)
T 2xrw_A 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG- 147 (371)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 6999999999999999999998665 7899999995 588888853 4899999999999999999999998
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
|+||||||+|||++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 148 --ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 222 (371)
T 2xrw_A 148 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222 (371)
T ss_dssp --CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred --eecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998754321 22345789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchh---------Hhh-------hhhhccccc-----cccccCCcc---CCCCCHHHHHHHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLV---------EWA-------RPHLGERRR-----FYRLIDPRL---EGHFSIKGAQKAAQLAAHC 211 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~---------~~~-------~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~li~~~ 211 (304)
..||............ .+. ......... +........ ........+.++.+||.+|
T Consensus 223 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 302 (371)
T 2xrw_A 223 GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 302 (371)
T ss_dssp SCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHH
Confidence 9999764321100000 000 000000000 000000000 0001123367899999999
Q ss_pred ccCCCCCCCCHHHHHHHh
Q 022003 212 LSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~l 229 (304)
|+.||++|||++|++++.
T Consensus 303 L~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 303 LVIDASKRISVDEALQHP 320 (371)
T ss_dssp SCSSGGGSCCHHHHHHSH
T ss_pred CcCChhhCCCHHHHhCCc
Confidence 999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=281.08 Aligned_cols=202 Identities=25% Similarity=0.359 Sum_probs=159.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++++.++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+
T Consensus 60 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 135 (276)
T 2h6d_A 60 REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHM---VVHR 135 (276)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHC---SSCC
T ss_pred HHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---CccC
Confidence 58999999999999999999999999999999999999999996543 6999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||+++.++.+||+|||++....... ......|+..|+|||++.+..+ +.++||||||+++|+|++|..||.
T Consensus 136 dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp CCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998764432 1234568999999999987765 689999999999999999999996
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... .......... ... +...+..+.++|.+||+.||.+|||+.|++++
T Consensus 213 ~~~~~------~~~~~~~~~~--------~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 213 DEHVP------TLFKKIRGGV--------FYI----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CSSHH------HHHHHHHHCC--------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCcHH------HHHHHhhcCc--------ccC----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 53211 1111000000 001 11124678999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=282.96 Aligned_cols=206 Identities=19% Similarity=0.248 Sum_probs=162.6
Q ss_pred hHhhHhhcCCCCcccceeeEEE--eCCeeEEEEecCCCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCI--EDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++||||+++++++. ..+..++||||+.++ |.+++.. ....+++..++.++.||+.||.|||+.+ +
T Consensus 55 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i 130 (305)
T 2wtk_C 55 KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---I 130 (305)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 6899999999999999999984 455789999999765 7776654 3457999999999999999999999998 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC--CCchhhhHHHHHHHHHHHhCC
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~ 156 (304)
+||||||+||+++.++.+||+|||++................||..|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 131 ~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 210 (305)
T 2wtk_C 131 VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210 (305)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSS
T ss_pred eecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998765433333344567899999999988654 478999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.||..... ........... .... ...+..+.++|.+||+.||.+|||+.|++++.
T Consensus 211 ~p~~~~~~------~~~~~~i~~~~--------~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 211 YPFEGDNI------YKLFENIGKGS--------YAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp CSCCCSSH------HHHHHHHHHCC--------CCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred CCCCCchH------HHHHHHHhcCC--------CCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 99975321 11111100000 0111 12246888999999999999999999999853
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=295.71 Aligned_cols=209 Identities=24% Similarity=0.345 Sum_probs=159.2
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|+++ +|||||++++++.+.+..|+|||||. |+|.+++......+.+..++.++.||+.||.|||+.+ |+|
T Consensus 66 ~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH 141 (432)
T 3p23_A 66 REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVH 141 (432)
T ss_dssp HHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEe
Confidence 699999999 89999999999999999999999995 6999999877666777778899999999999999998 999
Q ss_pred ccCCCCCeEECCC-----CcEEEccccCcccCCCCCc-ceeeecccccccccCcchhh---cCCCCchhhhHHHHHHHHH
Q 022003 81 RDFKTSNILLDAD-----YNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLE 151 (304)
Q Consensus 81 ~dlkp~Nili~~~-----~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~e 151 (304)
|||||+||||+.+ ..+||+|||+++....... ........||+.|+|||++. ...++.++|||||||++||
T Consensus 142 rDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~e 221 (432)
T 3p23_A 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 221 (432)
T ss_dssp CCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHH
Confidence 9999999999532 3588999999987653321 12233467999999999997 4567889999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 152 MLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 152 l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|++ |..||...... ..... .. .... ... ......+..+.+||.+||+.||.+|||++|++++.
T Consensus 222 llt~g~~pf~~~~~~----~~~~~---~~-~~~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 222 VISEGSHPFGKSLQR----QANIL---LG-ACSL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp HHTTSCBTTBSTTTH----HHHHH---TT-CCCC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred HHcCCCCCcchhhHH----HHHHH---hc-cCCc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 999 88998543211 00000 00 0000 000 01123466789999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=313.50 Aligned_cols=208 Identities=24% Similarity=0.370 Sum_probs=167.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+.++++++||||+++++++. ++..++||||+++|+|.+++..+...+++..++.++.||+.||.|||+.+ |+||
T Consensus 440 ~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHr 515 (656)
T 2j0j_A 440 QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHR 515 (656)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 6899999999999999999884 56789999999999999999877667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+|||++.++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 516 Dikp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 594 (656)
T 2j0j_A 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594 (656)
T ss_dssp CCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccchHhEEEeCCCCEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999987644322 12233456789999999999999999999999999999997 999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
...... ...... ... ... .+...+..+.++|.+||+.||.+|||+.++++.|+.
T Consensus 595 ~~~~~~---~~~~i~----~~~------~~~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 595 GVKNND---VIGRIE----NGE------RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp TCCHHH---HHHHHH----HTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHH---HHHHHH----cCC------CCC----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 543211 111110 000 011 111235689999999999999999999999998864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=288.21 Aligned_cols=208 Identities=23% Similarity=0.356 Sum_probs=163.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..++..++||||+++++|.+++.+....+++..++.++.||+.||.|||+.+ ++||
T Consensus 65 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 141 (302)
T 2j7t_A 65 VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHR 141 (302)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccC
Confidence 6899999999999999999999999999999999999999998776667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+||+++.++.+||+|||++...... ........||..|+|||++. +..++.++|||||||++|+|++|.
T Consensus 142 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 219 (302)
T 2j7t_A 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219 (302)
T ss_dssp CCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCC
Confidence 99999999999999999999987542110 11122356899999999984 567899999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.||....... .......... .... .+...+..+.++|.+||+.||.+|||+.+++++.
T Consensus 220 ~p~~~~~~~~------~~~~~~~~~~--~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 220 PPHHELNPMR------VLLKIAKSDP--PTLL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp CTTTTSCHHH------HHHHHHHSCC--CCCS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred CCCccCCHHH------HHHHHhccCC--cccC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 9997543211 0000000000 0000 1112346889999999999999999999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=298.16 Aligned_cols=153 Identities=22% Similarity=0.323 Sum_probs=135.5
Q ss_pred hHhhHhhcC------CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 2 AEVNFLGDL------VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 2 ~E~~il~~l------~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
+|+++++.+ +|+||+++++++...+..++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.+
T Consensus 142 ~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 220 (429)
T 3kvw_A 142 EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220 (429)
T ss_dssp HHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 477777776 57799999999999999999999994 69999887653 45999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEECCCCc--EEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 75 ERPVIYRDFKTSNILLDADYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|+||||||+||||+.++. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 221 ---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 292 (429)
T 3kvw_A 221 ---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292 (429)
T ss_dssp ---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHH
T ss_pred ---eecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHH
Confidence 999999999999999887 999999999765432 2235789999999999999999999999999999999
Q ss_pred HhCCCCCCCCC
Q 022003 153 LTGRRSMDKNR 163 (304)
Q Consensus 153 ~tg~~p~~~~~ 163 (304)
++|.+||....
T Consensus 293 ltG~~pf~~~~ 303 (429)
T 3kvw_A 293 LTGYPLLPGED 303 (429)
T ss_dssp HHSSCSSCCSS
T ss_pred HhCCCCCCCCC
Confidence 99999997653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=283.52 Aligned_cols=206 Identities=26% Similarity=0.363 Sum_probs=166.7
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++++. ||||+++++++..++..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ ++|
T Consensus 72 ~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H 147 (298)
T 1phk_A 72 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVH 147 (298)
T ss_dssp HHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 6899999995 999999999999999999999999999999999654 46999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh------cCCCCchhhhHHHHHHHHHHHh
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el~t 154 (304)
|||||+||+++.++.+||+|||++........ .....|+..|+|||++. ...++.++|||||||++|+|++
T Consensus 148 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~ 224 (298)
T 1phk_A 148 RDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224 (298)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred CCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH
Confidence 99999999999999999999999987654322 23456899999999985 4568899999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|..||...... ........... ....+. ....+..+.++|.+||+.||.+|||+.|++++
T Consensus 225 g~~p~~~~~~~------~~~~~~~~~~~---~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 225 GSPPFWHRKQM------LMLRMIMSGNY---QFGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp SSCSSCCSSHH------HHHHHHHHTCC---CCCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCcCccHH------HHHHHHhcCCc---ccCccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 99999654211 11110000000 000010 11235689999999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=294.79 Aligned_cols=218 Identities=22% Similarity=0.272 Sum_probs=158.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC-----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|++++++++||||+++++++... ...|+||||+. ++|.+++......+++..++.++.||+.||.|||+.+
T Consensus 78 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-- 154 (362)
T 3pg1_A 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG-- 154 (362)
T ss_dssp HHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--
Confidence 699999999999999999998653 36799999996 6899988877778999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhC
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg 155 (304)
|+||||||+||+++.++.+||+|||+++...... ......||..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 155 -ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 230 (362)
T 3pg1_A 155 -VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230 (362)
T ss_dssp -CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHS
T ss_pred -CEecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhC
Confidence 9999999999999999999999999998543322 2334578999999999886 6799999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhcc----------cccccccc-------CCccCCCCCHHHHHHHHHHHHHhccCCCCC
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGE----------RRRFYRLI-------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 218 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 218 (304)
..||........... ....... .......+ ............+..+.+||.+||+.||.+
T Consensus 231 ~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 307 (362)
T 3pg1_A 231 KALFRGSTFYNQLNK---IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307 (362)
T ss_dssp SCSCCCSSHHHHHHH---HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred CCCCCCCCHHHHHHH---HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhh
Confidence 999976432111000 0000000 00000000 000000011122467899999999999999
Q ss_pred CCCHHHHHHHh
Q 022003 219 RPLMSEVVEAL 229 (304)
Q Consensus 219 Rps~~ell~~l 229 (304)
|||+.|++++.
T Consensus 308 Rpt~~ell~hp 318 (362)
T 3pg1_A 308 RISTEQALRHP 318 (362)
T ss_dssp SCCHHHHHTSG
T ss_pred CCCHHHHHcCc
Confidence 99999999853
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=291.05 Aligned_cols=217 Identities=24% Similarity=0.327 Sum_probs=151.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+++|+.++||||+++++++... ...++|||++ +++|.+++.. ..+++..++.++.||+.||+|||+.+
T Consensus 77 ~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g- 152 (367)
T 2fst_X 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD- 152 (367)
T ss_dssp HHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 699999999999999999998754 5679999999 7899998854 46999999999999999999999998
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
|+||||||+||||+.++.+||+|||+++..... .....||.+|+|||++.+ ..++.++|||||||++|+|++
T Consensus 153 --ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 225 (367)
T 2fst_X 153 --IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225 (367)
T ss_dssp --CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHH
T ss_pred --eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999875432 234578999999999886 679999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhh-----hhcc-----ccccccccCCccCCC---CCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARP-----HLGE-----RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
|+.||...........+..... .+.. ...+.+.+....... .....+..+.+||.+||+.||.+|||
T Consensus 226 g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t 305 (367)
T 2fst_X 226 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305 (367)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC
Confidence 9999976532211110000000 0000 000000000000000 00012467899999999999999999
Q ss_pred HHHHHHHh
Q 022003 222 MSEVVEAL 229 (304)
Q Consensus 222 ~~ell~~l 229 (304)
++|++++.
T Consensus 306 ~~e~L~hp 313 (367)
T 2fst_X 306 AAQALAHA 313 (367)
T ss_dssp HHHHHTSG
T ss_pred HHHHhcCh
Confidence 99999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=283.67 Aligned_cols=204 Identities=24% Similarity=0.325 Sum_probs=152.0
Q ss_pred HhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCe
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPV 78 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~i 78 (304)
|..+++.++||||+++++++...+..++||||++ ++|.+++.. ....+++..++.++.||+.||+|||+. + +
T Consensus 56 ~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i 131 (290)
T 3fme_A 56 LDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---V 131 (290)
T ss_dssp HHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---C
T ss_pred HHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---e
Confidence 3345788899999999999999999999999996 588777654 456799999999999999999999997 8 9
Q ss_pred EeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchh----hcCCCCchhhhHHHHHHHHHHHh
Q 022003 79 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 79 iH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el~t 154 (304)
+||||||+||+++.++.+||+|||++....... ......||..|+|||++ .+..++.++|||||||++|+|++
T Consensus 132 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~ 208 (290)
T 3fme_A 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI 208 (290)
T ss_dssp CCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEECCCCCEEEeecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999998754322 22334689999999996 46678999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|..||...... ........... .+.. .....+.++.++|.+||+.||++|||+.|++++
T Consensus 209 g~~p~~~~~~~----~~~~~~~~~~~--------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 209 LRFPYDSWGTP----FQQLKQVVEEP--------SPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp TSCSSCCCSCH----HHHHHHHHHSC--------CCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCccccCch----HHHHHHHhccC--------CCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 99999753221 11111100000 0000 011235689999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.89 Aligned_cols=222 Identities=23% Similarity=0.298 Sum_probs=165.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC-----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+++|++++||||+++++++... ...++||||+. ++|.+++... .+++..++.++.||+.||+|||+.+
T Consensus 74 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~-- 148 (364)
T 3qyz_A 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN-- 148 (364)
T ss_dssp HHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 699999999999999999999765 36899999995 6999988654 5999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 149 -ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 227 (364)
T 3qyz_A 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227 (364)
T ss_dssp -EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred -eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH
Confidence 999999999999999999999999999876432211 11234578999999998764 558999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhh-----hc-----cccccc-cccCCccC--CCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPH-----LG-----ERRRFY-RLIDPRLE--GHFSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~-----~~-----~~~~~~-~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
|..||.................. +. ....+. ....+... .......+.++.+||.+||+.||++|||
T Consensus 228 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 307 (364)
T 3qyz_A 228 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307 (364)
T ss_dssp SSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC
Confidence 99999765432221111000000 00 000000 00000000 0000112467899999999999999999
Q ss_pred HHHHHHHh
Q 022003 222 MSEVVEAL 229 (304)
Q Consensus 222 ~~ell~~l 229 (304)
++|++++.
T Consensus 308 ~~e~l~hp 315 (364)
T 3qyz_A 308 VEQALAHP 315 (364)
T ss_dssp HHHHHTSG
T ss_pred HHHHhcCc
Confidence 99999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=284.20 Aligned_cols=207 Identities=25% Similarity=0.376 Sum_probs=158.1
Q ss_pred hHhhHhhcCC--CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++ |+||+++++++...+..++|||+. +++|.+++.... .+++..++.++.||+.||.|||+.+ |+
T Consensus 75 ~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---iv 149 (313)
T 3cek_A 75 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---IV 149 (313)
T ss_dssp HHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhccccCCceEEEEEEeecCCEEEEEEecC-CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ce
Confidence 5899999997 599999999999999999999954 889999997654 7999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-----------CCCCchhhhHHHHHH
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVV 148 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~i 148 (304)
||||||+||+++ ++.+||+|||++................||..|+|||++.+ ..++.++|||||||+
T Consensus 150 H~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~i 228 (313)
T 3cek_A 150 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228 (313)
T ss_dssp CCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHH
T ss_pred ecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHH
Confidence 999999999996 48999999999987654333333345678999999999875 478899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 149 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+|+|++|..||...... ...... ..++.....++...+..+.++|.+||+.||.+|||+.|++++
T Consensus 229 l~el~~g~~pf~~~~~~-----~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 229 LYYMTYGKTPFQQIINQ-----ISKLHA----------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHSSCTTTTCCSH-----HHHHHH----------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCCCchhhHHHH-----HHHHHH----------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 99999999999653221 111110 111111111111224688999999999999999999999985
Q ss_pred h
Q 022003 229 L 229 (304)
Q Consensus 229 l 229 (304)
.
T Consensus 294 ~ 294 (313)
T 3cek_A 294 P 294 (313)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=282.86 Aligned_cols=209 Identities=22% Similarity=0.367 Sum_probs=158.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEe-------------CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE-------------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 68 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~ 68 (304)
+|++++++++||||+++++++.. .+..++||||+++++|.+++......+++..++.++.|++.||+
T Consensus 51 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~ 130 (303)
T 1zy4_A 51 SEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130 (303)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHH
Confidence 69999999999999999998865 35679999999999999999876667899999999999999999
Q ss_pred HhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCc------------ceeeecccccccccCcchhhcC-C
Q 022003 69 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK------------THVSTRVMGTYGYAAPEYVMTG-H 135 (304)
Q Consensus 69 ~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~ 135 (304)
|||+.+ ++||||||+||+++.++.+||+|||++........ ........||..|+|||++.+. .
T Consensus 131 ~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 207 (303)
T 1zy4_A 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH 207 (303)
T ss_dssp HHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSC
T ss_pred HHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCC
Confidence 999998 99999999999999999999999999987543210 1122345689999999999864 7
Q ss_pred CCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCC
Q 022003 136 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 215 (304)
Q Consensus 136 ~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 215 (304)
++.++|||||||++|+|++ ||.... ........... ........+....+..+.++|.+||+.|
T Consensus 208 ~~~~~Di~slG~il~~l~~---p~~~~~-----~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~d 271 (303)
T 1zy4_A 208 YNEKIDMYSLGIIFFEMIY---PFSTGM-----ERVNILKKLRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHD 271 (303)
T ss_dssp CCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHHHHHHHHS--------TTCCCCTTCCTTTSHHHHHHHHHHTCSS
T ss_pred CcchhhHHHHHHHHHHHHh---ccCCch-----hHHHHHHhccc--------cccccCccccccchHHHHHHHHHHHhcC
Confidence 8999999999999999998 443110 00111110000 0111111222333567899999999999
Q ss_pred CCCCCCHHHHHHHh
Q 022003 216 PKARPLMSEVVEAL 229 (304)
Q Consensus 216 p~~Rps~~ell~~l 229 (304)
|.+|||+.+++++.
T Consensus 272 p~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 272 PNKRPGARTLLNSG 285 (303)
T ss_dssp GGGSCCHHHHHHSS
T ss_pred cccCcCHHHHhCCC
Confidence 99999999999964
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=285.63 Aligned_cols=206 Identities=28% Similarity=0.375 Sum_probs=158.6
Q ss_pred hHhhHhhcC-CCCcccceeeEEEe------CCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|+++++++ +||||+++++++.. .+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.
T Consensus 69 ~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 148 (326)
T 2x7f_A 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148 (326)
T ss_dssp HHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 588999999 89999999999987 46789999999999999999764 35699999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVV 148 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~i 148 (304)
+ ++|+||||+||+++.++.+||+|||++....... .......||..|+|||++. +..++.++|||||||+
T Consensus 149 ~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 223 (326)
T 2x7f_A 149 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223 (326)
T ss_dssp T---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHH
T ss_pred C---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHH
Confidence 8 9999999999999999999999999998754321 1223457899999999987 5678999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 149 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 149 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+|+|++|..||....... ... . .. ........ ....+..+.+||.+||..||.+|||+.+++++
T Consensus 224 l~~l~~g~~p~~~~~~~~---~~~--~-~~--~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 224 AIEMAEGAPPLCDMHPMR---ALF--L-IP--RNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHSSCTTTTSCHHH---HHH--H-HH--HSCCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCCCCCCcHHH---HHH--H-hh--cCccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 999999999996542210 000 0 00 00000111 11224688999999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=294.40 Aligned_cols=211 Identities=23% Similarity=0.313 Sum_probs=157.2
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCC------CCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP------LPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
+|+++|+++ +|||||++++++.+++..++|||||. |+|.+++...... ..+..++.++.||+.||+|||+.+
T Consensus 57 ~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 135 (434)
T 2rio_A 57 MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135 (434)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC
Confidence 689999886 89999999999999999999999995 6999999765321 133345789999999999999998
Q ss_pred CCCeEeccCCCCCeEECCC-------------CcEEEccccCcccCCCCCcce--eeecccccccccCcchhhc------
Q 022003 75 ERPVIYRDFKTSNILLDAD-------------YNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT------ 133 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~~-------------~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~------ 133 (304)
|+||||||+|||++.+ +.+||+|||+++......... ......||+.|+|||++.+
T Consensus 136 ---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 212 (434)
T 2rio_A 136 ---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQT 212 (434)
T ss_dssp ---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSC
T ss_pred ---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccccc
Confidence 9999999999999754 489999999998865432211 1234579999999999975
Q ss_pred -CCCCchhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHh
Q 022003 134 -GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 211 (304)
Q Consensus 134 -~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 211 (304)
..++.++|||||||++|||++ |..||....... ...... ... .+..........+.++.+||.+|
T Consensus 213 ~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~~i~~~----~~~-----~~~~~~~~~~~~~~~~~~li~~~ 279 (434)
T 2rio_A 213 KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----SNIIRG----IFS-----LDEMKCLHDRSLIAEATDLISQM 279 (434)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----HHHHHT----CCC-----CCCCTTCCCHHHHHHHHHHHHHH
T ss_pred ccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----HHHhcC----CCC-----cccccccccccchHHHHHHHHHH
Confidence 678999999999999999999 899996532211 111100 000 01111122446678999999999
Q ss_pred ccCCCCCCCCHHHHHHHh
Q 022003 212 LSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~l 229 (304)
|+.||.+|||+.|++++.
T Consensus 280 L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 280 IDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp TCSSGGGSCCHHHHHTSG
T ss_pred hhCChhhCCCHHHHHhCC
Confidence 999999999999999854
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=283.81 Aligned_cols=218 Identities=22% Similarity=0.327 Sum_probs=166.4
Q ss_pred hHhhHhhcCCCC------cccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 2 AEVNFLGDLVHL------NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 2 ~E~~il~~l~h~------niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
+|+++++.++|+ +|+++++++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.+
T Consensus 60 ~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 138 (339)
T 1z57_A 60 SEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK 138 (339)
T ss_dssp HHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence 588888888765 4999999999999999999999 889999987653 46899999999999999999999998
Q ss_pred CCCeEeccCCCCCeEECC-------------------CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC
Q 022003 75 ERPVIYRDFKTSNILLDA-------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH 135 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~-------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 135 (304)
|+||||||+|||++. ++.+||+|||+++..... .....||..|+|||++.+..
T Consensus 139 ---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~ 210 (339)
T 1z57_A 139 ---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALG 210 (339)
T ss_dssp ---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSC
T ss_pred ---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCC
Confidence 999999999999987 668999999999875432 23457899999999999999
Q ss_pred CCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhcc-------ccccc------------------cccCC
Q 022003 136 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-------RRRFY------------------RLIDP 190 (304)
Q Consensus 136 ~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~------------------~~~~~ 190 (304)
++.++|||||||++|+|++|..||..................... ...+. ....+
T Consensus 211 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (339)
T 1z57_A 211 WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP 290 (339)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC
T ss_pred CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc
Confidence 999999999999999999999999764322111110000000000 00000 00000
Q ss_pred c-cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 191 R-LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 191 ~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
. .........+.++.+||.+||+.||.+|||+.|++++
T Consensus 291 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 291 LKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 0 0001123457889999999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=282.34 Aligned_cols=216 Identities=25% Similarity=0.357 Sum_probs=164.8
Q ss_pred hHhhHhhcC---CCCcccceeeEEE-----eCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 2 AEVNFLGDL---VHLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 2 ~E~~il~~l---~h~niv~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
+|+++++.+ +||||+++++++. .....++||||+. ++|.+++... ...+++..++.++.||+.||.|||+
T Consensus 60 ~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 138 (326)
T 1blx_A 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138 (326)
T ss_dssp HHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 577777766 8999999999987 4567899999996 6999998765 3459999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
.+ |+||||||+||+++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|
T Consensus 139 ~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 212 (326)
T 1blx_A 139 HR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212 (326)
T ss_dssp TT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred CC---ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence 98 9999999999999999999999999998654221 22345789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhc--------c-----ccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLG--------E-----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~--------~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 219 (304)
++|..||........ ......... . ...+... .......+....+..+.+||.+||+.||.+|
T Consensus 213 ~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 288 (326)
T 1blx_A 213 FRRKPLFRGSSDVDQ---LGKILDVIGLPGEEDWPRDVALPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288 (326)
T ss_dssp HHSSCSCCCSSHHHH---HHHHHHHHCCCCGGGSCTTCSSCGGGSCCC-CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTS
T ss_pred HcCCCCCCCCCHHHH---HHHHHHHcCCCCcccCccccccchhhhccc-CcchhhhccccCCHHHHHHHHHHcCCCcccC
Confidence 999999976432111 000000000 0 0000000 0000011112235788999999999999999
Q ss_pred CCHHHHHHH
Q 022003 220 PLMSEVVEA 228 (304)
Q Consensus 220 ps~~ell~~ 228 (304)
||+.|++++
T Consensus 289 pt~~e~l~h 297 (326)
T 1blx_A 289 ISAYSALSH 297 (326)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.79 Aligned_cols=218 Identities=23% Similarity=0.295 Sum_probs=162.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC-----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|++++++++||||+++++++... ...++||||+. ++|.+++... .+++..++.++.||+.||+|||+.+
T Consensus 58 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~-- 132 (353)
T 2b9h_A 58 REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSN-- 132 (353)
T ss_dssp HHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 699999999999999999988764 67899999995 6999988653 6999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcce--------eeecccccccccCcchhhc-CCCCchhhhHHHHH
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--------VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGV 147 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ 147 (304)
|+||||||+|||++.++.+||+|||+++......... ......||..|+|||++.+ ..++.++|||||||
T Consensus 133 -ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 211 (353)
T 2b9h_A 133 -VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGC 211 (353)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHH
T ss_pred -eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHH
Confidence 9999999999999999999999999998764322111 1123578999999998865 77999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhHhhhhhhcc-----------c---c----ccccccCCccCCCCCHHHHHHHHHHHH
Q 022003 148 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-----------R---R----RFYRLIDPRLEGHFSIKGAQKAAQLAA 209 (304)
Q Consensus 148 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~---~----~~~~~~~~~~~~~~~~~~~~~~~~li~ 209 (304)
++|+|++|..||......... ......... . . ........... ......+.++.+||.
T Consensus 212 il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 287 (353)
T 2b9h_A 212 ILAELFLRRPIFPGRDYRHQL---LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQ 287 (353)
T ss_dssp HHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCcHHHH---HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHH
Confidence 999999999999764321100 000000000 0 0 00000000000 000123568899999
Q ss_pred HhccCCCCCCCCHHHHHHHh
Q 022003 210 HCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 210 ~~l~~dp~~Rps~~ell~~l 229 (304)
+||+.||++|||++|++++.
T Consensus 288 ~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 288 RMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp HHSCSSGGGSCCHHHHHTSG
T ss_pred HhcCcCcccCCCHHHHhcCc
Confidence 99999999999999999853
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=285.19 Aligned_cols=219 Identities=26% Similarity=0.348 Sum_probs=160.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCe-------eEEEEecCCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhh
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQ-------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLH 71 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~-------~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~~LH 71 (304)
+|++.++.++||||+++++++...+. .++||||+.+ +|...+. .....+++..++.++.|++.||.|||
T Consensus 68 ~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 146 (360)
T 3e3p_A 68 QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146 (360)
T ss_dssp HHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence 46677788899999999999976443 7899999965 5554443 34557999999999999999999999
Q ss_pred --cCCCCCeEeccCCCCCeEECC-CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHH
Q 022003 72 --EEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGV 147 (304)
Q Consensus 72 --~~~~~~iiH~dlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ 147 (304)
+.+ |+||||||+||||+. ++.+||+|||+++....... .....||..|+|||++.+. .++.++|||||||
T Consensus 147 ~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 220 (360)
T 3e3p_A 147 LPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGC 220 (360)
T ss_dssp STTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred CCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHH
Confidence 877 999999999999986 89999999999987654322 2345789999999998765 4899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCC----------------ccCCCCCHHHHHHHHHHHHHh
Q 022003 148 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP----------------RLEGHFSIKGAQKAAQLAAHC 211 (304)
Q Consensus 148 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~li~~~ 211 (304)
++|+|++|..||........ ...................++ ..........+.++.+||.+|
T Consensus 221 il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 298 (360)
T 3e3p_A 221 IFAEMMLGEPIFRGDNSAGQ--LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298 (360)
T ss_dssp HHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred HHHHHHhCCCCcCCCChHHH--HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHH
Confidence 99999999999976432211 111110000000000000000 000011112467899999999
Q ss_pred ccCCCCCCCCHHHHHHHh
Q 022003 212 LSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~l 229 (304)
|+.||.+|||+.|++++.
T Consensus 299 L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 299 LQYLPEERMKPYEALCHP 316 (360)
T ss_dssp TCSSGGGSCCHHHHTTSG
T ss_pred hccCccccCCHHHHhcCc
Confidence 999999999999999853
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=284.15 Aligned_cols=214 Identities=22% Similarity=0.306 Sum_probs=159.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCee------EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|++++++++||||+++++++...+.. ++||||+. ++|.+++.. .+++..++.++.||+.||+|||+.+
T Consensus 90 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~- 164 (371)
T 4exu_A 90 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAG- 164 (371)
T ss_dssp HHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 689999999999999999999877655 99999995 689887733 4999999999999999999999998
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
|+||||||+|||++.++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 165 --ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 237 (371)
T 4exu_A 165 --VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237 (371)
T ss_dssp --CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH
T ss_pred --CcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHh
Confidence 999999999999999999999999999865332 234578999999999987 789999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhcccc------------ccccccCCccCCC---CCHHHHHHHHHHHHHhccCCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERR------------RFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKAR 219 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~R 219 (304)
|..||......... ............ .+........... .....+..+.+||.+||+.||++|
T Consensus 238 g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 315 (371)
T 4exu_A 238 GKTLFKGKDYLDQL--TQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 315 (371)
T ss_dssp SSCSCCCSSHHHHH--HHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTS
T ss_pred CCCCCCCCChHHHH--HHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhc
Confidence 99999764321110 000000000000 0000000000000 001225789999999999999999
Q ss_pred CCHHHHHHHh
Q 022003 220 PLMSEVVEAL 229 (304)
Q Consensus 220 ps~~ell~~l 229 (304)
||++|++++.
T Consensus 316 pt~~ell~hp 325 (371)
T 4exu_A 316 LTAAQALTHP 325 (371)
T ss_dssp CCHHHHHTSG
T ss_pred CCHHHHhcCc
Confidence 9999999853
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=287.73 Aligned_cols=219 Identities=21% Similarity=0.296 Sum_probs=163.5
Q ss_pred hHhhHhhcCC-----------CCcccceeeEEEeCC----eeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLV-----------HLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l~-----------h~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~ 65 (304)
+|++++++++ |+||+++++++...+ ..++||||+ +++|.+++.+. ...+++..++.++.||+.
T Consensus 64 ~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~ 142 (373)
T 1q8y_A 64 DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142 (373)
T ss_dssp HHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHH
Confidence 5888888876 899999999998654 789999999 88999999764 346999999999999999
Q ss_pred HHHHhhcC-CCCCeEeccCCCCCeEEC------CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCc
Q 022003 66 GLAFLHEE-AERPVIYRDFKTSNILLD------ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 138 (304)
Q Consensus 66 ~l~~LH~~-~~~~iiH~dlkp~Nili~------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 138 (304)
||+|||+. + |+||||||+||||+ ..+.+||+|||++...... .....||..|+|||++.+..++.
T Consensus 143 aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~ 214 (373)
T 1q8y_A 143 GLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGC 214 (373)
T ss_dssp HHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCT
T ss_pred HHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCc
Confidence 99999998 8 99999999999994 4458999999999876432 22346899999999999999999
Q ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhh---hhhccc-----------------cccccccCC--------
Q 022003 139 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR---PHLGER-----------------RRFYRLIDP-------- 190 (304)
Q Consensus 139 ~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~-----------------~~~~~~~~~-------- 190 (304)
++|||||||++|+|++|..||................ ...... ......+..
T Consensus 215 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (373)
T 1q8y_A 215 GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 294 (373)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHH
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhh
Confidence 9999999999999999999997654322111100000 000000 000000000
Q ss_pred --ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 191 --RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 191 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.....++...+.++.+||.+||+.||++|||++|++++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 295 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 335 (373)
T ss_dssp HHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred hhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhCh
Confidence 001124567788999999999999999999999999853
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=283.53 Aligned_cols=207 Identities=22% Similarity=0.271 Sum_probs=141.4
Q ss_pred HhhcCCCCcccceeeEEEe----CCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 6 FLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 6 il~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.++.+.||||+++++++.. +...++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+.+ |+|
T Consensus 75 ~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH 151 (336)
T 3fhr_A 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAH 151 (336)
T ss_dssp HHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 4566799999999999876 445899999999999999997663 46999999999999999999999998 999
Q ss_pred ccCCCCCeEECC---CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 81 RDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 81 ~dlkp~Nili~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
|||||+|||++. ++.+||+|||+++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 152 ~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (336)
T 3fhr_A 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227 (336)
T ss_dssp SCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCHHHEEEEecCCCceEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 999999999976 455999999999875432 1234568999999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
||............. ....... .....+ .....+..+.+||.+||+.||++|||++|++++.
T Consensus 228 pf~~~~~~~~~~~~~--~~~~~~~---~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 228 PFYSNTGQAISPGMK--RRIRLGQ---YGFPNP-----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp CC--------------------------CCCTT-----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred CCCCccchhhhhhHH--Hhhhccc---cccCch-----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 997654322110000 0000000 000000 0112356899999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=276.38 Aligned_cols=205 Identities=24% Similarity=0.357 Sum_probs=163.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++...+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+ ++||
T Consensus 70 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~ 145 (287)
T 2wei_A 70 REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN---IVHR 145 (287)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 69999999999999999999999999999999999999999886543 6999999999999999999999998 9999
Q ss_pred cCCCCCeEECCC---CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDAD---YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+||+++.+ +.+||+|||++........ .....||..|+|||++.+ .++.++||||||+++|+|++|..|
T Consensus 146 dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p 221 (287)
T 2wei_A 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221 (287)
T ss_dssp CCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCC
Confidence 999999999754 4699999999987543321 223468999999998875 489999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|...... ....... ..... .+.... ...+.++.++|.+||+.||.+|||+.|++++
T Consensus 222 ~~~~~~~---~~~~~~~---~~~~~----~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 222 FYGKNEY---DILKRVE---TGKYA----FDLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp SCCSSHH---HHHHHHH---HCCCC----CCSGGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCCHH---HHHHHHH---cCCCC----CCchhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 9754321 1111000 00000 000000 1124688999999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=282.59 Aligned_cols=218 Identities=20% Similarity=0.268 Sum_probs=164.1
Q ss_pred hHhhHhhcCCCCc------ccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 2 AEVNFLGDLVHLN------LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 2 ~E~~il~~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
+|++++++++|++ ++.+++++...+..++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+
T Consensus 65 ~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ 143 (355)
T 2eu9_A 65 LEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ 143 (355)
T ss_dssp HHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 5888999987765 899999999999999999999 66777776554 357999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEE-------------------CCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC
Q 022003 75 ERPVIYRDFKTSNILL-------------------DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH 135 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili-------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 135 (304)
|+||||||+|||+ +.++.+||+|||+++..... .....||..|+|||++.+..
T Consensus 144 ---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~ 215 (355)
T 2eu9_A 144 ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELG 215 (355)
T ss_dssp ---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCC
T ss_pred ---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCC
Confidence 9999999999999 56789999999999875432 23357899999999999999
Q ss_pred CCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhhc-------ccccc------------------ccccCC
Q 022003 136 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-------ERRRF------------------YRLIDP 190 (304)
Q Consensus 136 ~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~------------------~~~~~~ 190 (304)
++.++|||||||++|+|++|..||.................... ....+ .....+
T Consensus 216 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (355)
T 2eu9_A 216 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP 295 (355)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC
T ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCc
Confidence 99999999999999999999999976432211110000000000 00000 000000
Q ss_pred -ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 191 -RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 191 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..........+.++.+||.+||+.||++|||+.|++++
T Consensus 296 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 296 LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00001122446789999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=281.61 Aligned_cols=207 Identities=28% Similarity=0.357 Sum_probs=143.8
Q ss_pred Hhh-HhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcC-CCC
Q 022003 3 EVN-FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEE-AER 76 (304)
Q Consensus 3 E~~-il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ 76 (304)
|+. +++.++||||+++++++...+..++||||+. ++|.+++.. ....+++..+..++.|++.||.|||+. +
T Consensus 70 e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-- 146 (327)
T 3aln_A 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146 (327)
T ss_dssp HHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred HHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--
Confidence 444 6778899999999999999999999999996 488887753 245799999999999999999999998 8
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchh----hcCCCCchhhhHHHHHHHHHH
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el 152 (304)
++||||||+||+++.++.+||+|||+++...... ......||..|+|||++ .+..++.++|||||||++|+|
T Consensus 147 -ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l 222 (327)
T 3aln_A 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222 (327)
T ss_dssp -CCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHH
T ss_pred -EeECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999998754322 12234689999999998 456789999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
++|..||......... .... .....+.+........+..+.+||.+||+.||.+|||+.+++++
T Consensus 223 ~~g~~pf~~~~~~~~~-----~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 223 ATGRFPYPKWNSVFDQ-----LTQV-------VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp HHSCCCSSCC------------CCC-------CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHCCCCCCCcchHHHH-----HHHH-------hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 9999999764321100 0000 00000111111111235689999999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=276.85 Aligned_cols=221 Identities=23% Similarity=0.320 Sum_probs=160.4
Q ss_pred hHhhHhhcCCCCcccceeeEEE--------------eCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCI--------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 67 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~--------------~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l 67 (304)
+|++++++++||||+++++++. .....++||||+. ++|.+++.+ ..+++..++.++.||+.||
T Consensus 57 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l 133 (320)
T 2i6l_A 57 REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGL 133 (320)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHH
Confidence 6999999999999999999874 3467899999996 699999854 3699999999999999999
Q ss_pred HHhhcCCCCCeEeccCCCCCeEEC-CCCcEEEccccCcccCCCCCc-ceeeecccccccccCcchhhc-CCCCchhhhHH
Q 022003 68 AFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYS 144 (304)
Q Consensus 68 ~~LH~~~~~~iiH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 144 (304)
+|||+.+ |+||||||+||+++ .++.+||+|||+++....... ........+|..|+|||++.+ ..++.++||||
T Consensus 134 ~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 210 (320)
T 2i6l_A 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 210 (320)
T ss_dssp HHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHH
T ss_pred HHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHh
Confidence 9999998 99999999999997 567999999999987543211 112233567899999998875 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCcchhHhhhhhh--cccccccc---------ccCCccC-CCCCHHHHHHHHHHHHHhc
Q 022003 145 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL--GERRRFYR---------LIDPRLE-GHFSIKGAQKAAQLAAHCL 212 (304)
Q Consensus 145 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~---------~~~~~~~-~~~~~~~~~~~~~li~~~l 212 (304)
|||++|+|++|..||................... .....+.. ...+... .......+.++.+||.+||
T Consensus 211 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 290 (320)
T 2i6l_A 211 AGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQIL 290 (320)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTS
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHc
Confidence 9999999999999997653211100000000000 00000000 0000000 0000123578999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 022003 213 SRDPKARPLMSEVVEA 228 (304)
Q Consensus 213 ~~dp~~Rps~~ell~~ 228 (304)
+.||++|||++|++++
T Consensus 291 ~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 291 TFSPMDRLTAEEALSH 306 (320)
T ss_dssp CSSGGGSCCHHHHHTS
T ss_pred CCCccccCCHHHHhCC
Confidence 9999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=279.89 Aligned_cols=155 Identities=25% Similarity=0.288 Sum_probs=133.1
Q ss_pred hHhhHhhcCC-CC-----cccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 2 AEVNFLGDLV-HL-----NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 2 ~E~~il~~l~-h~-----niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
+|+++++.++ |+ +|+++++++...+..|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||++.
T Consensus 99 ~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 177 (382)
T 2vx3_A 99 IEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE 177 (382)
T ss_dssp HHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT
T ss_pred HHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC
Confidence 4778888875 44 49999999999999999999995 59999987653 56999999999999999999999532
Q ss_pred CCCeEeccCCCCCeEEC--CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 75 ERPVIYRDFKTSNILLD--ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
.+|+||||||+||||+ .++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 178 -~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 251 (382)
T 2vx3_A 178 -LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEM 251 (382)
T ss_dssp -TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -CCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHH
Confidence 2399999999999994 4788999999999876432 2345789999999999999999999999999999999
Q ss_pred HhCCCCCCCCC
Q 022003 153 LTGRRSMDKNR 163 (304)
Q Consensus 153 ~tg~~p~~~~~ 163 (304)
++|..||....
T Consensus 252 ltg~~pf~~~~ 262 (382)
T 2vx3_A 252 HTGEPLFSGAN 262 (382)
T ss_dssp HHSSCSSCCSS
T ss_pred HhCCCCCCCCC
Confidence 99999998653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=278.21 Aligned_cols=213 Identities=22% Similarity=0.303 Sum_probs=160.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCe------eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|++++++++||||+++++++...+. .++||||+. ++|.+++.. .+++..++.++.||+.||.|||+.+
T Consensus 72 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~- 146 (353)
T 3coi_A 72 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAG- 146 (353)
T ss_dssp HHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 68999999999999999999987654 499999995 688887643 4999999999999999999999998
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHh
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~t 154 (304)
|+||||||+||+++.++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 147 --ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~ 219 (353)
T 3coi_A 147 --VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219 (353)
T ss_dssp --CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH
T ss_pred --cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999865322 233568999999999886 688999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhcccc------------cc----ccccCCccCCCCCHHHHHHHHHHHHHhccCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERR------------RF----YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 218 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 218 (304)
|..||......... ............ .+ .....+... ......+..+.+||.+||+.||++
T Consensus 220 g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~ 296 (353)
T 3coi_A 220 GKTLFKGKDYLDQL--TQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDK 296 (353)
T ss_dssp SSCSSBSSCHHHHH--HHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTT
T ss_pred CCCCCCCCCHHHHH--HHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCccc
Confidence 99999764321110 000000000000 00 000000010 111233578999999999999999
Q ss_pred CCCHHHHHHHh
Q 022003 219 RPLMSEVVEAL 229 (304)
Q Consensus 219 Rps~~ell~~l 229 (304)
|||++|++++.
T Consensus 297 Rpt~~e~l~hp 307 (353)
T 3coi_A 297 RLTAAQALTHP 307 (353)
T ss_dssp SCCHHHHHTSG
T ss_pred CCCHHHHhcCc
Confidence 99999999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=278.82 Aligned_cols=196 Identities=23% Similarity=0.341 Sum_probs=163.2
Q ss_pred hHhhHhhcCC--CCcccceeeEEEeCCeeEEEEecCCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|++++++++ |+||+++++++...+..++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||+.+ |
T Consensus 95 ~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---i 170 (320)
T 3a99_A 95 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---V 170 (320)
T ss_dssp HHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5899999996 59999999999999999999999976 8999998664 36999999999999999999999998 9
Q ss_pred EeccCCCCCeEEC-CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCC
Q 022003 79 IYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 79 iH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~ 156 (304)
+||||||+|||++ .++.+||+|||+++...... .....||..|+|||++.+..+ +.++|||||||++|+|++|.
T Consensus 171 vH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 246 (320)
T 3a99_A 171 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246 (320)
T ss_dssp ECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred EeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCC
Confidence 9999999999998 78999999999998765322 233568999999999987765 78899999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
.||.... .... .. ... .. ..+.++.+||.+||+.||++|||++|++++.
T Consensus 247 ~pf~~~~--------~~~~----~~----~~~----~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 247 IPFEHDE--------EIIR----GQ----VFF----RQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp CSCCSHH--------HHHH----CC----CCC----SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCCCChh--------hhhc----cc----ccc----cc----cCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 9996421 0000 00 001 11 1246889999999999999999999999854
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=276.57 Aligned_cols=196 Identities=24% Similarity=0.379 Sum_probs=159.6
Q ss_pred hHhhHhhcC----CCCcccceeeEEEeCCeeEEEEec-CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDL----VHLNLVKLIGYCIEDDQRLLVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l----~h~niv~~~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+++++++ +|+||+++++++...+..++|||+ +.+++|.+++.++. .+++..++.++.||+.||+|||+.+
T Consensus 83 ~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~-- 159 (312)
T 2iwi_A 83 LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRG-- 159 (312)
T ss_dssp HHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 589999998 899999999999999999999999 78899999996643 6999999999999999999999998
Q ss_pred CeEeccCCCCCeEEC-CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCC-chhhhHHHHHHHHHHHh
Q 022003 77 PVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 77 ~iiH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~t 154 (304)
|+||||||+||+++ .++.+||+|||+++...... .....|+..|+|||++.+..+. .++|||||||++|+|++
T Consensus 160 -i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 234 (312)
T 2iwi_A 160 -VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234 (312)
T ss_dssp -EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred -eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHH
Confidence 99999999999998 88999999999998765432 2345689999999999877664 59999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|..||.... .... ... . ++...+..+.++|.+||+.||++|||++|++++.
T Consensus 235 g~~pf~~~~--------~~~~----~~~--------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 235 GDIPFERDQ--------EILE----AEL--------H----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp SSCSCCSHH--------HHHH----TCC--------C----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred CCCCCCChH--------HHhh----hcc--------C----CcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 999996421 0000 000 0 1112246889999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=271.82 Aligned_cols=205 Identities=29% Similarity=0.404 Sum_probs=152.7
Q ss_pred HhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEec
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYR 81 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~ 81 (304)
+..+++.++||||+++++++..++..++||||+ ++.+..+.......+++..++.++.||+.||.|||+. + ++||
T Consensus 74 ~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~ 149 (318)
T 2dyl_A 74 LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHR 149 (318)
T ss_dssp HHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCC
T ss_pred HHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeC
Confidence 344678889999999999999999999999999 6677776655556799999999999999999999995 8 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+||+++.++.+||+|||++....... ......||..|+|||++. ...++.++|||||||++|+|++|.
T Consensus 150 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (318)
T 2dyl_A 150 DVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226 (318)
T ss_dssp CCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCC
Confidence 999999999999999999999997654322 123456899999999984 557899999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||...... ............ +.... ....+.++.++|.+||+.||.+|||+++++++
T Consensus 227 ~pf~~~~~~-----~~~~~~~~~~~~-------~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 227 FPYKNCKTD-----FEVLTKVLQEEP-------PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CTTTTCCSH-----HHHHHHHHHSCC-------CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCCCCCcc-----HHHHHHHhccCC-------CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 999753211 111111111000 00000 00124688999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=294.76 Aligned_cols=212 Identities=27% Similarity=0.325 Sum_probs=164.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEe------CCeeEEEEecCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|++++++++||||+++++++.. ++..++|||||+|++|.+++.... ..+++..++.++.|++.||+|||+.
T Consensus 61 ~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~ 140 (676)
T 3qa8_A 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140 (676)
T ss_dssp HHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 59999999999999999998765 667899999999999999997643 3699999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEECCCCc---EEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
+ |+||||||+||+++.++. +||+|||++........ .....||..|+|||++.+..++.++|||||||++|
T Consensus 141 g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLy 214 (676)
T 3qa8_A 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAF 214 (676)
T ss_dssp T---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHH
T ss_pred C---CccCCCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHH
Confidence 8 999999999999987765 99999999987654322 23467899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhh-------------hccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPH-------------LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
+|++|..||...... ..|.... ......+... ...........+..+.+||.+||+.||+
T Consensus 215 eLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~ 287 (676)
T 3qa8_A 215 ECITGFRPFLPNWQP-----VQWHGKVREKSNEHIVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQR 287 (676)
T ss_dssp HHHSSCSSCCSSCHH-----HHSSTTCC------CCSCCCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC
T ss_pred HHHHCCCCCCcccch-----hhhhhhhhcccchhhhhhhhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHh
Confidence 999999999653110 0110000 0000000000 0111223445678999999999999999
Q ss_pred CCCCHHHHH
Q 022003 218 ARPLMSEVV 226 (304)
Q Consensus 218 ~Rps~~ell 226 (304)
+|||+.|++
T Consensus 288 kRPTa~elL 296 (676)
T 3qa8_A 288 QRGTDPQNP 296 (676)
T ss_dssp ---CCTTCC
T ss_pred hCcCHHHHh
Confidence 999998755
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=294.73 Aligned_cols=190 Identities=27% Similarity=0.407 Sum_probs=153.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCe-----eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQ-----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+++|++++||||+++++++...+. .|+||||++|++|.+++.. .+++..++.++.||+.||.|||+.+
T Consensus 128 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g-- 202 (681)
T 2pzi_A 128 AERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG-- 202 (681)
T ss_dssp HHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 68999999999999999999988765 7999999999999987644 6999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCC
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 156 (304)
|+||||||+|||++.+ .+||+|||+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|.
T Consensus 203 -iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~ 273 (681)
T 2pzi_A 203 -LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDL 273 (681)
T ss_dssp -EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCC
T ss_pred -CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCC
Confidence 9999999999999875 8999999999876432 3456899999999987654 89999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHh
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEAL 229 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~ell~~l 229 (304)
+||......... ........+..+.++|.+||+.||.+||+ ++++.+.|
T Consensus 274 ~~~~~~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 274 PTRNGRYVDGLP------------------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp CEETTEECSSCC------------------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CCCccccccccc------------------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence 887642211100 00001123467889999999999999995 55555544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=260.05 Aligned_cols=191 Identities=20% Similarity=0.270 Sum_probs=146.7
Q ss_pred hHhhHh-hcCCCCcccceeeEEEe----CCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFL-GDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il-~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|++++ +.++||||+++++++.. .+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+
T Consensus 59 ~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~- 137 (299)
T 3m2w_A 59 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 137 (299)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 578887 56699999999999987 667899999999999999997653 46999999999999999999999998
Q ss_pred CCeEeccCCCCCeEECC---CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 76 RPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|+||||||+||+++. ++.+||+|||++.... +..++.++|||||||++|+|
T Consensus 138 --i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el 191 (299)
T 3m2w_A 138 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYIL 191 (299)
T ss_dssp --EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHH
T ss_pred --cccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHH
Confidence 999999999999988 7889999999986532 23467899999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
++|..||............. ... ...............+.++.+||.+||+.||.+|||+.|++++.
T Consensus 192 ~tg~~pf~~~~~~~~~~~~~-------~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 192 LCGYPPFYSNHGLAISPGMK-------TRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp HHSSCSCCC-------CCSC-------CSS---CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHCCCCCCCCcchhhhHHHH-------HHH---hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 99999997543321100000 000 00000000000011256899999999999999999999999854
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=255.24 Aligned_cols=184 Identities=13% Similarity=0.078 Sum_probs=145.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|++++++++||||+++++++..++..|+||||++|++|.+++.+. .....+..++.||+.||+|||+.+ |+||
T Consensus 80 ~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g---ivH~ 153 (286)
T 3uqc_A 80 SRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG---VALS 153 (286)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC---CccC
Confidence 6889999999999999999999999999999999999999998542 456678899999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||||+.+|.+||+++| |++ .++.++|||||||++|+|++|+.||..
T Consensus 154 Dikp~NIll~~~g~~kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~ 204 (286)
T 3uqc_A 154 IDHPSRVRVSIDGDVVLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPE 204 (286)
T ss_dssp CCSGGGEEEETTSCEEECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred CCCcccEEEcCCCCEEEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 999999999999999997443 333 378999999999999999999999987
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
........... ............ .....+.++.++|.+||+.||++| |+.|+++.|+..
T Consensus 205 ~~~~~~~~~~~---~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 205 AGVRSGLAPAE---RDTAGQPIEPAD--------IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp CSBCCCSEECC---BCTTSCBCCHHH--------HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred CCcchhhHHHH---HHhccCCCChhh--------cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 54432110000 000000000000 011234689999999999999999 999999998653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=270.74 Aligned_cols=170 Identities=18% Similarity=0.234 Sum_probs=135.8
Q ss_pred eeEEEEecCCCCCHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEcc
Q 022003 27 QRLLVYEFMPRGSLENHLF------RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 100 (304)
Q Consensus 27 ~~~lv~e~~~~~sL~~~l~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~D 100 (304)
..+++|+++ +++|.+++. .....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEe
Confidence 467888887 689999884 23445888899999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCcceeeecccccccccCcchh----------hcCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 022003 101 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 170 (304)
Q Consensus 101 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~ 170 (304)
||+++..... ....+| +.|+|||++ .+..++.++|||||||++|||++|+.||...........
T Consensus 255 FG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~ 328 (413)
T 3dzo_A 255 FEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW 328 (413)
T ss_dssp GGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG
T ss_pred ccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH
Confidence 9999875322 344567 999999999 445688899999999999999999999976432221110
Q ss_pred hHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 171 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.+... . ..+..+.+||.+||+.||++|||+.+++++
T Consensus 329 ----------------~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 329 ----------------IFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp ----------------GGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ----------------HHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000 0 124689999999999999999999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=264.71 Aligned_cols=199 Identities=13% Similarity=0.088 Sum_probs=147.8
Q ss_pred hHhhHhhcCC---------CCcccceeeEEE-----------------e-------------CCeeEEEEecCCCCCHHH
Q 022003 2 AEVNFLGDLV---------HLNLVKLIGYCI-----------------E-------------DDQRLLVYEFMPRGSLEN 42 (304)
Q Consensus 2 ~E~~il~~l~---------h~niv~~~~~~~-----------------~-------------~~~~~lv~e~~~~~sL~~ 42 (304)
+|+++|++++ |||||++.+++. + .+..|+|||||++|++.+
T Consensus 72 ~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~ 151 (336)
T 2vuw_A 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLE 151 (336)
T ss_dssp HHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETG
T ss_pred HHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHH
Confidence 5888888885 666666666543 2 678999999999997766
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeEeccCCCCCeEECCCC--------------------cEEEccc
Q 022003 43 HLFRRSLPLPWSIRMKIALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDADY--------------------NAKLSDF 101 (304)
Q Consensus 43 ~l~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~iiH~dlkp~Nili~~~~--------------------~~kl~Df 101 (304)
.+.+ ..+++..++.++.||+.||+||| +.+ |+||||||+||||+.++ .+||+||
T Consensus 152 ~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DF 226 (336)
T 2vuw_A 152 QMRT--KLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDY 226 (336)
T ss_dssp GGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCC
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeec
Confidence 6644 46899999999999999999999 888 99999999999999887 8999999
Q ss_pred cCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHH-HHHHHhCCCCCCCCCCCCCcchhHhhhhhhcc
Q 022003 102 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV-LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180 (304)
Q Consensus 102 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 180 (304)
|+++..... ...||+.|+|||++.+.. +.++||||||++ .+++++|..||.... ...........
T Consensus 227 G~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~ 292 (336)
T 2vuw_A 227 TLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLK 292 (336)
T ss_dssp TTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHH
T ss_pred cccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhh
Confidence 999875421 347899999999998766 899999998777 777888888874210 00000000000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH-HH
Q 022003 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV-EA 228 (304)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell-~~ 228 (304)
... .............+.++.+||.+||+.| |++|++ +|
T Consensus 293 ~~~----~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 293 QMT----FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp TCC----CSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhc----cCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 000 0011111123356889999999999977 999999 75
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=268.87 Aligned_cols=146 Identities=19% Similarity=0.187 Sum_probs=111.6
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++|+++ .|+||+++++++++++..|||||||+|++|.++|.+.+ ++++. .|+.||+.||+|+|++| |||
T Consensus 290 ~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~G---IIH 362 (569)
T 4azs_A 290 NEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQG---FWH 362 (569)
T ss_dssp HHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTT---CEE
T ss_pred HHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCC---cee
Confidence 699999999 79999999999999999999999999999999997654 67665 47899999999999999 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
|||||+||||+.+|.+||+|||+|+....... .....+||++|+|||++.+ .+..++|+||+|+++++|.++..
T Consensus 363 RDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 363 DDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 99999999999999999999999987643322 2345789999999999875 46778999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-27 Score=218.58 Aligned_cols=144 Identities=18% Similarity=0.221 Sum_probs=123.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++||||+++..++...+..|+||||+++++|.+++.+ +..++.|++.||+|||+++ |+||
T Consensus 388 ~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHr 455 (540)
T 3en9_A 388 REARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHN 455 (540)
T ss_dssp HHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECT
T ss_pred HHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccC
Confidence 699999999999999777777778888999999999999999865 5689999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcce-----eeecccccccccCcchhhc--CCCCchhhhHHHHHHHHHHHh
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~t 154 (304)
||||+|||++. .+||+|||+++......... ......||+.|+|||++.+ ..|+..+|+|+..+-..+.+.
T Consensus 456 DiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~ 533 (540)
T 3en9_A 456 DLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE 533 (540)
T ss_dssp TCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH
T ss_pred CCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH
Confidence 99999999998 99999999999875432211 1235689999999999986 678889999999999988887
Q ss_pred CCCCC
Q 022003 155 GRRSM 159 (304)
Q Consensus 155 g~~p~ 159 (304)
++.+|
T Consensus 534 ~r~rY 538 (540)
T 3en9_A 534 RRARY 538 (540)
T ss_dssp TCSCC
T ss_pred hcccc
Confidence 76655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=9.7e-21 Score=161.42 Aligned_cols=100 Identities=12% Similarity=0.064 Sum_probs=83.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++ | +++.+++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||+.+ |+||
T Consensus 153 ~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHr 217 (282)
T 1zar_A 153 NEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHG 217 (282)
T ss_dssp HHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeC
Confidence 6999999999 5 777775544 55799999999999998 421 224579999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 132 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 132 (304)
||||+||||+ ++.+||+|||+++. +..++|||++.
T Consensus 218 Dlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 218 DLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp CCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9999999999 99999999999864 34478999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=3.9e-16 Score=131.23 Aligned_cols=93 Identities=18% Similarity=0.111 Sum_probs=74.4
Q ss_pred hHhhHhhcCCCCcc--cceeeEEEeCCeeEEEEecCCC-C----CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh-cC
Q 022003 2 AEVNFLGDLVHLNL--VKLIGYCIEDDQRLLVYEFMPR-G----SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH-EE 73 (304)
Q Consensus 2 ~E~~il~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~ 73 (304)
+|+++|.++.|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.
T Consensus 119 ~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 119 KEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp HHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC
Confidence 58899999988864 344432 356899999932 3 77776532 235567889999999999999 98
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccC
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 107 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 107 (304)
+ |+||||||+|||++. .++|+|||++...
T Consensus 191 g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 E---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp C---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred C---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 8 999999999999988 8999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1e-12 Score=115.41 Aligned_cols=70 Identities=13% Similarity=0.096 Sum_probs=57.4
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC----------cEE
Q 022003 28 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----------NAK 97 (304)
Q Consensus 28 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~----------~~k 97 (304)
.+|||||+.|++|.++.. . .....++.||+.+|.+||+.| ||||||||.||||+++| .+.
T Consensus 186 ~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~ 255 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLTPI 255 (397)
T ss_dssp TEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEEEE
T ss_pred ceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccceE
Confidence 379999999888876431 1 234568899999999999998 99999999999998776 389
Q ss_pred EccccCcccC
Q 022003 98 LSDFGLAKDG 107 (304)
Q Consensus 98 l~Dfg~a~~~ 107 (304)
|+||+-+...
T Consensus 256 iID~~Q~V~~ 265 (397)
T 4gyi_A 256 IIXFPQMVSM 265 (397)
T ss_dssp ECCCTTCEET
T ss_pred EEEeCCcccC
Confidence 9999977653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1e-10 Score=98.12 Aligned_cols=98 Identities=17% Similarity=0.069 Sum_probs=78.0
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC------
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------ 74 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------ 74 (304)
+|+++|+.|. +..+.++++++...+..|+||||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 58 ~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~ 131 (263)
T 3tm0_A 58 REKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPY 131 (263)
T ss_dssp HHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSC
T ss_pred HHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCC
Confidence 5899999884 6678899999999889999999999999987641 11223467889999999999811
Q ss_pred --------------------------------------------------CCCeEeccCCCCCeEECCCCcEEEccccCc
Q 022003 75 --------------------------------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLA 104 (304)
Q Consensus 75 --------------------------------------------------~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a 104 (304)
...++|+|+++.||+++.++.+.|+||+.+
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 132 TNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp BCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred cchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 022899999999999987666679999876
Q ss_pred c
Q 022003 105 K 105 (304)
Q Consensus 105 ~ 105 (304)
.
T Consensus 212 ~ 212 (263)
T 3tm0_A 212 G 212 (263)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.3e-09 Score=95.65 Aligned_cols=102 Identities=15% Similarity=0.247 Sum_probs=80.9
Q ss_pred hHhhHhhcCC--CCcccceeeEEEeC---CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC--
Q 022003 2 AEVNFLGDLV--HLNLVKLIGYCIED---DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-- 74 (304)
Q Consensus 2 ~E~~il~~l~--h~niv~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-- 74 (304)
+|+++++.|. +..+.+++.++.+. +..|+||||++|..+.+.. ...++......++.+++..|..||+..
T Consensus 85 ~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~ 161 (359)
T 3dxp_A 85 REYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQ 161 (359)
T ss_dssp HHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTT
T ss_pred HHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCch
Confidence 5889999997 45578899888766 4579999999988775421 224778888899999999999999731
Q ss_pred -----------------------------------------------------CCCeEeccCCCCCeEECCCCc--EEEc
Q 022003 75 -----------------------------------------------------ERPVIYRDFKTSNILLDADYN--AKLS 99 (304)
Q Consensus 75 -----------------------------------------------------~~~iiH~dlkp~Nili~~~~~--~kl~ 99 (304)
...++|+|+++.||+++.++. +.|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~vi 241 (359)
T 3dxp_A 162 AIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVL 241 (359)
T ss_dssp TTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEEC
T ss_pred hccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEE
Confidence 134999999999999987753 6899
Q ss_pred cccCccc
Q 022003 100 DFGLAKD 106 (304)
Q Consensus 100 Dfg~a~~ 106 (304)
||+.+..
T Consensus 242 Dwe~a~~ 248 (359)
T 3dxp_A 242 DWELSTL 248 (359)
T ss_dssp CCTTCEE
T ss_pred Ccccccc
Confidence 9998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.92 E-value=1.5e-09 Score=90.59 Aligned_cols=96 Identities=18% Similarity=0.096 Sum_probs=72.0
Q ss_pred hHhhHhhcCCCCc--ccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----
Q 022003 2 AEVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA----- 74 (304)
Q Consensus 2 ~E~~il~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----- 74 (304)
+|+++++.+.+.+ +.++++++..++..++||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 62 ~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~ 132 (264)
T 1nd4_A 62 DEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCP 132 (264)
T ss_dssp HHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCC
T ss_pred HHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCC
Confidence 5889999886545 456888888888889999999998884 211 12 1256677778888888643
Q ss_pred --------------------------------------------------CCCeEeccCCCCCeEECCCCcEEEccccCc
Q 022003 75 --------------------------------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLA 104 (304)
Q Consensus 75 --------------------------------------------------~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a 104 (304)
...++|+|++|.||+++.++.+.|+||+.+
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 133 FDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp CBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred CchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence 112999999999999987766779999987
Q ss_pred cc
Q 022003 105 KD 106 (304)
Q Consensus 105 ~~ 106 (304)
..
T Consensus 213 ~~ 214 (264)
T 1nd4_A 213 GV 214 (264)
T ss_dssp EE
T ss_pred cc
Confidence 53
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=1.6e-09 Score=92.81 Aligned_cols=153 Identities=19% Similarity=0.233 Sum_probs=95.0
Q ss_pred hHhhHhhcCC-CCc--ccceeeEEEeCC---eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-
Q 022003 2 AEVNFLGDLV-HLN--LVKLIGYCIEDD---QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA- 74 (304)
Q Consensus 2 ~E~~il~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~- 74 (304)
+|+++|+.+. +.. +.+++......+ ..|+||++++|.+|..... ..++.++...++.+++..|..||+..
T Consensus 59 ~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~ 135 (304)
T 3sg8_A 59 NEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINI 135 (304)
T ss_dssp HHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCC
Confidence 5888998883 333 334444433332 3488999999988865332 24677777888888888888888621
Q ss_pred ------------------------------------------------------CCCeEeccCCCCCeEECC--CCcEEE
Q 022003 75 ------------------------------------------------------ERPVIYRDFKTSNILLDA--DYNAKL 98 (304)
Q Consensus 75 ------------------------------------------------------~~~iiH~dlkp~Nili~~--~~~~kl 98 (304)
...++|+|+++.||+++. ++.+.|
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~ 215 (304)
T 3sg8_A 136 SGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGI 215 (304)
T ss_dssp TTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEE
T ss_pred CCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEE
Confidence 123799999999999988 566789
Q ss_pred ccccCcccCCCCCcc-eee-----------ecccccccccC-cchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 99 SDFGLAKDGPEGDKT-HVS-----------TRVMGTYGYAA-PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 99 ~Dfg~a~~~~~~~~~-~~~-----------~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
+||+.+......... ... .......+... |+.... ...-.+.|++|.++|.+.+|..+|
T Consensus 216 iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 216 IDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred EeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 999988753221000 000 00000011111 221111 122368999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=9.9e-07 Score=73.88 Aligned_cols=100 Identities=20% Similarity=0.104 Sum_probs=71.5
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC------
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------ 74 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------ 74 (304)
+|+.+|+.|. +--+-++++++.+.+..++|||+++|.++.+..... ......+..+++..|..||+..
T Consensus 68 ~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~ 142 (272)
T 4gkh_A 68 DEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPF 142 (272)
T ss_dssp HHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCB
T ss_pred HHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCc
Confidence 4788888774 333568899999999999999999998887765321 1222345555666666666421
Q ss_pred -------------------------------------------------CCCeEeccCCCCCeEECCCCcEEEccccCcc
Q 022003 75 -------------------------------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAK 105 (304)
Q Consensus 75 -------------------------------------------------~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~ 105 (304)
...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 143 NSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp BCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0127999999999999987777799998875
Q ss_pred c
Q 022003 106 D 106 (304)
Q Consensus 106 ~ 106 (304)
.
T Consensus 223 ~ 223 (272)
T 4gkh_A 223 I 223 (272)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=3.4e-06 Score=72.12 Aligned_cols=102 Identities=21% Similarity=0.189 Sum_probs=68.8
Q ss_pred hHhhHhhcCCCC---cccceeeEEE-eCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC---
Q 022003 2 AEVNFLGDLVHL---NLVKLIGYCI-EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--- 74 (304)
Q Consensus 2 ~E~~il~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--- 74 (304)
+|+++|+.|.+. .+.+++.++. ..+..++|||+++|..|...... .++......++.++...|..||+..
T Consensus 58 ~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~ 134 (306)
T 3tdw_A 58 KEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVET 134 (306)
T ss_dssp HHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHH
T ss_pred HHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCccc
Confidence 589999999653 3456676664 34567899999999888763211 2344444455555555555555422
Q ss_pred ------------------------------------------------------CCCeEeccCCCCCeEECC---CCc-E
Q 022003 75 ------------------------------------------------------ERPVIYRDFKTSNILLDA---DYN-A 96 (304)
Q Consensus 75 ------------------------------------------------------~~~iiH~dlkp~Nili~~---~~~-~ 96 (304)
...++|+|+++.||+++. ++. +
T Consensus 135 ~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~ 214 (306)
T 3tdw_A 135 AISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLT 214 (306)
T ss_dssp HHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEE
T ss_pred ccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceE
Confidence 123799999999999987 455 4
Q ss_pred EEccccCccc
Q 022003 97 KLSDFGLAKD 106 (304)
Q Consensus 97 kl~Dfg~a~~ 106 (304)
.|+||+.+..
T Consensus 215 ~~iD~~~a~~ 224 (306)
T 3tdw_A 215 GIIDFGDAAI 224 (306)
T ss_dssp EECCCTTCEE
T ss_pred EEEehhhcCC
Confidence 8999998765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=5.2e-06 Score=72.41 Aligned_cols=30 Identities=13% Similarity=0.224 Sum_probs=25.4
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
.++|+|+++.||++++++.+.|+||+.+..
T Consensus 223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 223 VLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp EEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred eEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 399999999999998655578999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.98 E-value=2.3e-05 Score=62.60 Aligned_cols=99 Identities=15% Similarity=0.072 Sum_probs=66.5
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeee
Q 022003 38 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117 (304)
Q Consensus 38 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 117 (304)
-+|.+.|...+.+++++++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc------------
Confidence 38999999889999999999999999999877621110 11333456889999999888764 1110
Q ss_pred cccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh
Q 022003 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 118 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 154 (304)
.....+.|||... ...+.+.=|||||+++|..+-
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122356888653 455688899999999998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0018 Score=55.55 Aligned_cols=31 Identities=29% Similarity=0.320 Sum_probs=26.9
Q ss_pred CCeEeccCCCCCeEECCC----CcEEEccccCccc
Q 022003 76 RPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 106 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~----~~~kl~Dfg~a~~ 106 (304)
..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 349999999999999874 6899999998875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0016 Score=57.42 Aligned_cols=28 Identities=25% Similarity=0.269 Sum_probs=24.6
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
++|+|+.+.||+++.+ .++|+||..+..
T Consensus 229 L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 229 LIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp EECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 9999999999999776 489999987764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0024 Score=53.99 Aligned_cols=29 Identities=17% Similarity=0.086 Sum_probs=24.9
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 5667789999988764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0031 Score=53.72 Aligned_cols=39 Identities=21% Similarity=0.260 Sum_probs=31.6
Q ss_pred hHhhHhhcCC---CCcccceeeEEEeCCeeEEEEecCCCCCH
Q 022003 2 AEVNFLGDLV---HLNLVKLIGYCIEDDQRLLVYEFMPRGSL 40 (304)
Q Consensus 2 ~E~~il~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~sL 40 (304)
+|++.|+.|. ...+.+++.++...+..++|||+++|..+
T Consensus 77 ~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 77 AEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp HHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred HHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4788888873 35678899988888889999999998754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0028 Score=54.34 Aligned_cols=31 Identities=19% Similarity=0.198 Sum_probs=27.2
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 3499999999999998888999999997753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0022 Score=56.23 Aligned_cols=101 Identities=16% Similarity=0.161 Sum_probs=60.2
Q ss_pred hHhhHhhcCCCCcc-cceeeEEEeCCeeEEEEecCCCCCHHHH--------------hh---cC----CCCCC--HHHHH
Q 022003 2 AEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVYEFMPRGSLENH--------------LF---RR----SLPLP--WSIRM 57 (304)
Q Consensus 2 ~E~~il~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL~~~--------------l~---~~----~~~l~--~~~~~ 57 (304)
+|+++++.|.-.++ .++++.+. + .+||||++|..|..- +. .. ..... +..+.
T Consensus 102 rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~ 177 (379)
T 3feg_A 102 LESVMFAILAERSLGPQLYGVFP--E--GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTME 177 (379)
T ss_dssp HHHHHHHHHHHTTSSCCEEEEET--T--EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCeEEEEcC--C--ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHH
Confidence 58888888843333 46666543 2 289999988654311 10 11 11122 34555
Q ss_pred HHHHHHHH-------------------HHHHh----hcCC-CCCeEeccCCCCCeEECCC----CcEEEccccCccc
Q 022003 58 KIALGAAK-------------------GLAFL----HEEA-ERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 106 (304)
Q Consensus 58 ~i~~qi~~-------------------~l~~L----H~~~-~~~iiH~dlkp~Nili~~~----~~~kl~Dfg~a~~ 106 (304)
.|+.++-. .+..| ...+ +..++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 178 ~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 178 RYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 56554422 12222 2211 2338999999999999876 7899999988753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.0075 Score=53.58 Aligned_cols=28 Identities=18% Similarity=0.278 Sum_probs=25.8
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
++|+|+++.|||++.++ ++|+||+.+..
T Consensus 234 liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred EEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 99999999999998776 99999998875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=95.08 E-value=0.058 Score=42.88 Aligned_cols=115 Identities=9% Similarity=0.076 Sum_probs=77.8
Q ss_pred CCCcccceeeEEEeCCeeEEEEecCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 022003 11 VHLNLVKLIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 89 (304)
Q Consensus 11 ~h~niv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nil 89 (304)
.||+++.. .+-...+.+.+-++.-+.+ ++.. + ..++....+.++.+|+....+++. -+|--|+|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 68888877 5666666666655554322 3332 2 247789999999999988876665 678899999999
Q ss_pred ECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 90 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 90 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
++.++.+++.-.|+-... +|. .++...=.-.+=|++..+++++..|.
T Consensus 112 f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999876653321 221 11222223367778888888877664
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=94.60 E-value=0.19 Score=40.11 Aligned_cols=82 Identities=9% Similarity=0.068 Sum_probs=60.6
Q ss_pred CCCcccceeeEEEeCCeeEEEEecCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCCeEeccCCCCCe
Q 022003 11 VHLNLVKLIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLA-FLHEEAERPVIYRDFKTSNI 88 (304)
Q Consensus 11 ~h~niv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~~iiH~dlkp~Ni 88 (304)
.||++ -..+-.+++.+.+.++.-+++ ++. .++ .++....+.++.+|+.... +++. -+|--|+|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 57777 444456677777767665333 444 332 4778999999999988777 6655 68889999999
Q ss_pred EECCCCcEEEccccCc
Q 022003 89 LLDADYNAKLSDFGLA 104 (304)
Q Consensus 89 li~~~~~~kl~Dfg~a 104 (304)
+++.++.+++.-.|+-
T Consensus 116 ~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 116 MFNRALEPFFLHVGVK 131 (219)
T ss_dssp EECTTCCEEESCCEET
T ss_pred EEeCCCcEEEEEcCCc
Confidence 9999999999877653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.08 E-value=0.055 Score=45.97 Aligned_cols=29 Identities=24% Similarity=0.286 Sum_probs=24.8
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3389999999999998 4 899999988754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.96 E-value=0.02 Score=48.64 Aligned_cols=30 Identities=30% Similarity=0.301 Sum_probs=25.5
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
.++|+|+++.||+++.++.+.|+||+.+..
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 399999999999998876668999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.37 E-value=0.068 Score=45.90 Aligned_cols=30 Identities=13% Similarity=0.178 Sum_probs=26.8
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 399999999999999888899999987764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=92.92 E-value=0.11 Score=46.75 Aligned_cols=35 Identities=23% Similarity=0.197 Sum_probs=24.3
Q ss_pred hHhhHhhcCCCCccc-ceeeEEEeCCeeEEEEecCCCCCH
Q 022003 2 AEVNFLGDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSL 40 (304)
Q Consensus 2 ~E~~il~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~sL 40 (304)
+|+.+++.|...+++ ++++.+ .+ .+||||++|..|
T Consensus 153 ~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 153 REKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred HHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 588899998765554 677665 22 359999987543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.26 E-value=0.063 Score=46.58 Aligned_cols=29 Identities=21% Similarity=0.251 Sum_probs=24.1
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
.++|+|+++.|||++.++ +.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 389999999999997654 89999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=91.43 E-value=0.067 Score=47.63 Aligned_cols=30 Identities=30% Similarity=0.304 Sum_probs=24.2
Q ss_pred CeEeccCCCCCeEECCC----------------------------CcEEEccccCccc
Q 022003 77 PVIYRDFKTSNILLDAD----------------------------YNAKLSDFGLAKD 106 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~----------------------------~~~kl~Dfg~a~~ 106 (304)
.++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 38999999999999875 6789999987753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.61 E-value=0.21 Score=43.85 Aligned_cols=29 Identities=28% Similarity=0.319 Sum_probs=24.6
Q ss_pred eEeccCCCCCeEE------CCCCcEEEccccCccc
Q 022003 78 VIYRDFKTSNILL------DADYNAKLSDFGLAKD 106 (304)
Q Consensus 78 iiH~dlkp~Nili------~~~~~~kl~Dfg~a~~ 106 (304)
++|+|+.+.|||+ ++++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999988753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=85.84 E-value=0.33 Score=43.02 Aligned_cols=29 Identities=17% Similarity=0.332 Sum_probs=25.7
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
.++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 3899999999999 7888999999988763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=83.97 E-value=1.2 Score=36.89 Aligned_cols=24 Identities=25% Similarity=0.191 Sum_probs=19.8
Q ss_pred CeEeccCCCCCeEECCCCcEEEccc
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDF 101 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Df 101 (304)
.++|+|+.+.||+++.++. .+.|-
T Consensus 189 ~LvHGDlw~gNvl~~~~g~-~~iDp 212 (288)
T 3f7w_A 189 ARIHGDLWNGNVLWQDDGA-VVIDP 212 (288)
T ss_dssp EEECSCCSGGGEEEETTEE-EECSC
T ss_pred eeeecCCCCCcEEEcCCCe-EEEec
Confidence 4999999999999998874 46563
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 304 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 5e-66
Identities = 61/235 (25%), Positives = 106/235 (45%), Gaps = 19/235 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
EV L H+N++ +GY Q +V ++ SL +HL + IA
Sbjct: 52 KNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
A+G+ +LH + +I+RD K++NI L D K+ DFGLA +H ++
Sbjct: 111 RQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 121 GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
G+ + APE + + +SDVY+FG+VL E++TG+ P N +
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFM 221
Query: 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
+G L ++ + + +L A CL + RPL +++ +++ L
Sbjct: 222 VGRGYLSPDL--SKVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-56
Identities = 67/232 (28%), Positives = 107/232 (46%), Gaps = 20/232 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + L H LV+L G C+E LV+EFM G L ++L + + +
Sbjct: 48 IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 107
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
L +G+A+L E VI+RD N L+ + K+SDFG+ + + D+ ST
Sbjct: 108 LDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTK 163
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
+A+PE +S+SDV+SFGV++ E+ + + +NR N E +VE
Sbjct: 164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI------ 215
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
+RL PRL + Q+ HC P+ RP S ++ L +
Sbjct: 216 -STGFRLYKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-55
Identities = 45/230 (19%), Positives = 91/230 (39%), Gaps = 20/230 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + +L H LV+L G C + ++ E+M G L N+L +++
Sbjct: 47 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 106
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ + +L + ++RD N L++ K+SDFGL++ + D+ S
Sbjct: 107 KDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSK 162
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
++ PE +M +S+SD+++FGV++ E+ + + + N E
Sbjct: 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------------- 209
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230
I L + ++K + C RP ++ +
Sbjct: 210 ---TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 9e-55
Identities = 58/258 (22%), Positives = 100/258 (38%), Gaps = 23/258 (8%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 57
AE+ L H N++ I +D+ Q LV ++ GSL ++L R + +
Sbjct: 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMI 103
Query: 58 KIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
K+AL A GLA LH E + + +RD K+ NIL+ + ++D GLA
Sbjct: 104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163
Query: 113 T--HVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRR----SMD 160
T +GT Y APE + R+D+Y+ G+V E+ D
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223
Query: 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
P + + + + + +L S + + A++ C + AR
Sbjct: 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 221 LMSEVVEALKPLPNLKDM 238
+ + L L + +
Sbjct: 284 TALRIKKTLSQLSQQEGI 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-54
Identities = 62/246 (25%), Positives = 101/246 (41%), Gaps = 24/246 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
+ E + D H N++ L+G C+ + L+V +M G L N + + +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVST 117
L AKG+ FL + ++RD N +LD + K++DFGLA+D E D H T
Sbjct: 136 GLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
+ A E + T T++SDV+SFGV+L E++T P + N +
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYL 247
Query: 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 237
L + RL+ P ++ C + RP SE+V + +
Sbjct: 248 L----QGRRLLQPEYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI--FST 294
Query: 238 MASSSY 243
Y
Sbjct: 295 FIGEHY 300
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-53
Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKI 59
+AE N + L H LV+L + ++ E+M GSL + L S + L + + +
Sbjct: 56 LAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A A+G+AF+ E R I+RD + +NIL+ + K++DFGLA+ + ++
Sbjct: 115 AAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGA 170
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+ APE + G T +SDV+SFG++L E++T R N E +
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQ 221
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
R YR++ P + ++ QL C P+ RP + L+
Sbjct: 222 NLERGYRMVRPD---NCP----EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 7e-53
Identities = 53/253 (20%), Positives = 102/253 (40%), Gaps = 33/253 (13%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E+ L + +V G D + + E M GSL+ L + +P I K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVS 110
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ KGL +L E+ +++RD K SNIL+++ KL DFG++ + ++ +
Sbjct: 111 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFV 164
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR----------------------- 157
GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 158 ---SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 214
+ + +RP + +++ S + + CL +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 215 DPKARPLMSEVVE 227
+P R + +++
Sbjct: 285 NPAERADLKQLMV 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-52
Identities = 55/245 (22%), Positives = 103/245 (42%), Gaps = 24/245 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E +G H N+++L G + +++ E+M G+L+ L + + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRV 119
G A G+ +L ++RD NIL++++ K+SDFGL++ + + T+ ++
Sbjct: 117 RGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+ APE + TS SDV+SFG+V+ E++T N E
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------ 221
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL----PNL 235
+ I+ + QL C ++ RP +++V L L +L
Sbjct: 222 ----VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277
Query: 236 KDMAS 240
K +A
Sbjct: 278 KTLAD 282
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-52
Identities = 56/253 (22%), Positives = 95/253 (37%), Gaps = 41/253 (16%)
Query: 1 MAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------- 49
M+E+ + L H N+V L+G C L++E+ G L N+L +
Sbjct: 88 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147
Query: 50 ------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 97
L + + A AKG+ FL + ++RD N+L+ K
Sbjct: 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVK 204
Query: 98 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157
+ DFGLA+D V + APE + G T +SDV+S+G++L E+ +
Sbjct: 205 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264
Query: 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217
+ P + FY+LI + ++ + C + D +
Sbjct: 265 NPYPGIPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSR 309
Query: 218 ARPLMSEVVEALK 230
RP + L
Sbjct: 310 KRPSFPNLTSFLG 322
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-52
Identities = 55/248 (22%), Positives = 99/248 (39%), Gaps = 22/248 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
M E + L + +V+LIG C + + +LV E G L L + +P S ++
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRV 119
+ G+ +L E + ++RD N+LL + AK+SDFGL+K G + +
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+ APE + +SRSDV+S+GV + E L+ + +P + E
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPE------- 220
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK-PLPNLKDM 238
I+ + + L + C + RP V + ++ +L
Sbjct: 221 ----VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
Query: 239 ASSSYYFQ 246
++
Sbjct: 277 VEGHHHHH 284
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-52
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 26/232 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRS-LPLPWSIRMK 58
+AE + + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K
Sbjct: 48 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 107
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 118
+L + + +L ++RD N+L+ D AK+SDFGL K+ T
Sbjct: 108 FSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----- 159
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 178
+ APE + +++SDV+SFG++L E+ + R P L +
Sbjct: 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVV---- 210
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230
R + ++ +C D RP ++ E L+
Sbjct: 211 ---PRVEKGYKMDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (431), Expect = 9e-52
Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 22/235 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
++E + +G H N++ L G + +++ EFM GSL++ L + + +
Sbjct: 75 LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV- 119
G A G+ +L + ++RD NIL++++ K+SDFGL++ + T
Sbjct: 135 RGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 120 --MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
+ APE + TS SDV+S+G+V+ E+++ RP + +
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMTNQDV---- 242
Query: 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
I+ + QL C +D RP ++V L +
Sbjct: 243 -------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-51
Identities = 64/260 (24%), Positives = 99/260 (38%), Gaps = 41/260 (15%)
Query: 1 MAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR------------ 47
M+E+ L L H+N+V L+G C L++ E+ G L N L R+
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 48 -----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 102
L L + + AKG+AFL + I+RD NILL K+ DFG
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFG 190
Query: 103 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 162
LA+D V + APE + T SDV+S+G+ L E+ + S
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 163 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 222
P FY++I + + C DP RP
Sbjct: 251 MPVDSK---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295
Query: 223 SEVVEALKPLPNLKDMASSS 242
++V+ ++ K ++ S+
Sbjct: 296 KQIVQLIE-----KQISEST 310
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 2e-51
Identities = 51/233 (21%), Positives = 100/233 (42%), Gaps = 21/233 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKI 59
+ E + ++ H NLV+L+G C + ++ EFM G+L ++L + + + + +
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A + + +L + + I+RD N L+ ++ K++DFGL++ GD
Sbjct: 121 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGA 176
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+ APE + + +SDV++FGV+L E+ T S +
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------ 224
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
Y L++ +K +L C +P RP +E+ +A + +
Sbjct: 225 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 3e-51
Identities = 57/255 (22%), Positives = 95/255 (37%), Gaps = 42/255 (16%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------- 49
E + + + N+VKL+G C L++E+M G L L S
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 50 ------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 97
PL + ++ IA A G+A+L E R ++RD T N L+ + K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 98 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157
++DFGL+++ D + PE + T+ SDV+++GVVL E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217
+ E ++ + R G L L C S+ P
Sbjct: 241 QPYYGMAHEE--VIYYVRD--GNILACPENCPLEL------------YNLMRLCWSKLPA 284
Query: 218 ARPLMSEVVEALKPL 232
RP + L+ +
Sbjct: 285 DRPSFCSIHRILQRM 299
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-50
Identities = 54/245 (22%), Positives = 101/245 (41%), Gaps = 24/245 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+AE N + L + +V++IG C E + +LV E G L +L + + +++
Sbjct: 56 LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 113
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRV 119
+ G+ +L E ++RD N+LL + AK+SDFGL+K + T
Sbjct: 114 HQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+ APE + +S+SDV+SFGV++ E + + +P E
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSE------- 218
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 239
+++ ++ L C + D + RP + V L+ D+
Sbjct: 219 ----VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY--YYDVV 272
Query: 240 SSSYY 244
+ ++
Sbjct: 273 NEGHH 277
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-50
Identities = 55/227 (24%), Positives = 90/227 (39%), Gaps = 26/227 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYI 112
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
A L++ H + VI+RD K N+LL + K++DFG + P +T +
Sbjct: 113 TELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----C 165
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GT Y PE + + D++S GV+ E L G+ P + E +
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRV 219
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
F + A L + L +P RP++ EV+E
Sbjct: 220 EFTFPDFVTE------------GARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 3e-50
Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 32/247 (12%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
M E++ L H N+VKL+ ++ ++ EF G+++ + PL S +
Sbjct: 57 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
L +LH + +I+RD K NIL D + KL+DFG++ + +
Sbjct: 117 KQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFI 171
Query: 121 GTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 175
GT + APE VM ++DV+S G+ L+EM P+ E N +
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLL 225
Query: 176 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV-------VEA 228
+ L P +S CL ++ AR S++ V++
Sbjct: 226 KIA--KSEPPTLAQPS---RWS----SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276
Query: 229 LKPLPNL 235
KP+ L
Sbjct: 277 NKPIREL 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-49
Identities = 44/232 (18%), Positives = 93/232 (40%), Gaps = 20/232 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + + + ++ +L+G C+ +L + + MP G L +++ + +
Sbjct: 59 LDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWC 117
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 118 VQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
+ A E ++ T +SDV+S+GV + E++T P E
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------------- 221
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
+++ + C D +RP E++ +
Sbjct: 222 ---ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-49
Identities = 60/231 (25%), Positives = 93/231 (40%), Gaps = 20/231 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ EVN + L H NL++L G + ++ V E P GSL + L + + A
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRV 119
+ A+G+ +L + I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 118 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+ + APE + T + SD + FGV L EM T + P N +
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDK 229
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230
E R PR E Q + C + P+ RP + + L
Sbjct: 230 EGERL-----PRPEDC-----PQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-49
Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 20/228 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+ L H N+VK G+ E + + L E+ G L + + +P +
Sbjct: 51 KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFF 109
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++
Sbjct: 110 HQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166
Query: 121 GTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
GT Y APE + + DV+S G+VL ML G D+ + +
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE----------- 215
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+ + + + K L L +P AR + ++ +
Sbjct: 216 ----YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-48
Identities = 52/233 (22%), Positives = 94/233 (40%), Gaps = 22/233 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKI 59
+ E + L H LV+L ++ +V E+M +GSL + L L + +
Sbjct: 60 LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A A G+A++ ++RD + +NIL+ + K++DFGLA+ + ++
Sbjct: 119 AAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGA 174
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
+ APE + G T +SDV+SFG++L E+ T R N E
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------------ 222
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
++ + + L C ++P+ RP + L+
Sbjct: 223 ----VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 1e-48
Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 26/234 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSL---PLPWSI 55
++EVN L +L H N+V+ I+ L V E+ G L + + + + L
Sbjct: 51 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 110
Query: 56 RMKIALGAAKGLAFLHE--EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 113
+++ L H + V++RD K +N+ LD N KL DFGLA+ T
Sbjct: 111 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDT 168
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 173
+ +GT Y +PE + +SD++S G +L E+ P + E
Sbjct: 169 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKEL 222
Query: 174 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
A + R+ +S + ++ L+ RP + E++E
Sbjct: 223 AGKIREGKF-------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-48
Identities = 54/248 (21%), Positives = 95/248 (38%), Gaps = 38/248 (15%)
Query: 1 MAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------- 49
E+ L L H N++ L+G C L E+ P G+L + L + +
Sbjct: 58 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 117
Query: 50 -----PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 104
L + A A+G+ +L + + I+RD NIL+ +Y AK++DFGL+
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS 174
Query: 105 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 164
+ K T + A E + T+ SDV+S+GV+L E+++ + P
Sbjct: 175 RGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----P 226
Query: 165 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224
E Y + + + L C P RP ++
Sbjct: 227 YCGMTCAEL-----------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 225 VVEALKPL 232
++ +L +
Sbjct: 276 ILVSLNRM 283
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-47
Identities = 51/232 (21%), Positives = 87/232 (37%), Gaps = 27/232 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 56
E L L H N+V+ +LV E M G+L+ +L R + +
Sbjct: 56 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVL 114
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHV 115
KGL FLH P+I+RD K NI + + K+ D GLA +
Sbjct: 115 RSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASF 169
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 175
+ V+GT + APE + DVY+FG+ +LEM T + + +
Sbjct: 170 AKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------- 221
Query: 176 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+ R+ F + ++ C+ ++ R + +++
Sbjct: 222 --------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 2e-47
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 31/231 (13%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ EV FL L H N ++ G + + LV E+ + + + PL +
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVT 121
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
GA +GLA+LH +I+RD K NILL KL DFG A + +
Sbjct: 122 HGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFV 172
Query: 121 GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLVEWARP 176
GT + APE ++ G + DV+S G+ +E+ + + + N + +++ + P
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 177 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
GH+S + CL + P+ RP +++
Sbjct: 233 -------------ALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 7e-47
Identities = 54/233 (23%), Positives = 92/233 (39%), Gaps = 23/233 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E + H ++VKLIG ++ ++ E G L + L R L + + A
Sbjct: 56 LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ LA+L + ++RD N+L+ ++ KL DFGL++ + + +++
Sbjct: 115 YQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGK 170
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL-G 179
+ APE + TS SDV+ FGV + E+L +P + G
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENG 225
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
ER P L L C + DP RP +E+ L +
Sbjct: 226 ERLPMPPNCPPTL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 5e-45
Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 32/255 (12%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---------RRSLPL 51
+ E + + + ++V+L+G + L++ E M RG L+++L P
Sbjct: 71 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130
Query: 52 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 111
S +++A A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D
Sbjct: 131 SLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
Query: 112 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 171
+ + + +PE + G T+ SDV+SFGVVL E+ T + N +
Sbjct: 188 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---- 243
Query: 172 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231
R + +L C +PK RP E++ ++K
Sbjct: 244 ------------VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291
Query: 232 L--PNLKDMASSSYY 244
P +++ S YY
Sbjct: 292 EMEPGFREV--SFYY 304
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-44
Identities = 54/247 (21%), Positives = 97/247 (39%), Gaps = 27/247 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E+ + + + N+V + + D+ +V E++ GSL + + + +
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVC 122
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ L FLH VI+RD K+ NILL D + KL+DFG + ++
Sbjct: 123 RECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMV 177
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GT + APE V + D++S G++ +EM+ G P N +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIA-- 229
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-----ALKPLPNL 235
L +P S CL D + R E+++ KPL +L
Sbjct: 230 TNGTPELQNPE---KLS----AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSL 282
Query: 236 KDMASSS 242
+ +++
Sbjct: 283 TPLIAAA 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-43
Identities = 65/237 (27%), Positives = 93/237 (39%), Gaps = 34/237 (14%)
Query: 12 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR---------------SLPLPWSI 55
HLN+V L+G C + L ++ EF G+L +L + L
Sbjct: 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 115
+ + AKG+ FL R I+RD NILL K+ DFGLA+D +
Sbjct: 136 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 175
+ APE + T +SDV+SFGV+L E+ + S P + E
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFC 247
Query: 176 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232
L E R R + + + Q C +P RP SE+VE L L
Sbjct: 248 RRLKEGTR------MRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-42
Identities = 47/228 (20%), Positives = 81/228 (35%), Gaps = 22/228 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E + + L H VKL +D++ + G L ++ + +
Sbjct: 56 TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYT 114
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
L +LH + +I+RD K NILL+ D + +++DFG AK K + +
Sbjct: 115 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GT Y +PE + SD+++ G ++ +++ G P N + +
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIKL 225
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228
F P KA L L D R E+
Sbjct: 226 EYDFPEKFFP------------KARDLVEKLLVLDATKRLGCEEMEGY 261
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-42
Identities = 58/248 (23%), Positives = 99/248 (39%), Gaps = 35/248 (14%)
Query: 1 MAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------- 50
++E+ + + H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 51 ------LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 104
L + A A+G+ +L + I+RD N+L+ D K++DFGLA
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 105 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 164
+D D +T + APE + T +SDV+SFGV+L E+ T S P
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242
Query: 165 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224
E ++L+ + + C P RP +
Sbjct: 243 VEE----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 286
Query: 225 VVEALKPL 232
+VE L +
Sbjct: 287 LVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 145 bits (366), Expect = 1e-41
Identities = 59/291 (20%), Positives = 111/291 (38%), Gaps = 29/291 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E++ + L H L+ L + + +L+ EF+ G L + + + + +
Sbjct: 74 KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTR 118
A +GL +H E +++ D K NI+ + + K+ DFGLA +
Sbjct: 134 RQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---V 187
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 178
T +AAPE V + +D+++ GV+ +L+G P + +E +
Sbjct: 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVK 241
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKP-LPNL 235
F + +A + L ++P+ R + + +E LK NL
Sbjct: 242 RCDWEFDEDAFSSVS--------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293
Query: 236 KDMASSSYYFQTMQ--AERIGSSPNTRNGIR--AQGGSLSRNGQRSLSIPN 282
SS Y + Q E+ P + I A SL ++ + I +
Sbjct: 294 TSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYD 344
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 145 bits (366), Expect = 1e-41
Identities = 51/229 (22%), Positives = 82/229 (35%), Gaps = 22/229 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+ + L H LV L +D++ +++YEFM G L + + ++
Sbjct: 71 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 130
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--AKLSDFGLAKDGPEGDKTHVSTR 118
KGL +H E ++ D K NI+ + KL DFGL V
Sbjct: 131 RQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--- 184
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 178
GT +AAPE + +D++S GV+ +L+G P G N E R
Sbjct: 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVK 238
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+ ++ L DP R + + +E
Sbjct: 239 SCDWNMDDSAFSGI--------SEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 5e-40
Identities = 47/297 (15%), Positives = 109/297 (36%), Gaps = 35/297 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E++ L H N++ L ++ ++++EF+ + + + L +
Sbjct: 49 KKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYV 108
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTR 118
+ L FLH + + D + NI+ ++ K+ +FG A+ GD +
Sbjct: 109 HQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--- 162
Query: 119 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 178
+ Y APE +++ +D++S G ++ +L+G P + +
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIM 216
Query: 179 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV------EALKPL 232
F + + +A L ++ K+R SE + + ++ +
Sbjct: 217 NAEYTFDEEAFKEI--------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
Query: 233 PN--LKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYAS 287
++ + YY ++ + R + GG++ Q+ +S+ AS
Sbjct: 269 STKVIRTLKHRRYYHTLIKKDLNMVVSAAR---ISCGGAIRS--QKGVSVAKVKVAS 320
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 137 bits (346), Expect = 2e-39
Identities = 55/235 (23%), Positives = 95/235 (40%), Gaps = 24/235 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIR 56
E L H +V + + +V E++ +L + + P+
Sbjct: 55 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRA 113
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHV 115
+++ A + L F H+ +I+RD K +NI++ A K+ DFG+A+ G+
Sbjct: 114 IEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 175
+ V+GT Y +PE + +RSDVYS G VL E+LTG P + V A
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAY 224
Query: 176 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEAL 229
H+ E L + + L+++P+ R +E+ L
Sbjct: 225 QHVREDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 137 bits (345), Expect = 3e-39
Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 28/234 (11%)
Query: 1 MAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
+ EV+ L + H N+++L + LV++ M +G L ++L + L KI
Sbjct: 57 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKI 115
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
+ + LH+ +++RD K NILLD D N KL+DFG + G+K V
Sbjct: 116 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REV 169
Query: 120 MGTYGYAAPEYVMTGHL------TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 173
GT Y APE + D++S GV++ +L G P +
Sbjct: 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLM 223
Query: 174 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
R + +F + L + L P+ R E +
Sbjct: 224 LRMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (345), Expect = 2e-38
Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 24/219 (10%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 62
++ + +V + D+ + + M G L HL + + +R A
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAAE 115
Query: 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 122
GL +H R V+YRD K +NILLD + ++SD GLA D + +GT
Sbjct: 116 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGT 168
Query: 123 YGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 181
+GY APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---- 224
Query: 182 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
L FS + L L RD R
Sbjct: 225 -------AVELPDSFS----PELRSLLEGLLQRDVNRRL 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 1e-37
Identities = 44/227 (19%), Positives = 77/227 (33%), Gaps = 18/227 (7%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E+ L + H N+V L L+ + + G L + + + ++
Sbjct: 55 ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLI 113
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+ +LH+ + LD D +SDFGL+K D V +
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTAC 170
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GT GY APE + + D +S GV+ +L G P + N + L
Sbjct: 171 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKA 224
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
F + + A H + +DP+ R + ++
Sbjct: 225 EYEFDSPYWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (331), Expect = 5e-37
Identities = 39/238 (16%), Positives = 72/238 (30%), Gaps = 21/238 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E + + I +C + ++ + SLE+ S + +A
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 109
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDGPEGD-----K 112
+ ++H + I+RD K N L + DFGLAK +
Sbjct: 110 DQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166
Query: 113 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 172
+ + GT YA+ + + R D+ S G VL+ G + + E
Sbjct: 167 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
Query: 173 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230
+ L + + A C S +P S + + +
Sbjct: 227 R------ISEKKMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-37
Identities = 58/221 (26%), Positives = 83/221 (37%), Gaps = 25/221 (11%)
Query: 1 MAEVNFLG-DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
M E L H L + + V E++ G L H+ S
Sbjct: 50 MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFY 108
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
A GL FLH + ++YRD K NILLD D + K++DFG+ K+ GD
Sbjct: 109 AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTF 163
Query: 120 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 179
GT Y APE ++ D +SFGV+L EML G+ P + E
Sbjct: 164 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRM 217
Query: 180 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
+ + R ++ A L R+P+ R
Sbjct: 218 DNPFYPRWLEKE------------AKDLLVKLFVREPEKRL 246
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-36
Identities = 54/238 (22%), Positives = 94/238 (39%), Gaps = 17/238 (7%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E+ L +L H N++ L+ LV++FM LE + SL L S
Sbjct: 48 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYM 106
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
L +GL +LH+ +++RD K +N+LLD + KL+DFGLAK ++ + T +
Sbjct: 107 LMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQV 161
Query: 121 GTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRP----------NGEHN 169
T Y APE + + D+++ G +L E+L + + G
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 221
Query: 170 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+W ++ H L +P AR ++ ++
Sbjct: 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 6e-36
Identities = 54/254 (21%), Positives = 92/254 (36%), Gaps = 24/254 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSI 55
+A + L H N+V+L C LV+E + + +P
Sbjct: 58 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 117
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 115
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 118 IKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMA 171
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV---- 171
T V+ T Y APE ++ + D++S G + EM + + + +
Sbjct: 172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
Query: 172 ------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225
+W R R+ F+ +E + + L CL+ +P R
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYSA 290
Query: 226 VEA--LKPLPNLKD 237
+ + L K+
Sbjct: 291 LSHPYFQDLERCKE 304
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-35
Identities = 49/231 (21%), Positives = 82/231 (35%), Gaps = 25/231 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
EV+ L ++ H N++ L +L+ E + G L + L + L +
Sbjct: 61 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFL 119
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDGPEGDKTHVS 116
G+ +LH + + D K NI+L K+ DFGLA G++
Sbjct: 120 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 173
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 176
+ GT + APE V L +D++S GV+ +L+G P E
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGDTKQETLAN 227
Query: 177 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
F + A L +DPK R + + ++
Sbjct: 228 VSAVNYEFEDEYFSNT--------SALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (319), Expect = 5e-35
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 27/220 (12%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E L + H ++++ G + Q ++ +++ G L R+S P + A
Sbjct: 52 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYA 110
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
L +LH + +IYRD K NILLD + + K++DFG AK P+ T
Sbjct: 111 AEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----- 162
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GT Y APE V T D +SFG+++ EML G P + N ++ L
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNA 216
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
RF + L + ++RD R
Sbjct: 217 ELRFPPFFNE------------DVKDLLSRLITRDLSQRL 244
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-34
Identities = 54/253 (21%), Positives = 101/253 (39%), Gaps = 21/253 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E++ L +L H N+VKL+ +++ LV+EF+ + + +P +
Sbjct: 49 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ + V+
Sbjct: 109 FQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV 164
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
+ A + + ++ D++S G + EM+T R + + + E
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224
Query: 181 RRRFYRLIDPRLEGHFSIKGAQK-----------AAQLAAHCLSRDPKARPLMSEVV--- 226
P + F Q L + L DP R +
Sbjct: 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284
Query: 227 ---EALKPLPNLK 236
+ KP+P+L+
Sbjct: 285 FFQDVTKPVPHLR 297
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (311), Expect = 3e-34
Identities = 34/242 (14%), Positives = 68/242 (28%), Gaps = 23/242 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
E L + + Y ++ ++ + SLE+ L A
Sbjct: 48 RDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAA 107
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-----AKLSDFGLAKDGPEGD---- 111
+ +HE + ++YRD K N L+ + + DFG+ K +
Sbjct: 108 KQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164
Query: 112 -KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 170
+ GT Y + + + R D+ + G V + L G +
Sbjct: 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
Query: 171 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230
E + L F ++ + + + A P +
Sbjct: 225 YERI------GEKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274
Query: 231 PL 232
+
Sbjct: 275 KV 276
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-33
Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 20/244 (8%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMK 58
+ E+ L H N++ + + ++ + L++ ++ L
Sbjct: 54 LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY 113
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVST 117
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T
Sbjct: 114 FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170
Query: 118 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 176
+ T Y APE ++ ++S D++S G +L EML+ R + N +
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 177 HLGERRRFYRLIDPRLEGHFSIKGAQK-------------AAQLAAHCLSRDPKARPLMS 223
+ + S+ K A L L+ +P R +
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290
Query: 224 EVVE 227
+ +
Sbjct: 291 QALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 120 bits (302), Expect = 5e-33
Identities = 50/238 (21%), Positives = 93/238 (39%), Gaps = 16/238 (6%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E++ L +L H N+VKL + +LV+E + L+ L L
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFL 106
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
L G+A+ H+ R V++RD K N+L++ + K++DFGLA+ + + ++
Sbjct: 107 LQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIV 162
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNL 170
+ A + + ++ D++S G + EM+ G G N
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222
Query: 171 VEWAR-PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
W L + + + +P F + L + L DP R + +E
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 8e-33
Identities = 63/220 (28%), Positives = 83/220 (37%), Gaps = 24/220 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E L + H L L D+ V E+ G L HL R
Sbjct: 53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYG 111
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
L +LH R V+YRD K N++LD D + K++DFGL K+G T
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFC 166
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GT Y APE + D + GVV+ EM+ GR P + L E
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILME 220
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
RF R + P +A L A L +DPK R
Sbjct: 221 EIRFPRTLSP------------EAKSLLAGLLKKDPKQRL 248
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 2e-32
Identities = 46/231 (19%), Positives = 76/231 (32%), Gaps = 35/231 (15%)
Query: 1 MAEVNFLGDL--VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 58
EV L + +++L+ + D +L+ E L +
Sbjct: 55 PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 114
Query: 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVST 117
+ + H V++RD K NIL+D + KL DFG K V T
Sbjct: 115 FFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYT 167
Query: 118 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 176
GT Y+ PE++ RS V+S G++L +M+ G + + ++
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRG--- 219
Query: 177 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
S + L CL+ P RP E+
Sbjct: 220 ------------QVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 6e-32
Identities = 44/224 (19%), Positives = 78/224 (34%), Gaps = 24/224 (10%)
Query: 12 HLNLVKLIGYC----IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKG 66
++V+++ L+V E + G L + + R +I +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 67 LAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTY 123
+ +LH + +RD K N+L + KL+DFG AK+ + T
Sbjct: 124 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTP 177
Query: 124 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 183
Y APE + D++S GV++ +L G H L R
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMG 232
Query: 184 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
Y +P S ++ L + L +P R ++E +
Sbjct: 233 QYEFPNPEWS-EVS----EEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 2e-31
Identities = 58/267 (21%), Positives = 93/267 (34%), Gaps = 34/267 (12%)
Query: 3 EVNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLEN--HLFRRSLPLPWS 54
E+ + L H N+V+L + ++ LV +++P H R LP
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 55 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKT 113
+ LA++H + +RD K N+LLD D KL DFG AK G+
Sbjct: 123 YVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 114 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 173
+ + Y A TS DV+S G VL E+L G+ + + +
Sbjct: 180 V--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 174 ARPHLGE-----------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR--- 219
+F ++ F + +A L + L P AR
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
Query: 220 ------PLMSEVVEALKPLPNLKDMAS 240
E+ + LPN +D +
Sbjct: 298 LEACAHSFFDELRDPNVKLPNGRDTPA 324
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-29
Identities = 50/252 (19%), Positives = 85/252 (33%), Gaps = 29/252 (11%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFRRSLPLP 52
+ E+ L L H N+V LI C LV++F
Sbjct: 57 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFT 115
Query: 53 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 112
S ++ GL ++H +++RD K +N+L+ D KL+DFGLA+
Sbjct: 116 LSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 172
Query: 113 THVS--TRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 169
+ + T + T Y PE ++ D++ G ++ EM T M N +
Sbjct: 173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232
Query: 170 LV-------------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ-LAAHCLSRD 215
L+ L E+ + +++ A L L D
Sbjct: 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292
Query: 216 PKARPLMSEVVE 227
P R + +
Sbjct: 293 PAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-28
Identities = 47/239 (19%), Positives = 85/239 (35%), Gaps = 17/239 (7%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E+ L +L H N+V+L D + LV+EF + + I
Sbjct: 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFL 107
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
KGL F H R V++RD K N+L++ + KL++FGLA+ + + S V+
Sbjct: 108 FQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVV 163
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-----------GEHN 169
+ ++ D++S G + E+ R + G
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223
Query: 170 LVEWAR-PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 227
+W L + + + + K L + L +P R E ++
Sbjct: 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (266), Expect = 3e-27
Identities = 47/220 (21%), Positives = 76/220 (34%), Gaps = 27/220 (12%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 60
+ E L + LVKL ++ +V E++ G + +HL R A
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYA 147
Query: 61 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 120
+LH +IYRD K N+L+D +++DFG AK T +
Sbjct: 148 AQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LC 199
Query: 121 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 180
GT APE +++ D ++ GV++ EM G P ++ +
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVSG 253
Query: 181 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 220
+ RF L + L D R
Sbjct: 254 KVRFPSHFSS------------DLKDLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 6e-27
Identities = 50/266 (18%), Positives = 94/266 (35%), Gaps = 25/266 (9%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF---MPRGSLENHLFRRSLPLPWSIRM 57
E+ L + H N++ L+ D+ +F MP + + L
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 124
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 117
+ KGL ++H +I+RD K N+ ++ D K+ DFGLA+ ++
Sbjct: 125 FLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTG 177
Query: 118 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV------ 171
V+ + A + T D++S G ++ EM+TG+ + + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 172 ---EWARPHLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224
E+ + + + Y P LE + A L L D + R E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 225 VVEA--LKPLPNLKDMASSSYYFQTM 248
+ + L + +D Y +
Sbjct: 298 ALAHPYFESLHDTEDEPQVQKYDDSF 323
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 2e-24
Identities = 55/254 (21%), Positives = 98/254 (38%), Gaps = 23/254 (9%)
Query: 1 MAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 59
E L + LV L + + L+ +++ G L HL +R +++ +
Sbjct: 76 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 135
Query: 60 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 119
+ + L + +IYRD K NILLD++ + L+DFGL+K+ + +
Sbjct: 136 G----EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDF 190
Query: 120 MGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 177
GT Y AP+ V G D +S GV++ E+LTG +++ E +R
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT--VDGEKNSQAEISRRI 248
Query: 178 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPNLK 236
L + + + A L L +DPK R + +K +
Sbjct: 249 LKSEPPYPQEMSA------------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
Query: 237 DMASSSYYFQTMQA 250
+ + + A
Sbjct: 297 KINWDDLAAKKVPA 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 96.4 bits (239), Expect = 1e-23
Identities = 43/252 (17%), Positives = 82/252 (32%), Gaps = 35/252 (13%)
Query: 1 MAEVNFLGDL-VHLNLVKLIGYCIEDDQRL--LVYEFMPRGSLENHLFRRSLPLPWSIRM 57
E+ L +L N++ L + R LV+E + + L
Sbjct: 77 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIR 132
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVS 116
K L + H +++RD K N+++D + +L D+GLA+ G +
Sbjct: 133 FYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--- 186
Query: 117 TRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN---------- 165
+ + + PE ++ D++S G +L M+ + N
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
Query: 166 -GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK---------AAQLAAHCLSRD 215
G +L ++ + E + I R + A L D
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
Query: 216 PKARPLMSEVVE 227
++R E +E
Sbjct: 307 HQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.7 bits (229), Expect = 4e-22
Identities = 51/257 (19%), Positives = 90/257 (35%), Gaps = 40/257 (15%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 54
E+ + + H N++ L+ E LV E M +
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHE 119
Query: 55 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 114
+ G+ LH +I+RD K SNI++ +D K+ DFGLA+
Sbjct: 120 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM- 175
Query: 115 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR----------------RS 158
T + T Y APE ++ D++S G ++ EM+ +
Sbjct: 176 --TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
Query: 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL--------EGHFSIKGAQKAAQLAAH 210
+ P L R ++ R ++ L P+L + + A +A L +
Sbjct: 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 293
Query: 211 CLSRDPKARPLMSEVVE 227
L DP R + + ++
Sbjct: 294 MLVIDPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 7e-20
Identities = 51/273 (18%), Positives = 100/273 (36%), Gaps = 29/273 (10%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYC-----IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 55
E+ L + H N++ L+ +E+ + + + L N + + L
Sbjct: 65 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDH 122
Query: 56 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 115
+ +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V
Sbjct: 123 VQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 179
Query: 116 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN----------RPN 165
+TR + A + H D++S G ++ E+LTGR R
Sbjct: 180 ATR----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 166 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLM 222
G + R + + + + +F+ I A L L D R
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 223 SEVVEA--LKPLPNLKDMASSSYYFQTMQAERI 253
++ + + D + Y Q+ ++ +
Sbjct: 296 AQALAHAYFAQYHDPDDEPVADPYDQSFESRDL 328
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 79.7 bits (195), Expect = 1e-17
Identities = 43/261 (16%), Positives = 86/261 (32%), Gaps = 37/261 (14%)
Query: 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRM 57
A+ + +++KL+ + +V+E + L +P
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 58 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVS 116
+I+ GL ++H +I+ D K N+L++ D L +A G
Sbjct: 129 QISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 117 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR- 175
T + T Y +PE ++ +D++S ++ E++TG + + + +
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 176 -----------------------PHLGERRRFYRLIDPRLEG------HFSIKGAQKAAQ 206
G R +L LE FS A++ +
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 207 LAAHCLSRDPKARPLMSEVVE 227
+ L DP+ R +V
Sbjct: 307 FLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 47.9 bits (113), Expect = 3e-07
Identities = 13/110 (11%), Positives = 32/110 (29%), Gaps = 16/110 (14%)
Query: 1 MAEVNFLGDLVHLNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 56
L KL G + + ++ E + L
Sbjct: 54 SVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENP 105
Query: 57 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106
++ + +A + R +++ D N+L+ + + DF + +
Sbjct: 106 DEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 304 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.77 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.82 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.33 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.59 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.85 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-53 Score=355.77 Aligned_cols=208 Identities=26% Similarity=0.396 Sum_probs=171.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+++..|+|||||++|+|.+++..+ ..+++..++.++.||+.||+|||+.+ |+||
T Consensus 52 ~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---IiHr 127 (271)
T d1nvra_ 52 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHR 127 (271)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CccC
Confidence 6999999999999999999999999999999999999999998554 47999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||++.++.+||+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.
T Consensus 128 DiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~ 207 (271)
T d1nvra_ 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207 (271)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred cccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987654443334455789999999999998876 578999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
........ ...+.. .... .. .....+.++.+||.+||+.||++|||++|++++
T Consensus 208 ~~~~~~~~-~~~~~~-----~~~~---~~------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 208 QPSDSCQE-YSDWKE-----KKTY---LN------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp SSSTTSHH-HHHHHT-----TCTT---ST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCChHHHH-HHHHhc-----CCCC---CC------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 54322111 111100 0000 00 011224688899999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=352.17 Aligned_cols=201 Identities=27% Similarity=0.428 Sum_probs=170.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+++..|+|||||++|+|.+++.+.. .+++..++.++.||+.||+|||+++ |+||
T Consensus 55 ~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~---ivHr 130 (263)
T d2j4za1 55 REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKR---VIHR 130 (263)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeee
Confidence 69999999999999999999999999999999999999999996543 6999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||+++...... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||..
T Consensus 131 DiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 131 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp CCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred eeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 999999999999999999999998754322 3346799999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.... .......... .. ++...++++.+||.+||+.||++|||++|+++|
T Consensus 207 ~~~~------~~~~~i~~~~--------~~----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 207 NTYQ------ETYKRISRVE--------FT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp SSHH------HHHHHHHTTC--------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCHH------HHHHHHHcCC--------CC----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 4221 1111111100 11 111235789999999999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=352.17 Aligned_cols=215 Identities=27% Similarity=0.475 Sum_probs=168.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++. .+.+++|||||++|+|.+++......+++..+..++.||+.||+|||+++ |+||
T Consensus 53 ~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHr 128 (276)
T d1uwha_ 53 NEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 128 (276)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---Eecc
Confidence 6999999999999999999875 45689999999999999999877778999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc---CCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+||||+.++.+||+|||+++...............||+.|+|||++.+ ..|+.++|||||||++|||+||+.|
T Consensus 129 DlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~P 208 (276)
T d1uwha_ 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208 (276)
T ss_dssp CCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCC
Confidence 9999999999999999999999987654443334455789999999999864 3589999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
|........ ...... .. ...+.. ...+..++.++.+||.+||+.||++|||++|++++|+.+
T Consensus 209 f~~~~~~~~--~~~~~~----~~-----~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 209 YSNINNRDQ--IIFMVG----RG-----YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp TTTCCCHHH--HHHHHH----HT-----SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCChHHH--HHHHHh----cC-----CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 976432211 111110 00 011111 111223357899999999999999999999999998643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=352.36 Aligned_cols=205 Identities=23% Similarity=0.333 Sum_probs=170.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+++..|+|||||+||+|.+++.++ .+++..++.++.||+.||+|||++| |+||
T Consensus 66 ~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---iiHr 140 (293)
T d1yhwa1 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHR 140 (293)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence 7999999999999999999999999999999999999999988654 5999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..
T Consensus 141 DiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 9999999999999999999999987654322 23456799999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... ... ....... ... ..+...+.++.+||.+||+.||++|||++|+++|
T Consensus 219 ~~~~~---~~~---~~~~~~~--~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 219 ENPLR---ALY---LIATNGT--PEL-------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SCHHH---HHH---HHHHHCS--CCC-------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCHHH---HHH---HHHhCCC--CCC-------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 43211 111 0000000 000 0112235789999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=355.61 Aligned_cols=205 Identities=22% Similarity=0.282 Sum_probs=167.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+++..|+|||||+||+|.+++...+ .+++..++.++.|++.||+|||+.+ |+||
T Consensus 57 ~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~---iiHr 132 (288)
T d1uu3a_ 57 RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG---IIHR 132 (288)
T ss_dssp HHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhcccc---EEcC
Confidence 69999999999999999999999999999999999999999886554 7999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+|||++.++.+||+|||+|+..............+||+.|+|||++.+..|+.++|||||||++|+|++|..||..
T Consensus 133 DiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (288)
T d1uu3a_ 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212 (288)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence 99999999999999999999999987544433344456899999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..... . ........ .. ++...+.++.+||.+||+.||++|||++|++++
T Consensus 213 ~~~~~---~---~~~i~~~~--------~~----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 213 GNEYL---I---FQKIIKLE--------YD----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp SSHHH---H---HHHHHTTC--------CC----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred cCHHH---H---HHHHHcCC--------CC----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 42211 1 11111100 11 111235688999999999999999999997643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.8e-52 Score=354.19 Aligned_cols=211 Identities=24% Similarity=0.400 Sum_probs=165.2
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++++|||||++++++..++..++|||||++|+|.+++......+++..+..++.||+.||.|||+.+ |+|
T Consensus 75 ~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiH 151 (299)
T d1jpaa_ 75 LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVH 151 (299)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---Ccc
Confidence 37999999999999999999999999999999999999999999887778999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCccee---eecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 156 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~ 156 (304)
|||||+||||+.++.+||+|||+++.......... .....||+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 152 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~ 231 (299)
T d1jpaa_ 152 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231 (299)
T ss_dssp SCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCC
Confidence 99999999999999999999999987654322211 122457899999999999999999999999999999998 89
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
.||...... ....... ... .+. .+..++..+.+||.+||+.||++|||+.||++.|+.
T Consensus 232 ~Pf~~~~~~---~~~~~i~----~~~------~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 232 RPYWDMTNQ---DVINAIE----QDY------RLP----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp CTTTTCCHH---HHHHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCHH---HHHHHHH----cCC------CCC----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 999764321 1111111 000 011 122345789999999999999999999999998864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=357.85 Aligned_cols=210 Identities=25% Similarity=0.393 Sum_probs=174.5
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC----------------------CCCCHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------------------LPLPWSIRMK 58 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------------~~l~~~~~~~ 58 (304)
+|+++|+++ +|||||++++++.+.+..++|||||++|+|.+++..+. ..+++..++.
T Consensus 89 ~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 168 (325)
T d1rjba_ 89 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 168 (325)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHH
T ss_pred HHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHH
Confidence 699999998 89999999999999999999999999999999996543 2489999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCc
Q 022003 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 138 (304)
Q Consensus 59 i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 138 (304)
++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.
T Consensus 169 i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 245 (325)
T d1rjba_ 169 FAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245 (325)
T ss_dssp HHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCc
Confidence 9999999999999988 9999999999999999999999999998765544444455567899999999999999999
Q ss_pred hhhhHHHHHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 139 RSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 139 ~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
++|||||||++|||+| |..||....... ........ . ..+. .+...+.++.+||.+||+.||+
T Consensus 246 ~~DiwS~Gvil~emlt~g~~Pf~~~~~~~--~~~~~~~~----~------~~~~----~p~~~~~~l~~li~~cl~~dP~ 309 (325)
T d1rjba_ 246 KSDVWSYGILLWEIFSLGVNPYPGIPVDA--NFYKLIQN----G------FKMD----QPFYATEEIYIIMQSCWAFDSR 309 (325)
T ss_dssp HHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHT----T------CCCC----CCTTCCHHHHHHHHHHTCSSGG
T ss_pred ceeccchhHHHHHHHhCCCCCCCCCCHHH--HHHHHHhc----C------CCCC----CCCcCCHHHHHHHHHHcCCChh
Confidence 9999999999999998 899997653321 11111110 0 0111 1223357899999999999999
Q ss_pred CCCCHHHHHHHhC
Q 022003 218 ARPLMSEVVEALK 230 (304)
Q Consensus 218 ~Rps~~ell~~l~ 230 (304)
+|||++||+++|.
T Consensus 310 ~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 310 KRPSFPNLTSFLG 322 (325)
T ss_dssp GSCCHHHHHHHHH
T ss_pred HCcCHHHHHHHHh
Confidence 9999999999884
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=350.64 Aligned_cols=207 Identities=25% Similarity=0.386 Sum_probs=170.1
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+++..++|||||++|+|.+++.+....+++..+..++.||+.||+|||+++ |+||
T Consensus 58 ~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHr 134 (288)
T d2jfla1 58 VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHR 134 (288)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEe
Confidence 6999999999999999999999999999999999999999998776667999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-----cCCCCchhhhHHHHHHHHHHHhCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~ 156 (304)
||||+|||++.++.+||+|||+++..... ........||+.|+|||++. +..|+.++|||||||++|||+||.
T Consensus 135 DiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~ 212 (288)
T d2jfla1 135 DLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212 (288)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSS
T ss_pred ecChhheeECCCCCEEEEechhhhccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCC
Confidence 99999999999999999999999764321 11223467999999999984 456899999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||....... ...... .... +.. ..+...+.++.+||.+||+.||++|||++|+++|
T Consensus 213 ~Pf~~~~~~~---~~~~i~--~~~~--------~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 213 PPHHELNPMR---VLLKIA--KSEP--------PTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CTTTTSCGGG---HHHHHH--HSCC--------CCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCCCCHHH---HHHHHH--cCCC--------CCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9997653221 111000 0000 000 0112335789999999999999999999999885
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=357.98 Aligned_cols=214 Identities=25% Similarity=0.392 Sum_probs=167.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH 80 (304)
+|+++|++++|||||+++++|.+.+.+|+|||||+||+|.+++.++. .+++..++.++.||+.||.|||+ ++ |+|
T Consensus 53 ~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~---IiH 128 (322)
T d1s9ja_ 53 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK---IMH 128 (322)
T ss_dssp HHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC---CCC
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCC---EEc
Confidence 79999999999999999999999999999999999999999996654 69999999999999999999997 47 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||||+.+|.+||+|||+|+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 129 RDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp SCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred cccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999999865321 2334689999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccc------------------------cc-------cccccCCccCCCCCHHHHHHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGER------------------------RR-------FYRLIDPRLEGHFSIKGAQKAAQLAA 209 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~------------------------~~-------~~~~~~~~~~~~~~~~~~~~~~~li~ 209 (304)
......... .+........ .. ......+... ....+.++.+||.
T Consensus 205 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~ 279 (322)
T d1s9ja_ 205 PPDAKELEL--MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVN 279 (322)
T ss_dssp CCCTTHHHH--HC------------------------------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHH
T ss_pred CCCHHHHHH--HHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCc---cccCCHHHHHHHH
Confidence 643221100 0000000000 00 0000001110 0112468899999
Q ss_pred HhccCCCCCCCCHHHHHHH
Q 022003 210 HCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 210 ~~l~~dp~~Rps~~ell~~ 228 (304)
+||+.||++|||++|+++|
T Consensus 280 ~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 280 KCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp HHTCSSTTTSCCHHHHHTS
T ss_pred HHcCCChhHCcCHHHHhhC
Confidence 9999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=344.15 Aligned_cols=205 Identities=24% Similarity=0.377 Sum_probs=164.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEe----CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|+++|++++|||||++++++.. +..+|+|||||++|+|.+++.+. ..+++..++.++.||+.||+|||+++ .+
T Consensus 57 ~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~ 134 (270)
T d1t4ha_ 57 EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PP 134 (270)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SC
T ss_pred HHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CC
Confidence 69999999999999999999875 34679999999999999999654 37999999999999999999999976 45
Q ss_pred eEeccCCCCCeEEC-CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCC
Q 022003 78 VIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 78 iiH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 156 (304)
|+||||||+||||+ +++.+||+|||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+
T Consensus 135 IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~ 209 (270)
T d1t4ha_ 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 209 (270)
T ss_dssp CCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCC
Confidence 99999999999996 5789999999999864332 2334689999999998865 6999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||....... ....... .... .+.. +...++++.+||.+||+.||++|||++|+++|
T Consensus 210 ~Pf~~~~~~~--~~~~~i~----~~~~-----~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 210 YPYSECQNAA--QIYRRVT----SGVK-----PASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CTTTTCSSHH--HHHHHHT----TTCC-----CGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCcccHH--HHHHHHH----cCCC-----Cccc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 9996532211 1111110 0000 0011 11124578999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-52 Score=349.33 Aligned_cols=209 Identities=24% Similarity=0.367 Sum_probs=158.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--CCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCC--
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEA-- 74 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~-- 74 (304)
+|+++|++++|||||++++++.+ ++.+|+|||||++|+|.+++.+ ....+++..++.++.||+.||+|||+.+
T Consensus 52 ~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~ 131 (269)
T d2java1 52 SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131 (269)
T ss_dssp HHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-
T ss_pred HHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 69999999999999999999865 4568999999999999999864 2457999999999999999999999864
Q ss_pred CCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh
Q 022003 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 154 (304)
..+|+||||||+||||+.++.+||+|||+++....... ......||+.|+|||++.+..|+.++|||||||++|||+|
T Consensus 132 ~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~t 209 (269)
T d2java1 132 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 209 (269)
T ss_dssp --------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhh
Confidence 13499999999999999999999999999988654322 2345689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
|+.||...... ........ ..+ +. .+...+.++.+||.+||+.||++|||++|++++.
T Consensus 210 g~~Pf~~~~~~---~~~~~i~~-----~~~-----~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp 267 (269)
T d2java1 210 LMPPFTAFSQK---ELAGKIRE-----GKF-----RR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 267 (269)
T ss_dssp SSCSCCCSSHH---HHHHHHHH-----TCC-----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred CCCCCCCCCHH---HHHHHHHc-----CCC-----CC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence 99999754221 11111100 000 11 1122356899999999999999999999999853
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-51 Score=350.27 Aligned_cols=208 Identities=22% Similarity=0.340 Sum_probs=160.0
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
.+|+++|++++|||||++++++.+++.+|+|||||+||+|.+++.++ ..+++..+..++.||+.||+|||+.+ |+|
T Consensus 55 ~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiH 130 (307)
T d1a06a_ 55 ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG---IVH 130 (307)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce---eee
Confidence 37999999999999999999999999999999999999999999664 47999999999999999999999998 999
Q ss_pred ccCCCCCeEEC---CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 81 RDFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 81 ~dlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
|||||+|||+. +++.+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus 131 rDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 207 (307)
T d1a06a_ 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207 (307)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCC
Confidence 99999999994 57899999999998754332 2334679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
||....... .. .........+ ........+.++.+||.+||+.||++|||++|+++|.
T Consensus 208 Pf~~~~~~~---~~---~~i~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 265 (307)
T d1a06a_ 208 PFYDENDAK---LF---EQILKAEYEF--------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265 (307)
T ss_dssp SCCCSSHHH---HH---HHHHTTCCCC--------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred CCCCCCHHH---HH---HHHhccCCCC--------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 997542211 11 1111111110 0111122357899999999999999999999999963
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=345.42 Aligned_cols=211 Identities=28% Similarity=0.469 Sum_probs=163.6
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|++++++++|||||++++++..++..++|||||++|+|.+++......+++..+..++.||+.||+|||+.+ |+|
T Consensus 48 ~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiH 124 (263)
T d1sm2a_ 48 IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124 (263)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eee
Confidence 37999999999999999999999999999999999999999999877778999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC-CCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~~p~ 159 (304)
|||||+|||++.++.+||+|||+++....... .......||..|+|||++.+..|+.++|||||||++|||+|+ .+||
T Consensus 125 rDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~ 203 (263)
T d1sm2a_ 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203 (263)
T ss_dssp TTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccchhheeecCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC
Confidence 99999999999999999999999987654322 223345789999999999999999999999999999999995 4444
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
..... ......... . .+...| ..++.++.+||.+||+.||++|||++|++++|+.+
T Consensus 204 ~~~~~---~~~~~~i~~----~---~~~~~p-------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 204 ENRSN---SEVVEDIST----G---FRLYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CSCCH---HHHHHHHHH----T---CCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCH---HHHHHHHHh----c---CCCCCc-------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 43211 111111111 0 011111 12356899999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=347.40 Aligned_cols=209 Identities=25% Similarity=0.394 Sum_probs=173.1
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++++|||||++++++.. +.+|+|||||++|+|.+++......+++..+..++.||+.||+|||+++ |+|
T Consensus 57 ~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiH 132 (285)
T d1u59a_ 57 MREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 132 (285)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 379999999999999999999865 4689999999999999998777678999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
|||||+||||+.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |..|
T Consensus 133 rDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~P 212 (285)
T d1u59a_ 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 212 (285)
T ss_dssp CCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCC
Confidence 999999999999999999999999987544332 22234568999999999999999999999999999999998 8999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
|...... ....... ... .+. .+...+.++.+||.+||+.||++|||+.+|++.|+
T Consensus 213 f~~~~~~---~~~~~i~----~~~------~~~----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 213 YKKMKGP---EVMAFIE----QGK------RME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp TTTCCTH---HHHHHHH----TTC------CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHH----cCC------CCC----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 9765321 1111111 100 011 12233578999999999999999999999998875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-51 Score=344.38 Aligned_cols=208 Identities=25% Similarity=0.371 Sum_probs=169.0
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++++|||||++++++.. +..++|||||++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+|
T Consensus 56 ~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~---iiH 130 (277)
T d1xbba_ 56 LAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVH 130 (277)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC---ccc
Confidence 379999999999999999999865 4678999999999999998655 46999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcc-eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
|||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |..|
T Consensus 131 rDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~P 210 (277)
T d1xbba_ 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210 (277)
T ss_dssp SCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCC
Confidence 999999999999999999999999876544332 22334578999999999999999999999999999999998 8999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
|...... ....... ... .+. .+..++.++.+||.+||+.||++|||+++|++.|+
T Consensus 211 f~~~~~~---~~~~~i~----~~~------~~~----~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 211 YRGMKGS---EVTAMLE----KGE------RMG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp STTCCHH---HHHHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHH----cCC------CCC----CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 9764321 1111111 100 011 12233578999999999999999999999988774
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.5e-50 Score=349.32 Aligned_cols=208 Identities=20% Similarity=0.292 Sum_probs=173.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++|+|||||++++++.+++.+|||||||+||+|.+++.+...++++..++.++.||+.||+|||+.| |+||
T Consensus 75 ~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHR 151 (352)
T d1koba_ 75 NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHL 151 (352)
T ss_dssp HHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 6999999999999999999999999999999999999999998777778999999999999999999999998 9999
Q ss_pred cCCCCCeEEC--CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 82 DFKTSNILLD--ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 82 dlkp~Nili~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||||+||||+ .++.+||+|||+|+....... .....||+.|+|||++.+..|+.++|||||||++|+|+||..||
T Consensus 152 DiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf 228 (352)
T d1koba_ 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 228 (352)
T ss_dssp CCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred ccccccccccccCCCeEEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 9999999997 678999999999998754332 34467899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
....... ... ........ .........+.++.+||.+||+.||.+|||++|+++|-
T Consensus 229 ~~~~~~~---~~~---~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp 284 (352)
T d1koba_ 229 AGEDDLE---TLQ---NVKRCDWE--------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284 (352)
T ss_dssp CCSSHHH---HHH---HHHHCCCC--------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CCCCHHH---HHH---HHHhCCCC--------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 7543211 111 00000000 11111122357889999999999999999999999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-50 Score=345.61 Aligned_cols=213 Identities=23% Similarity=0.333 Sum_probs=173.9
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
++|+++|++++|||||++++++.+++..++|||||++|+|.+++.+. ...+++..+..++.||+.||+|||+++ |+
T Consensus 61 ~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---ii 137 (287)
T d1opja_ 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 137 (287)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 37999999999999999999999999999999999999999998654 557999999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||||||+||||+.++.+||+|||+++....... .......|+..|+|||++.+..|+.++|||||||++|||++|..||
T Consensus 138 HrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCccccCeEEECCCCcEEEccccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654322 2233456889999999999999999999999999999999977666
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
...... ......... . ..+. .+...+.++.+||.+||+.||++|||++|+++.|+.+.
T Consensus 217 ~~~~~~--~~~~~~i~~----~------~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 217 YPGIDL--SQVYELLEK----D------YRME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp STTCCH--HHHHHHHHT----T------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCcchH--HHHHHHHhc----C------CCCC----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 433211 111111110 0 0111 12233578999999999999999999999999887553
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-50 Score=352.29 Aligned_cols=208 Identities=22% Similarity=0.296 Sum_probs=172.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++|+|||||++++++.+++.+|||||||+||+|.+++.+....+++..++.++.||+.||+|||+++ |+||
T Consensus 72 ~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHr 148 (350)
T d1koaa2 72 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHL 148 (350)
T ss_dssp HHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---Ceee
Confidence 6999999999999999999999999999999999999999999776668999999999999999999999999 9999
Q ss_pred cCCCCCeEEC--CCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 82 DFKTSNILLD--ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 82 dlkp~Nili~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||
T Consensus 149 DiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf 225 (350)
T d1koaa2 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 225 (350)
T ss_dssp CCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eechhHeeeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCC
Confidence 9999999995 46889999999998865432 234467999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
....... ... ........+ .. ......+.++.+||.+||+.||++|||++|+++|-
T Consensus 226 ~~~~~~~---~~~---~i~~~~~~~----~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 281 (350)
T d1koaa2 226 GGENDDE---TLR---NVKSCDWNM----DD----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281 (350)
T ss_dssp CCSSHHH---HHH---HHHHTCCCS----CC----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred CCCCHHH---HHH---HHHhCCCCC----Cc----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 7542211 111 100000000 00 01112356889999999999999999999999973
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-50 Score=347.08 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=165.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+++..|+|||||.+|+|..++..+ ..+++..++.++.||+.||.|||+++ |+||
T Consensus 64 ~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHr 139 (309)
T d1u5ra_ 64 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHR 139 (309)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCC
T ss_pred HHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---Eecc
Confidence 6999999999999999999999999999999999999887766444 47999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc---CCCCchhhhHHHHHHHHHHHhCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRS 158 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p 158 (304)
||||+||||+.++.+||+|||+++.... .....||+.|+|||++.+ ..|+.++|||||||++|||++|..|
T Consensus 140 DiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~P 213 (309)
T d1u5ra_ 140 DVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213 (309)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCC
Confidence 9999999999999999999999987533 234579999999999864 4689999999999999999999999
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
|....... ........ . .+... ....+.++.+||.+||+.||.+|||++|+++|
T Consensus 214 f~~~~~~~-----~~~~i~~~---~-----~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 214 LFNMNAMS-----ALYHIAQN---E-----SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp TTTSCHHH-----HHHHHHHS---C-----CCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCHHH-----HHHHHHhC---C-----CCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 97542211 11000000 0 01110 11235789999999999999999999999885
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=335.24 Aligned_cols=210 Identities=21% Similarity=0.391 Sum_probs=175.7
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|++++++++|||||++++++.+++.+++||||+++|+|.+++......+++..++.++.|+++||+|||+.+ |+|
T Consensus 47 ~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH 123 (258)
T d1k2pa_ 47 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 123 (258)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCC
T ss_pred HHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---ccc
Confidence 37999999999999999999999999999999999999999998777778999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+|||++.++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus 124 ~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf 202 (258)
T d1k2pa_ 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 202 (258)
T ss_dssp SCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccceeEEEcCCCcEEECcchhheeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCC
Confidence 99999999999999999999999987654322 22334678999999999999999999999999999999998 78899
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
...... ....... .. .....| ...+.++.+||.+||+.||++|||++|++++|..
T Consensus 203 ~~~~~~---~~~~~i~----~~---~~~~~p-------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 203 ERFTNS---ETAEHIA----QG---LRLYRP-------HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTSCHH---HHHHHHH----TT---CCCCCC-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCHH---HHHHHHH----hC---CCCCCc-------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 765321 1111111 11 011111 1234689999999999999999999999999854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=338.74 Aligned_cols=213 Identities=24% Similarity=0.392 Sum_probs=167.0
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++++|||||++++++.+.+..++|||||.+++|.+++......+++..+..++.||+.||+|||+.+ |+|
T Consensus 57 ~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiH 133 (283)
T d1mqba_ 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVH 133 (283)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---ccc
Confidence 37999999999999999999999999999999999999999998877778999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCc-ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
|||||+||||+.++.+||+|||+++....... ........||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 134 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp SCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 99999999999999999999999987644322 22233456899999999999999999999999999999999976665
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
...... ........ .. ..+. .+...+..+.+||.+||+.||++|||+.||++.|+.+
T Consensus 214 ~~~~~~--~~~~~~i~----~~------~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 214 YWELSN--HEVMKAIN----DG------FRLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp TTTCCH--HHHHHHHH----TT------CCCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cccCCH--HHHHHHHh----cc------CCCC----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 432211 11111111 10 0111 1223357899999999999999999999999988643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=344.44 Aligned_cols=204 Identities=30% Similarity=0.373 Sum_probs=171.1
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++++|||||++++++.+++.+|+|||||+||+|.+++.+.. .+++..++.++.||+.||+|||+++ |+|
T Consensus 53 ~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~---iiH 128 (337)
T d1o6la_ 53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD---VVY 128 (337)
T ss_dssp HHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CBC
T ss_pred HHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcC---ccc
Confidence 369999999999999999999999999999999999999999986654 6999999999999999999999999 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.+|.+||+|||+|+....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.
T Consensus 129 RDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~ 206 (337)
T d1o6la_ 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCC
Confidence 99999999999999999999999987543222 2345789999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~~ 228 (304)
..... ............ ++...+.++.+||.+||+.||++|++ ++|+++|
T Consensus 207 ~~~~~------~~~~~i~~~~~~------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 207 NQDHE------RLFELILMEEIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CSSHH------HHHHHHHHCCCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CcCHH------HHHHHHhcCCCC------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 65321 111111111111 11223568899999999999999995 7888875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=337.15 Aligned_cols=209 Identities=27% Similarity=0.407 Sum_probs=167.4
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
++|+++|++++|||||++++++. ++..++|||||++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+
T Consensus 56 ~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---iv 131 (272)
T d1qpca_ 56 LAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131 (272)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 37999999999999999999875 45689999999999999987554 335999999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||||||+||||+.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||++|||+||..|+
T Consensus 132 HrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cCccchhheeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 99999999999999999999999999865432 22234457899999999999999999999999999999999966554
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
...... ........ .. ..+.. +...+.++.+||.+||+.||++|||++||++.|+
T Consensus 211 ~~~~~~--~~~~~~i~----~~------~~~~~----p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 211 YPGMTN--PEVIQNLE----RG------YRMVR----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp STTCCH--HHHHHHHH----TT------CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCH--HHHHHHHH----hc------CCCCC----cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 332111 11111111 00 11111 1123568999999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=339.76 Aligned_cols=206 Identities=23% Similarity=0.312 Sum_probs=169.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+.+..|||||||+||+|.+++.++. .+++..++.++.||+.||+|||+.+ |+||
T Consensus 62 ~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~---ivHr 137 (293)
T d1jksa_ 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQ---IAHF 137 (293)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcc---eeec
Confidence 69999999999999999999999999999999999999999996654 7999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCC----cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 82 DFKTSNILLDADY----NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 82 dlkp~Nili~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
||||+|||++.++ .+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 138 DiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 214 (293)
T d1jksa_ 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 214 (293)
T ss_dssp CCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccceEEEecCCCcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCC
Confidence 9999999998776 499999999987654322 334578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
||....... ... ........+.... ....+.++.+||.+||+.||++|||++|+++|
T Consensus 215 Pf~~~~~~~---~~~---~i~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 215 PFLGDTKQE---TLA---NVSAVNYEFEDEY--------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp SSCCSSHHH---HHH---HHHTTCCCCCHHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCHHH---HHH---HHHhcCCCCCchh--------cCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 997543211 111 0000000000000 01124688999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=334.72 Aligned_cols=208 Identities=24% Similarity=0.367 Sum_probs=161.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++. ++..++|||||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||
T Consensus 57 ~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHr 132 (273)
T d1mp8a_ 57 QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHR 132 (273)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eecc
Confidence 6999999999999999999985 56789999999999999998777778999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 160 (304)
||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.
T Consensus 133 DlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~ 211 (273)
T d1mp8a_ 133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211 (273)
T ss_dssp CCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccchhheeecCCCcEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCC
Confidence 9999999999999999999999987543322 22334568999999999999999999999999999999998 888887
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
...... ...... ... .+. .+...+.++.+||.+||+.||++|||++||+++|+.
T Consensus 212 ~~~~~~---~~~~i~----~~~------~~~----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 212 GVKNND---VIGRIE----NGE------RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp TCCGGG---HHHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHH---HHHHHH----cCC------CCC----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 653321 111111 000 011 112335789999999999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=339.92 Aligned_cols=210 Identities=21% Similarity=0.337 Sum_probs=170.3
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++++|||||++++++.++ ..+++|||+.+++|.+++..+...+++..+..++.||+.||+|||+++ |+|
T Consensus 59 ~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiH 134 (317)
T d1xkka_ 59 LDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVH 134 (317)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---ccc
Confidence 3699999999999999999999865 567888999999999999888778999999999999999999999988 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
|||||+||||+.++.+||+|||+++...............||..|+|||++.++.|+.++|||||||++|||+| |..||
T Consensus 135 rDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~ 214 (317)
T d1xkka_ 135 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214 (317)
T ss_dssp SCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999998765544444445678999999999999999999999999999999998 78888
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... +...... .. + +. .+..++.++.+||.+||+.||++|||+.|++++|+.
T Consensus 215 ~~~~~~~---~~~~i~~----~~---~---~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 215 DGIPASE---ISSILEK----GE---R---LP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp TTSCGGG---HHHHHHH----TC---C---CC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCHHH---HHHHHHc----CC---C---CC----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 6543221 1111110 00 0 11 112235689999999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-48 Score=336.03 Aligned_cols=200 Identities=27% Similarity=0.396 Sum_probs=168.6
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+++..|+|||||.||+|..++.... .+++..++.++.||+.||+|||+++ |+||
T Consensus 53 ~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---iiHr 128 (316)
T d1fota_ 53 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKD---IIYR 128 (316)
T ss_dssp HHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTT---EECC
T ss_pred HHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCc---EEcc
Confidence 69999999999999999999999999999999999999999886554 6899999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
||||+||||+.+|.+||+|||+|+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||..
T Consensus 129 DiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 129 DLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp CCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence 99999999999999999999999876432 2346899999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~ 228 (304)
.... ........... . ++...+.++.++|.+||+.||.+|+ |++++++|
T Consensus 204 ~~~~------~~~~~i~~~~~--------~----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 204 SNTM------KTYEKILNAEL--------R----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp SSHH------HHHHHHHHCCC--------C----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred cCHH------HHHHHHHcCCC--------C----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 4221 11111111100 1 1112246789999999999999996 89999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=331.35 Aligned_cols=208 Identities=18% Similarity=0.253 Sum_probs=171.3
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+++.+|+|||||+||+|.+++.++...+++.+++.++.||+.||+|||+.+ |+||
T Consensus 50 ~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHr 126 (321)
T d1tkia_ 50 KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHF 126 (321)
T ss_dssp HHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcc
Confidence 7999999999999999999999999999999999999999999877768999999999999999999999998 9999
Q ss_pred cCCCCCeEECCC--CcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCC
Q 022003 82 DFKTSNILLDAD--YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 159 (304)
||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||
T Consensus 127 DlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf 203 (321)
T d1tkia_ 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203 (321)
T ss_dssp CCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccceeecCCCceEEEEcccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCC
Confidence 999999999754 589999999998764432 234467899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l 229 (304)
....... .. .........+.....+ ..+.++.+||.+||+.||++|||++|+++|-
T Consensus 204 ~~~~~~~---~~---~~i~~~~~~~~~~~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 204 LAETNQQ---II---ENIMNAEYTFDEEAFK--------EISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CCSSHHH---HH---HHHHHTCCCCCHHHHT--------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCCCHHH---HH---HHHHhCCCCCChhhcc--------CCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 7643211 11 1011100011000000 1246789999999999999999999999863
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=338.09 Aligned_cols=211 Identities=20% Similarity=0.262 Sum_probs=167.3
Q ss_pred hHhhHhhcC-CCCcccceeeEEEe----CCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|++++.++ +|||||++++++.+ +..+|+|||||+||+|.+++.++ ...+++..++.++.||+.||+|||+.+
T Consensus 53 ~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~- 131 (335)
T d2ozaa1 53 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 131 (335)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC-
Confidence 689887655 89999999999876 45789999999999999999765 357999999999999999999999998
Q ss_pred CCeEeccCCCCCeEECC---CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 76 RPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|+||||||+|||++. ++.+||+|||+++....... .....||+.|+|||++.+..|+.++|||||||++|+|
T Consensus 132 --iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~l 206 (335)
T d2ozaa1 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 206 (335)
T ss_dssp --EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHH
T ss_pred --CccccccccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHH
Confidence 999999999999975 56799999999987654332 3346799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+||+.||............. . .. ...............+.++.+||.+||+.||++|||+.|+++|
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~--~-~i-------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 207 LCGYPPFYSNHGLAISPGMK--T-RI-------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp TTSSCSCEETTCC-----------CC-------CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhCCCCCCCCCHHHHHHHHH--H-HH-------hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 99999997654322211100 0 00 0000001111112346789999999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.5e-48 Score=338.26 Aligned_cols=203 Identities=27% Similarity=0.321 Sum_probs=166.8
Q ss_pred HhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 82 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~d 82 (304)
|+++++.++|||||++++++.+.+.+|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||+.+ |+|||
T Consensus 57 ~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrD 132 (364)
T d1omwa3 57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRD 132 (364)
T ss_dssp HHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---cccee
Confidence 477888889999999999999999999999999999999999665 46899999999999999999999999 99999
Q ss_pred CCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhh-cCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 022003 83 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDK 161 (304)
Q Consensus 83 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~ 161 (304)
|||+||||+.+|.+||+|||+|+...... .....||+.|+|||++. +..|+.++|||||||++|||+||..||..
T Consensus 133 lKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 133 LKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp CSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998765432 23457999999999987 45799999999999999999999999976
Q ss_pred CCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 022003 162 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 228 (304)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~~ 228 (304)
....... ......... .... +...+.++.+||.+||+.||++||| ++|+++|
T Consensus 209 ~~~~~~~---~~~~~~~~~--------~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 209 HKTKDKH---EIDRMTLTM--------AVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SCSSCHH---HHHHHSSSC--------CCCC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCHHHHH---HHHHhcccC--------CCCC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 5432211 111111110 0111 1123568999999999999999998 6888875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-48 Score=329.16 Aligned_cols=207 Identities=26% Similarity=0.356 Sum_probs=169.9
Q ss_pred ChHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
++|+++|++++ |||||++++++.+++..|||||||++|+|.+++..++ .+++..++.++.||+.||+|||+++ |+
T Consensus 57 ~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~---iv 132 (277)
T d1phka_ 57 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLN---IV 132 (277)
T ss_dssp HHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcC---Cc
Confidence 36999999997 9999999999999999999999999999999996654 7999999999999999999999998 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc------CCCCchhhhHHHHHHHHHHH
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~ 153 (304)
||||||+|||++.++.+||+|||+++....... .....||..|+|||++.+ ..++.++||||+||++|+|+
T Consensus 133 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml 209 (277)
T d1phka_ 133 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 209 (277)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred ccccccceEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhc
Confidence 999999999999999999999999998754332 334679999999999863 35788999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 154 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 154 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
+|+.||....... ... ....... ....+ .....++++.+||.+||+.||++|||++|+++|
T Consensus 210 ~g~~Pf~~~~~~~---~~~---~i~~~~~---~~~~~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 210 AGSPPFWHRKQML---MLR---MIMSGNY---QFGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HSSCSSCCSSHHH---HHH---HHHHTCC---CCCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cCCCCCCCCCHHH---HHH---HHHhCCC---CCCCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 9999997643211 111 0010000 00011 111345789999999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-48 Score=338.14 Aligned_cols=201 Identities=22% Similarity=0.287 Sum_probs=169.4
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++++|||||++++++.+.+..++||||+.+|+|..++.+.. .+++..++.++.||+.||.|||+++ |+|
T Consensus 89 ~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~---iiH 164 (350)
T d1rdqe_ 89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD---LIY 164 (350)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 379999999999999999999999999999999999999999986654 6999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||||+.+|.+||+|||+++..... .....||+.|+|||++.+..|+.++|||||||++|+|+||..||.
T Consensus 165 RDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 239 (350)
T d1rdqe_ 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC
Confidence 999999999999999999999999876432 234679999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~~ 228 (304)
..... .......... ... +...+.++.+||.+||+.||.+|+ |++++++|
T Consensus 240 ~~~~~------~~~~~i~~~~--------~~~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 240 ADQPI------QIYEKIVSGK--------VRF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CSSHH------HHHHHHHHCC--------CCC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CcCHH------HHHHHHhcCC--------CCC----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 54211 1111111110 011 112356899999999999999994 89999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=332.45 Aligned_cols=221 Identities=22% Similarity=0.236 Sum_probs=166.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++..++..|+|||||.++++..++ .....+++..++.++.||+.||+|||+++ |+||
T Consensus 49 ~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHr 124 (299)
T d1ua2a_ 49 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHR 124 (299)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecc
Confidence 6999999999999999999999999999999999877666554 55567999999999999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.
T Consensus 125 DiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp CCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCcceEEecCCCccccccCccccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence 9999999999999999999999987654322 2334578999999999874 568999999999999999999999997
Q ss_pred CCCCCCCcchhHhhh-----hhhccccccccccCCccCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWAR-----PHLGERRRFYRLIDPRLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.....+....+.-.. ..+...........-...... ....++++.+||.+||+.||++|||++|+++|
T Consensus 203 ~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 203 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 643221110000000 000000000000000000000 01224689999999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=327.51 Aligned_cols=210 Identities=26% Similarity=0.379 Sum_probs=169.5
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++.+ +..++|||||++|+|.+++..+...+++..+..++.||+.||.|||+++ |+||
T Consensus 60 ~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHr 135 (273)
T d1u46a_ 60 REVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHR 135 (273)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---Eeee
Confidence 69999999999999999999965 4678999999999999988777667999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcce-eeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 159 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 159 (304)
||||+||+++.++.+||+|||+++......... ......|+..|+|||++.+..++.++|||||||++|||+| |..||
T Consensus 136 Dikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf 215 (273)
T d1u46a_ 136 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215 (273)
T ss_dssp CCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred eecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCC
Confidence 999999999999999999999999875543332 2233567889999999999999999999999999999998 89999
Q ss_pred CCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 160 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
....... .. ........ .+.. +...+..+.+||.+||+.||++|||+.||++.|+.
T Consensus 216 ~~~~~~~---~~---~~i~~~~~------~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 216 IGLNGSQ---IL---HKIDKEGE------RLPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp TTCCHHH---HH---HHHHTSCC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcCHHH---HH---HHHHhCCC------CCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 7543211 11 11111111 1111 11234689999999999999999999999988753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.3e-47 Score=320.90 Aligned_cols=212 Identities=25% Similarity=0.355 Sum_probs=163.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCC----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 77 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 77 (304)
+|+++|++++|||||++++++...+ ..|+|||||+|++|.+++...+ .+++.+++.++.||+.||+|||+.+
T Consensus 56 ~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~--- 131 (277)
T d1o6ya_ 56 REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--- 131 (277)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6999999999999999999998754 3789999999999999886554 6999999999999999999999998
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCcccCCCCCc-ceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCC
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 156 (304)
|+||||||+|||++.++.++|+|||.+........ .......+||+.|+|||++.+..++.++|||||||++|+|+||.
T Consensus 132 iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~ 211 (277)
T d1o6ya_ 132 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211 (277)
T ss_dssp EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCC
Confidence 99999999999999999999999999876543222 22334567999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhCC
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKP 231 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~ell~~l~~ 231 (304)
.||...... +................. ...+.++.++|.+||+.||.+|| |++++++.|..
T Consensus 212 ~Pf~~~~~~------~~~~~~~~~~~~~~~~~~--------~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 212 PPFTGDSPV------SVAYQHVREDPIPPSARH--------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CSCCCSSHH------HHHHHHHHCCCCCGGGTS--------SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCCcCHH------HHHHHHHhcCCCCCchhc--------cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999754321 111111111111111111 12247899999999999999999 89999887754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=325.78 Aligned_cols=211 Identities=24% Similarity=0.364 Sum_probs=163.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+.+|++++|||||++++++. ++..++|||||++|+|..++... ...+++..+..++.||+.||+|||+.+ |+|
T Consensus 61 ~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH 136 (285)
T d1fmka3 61 QEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 136 (285)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eec
Confidence 6999999999999999999985 45689999999999999988643 346999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+||||+.++.+||+|||+++....... .......||+.|+|||++....++.++|||||||++|||++|..|+.
T Consensus 137 ~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 137 RDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp SCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 99999999999999999999999987643322 22334578999999999999999999999999999999999766654
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCCC
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 233 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~~ 233 (304)
..... ......... . ..+.. +...+.++.+||.+||+.||++|||+++|++.|+...
T Consensus 216 ~~~~~--~~~~~~i~~----~------~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 216 PGMVN--REVLDQVER----G------YRMPC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp TTCCH--HHHHHHHHT----T------CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCH--HHHHHHHHh----c------CCCCC----CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 43211 111111110 0 01111 1233568999999999999999999999999887643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-48 Score=330.31 Aligned_cols=211 Identities=25% Similarity=0.400 Sum_probs=171.2
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC-----------------------CCCCCHHHHHH
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-----------------------SLPLPWSIRMK 58 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----------------------~~~l~~~~~~~ 58 (304)
+|+++|++++||||+++++++...+..++||||+++|+|.+++... ...+++..+..
T Consensus 65 ~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 144 (301)
T d1lufa_ 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 144 (301)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHH
T ss_pred HHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHH
Confidence 6999999999999999999999999999999999999999998542 12489999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCc
Q 022003 59 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 138 (304)
Q Consensus 59 i~~qi~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 138 (304)
++.||+.||+|||+.+ ++||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..|+.
T Consensus 145 i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ 221 (301)
T d1lufa_ 145 IARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 221 (301)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh
Confidence 9999999999999988 9999999999999999999999999998654443333444567899999999999999999
Q ss_pred hhhhHHHHHHHHHHHhCC-CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCC
Q 022003 139 RSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 217 (304)
Q Consensus 139 ~~DiwslG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 217 (304)
++|||||||++|||++|. +||...... ....... ... .+.. +...+.++.+||.+||+.||+
T Consensus 222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~---e~~~~v~----~~~------~~~~----p~~~~~~~~~li~~cl~~~P~ 284 (301)
T d1lufa_ 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHE---EVIYYVR----DGN------ILAC----PENCPLELYNLMRLCWSKLPA 284 (301)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH----TTC------CCCC----CTTCCHHHHHHHHHHTCSSGG
T ss_pred hhhhccchhhHHHHHccCCCCCCCCCHH---HHHHHHH----cCC------CCCC----CccchHHHHHHHHHHcCCChh
Confidence 999999999999999986 566543221 1111111 110 0111 122346899999999999999
Q ss_pred CCCCHHHHHHHhCCC
Q 022003 218 ARPLMSEVVEALKPL 232 (304)
Q Consensus 218 ~Rps~~ell~~l~~~ 232 (304)
+|||+.||++.|+.+
T Consensus 285 ~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 285 DRPSFCSIHRILQRM 299 (301)
T ss_dssp GSCCHHHHHHHHHHT
T ss_pred HCcCHHHHHHHHHHh
Confidence 999999999998765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=329.72 Aligned_cols=212 Identities=28% Similarity=0.384 Sum_probs=162.6
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeC-CeeEEEEecCCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAA 64 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~ 64 (304)
+|++++.++ +|+|||.+++++... ..+++|||||++|+|.+++..+ ...+++..+..++.||+
T Consensus 65 ~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~ 144 (299)
T d1ywna1 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 144 (299)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHH
Confidence 467777776 688999999988765 4689999999999999999643 23589999999999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHH
Q 022003 65 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 144 (304)
Q Consensus 65 ~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 144 (304)
.||+|||+++ |+||||||+||||+.++.+||+|||+|+...............||+.|+|||++.+..++.++||||
T Consensus 145 ~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS 221 (299)
T d1ywna1 145 KGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221 (299)
T ss_dssp HHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceee
Confidence 9999999988 9999999999999999999999999998765444433444567999999999999999999999999
Q ss_pred HHHHHHHHHhCC-CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 022003 145 FGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 145 lG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
|||++|||+||. +||....... ...... .... .+.. +...+.++.+||.+||+.||++|||++
T Consensus 222 ~Gvil~ellt~~~~p~~~~~~~~--~~~~~~----~~~~------~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~ 285 (299)
T d1ywna1 222 FGVLLWEIFSLGASPYPGVKIDE--EFCRRL----KEGT------RMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFS 285 (299)
T ss_dssp HHHHHHHHHTTSCCSSTTCCCSH--HHHHHH----HHTC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hHHHHHHHHhCCCCCCCCCCHHH--HHHHHH----hcCC------CCCC----CccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 999999999875 5675443211 111111 1110 1111 112356899999999999999999999
Q ss_pred HHHHHhCCC
Q 022003 224 EVVEALKPL 232 (304)
Q Consensus 224 ell~~l~~~ 232 (304)
|++++|+.+
T Consensus 286 eil~~L~~i 294 (299)
T d1ywna1 286 ELVEHLGNL 294 (299)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=328.91 Aligned_cols=210 Identities=27% Similarity=0.415 Sum_probs=173.4
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~ 65 (304)
+|+.++.++ +|||||++++++.+++..++|||||.+|+|.+++..+. ..+++.+++.++.||+.
T Consensus 67 ~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 146 (299)
T d1fgka_ 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 146 (299)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHH
Confidence 578888888 89999999999999999999999999999999996543 35899999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||+|||+.+ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||
T Consensus 147 al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~ 223 (299)
T d1fgka_ 147 GMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223 (299)
T ss_dssp HHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHh
Confidence 999999999 99999999999999999999999999987655444434455678999999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|||++ |.+||...... ..... +.... .+.... ..+.++.+||.+||+.||++|||+.|
T Consensus 224 Gvvl~ell~~g~~p~~~~~~~---~~~~~----i~~~~------~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~~e 286 (299)
T d1fgka_ 224 GVLLWEIFTLGGSPYPGVPVE---ELFKL----LKEGH------RMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQ 286 (299)
T ss_dssp HHHHHHHHTTSCCSSTTCCHH---HHHHH----HHTTC------CCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHhccCCCCCCCCCCHH---HHHHH----HHcCC------CCCCCc----cchHHHHHHHHHHccCCHhHCcCHHH
Confidence 999999998 68888654321 11111 11111 111111 23468999999999999999999999
Q ss_pred HHHHhCC
Q 022003 225 VVEALKP 231 (304)
Q Consensus 225 ll~~l~~ 231 (304)
|++.|+.
T Consensus 287 il~~L~~ 293 (299)
T d1fgka_ 287 LVEDLDR 293 (299)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=322.43 Aligned_cols=206 Identities=27% Similarity=0.410 Sum_probs=162.0
Q ss_pred hHhhHhhcCCCCcccceeeEEEe-CCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
+|++++++++|||||++++++.+ ++.+++||||+++|+|.+++.++ ...+++..++.++.||+.||.|||+.+ |+
T Consensus 49 ~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---iv 125 (262)
T d1byga_ 49 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 125 (262)
T ss_dssp HTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---ee
Confidence 69999999999999999999865 45689999999999999999654 335899999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHh-CCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 158 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 158 (304)
||||||+|||++.++.+||+|||+++..... .....+|..|+|||++.+..++.++|||||||++|||+| |.+|
T Consensus 126 H~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p 200 (262)
T d1byga_ 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 200 (262)
T ss_dssp CSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999864322 233467889999999999999999999999999999998 6777
Q ss_pred CCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 159 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
|...... +....... ...+.. +...+..+.+||.+||+.||++|||+.+++++|+.+
T Consensus 201 ~~~~~~~---~~~~~i~~----------~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 201 YPRIPLK---DVVPRVEK----------GYKMDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CTTSCGG---GHHHHHTT----------TCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHHc----------CCCCCC----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 7654221 22221111 011111 222346889999999999999999999999998643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=327.66 Aligned_cols=208 Identities=25% Similarity=0.370 Sum_probs=169.3
Q ss_pred hHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAK 65 (304)
Q Consensus 2 ~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~ 65 (304)
+|+++|+++ +|||||++++++.+.+.+++|||||++|+|.+++.++ ...+++..+..++.||+.
T Consensus 59 ~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~ 138 (309)
T d1fvra_ 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 138 (309)
T ss_dssp HHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHH
Confidence 799999999 7999999999999999999999999999999999654 357999999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHH
Q 022003 66 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 145 (304)
Q Consensus 66 ~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 145 (304)
||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ......||..|+|||.+.+..|+.++|||||
T Consensus 139 gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSf 212 (309)
T d1fvra_ 139 GMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 212 (309)
T ss_dssp HHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred HHHhhhcCC---ccccccccceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehh
Confidence 999999988 9999999999999999999999999998654322 2234568999999999999999999999999
Q ss_pred HHHHHHHHhCCC-CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 022003 146 GVVLLEMLTGRR-SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 224 (304)
Q Consensus 146 G~il~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 224 (304)
||++|||++|.. ||..... ..+..... ... .+. .+...+.++.+||.+||+.||++|||++|
T Consensus 213 Gvil~ell~~~~~p~~~~~~---~~~~~~i~----~~~------~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~e 275 (309)
T d1fvra_ 213 GVLLWEIVSLGGTPYCGMTC---AELYEKLP----QGY------RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQ 275 (309)
T ss_dssp HHHHHHHHTTSCCTTTTCCH---HHHHHHGG----GTC------CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhcCCCCCCCCCH---HHHHHHHH----hcC------CCC----CCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 999999999765 5654321 11111111 110 111 12233578999999999999999999999
Q ss_pred HHHHhCCC
Q 022003 225 VVEALKPL 232 (304)
Q Consensus 225 ll~~l~~~ 232 (304)
|+++|+.+
T Consensus 276 il~~L~~i 283 (309)
T d1fvra_ 276 ILVSLNRM 283 (309)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99988654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=329.80 Aligned_cols=203 Identities=28% Similarity=0.412 Sum_probs=167.2
Q ss_pred hHhhHhh-cCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLG-DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|..++. .++|||||++++++.+++..|||||||++|+|.+++.... .+++..++.++.||+.||+|||+++ |+|
T Consensus 51 ~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~---iiH 126 (320)
T d1xjda_ 51 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG---IVY 126 (320)
T ss_dssp HHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CBC
T ss_pred HHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 4666665 6899999999999999999999999999999999996544 6999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
|||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.
T Consensus 127 rDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~ 204 (320)
T d1xjda_ 127 RDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 204 (320)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCcccceeecCCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCC
Confidence 99999999999999999999999987543322 2344679999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 022003 161 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~~ 228 (304)
+..... ... ..... .+.. +...+.++.+||.+||+.||++|||+. |+++|
T Consensus 205 ~~~~~~---~~~---~i~~~--------~~~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 205 GQDEEE---LFH---SIRMD--------NPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CSSHHH---HHH---HHHHC--------CCCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCCHHH---HHH---HHHcC--------CCCC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 543211 111 11111 1111 112356899999999999999999985 67664
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=327.89 Aligned_cols=212 Identities=27% Similarity=0.412 Sum_probs=173.9
Q ss_pred ChHhhHhhcC-CCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCC-----------------CCCCHHHHHHHHHH
Q 022003 1 MAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------------LPLPWSIRMKIALG 62 (304)
Q Consensus 1 l~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------~~l~~~~~~~i~~q 62 (304)
++|+.+++++ +|||||++++++.+.+..++|||||++|+|.+++.+.. ..+++..+..++.|
T Consensus 74 ~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 153 (311)
T d1t46a_ 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ 153 (311)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHH
Confidence 3699999999 69999999999999999999999999999999986532 25899999999999
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhh
Q 022003 63 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 142 (304)
Q Consensus 63 i~~~l~~LH~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 142 (304)
|+.||+|||+++ ++||||||+||+++.++.+|++|||+++...............||+.|+|||++.+..++.++||
T Consensus 154 i~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DI 230 (311)
T d1t46a_ 154 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230 (311)
T ss_dssp HHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccc
Confidence 999999999998 99999999999999999999999999998766555555556789999999999999999999999
Q ss_pred HHHHHHHHHHHhC-CCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 143 YSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 143 wslG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
|||||++|||+|+ .++|....... ........ . ..+.. +...+..+.+||.+||+.||++|||
T Consensus 231 wS~G~~l~ellt~g~p~~~~~~~~~--~~~~~i~~----~------~~~~~----~~~~~~~l~~Li~~cl~~dP~~RPs 294 (311)
T d1t46a_ 231 WSYGIFLWELFSLGSSPYPGMPVDS--KFYKMIKE----G------FRMLS----PEHAPAEMYDIMKTCWDADPLKRPT 294 (311)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCSSH--HHHHHHHH----T------CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred cchHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhc----C------CCCCC----cccccHHHHHHHHHHcCCChhHCcC
Confidence 9999999999994 55554432211 11111111 0 11111 1123578999999999999999999
Q ss_pred HHHHHHHhCC
Q 022003 222 MSEVVEALKP 231 (304)
Q Consensus 222 ~~ell~~l~~ 231 (304)
++||++.|+.
T Consensus 295 ~~~il~~L~~ 304 (311)
T d1t46a_ 295 FKQIVQLIEK 304 (311)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998853
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=324.33 Aligned_cols=213 Identities=27% Similarity=0.446 Sum_probs=172.6
Q ss_pred ChHhhHhhcCCCCcccceeeEEEe-CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
++|+++|++++|||||++++++.. ++..++|||||++++|.+++......+++..+..++.|++.||.|||+.+ |+
T Consensus 76 ~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---ii 152 (311)
T d1r0pa_ 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FV 152 (311)
T ss_dssp HHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cc
Confidence 379999999999999999999876 45889999999999999999888778899999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcc--eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 157 (304)
||||||+||||++++.+||+|||+++........ .......||..|+|||.+.+..++.++|||||||++|||+||..
T Consensus 153 HrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~ 232 (311)
T d1r0pa_ 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232 (311)
T ss_dssp CSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCC
Confidence 9999999999999999999999999876543221 12223568999999999999999999999999999999999887
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCCC
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 232 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~~ 232 (304)
||...... ......... .. +...| ...+.++.+||.+||+.||++|||+.||+++|+.+
T Consensus 233 p~~~~~~~--~~~~~~i~~----g~---~~~~p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 233 PPYPDVNT--FDITVYLLQ----GR---RLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CSCC--------CHHHHHT----TC---CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCH--HHHHHHHHc----CC---CCCCc-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 77653221 111111111 00 11111 12346899999999999999999999999998755
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=324.56 Aligned_cols=221 Identities=23% Similarity=0.307 Sum_probs=165.8
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++++|||||++++++.+++..|+||||+.++.+..........+++..++.++.||+.||+|||+.+ |+|
T Consensus 49 ~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiH 125 (298)
T d1gz8a_ 49 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLH 125 (298)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEc
Confidence 36999999999999999999999999999999999654444444455667999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC-CCchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~ 159 (304)
|||||+|||++.++.+||+|||+++....... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||
T Consensus 126 rDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf 203 (298)
T d1gz8a_ 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203 (298)
T ss_dssp SCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC
Confidence 99999999999999999999999987643322 233457899999999987655 588999999999999999999999
Q ss_pred CCCCCCCCcchhHhhhh-------hhcccccc---ccccCCccCCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 022003 160 DKNRPNGEHNLVEWARP-------HLGERRRF---YRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 226 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~-------~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 226 (304)
........ ....... .+...... ........... .....+.++.+||.+||+.||++|||++|++
T Consensus 204 ~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 204 PGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp CCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCHHHH--HHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 75432110 0000000 00000000 00000000000 0012246889999999999999999999999
Q ss_pred HH
Q 022003 227 EA 228 (304)
Q Consensus 227 ~~ 228 (304)
+|
T Consensus 282 ~H 283 (298)
T d1gz8a_ 282 AH 283 (298)
T ss_dssp TS
T ss_pred CC
Confidence 86
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=324.02 Aligned_cols=220 Identities=24% Similarity=0.296 Sum_probs=166.4
Q ss_pred hHhhHhhcC---CCCcccceeeEEEe-----CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDL---VHLNLVKLIGYCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l---~h~niv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|+++|+.| +||||+++++++.. ....+++|||+.++++..........+++..++.++.||+.||+|||++
T Consensus 56 ~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~ 135 (305)
T d1blxa_ 56 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 135 (305)
T ss_dssp HHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 588887766 79999999999864 3468999999988777666666667899999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 153 (304)
+ |+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 136 ~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell 209 (305)
T d1blxa_ 136 R---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 209 (305)
T ss_dssp T---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred C---EEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHH
Confidence 8 999999999999999999999999998864322 2334568999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhHhhhh-----hhc-----cccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 022003 154 TGRRSMDKNRPNGEHNLVEWARP-----HLG-----ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 223 (304)
Q Consensus 154 tg~~p~~~~~~~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 223 (304)
+|+.||................. .+. ....+.... ......+....++.+.+||.+||+.||++|||++
T Consensus 210 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~ 288 (305)
T d1blxa_ 210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS-AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288 (305)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCC-CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhcccc-ccchhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence 99999976532211110000000 000 000000000 0000111222356889999999999999999999
Q ss_pred HHHHH
Q 022003 224 EVVEA 228 (304)
Q Consensus 224 ell~~ 228 (304)
|+++|
T Consensus 289 e~L~H 293 (305)
T d1blxa_ 289 SALSH 293 (305)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-47 Score=319.96 Aligned_cols=195 Identities=24% Similarity=0.356 Sum_probs=162.1
Q ss_pred hHhhHhhcCC--CCcccceeeEEEeCCeeEEEEecCCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|+.+|++++ |||||++++++.+.+..++||||+.+ +++.+++.++ ..+++..++.++.||+.||+|||+.+ |
T Consensus 56 ~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---i 131 (273)
T d1xwsa_ 56 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---V 131 (273)
T ss_dssp HHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 6999999997 89999999999999999999999976 5787877554 47999999999999999999999998 9
Q ss_pred EeccCCCCCeEECC-CCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCC-CchhhhHHHHHHHHHHHhCC
Q 022003 79 IYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 79 iH~dlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~ 156 (304)
+||||||+|||++. ++.+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+
T Consensus 132 iHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~ 207 (273)
T d1xwsa_ 132 LHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207 (273)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred ccccCcccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCC
Confidence 99999999999985 479999999999875432 2334679999999999987765 67799999999999999999
Q ss_pred CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 157 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.||.... .... .. ..+.+ ..+.++.+||.+||+.||++|||++|++++
T Consensus 208 ~Pf~~~~--------~i~~----~~----~~~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 208 IPFEHDE--------EIIR----GQ----VFFRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CSCCSHH--------HHHH----CC----CCCSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCch--------HHhh----cc----cCCCC--------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 9996421 0000 00 00111 124689999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=322.52 Aligned_cols=212 Identities=25% Similarity=0.395 Sum_probs=173.6
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhh
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------SLPLPWSIRMKIALGAAKGLAFLH 71 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------~~~l~~~~~~~i~~qi~~~l~~LH 71 (304)
++|++++++++|||||++++++...+..++|||||.+|+|.+++... ...+++..+..++.|++.||.|||
T Consensus 71 ~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH 150 (308)
T d1p4oa_ 71 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN 150 (308)
T ss_dssp HHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 37999999999999999999999999999999999999999988532 235799999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHH
Q 022003 72 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 151 (304)
Q Consensus 72 ~~~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 151 (304)
+.+ |+||||||+||||+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++||
T Consensus 151 ~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~E 227 (308)
T d1p4oa_ 151 ANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 227 (308)
T ss_dssp HTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHH
Confidence 988 99999999999999999999999999987654444444455678999999999999999999999999999999
Q ss_pred HHhCC-CCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 152 MLTGR-RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 152 l~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
|+||. +||...... ....... .... +. .+...+..+.++|.+||+.||++|||+++|+++|+
T Consensus 228 l~t~~~~p~~~~~~~---~~~~~i~----~~~~------~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~ 290 (308)
T d1p4oa_ 228 IATLAEQPYQGLSNE---QVLRFVM----EGGL------LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290 (308)
T ss_dssp HHHTSCCTTTTSCHH---HHHHHHH----TTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred HHhCCCCCCCCCCHH---HHHHHHH----hCCC------CC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99985 666543211 1111110 1000 11 11123568999999999999999999999999997
Q ss_pred CC
Q 022003 231 PL 232 (304)
Q Consensus 231 ~~ 232 (304)
..
T Consensus 291 ~~ 292 (308)
T d1p4oa_ 291 EE 292 (308)
T ss_dssp GG
T ss_pred Hh
Confidence 64
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=317.01 Aligned_cols=227 Identities=24% Similarity=0.290 Sum_probs=166.2
Q ss_pred HhhHhhcCCCCcccceeeEEEeCC----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC----
Q 022003 3 EVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA---- 74 (304)
Q Consensus 3 E~~il~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---- 74 (304)
|+..+.+++|||||++++++.+.+ .+|+|||||++|+|.+++.+. .+++..++.++.|++.||+|||+..
T Consensus 47 ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~ 124 (303)
T d1vjya_ 47 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124 (303)
T ss_dssp HHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred HHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence 555667889999999999998754 579999999999999999764 5999999999999999999999741
Q ss_pred -CCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcce--eeecccccccccCcchhhcC------CCCchhhhHHH
Q 022003 75 -ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSF 145 (304)
Q Consensus 75 -~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Diwsl 145 (304)
.++|+||||||+||||+.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||
T Consensus 125 ~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp CBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred cCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence 1239999999999999999999999999998764433221 23346799999999998754 26779999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchhH----hhhhhhccccccccccCCccCCCC-CHHHHHHHHHHHHHhccCCCCCCC
Q 022003 146 GVVLLEMLTGRRSMDKNRPNGEHNLVE----WARPHLGERRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARP 220 (304)
Q Consensus 146 G~il~el~tg~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rp 220 (304)
||++|||+||..||............. ........ .......+|...... .......+.+|+.+||+.||++||
T Consensus 205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 283 (303)
T d1vjya_ 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK-VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH-HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC
T ss_pred HHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHH-HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCc
Confidence 999999999998875433222111000 00000000 000111222221111 224566799999999999999999
Q ss_pred CHHHHHHHhCCC
Q 022003 221 LMSEVVEALKPL 232 (304)
Q Consensus 221 s~~ell~~l~~~ 232 (304)
|+.||++.|+.+
T Consensus 284 s~~ei~~~L~~i 295 (303)
T d1vjya_ 284 TALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999988644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-45 Score=312.45 Aligned_cols=221 Identities=22% Similarity=0.272 Sum_probs=162.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+++|++++|||||++++++..++..+++|||+.++.+..+ .+....+++..++.++.||+.||+|||+.+ |+||
T Consensus 49 ~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHr 124 (286)
T d1ob3a_ 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124 (286)
T ss_dssp HHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHH-HTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHH-HhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEec
Confidence 799999999999999999999999999999999976555554 455568999999999999999999999988 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCCCCCC
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMD 160 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~ 160 (304)
||||+||||+.++.+||+|||++........ ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 125 DiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 125 DLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp CCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 9999999999999999999999987543222 23345689999999998754 57999999999999999999999997
Q ss_pred CCCCCCCcchhHhhh-----hhhcccccccc------ccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 161 KNRPNGEHNLVEWAR-----PHLGERRRFYR------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 161 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
.....+......... ..+........ ...+..........+.++.+||.+||+.||++|||++|+++|
T Consensus 203 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 543211100000000 00000000000 000000011111234688999999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=314.98 Aligned_cols=222 Identities=25% Similarity=0.288 Sum_probs=162.3
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeC------CeeEEEEecCCCCCHHHHh--hcCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLHE 72 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l--~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 72 (304)
.+|+++|++++|||||++++++... .+++||||||+++.+..+. ......+++..++.++.||+.||+|||+
T Consensus 61 ~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~ 140 (350)
T d1q5ka_ 61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140 (350)
T ss_dssp CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3699999999999999999998643 2478999999665333332 1345579999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEECCCC-cEEEccccCcccCCCCCcceeeecccccccccCcchhhc-CCCCchhhhHHHHHHHH
Q 022003 73 EAERPVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 73 ~~~~~iiH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ 150 (304)
++ |+||||||+|||++.++ .+||+|||+++....... .....||..|+|||++.+ ..|+.++|||||||++|
T Consensus 141 ~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~ 214 (350)
T d1q5ka_ 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214 (350)
T ss_dssp TT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred cC---CcccCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEE
Confidence 88 99999999999999775 899999999987654322 334578999999998875 57899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHh---------hhhhhcc--ccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEW---------ARPHLGE--RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~---------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 219 (304)
||++|..||......+....+.. ....... ...+................+.++.+||.+||+.||++|
T Consensus 215 el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 294 (350)
T d1q5ka_ 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294 (350)
T ss_dssp HHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred ehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHC
Confidence 99999999975432211100000 0000000 000011100011111122335789999999999999999
Q ss_pred CCHHHHHHH
Q 022003 220 PLMSEVVEA 228 (304)
Q Consensus 220 ps~~ell~~ 228 (304)
||+.|+++|
T Consensus 295 ~ta~e~L~H 303 (350)
T d1q5ka_ 295 LTPLEACAH 303 (350)
T ss_dssp CCHHHHHTS
T ss_pred cCHHHHhcC
Confidence 999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=308.01 Aligned_cols=216 Identities=24% Similarity=0.329 Sum_probs=164.4
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCC------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 74 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 74 (304)
++|+++|++++|||||+++++|...+ .+|+||||| +.+|..++... .+++..++.++.||+.||+|||+++
T Consensus 65 ~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ 141 (346)
T d1cm8a_ 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAG 141 (346)
T ss_dssp HHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCC
Confidence 37999999999999999999998655 579999999 77888877543 6999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHH
Q 022003 75 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEML 153 (304)
Q Consensus 75 ~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~ 153 (304)
|+||||||+|||++.++.+|++|||+++..... .....||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 142 ---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell 213 (346)
T d1cm8a_ 142 ---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 213 (346)
T ss_dssp ---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH
T ss_pred ---CcccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHH
Confidence 999999999999999999999999999876432 2345789999999998864 5789999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhHhhhhh--------h--cc----ccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 022003 154 TGRRSMDKNRPNGEHNLVEWARPH--------L--GE----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 219 (304)
Q Consensus 154 tg~~p~~~~~~~~~~~~~~~~~~~--------~--~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 219 (304)
+|..||.................. . .. ...+.+....... ......+.++.+||.+||+.||.+|
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R 292 (346)
T d1cm8a_ 214 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQR 292 (346)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHC
Confidence 999999765321110000000000 0 00 0000000000000 0111234688999999999999999
Q ss_pred CCHHHHHHH
Q 022003 220 PLMSEVVEA 228 (304)
Q Consensus 220 ps~~ell~~ 228 (304)
||++|+++|
T Consensus 293 ~ta~eiL~H 301 (346)
T d1cm8a_ 293 VTAGEALAH 301 (346)
T ss_dssp CCHHHHHHS
T ss_pred cCHHHHhcC
Confidence 999999996
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-43 Score=302.64 Aligned_cols=224 Identities=22% Similarity=0.279 Sum_probs=161.8
Q ss_pred hHhhHhhcCCCCcccceeeEEEe--------CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 73 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 73 (304)
+|+++|++++||||+++++++.. .+..|+|||||.++.+. .+......+++..++.++.||+.||.|||+.
T Consensus 58 ~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~ 136 (318)
T d3blha1 58 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136 (318)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccC
Confidence 79999999999999999999865 34689999999665554 4545566899999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcc--eeeecccccccccCcchhhcC-CCCchhhhHHHHHHHH
Q 022003 74 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLL 150 (304)
Q Consensus 74 ~~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ 150 (304)
+ |+||||||+|||++.++.+||+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||++|
T Consensus 137 ~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~ 213 (318)
T d3blha1 137 K---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 213 (318)
T ss_dssp T---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred C---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceee
Confidence 8 999999999999999999999999999876543221 122335799999999998754 6899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhhhccc-------cccccccCCccCCCCC-------HHHHHHHHHHHHHhccCCC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPHLGER-------RRFYRLIDPRLEGHFS-------IKGAQKAAQLAAHCLSRDP 216 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~dp 216 (304)
||++|+.||...................... ................ ...+.++.+||.+||+.||
T Consensus 214 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 293 (318)
T d3blha1 214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293 (318)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSST
T ss_pred eHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCCh
Confidence 9999999997543211111110000000000 0000000000000000 0114577899999999999
Q ss_pred CCCCCHHHHHHHh
Q 022003 217 KARPLMSEVVEAL 229 (304)
Q Consensus 217 ~~Rps~~ell~~l 229 (304)
++|||++|+++|-
T Consensus 294 ~~R~sa~elL~Hp 306 (318)
T d3blha1 294 AQRIDSDDALNHD 306 (318)
T ss_dssp TTSCCHHHHHHSG
T ss_pred hHCcCHHHHHcCh
Confidence 9999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-44 Score=307.30 Aligned_cols=209 Identities=27% Similarity=0.364 Sum_probs=168.7
Q ss_pred ChHhhHhhcCCC-CcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 022003 1 MAEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 79 (304)
Q Consensus 1 l~E~~il~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 79 (304)
++|+++|++++| |||+++++++.+....++||||+.+|+|.+++.... .+++..++.++.||+.||+|||+.+ |+
T Consensus 76 ~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~---iv 151 (322)
T d1vzoa_ 76 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---II 151 (322)
T ss_dssp CCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC---EE
Confidence 479999999977 899999999999999999999999999999986554 6789999999999999999999988 99
Q ss_pred eccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC--CCCchhhhHHHHHHHHHHHhCCC
Q 022003 80 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRR 157 (304)
Q Consensus 80 H~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~ 157 (304)
||||||+|||++.+|.+||+|||+++........ ......|++.|+|||.+.+. .++.++|||||||++|+|++|..
T Consensus 152 HrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~ 230 (322)
T d1vzoa_ 152 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230 (322)
T ss_dssp CCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred eccCCccceeecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876443222 23446789999999999754 47889999999999999999999
Q ss_pred CCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 022003 158 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 228 (304)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~~ 228 (304)
||............. ...... .+. .+...+.++.+||.+||+.||++||| ++|+++|
T Consensus 231 PF~~~~~~~~~~~i~--~~~~~~--------~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 231 PFTVDGEKNSQAEIS--RRILKS--------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp TTSCTTSCCCHHHHH--HHHHHC--------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCCCHHHHHHHHH--HhcccC--------CCC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 997765443322111 111110 011 12233578999999999999999994 7888864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=305.57 Aligned_cols=223 Identities=22% Similarity=0.284 Sum_probs=162.0
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCC----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
++|+++|++|+||||+++++++.... ..+++++++.+|+|.+++..+ .+++..++.++.||+.||+|||+++
T Consensus 54 ~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~-- 129 (345)
T d1pmea_ 54 LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN-- 129 (345)
T ss_dssp HHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 47999999999999999999987653 223444555689999999654 5999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCc-ceeeecccccccccCcchhh-cCCCCchhhhHHHHHHHHHHHh
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLT 154 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~t 154 (304)
|+||||||+||||+.++.+||+|||+++....... .......+||+.|+|||++. +..++.++||||+||++|+|++
T Consensus 130 -iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~ 208 (345)
T d1pmea_ 130 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 208 (345)
T ss_dssp -EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred -CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhh
Confidence 99999999999999999999999999987543222 12233467899999999985 5578999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhHhhhhhhcc----------ccccccccCCccCC---CCCHHHHHHHHHHHHHhccCCCCCCCC
Q 022003 155 GRRSMDKNRPNGEHNLVEWARPHLGE----------RRRFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPL 221 (304)
Q Consensus 155 g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps 221 (304)
|..||......+.............. .............. ......+.++.+||.+||+.||++|||
T Consensus 209 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 288 (345)
T d1pmea_ 209 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 288 (345)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC
Confidence 99999754321111000000000000 00000000000000 000112357899999999999999999
Q ss_pred HHHHHHH
Q 022003 222 MSEVVEA 228 (304)
Q Consensus 222 ~~ell~~ 228 (304)
++|++++
T Consensus 289 a~e~L~h 295 (345)
T d1pmea_ 289 VEQALAH 295 (345)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-43 Score=300.40 Aligned_cols=215 Identities=19% Similarity=0.184 Sum_probs=164.4
Q ss_pred hHhhHhhcCCCCccc-ceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|++++++++|+|++ .+.+++..++..++||||+ +++|.+.+......+++..+..++.|++.||+|||+++ |+|
T Consensus 51 ~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH 126 (299)
T d1ckia_ 51 IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIH 126 (299)
T ss_dssp HHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 599999999877655 5556667788899999999 67888887777778999999999999999999999999 999
Q ss_pred ccCCCCCeEECC---CCcEEEccccCcccCCCCCcc-----eeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHH
Q 022003 81 RDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 152 (304)
Q Consensus 81 ~dlkp~Nili~~---~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 152 (304)
|||||+|||++. +..+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 127 rDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el 206 (299)
T d1ckia_ 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206 (299)
T ss_dssp SCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHH
T ss_pred ccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHH
Confidence 999999999864 457999999999986543321 123346799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhHhh-hhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhCC
Q 022003 153 LTGRRSMDKNRPNGEHNLVEWA-RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 231 (304)
Q Consensus 153 ~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~~ 231 (304)
++|..||............... ...... .. +.... ..+.++.++|.+||+.||++||+++++.+.|+.
T Consensus 207 ~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~-----~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 207 NLGSLPWQGLKAATKRQKYERISEKKMST--PI-----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HHSSCTTCCCC-------HHHHHHHHHHS--CH-----HHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred HhCCCcccccchHHHHHHHHHhhcccCCC--Ch-----hHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 9999999876544332221111 100000 00 00011 124688999999999999999999988877653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.5e-43 Score=303.57 Aligned_cols=217 Identities=18% Similarity=0.231 Sum_probs=162.3
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 78 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 78 (304)
+|+++|++++ ||||+++++++... ...++|||||.+++|..+. ..+++..++.++.||+.||+|||+++ |
T Consensus 78 ~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---I 150 (328)
T d3bqca1 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---I 150 (328)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---c
Confidence 6999999995 99999999999854 5689999999999987754 35999999999999999999999999 9
Q ss_pred EeccCCCCCeEECCCC-cEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhCC
Q 022003 79 IYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 156 (304)
Q Consensus 79 iH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~ 156 (304)
+||||||+||||+.++ .+||+|||+++....... .....||..|+|||++.+. .++.++||||+||++|+|++|.
T Consensus 151 vHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~ 227 (328)
T d3bqca1 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227 (328)
T ss_dssp ECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred ccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCC
Confidence 9999999999998654 699999999987654322 3345789999999998765 5799999999999999999999
Q ss_pred CCCCCCCCCCCcchhH-----------hhh-hhhccccccccccCC--------ccCCCCCHHHHHHHHHHHHHhccCCC
Q 022003 157 RSMDKNRPNGEHNLVE-----------WAR-PHLGERRRFYRLIDP--------RLEGHFSIKGAQKAAQLAAHCLSRDP 216 (304)
Q Consensus 157 ~p~~~~~~~~~~~~~~-----------~~~-~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp 216 (304)
.||............. +.. ........+...... ..........+.++.+||.+||+.||
T Consensus 228 ~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 307 (328)
T d3bqca1 228 EPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 307 (328)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSG
T ss_pred CCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCCh
Confidence 9997654321100000 000 000000000000000 00000111235688999999999999
Q ss_pred CCCCCHHHHHHH
Q 022003 217 KARPLMSEVVEA 228 (304)
Q Consensus 217 ~~Rps~~ell~~ 228 (304)
++|||++|+++|
T Consensus 308 ~~R~ta~e~L~H 319 (328)
T d3bqca1 308 QSRLTAREAMEH 319 (328)
T ss_dssp GGSCCHHHHHTS
T ss_pred hHCcCHHHHhcC
Confidence 999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=296.83 Aligned_cols=220 Identities=21% Similarity=0.253 Sum_probs=167.6
Q ss_pred ChHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 1 MAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 1 l~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
++|+++|++++||||+++++++.+....++||+++.+++|..++. ....+++..++.++.|++.||+|||+++ |+|
T Consensus 49 ~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvH 124 (292)
T d1unla_ 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLH 124 (292)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCC---Eee
Confidence 379999999999999999999999999999999998888887764 4457999999999999999999999998 999
Q ss_pred ccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCC-CCchhhhHHHHHHHHHHHhCCCCC
Q 022003 81 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSM 159 (304)
Q Consensus 81 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~ 159 (304)
|||||+||||+.++.+||+|||.++....... ......++..|+|||++.+.. ++.++|||||||++|||++|+.||
T Consensus 125 rDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 202 (292)
T d1unla_ 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred ecccCcccccccCCceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence 99999999999999999999999988654332 223345688899999987654 699999999999999999999997
Q ss_pred CCCCCCCCcchhHhhhhhhcc--------ccccc------cccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 022003 160 DKNRPNGEHNLVEWARPHLGE--------RRRFY------RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 225 (304)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 225 (304)
....... ............ ..... ...............+..+.+||.+||+.||++|||++|+
T Consensus 203 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~ 280 (292)
T d1unla_ 203 FPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp CCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCHH--HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 5432211 111100000000 00000 0000001111222335688999999999999999999999
Q ss_pred HHH
Q 022003 226 VEA 228 (304)
Q Consensus 226 l~~ 228 (304)
++|
T Consensus 281 L~H 283 (292)
T d1unla_ 281 LQH 283 (292)
T ss_dssp TTS
T ss_pred hcC
Confidence 985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-41 Score=290.41 Aligned_cols=216 Identities=16% Similarity=0.138 Sum_probs=171.8
Q ss_pred hHhhHhhcCCC-CcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 022003 2 AEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 80 (304)
Q Consensus 2 ~E~~il~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 80 (304)
+|+++++.|+| +|++.+++++..+...++||||+ +++|.+++......+++..+..++.|++.||+|||+.+ |+|
T Consensus 49 ~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiH 124 (293)
T d1csna_ 49 DEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVY 124 (293)
T ss_dssp HHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EEC
T ss_pred HHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 58999999976 89999999999999999999999 78999999877778999999999999999999999999 999
Q ss_pred ccCCCCCeEECC-----CCcEEEccccCcccCCCCCcc-----eeeecccccccccCcchhhcCCCCchhhhHHHHHHHH
Q 022003 81 RDFKTSNILLDA-----DYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 150 (304)
Q Consensus 81 ~dlkp~Nili~~-----~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 150 (304)
|||||+||||+. ++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|
T Consensus 125 rDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ 204 (293)
T d1csna_ 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFM 204 (293)
T ss_dssp CCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHH
Confidence 999999999964 578999999999876543221 1233467999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhC
Q 022003 151 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 230 (304)
Q Consensus 151 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~l~ 230 (304)
||++|..||.................. .......+ +. . ..++++.+++..|+..+|++||+++.+.+.|+
T Consensus 205 elltg~~Pf~~~~~~~~~~~~~~i~~~-~~~~~~~~-l~----~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 205 YFLRGSLPWQGLKAATNKQKYERIGEK-KQSTPLRE-LC----A----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp HHHHSSCTTSSCCSCCHHHHHHHHHHH-HHHSCHHH-HT----T----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHHhCCCcCCCccchhHHHHHHHHHhc-cCCCChHH-hc----C----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 999999999765443322211111100 00000001 11 1 12467899999999999999999988887665
Q ss_pred C
Q 022003 231 P 231 (304)
Q Consensus 231 ~ 231 (304)
.
T Consensus 275 ~ 275 (293)
T d1csna_ 275 K 275 (293)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=302.41 Aligned_cols=218 Identities=23% Similarity=0.294 Sum_probs=156.4
Q ss_pred hHhhHhhcCCCCcccceeeEEEe------CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 75 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 75 (304)
+|+.+|++++|||||++++++.. .+.+|+|||||.+ ++.+.+. ..+++..++.++.||+.||.|||+.|
T Consensus 65 ~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g- 139 (355)
T d2b1pa1 65 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG- 139 (355)
T ss_dssp HHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc-
Confidence 69999999999999999999964 3678999999965 4555443 35899999999999999999999999
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHHHHHHhC
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 155 (304)
|+||||||+|||++.++.+|++|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus 140 --iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g 214 (355)
T d2b1pa1 140 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214 (355)
T ss_dssp --CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred --cccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhC
Confidence 9999999999999999999999999988754432 23445789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhH---------hhh-------hhhccc-----cccccccCCccC---CCCCHHHHHHHHHHHHHh
Q 022003 156 RRSMDKNRPNGEHNLVE---------WAR-------PHLGER-----RRFYRLIDPRLE---GHFSIKGAQKAAQLAAHC 211 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~---------~~~-------~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~ 211 (304)
+.||............. +.. ...... ............ .......+.++.+||.+|
T Consensus 215 ~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~m 294 (355)
T d2b1pa1 215 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294 (355)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHH
Confidence 99997543211100000 000 000000 000000100000 111234577899999999
Q ss_pred ccCCCCCCCCHHHHHHHh
Q 022003 212 LSRDPKARPLMSEVVEAL 229 (304)
Q Consensus 212 l~~dp~~Rps~~ell~~l 229 (304)
|+.||++|||++|+++|-
T Consensus 295 L~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 295 LVIDPAKRISVDDALQHP 312 (355)
T ss_dssp SCSSTTTSCCHHHHHTST
T ss_pred CcCChhHCcCHHHHhcCc
Confidence 999999999999999863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=295.21 Aligned_cols=218 Identities=22% Similarity=0.307 Sum_probs=157.7
Q ss_pred hHhhHhhcCCCCcccceeeEEEeC-----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 76 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 76 (304)
+|+++|++++|||||++++++... ...++||+|+.||+|.+++..+ .+++..++.++.||+.||+|||+++
T Consensus 66 ~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~g-- 141 (348)
T d2gfsa1 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD-- 141 (348)
T ss_dssp HHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 799999999999999999998643 3446667777799999998543 6999999999999999999999998
Q ss_pred CeEeccCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcC-CCCchhhhHHHHHHHHHHHhC
Q 022003 77 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 155 (304)
Q Consensus 77 ~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg 155 (304)
|+||||||+|||++.++.+|++|||++..... ......||..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 142 -iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g 215 (348)
T d2gfsa1 142 -IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215 (348)
T ss_dssp -CCCCCCCGGGEEECTTCCEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred -CcccccCCccccccccccccccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhC
Confidence 99999999999999999999999999976432 23345789999999987765 568999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHhhhhhhcc----------ccccccccCCccCCC---CCHHHHHHHHHHHHHhccCCCCCCCCH
Q 022003 156 RRSMDKNRPNGEHNLVEWARPHLGE----------RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLM 222 (304)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~ 222 (304)
..||...........+......... ...+........... .....+.++.+||.+||+.||++|||+
T Consensus 216 ~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta 295 (348)
T d2gfsa1 216 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295 (348)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH
Confidence 9999754322111100000000000 000000000000000 001124678999999999999999999
Q ss_pred HHHHHHh
Q 022003 223 SEVVEAL 229 (304)
Q Consensus 223 ~ell~~l 229 (304)
+|+++|-
T Consensus 296 ~elL~Hp 302 (348)
T d2gfsa1 296 AQALAHA 302 (348)
T ss_dssp HHHHTSG
T ss_pred HHHhcCH
Confidence 9999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-36 Score=267.40 Aligned_cols=219 Identities=21% Similarity=0.258 Sum_probs=154.1
Q ss_pred hHhhHhhcCC-----------CCcccceeeEEEeC--CeeEEEEecCCCCCH--HHHhhcCCCCCCHHHHHHHHHHHHHH
Q 022003 2 AEVNFLGDLV-----------HLNLVKLIGYCIED--DQRLLVYEFMPRGSL--ENHLFRRSLPLPWSIRMKIALGAAKG 66 (304)
Q Consensus 2 ~E~~il~~l~-----------h~niv~~~~~~~~~--~~~~lv~e~~~~~sL--~~~l~~~~~~l~~~~~~~i~~qi~~~ 66 (304)
+|+++++.++ |+||+++++++... ...+++|+++..+.. ..........+++..++.++.||+.|
T Consensus 58 ~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~a 137 (362)
T d1q8ya_ 58 DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137 (362)
T ss_dssp HHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHH
Confidence 5888888775 57899999988653 455666666544432 22233445679999999999999999
Q ss_pred HHHhhc-CCCCCeEeccCCCCCeEECCCC------cEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCch
Q 022003 67 LAFLHE-EAERPVIYRDFKTSNILLDADY------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 139 (304)
Q Consensus 67 l~~LH~-~~~~~iiH~dlkp~Nili~~~~------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 139 (304)
|+|||+ .+ |+||||||+||||+.++ .++++|||.+...... .....||+.|+|||++.+..++.+
T Consensus 138 l~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~ 209 (362)
T d1q8ya_ 138 LDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCG 209 (362)
T ss_dssp HHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTH
T ss_pred HHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCcc
Confidence 999997 77 99999999999997665 4999999999865332 234678999999999999999999
Q ss_pred hhhHHHHHHHHHHHhCCCCCCCCCCCCCcchhHhhhh---hhcc--------c---------cccccccCC---------
Q 022003 140 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP---HLGE--------R---------RRFYRLIDP--------- 190 (304)
Q Consensus 140 ~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~--------~---------~~~~~~~~~--------- 190 (304)
+||||+||++++|++|+.||................. .+.. . ......+..
T Consensus 210 ~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (362)
T d1q8ya_ 210 ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289 (362)
T ss_dssp HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHH
T ss_pred ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhh
Confidence 9999999999999999999976543222111110000 0000 0 000000000
Q ss_pred -ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 022003 191 -RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 228 (304)
Q Consensus 191 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 228 (304)
..........+.++.+||.+||+.||.+|||++|+++|
T Consensus 290 ~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00112345678899999999999999999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.77 E-value=4.3e-20 Score=146.52 Aligned_cols=127 Identities=13% Similarity=0.110 Sum_probs=90.9
Q ss_pred hHhhHhhcCCCCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 022003 2 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 81 (304)
Q Consensus 2 ~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 81 (304)
+|+..+.++.|.+++..+++. ..++||||+++..+.+ ++...+..++.|++.+|+|||+.+ |+||
T Consensus 63 ~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHr 127 (191)
T d1zara2 63 NEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHG 127 (191)
T ss_dssp HHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHHccCCCcceEEEec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEc
Confidence 477889999999999888753 2379999998765543 344556789999999999999998 9999
Q ss_pred cCCCCCeEECCCCcEEEccccCcccCCCCCcceeeecccccccccCcchhhcCCCCchhhhHHHHHHH
Q 022003 82 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 149 (304)
Q Consensus 82 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 149 (304)
||||+|||++++ .++|+|||+|.............+.+.. -.+ +....|+.++|+||+.--+
T Consensus 128 DiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 128 DLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred cCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence 999999999865 5899999999775432211100000000 001 2246788999999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.19 E-value=2e-06 Score=69.61 Aligned_cols=99 Identities=17% Similarity=0.084 Sum_probs=66.5
Q ss_pred hHhhHhhcCC-CCcccceeeEEEeCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC------
Q 022003 2 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------ 74 (304)
Q Consensus 2 ~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------ 74 (304)
+|+..+..|. +--+.++++++..++..++||++++|..+....... .....++.+++..+..||+..
T Consensus 58 ~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~ 131 (263)
T d1j7la_ 58 REKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPY 131 (263)
T ss_dssp HHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSC
T ss_pred HHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCcccccc
Confidence 4777777663 333568888888888999999999998876654211 111223444444444454321
Q ss_pred --------------------------------------------------CCCeEeccCCCCCeEECCCCcEEEccccCc
Q 022003 75 --------------------------------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLA 104 (304)
Q Consensus 75 --------------------------------------------------~~~iiH~dlkp~Nili~~~~~~kl~Dfg~a 104 (304)
...++|+|+.+.||++++++..-|+||+.+
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a 211 (263)
T d1j7la_ 132 TNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp BCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred CcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence 011789999999999988766679999877
Q ss_pred cc
Q 022003 105 KD 106 (304)
Q Consensus 105 ~~ 106 (304)
..
T Consensus 212 ~~ 213 (263)
T d1j7la_ 212 GR 213 (263)
T ss_dssp EE
T ss_pred cc
Confidence 53
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=1.7e-05 Score=63.49 Aligned_cols=40 Identities=18% Similarity=0.160 Sum_probs=30.0
Q ss_pred hHhhHhhcCCC--CcccceeeEEEeCCeeEEEEecCCCCCHH
Q 022003 2 AEVNFLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLE 41 (304)
Q Consensus 2 ~E~~il~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 41 (304)
+|++.|+.|.. -.+.+++.+..+++..++||++++|.++.
T Consensus 53 ~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 53 DEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp HHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred HHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 47778877743 23567788888888899999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.82 E-value=0.0013 Score=55.91 Aligned_cols=28 Identities=25% Similarity=0.227 Sum_probs=24.8
Q ss_pred eEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 78 VIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 78 iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
++|+|+++.|||+++++ ++|+||..+..
T Consensus 225 LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 225 LIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred eeccCCcCCceeEcCCc-eEEechhhccc
Confidence 89999999999998764 89999988764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.33 E-value=0.00066 Score=57.88 Aligned_cols=35 Identities=29% Similarity=0.270 Sum_probs=23.9
Q ss_pred hHhhHhhcCCCCccc-ceeeEEEeCCeeEEEEecCCCCCH
Q 022003 2 AEVNFLGDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSL 40 (304)
Q Consensus 2 ~E~~il~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~sL 40 (304)
+|.++++.+.-.+++ ++++++. + .+||||++|..|
T Consensus 93 ~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~efi~g~~l 128 (395)
T d1nw1a_ 93 AESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCEEEC
T ss_pred HHHHHHHHHHhCCCCCeEEEEcC--C--ceEEEEeccccC
Confidence 588888888544554 7777653 2 678999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.59 E-value=0.0042 Score=50.78 Aligned_cols=31 Identities=29% Similarity=0.285 Sum_probs=27.0
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
.++||+|+.++||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4499999999999999887778999998753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.85 E-value=0.057 Score=44.00 Aligned_cols=29 Identities=21% Similarity=0.225 Sum_probs=23.5
Q ss_pred CCeEeccCCCCCeEECCCCcEEEccccCccc
Q 022003 76 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 106 (304)
Q Consensus 76 ~~iiH~dlkp~Nili~~~~~~kl~Dfg~a~~ 106 (304)
..+||+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 448999999999999743 45789998764
|